data_2ee5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ee5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.861 0.276 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 tp -51.1 -42.6 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.25 -31.78 22.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -85.51 -44.63 12.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.84 -46.84 84.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.7 m -88.05 171.54 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 p -124.15 165.64 17.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.37 65.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.49 -47.82 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -126.82 91.74 46.38 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.6 0.714 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -30.53 21.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.686 2.257 . . . . 0.0 112.329 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.7 mt -84.3 135.22 41.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.63 0.729 . . . . 0.0 111.129 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 130.32 19.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 40' ' ' PHE . 5.4 tp -52.2 -53.19 46.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' LEU . 16.8 t80 -36.27 -56.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.465 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 53.0 t -54.45 -62.63 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -47.68 -59.74 3.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -44.43 -36.59 2.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.3 m -75.24 -38.38 60.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -72.9 -60.12 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -54.02 -32.9 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -63.28 -57.67 9.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.9 mt -50.35 -53.54 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.42 -45.04 85.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.58 -41.23 97.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.7 p -89.05 23.35 2.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.65 135.43 4.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.474 HD12 ' CE1' ' A' ' 154' ' ' HIS . 15.1 tp -103.72 35.48 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.1 p -121.63 40.34 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 56' ' ' GLU . 18.4 m -92.28 112.31 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.7 tt0 -34.76 120.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.14 77.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.504 HD12 ' CE2' ' A' ' 59' ' ' TYR . 1.6 pt? -61.25 -29.05 69.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' CE2' HD12 ' A' ' 58' ' ' LEU . 39.2 m-85 -108.41 -49.62 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -49.63 -49.78 45.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.9 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.809 0.337 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -51.0 -45.74 61.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -65.11 -35.03 79.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.93 -58.4 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.0 p30 -64.35 -36.05 82.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.456 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 57.4 mt -54.3 -47.35 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -78.25 -40.08 38.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -64.7 -67.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -44.99 -45.65 10.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.87 -34.92 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.9 -52.04 48.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.57 -21.56 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -145.47 113.82 6.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -84.6 -3.23 58.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -101.91 23.53 11.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.458 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 6.0 tt -68.97 156.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.458 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 6.6 t30 -125.94 91.63 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASN . 84.3 mt -36.94 -48.06 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -51.47 -48.71 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -54.39 -39.57 67.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.8 mmm -66.97 -32.44 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 56.94 47.22 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -81.45 179.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.2 t -87.55 127.42 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.9 t -40.19 -47.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -48.31 -40.47 25.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.76 -61.99 2.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.6 -38.28 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' LEU . . . -57.75 -50.09 74.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.19 -49.81 64.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.21 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 41' ' ' VAL . 34.2 tp -58.86 -46.56 87.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' ALA . 30.0 mtmt -67.24 -52.01 46.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.45 -45.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -53.45 -53.42 51.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -58.15 -33.61 69.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -28.58 64.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LEU . 1.9 t70 -75.22 -31.57 60.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' ASP . 67.2 mt -35.72 143.51 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.743 2.295 . . . . 0.0 112.283 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -139.05 154.28 72.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.639 0.733 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.6 Cg_endo -69.82 130.09 18.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.309 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 107' ' ' PRO . 12.0 tp -35.73 -51.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -91.95 126.33 53.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.669 0.747 . . . . 0.0 111.155 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.431 ' CG ' HD11 ' A' ' 113' ' ' LEU . 53.2 Cg_endo -69.81 161.49 45.75 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -78.95 -11.49 60.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.9 t -88.67 5.45 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.431 HD11 ' CG ' ' A' ' 110' ' ' PRO . 80.0 mt -133.96 19.85 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.488 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.2 m170 -71.09 -60.11 3.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.56 0.695 . . . . 0.0 110.855 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.76 -27.13 26.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.363 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.79 -32.14 72.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -77.27 -34.38 55.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' A' ' 197' ' ' HIS . 9.6 mt -78.95 -44.04 23.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.2 -23.66 62.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.64 -9.48 29.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.446 ' CB ' HG21 ' A' ' 200' ' ' VAL . . . -95.18 -28.79 14.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -80.98 -3.44 51.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.462 ' CG2' ' HD2' ' A' ' 124' ' ' PRO . 67.4 mt -56.37 138.29 75.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.84 -50.71 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.649 2.232 . . . . 0.0 112.324 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.99 107.36 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -46.32 -52.21 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.471 HG22 ' CD2' ' A' ' 131' ' ' HIS . 25.6 m -55.09 -61.39 2.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.29 -45.87 17.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -50.18 -42.58 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.404 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 43.7 mt -70.75 -42.34 70.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.471 ' CD2' HG22 ' A' ' 127' ' ' THR . 12.0 m170 -60.66 -54.52 44.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.88 62.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.68 -24.89 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -78.26 -30.06 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.7 -31.48 18.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -38.11 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.089 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.23 -8.69 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -76.06 -28.85 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -73.04 -19.32 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -53.53 137.54 36.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.8 t-80 -38.69 141.58 0.57 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 110.896 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.77 -8.81 24.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 0.0 112.374 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.3 t -99.12 -42.25 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -85.56 -29.85 23.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -52.41 -48.79 65.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.32 -50.96 69.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.46 -59.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 152' ' ' ILE . 13.5 t80 -40.4 -40.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -69.74 -48.19 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.18 -48.91 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.54 -64.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 148' ' ' PHE . 92.0 mt -48.52 -49.21 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.0 m -40.45 -34.87 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.474 ' CE1' HD12 ' A' ' 53' ' ' LEU . 40.2 t60 -80.1 -45.95 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 59.1 mt -49.58 -49.17 47.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -48.26 -41.09 26.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.434 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 98.7 mtt180 -64.34 -36.81 85.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.5 t -68.47 -42.48 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.6 p -62.64 -30.74 71.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -60.84 -50.32 73.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -98.01 38.96 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.562 ' CE1' ' HD2' ' A' ' 163' ' ' LYS . 2.1 p80 -56.04 -31.65 63.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.562 ' HD2' ' CE1' ' A' ' 162' ' ' HIS . 12.5 mptt -53.74 -22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.6 mt -100.65 -58.69 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -80.08 11.57 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 162' ' ' HIS . 6.6 mt 34.71 46.35 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.9 mmm -142.58 120.93 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.6 p -105.47 177.32 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.03 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -46.55 66.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -59.58 -46.97 87.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.62 -41.22 98.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.6 p -58.75 -28.52 65.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.2 mt -86.81 -42.25 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.31 -16.93 57.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.403 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 14.3 m-85 -107.95 -7.13 16.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.576 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.2 t90 -51.68 -45.45 91.55 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.939 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -48.0 -65.44 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 180' ' ' LEU . 8.4 m -61.17 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 179' ' ' THR . 86.9 mt -34.35 -44.61 0.2 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 3.9 mtt -146.91 119.9 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.841 -179.923 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 30.7 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.857 0.36 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.489 ' CG ' HD22 ' A' ' 118' ' ' LEU . 16.6 m-70 -47.8 -66.42 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 197' ' ' HIS . 0.6 OUTLIER -37.42 -48.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.4 t -55.26 -48.19 74.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.851 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.446 HG21 ' CB ' ' A' ' 121' ' ' ALA . 23.1 t -45.49 -69.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.82 -61.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -44.0 -47.55 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 204' ' ' PHE . 70.7 m -54.16 -62.71 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' CYS . 14.1 m-85 -34.66 -52.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 61.1 mt -60.6 -59.97 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -45.88 -48.92 15.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' A' ' 207' ' ' GLN . 8.8 mm-40 -106.2 31.4 5.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.55 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 6.4 t -67.26 -21.15 65.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.48 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 74.4 mm-40 -87.07 -54.3 4.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.92 -36.55 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -49.53 -62.92 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -106.75 -54.36 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.48 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 65.4 m-85 -55.46 -30.88 61.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 70.85 27.83 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -68.51 137.48 30.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.5 mt-10 -37.9 154.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.06 112.57 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.82 173.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.841 0.267 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.5 tp -53.06 -39.79 63.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -55.21 -29.4 57.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.17 -40.85 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.55 -44.04 88.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 m -81.42 173.45 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 p -111.75 143.71 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.63 3.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.22 -43.47 98.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -131.68 106.17 14.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.54 0.686 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -35.44 12.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.623 2.215 . . . . 0.0 112.347 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.84 130.03 79.7 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.723 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.77 68.41 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.448 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.87 -47.97 78.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -45.34 -63.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.0 t -48.45 -53.77 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 150' ' ' TYR . 15.3 mm-40 -48.95 -55.84 10.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 50.6 mmtt -50.51 -41.16 53.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.8 m -63.56 -43.55 96.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 150' ' ' TYR . 44.4 t -66.64 -61.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 47' ' ' PHE . 10.6 pt-20 -53.11 -47.51 68.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.414 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 60.4 t80 -48.26 -64.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mt -38.55 -62.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -45.9 -47.83 16.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -56.46 -47.21 79.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -84.76 29.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.12 141.26 6.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -106.49 -14.32 15.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.7 p -84.48 34.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 56' ' ' GLU . 36.7 m -68.73 157.05 37.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 55' ' ' THR . 1.8 mp0 -100.89 147.86 25.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 60' ' ' ARG . . . 48.01 75.87 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.48 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.413 ' CD2' ' HB ' ' A' ' 55' ' ' THR . 4.5 mm? -95.0 122.79 38.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 63.32 26.49 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 57' ' ' GLY . 7.0 ptm180 -127.24 -10.16 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.2 -46.17 79.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -70.19 -28.68 65.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.944 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.02 -60.96 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.1 p30 -53.92 -36.77 63.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.459 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 50.2 mt -53.39 -56.6 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.55 -52.44 38.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -53.16 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -68.32 -29.79 68.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -68.66 -49.43 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -63.99 -33.0 74.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -158.67 156.07 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -105.71 -15.4 14.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -80.75 45.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.2 pt -106.0 177.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -142.48 130.04 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.71 -42.44 21.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.82 -44.12 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.7 t -64.95 -28.86 69.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.8 mmm -70.6 -33.61 71.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 62.35 34.59 15.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.82 156.66 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 p -67.66 146.88 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.3 t -53.22 -49.46 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -42.99 -49.94 5.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.4 -62.86 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.5 t -53.79 -50.23 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.137 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.12 59.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.71 -49.29 7.26 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.0 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.71 -45.08 77.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 99' ' ' ALA . 20.9 mtmt -64.08 -53.43 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.01 -44.29 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -54.65 -54.03 46.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -57.07 -39.19 74.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.39 -35.79 82.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 104' ' ' LEU . 9.6 t0 -59.85 -40.45 88.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.9 mt -36.86 143.06 0.34 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.62 154.29 79.49 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.709 . . . . 0.0 110.851 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 108' ' ' LEU . 54.0 Cg_endo -69.78 131.14 20.59 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.37 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 107' ' ' PRO . 26.1 tp -35.73 -38.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -103.12 125.58 34.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 157.08 61.69 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.737 2.291 . . . . 0.0 112.327 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -76.02 -22.1 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.6 m -72.3 -7.18 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -130.27 28.83 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.479 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 2.9 m170 -74.57 -61.97 1.04 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.859 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.6 Cg_endo -69.74 -23.36 30.98 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -67.55 -32.17 72.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.22 -33.53 69.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 121' ' ' ALA . 6.3 mt -81.67 -55.64 4.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.77 -32.62 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.26 -26.8 23.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -79.46 -23.63 42.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -83.03 1.17 41.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.56 129.27 90.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.638 0.733 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -47.05 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.343 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.7 m-20 -61.6 97.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -34.45 -50.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.4 m -55.68 -57.76 10.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -54.87 -44.8 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.83 -54.23 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.7 mt -68.93 -62.21 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -38.68 -43.28 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.41 79.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.31 -23.44 65.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -78.54 -32.64 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -85.34 -34.4 21.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.55 -39.86 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.4 p -62.57 -8.74 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -76.83 -30.35 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.85 -22.98 61.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 141' ' ' HIS . 5.6 m-85 -51.45 133.4 29.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 1.2 t-80 -35.03 141.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.526 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.2 Cg_endo -69.84 -13.12 34.05 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.715 2.276 . . . . 0.0 112.301 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.2 t -95.0 -37.09 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -87.32 -38.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -45.06 -44.94 10.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -61.27 -56.27 22.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.07 -54.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -49.03 -45.52 42.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 149' ' ' ARG . 7.5 mtp-105 -64.2 -49.08 73.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.565 ' CE2' ' OE2' ' A' ' 42' ' ' GLU . 39.1 t80 -52.59 -45.29 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.923 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.03 -57.36 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.135 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.46 ' CG2' ' HA ' ' A' ' 205' ' ' ILE . 70.3 mt -49.66 -48.97 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -47.54 -39.87 17.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -77.57 -31.24 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.03 -45.95 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -54.72 -38.63 67.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.45 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 84.2 mtt180 -65.59 -37.02 85.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.91 -43.25 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.6 p -60.8 -40.08 91.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 34.9 mt-30 -48.13 -37.7 16.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -105.06 32.83 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 166' ' ' LEU . 12.4 p80 -51.19 -38.73 53.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -57.44 -32.49 66.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 52.7 mt -87.81 -58.26 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 55' ' ' THR . 10.6 m-20 -76.08 4.07 9.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 162' ' ' HIS . 13.5 mt 46.15 42.67 10.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 31.2 mmm -144.37 122.59 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.6 p -100.63 156.89 17.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.69 -37.64 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.31 -47.47 64.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -58.49 -38.4 77.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.57 -48.07 61.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.2 p -51.92 -48.76 64.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.0 mt -62.01 -39.4 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.59 -17.07 53.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.424 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 33.0 m-85 -109.43 -10.57 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.571 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -48.76 -46.47 72.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.54 0.686 . . . . 0.0 110.9 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.91 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 180' ' ' LEU . 16.5 m -61.08 -64.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 179' ' ' THR . 59.5 mt -36.96 -62.31 0.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 86.0 mtp -117.1 81.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.613 0.72 . . . . 0.0 110.839 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.419 ' CD2' HD22 ' A' ' 118' ' ' LEU . 65.5 m80 -50.78 -72.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -47.85 -51.15 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.6 t -46.12 -42.22 13.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 89.2 t -41.09 -70.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 202' ' ' GLU . 84.2 t -54.86 -59.66 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 201' ' ' VAL . 15.9 tt0 -35.85 -51.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 53.0 m -54.03 -57.9 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -40.09 -34.37 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.46 ' HA ' ' CG2' ' A' ' 152' ' ' ILE . 66.9 mt -75.32 -59.84 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -53.93 -53.43 52.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.63 18.91 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 19.3 t -60.6 -12.01 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 213' ' ' TYR . 14.9 mm-40 -95.96 -57.2 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -40.59 -38.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -49.63 -61.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -107.86 -53.96 2.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 209' ' ' GLN . 53.2 m-85 -58.06 -28.59 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 64.64 42.83 4.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.68 51.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -63.9 134.9 56.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.25 131.73 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.18 163.92 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.847 0.269 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 tp -55.41 -46.0 76.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -48.67 -35.57 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.63 -48.91 17.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.2 mt -56.03 -44.49 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.76 171.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.5 p -108.12 144.03 36.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.94 -37.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.51 -42.19 95.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -128.83 96.47 29.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.703 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -24.65 29.54 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.8 mt -92.95 130.96 34.54 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 122.5 9.16 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -50.67 -27.43 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -62.3 -61.67 2.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -50.02 -50.94 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -51.83 -60.05 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 45.1 mmtt -44.3 -39.33 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 95.2 m -67.5 -45.6 75.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.63 -59.54 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.26 -27.7 16.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -70.83 -54.33 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.8 mt -56.37 -20.5 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -91.06 -22.05 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.33 -17.62 22.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -82.56 18.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.144 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.38 -42.55 2.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.5 tp 64.7 44.0 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.1 p -133.16 30.0 3.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -90.93 127.84 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -60.39 120.76 10.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 48.71 76.04 0.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -89.38 4.36 49.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.934 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.62 -48.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -59.05 -48.15 82.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.791 0.329 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.478 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -39.34 -58.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -50.59 -44.57 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.73 -51.0 70.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -50.97 -52.1 45.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.3 mt -43.75 -46.46 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.12 -62.63 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ASP . 48.5 mttt -50.67 -64.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -39.41 -42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -71.66 -38.49 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' LYS . 11.1 t0 -65.33 -41.75 93.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.28 -31.57 71.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -166.89 148.35 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -94.66 -19.55 20.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -78.3 48.47 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 pt -109.98 -176.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.6 125.44 7.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -70.72 -46.69 62.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.01 -48.48 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -59.79 -43.81 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.9 mtp -59.25 -19.39 45.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 47.6 39.42 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.71 164.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 p -74.88 131.89 41.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.3 t -44.36 -48.93 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -46.18 -40.21 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.77 -62.79 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.8 t -52.69 -36.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.85 72.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.57 -54.04 4.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.02 -44.39 61.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.0 tp -45.85 -43.67 13.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.11 -47.12 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -39.38 -45.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.25 -54.18 46.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -49.61 -47.22 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -54.49 -37.69 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.5 mt -41.45 141.01 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.657 0.741 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.13 32.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -133.25 150.6 75.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.881 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.24 37.47 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.336 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.1 tp -43.03 -53.84 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mt -85.42 124.09 72.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.417 ' CG ' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.79 149.02 66.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -70.43 -8.96 54.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.5 m -83.65 -12.46 55.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.848 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.527 HD11 ' CE1' ' A' ' 140' ' ' PHE . 43.0 mt -120.52 26.25 9.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.486 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.4 m170 -71.02 -60.12 3.04 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.78 -20.62 34.49 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.258 . . . . 0.0 112.328 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -70.89 -39.14 72.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.09 -28.72 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.9 mt -83.68 -50.21 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.11 -26.36 11.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.61 -21.75 21.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.27 -15.4 50.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -95.47 10.23 37.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.3 mt -73.51 132.19 81.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.584 0.707 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -45.39 1.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.375 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 105.56 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -41.37 -53.04 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.557 HG21 ' CD2' ' A' ' 131' ' ' HIS . 3.0 m -56.02 -59.72 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -49.22 -39.3 29.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -57.46 -42.79 83.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.6 -54.12 8.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.557 ' CD2' HG21 ' A' ' 127' ' ' THR . 15.6 m-70 -46.76 -44.06 18.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.06 -59.66 4.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.82 -33.75 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -65.68 -34.97 79.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -82.62 -41.38 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.419 ' HA ' ' NZ ' ' A' ' 139' ' ' LYS . 87.8 mt -59.62 -21.14 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.488 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 9.5 p -92.64 -5.91 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -81.02 -35.27 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' A' ' 136' ' ' ILE . 5.8 pttm -80.57 -7.78 59.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.527 ' CE1' HD11 ' A' ' 113' ' ' LEU . 2.7 m-85 -51.4 149.88 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.579 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -41.83 140.64 1.41 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.81 -16.66 37.43 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.653 2.235 . . . . 0.0 112.286 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 91.1 t -96.97 -38.72 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -83.89 -40.23 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 71.4 t80 -46.56 -42.86 16.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -45.18 94.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.1 t -68.33 -61.11 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -44.45 -46.86 9.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.421 ' HB3' ' NH1' ' A' ' 149' ' ' ARG . 7.8 ttp-105 -62.57 -47.97 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.03 -54.19 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 85.0 t -46.4 -65.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.12 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 77.8 mt -44.0 -53.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.9 m -39.77 -36.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -80.36 -43.31 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.5 mt -49.2 -42.99 41.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -52.26 -48.57 65.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -56.91 -29.84 63.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.4 t -80.46 -29.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.093 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 p -75.65 -20.44 58.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.94 -44.37 63.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -97.01 29.48 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.559 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 16.8 p80 -52.48 -39.25 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.559 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 0.8 OUTLIER -59.15 -21.19 58.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 49.6 mt -92.73 -64.96 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -76.08 1.41 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 162' ' ' HIS . 43.5 mt 54.6 46.28 25.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.417 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 21.0 mtp -141.12 112.55 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.445 HG21 ' CG ' ' A' ' 162' ' ' HIS . 33.7 p -98.24 160.63 14.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -45.96 -35.39 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -49.05 62.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.86 -44.17 77.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.77 -44.36 96.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -53.07 -40.31 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.455 HG12 ' NE2' ' A' ' 198' ' ' GLN . 9.6 mt -80.71 -41.21 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.142 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.58 -20.77 66.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -108.75 0.04 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.577 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.13 -45.92 95.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.533 0.682 . . . . 0.0 110.872 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -47.95 -58.54 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.688 2.259 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -69.69 -62.96 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.1 mt -40.52 -52.23 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 16.1 mmm -128.52 123.25 33.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 0.0 110.842 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 87.0 mt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.849 0.357 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -48.74 -71.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.455 ' NE2' HG12 ' A' ' 174' ' ' ILE . 7.1 tt0 -40.7 -53.67 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 t -45.88 -41.96 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.6 t -53.8 -60.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.56 -66.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -38.68 -52.33 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 51.5 m -48.85 -64.6 0.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 203' ' ' THR . 7.4 m-85 -34.16 -48.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 48.3 mt -66.25 -50.37 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -53.86 -45.61 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -110.02 30.42 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.517 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 0.8 OUTLIER -64.12 -15.32 59.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 213' ' ' TYR . 67.6 mm-40 -88.92 -54.47 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 210' ' ' PHE . 0.9 OUTLIER -42.76 -40.46 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -45.91 -63.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -105.54 -53.32 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 209' ' ' GLN . 56.9 m-85 -56.03 -35.2 66.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.931 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 71.02 28.02 3.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.68 -166.41 1.77 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.508 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.84 151.99 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 54.1 mt -76.42 132.05 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 m -110.22 174.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.814 0.256 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.0 tp -70.6 -39.39 73.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.34 -28.57 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.12 -41.24 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.37 -39.0 78.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -96.26 164.65 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -107.41 168.49 9.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.49 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -53.52 -46.75 70.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -130.74 103.88 15.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -33.6 16.21 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.644 2.23 . . . . 0.0 112.369 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.436 HG22 ' CG ' ' A' ' 42' ' ' GLU . 29.8 mt -74.68 131.36 79.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.611 0.72 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 147.64 63.68 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.472 ' CD1' ' CG ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.33 -50.03 71.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -42.53 -67.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.0 t -46.93 -54.36 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' CG ' HG22 ' A' ' 37' ' ' ILE . 33.1 mt-10 -47.23 -58.04 4.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.472 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 51.8 mmtt -53.05 -37.56 61.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.4 m -65.22 -43.94 89.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.02 -51.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.27 -45.72 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.477 ' CE1' HG21 ' A' ' 93' ' ' VAL . 33.4 t80 -53.53 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.2 mt -37.48 -56.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -52.06 -48.05 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.05 -44.1 87.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 t -85.87 23.92 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.1 139.65 10.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -110.29 -27.44 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.964 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.9 m -84.48 39.75 0.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 56' ' ' GLU . 11.5 m -82.72 111.67 18.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.4 tt0 -35.97 130.85 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 36.57 77.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mp -60.2 -61.73 2.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.955 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -93.3 -43.45 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -42.54 -49.02 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.096 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.776 0.322 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -60.84 -53.83 52.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.35 -27.35 65.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.57 -62.89 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 13.4 p30 -61.71 -44.55 96.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.449 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 47.2 mt -43.5 -42.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.52 -54.81 4.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -51.22 -61.17 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -51.12 -38.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 75' ' ' PHE . 7.7 t80 -62.9 -28.74 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.74 -63.16 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -55.38 -29.31 58.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -131.04 99.05 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -69.92 -17.28 63.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.85 32.62 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.461 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 7.1 tt -73.61 157.22 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.461 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 4.8 t30 -132.35 94.74 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -40.49 -46.58 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.48 -50.65 78.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -55.54 -41.41 73.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.4 mmm -62.09 -33.86 75.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 61.55 46.51 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.7 m -78.75 165.72 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.7 p -67.26 139.44 57.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.9 t -52.82 -55.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -45.92 -44.45 14.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.54 -63.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 47' ' ' PHE . 93.7 t -45.04 -55.55 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.64 -38.7 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.35 -60.82 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.51 -43.92 8.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 tp -47.81 -44.55 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -68.01 -48.09 66.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.14 -38.38 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.068 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.25 -46.45 86.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -61.16 -47.51 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.79 79.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 104' ' ' LEU . 6.7 t70 -59.42 -36.92 76.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' ASP . 96.2 mt -36.78 144.15 0.29 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -22.12 32.73 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.21 153.97 69.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.629 0.728 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 133.03 24.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.4 tp -38.38 -49.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.0 mt -84.2 123.63 75.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 111.162 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.406 ' CG ' HD11 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.79 153.93 68.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.691 2.261 . . . . 0.0 112.318 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.472 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 13.5 m-85 -72.62 -17.5 61.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 m -72.92 -30.45 63.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.406 HD11 ' CG ' ' A' ' 110' ' ' PRO . 19.6 mt -106.39 27.85 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.497 ' CD2' ' CE ' ' A' ' 181' ' ' MET . 4.0 m170 -71.49 -60.16 2.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.601 0.715 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.75 -33.83 15.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.247 . . . . 0.0 112.335 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -59.03 -33.3 70.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.85 -40.28 69.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.2 mt -75.09 -58.57 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -42.71 -29.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.95 -28.4 20.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -76.8 -20.91 55.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -92.14 16.21 11.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 30.8 mt -78.22 132.64 66.01 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.59 0.71 . . . . 0.0 111.135 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -45.39 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.671 2.247 . . . . 0.0 112.349 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 126' ' ' LYS . 75.7 m-20 -66.34 92.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 125' ' ' ASP . 38.1 tttt -34.91 -51.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 42.4 m -53.25 -59.92 3.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' ARG . 45.1 mm-40 -54.83 -52.6 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 128' ' ' GLU . 11.4 ttm180 -36.87 -43.5 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 131' ' ' HIS . 22.8 mt -75.84 -61.56 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 130' ' ' LEU . 11.8 m-70 -36.53 -49.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.1 -55.14 30.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.0 mt -55.9 -41.37 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -56.3 -29.67 61.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -90.37 -46.33 8.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.7 mt -56.43 -29.2 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.521 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 7.8 p -76.15 -15.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -73.37 -25.44 60.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -77.38 -19.13 56.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 7.9 m-85 -50.51 146.98 4.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.569 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.4 t-80 -45.48 141.39 3.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.569 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -21.0 34.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.7 -38.89 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -83.65 -44.06 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 14.1 t80 -40.97 -56.77 2.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -46.9 -34.45 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.38 -58.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.414 ' CZ ' HD13 ' A' ' 152' ' ' ILE . 24.0 t80 -43.17 -41.65 3.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -70.47 -44.79 67.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.42 ' CB ' HD12 ' A' ' 37' ' ' ILE . 76.6 t80 -57.71 -42.37 83.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.414 HD13 ' CZ ' ' A' ' 148' ' ' PHE . 86.0 mt -43.4 -53.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.146 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.8 m -41.25 -34.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -83.61 -39.68 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 92.8 mt -56.2 -45.52 79.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.98 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -50.36 -43.66 54.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -59.86 -30.84 69.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.72 -45.65 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.6 p -57.84 -29.95 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.06 -46.48 88.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -100.86 40.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 166' ' ' LEU . 10.6 p80 -58.54 -41.05 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.403 ' HG2' ' NE2' ' A' ' 162' ' ' HIS . 17.0 mmmt -55.32 -27.57 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 79.9 mt -90.29 -57.07 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.3 OUTLIER -84.17 18.07 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 162' ' ' HIS . 12.1 mt 34.32 52.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 49.1 mmm -146.34 108.73 4.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 169' ' ' ALA . 73.9 p -93.94 151.19 19.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.79 -37.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.89 -49.09 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 168' ' ' THR . 41.1 m-20 -54.54 -42.8 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.43 -48.05 79.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 p -58.55 -39.36 80.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.31 -37.48 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.175 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.91 -15.44 63.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -108.16 -8.43 15.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.556 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -56.73 -47.29 99.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.871 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.2 Cg_exo -48.0 -62.12 0.49 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 180' ' ' LEU . 16.7 m -67.85 -62.97 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.129 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 179' ' ' THR . 48.2 mt -33.2 -44.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.497 ' CE ' ' CD2' ' A' ' 114' ' ' HIS . 31.2 mtp -146.86 140.2 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.426 ' NE ' ' OH ' ' A' ' 111' ' ' TYR . 9.7 ptp180 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.827 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.831 0.348 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -43.03 -69.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -67.16 -39.36 86.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 t -43.45 -40.37 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.823 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 66.4 t -52.58 -58.25 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.16 -39.96 82.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -58.04 -52.4 65.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.4 m -49.51 -61.77 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' A' ' 208' ' ' CYS . 10.0 m-85 -33.83 -52.67 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 38.8 mt -62.61 -47.7 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -55.92 -47.63 77.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.9 mm-40 -109.84 31.67 5.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.518 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 2.4 t -63.55 -21.42 66.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.533 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 10.3 mm-40 -86.53 -51.17 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -45.04 -35.3 2.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.518 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -52.76 -62.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -108.07 -55.06 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.533 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 54.7 m-85 -56.63 -14.57 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 52.37 38.75 25.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.41 150.68 33.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -49.95 153.3 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.915 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.406 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 93.2 mt -73.69 126.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.092 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.2 m -104.81 177.68 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.444 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 53.5 Cg_endo . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.802 0.251 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.2 tp -53.22 -53.61 48.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -44.37 -33.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.444 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 11.5 t70 -79.24 -48.8 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.4 mt -57.03 -43.95 82.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.7 m -82.06 -179.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -117.61 147.52 42.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.14 -45.03 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -52.23 -43.09 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.75 108.37 13.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.552 0.691 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -39.39 6.55 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.455 HG22 ' CG ' ' A' ' 42' ' ' GLU . 22.3 mt -73.99 132.94 79.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.648 0.737 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 0.0 112.363 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.405 HD23 ' CE ' ' A' ' 43' ' ' LYS . 2.2 tm? -45.1 -48.02 12.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.513 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 82.0 t80 -43.2 -70.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.2 t -44.17 -50.48 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.069 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' CG ' HG22 ' A' ' 37' ' ' ILE . 16.6 mt-10 -49.13 -53.89 18.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' CE ' HD23 ' A' ' 39' ' ' LEU . 12.2 mmtp -52.15 -40.76 61.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.0 m -66.53 -47.47 72.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.56 -46.21 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.71 -43.96 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.491 ' CD2' HG23 ' A' ' 93' ' ' VAL . 63.8 t80 -50.78 -63.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.5 mt -39.67 -62.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -49.01 -50.3 36.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.44 -39.0 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.9 p -88.65 25.43 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.29 137.91 1.89 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp -113.47 47.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.773 0.32 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.6 p -132.75 37.45 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -96.72 119.61 35.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.1 tt0 -37.93 123.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.17 73.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.528 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.75 -24.73 63.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -102.59 -57.04 2.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.435 ' CG ' ' HA3' ' A' ' 57' ' ' GLY . 15.7 ptm180 -46.65 -33.06 3.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.142 179.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.795 0.331 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.1 -45.33 32.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -73.9 -30.94 62.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -62.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -50.63 -34.47 26.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.48 -44.6 89.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -79.06 -46.59 17.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 76' ' ' ASP . 93.2 mttt -59.79 -66.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -40.26 -47.01 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 42.9 t80 -64.29 -37.91 89.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 73' ' ' LYS . 37.6 m-20 -68.74 -58.85 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -53.38 -29.25 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.06 149.88 14.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.23 -17.72 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -83.43 50.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 -177.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -149.26 136.31 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.7 mt -81.28 -46.78 14.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.5 t -44.14 -54.16 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.1 t -55.57 -43.28 75.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.7 mmm -55.95 -28.83 58.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 51.97 45.94 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.99 164.84 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 t -75.22 128.16 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.3 t -40.31 -51.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -38.72 -53.01 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.15 -60.93 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.491 HG23 ' CD2' ' A' ' 47' ' ' PHE . 94.4 t -47.26 -51.23 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.75 -45.05 58.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.12 -63.35 3.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.78 -42.15 5.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.884 0.373 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.3 tp -48.69 -45.57 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -69.62 -51.17 37.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -40.26 -39.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -58.99 -47.46 85.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.433 ' CB ' ' CG2' ' A' ' 179' ' ' THR . 51.6 m-85 -62.27 -48.87 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.15 -37.13 71.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -34.8 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -41.65 141.29 1.23 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -19.06 36.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.693 2.262 . . . . 0.0 112.357 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -134.14 152.55 78.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.62 26.02 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.708 2.272 . . . . 0.0 112.342 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.2 tp -44.25 -44.26 7.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.49 123.94 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.617 0.723 . . . . 0.0 111.162 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 146.37 59.92 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.345 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.65 ' CD2' ' CE1' ' A' ' 114' ' ' HIS . 73.7 m-85 -66.26 -32.55 74.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m -61.14 -15.11 30.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.3 mt -122.0 28.47 7.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.65 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 3.9 m170 -73.0 -60.79 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.569 0.7 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.76 -31.82 19.79 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.694 2.263 . . . . 0.0 112.38 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -59.96 -28.86 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.0 -46.66 33.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 121' ' ' ALA . 12.0 mt -65.12 -55.2 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -45.72 -37.19 5.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.53 -21.08 32.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -86.63 -18.44 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -89.81 -8.85 51.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.4 mt -56.81 130.17 78.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 111.141 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -46.08 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.12 116.94 10.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -50.99 -49.55 60.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.41 HG22 ' CD2' ' A' ' 131' ' ' HIS . 99.0 m -53.57 -55.7 23.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -60.38 -38.95 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -57.75 -49.97 74.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.76 -60.52 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.41 ' CD2' HG22 ' A' ' 127' ' ' THR . 15.9 m-70 -43.58 -50.15 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.77 78.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 mt -74.57 -27.26 60.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -78.0 -27.16 48.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.0 pt-20 -86.11 -32.99 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 84.9 mt -74.2 -38.01 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.8 p -62.05 -11.81 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -74.96 -43.09 56.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -61.55 -32.97 73.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -40.52 137.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.573 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -39.33 141.16 0.69 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.849 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.78 -18.99 36.62 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 92.1 t -89.86 -37.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.91 -40.26 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.513 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 6.2 t80 -48.69 -51.69 27.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.92 -51.85 21.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.0 -67.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.551 ' CZ ' HD12 ' A' ' 152' ' ' ILE . 38.5 t80 -40.21 -40.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 4.6 mmp_? -66.39 -45.1 81.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.07 -48.15 77.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.99 -64.75 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.551 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 91.6 mt -42.82 -53.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.3 m -40.26 -36.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.121 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -78.9 -36.89 41.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 152' ' ' ILE . 53.1 mt -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -47.21 -47.37 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -55.57 -37.65 68.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.94 -50.41 54.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.2 p -55.23 -37.8 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -50.7 -39.87 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -108.46 40.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.501 ' CG ' HG23 ' A' ' 168' ' ' THR . 17.9 p80 -58.67 -35.68 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -58.16 -31.99 67.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.55 -57.85 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 166' ' ' LEU . 2.6 m-20 -83.39 17.23 2.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 162' ' ' HIS . 22.0 mt 34.96 50.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 39.4 mmm -146.42 113.83 6.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.501 HG23 ' CG ' ' A' ' 162' ' ' HIS . 9.2 p -95.76 153.36 17.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.97 -49.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.07 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -50.17 74.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -53.34 -44.39 68.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.5 mt -61.69 -41.62 97.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -59.38 -48.9 79.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 42.7 mt -62.74 -34.57 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 40.9 m -69.51 -22.86 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -102.25 -5.77 23.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.583 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -55.1 -46.05 99.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.609 0.718 . . . . 0.0 110.97 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.8 Cg_exo -47.95 -63.12 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 0.0 112.363 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 180' ' ' LEU . 87.1 m -65.44 -61.4 2.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 179' ' ' THR . 78.6 mt -34.24 -42.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 8.7 ptp -166.6 142.24 4.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.846 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.88 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 197' ' ' HIS . 51.1 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.814 0.34 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 196' ' ' ILE . 39.1 m-70 -35.4 -61.19 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -56.77 -48.1 78.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 m -49.74 -36.97 27.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.21 -70.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.166 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.17 -53.37 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.454 ' C ' ' OE1' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -38.69 -48.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 204' ' ' PHE . 60.8 m -58.79 -62.12 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.1 m-85 -34.41 -40.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 70.6 mt -78.67 -52.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -48.57 -44.92 37.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.6 mm-40 -113.31 35.4 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 6.1 t -64.07 -15.98 60.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.466 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 12.8 mm-40 -89.07 -53.68 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.69 -36.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -53.07 -63.47 1.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -107.53 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.466 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 89.4 m-85 -61.27 -9.98 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 48.5 t30 47.24 43.86 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.63 145.87 28.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.519 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -43.79 143.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.46 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 75.7 mt -63.35 131.15 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.118 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.1 m -112.26 173.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.159 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 219' ' ' GLU . 5.0 tm-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.851 0.271 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.1 tp -52.49 -45.1 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -49.65 -32.04 12.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.96 -41.47 20.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -63.03 -41.86 99.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 36' ' ' PRO . 23.6 m -85.27 164.8 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 p -110.63 147.91 33.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.57 -45.02 4.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -58.58 -41.14 85.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -130.99 97.62 20.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 53.9 Cg_endo -69.68 -47.44 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.377 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.8 mt -64.09 132.41 95.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.73 . . . . 0.0 111.109 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 140.05 41.67 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -51.32 70.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.42 ' CD1' ' CD2' ' A' ' 75' ' ' PHE . 28.7 t80 -42.13 -64.42 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.7 t -46.6 -54.32 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.122 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -50.3 -55.27 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -47.26 -40.97 17.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 81.8 m -63.62 -46.37 86.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -64.89 -56.35 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.28 -45.38 88.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.555 ' CE2' HG23 ' A' ' 93' ' ' VAL . 63.6 t80 -42.92 -60.17 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.0 mt -51.34 -48.88 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -56.07 -47.74 77.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -44.55 -47.52 10.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.3 p -84.04 29.84 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.21 163.11 9.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 tp -103.03 37.08 2.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.346 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.52 40.68 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.472 HG23 ' CD2' ' A' ' 58' ' ' LEU . 39.6 m -88.88 133.85 34.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.191 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -98.13 110.82 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.37 72.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.472 ' CD2' HG23 ' A' ' 55' ' ' THR . 20.3 mt -114.79 119.62 37.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 62.67 28.96 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -129.9 -36.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.815 0.34 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.42 -54.04 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -60.54 -32.63 71.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -67.99 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -52.92 -34.72 56.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.494 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 49.0 mt -56.68 -40.47 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -85.34 -59.76 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -46.8 -59.66 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 70' ' ' ASN . 40.1 mm-40 -49.71 -51.58 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CD2' ' CD1' ' A' ' 40' ' ' PHE . 58.2 t80 -58.59 -37.35 75.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.46 -60.1 3.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -58.76 -38.83 79.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.22 111.5 5.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -68.09 -32.41 72.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.4 m-80 -38.88 -36.91 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 80' ' ' ASN . 13.7 tt -34.51 146.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -134.89 100.68 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 82' ' ' ASN . 56.2 mt -34.35 -54.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.18 -47.31 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' ASN . 3.3 t -63.04 -48.1 80.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.7 mmm -57.33 -35.5 69.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 61.33 49.96 5.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.45 171.1 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.114 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.7 p -66.28 123.68 20.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 91.4 t -44.97 -56.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.109 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -37.78 -41.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.51 -60.47 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.555 HG23 ' CE2' ' A' ' 47' ' ' PHE . 99.1 t -45.05 -51.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.9 -44.23 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -50.34 11.68 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.449 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.22 -51.61 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.9 tp -43.77 -44.51 6.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 37.8 mtmt -72.85 -47.7 43.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.15 -45.63 4.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -57.43 -46.92 83.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -57.0 -44.24 82.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.54 90.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -40.48 76.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.4 mt -37.23 145.39 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -18.99 36.38 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.709 2.272 . . . . 0.0 112.306 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.8 152.27 70.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.601 0.715 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.4 Cg_endo -69.77 129.01 16.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 107' ' ' PRO . 11.2 tp -34.45 -45.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.2 mt -96.58 121.7 59.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 111.162 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 151.71 69.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.402 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.97 -22.35 64.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.2 m -68.77 -21.65 64.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 mt -113.89 28.69 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.501 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 3.4 m170 -75.68 -62.94 0.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.81 -23.38 30.64 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.613 2.209 . . . . 0.0 112.334 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.4 -32.48 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.3 mt -75.15 -27.09 59.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.14 -51.02 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.95 -25.9 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -91.94 -29.45 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.08 -21.06 60.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -92.27 20.32 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 87.7 mt -84.33 134.16 43.52 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 111.154 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -44.35 2.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.28 . . . . 0.0 112.381 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 126' ' ' LYS . 24.1 t0 -69.18 95.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 125' ' ' ASP . 44.1 tttp -38.11 -43.67 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.0 m -58.72 -66.65 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -46.23 -43.55 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -48.07 -42.15 27.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.2 mt -73.12 -52.86 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -49.08 -52.71 24.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.4 -57.61 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.25 -35.22 74.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -61.61 -30.8 70.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.14 -44.94 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.59 -32.71 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.1 p -68.6 -16.18 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.121 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -72.1 -32.06 66.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -68.55 -30.3 69.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 141' ' ' HIS . 8.4 m-85 -43.59 138.45 2.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.515 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -37.25 141.37 0.43 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.556 0.693 . . . . 0.0 110.851 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.515 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.3 Cg_endo -69.78 -17.04 37.72 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.71 -32.34 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -86.76 -39.16 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -49.54 -47.7 48.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.57 -54.53 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.71 -56.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.553 ' CZ ' HD13 ' A' ' 152' ' ' ILE . 45.9 t80 -46.76 -48.5 20.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -65.05 -48.51 73.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -54.74 -41.98 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.52 -59.55 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.553 HD13 ' CZ ' ' A' ' 148' ' ' PHE . 73.0 mt -47.67 -53.89 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' ILE . 24.4 m -36.83 -36.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -81.75 -39.41 24.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 152' ' ' ILE . 71.4 mt -56.93 -40.13 75.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.858 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.463 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 43.8 t-20 -56.84 -41.74 78.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.21 -54.07 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.4 p -46.46 -32.78 3.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' A' ' 156' ' ' ASN . 1.5 mt-30 -67.18 -46.65 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -88.15 39.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.424 ' CB ' HG21 ' A' ' 168' ' ' THR . 15.9 p80 -67.91 -20.37 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -68.83 -30.81 69.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 50.4 mt -102.47 -53.72 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.38 -23.43 66.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 34.8 mt 65.01 39.95 5.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 42.4 mmm -150.11 118.98 6.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.424 HG21 ' CB ' ' A' ' 162' ' ' HIS . 74.3 p -98.16 172.67 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.96 -38.48 73.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -59.69 -47.19 86.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -63.28 -39.48 94.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 10.9 mt -66.57 -38.54 87.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 t -61.29 -41.4 96.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.5 mt -77.85 -34.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 42.3 m -68.95 -14.85 63.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.497 ' CE2' ' HG2' ' A' ' 98' ' ' LYS . 13.3 m-85 -111.48 -5.76 14.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.578 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -54.55 -46.33 99.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -47.96 -53.36 6.74 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.306 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 26.2 m -78.77 -68.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 33.0 mt -34.22 -64.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.539 ' HG2' ' CH2' ' A' ' 177' ' ' TRP . 1.0 OUTLIER -112.33 96.9 6.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 181' ' ' MET . 33.6 ttm-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.633 0.73 . . . . 0.0 110.865 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 32.0 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.881 0.372 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -37.83 -47.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.72 -51.67 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.9 m -40.83 -42.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 57.9 t -40.44 -71.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 202' ' ' GLU . 85.5 t -60.08 -61.11 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 201' ' ' VAL . 20.9 tt0 -35.77 -42.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.3 m -62.72 -59.93 4.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.2 m-85 -33.98 -47.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 47.4 mt -71.66 -48.71 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -51.84 -45.34 63.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.459 ' NE2' ' HA ' ' A' ' 207' ' ' GLN . 6.4 mm-40 -113.74 34.1 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 21.6 t -63.54 -21.85 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.489 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 47.3 mm-40 -84.5 -54.54 4.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -41.13 -34.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 22.3 m-85 -52.62 -63.4 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -106.11 -56.35 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.489 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 72.1 m-85 -56.92 -17.16 8.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.915 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 51.67 40.1 26.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.925 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.07 135.77 15.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -42.5 137.08 2.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 0.0 110.936 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 68.1 mt -48.43 127.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.42 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.798 0.249 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.44 -45.61 92.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -46.79 -31.57 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.97 -44.05 27.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.14 -42.09 96.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.81 158.21 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -100.48 150.53 22.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -45.89 -46.17 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -53.7 -40.32 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 15.2 mmtp -133.75 94.73 18.45 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.7 Cg_endo -69.76 -35.95 11.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.704 2.269 . . . . 0.0 112.365 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.407 HG21 ' CG ' ' A' ' 42' ' ' GLU . 18.9 mt -74.22 131.33 80.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 111.113 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 121.56 8.26 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.713 2.276 . . . . 0.0 112.345 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.465 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -44.67 -53.88 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -38.72 -68.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.2 t -45.41 -54.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' CG ' HG21 ' A' ' 37' ' ' ILE . 88.5 mt-10 -45.94 -60.9 1.99 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.465 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 54.5 mmtt -46.94 -39.29 12.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.6 m -68.64 -52.49 30.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.93 -32.65 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -82.64 -36.29 26.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.506 ' CE1' HG22 ' A' ' 93' ' ' VAL . 6.3 t80 -63.15 -55.87 21.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 51' ' ' THR . 23.1 mt -47.75 -52.47 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -70.94 -24.32 62.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.84 -17.71 59.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 48' ' ' ILE . 8.4 t -91.98 26.33 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.54 -34.4 3.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 tp 68.21 53.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.3 p -114.65 -25.33 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -42.74 129.52 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 57' ' ' GLY . 7.3 mp0 -74.21 140.96 45.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 33.93 37.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.2 pp -38.22 -32.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -82.03 -61.83 1.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -55.33 -14.02 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.854 0.359 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.13 -58.65 6.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.823 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.19 -34.95 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -50.56 -62.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.3 p30 -58.9 -41.26 86.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.49 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 70.7 mt -46.61 -41.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.56 -57.7 2.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -49.09 -56.24 9.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -54.39 -46.54 73.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -62.38 -35.16 78.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.85 -53.31 52.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -74.42 -24.82 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -130.6 89.62 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.6 -34.63 75.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.68 39.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.417 HG12 ' N ' ' A' ' 82' ' ' ASN . 9.6 tt -79.99 154.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' ND2' ' HB ' ' A' ' 84' ' ' VAL . 5.0 t30 -124.79 94.56 4.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -41.15 -49.12 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.955 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.423 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 63.3 t -47.41 -44.62 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 t -60.18 -40.49 90.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 77.9 mtp -63.14 -37.97 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 62.95 47.4 4.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.0 m -84.76 171.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.7 p -68.71 118.96 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.9 t -36.56 -54.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -40.04 -47.78 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 -63.08 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.506 HG22 ' CE1' ' A' ' 47' ' ' PHE . 90.4 t -50.05 -46.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.84 -50.66 33.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -54.16 6.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.64 -40.85 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.1 tp -53.24 -56.31 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.463 ' CG ' ' CE2' ' A' ' 176' ' ' PHE . 6.1 mtmp? -60.34 -46.27 90.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.33 -46.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 7.3 t80 -57.41 -53.19 60.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -51.46 -41.01 60.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.53 -36.47 81.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -62.23 -38.75 90.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' ASP . 95.9 mt -34.89 144.64 0.21 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 110.934 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.28 36.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -139.26 153.82 71.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.77 128.65 16.32 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 2.263 . . . . 0.0 112.357 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 107' ' ' PRO . 23.8 tp -34.97 -39.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.9 mt -98.46 121.41 56.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 144.19 53.21 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 23.6 m-85 -59.38 -30.76 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.9 p -61.36 -16.35 45.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.45 29.92 7.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.51 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 3.1 m170 -76.39 -63.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.74 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.2 Cg_endo -69.73 -20.54 34.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.724 2.283 . . . . 0.0 112.364 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.6 -34.02 71.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mt -73.36 -37.09 66.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 121' ' ' ALA . 5.1 mt -77.49 -53.21 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -43.8 -32.37 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.42 -31.74 21.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -71.72 -19.74 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -92.92 26.25 2.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.949 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.1 mt -92.53 129.87 39.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.606 0.717 . . . . 0.0 111.138 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -44.36 2.11 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.63 2.22 . . . . 0.0 112.35 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.448 ' HB2' ' CG ' ' A' ' 128' ' ' GLU . 0.6 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -37.36 -57.99 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.9 m -46.66 -47.85 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.448 ' CG ' ' HB2' ' A' ' 125' ' ' ASP . 37.5 mm-40 -64.38 -48.61 74.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -45.97 -57.46 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.457 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 16.3 mt -63.33 -67.12 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 130' ' ' LEU . 9.3 m-70 -34.38 -40.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.12 -63.25 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.61 -30.27 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -65.96 -32.77 74.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -87.93 -47.65 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.3 mt -57.55 -26.07 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.174 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.7 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -76.39 -34.75 58.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -64.07 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.936 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.2 m-85 -40.7 129.73 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.577 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -33.95 141.11 0.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.7 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.577 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.75 -13.75 35.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.725 2.283 . . . . 0.0 112.352 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 95.4 t -97.84 -35.83 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.071 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.53 -39.61 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 1.4 t80 -47.22 -47.87 24.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.81 66.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.4 t -70.14 -57.99 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.557 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 41.3 t80 -48.4 -46.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -62.06 -51.18 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -53.66 -47.73 70.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.8 t -54.77 -58.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.557 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 86.3 mt -46.78 -52.09 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.6 m -41.36 -37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -80.72 -35.13 33.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 152' ' ' ILE . 97.0 mt -57.81 -42.99 85.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -52.6 -44.52 66.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -55.3 -43.4 74.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.35 -42.32 95.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 p -67.53 -27.11 66.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -69.97 -40.42 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -102.14 50.38 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.464 ' CB ' HG22 ' A' ' 168' ' ' THR . 0.6 OUTLIER -80.15 41.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.833 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -122.21 -43.47 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 mt -87.91 -40.97 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.158 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.84 -23.69 18.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 mt 63.99 48.27 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 37.8 mmm -132.2 97.14 4.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.464 HG22 ' CB ' ' A' ' 162' ' ' HIS . 72.3 p -85.36 167.85 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -52.32 -41.33 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.054 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.53 -56.42 20.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -50.69 -42.73 57.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.09 -43.95 97.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.6 t -57.9 -46.07 85.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.49 -35.16 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.9 t -68.59 -26.17 65.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 98' ' ' LYS . 16.7 m-85 -101.18 -6.58 24.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.589 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -54.61 -45.8 99.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.562 0.696 . . . . 0.0 110.907 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.1 Cg_exo -48.01 -50.18 12.39 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.268 . . . . 0.0 112.304 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 180' ' ' LEU . 20.8 m -81.87 -65.55 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 26.0 mt -33.45 -59.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.558 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 1.4 ttm -114.58 116.62 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.868 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.821 0.343 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -40.37 -51.65 2.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.15 -55.05 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 m -45.32 -38.62 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 94.0 t -45.17 -70.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.9 t -64.74 -60.37 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 201' ' ' VAL . 22.9 tt0 -34.59 -45.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 84.2 m -60.16 -59.15 5.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.2 m-85 -34.62 -54.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 50.5 mt -62.66 -55.52 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -46.28 -54.99 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.935 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 16.5 mm-40 -99.26 27.25 5.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.592 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 3.5 t -61.37 -14.42 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' TYR . 20.9 mm-40 -95.32 -57.53 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.49 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.6 t80 -39.67 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -52.9 -62.29 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -128.2 -26.78 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 215' ' ' GLY . 27.7 m-85 -83.21 30.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 213' ' ' TYR . 27.5 m-20 33.64 33.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -57.26 146.27 36.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.34 133.28 34.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.464 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 85.5 mt -48.29 122.82 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.1 m -111.49 166.31 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.811 0.255 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.72 -52.4 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.954 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -44.9 -30.13 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.99 -45.03 15.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.05 -44.76 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 m -83.0 164.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -114.2 164.7 13.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.21 63.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -51.66 -54.13 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 mmtp -119.69 96.41 49.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -35.94 11.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.238 . . . . 0.0 112.328 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.5 mt -85.73 134.71 39.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.77 150.48 68.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -68.66 -47.2 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -40.79 -58.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.8 t -55.28 -62.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -45.8 -62.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -50.74 -37.25 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 68.8 m -69.86 -31.98 70.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.4 t -78.68 -60.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.46 -40.72 60.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.615 ' CE1' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -51.04 -41.1 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mt -59.9 -64.13 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -33.7 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.58 -24.64 56.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.1 p -107.7 29.23 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.08 134.66 5.21 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.58 -10.65 14.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.931 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.0 m -91.68 40.9 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 56' ' ' GLU . 6.0 m -92.45 113.78 26.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.7 tt0 -33.98 121.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.27 69.3 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -66.49 -9.56 35.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.93 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CD2' HD21 ' A' ' 58' ' ' LEU . 8.9 m-85 -122.75 -37.75 2.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -74.1 -40.2 62.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 69' ' ' ASP . 45.4 m . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.788 0.328 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -35.72 -59.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -52.65 -38.4 60.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.9 t70 -47.84 -56.69 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.8 p30 -68.94 -36.08 77.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.458 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 57.8 mt -51.09 -42.36 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -82.92 -54.01 5.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -54.39 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -45.04 -46.02 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.58 -31.37 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.15 -48.05 38.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.35 -30.15 65.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.1 93.18 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.89 37.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tt -76.58 153.13 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 83' ' ' LEU . 6.0 t30 -124.62 83.87 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 82' ' ' ASN . 26.4 mt -34.35 -47.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.22 -54.79 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -52.35 -42.01 63.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 75.2 mtp -60.9 -36.39 79.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 59.4 45.0 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 160.97 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.183 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 p -56.12 118.18 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.1 t -41.52 -54.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -43.23 -35.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.1 -59.3 4.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.615 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 89.6 t -50.39 -51.03 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.39 -45.34 35.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.32 -55.39 18.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.469 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.8 -40.77 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 14.5 tp -48.75 -39.95 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.505 ' CG ' ' CE1' ' A' ' 176' ' ' PHE . 42.6 mtmt -74.41 -45.95 43.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.13 -34.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 6.9 t80 -68.48 -48.09 65.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -56.66 -41.29 76.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.44 86.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.44 -35.4 73.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.3 mt -39.2 144.56 0.44 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -29.12 24.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.91 154.14 81.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 143.8 51.97 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.569 HD22 ' CD1' ' A' ' 148' ' ' PHE . 13.5 tp -48.16 -58.46 4.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.95 131.17 54.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.656 0.741 . . . . 0.0 111.106 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.404 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.77 162.09 43.41 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.317 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.538 ' CD2' ' CE1' ' A' ' 114' ' ' HIS . 52.8 m-85 -79.87 -25.78 40.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -69.74 -17.03 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.489 ' O ' ' CD1' ' A' ' 117' ' ' LEU . 43.3 mt -122.42 31.92 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.538 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 3.9 m170 -74.28 -61.76 1.14 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.582 0.706 . . . . 0.0 110.828 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.5 Cg_endo -69.77 -10.73 29.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -68.01 -44.03 77.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' A' ' 113' ' ' LEU . 4.3 mp -67.23 -34.93 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.528 HD11 ' CE1' ' A' ' 197' ' ' HIS . 9.6 mt -77.45 -58.5 3.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -42.76 -30.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.46 -31.76 18.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.451 ' CB ' HG23 ' A' ' 200' ' ' VAL . . . -69.08 -21.98 64.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -90.21 19.06 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.8 mt -85.53 132.71 43.85 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -44.57 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.319 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.3 m-20 -64.36 95.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.1 ttpt -35.58 -53.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 131' ' ' HIS . 55.4 m -57.34 -61.37 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.121 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -46.38 -46.23 18.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.863 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -48.35 -51.99 23.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.55 -60.1 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.532 ' CD2' HG22 ' A' ' 127' ' ' THR . 14.9 m-70 -40.96 -53.85 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.73 -49.57 65.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.05 -28.02 69.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -74.66 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -86.1 -32.43 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.66 -21.71 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.9 -7.72 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -77.04 -38.6 52.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -12.8 60.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.443 ' O ' ' C ' ' A' ' 141' ' ' HIS . 2.8 m-85 -53.68 135.92 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.2 t-80 -34.49 141.51 0.25 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.572 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.77 -14.53 36.18 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.665 2.244 . . . . 0.0 112.383 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.7 t -95.36 -25.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.105 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -94.84 -34.59 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -64.87 -54.42 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -45.52 -45.39 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 148' ' ' PHE . 11.7 t -77.16 -63.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.569 ' CD1' HD22 ' A' ' 108' ' ' LEU . 27.8 t80 -37.23 -41.4 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -64.77 -54.35 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -53.31 -51.14 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.6 t -48.11 -56.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 89.0 mt -55.83 -49.25 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.7 m -42.88 -31.03 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -85.17 -42.99 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 83.0 mt -54.93 -46.58 74.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -51.76 -48.3 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -53.55 -38.22 63.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.15 -45.67 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.165 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.2 p -58.35 -21.51 50.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -51.62 -53.75 35.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -102.32 37.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.506 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 24.5 p80 -49.97 -27.67 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.506 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 3.9 mmmp? -70.12 -32.58 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 92.2 mt -82.66 -65.32 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -2.3 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.5 mt 55.25 46.81 22.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 25.6 mtp -144.69 116.92 8.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.844 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.446 HG23 ' CG ' ' A' ' 162' ' ' HIS . 39.1 p -101.15 159.16 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.107 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.29 -35.03 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.77 -48.97 57.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -55.22 -36.11 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 14.0 mt -72.56 -43.3 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -58.11 -36.91 73.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.467 HG12 ' NE2' ' A' ' 198' ' ' GLN . 17.6 mt -77.8 -35.85 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.6 -18.47 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.505 ' CE1' ' CG ' ' A' ' 98' ' ' LYS . 11.6 m-85 -108.71 -8.83 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.571 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -54.34 -46.42 99.0 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.566 0.698 . . . . 0.0 110.917 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -47.95 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 3.9 m -69.1 -59.45 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 56.7 mt -33.83 -47.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 34.3 mmm -143.0 136.53 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.851 -179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 197' ' ' HIS . 96.8 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.851 0.358 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.528 ' CE1' HD11 ' A' ' 118' ' ' LEU . 53.1 m-70 -36.74 -62.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.526 ' OE1' ' CD1' ' A' ' 177' ' ' TRP . 18.2 mm100 -43.64 -54.17 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 m -50.61 -36.94 37.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' A' ' 117' ' ' LEU . 23.2 t -54.81 -71.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.09 -54.27 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -45.6 -51.77 11.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 204' ' ' PHE . 93.3 m -50.06 -63.02 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.4 m-85 -34.25 -53.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.11 -54.87 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -49.06 -57.55 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 10.3 mm-40 -96.52 28.48 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.491 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 3.1 t -61.86 -20.66 63.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 213' ' ' TYR . 10.9 mm-40 -88.57 -51.44 5.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -44.75 -37.97 4.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -48.88 -63.07 1.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -104.05 -54.29 2.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 209' ' ' GLN . 60.2 m-85 -56.82 -36.18 69.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.7 t30 73.25 36.23 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.21 174.72 49.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.98 142.71 53.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.455 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 92.9 mt -68.25 137.87 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.62 168.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.22 0 CA-C-O 120.821 0.259 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.1 tp -54.6 -43.82 72.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -51.06 -37.35 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.19 -49.71 26.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.3 -46.43 79.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.08 168.41 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.5 p -112.33 162.88 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.72 -43.94 73.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.3 -45.46 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -128.93 86.15 58.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -34.34 14.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.39 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.1 mt -78.73 129.2 74.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 111.143 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.658 2.239 . . . . 0.0 112.334 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.471 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -47.69 -48.61 29.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -41.13 -66.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' CD1' ' A' ' 97' ' ' LEU . 41.8 t -45.84 -61.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -40.23 -61.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.471 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 43.2 mmtt -46.39 -41.27 13.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 86.7 m -68.69 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.79 -61.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -53.62 -35.94 61.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.544 ' CE2' HG22 ' A' ' 93' ' ' VAL . 30.3 t80 -56.72 -49.23 75.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.0 mt -61.67 -20.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -89.75 -14.1 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -95.44 -20.41 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -85.16 23.88 1.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.01 -29.79 3.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.477 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp 63.25 52.05 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.926 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 16.7 p -133.35 31.61 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 m -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.152 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.09 114.39 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.76 90.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.54 -30.13 12.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.98 -47.62 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -59.59 -15.96 22.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' ASP . 91.5 m . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 19.3 m-20 -39.13 -49.34 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.49 -29.41 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 66' ' ' THR . 8.5 t0 -59.39 -54.32 48.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 67' ' ' ASP . 20.2 p30 -54.72 -39.26 68.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.436 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 58.2 mt -49.03 -39.53 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -91.25 -55.1 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HE2' ' CG ' ' A' ' 69' ' ' ASP . 50.1 mtmt -46.29 -48.09 18.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -66.31 -56.64 10.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -40.0 -43.42 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.88 -53.09 52.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -56.5 -40.06 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -149.86 134.33 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -91.01 -20.2 22.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -81.13 45.21 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 pt -106.12 -178.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -145.18 154.53 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.3 mt -89.24 -34.24 16.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.83 -56.63 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -52.32 -31.14 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.5 mmm -69.58 -27.8 65.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 59.13 48.16 10.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.45 162.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' VAL . 58.9 p -69.85 121.18 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' THR . 88.4 t -37.07 -55.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.09 -47.14 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.52 -62.75 1.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.544 HG22 ' CE2' ' A' ' 47' ' ' PHE . 97.2 t -44.41 -43.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.9 78.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -55.28 26.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -44.96 35.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 111.121 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.457 ' CD1' HG13 ' A' ' 41' ' ' VAL . 26.7 tp -44.11 -43.84 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -75.8 -46.57 29.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.09 -43.06 3.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -56.79 -46.58 81.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -60.53 -50.22 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.37 -39.88 73.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.57 -39.87 71.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.2 mt -39.02 143.36 0.48 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.711 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.62 31.8 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -133.49 154.83 81.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.731 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.03 68.23 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 148' ' ' PHE . 11.1 tp -62.63 -40.67 97.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 117' ' ' LEU . 65.1 mt -95.51 128.34 38.49 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 111.127 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 160.48 49.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.344 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.54 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 30.6 m-85 -75.45 -36.18 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.5 t -56.19 -14.57 2.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.445 HD12 ' CE1' ' A' ' 140' ' ' PHE . 23.1 mt -127.73 32.0 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.54 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.2 m170 -75.88 -63.15 0.66 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.822 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.71 -11.46 30.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.327 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.92 -32.94 57.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.437 ' CD1' HG21 ' A' ' 109' ' ' ILE . 2.5 mt -70.39 -45.77 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.7 mt -68.09 -55.04 13.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -47.88 -29.35 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.15 -24.89 26.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -81.06 -32.19 34.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -75.75 -1.29 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.0 mt -62.43 130.76 93.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.639 0.733 . . . . 0.0 111.151 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.58 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.38 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.25 110.81 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -46.07 -54.96 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.2 m -50.98 -56.81 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -56.25 -38.06 70.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -55.25 -46.54 76.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 131' ' ' HIS . 13.1 mt -70.76 -66.51 0.6 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' LEU . 12.7 m-70 -35.69 -51.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.09 -57.51 9.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 9.3 mt -59.47 -20.52 55.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -81.65 -34.11 30.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -80.69 -28.61 36.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.4 mt -72.58 -34.59 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.097 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.562 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 9.5 p -73.0 -0.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -79.07 -42.92 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 18.91 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.562 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 2.7 m-85 -77.67 143.43 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -37.16 141.13 0.43 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.526 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.73 -25.6 28.58 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.323 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.3 t -92.18 -35.39 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.422 ' OD1' ' CG ' ' A' ' 141' ' ' HIS . 17.6 m120 -81.42 -45.78 15.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.554 ' CE1' ' HD3' ' A' ' 149' ' ' ARG . 4.3 t80 -43.38 -48.53 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -56.25 -59.8 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.7 -63.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.552 ' CD1' HD22 ' A' ' 108' ' ' LEU . 30.0 t80 -43.97 -44.44 7.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.554 ' HD3' ' CE1' ' A' ' 145' ' ' TYR . 8.2 ttp85 -62.14 -49.04 77.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -59.33 -53.96 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -45.49 -59.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.545 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 75.0 mt -52.08 -52.67 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 m -41.51 -29.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -88.44 -42.37 12.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.599 ' CD2' ' CE2' ' A' ' 176' ' ' PHE . 89.8 mt -54.53 -46.84 73.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -51.35 -40.95 60.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -61.3 -41.49 97.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.74 -42.92 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.7 p -61.8 -19.67 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -58.05 -53.2 60.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -99.76 37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.497 ' CG ' HG22 ' A' ' 168' ' ' THR . 19.7 p80 -53.43 -28.25 28.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -67.31 -27.26 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 79.3 mt -89.46 -59.03 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' LEU . 3.5 p30 -81.49 15.48 2.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 165' ' ' ASN . 27.3 mt 36.82 50.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 64.3 mmm -145.06 115.24 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.497 HG22 ' CG ' ' A' ' 162' ' ' HIS . 66.1 p -101.19 167.44 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.67 -40.39 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -58.26 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -58.65 -55.67 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.76 -21.73 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.435 ' HB2' ' N ' ' A' ' 202' ' ' GLU . 4.7 p -82.92 -39.16 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 49.4 mt -75.75 -25.1 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.3 p -79.39 -36.92 38.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.599 ' CE2' ' CD2' ' A' ' 155' ' ' LEU . 7.2 m-85 -85.24 -38.71 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.608 ' O ' ' CE3' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -39.26 -57.14 2.37 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.546 0.689 . . . . 0.0 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.533 ' HD3' ' CD1' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -48.07 -65.89 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.662 2.242 . . . . 0.0 112.317 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.489 ' O ' ' C ' ' A' ' 180' ' ' LEU . 94.6 m -54.39 -55.47 28.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.489 ' C ' ' O ' ' A' ' 179' ' ' THR . 32.8 mt -30.24 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.485 ' N ' ' O ' ' A' ' 179' ' ' THR . 2.5 ptt? -175.65 143.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.89 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.828 0.346 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -41.74 -52.54 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.903 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -63.11 -46.11 88.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.6 t -55.0 -40.93 70.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 79.1 t -37.62 -67.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.5 t -63.9 -51.72 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.435 ' N ' ' HB2' ' A' ' 173' ' ' SER . 15.6 tt0 -37.37 -53.93 1.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.6 m -56.3 -57.26 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 10.7 m-85 -42.62 -36.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 86.0 mt -71.73 -58.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.448 ' HB3' ' CG2' ' A' ' 218' ' ' VAL . 11.3 mt-30 -54.96 -54.76 38.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.401 ' HG3' ' CD1' ' A' ' 130' ' ' LEU . 61.6 mm-40 -86.44 24.2 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.73 -18.62 62.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 213' ' ' TYR . 18.2 mm-40 -91.6 -51.14 5.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -45.24 -38.49 5.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -50.3 -63.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -106.68 -54.79 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 209' ' ' GLN . 71.4 m-85 -59.62 -16.95 29.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 48.28 47.07 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -90.04 165.6 31.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.89 132.87 42.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 93.4 mt -58.63 106.84 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 206' ' ' GLN . 30.1 m -64.01 168.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.807 0.253 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.1 tp -61.0 -42.69 98.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.51 -29.23 24.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.81 -48.74 12.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.37 -45.18 84.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.2 168.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -107.64 146.83 31.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.79 -40.97 6.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.103 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.02 -44.48 82.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -131.02 99.57 17.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.617 0.722 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -35.51 12.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.343 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.71 129.36 74.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 117.37 5.05 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.459 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -40.09 -46.3 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -44.69 -64.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.0 t -43.16 -59.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.168 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -45.1 -61.34 1.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.459 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 49.0 mmtt -46.09 -43.17 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 90.1 m -65.29 -30.33 71.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.493 HG11 ' CG ' ' A' ' 154' ' ' HIS . 95.6 t -79.27 -54.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.04 -43.04 86.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 48' ' ' ILE . 3.2 t80 -49.59 -60.27 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 76.8 mt -45.11 -44.64 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HG2' ' NH2' ' A' ' 157' ' ' ARG . 64.7 mt-10 -63.03 -45.65 91.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.02 -42.3 94.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.6 p -85.89 29.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.147 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.71 153.9 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -120.28 38.96 3.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.6 p -117.49 42.3 2.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -97.86 133.51 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.04 120.95 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.51 80.07 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.0 -49.69 69.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 20.1 m-85 -99.49 -48.96 4.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -38.04 -42.03 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.807 0.337 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -45.77 -52.72 10.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.828 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -67.89 -32.18 72.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.32 -67.9 0.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -49.12 -42.13 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.0 mt -50.22 -40.81 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -81.27 -57.08 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -50.98 -59.67 3.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -49.09 -47.78 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -61.77 -41.39 97.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.31 -48.09 82.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.1 -29.65 61.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -132.53 93.14 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.802 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -60.57 -34.34 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.17 36.6 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.1 tt -77.53 156.16 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' SER . 2.9 t30 -122.04 87.82 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 82' ' ' ASN . 60.0 mt -37.27 -49.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.438 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 50.1 t -50.05 -42.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ASN . 45.6 t -59.96 -35.14 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.7 mmm -68.99 -34.17 74.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 59.22 50.15 8.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -84.79 172.24 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 90' ' ' VAL . 37.1 p -75.04 117.14 16.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 89' ' ' THR . 75.4 t -36.68 -52.89 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 90' ' ' VAL . 2.6 t-20 -37.16 -46.38 0.7 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.08 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.447 HG23 ' CE1' ' A' ' 47' ' ' PHE . 81.5 t -43.66 -46.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.095 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -51.88 -48.57 64.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.95 -62.71 4.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.82 -42.57 5.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 111.066 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.8 tp -52.04 -46.91 65.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 99' ' ' ALA . 42.3 mtmt -69.29 -47.92 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.5 -41.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.73 -55.22 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -54.16 -52.78 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.46 ' CA ' HG22 ' A' ' 179' ' ' THR . . . -54.28 -42.2 69.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.78 -35.57 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -42.47 141.42 1.5 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -19.49 35.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.642 2.228 . . . . 0.0 112.375 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 155.18 73.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.571 0.701 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 151.07 68.73 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.66 2.24 . . . . 0.0 112.376 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 tp -52.46 -51.39 59.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.447 HG22 ' CD1' ' A' ' 117' ' ' LEU . 29.1 mt -83.42 132.31 50.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 0.0 111.129 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.463 ' CG ' HD11 ' A' ' 113' ' ' LEU . 53.9 Cg_endo -69.71 146.76 61.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.369 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.517 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 20.9 m-85 -60.55 -26.0 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE2' ' A' ' 116' ' ' GLU . 33.1 m -65.57 -35.85 82.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.563 HD13 ' CE1' ' A' ' 140' ' ' PHE . 65.4 mt -92.17 35.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.517 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 4.1 m170 -77.56 -60.02 0.77 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.3 Cg_endo -69.79 -58.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.504 ' OE1' ' CD2' ' A' ' 113' ' ' LEU . 5.2 pt-20 -44.57 -38.13 4.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 113' ' ' LEU . 10.8 mt -66.64 -38.48 86.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.468 ' CD2' ' HA ' ' A' ' 197' ' ' HIS . 6.9 mt -76.65 -56.27 4.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.91 -28.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -81.74 -31.12 32.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.073 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -78.15 -31.9 49.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -82.94 16.77 2.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 73.5 mt -79.03 129.86 71.68 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.638 0.733 . . . . 0.0 111.16 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.93 2.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 126' ' ' LYS . 31.7 m-20 -67.21 95.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 125' ' ' ASP . 27.5 ttpt -33.49 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.5 m -57.49 -61.76 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.149 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -44.74 -56.47 4.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -37.75 -52.23 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.459 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 22.2 mt -64.87 -66.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 130' ' ' LEU . 20.1 m-70 -34.56 -45.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.61 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.9 mt -51.65 -27.53 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -75.18 -37.87 61.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.9 -26.11 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.449 ' O ' ' CD ' ' A' ' 139' ' ' LYS . 36.2 mt -75.33 -36.33 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.564 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 8.5 p -69.83 -0.41 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -82.01 -29.61 31.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' CD ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -97.18 14.17 26.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.3 m-85 -75.11 140.59 43.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 4.4 t-80 -34.39 141.05 0.26 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.74 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.275 . . . . 0.0 112.355 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.8 -33.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -83.26 -47.78 11.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -42.68 -44.88 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.2 -55.49 34.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.33 -60.1 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 20.8 t80 -38.43 -42.02 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -72.32 -49.52 33.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -52.51 -45.13 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.57 -64.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.481 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 82.1 mt -43.4 -51.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.7 m -43.37 -35.44 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.493 ' CG ' HG11 ' A' ' 45' ' ' VAL . 77.2 t60 -83.36 -37.56 23.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 98.8 mt -56.37 -46.32 80.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -51.69 -41.97 61.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.451 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 2.6 mtp-105 -57.12 -35.56 69.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 -42.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.5 p -64.86 -34.53 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 36.2 mt-30 -54.18 -42.25 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.29 37.35 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 166' ' ' LEU . 29.8 p80 -53.96 -34.07 58.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -55.93 -31.22 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 74.2 mt -89.75 -58.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.178 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -76.89 7.56 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 162' ' ' HIS . 34.7 mt 40.85 53.38 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 75.4 mmm -152.29 119.85 6.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 169' ' ' ALA . 69.2 p -102.01 153.13 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.173 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.82 -44.29 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.105 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -61.81 -50.87 70.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -53.57 -39.91 65.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 38.9 mt -67.31 -44.35 79.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t -53.59 -50.1 66.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.98 -41.28 89.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.12 -30.66 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.58 -2.27 54.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.582 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.86 -45.95 92.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.96 -53.94 5.92 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.721 2.281 . . . . 0.0 112.296 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.46 HG22 ' CA ' ' A' ' 102' ' ' ALA . 20.5 m -76.28 -67.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 179' ' ' THR . 24.8 mt -34.29 -48.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 4.4 mmm -136.44 120.98 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.905 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.526 0.679 . . . . 0.0 110.905 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 197' ' ' HIS . 72.7 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.89 0.376 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 51.2 m80 -36.18 -50.67 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.05 -47.35 71.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.2 m -47.4 -36.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.6 t -48.18 -50.46 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 202' ' ' GLU . 45.2 t -65.69 -59.65 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' VAL . 65.4 tt0 -34.48 -64.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 205' ' ' ILE . 38.2 m -41.49 -66.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.8 m-85 -35.43 -33.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 203' ' ' THR . 82.3 mt -84.64 -46.52 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 203' ' ' THR . 5.6 mm-40 -56.27 -59.28 5.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 6.5 mm-40 -94.61 31.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.5 t -58.64 -21.55 54.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.576 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 5.8 mm-40 -86.24 -54.67 4.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -40.03 -35.77 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -54.71 -63.19 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -107.73 -56.51 2.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.576 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 63.1 m-85 -60.06 -11.55 6.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 46.18 43.65 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.89 168.83 53.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.92 141.89 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.464 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.9 mt -73.91 133.42 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.416 ' N ' HG21 ' A' ' 217' ' ' ILE . 29.6 m -109.8 170.97 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.13 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.769 0.237 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.0 tp -46.91 -40.89 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' CB ' HG22 ' A' ' 143' ' ' VAL . 4.8 pt20 -50.81 -44.65 59.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.95 -46.24 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -57.52 -37.28 72.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 m -89.67 164.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 35' ' ' LYS . 20.4 p -106.53 133.18 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -34.68 -44.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -58.13 -47.68 82.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' THR . 33.1 mmtm -124.75 96.65 40.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.549 0.69 . . . . 0.0 110.862 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -40.35 5.35 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.452 ' CG1' ' OD2' ' A' ' 146' ' ' ASP . 15.7 mt -80.51 130.73 63.75 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.673 0.749 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 54.1 Cg_endo -69.71 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.36 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -38.29 -54.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -39.25 -63.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.442 ' CG2' ' HG2' ' A' ' 38' ' ' PRO . 43.1 t -44.31 -52.67 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -53.7 -61.25 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.463 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 48.3 mmtt -44.16 -33.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 87.8 m -76.04 -50.44 14.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.463 HG11 ' CG ' ' A' ' 154' ' ' HIS . 96.6 t -58.61 -39.66 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -78.1 -26.36 48.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 47' ' ' PHE . 1.1 t80 -79.26 -33.76 43.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.5 mt -66.93 -34.24 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -84.36 -33.98 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.83 -24.62 52.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.6 p -84.3 28.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.104 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.64 -32.02 4.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.469 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 tp 70.45 27.54 3.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.807 0.337 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.56 44.65 1.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -101.17 135.59 42.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 57' ' ' GLY . 4.0 mt-10 -65.43 115.62 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.56 68.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.439 ' CD1' ' CG ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -62.48 -15.58 50.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CG ' ' CD1' ' A' ' 58' ' ' LEU . 20.0 m-85 -98.22 -56.11 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -15.53 18.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.091 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.771 0.319 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.469 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 5.1 m-20 -57.81 -58.29 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -50.23 -28.34 7.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -60.37 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -57.47 -45.55 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 79.3 mt -47.1 -42.82 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -83.74 -64.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -41.72 -54.0 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.401 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 31.6 mm-40 -58.85 -40.22 83.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 78' ' ' ASP . 65.2 t80 -64.73 -61.15 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.32 -57.09 9.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -52.0 -26.63 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.446 ' CG ' ' O ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -162.23 116.22 1.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -71.61 -33.31 68.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -41.07 -46.23 2.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.46 HG12 ' N ' ' A' ' 82' ' ' ASN . 1.8 tt -45.85 145.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' N ' HG12 ' A' ' 81' ' ' ILE . 56.3 t30 -128.71 119.32 24.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 mt -47.96 -52.94 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.75 -48.27 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -62.9 -44.69 95.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.6 mtp -52.17 -33.9 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 57.72 49.74 11.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -84.5 171.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.3 p -70.96 116.49 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.4 t -39.55 -45.69 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -48.85 -41.92 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB2' ' CB ' ' A' ' 67' ' ' ASP . . . -62.73 -63.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.498 HG21 ' CE1' ' A' ' 47' ' ' PHE . 87.0 t -50.33 -51.59 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.73 -36.79 5.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.76 -57.21 3.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.02 -41.72 3.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.088 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -49.33 -53.76 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -64.46 -43.92 92.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.79 -50.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -55.04 -57.87 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.471 ' HB3' ' CG2' ' A' ' 179' ' ' THR . 34.3 m-85 -50.65 -39.3 50.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.13 80.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.28 -33.99 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.0 mt -40.29 141.44 0.84 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.937 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.39 32.22 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.248 . . . . 0.0 112.388 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.59 155.81 75.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 141.22 44.56 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.553 HD22 ' CD1' ' A' ' 148' ' ' PHE . 15.4 tp -43.62 -51.6 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 91.2 mt -82.09 128.97 66.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 158.84 55.58 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.34 -29.05 47.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -65.48 -5.33 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.566 HD13 ' CE1' ' A' ' 140' ' ' PHE . 13.6 mt -133.46 22.09 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.485 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.4 m170 -70.79 -60.17 3.19 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.892 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.2 Cg_endo -69.77 -16.39 37.5 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 0.0 112.309 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.29 -36.8 63.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.7 mt -71.79 -26.33 62.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.72 -48.47 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -53.59 -31.4 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.17 -25.43 25.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.454 ' CB ' HG21 ' A' ' 200' ' ' VAL . . . -78.87 -21.33 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -89.47 11.2 20.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' A' ' 124' ' ' PRO . 85.9 mt -76.62 138.52 66.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.654 0.74 . . . . 0.0 111.151 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 123' ' ' ILE . 53.6 Cg_endo -69.8 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.276 . . . . 0.0 112.299 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.35 101.27 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -44.01 -48.73 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.555 HG22 ' CD2' ' A' ' 131' ' ' HIS . 89.6 m -56.93 -60.8 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -49.94 -48.07 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -45.47 -51.53 11.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.0 mt -65.79 -53.7 36.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.555 ' CD2' HG22 ' A' ' 127' ' ' THR . 12.0 m-70 -45.48 -55.97 5.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.2 -54.87 17.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.5 mt -55.53 -36.69 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -68.16 -22.45 64.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -89.27 -48.32 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.426 ' O ' ' CD1' ' A' ' 140' ' ' PHE . 19.0 mt -56.61 -34.47 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.492 ' O ' ' CE1' ' A' ' 145' ' ' TYR . 7.1 p -71.25 -6.75 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -87.51 -37.91 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 23.2 1.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 113' ' ' LEU . 2.3 m-30 -81.79 175.2 10.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.886 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -65.3 141.14 98.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.584 0.707 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.572 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.8 -15.6 37.01 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.266 . . . . 0.0 112.32 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.461 HG22 ' CB ' ' A' ' 28' ' ' GLN . 69.6 t -99.21 -25.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -93.98 -33.46 13.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CE1' ' O ' ' A' ' 137' ' ' VAL . 83.1 t80 -65.21 -56.77 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.452 ' OD2' ' CG1' ' A' ' 37' ' ' ILE . 4.6 p-10 -42.86 -49.42 5.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.46 -55.89 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.553 ' CD1' HD22 ' A' ' 108' ' ' LEU . 17.4 t80 -42.49 -41.69 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.468 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 19.4 mtp180 -59.8 -59.89 4.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -54.05 -34.63 60.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.8 t -59.39 -63.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.529 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 21.5 mt -53.01 -53.25 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -39.82 -33.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.463 ' CG ' HG11 ' A' ' 45' ' ' VAL . 74.0 t60 -84.36 -41.86 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 76.0 mt -50.83 -48.75 59.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 205' ' ' ILE . 3.9 t-20 -49.33 -45.84 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.45 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 57.5 mtt-85 -53.57 -38.67 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.5 t -74.77 -43.39 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 26.2 p -60.67 -25.22 66.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 41.2 mt-30 -65.55 -37.03 85.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -105.72 36.35 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.545 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 17.5 p80 -55.0 -38.3 67.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.545 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 18.0 mmmt -59.46 -36.72 76.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.53 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -73.31 2.17 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 162' ' ' HIS . 28.3 mt 49.8 42.82 24.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.7 mmm -141.88 112.02 6.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.3 p -94.11 155.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -41.06 -36.37 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.66 -52.57 50.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -57.44 -45.03 85.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.5 mt -62.46 -46.52 88.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -57.53 -24.23 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.82 -39.44 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 8.4 p -63.35 -32.67 74.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.418 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.4 m-85 -90.02 -12.98 36.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -48.76 -46.57 72.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -48.01 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 101' ' ' PHE . 40.0 m -64.41 -59.89 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 179' ' ' THR . 70.2 mt -33.72 -48.15 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.524 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 13.2 ptm -159.06 150.82 20.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.61 0.719 . . . . 0.0 110.853 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.841 0.353 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -43.32 -44.82 5.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.18 -54.41 47.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 t -52.81 -40.42 63.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.454 HG21 ' CB ' ' A' ' 121' ' ' ALA . 85.3 t -47.1 -69.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.157 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 202' ' ' GLU . 83.1 t -58.14 -60.28 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 201' ' ' VAL . 66.6 tt0 -37.62 -43.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 56.9 m -59.46 -55.38 35.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 208' ' ' CYS . 9.4 m-85 -38.73 -58.22 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.501 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 63.2 mt -55.56 -50.75 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -53.69 -60.13 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.417 ' OE1' ' CB ' ' A' ' 210' ' ' PHE . 11.0 mm-40 -92.52 25.57 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.926 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 1.8 t -60.4 -14.82 21.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' TYR . 14.0 mm-40 -95.86 -57.91 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.471 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.8 t80 -39.76 -30.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.4 m-85 -52.6 -61.87 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -127.02 -28.33 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 209' ' ' GLN . 26.2 m-85 -83.99 26.82 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' TYR . 75.9 m-20 33.48 34.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -59.08 145.87 43.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.12 129.93 35.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 53.3 mt -41.32 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.08 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.26 163.96 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.837 0.265 . . . . 0.0 112.383 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.0 tp -49.39 -49.87 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.85 -34.66 5.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 33.2 t70 -77.28 -45.81 25.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.9 mt -59.45 -46.04 89.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.3 m -88.27 163.22 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.9 p -108.87 149.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.105 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.73 -46.94 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -50.14 -44.45 52.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.923 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -132.66 99.17 15.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.606 0.717 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -41.17 4.47 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.692 2.261 . . . . 0.0 112.344 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.1 mt -74.84 134.81 74.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.584 0.707 . . . . 0.0 111.164 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.32 64.65 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.643 2.228 . . . . 0.0 112.356 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.48 HD12 ' CE ' ' A' ' 43' ' ' LYS . 1.1 tm? -65.12 -59.36 4.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' LEU . 24.9 t80 -36.09 -64.86 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.2 t -46.67 -63.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -40.53 -56.01 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.48 ' CE ' HD12 ' A' ' 39' ' ' LEU . 64.2 mmtt -53.92 -39.43 65.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 80.7 m -65.23 -41.88 93.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.66 -43.86 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -70.45 -38.76 74.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.498 ' CE1' HG23 ' A' ' 93' ' ' VAL . 11.0 t80 -56.58 -50.15 72.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 mt -48.83 -68.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 50' ' ' ASP . 2.7 pp20? -55.18 -53.19 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 21.1 t70 -45.46 -42.89 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 p -88.66 29.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 108.65 1.45 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.22 51.41 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 0.0 110.953 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 80.4 m -132.7 30.88 4.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 7.5 m -66.54 122.33 17.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.15 130.38 42.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 45.18 87.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.492 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 4.6 mp -83.16 143.61 30.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.353 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 58' ' ' LEU . 2.6 m-85 47.87 27.88 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 tpp85 -123.41 -46.84 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.926 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.807 0.337 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.96 -58.27 8.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -58.91 -33.88 71.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.95 -66.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -57.19 -37.85 72.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.496 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 38.7 mt -52.25 -37.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -90.63 -55.65 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.04 -54.87 20.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -54.04 -43.84 70.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -57.38 -40.68 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.29 -62.0 2.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -58.94 -28.65 66.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -129.67 103.98 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -76.33 -27.24 56.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -96.23 37.21 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.1 tt -80.69 153.77 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -123.0 94.78 4.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -37.23 -50.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.4 t -43.66 -46.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -57.88 -46.41 84.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.0 mtp -56.16 -38.11 70.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 62.05 50.12 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.02 178.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 p -75.63 117.76 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -42.08 -51.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -40.39 -49.48 2.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 71' ' ' ILE . . . -47.45 -56.15 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 47' ' ' PHE . 98.3 t -46.65 -55.24 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -47.07 -45.36 21.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.49 -60.27 5.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.31 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.9 tp -47.98 -42.94 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -64.96 -43.33 93.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.912 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.94 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -60.54 -35.87 77.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -82.15 -41.0 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.861 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.4 -41.71 98.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -57.28 -40.17 77.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.442 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 47.7 mt -36.56 146.98 0.21 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.602 0.715 . . . . 0.0 110.946 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -27.46 26.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 153.98 81.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.64 0.733 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 156.58 63.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.337 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.67 -45.91 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.3 mt -95.93 117.65 66.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 111.146 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 137.69 36.12 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.662 2.242 . . . . 0.0 112.323 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.573 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 6.0 m-85 -53.05 -36.47 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -54.91 -23.52 19.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.426 HD13 ' CE1' ' A' ' 140' ' ' PHE . 60.8 mt -112.97 30.81 6.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.858 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.573 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.6 m170 -74.3 -61.8 1.13 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 110.847 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.1 Cg_endo -69.73 -40.32 5.5 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -47.09 -33.55 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.62 -43.02 66.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 121' ' ' ALA . 6.3 mt -69.1 -57.95 4.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -43.05 -25.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.06 -27.72 15.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.74 -31.72 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -74.1 -15.55 61.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 90.4 mt -50.26 129.35 24.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -46.94 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.252 . . . . 0.0 112.372 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -59.04 106.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -46.94 -46.49 21.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.488 HG23 ' CD2' ' A' ' 131' ' ' HIS . 70.6 m -59.78 -67.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 129' ' ' ARG . 58.0 mm-40 -46.6 -51.76 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 128' ' ' GLU . 12.2 ttm180 -36.79 -48.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.472 ' CD2' ' HG2' ' A' ' 207' ' ' GLN . 23.0 mt -73.26 -66.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.488 ' CD2' HG23 ' A' ' 127' ' ' THR . 29.9 m-70 -34.14 -49.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.864 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.92 -59.94 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.84 -40.01 59.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -63.45 -26.47 68.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.44 -39.79 13.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.47 -41.56 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 140' ' ' PHE . 12.9 p -58.75 -24.9 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -60.04 -32.28 70.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -60.42 -34.88 74.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 141' ' ' HIS . 22.6 m-85 -44.91 132.34 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.565 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.1 t-80 -33.99 141.85 0.23 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -9.55 26.38 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.369 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.6 t -98.83 -38.99 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -84.28 -38.17 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.505 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 35.5 t80 -51.71 -43.75 62.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.93 -45.71 82.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.23 -59.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.529 ' CE2' HD11 ' A' ' 152' ' ' ILE . 41.0 t80 -47.92 -42.92 28.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.505 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 14.0 mmm180 -65.87 -38.76 89.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -65.28 -45.71 83.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.67 -60.35 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.529 HD11 ' CE2' ' A' ' 148' ' ' PHE . 84.7 mt -46.97 -48.58 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.3 m -44.09 -36.21 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -80.79 -36.39 31.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.92 -47.0 87.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -49.04 -43.08 40.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.462 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 26.8 mtp85 -61.79 -38.08 86.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.23 -47.51 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.2 p -56.63 -36.4 69.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.2 mt-30 -53.01 -42.04 65.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.928 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -110.66 35.93 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 166' ' ' LEU . 22.5 p80 -47.35 -35.78 8.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 24.3 mmtp -57.71 -33.82 68.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 92.9 mt -80.13 -59.7 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.145 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -81.99 13.04 3.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 162' ' ' HIS . 16.7 mt 39.53 54.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.465 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 18.0 mmm -154.47 116.06 4.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 p -93.5 154.86 17.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -40.02 -42.73 1.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.101 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -63.64 -52.48 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -52.63 -48.21 66.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.41 -44.94 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 71.2 p -63.39 -42.42 98.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.04 -33.59 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 m -72.95 -18.85 61.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -104.25 -9.58 18.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.562 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -50.23 -46.73 83.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.567 0.699 . . . . 0.0 110.909 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.9 Cg_exo -47.97 -59.78 1.12 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.665 2.243 . . . . 0.0 112.334 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 180' ' ' LEU . 25.5 m -69.42 -64.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 179' ' ' THR . 85.2 mt -33.28 -50.18 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 19.4 ptm -157.17 131.26 8.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.845 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 197' ' ' HIS . 40.6 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.454 ' C ' ' O ' ' A' ' 196' ' ' ILE . 94.7 m-70 -34.2 -38.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 196' ' ' ILE . 75.5 mt-30 -80.72 -50.6 9.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.2 p -54.65 -24.89 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.97 -66.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.53 -37.41 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -55.24 -45.51 76.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.9 m -60.07 -53.87 52.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -39.15 -38.86 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.439 ' HA ' ' CG2' ' A' ' 152' ' ' ILE . 60.5 mt -74.56 -65.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -45.39 -52.55 9.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.472 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 24.1 mp0 -94.2 29.35 2.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.438 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 35.7 t -67.0 -29.62 69.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 213' ' ' TYR . 9.6 mm-40 -81.85 -45.14 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -48.93 -37.57 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.438 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -49.47 -63.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -105.21 -55.76 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 209' ' ' GLN . 80.7 m-85 -57.41 -23.97 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.922 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 59.86 39.76 20.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.851 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -72.92 -177.9 33.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.64 145.44 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.66 116.35 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.0 m -91.56 174.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.808 0.253 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.0 tp -60.36 -49.04 79.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -47.46 -28.24 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -45.54 14.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.76 -44.93 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 m -91.2 167.14 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -113.44 167.69 10.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.08 -48.45 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.24 -54.77 43.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -115.3 85.23 12.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -31.71 19.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.0 mt -80.87 130.17 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 111.134 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.09 47.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -67.19 -31.77 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 100' ' ' PHE . 42.0 t80 -56.38 -48.47 76.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.538 HG23 ' CE1' ' A' ' 101' ' ' PHE . 19.7 t -65.12 -50.68 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.074 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -58.48 -60.99 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -46.3 -30.37 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 40' ' ' PHE . 65.6 m -76.72 -34.37 58.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.2 t -76.78 -60.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -54.54 -39.9 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.442 ' CZ ' HG23 ' A' ' 51' ' ' THR . 20.3 t80 -53.24 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mt -46.05 -52.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.22 -52.41 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.19 -33.54 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.442 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 82.1 p -91.92 23.66 3.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.09 154.69 24.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.501 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.78 47.73 2.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.0 p -132.39 40.32 3.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -97.84 130.88 44.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -67.14 127.22 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.59 77.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.533 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.27 -66.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.96 -37.11 22.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -50.34 -47.56 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.83 -47.38 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -65.43 -20.82 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.14 -69.87 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.2 p30 -47.49 -39.25 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.498 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 50.1 mt -47.15 -42.54 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.97 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -45.98 -58.4 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -54.2 -58.18 8.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -55.39 -27.91 50.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.55 -57.33 7.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -73.09 -23.61 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -124.38 120.37 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -95.06 -14.01 24.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -104.55 31.18 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 3.2 tt -76.27 158.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.509 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 7.0 t30 -126.24 94.72 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.9 mt -44.87 -45.71 10.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -48.68 -36.81 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.2 t -66.59 -39.24 88.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.7 mmm -69.06 -28.9 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 55.83 35.86 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.2 m -66.67 148.72 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.8 p -55.63 129.91 40.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.43 -41.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -52.34 -39.22 60.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.47 -59.76 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.0 -53.31 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.59 -33.62 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 -57.7 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.463 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.4 -31.59 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 46.1 tp -56.39 -47.96 77.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -64.37 -34.43 78.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.31 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.439 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . 7.3 t80 -67.08 -24.96 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.538 ' CE1' HG23 ' A' ' 41' ' ' VAL . 51.9 m-85 -90.11 -28.6 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.14 -34.66 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.0 -36.23 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.4 mt -38.56 142.55 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.925 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.24 32.31 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.23 157.37 76.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.85 26.59 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.338 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.401 HD23 ' CD1' ' A' ' 148' ' ' PHE . 16.8 tp -40.59 -42.54 1.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.41 130.02 36.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 111.136 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 159.36 53.67 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.665 2.243 . . . . 0.0 112.343 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.31 -20.64 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.3 t -76.58 -1.51 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.827 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.457 HD12 ' CE1' ' A' ' 140' ' ' PHE . 18.3 mt -134.78 17.72 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.466 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 3.8 m170 -61.47 -60.49 10.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.606 0.717 . . . . 0.0 110.832 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.76 -36.57 10.55 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.691 2.261 . . . . 0.0 112.375 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -51.86 -32.03 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.429 HD22 ' CG1' ' A' ' 200' ' ' VAL . 3.2 mt -73.28 -23.87 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.961 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 121' ' ' ALA . 19.1 mt -94.65 -59.25 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -45.03 -24.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.414 ' CB ' ' HB1' ' A' ' 132' ' ' ALA . . . -96.04 -27.33 15.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -79.65 -18.29 51.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -86.31 -0.63 56.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 79.6 mt -66.37 129.85 94.18 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.631 0.729 . . . . 0.0 111.107 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.0 2.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.4 t70 -61.65 94.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 125' ' ' ASP . 3.4 ttmt -34.88 -39.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.6 m -65.16 -67.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -49.07 -48.55 44.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -45.0 -55.16 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 18.7 mt -65.92 -58.74 4.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.65 -43.37 2.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.414 ' HB1' ' CB ' ' A' ' 120' ' ' ALA . . . -59.69 -45.51 91.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mt -69.07 -25.59 64.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -76.25 -30.51 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 0.5 OUTLIER -88.71 -30.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.415 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 54.9 mt -71.83 -25.12 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.35 -7.58 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -81.89 -31.24 31.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -88.94 14.05 11.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.457 ' CE1' HD12 ' A' ' 113' ' ' LEU . 3.0 m-85 -77.84 166.88 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.524 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.9 t-80 -54.96 140.85 60.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.597 0.713 . . . . 0.0 110.88 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.524 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.71 -24.31 30.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.703 2.269 . . . . 0.0 112.334 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.2 t -91.11 -40.84 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 145' ' ' TYR . 28.8 m120 -77.7 -48.99 15.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CZ ' ' HD2' ' A' ' 149' ' ' ARG . 19.7 t80 -37.39 -56.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -49.18 -65.26 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.1 t -49.75 -59.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.401 ' CD1' HD23 ' A' ' 108' ' ' LEU . 39.3 t80 -43.26 -45.78 5.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.495 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 5.3 mtt-85 -63.3 -56.48 16.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -46.04 -45.2 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -56.09 -62.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.2 mt -48.02 -50.93 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -42.18 -38.78 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -79.74 -35.73 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 95.6 mt -57.29 -44.02 83.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 205' ' ' ILE . 8.5 t-20 -52.1 -46.55 65.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.45 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 44.2 mtt-85 -57.14 -42.39 80.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.32 -47.24 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.6 p -59.3 -40.16 85.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.8 mt-30 -49.7 -44.2 47.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -100.29 54.17 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.471 ' CG ' HG23 ' A' ' 168' ' ' THR . 2.3 p80 -84.58 29.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -110.17 -36.76 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.7 mt -92.27 -47.32 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -88.33 -6.8 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.8 mt 49.44 50.34 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 74.1 mmm -127.6 85.62 2.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.471 HG23 ' CG ' ' A' ' 162' ' ' HIS . 71.0 p -77.77 153.24 33.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.14 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -39.03 -36.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -66.96 -48.72 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -61.76 -40.34 94.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 13.1 mt -65.49 -47.73 75.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.7 p -55.61 -48.37 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.2 mt -65.67 -38.97 83.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.7 m -63.08 -9.73 11.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.408 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.8 m-85 -118.27 -9.48 10.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.581 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -50.64 -46.0 85.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.556 0.694 . . . . 0.0 110.942 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.6 Cg_exo -47.98 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.651 2.234 . . . . 0.0 112.37 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.455 ' CG2' ' HB3' ' A' ' 101' ' ' PHE . 52.9 m -63.95 -63.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 179' ' ' THR . 45.6 mt -34.3 -60.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 7.4 ptp -139.11 127.63 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.596 0.712 . . . . 0.0 110.854 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 51.5 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.908 0.385 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -42.05 -55.46 3.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -40.97 72.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.7 t -50.19 -36.76 31.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.429 ' CG1' HD22 ' A' ' 117' ' ' LEU . 93.4 t -53.47 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.122 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.98 -52.7 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -46.83 -45.88 20.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.4 m -55.77 -57.24 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 208' ' ' CYS . 12.7 m-85 -38.97 -52.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.418 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 68.6 mt -58.54 -53.86 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -52.76 -55.2 24.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 10.2 mm-40 -93.36 24.68 3.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.562 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 13.2 t -63.37 -7.3 6.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 213' ' ' TYR . 5.8 mm-40 -103.44 -60.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.465 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 4.0 t80 -40.02 -27.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -56.09 -61.97 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -125.88 -26.86 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.501 ' O ' ' N ' ' A' ' 215' ' ' GLY . 32.1 m-85 -83.94 25.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' TYR . 0.4 OUTLIER 34.4 32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -61.7 175.86 5.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -110.06 146.29 35.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.882 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.454 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 89.8 mt -65.42 111.51 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.28 168.24 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.425 ' C ' ' CD ' ' A' ' 219' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.82 0.258 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.1 tp -47.3 -56.35 6.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.437 ' CB ' HG23 ' A' ' 143' ' ' VAL . 7.4 pt20 -44.22 -32.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.81 -49.4 18.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.63 -42.09 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.3 m -89.33 156.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.8 p -103.65 159.85 15.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.65 -44.82 63.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -57.36 -46.5 83.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -126.48 88.28 54.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.859 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -36.13 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.98 131.29 63.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.721 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 120.98 7.68 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.403 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.43 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -43.89 -50.08 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.493 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 84.7 t80 -42.58 -66.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.5 t -42.72 -57.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -48.56 -57.7 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 47.6 mmtt -46.77 -39.81 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 88.7 m -67.01 -36.8 82.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.2 t -72.44 -53.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -60.63 -35.87 77.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 50' ' ' ASP . 65.6 t80 -60.77 -65.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -37.2 -39.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.57 -41.68 60.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 47' ' ' PHE . 5.4 m-20 -62.18 -43.73 98.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -79.57 -29.82 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.144 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.04 119.7 1.09 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.495 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -94.62 -32.86 13.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.43 39.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 56' ' ' GLU . 24.3 m -87.16 112.47 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.3 tt0 -37.01 125.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.19 89.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -106.03 -36.88 6.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.819 0.342 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -84.13 -61.23 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -12.02 2.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.738 0.304 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -43.26 -49.69 6.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -63.75 -29.45 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.3 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 20.8 p30 -50.52 -43.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.46 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 81.1 mt -51.05 -42.52 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -78.51 -57.29 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.93 -67.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -38.74 -52.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 86.2 t80 -54.16 -55.59 26.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.98 -46.47 71.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -60.83 -33.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.28 141.88 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -93.33 -18.7 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -78.32 46.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.7 pt -109.25 175.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -142.16 117.53 10.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.97 -43.09 83.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.11 -42.24 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 t -60.55 -43.57 97.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 mtp -60.54 -29.82 69.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.811 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.11 43.42 29.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.58 168.36 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 p -65.9 118.16 9.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -38.72 -47.29 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -46.31 -42.97 15.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.39 -59.91 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 47' ' ' PHE . 58.7 t -51.59 -59.68 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.78 -38.88 0.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.113 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.3 -58.72 2.69 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.44 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.36 -39.99 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 111.091 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.4 tp -52.23 -51.21 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -67.26 -41.19 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.88 -39.87 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.61 -52.55 64.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.414 ' CB ' ' CG2' ' A' ' 179' ' ' THR . 49.4 m-85 -60.34 -43.66 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.32 -41.26 79.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -35.56 65.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.0 mt -39.24 143.9 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.652 0.739 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.61 34.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.706 2.271 . . . . 0.0 112.326 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 156.85 68.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 140.39 42.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.371 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -43.91 -49.48 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.422 HG23 ' CD1' ' A' ' 117' ' ' LEU . 55.7 mt -87.45 125.02 66.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.609 0.719 . . . . 0.0 111.142 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 150.61 68.42 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -67.03 -25.59 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 t -65.14 -15.94 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.555 HD13 ' CE1' ' A' ' 140' ' ' PHE . 21.5 mt -118.55 26.0 9.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.485 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.8 m170 -71.63 -60.22 2.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.598 0.713 . . . . 0.0 110.903 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.74 -25.56 28.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.27 . . . . 0.0 112.326 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -68.16 -35.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.422 ' CD1' HG23 ' A' ' 109' ' ' ILE . 7.5 mt -72.52 -25.68 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 121' ' ' ALA . 9.8 mt -88.75 -58.65 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -39.47 -30.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.68 -37.68 20.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -65.54 -17.77 64.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.095 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -96.79 26.42 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.98 131.48 39.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.649 0.737 . . . . 0.0 111.139 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -45.78 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.2 m-20 -70.92 95.53 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -35.61 -54.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.9 m -51.64 -51.95 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.85 -45.46 90.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -50.11 -44.46 52.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.25 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -43.15 -50.35 6.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.61 -60.21 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 22.8 mt -52.04 -38.12 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -62.93 -26.4 68.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 -42.06 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.409 ' O ' ' CE1' ' A' ' 140' ' ' PHE . 86.4 mt -64.5 -18.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.51 -6.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -78.95 -39.03 35.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -76.02 -1.93 28.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -64.67 137.05 57.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.528 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -38.69 141.73 0.56 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.599 0.714 . . . . 0.0 110.86 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.528 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.7 -15.98 37.58 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.437 HG23 ' CB ' ' A' ' 28' ' ' GLN . 21.4 t -96.04 -39.0 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -76.33 -41.97 46.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 3.1 t80 -56.58 -59.45 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 145' ' ' TYR . 3.4 t0 -35.69 -45.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 49.0 t -76.5 -44.21 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.54 ' CZ ' HD13 ' A' ' 152' ' ' ILE . 31.2 t80 -52.86 -46.13 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -66.28 -48.11 71.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -56.28 -44.7 80.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.74 -64.23 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.181 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.54 HD13 ' CZ ' ' A' ' 148' ' ' PHE . 78.1 mt -45.46 -52.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.122 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.8 m -41.04 -38.31 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -78.81 -39.45 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 98.7 mt -56.58 -47.1 80.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.79 -44.76 39.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.457 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 22.4 mtt-85 -60.38 -28.03 67.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.04 -40.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 84.2 p -64.0 -26.36 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 40.1 mt-30 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.424 ' OE1' ' C ' ' A' ' 160' ' ' GLN . 2.1 mm100 -103.38 32.43 3.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.543 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 11.5 p80 -52.73 -43.43 65.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.543 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 14.3 mmtp -59.54 -28.55 67.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.09 -55.92 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 166' ' ' LEU . 1.3 m-20 -92.4 22.1 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 162' ' ' HIS . 11.5 mt 35.18 53.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.5 mmm -148.64 110.39 4.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ALA . 61.2 p -96.59 154.01 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.08 -41.6 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.95 -50.04 65.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 168' ' ' THR . 38.8 m-20 -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.65 -42.43 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 t -60.27 -27.95 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 47.5 mt -83.43 -35.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.98 -21.33 64.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -104.5 -11.32 17.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.22 -46.45 93.93 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.598 0.713 . . . . 0.0 110.933 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.4 Cg_exo -48.0 -57.4 2.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 0.0 112.346 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 180' ' ' LEU . 59.8 m -73.35 -61.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 80.7 mt -32.54 -48.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.479 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 14.1 ptm -158.29 141.97 15.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.829 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.848 -179.88 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -47.84 -58.76 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.84 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -53.36 -50.32 65.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 m -50.1 -41.48 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 66.8 t -44.07 -71.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 202' ' ' GLU . 95.3 t -61.1 -59.68 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 201' ' ' VAL . 10.1 tt0 -34.16 -47.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -60.0 -57.04 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -39.12 -34.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.401 ' HA ' ' CG2' ' A' ' 152' ' ' ILE . 95.2 mt -80.81 -62.0 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -47.91 -51.94 21.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 207' ' ' GLN . 26.5 mp0 -95.42 30.6 2.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.485 ' NE2' ' CD2' ' A' ' 213' ' ' TYR . 6.1 mm-40 -84.65 -53.88 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -40.45 -37.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -53.06 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.21 -55.29 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.485 ' CD2' ' NE2' ' A' ' 209' ' ' GLN . 69.9 m-85 -60.34 -9.96 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.959 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 t30 49.07 37.19 10.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -68.66 172.05 36.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.71 154.86 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.16 132.57 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.85 177.98 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.761 0.234 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.1 tp -45.03 -55.37 5.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.564 ' NE2' ' CE1' ' A' ' 141' ' ' HIS . 5.2 pt20 -46.46 -36.16 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.63 -39.95 61.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.19 -44.84 82.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -93.37 171.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 p -111.53 147.95 34.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.56 -45.12 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -54.59 -45.44 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -129.34 93.42 35.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 110.948 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -38.92 7.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.732 2.288 . . . . 0.0 112.346 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.451 HD11 ' CB ' ' A' ' 150' ' ' TYR . 27.8 mt -78.2 128.46 78.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.664 0.745 . . . . 0.0 111.089 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.87 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.699 2.266 . . . . 0.0 112.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.447 HD12 ' CG ' ' A' ' 43' ' ' LYS . 2.4 tm? -99.13 -49.21 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -46.53 -50.32 17.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.5 t -57.51 -58.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.091 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -46.45 -56.21 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CG ' HD12 ' A' ' 39' ' ' LEU . 12.0 mmtp -43.97 -44.53 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 85.3 m -66.76 -62.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -45.36 -47.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.12 -37.17 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.562 ' CD1' HG21 ' A' ' 93' ' ' VAL . 4.9 t80 -55.61 -59.19 5.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 47' ' ' PHE . 10.7 mt -34.82 -68.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.96 -45.71 89.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -40.13 -50.49 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -87.26 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 48' ' ' ILE . . . 149.15 156.21 7.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.506 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.05 41.45 3.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.307 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 p -129.92 41.85 3.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.4 m -95.96 116.25 28.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -39.12 116.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 72.37 0.56 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.506 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -41.73 -45.33 3.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 110.948 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.442 ' O ' ' C ' ' A' ' 60' ' ' ARG . 6.5 m-85 -117.9 -41.69 2.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 59' ' ' TYR . 16.8 tpp85 -34.7 -47.22 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.8 0.333 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.01 -50.47 19.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.97 -39.08 84.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -46.3 -53.2 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.0 p30 -66.03 -38.2 87.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.5 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 68.6 mt -51.42 -39.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -87.06 -60.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -46.83 -35.63 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 70' ' ' ASN . 52.1 mm-40 -77.7 -43.31 31.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -53.47 -28.81 32.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -75.71 -60.68 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -61.52 -25.84 67.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -130.62 107.07 8.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -79.68 -25.41 41.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -97.35 36.56 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.0 tt -79.83 147.46 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -124.86 102.87 7.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -44.65 -50.22 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.5 t -46.46 -50.1 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -56.5 -46.47 80.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.3 mmm -60.03 -26.8 66.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 51.96 51.45 16.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -85.36 160.2 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 p -56.13 125.18 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.2 t -43.48 -46.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.147 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -51.73 -35.72 44.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.69 -58.44 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.562 HG21 ' CD1' ' A' ' 47' ' ' PHE . 78.4 t -58.49 -37.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.22 88.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.076 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.16 -45.89 7.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.39 -46.71 73.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.2 tp -46.06 -44.19 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 30.9 mtmt -71.25 -42.06 69.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.33 -48.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 4.6 t80 -58.47 -48.61 80.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.446 ' CB ' HG22 ' A' ' 179' ' ' THR . 16.9 m-85 -53.95 -47.62 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.457 ' N ' HG23 ' A' ' 179' ' ' THR . . . -59.1 -41.46 88.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -53.18 -34.63 57.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -39.26 147.47 0.3 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -25.02 28.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.377 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -135.48 155.82 78.2 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 136.57 33.3 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.717 2.278 . . . . 0.0 112.38 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.549 HD23 ' CD1' ' A' ' 148' ' ' PHE . 24.1 tp -43.55 -41.3 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.2 mt -95.05 123.88 55.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.702 . . . . 0.0 111.139 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 140.85 43.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.248 . . . . 0.0 112.323 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 6.3 m-85 -62.75 -22.4 66.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -66.81 -22.19 66.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.4 mt -116.58 32.11 6.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.549 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.3 m170 -74.62 -61.48 1.11 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 0.0 110.832 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.72 -27.18 26.96 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.688 2.259 . . . . 0.0 112.325 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -63.77 -33.99 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -73.42 -41.54 63.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 121' ' ' ALA . 8.8 mt -69.82 -57.2 5.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -43.82 -35.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.437 ' CB ' ' HB1' ' A' ' 132' ' ' ALA . . . -81.7 -26.79 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.081 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.9 -30.4 50.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -77.56 -10.99 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 55.4 mt -51.85 132.61 38.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.16 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -65.63 113.7 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -52.09 -50.89 60.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.8 m -54.59 -65.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.172 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -43.45 -52.81 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -41.01 -52.56 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.5 mt -60.47 -57.22 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 120' ' ' ALA . . . -48.34 -51.64 25.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.01 -24.6 67.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -77.71 -33.04 53.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.1 pt-20 -83.69 -35.46 24.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.467 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 54.3 mt -69.2 -36.57 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.16 -21.13 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -72.09 -39.48 68.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -59.62 -33.52 71.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -41.98 145.82 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.564 ' CE1' ' NE2' ' A' ' 28' ' ' GLN . 2.4 t-80 -43.25 142.18 1.68 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.816 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.84 -6.4 18.54 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.413 HG21 ' CB ' ' A' ' 28' ' ' GLN . 48.8 t -99.19 -45.9 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -79.22 -38.06 36.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.3 t80 -42.74 -47.92 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -52.42 65.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -55.93 -64.12 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.561 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 31.3 t80 -43.55 -49.37 7.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 mtp85 -60.5 -47.06 87.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.451 ' CB ' HD11 ' A' ' 37' ' ' ILE . 71.8 t80 -59.13 -44.28 92.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 70.9 t -56.93 -60.53 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.561 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 56.3 mt -48.5 -50.14 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.6 m -40.4 -32.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.6 -36.83 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 152' ' ' ILE . 75.1 mt -55.96 -46.81 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -49.28 -41.68 38.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 23.3 mtp85 -60.63 -32.84 71.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.72 -39.4 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 p -66.22 -28.05 68.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.3 mt-30 -63.33 -37.35 86.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.473 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 16.2 mm-40 -98.3 32.31 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.448 ' HB2' ' CG2' ' A' ' 168' ' ' THR . 7.8 p80 -57.13 -21.32 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -82.96 -17.56 43.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 60.2 mt -100.12 -63.93 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.73 22.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 165' ' ' ASN . 22.8 mt 33.12 54.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 38.1 mmm -142.68 105.82 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 169' ' ' ALA . 72.4 p -94.7 150.05 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -33.81 -50.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -55.04 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -55.16 -38.81 68.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -71.67 -34.65 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.5 ' CD1' ' OE1' ' A' ' 198' ' ' GLN . 27.5 mt -80.7 -28.39 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.9 m -75.9 -21.21 57.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.559 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 14.3 m-85 -103.7 -8.74 19.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.568 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.5 OUTLIER -54.37 -46.92 98.88 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.52 0.676 . . . . 0.0 110.902 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.7 Cg_exo -48.02 -48.64 15.84 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.457 HG23 ' N ' ' A' ' 102' ' ' ALA . 39.7 m -81.83 -59.13 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 58.9 mt -33.17 -69.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.565 ' HG2' ' CH2' ' A' ' 177' ' ' TRP . 3.2 ttp -121.01 118.75 30.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 182' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.585 0.707 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.861 0.362 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.408 ' CD2' HD21 ' A' ' 118' ' ' LEU . 6.0 m80 -50.81 -60.16 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.5 ' OE1' ' CD1' ' A' ' 174' ' ' ILE . 70.1 mt-30 -57.2 -43.94 83.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 t -55.92 -39.34 71.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 92.8 t -46.7 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.124 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.42 -55.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.147 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -40.62 -40.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 204' ' ' PHE . 49.5 m -58.98 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 208' ' ' CYS . 10.7 m-85 -36.08 -56.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 60.7 mt -59.56 -46.43 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -55.57 -58.03 9.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -99.72 28.98 4.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.554 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -57.91 -27.48 63.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -82.34 -54.55 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.18 -36.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.554 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -50.54 -63.17 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -104.61 -55.74 2.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -55.0 -35.63 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 71.28 39.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -75.53 178.04 48.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.48 137.14 47.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 77.7 mt -59.16 125.92 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.28 170.31 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.166 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.94 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.21 0 CA-C-O 120.789 0.245 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.8 tp -78.74 -45.51 20.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -48.15 -28.12 2.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -78.02 -45.66 23.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.5 mt -66.16 -42.78 88.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.3 m -87.77 155.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -103.68 157.78 16.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.05 -44.19 30.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -58.74 -48.84 79.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -121.63 87.6 45.99 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.54 0.686 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.17 9.57 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.656 2.237 . . . . 0.0 112.364 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -77.35 132.95 68.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.643 0.735 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 140.02 41.44 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.26 . . . . 0.0 112.316 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.528 ' CD1' ' CG ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -55.24 -54.07 48.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 39' ' ' LEU . 82.4 t80 -38.17 -69.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.0 t -42.79 -55.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -50.29 -57.84 6.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.528 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 36.2 mmtt -46.74 -39.13 11.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.01 -44.73 75.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.67 -53.09 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.8 -45.37 94.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.547 ' CD1' HD13 ' A' ' 83' ' ' LEU . 57.8 t80 -43.06 -63.21 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -53.88 -57.3 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -40.85 -53.37 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -59.7 -39.72 85.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -86.37 26.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.148 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.48 172.55 48.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.469 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.66 37.36 3.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.6 p -116.63 29.68 7.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.46 ' O ' ' CD2' ' A' ' 58' ' ' LEU . 77.9 m -68.81 114.23 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.182 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.03 114.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.43 96.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.46 ' CD2' ' O ' ' A' ' 55' ' ' THR . 1.8 mm? -90.08 112.29 23.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.348 . . . . 0.0 110.917 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 72.29 33.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -126.63 -38.02 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.45 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 21.3 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.838 0.351 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.2 -55.9 7.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -59.46 -21.36 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.93 -61.41 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.7 p30 -61.46 -41.0 96.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.476 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 80.9 mt -52.34 -43.11 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -81.88 -53.88 5.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ASP . 50.9 mttt -54.62 -65.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -40.94 -44.33 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.5 -35.9 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.9 t0 -66.98 -55.48 14.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -54.72 -34.53 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -158.12 151.81 23.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.15 -19.07 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -80.81 49.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.57 -177.78 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.471 ' ND2' ' HB ' ' A' ' 84' ' ' VAL . 4.9 t30 -145.72 139.82 26.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.547 HD13 ' CD1' ' A' ' 47' ' ' PHE . 14.7 mt -84.25 -41.25 17.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.471 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 88.4 t -48.55 -50.22 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -57.53 -41.59 81.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 mtp -61.27 -26.43 67.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 54.08 45.81 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.6 151.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.107 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 p -60.83 129.77 43.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.5 t -42.83 -52.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.45 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 9.9 m120 -40.82 -48.07 3.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.5 -62.86 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.468 HG23 ' CE2' ' A' ' 47' ' ' PHE . 65.6 t -48.7 -54.03 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.46 -41.39 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.78 -60.16 4.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.67 -41.29 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.7 tp -49.64 -49.92 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 101' ' ' PHE . 32.5 mtmt -68.22 -47.46 67.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.13 -33.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -65.38 -47.12 77.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 98' ' ' LYS . 41.5 m-85 -57.04 -44.49 82.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.49 -39.6 88.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.49 -37.99 82.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -37.78 141.6 0.47 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -24.12 29.74 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.232 . . . . 0.0 112.343 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.68 153.83 77.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.655 0.74 . . . . 0.0 110.838 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 134.77 28.76 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.351 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.532 HD22 ' CD1' ' A' ' 148' ' ' PHE . 19.1 tp -38.95 -52.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.3 mt -87.35 124.35 68.27 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 0.0 111.155 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.422 ' CG ' HD13 ' A' ' 113' ' ' LEU . 54.1 Cg_endo -69.77 154.82 67.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.69 2.26 . . . . 0.0 112.352 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.528 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 21.7 m-85 -68.85 -26.47 65.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 m -65.71 -25.41 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.863 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.422 HD13 ' CG ' ' A' ' 110' ' ' PRO . 25.6 mt -111.58 36.66 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.967 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.552 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 2.7 m170 -77.94 -65.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.561 0.696 . . . . 0.0 110.829 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.71 -21.44 33.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.739 2.293 . . . . 0.0 112.344 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.64 -28.55 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -79.91 -36.6 36.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.6 -46.47 25.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.95 -31.79 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.84 -29.25 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.7 -21.17 59.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -91.97 22.04 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.07 130.07 45.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -44.83 1.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 102.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -40.18 -60.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.444 HG22 ' CD2' ' A' ' 131' ' ' HIS . 98.7 m -50.04 -57.09 8.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -50.27 -56.51 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -41.59 -57.15 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.468 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 52.7 mt -58.26 -54.18 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.444 ' CD2' HG22 ' A' ' 127' ' ' THR . 10.2 m-70 -47.0 -50.58 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.14 -44.45 64.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.5 mt -71.02 -29.9 65.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -74.07 -30.18 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -87.32 -36.87 17.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.7 mt -69.89 -37.71 73.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 5.2 p -63.7 -7.73 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -77.61 -38.65 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.934 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -64.87 -29.88 70.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.1 m-85 -43.68 128.34 5.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.574 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -34.09 141.49 0.24 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.574 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.72 -10.11 27.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.09 -40.38 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -83.44 -35.12 25.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 4.4 t80 -57.0 -43.43 81.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.66 -49.31 70.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.96 -50.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.532 ' CD1' HD22 ' A' ' 108' ' ' LEU . 37.4 t80 -54.13 -45.69 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -65.37 -47.15 77.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -59.27 -46.07 89.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 85.0 t -53.19 -59.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.162 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.516 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 73.6 mt -48.88 -52.01 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.074 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.1 m -39.52 -34.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -83.44 -35.67 24.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.529 HD23 ' CE2' ' A' ' 176' ' ' PHE . 68.9 mt -61.48 -49.53 76.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -50.01 -49.8 49.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -53.64 -43.36 68.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.8 -50.05 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.8 p -52.5 -21.64 3.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -58.18 -44.13 87.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.466 ' NE2' HD13 ' A' ' 164' ' ' ILE . 24.8 mt-30 -101.25 30.3 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.424 ' HA ' ' ND2' ' A' ' 165' ' ' ASN . 7.4 p80 -45.48 -25.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -74.91 -36.61 62.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.466 HD13 ' NE2' ' A' ' 161' ' ' GLN . 77.0 mt -84.29 -56.41 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -81.08 16.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 165' ' ' ASN . 11.2 mt 34.49 54.78 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 7.7 mmm -150.12 108.39 3.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.409 HG21 ' ND1' ' A' ' 162' ' ' HIS . 72.4 p -94.09 157.76 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -38.67 -43.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -62.72 -58.73 6.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -45.6 -51.66 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.52 -30.78 70.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -75.69 -32.87 60.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.488 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 62.5 mt -78.24 -31.04 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.3 m -75.26 -34.05 61.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.529 ' CE2' HD23 ' A' ' 155' ' ' LEU . 12.0 m-85 -89.09 -40.75 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.623 ' O ' ' CE3' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.01 -56.81 0.7 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 0.0 110.948 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.527 ' HD3' ' CD1' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.02 -63.7 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.487 ' O ' ' C ' ' A' ' 180' ' ' LEU . 28.6 m -59.37 -56.09 26.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 179' ' ' THR . 83.3 mt -31.34 -59.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.453 ' O ' ' C ' ' A' ' 182' ' ' ARG . 4.0 ttp -125.94 117.72 23.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 181' ' ' MET . 17.3 ttm180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.795 0.331 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -50.58 -50.82 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.21 -44.35 72.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.0 m -54.02 -48.31 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 74.2 t -38.69 -56.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.54 -50.03 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -46.71 -45.38 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 204' ' ' PHE . 97.7 m -57.93 -61.77 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.8 m-85 -35.04 -47.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 68.6 mt -67.64 -58.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.422 ' NE2' ' O ' ' A' ' 219' ' ' GLU . 18.2 mt-30 -46.37 -41.39 13.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.468 ' HG3' ' CD1' ' A' ' 130' ' ' LEU . 7.1 mm-40 -116.28 34.9 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.567 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -68.38 -22.77 64.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -85.38 -55.35 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -39.95 -34.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.567 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.0 m-85 -51.81 -63.18 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.864 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -104.98 -55.86 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -58.01 -22.53 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.929 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 57.35 38.12 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.18 143.4 23.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -41.98 145.04 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.908 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.36 143.56 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.26 170.32 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.422 ' O ' ' NE2' ' A' ' 206' ' ' GLN . 12.7 tm-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.834 0.264 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.53 -53.86 26.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -46.21 -32.01 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -40.68 30.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.01 -43.79 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.9 m -90.98 172.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.0 p -112.03 161.61 16.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.38 -44.78 72.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.39 -45.2 80.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -127.21 95.37 36.55 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -38.03 8.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.2 mt -75.04 136.56 72.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.666 0.746 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 169.51 18.72 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.706 2.27 . . . . 0.0 112.333 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.42 HD13 ' C ' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -84.69 -46.07 11.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.923 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -48.19 -64.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 44' ' ' CYS . 55.4 t -43.94 -65.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -39.77 -53.61 2.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -56.48 -37.19 70.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.41 ' N ' ' O ' ' A' ' 41' ' ' VAL . 69.4 m -69.16 -45.52 69.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.01 -49.1 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.96 -43.37 83.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.495 ' CE1' HG22 ' A' ' 93' ' ' VAL . 13.2 t80 -56.52 -61.39 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.8 mt -41.05 -44.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -64.39 -42.32 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.19 -35.19 79.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 p -90.98 29.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.64 150.66 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -120.74 -34.51 3.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.916 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.1 p -56.36 -14.7 3.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.4 m -40.95 105.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -44.51 111.38 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.73 105.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mp -105.88 -33.62 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -104.74 -55.63 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.482 ' HD3' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -59.37 -34.82 72.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.482 ' CG2' ' HD3' ' A' ' 60' ' ' ARG . 3.2 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ASP . 87.3 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -41.92 -49.96 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -67.58 -28.83 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.0 t70 -53.23 -53.61 48.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.6 p30 -60.14 -38.8 84.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.42 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 54.4 mt -49.92 -50.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.49 -61.01 2.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -46.04 -58.99 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -53.42 -42.04 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -64.66 -37.75 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.06 -49.13 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -76.81 -24.93 52.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -133.31 99.66 4.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -72.32 -29.32 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -91.49 34.91 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.1 tt -77.98 150.13 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -118.38 93.61 4.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -44.51 -42.08 6.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -52.81 -44.02 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 t -65.69 -27.71 68.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.6 mtp -70.96 -38.15 72.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 60.18 49.53 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 m -84.49 162.52 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' VAL . 66.8 p -67.23 115.18 6.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' THR . 60.9 t -33.65 -54.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.154 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -37.16 -49.33 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.05 -60.37 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.495 HG22 ' CE1' ' A' ' 47' ' ' PHE . 77.2 t -48.08 -62.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -41.28 -35.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.15 -57.43 2.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.517 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.1 -43.66 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 111.066 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.3 tp -43.41 -45.29 6.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.557 ' HG2' ' CE1' ' A' ' 176' ' ' PHE . 28.5 mtmt -65.06 -46.82 79.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.67 -34.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -65.93 -38.76 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.84 -36.35 50.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.06 -39.31 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -59.95 -37.52 79.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -40.42 146.39 0.44 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 -21.67 32.99 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.336 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -142.82 155.07 63.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.542 0.687 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.74 48.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.423 HD22 ' CD1' ' A' ' 148' ' ' PHE . 9.0 tp -43.66 -40.85 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mt -83.37 128.7 63.35 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.676 0.75 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 147.05 62.09 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.722 2.282 . . . . 0.0 112.318 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.554 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 4.7 m-85 -64.66 -37.85 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.3 m -55.91 -15.11 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.566 HD12 ' CE1' ' A' ' 140' ' ' PHE . 31.8 mt -128.44 35.64 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.554 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.2 m170 -76.08 -63.32 0.62 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 0.0 110.859 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.69 -10.3 28.27 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -74.7 -33.78 62.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.18 -36.15 66.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.91 -54.3 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -49.53 -33.06 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.43 ' HB3' ' CB ' ' A' ' 132' ' ' ALA . . . -82.66 -22.46 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.75 -33.81 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -71.45 -10.23 59.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.44 127.92 85.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.622 0.725 . . . . 0.0 111.137 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -44.77 1.88 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.667 2.244 . . . . 0.0 112.351 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.77 108.64 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -46.66 -55.99 6.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 m -57.34 -65.26 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -42.42 -56.35 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -38.62 -46.14 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.7 mt -69.27 -58.47 3.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -44.8 -51.85 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 120' ' ' ALA . . . -49.97 -46.23 52.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 20.0 mt -68.53 -28.27 66.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -75.13 -32.54 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.04 -31.29 25.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 74.8 mt -75.26 -32.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.434 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.8 p -76.03 0.35 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.141 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -82.33 -41.13 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.25 22.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.566 ' CE1' HD12 ' A' ' 113' ' ' LEU . 2.3 m-85 -80.1 141.44 35.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.7 t-80 -39.91 141.94 0.73 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.604 0.716 . . . . 0.0 110.833 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.8 Cg_endo -69.81 -8.06 22.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 74.3 t -99.19 -48.33 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -73.47 -43.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -48.51 -42.19 32.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.95 -56.22 23.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.63 -62.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.168 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.552 ' CZ ' HD12 ' A' ' 152' ' ' ILE . 26.3 t80 -39.43 -39.94 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -70.43 -46.33 64.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.29 -36.66 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.0 t -63.1 -64.69 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.078 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.552 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 80.2 mt -47.98 -52.1 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -40.94 -35.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.149 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -83.26 -40.91 18.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 97.5 mt -54.47 -44.45 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -50.88 -45.34 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.449 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 72.0 mtt85 -55.77 -39.26 70.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 76.3 t -69.12 -38.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 p -64.32 -35.34 80.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.449 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 38.7 mt-30 -54.51 -38.0 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.49 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 21.4 mm-40 -99.1 28.77 4.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.516 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 9.8 p80 -54.6 -31.71 57.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 20.5 mmtp -73.54 -21.69 60.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.455 ' CD1' ' OE1' ' A' ' 161' ' ' GLN . 74.3 mt -95.37 -57.59 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -89.86 26.24 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 165' ' ' ASN . 14.2 mt 32.56 41.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 9.7 mmm -128.72 104.5 7.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.453 ' CG2' ' HB2' ' A' ' 162' ' ' HIS . 60.8 p -96.57 150.67 20.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -36.16 -33.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 168' ' ' THR . 10.0 t70 -63.84 -57.43 9.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -51.4 -57.15 9.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 10.6 mt -53.67 -29.01 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.0 t -81.13 -37.36 28.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 70.1 mt -74.51 -24.78 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -75.27 -39.07 60.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.557 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 9.6 m-85 -88.99 -38.81 14.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.626 ' O ' ' CE3' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.78 -56.7 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.563 0.696 . . . . 0.0 110.906 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.501 ' CD ' ' O ' ' A' ' 174' ' ' ILE . 65.7 Cg_exo -48.04 -52.37 8.37 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 180' ' ' LEU . 58.7 m -70.42 -62.0 1.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 95.9 mt -34.05 -45.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 13.6 mtm -145.5 133.32 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 110.884 -179.941 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 197' ' ' HIS . 91.0 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.864 0.364 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 196' ' ' ILE . 60.0 m-70 -35.79 -48.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -68.3 -60.14 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 200' ' ' VAL . 21.1 m -43.28 -41.47 3.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 199' ' ' SER . 99.5 t -36.75 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' GLU . 90.6 t -68.86 -55.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -34.24 -49.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.5 m -55.68 -62.9 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 11.7 m-85 -35.71 -51.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 85.8 mt -60.48 -57.35 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -49.43 -52.31 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.9 mm-40 -101.72 30.69 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 1.4 t -65.34 -19.45 65.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 213' ' ' TYR . 32.7 mm-40 -87.9 -45.89 9.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -37.17 20.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -50.71 -63.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -104.77 -55.45 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 209' ' ' GLN . 52.2 m-85 -58.25 -25.1 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 57.47 45.21 20.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -83.73 -179.04 52.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.64 147.93 44.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.445 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 45.8 mt -75.13 139.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.145 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.05 177.68 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.817 0.257 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.8 tp -72.39 -48.47 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.47 ' CB ' HG23 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -48.7 -25.27 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.49 -49.4 12.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.29 -43.81 97.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.9 m -94.98 156.43 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.4 p -105.25 162.5 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.58 -39.02 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -63.45 -45.62 90.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -128.17 81.74 69.87 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -31.33 20.75 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.712 2.275 . . . . 0.0 112.359 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -82.4 127.82 69.49 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.563 0.696 . . . . 0.0 111.139 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 161.67 45.03 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.683 2.256 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.514 ' CD1' ' CG ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.63 -56.33 5.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -38.6 -63.83 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.1 t -44.95 -58.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -48.79 -59.93 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.514 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 51.3 mmtt -43.52 -39.8 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.84 -48.87 57.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.2 t -58.71 -45.59 90.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.422 ' CD ' ' HA ' ' A' ' 43' ' ' LYS . 11.7 pt-20 -67.22 -41.31 85.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.563 ' CE1' HG22 ' A' ' 93' ' ' VAL . 17.7 t80 -53.02 -63.39 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 98.1 mt -39.98 -48.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.05 -43.52 98.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.23 -41.03 96.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 t -85.66 28.55 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.141 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.52 165.07 24.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.42 41.52 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 p -129.12 43.36 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -95.09 136.52 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.176 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -81.42 117.88 22.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.4 99.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.13 -0.41 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CD1' ' HE2' ' A' ' 98' ' ' LYS . 15.7 m-85 -123.11 -38.31 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -85.0 -29.3 25.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.3 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.786 0.326 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.471 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 51.4 m-20 -60.6 -53.36 58.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.424 ' OE1' ' N ' ' A' ' 96' ' ' ALA . 44.2 mt-30 -49.12 -40.73 33.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.52 -68.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 24.8 p30 -59.82 -39.5 85.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.501 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 45.4 mt -43.93 -44.15 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -77.45 -46.28 23.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -56.95 -63.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -43.2 -44.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.13 -42.12 97.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.08 -46.25 88.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -61.63 -36.22 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -158.34 154.78 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.6 m170 -102.06 -20.69 14.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.47 54.85 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 pt -118.78 -178.8 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -144.69 145.12 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.4 mt -89.15 -42.59 11.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.01 -53.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -50.33 -46.58 55.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.6 mtp -52.97 -28.53 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 53.23 41.45 32.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.66 163.95 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.8 t -70.91 149.38 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.6 t -59.98 -54.41 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -40.19 -39.52 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.471 ' CB ' ' HB2' ' A' ' 67' ' ' ASP . . . -62.1 -64.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.563 HG22 ' CE1' ' A' ' 47' ' ' PHE . 94.1 t -45.28 -50.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -43.89 -51.89 7.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.408 ' C ' ' OE1' ' A' ' 68' ' ' GLN . . . -65.19 -47.31 82.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.424 ' N ' ' OE1' ' A' ' 68' ' ' GLN . . . -46.32 -48.84 18.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.064 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.2 tp -48.84 -50.01 36.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.502 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 43.9 mtmt -65.61 -46.76 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.56 -47.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.66 -53.29 60.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -53.5 -50.25 65.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.436 ' N ' HG22 ' A' ' 179' ' ' THR . . . -52.85 -42.76 65.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 104' ' ' LEU . 13.1 t0 -52.51 -42.13 64.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 103' ' ' ASP . 80.5 mt -36.62 141.04 0.39 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -18.89 36.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.79 152.68 56.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.674 0.75 . . . . 0.0 110.859 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.73 134.82 28.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 107' ' ' PRO . 5.4 tp -33.95 -52.87 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.0 mt -73.86 127.0 89.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.634 0.731 . . . . 0.0 111.161 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 143.93 52.4 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.272 . . . . 0.0 112.331 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.538 ' CD1' ' CE1' ' A' ' 114' ' ' HIS . 4.1 m-85 -59.71 -32.16 70.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 t -59.29 -24.07 62.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.586 HD13 ' CE1' ' A' ' 140' ' ' PHE . 18.1 mt -117.64 30.21 7.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.538 ' CE1' ' CD1' ' A' ' 111' ' ' TYR . 3.6 m170 -75.03 -62.42 0.87 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.642 0.734 . . . . 0.0 110.849 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.4 Cg_endo -69.78 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -81.04 -30.76 34.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.467 HD22 ' CG1' ' A' ' 200' ' ' VAL . 3.0 mt -74.22 -38.15 63.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 197' ' ' HIS . 10.2 mt -75.39 -59.81 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -40.35 -33.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -84.27 -33.99 23.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.076 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -67.16 -26.39 66.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -87.0 26.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 95.3 mt -95.64 130.76 30.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 111.182 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -46.63 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 0.0 112.372 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 61.9 m-20 -60.39 91.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 125' ' ' ASP . 32.8 tttt -34.7 -56.49 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.0 m -53.1 -58.58 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.65 -57.73 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -39.92 -56.96 1.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.2 mt -55.76 -56.77 16.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -48.64 -38.48 21.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.03 96.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.5 mt -77.19 -24.35 51.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -81.67 -23.62 36.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.04 -33.9 16.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.468 ' O ' ' CE1' ' A' ' 140' ' ' PHE . 48.5 mt -74.83 -26.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.59 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.1 p -77.93 -11.16 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -74.74 -41.7 59.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -81.39 19.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.1 m-85 -80.73 138.03 36.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.561 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.6 t-80 -38.06 142.64 0.45 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.561 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.75 -7.72 21.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.362 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.47 HG23 ' CB ' ' A' ' 28' ' ' GLN . 92.8 t -99.75 -39.11 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.77 -46.48 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.467 ' CE2' ' O ' ' A' ' 137' ' ' VAL . 1.3 t80 -41.83 -54.56 3.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.34 -65.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.3 t -50.52 -40.58 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.564 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 3.9 t80 -51.07 -48.54 61.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -58.14 -58.35 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -52.58 -45.06 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.51 -66.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.564 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 64.3 mt -54.22 -56.16 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.9 m -41.09 -34.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -76.89 -42.73 38.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 30.5 mt -60.81 -51.83 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -45.12 -44.27 10.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 56.7 mtt-85 -56.96 -50.47 72.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.23 -50.17 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 p -51.58 -29.67 18.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 157' ' ' ARG . 35.2 mm-40 -46.51 -57.39 4.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -100.58 41.63 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 167' ' ' MET . 27.3 p80 -57.81 -21.44 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -71.06 -34.15 70.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.83 -58.76 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.088 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -79.58 12.84 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 15.2 mt 38.11 53.86 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.435 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 19.7 mmm -148.53 108.05 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 30.5 p -92.22 166.77 12.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.167 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -53.27 -34.25 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' CG ' ' HG3' ' A' ' 202' ' ' GLU . 1.1 m-20 -70.38 -48.49 56.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -55.82 -35.9 66.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.8 -46.9 64.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.2 t -53.9 -38.96 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 15.7 mt -78.95 -33.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.6 m -70.58 -25.6 63.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.502 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 21.4 m-85 -97.72 -16.8 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.564 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -46.69 -47.16 50.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.567 0.699 . . . . 0.0 110.901 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.1 Cg_exo -48.03 -48.6 15.95 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.692 2.262 . . . . 0.0 112.31 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 102' ' ' ALA . 76.0 m -84.02 -64.48 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 179' ' ' THR . 49.8 mt -34.61 -63.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 46.2 mmm -111.16 117.37 33.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 0.0 110.874 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 36.5 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.858 0.361 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.557 ' CE1' HD12 ' A' ' 118' ' ' LEU . 53.3 m-70 -42.58 -60.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -49.64 -44.52 47.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.0 m -60.64 -42.71 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.467 ' CG1' HD22 ' A' ' 117' ' ' LEU . 90.9 t -38.08 -69.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 202' ' ' GLU . 60.3 t -62.32 -55.88 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.419 ' HG3' ' CG ' ' A' ' 170' ' ' ASP . 2.1 tm-20 -37.88 -40.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 204' ' ' PHE . 65.8 m -64.9 -60.87 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.12 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' CYS . 12.3 m-85 -34.11 -54.11 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.85 -56.59 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.155 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -46.38 -49.65 17.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.465 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.7 mm-40 -109.51 34.19 3.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.549 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 4.2 t -65.79 -19.72 65.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.889 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 209' ' ' GLN . 3.7 mm-40 -84.94 -54.98 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.87 -38.63 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.549 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -47.47 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.13 -53.7 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -58.5 -25.12 62.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 58.68 43.15 19.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -87.36 144.17 19.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 215' ' ' GLY . 10.1 mm-40 -35.14 149.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.465 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.6 mt -74.29 133.81 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.176 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.5 172.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.825 0.261 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 tp -47.54 -46.81 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -53.07 -30.4 35.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -46.02 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.8 mt -59.83 -44.11 94.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 m -90.43 171.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 p -118.95 156.26 29.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -46.9 -45.97 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -59.66 -46.21 89.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -126.58 86.73 57.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -29.89 22.91 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.684 2.256 . . . . 0.0 112.361 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.8 mt -84.16 134.51 43.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 111.154 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 146.81 61.62 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.435 ' CD1' ' CG ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -67.17 -40.81 86.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -51.6 -60.88 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.1 t -49.24 -63.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -40.61 -55.43 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 40.9 mmtt -55.87 -41.21 74.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.5 m -61.33 -40.71 95.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.449 ' CG1' ' CG ' ' A' ' 154' ' ' HIS . 25.2 t -71.22 -54.85 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -50.33 -33.69 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.42 ' CE2' HG21 ' A' ' 93' ' ' VAL . 19.5 t80 -60.74 -62.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.8 mt -47.34 -43.04 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.14 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.95 -26.51 59.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.35 -22.4 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -110.75 11.62 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 164.02 6.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.83 75.15 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -25.08 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -51.34 117.22 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.33 117.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.7 94.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.471 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.75 -34.73 9.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.7 -63.96 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HB2' ' NH1' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -53.34 -16.22 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.2 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.766 0.317 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -54.66 -60.49 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HA ' ' CD1' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -59.92 -44.78 94.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -41.62 -49.5 4.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 16.1 p30 -73.17 -34.78 66.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.453 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 52.1 mt -55.4 -45.97 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -79.57 -48.63 13.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -57.46 -59.27 5.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -50.26 -48.24 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.4 ' O ' ' O ' ' A' ' 78' ' ' ASP . 40.8 t80 -50.01 -56.05 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -54.59 -33.11 59.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -81.72 -18.41 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 75' ' ' PHE . 5.2 t0 -149.53 118.87 6.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -83.75 -24.23 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -98.57 36.38 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 tt -79.73 151.76 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -124.24 94.53 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.7 mt -40.55 -44.39 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.0 t -49.05 -47.88 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 t -58.11 -43.22 87.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 85.4 mtp -59.03 -36.13 74.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 59.28 44.75 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -80.18 173.84 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.9 p -69.11 111.88 5.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.5 t -37.44 -50.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -45.36 -45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.37 -63.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' A' ' 47' ' ' PHE . 95.5 t -45.83 -44.85 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.95 -38.59 67.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.58 -56.29 3.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.87 -36.92 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 111.099 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.8 tp -60.08 -47.39 86.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -65.96 -38.73 89.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.44 -36.87 55.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.093 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -62.9 -40.69 98.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.02 -41.68 99.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.07 80.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -34.31 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -41.48 147.4 0.48 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -28.71 24.8 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.94 139.47 16.07 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.605 0.717 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.9 Cg_endo -69.77 136.51 33.16 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.674 2.249 . . . . 0.0 112.321 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.44 HD23 ' CD1' ' A' ' 148' ' ' PHE . 5.5 mp -34.97 -49.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.2 mt -91.51 107.41 21.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 0.0 111.133 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 149.42 67.15 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.407 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.427 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 0.7 OUTLIER -62.48 -27.42 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 m -66.02 -8.19 21.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.527 HD12 ' CE1' ' A' ' 140' ' ' PHE . 70.4 mt -128.39 21.7 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.487 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.1 m170 -67.93 -60.13 5.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 0.0 110.81 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.78 -25.15 28.8 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.93 -27.35 67.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.77 -18.71 53.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.422 HD23 ' CD2' ' A' ' 197' ' ' HIS . 10.6 mt -92.56 -47.83 6.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -48.29 -40.37 24.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -83.73 -20.47 33.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.61 -21.79 51.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -93.8 17.87 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 96.5 mt -81.73 129.58 64.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 111.145 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -44.79 1.87 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.317 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.2 t70 -67.02 94.08 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.838 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.0 tptp -34.64 -50.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.2 m -52.5 -57.76 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -56.74 -49.18 75.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -45.74 -53.98 8.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.437 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 37.3 mt -65.57 -62.24 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -41.82 -28.65 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.414 ' HB1' ' CB ' ' A' ' 120' ' ' ALA . . . -75.52 -50.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 13.5 mt -65.77 -22.81 66.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -81.94 -30.61 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.926 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -85.89 -29.75 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.464 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 11.1 p -86.66 -6.48 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -77.78 -41.57 36.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -16.06 62.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.527 ' CE1' HD12 ' A' ' 113' ' ' LEU . 3.1 m-85 -46.82 151.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.539 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.9 t-80 -42.46 138.32 2.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.539 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.74 -20.72 34.59 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.35 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.27 -44.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -73.9 -48.06 33.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -39.24 -53.71 1.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -47.65 -48.93 28.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 30.5 t -69.26 -57.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.159 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.44 ' CD1' HD23 ' A' ' 108' ' ' LEU . 10.7 t80 -42.24 -45.5 4.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -60.85 -53.59 55.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -54.57 -43.83 72.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 82.0 t -52.61 -62.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.154 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.423 HD13 ' CZ ' ' A' ' 148' ' ' PHE . 3.3 mt -46.49 -51.13 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.4 m -40.93 -37.91 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.449 ' CG ' ' CG1' ' A' ' 45' ' ' VAL . 84.6 t60 -80.26 -39.2 29.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.52 -45.85 73.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -51.22 -49.82 60.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -51.79 -53.24 42.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.24 -35.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.8 p -66.24 -22.34 66.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -73.98 -31.59 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.426 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 3.1 mm100 -95.78 27.7 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.516 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 11.1 p80 -60.11 -16.47 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.827 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 14.0 mmmt -86.5 -5.53 59.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.33 -60.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.37 9.31 11.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.8 mt 47.46 43.95 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.405 ' HE1' ' CD2' ' A' ' 172' ' ' LEU . 23.2 mtp -129.96 106.26 8.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ALA . 78.1 p -97.57 151.24 20.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.77 -35.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 168' ' ' THR . 2.1 t70 -66.04 -60.45 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -47.81 -49.07 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.405 ' CD2' ' HE1' ' A' ' 167' ' ' MET . 7.4 mt -62.13 -49.06 77.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 t -51.71 -43.57 62.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -77.0 -38.01 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.19 -16.0 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -107.16 -11.72 15.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.565 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.23 -46.77 93.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.526 0.679 . . . . 0.0 110.896 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.0 -63.59 0.3 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 180' ' ' LEU . 28.9 m -67.04 -57.97 5.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 179' ' ' THR . 39.9 mt -34.22 -51.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.432 ' SD ' ' CZ2' ' A' ' 177' ' ' TRP . 0.6 OUTLIER -152.52 119.2 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 42.7 ttm-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.884 -179.949 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.847 0.356 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.422 ' CD2' HD23 ' A' ' 118' ' ' LEU . 32.8 m80 -41.35 -47.95 3.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -73.43 -56.24 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.0 m -42.09 -39.34 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.2 t -46.6 -72.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' PHE . 68.9 t -55.04 -57.34 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -39.84 -36.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 60.3 m -69.86 -39.05 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.189 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' VAL . 12.2 m-85 -55.53 -41.79 73.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.15 -54.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.06 -56.17 25.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.437 ' HG3' ' CD2' ' A' ' 130' ' ' LEU . 38.4 mm-40 -81.9 16.9 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.571 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 18.2 t -58.55 -22.74 56.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.92 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.582 ' N ' ' CD ' ' A' ' 209' ' ' GLN . 0.2 OUTLIER -78.59 -62.51 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -39.5 -39.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 17.4 m-30 -52.2 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -107.57 -52.17 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 209' ' ' GLN . 65.4 m-85 -62.22 -11.71 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 61.3 t30 45.78 41.04 7.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -70.46 -151.35 0.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.435 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.07 165.98 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.0 mt -75.56 121.57 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.9 175.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.813 0.256 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.78 -49.25 71.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.956 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -43.87 -37.2 2.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.91 -50.58 33.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.26 -45.49 83.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -91.74 171.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.1 p -120.28 158.06 27.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.21 -46.27 45.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.51 -44.28 72.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -132.1 90.4 35.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.97 8.45 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.7 mt -72.8 130.25 85.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 39' ' ' LEU . 54.0 Cg_endo -69.79 108.8 2.16 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.316 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.469 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -36.04 -57.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 39' ' ' LEU . 31.0 t80 -34.21 -64.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.409 ' CG2' ' HG2' ' A' ' 38' ' ' PRO . 79.7 t -43.82 -59.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -42.91 -61.94 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 64.0 mmtt -43.53 -41.09 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.9 m -68.35 -41.35 80.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -65.94 -51.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.67 -45.28 93.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 93' ' ' VAL . 32.5 t80 -45.69 -57.14 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.8 mt -45.27 -44.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -62.4 -57.41 11.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.65 -39.38 35.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -84.51 29.93 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.44 164.19 21.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.486 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.6 tp -126.81 41.04 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.748 0.309 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -124.38 37.99 4.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.6 m -98.75 128.38 44.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.36 145.75 29.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.75 45.24 4.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.535 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 59' ' ' TYR . 2.2 pt? -58.41 -37.96 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.437 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 60.7 m-85 -99.18 -51.95 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -44.03 -54.24 5.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.18 179.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.762 0.315 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.505 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 2.5 m-20 -41.26 -61.23 1.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -40.8 -40.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -67.17 -50.41 61.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -50.29 -47.22 55.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.4 mt -44.77 -43.9 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -82.82 -52.26 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -52.85 -62.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.27 -45.65 34.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.57 -44.23 97.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -63.32 -53.3 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -52.25 -39.27 60.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.23 152.58 22.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.78 -22.19 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.84 51.73 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.0 pt -107.19 -174.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 0.3 OUTLIER -151.03 119.32 6.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.26 -50.87 64.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.54 -40.92 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 68.6 m -60.39 -45.49 93.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.3 mtp -52.74 -32.44 43.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 60.86 45.66 9.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.01 168.87 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 90' ' ' VAL . 24.9 p -75.29 116.33 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 89' ' ' THR . 85.2 t -33.75 -54.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.092 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -36.12 -57.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -39.04 -59.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.55 HG22 ' CE1' ' A' ' 47' ' ' PHE . 96.9 t -46.01 -55.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.17 -44.48 16.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.24 -60.26 6.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.511 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.05 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.5 tp -53.47 -48.94 68.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 101' ' ' PHE . 29.7 mtmt -69.26 -52.5 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.8 -42.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.123 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -59.16 -47.74 84.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' LYS . 16.2 m-85 -56.18 -51.45 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.48 71.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 104' ' ' LEU . 64.4 m-20 -51.3 -42.77 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.6 mt -34.22 142.26 0.23 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -22.89 31.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -134.7 152.93 78.5 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.582 0.706 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 132.06 22.47 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.34 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -38.47 -47.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 mt -91.87 121.31 67.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 0.0 111.15 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.63 40.86 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.571 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 8.7 m-85 -54.68 -34.31 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE1' ' A' ' 116' ' ' GLU . 22.2 m -55.56 -29.15 58.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.571 HD13 ' CE1' ' A' ' 140' ' ' PHE . 32.2 mt -110.8 36.16 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.571 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 2.1 m170 -79.13 -65.49 0.3 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.632 0.73 . . . . 0.0 110.879 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.544 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.3 Cg_endo -69.74 -31.89 19.72 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.382 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 112' ' ' SER . 24.5 mp0 -60.47 -35.38 75.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.14 -39.46 68.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD22 ' CG ' ' A' ' 197' ' ' HIS . 4.9 mt -70.45 -55.48 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -46.82 -36.22 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.488 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -75.99 -25.78 56.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.413 ' CB ' HG23 ' A' ' 200' ' ' VAL . . . -78.15 -28.68 48.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -90.47 27.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 89.0 mt -89.5 135.18 31.26 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.654 0.74 . . . . 0.0 111.109 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -48.64 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.647 2.231 . . . . 0.0 112.345 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -66.15 95.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 125' ' ' ASP . 14.1 tptm -36.82 -53.44 0.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.503 HG22 ' CD2' ' A' ' 131' ' ' HIS . 50.7 m -52.23 -51.32 59.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -60.31 -49.05 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -47.2 -49.7 22.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.93 -62.65 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.503 ' CD2' HG22 ' A' ' 127' ' ' THR . 11.9 m-70 -40.43 -50.84 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.29 48.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.03 -34.12 76.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -68.32 -35.93 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 4.0 pt-20 -81.8 -32.7 31.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.462 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 51.0 mt -73.2 -34.77 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.35 -18.6 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.88 -34.48 75.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -66.95 -34.97 78.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.571 ' CE1' HD13 ' A' ' 113' ' ' LEU . 11.8 m-85 -42.66 132.39 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -33.47 142.68 0.19 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.523 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.82 -16.94 37.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 91.9 t -90.94 -39.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.15 -38.26 24.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.407 ' CZ ' ' HD3' ' A' ' 149' ' ' ARG . 46.3 t80 -52.47 -42.26 64.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.97 -42.44 80.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.84 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.439 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 98.9 t -74.31 -44.37 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.566 ' CZ ' HD12 ' A' ' 152' ' ' ILE . 26.2 t80 -58.76 -40.92 85.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.854 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 145' ' ' TYR . 47.2 ttp180 -67.62 -49.95 60.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -60.8 -47.66 85.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 147' ' ' VAL . 93.2 t -50.83 -65.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.139 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.566 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 75.8 mt -41.97 -50.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -40.51 -40.8 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -73.46 -40.14 64.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.65 -44.03 93.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.441 ' HA ' ' CG2' ' A' ' 205' ' ' ILE . 52.4 t-20 -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -58.93 -48.22 82.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.5 t -55.04 -46.86 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.3 p -56.57 -29.43 62.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -47.48 -56.35 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -100.45 33.73 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.573 ' CE1' ' HD3' ' A' ' 163' ' ' LYS . 7.3 p80 -51.62 -19.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.573 ' HD3' ' CE1' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -55.31 -34.68 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.49 -56.46 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -27.16 68.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 162' ' ' HIS . 75.8 mt 64.12 39.4 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.6 mmm -131.52 82.75 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.499 HG21 ' CG ' ' A' ' 162' ' ' HIS . 32.8 p -71.99 163.43 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.14 -46.74 5.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -60.25 -59.61 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -47.53 -50.01 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.35 -47.75 78.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.6 t -59.1 -44.58 91.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 57.9 mt -70.25 -31.49 47.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 48.9 t -70.79 -34.8 72.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.444 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 22.7 m-85 -90.23 -15.55 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.563 ' CZ3' ' HG2' ' A' ' 181' ' ' MET . 0.8 OUTLIER -47.55 -46.67 60.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.926 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.3 Cg_exo -48.04 -51.66 9.58 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.461 ' O ' ' C ' ' A' ' 180' ' ' LEU . 89.6 m -76.44 -63.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 179' ' ' THR . 87.4 mt -33.49 -70.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.563 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 2.3 ttm -100.03 112.04 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.812 -179.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 75.9 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.834 0.35 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.455 ' CG ' HD22 ' A' ' 118' ' ' LEU . 61.0 m80 -39.08 -63.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -51.91 -58.08 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.3 m -43.37 -44.16 5.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.413 HG23 ' CB ' ' A' ' 121' ' ' ALA . 48.1 t -46.25 -68.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.53 -47.32 93.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -46.32 -48.71 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.1 m -57.42 -57.87 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.457 ' C ' ' O ' ' A' ' 203' ' ' THR . 10.2 m-85 -33.98 -49.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' A' ' 156' ' ' ASN . 49.9 mt -70.39 -50.67 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -48.5 -45.45 37.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.42 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 9.4 mm-40 -117.44 36.92 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 22.9 t -64.1 -30.74 71.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -75.13 -51.67 12.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -43.82 -37.04 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -51.19 -63.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -101.25 -56.7 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -56.26 -38.04 70.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 73.18 42.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.3 169.29 53.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -58.82 136.05 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.42 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 66.3 mt -61.39 121.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -94.15 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.954 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m 61.11 45.57 8.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m -90.94 101.26 14.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.839 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.69 141.05 14.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 m -97.14 162.63 13.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.1 p -116.11 -24.35 8.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.2 -157.79 15.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.485 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.61 153.92 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.845 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -137.93 153.98 49.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -174.02 170.37 3.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -129.78 140.78 39.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.612 0.72 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 153.82 68.31 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.698 2.266 . . . . 0.0 112.308 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -168.17 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 p -87.99 174.84 8.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -144.49 128.03 17.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 18' ' ' TRP . 4.8 ptm180 -111.19 -179.27 3.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 16' ' ' ARG . 10.0 p-10 -35.42 -34.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.441 ' N ' ' O ' ' A' ' 16' ' ' ARG . 54.5 t-105 -174.17 164.41 4.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -138.53 105.32 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 t -168.95 143.54 3.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.616 ' H ' ' ND2' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -92.2 11.09 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.469 ' CD2' HD23 ' A' ' 30' ' ' LEU . 7.4 m-85 -100.44 -47.76 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.577 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -46.83 -43.67 18.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' N ' ' CD1' ' A' ' 23' ' ' PHE . . . -64.69 -37.72 94.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 15.0 mmt -85.89 146.17 42.78 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.568 0.699 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 156.91 62.06 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 tp -51.1 -42.6 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.25 -31.78 22.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -85.51 -44.63 12.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.469 HD23 ' CD2' ' A' ' 22' ' ' TYR . 11.1 mt -57.84 -46.84 84.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.7 m -88.05 171.54 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 p -124.15 165.64 17.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.37 65.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.49 -47.82 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -126.82 91.74 46.38 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.6 0.714 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -30.53 21.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.686 2.257 . . . . 0.0 112.329 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.7 mt -84.3 135.22 41.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.63 0.729 . . . . 0.0 111.129 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 130.32 19.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 40' ' ' PHE . 5.4 tp -52.2 -53.19 46.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' LEU . 16.8 t80 -36.27 -56.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.465 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 53.0 t -54.45 -62.63 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -47.68 -59.74 3.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -44.43 -36.59 2.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.3 m -75.24 -38.38 60.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -72.9 -60.12 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -54.02 -32.9 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -63.28 -57.67 9.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.9 mt -50.35 -53.54 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.42 -45.04 85.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.58 -41.23 97.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.7 p -89.05 23.35 2.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.65 135.43 4.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.474 HD12 ' CE1' ' A' ' 154' ' ' HIS . 15.1 tp -103.72 35.48 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.1 p -121.63 40.34 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 56' ' ' GLU . 18.4 m -92.28 112.31 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.7 tt0 -34.76 120.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.14 77.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.504 HD12 ' CE2' ' A' ' 59' ' ' TYR . 1.6 pt? -61.25 -29.05 69.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' CE2' HD12 ' A' ' 58' ' ' LEU . 39.2 m-85 -108.41 -49.62 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -49.63 -49.78 45.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.9 t -107.89 123.26 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.6 m -106.7 -37.06 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.83 -99.76 2.24 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -93.66 154.7 17.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -105.47 -37.71 6.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 m -46.55 -40.02 11.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.165 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -51.0 -45.74 61.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -65.11 -35.03 79.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.93 -58.4 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.0 p30 -64.35 -36.05 82.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.456 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 57.4 mt -54.3 -47.35 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -78.25 -40.08 38.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -64.7 -67.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -44.99 -45.65 10.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.87 -34.92 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.9 -52.04 48.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.57 -21.56 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -145.47 113.82 6.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -84.6 -3.23 58.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -101.91 23.53 11.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.458 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 6.0 tt -68.97 156.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.458 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 6.6 t30 -125.94 91.63 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASN . 84.3 mt -36.94 -48.06 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -51.47 -48.71 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -54.39 -39.57 67.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.8 mmm -66.97 -32.44 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 56.94 47.22 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -81.45 179.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.2 t -87.55 127.42 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.9 t -40.19 -47.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -48.31 -40.47 25.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.76 -61.99 2.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.6 -38.28 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' LEU . . . -57.75 -50.09 74.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.19 -49.81 64.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.21 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 41' ' ' VAL . 34.2 tp -58.86 -46.56 87.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' ALA . 30.0 mtmt -67.24 -52.01 46.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.45 -45.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -53.45 -53.42 51.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -58.15 -33.61 69.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -28.58 64.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LEU . 1.9 t70 -75.22 -31.57 60.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' ASP . 67.2 mt -35.72 143.51 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.743 2.295 . . . . 0.0 112.283 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -139.05 154.28 72.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.639 0.733 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.6 Cg_endo -69.82 130.09 18.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.309 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 107' ' ' PRO . 12.0 tp -35.73 -51.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -91.95 126.33 53.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.669 0.747 . . . . 0.0 111.155 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.431 ' CG ' HD11 ' A' ' 113' ' ' LEU . 53.2 Cg_endo -69.81 161.49 45.75 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -78.95 -11.49 60.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.9 t -88.67 5.45 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.431 HD11 ' CG ' ' A' ' 110' ' ' PRO . 80.0 mt -133.96 19.85 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.488 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.2 m170 -71.09 -60.11 3.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.56 0.695 . . . . 0.0 110.855 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.76 -27.13 26.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.363 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.79 -32.14 72.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -77.27 -34.38 55.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' A' ' 197' ' ' HIS . 9.6 mt -78.95 -44.04 23.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.2 -23.66 62.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.64 -9.48 29.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.446 ' CB ' HG21 ' A' ' 200' ' ' VAL . . . -95.18 -28.79 14.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -80.98 -3.44 51.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.462 ' CG2' ' HD2' ' A' ' 124' ' ' PRO . 67.4 mt -56.37 138.29 75.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.84 -50.71 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.649 2.232 . . . . 0.0 112.324 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.99 107.36 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -46.32 -52.21 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.471 HG22 ' CD2' ' A' ' 131' ' ' HIS . 25.6 m -55.09 -61.39 2.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.29 -45.87 17.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -50.18 -42.58 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.404 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 43.7 mt -70.75 -42.34 70.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.471 ' CD2' HG22 ' A' ' 127' ' ' THR . 12.0 m170 -60.66 -54.52 44.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.88 62.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.68 -24.89 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -78.26 -30.06 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.7 -31.48 18.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -38.11 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.089 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.23 -8.69 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -76.06 -28.85 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -73.04 -19.32 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -53.53 137.54 36.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.8 t-80 -38.69 141.58 0.57 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 110.896 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.77 -8.81 24.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 0.0 112.374 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.3 t -99.12 -42.25 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -85.56 -29.85 23.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -52.41 -48.79 65.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.32 -50.96 69.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.46 -59.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 152' ' ' ILE . 13.5 t80 -40.4 -40.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -69.74 -48.19 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.18 -48.91 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.54 -64.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 148' ' ' PHE . 92.0 mt -48.52 -49.21 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.0 m -40.45 -34.87 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.474 ' CE1' HD12 ' A' ' 53' ' ' LEU . 40.2 t60 -80.1 -45.95 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 59.1 mt -49.58 -49.17 47.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -48.26 -41.09 26.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.434 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 98.7 mtt180 -64.34 -36.81 85.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.5 t -68.47 -42.48 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.6 p -62.64 -30.74 71.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -60.84 -50.32 73.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -98.01 38.96 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.562 ' CE1' ' HD2' ' A' ' 163' ' ' LYS . 2.1 p80 -56.04 -31.65 63.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.562 ' HD2' ' CE1' ' A' ' 162' ' ' HIS . 12.5 mptt -53.74 -22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.6 mt -100.65 -58.69 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -80.08 11.57 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 162' ' ' HIS . 6.6 mt 34.71 46.35 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.9 mmm -142.58 120.93 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.6 p -105.47 177.32 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.03 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -46.55 66.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -59.58 -46.97 87.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.62 -41.22 98.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.6 p -58.75 -28.52 65.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.2 mt -86.81 -42.25 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.31 -16.93 57.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.403 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 14.3 m-85 -107.95 -7.13 16.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.576 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.2 t90 -51.68 -45.45 91.55 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.939 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -48.0 -65.44 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 180' ' ' LEU . 8.4 m -61.17 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 179' ' ' THR . 86.9 mt -34.35 -44.61 0.2 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 3.9 mtt -146.91 119.9 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -117.73 78.24 11.96 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.841 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -174.6 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.498 ' OD1' ' CD1' ' A' ' 185' ' ' PHE . 3.2 t70 -88.29 139.09 30.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.498 ' CD1' ' OD1' ' A' ' 184' ' ' ASP . 15.0 p90 -44.3 -35.1 2.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.44 64.76 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -90.85 0.46 57.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -107.46 1.26 23.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.53 -21.92 60.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 191' ' ' LEU . 5.1 t80 -127.8 171.69 11.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' PHE . 3.9 mm? -36.2 139.55 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.915 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.0 t -106.86 126.03 51.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.0 m -98.04 153.2 18.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 196' ' ' ILE . 17.3 m -48.93 147.02 2.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -64.18 74.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 194' ' ' THR . 30.7 mt -92.64 -32.86 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.489 ' CG ' HD22 ' A' ' 118' ' ' LEU . 16.6 m-70 -47.8 -66.42 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 197' ' ' HIS . 0.6 OUTLIER -37.42 -48.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.4 t -55.26 -48.19 74.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.851 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.446 HG21 ' CB ' ' A' ' 121' ' ' ALA . 23.1 t -45.49 -69.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.82 -61.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -44.0 -47.55 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 204' ' ' PHE . 70.7 m -54.16 -62.71 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' CYS . 14.1 m-85 -34.66 -52.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 61.1 mt -60.6 -59.97 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -45.88 -48.92 15.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' A' ' 207' ' ' GLN . 8.8 mm-40 -106.2 31.4 5.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.55 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 6.4 t -67.26 -21.15 65.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.48 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 74.4 mm-40 -87.07 -54.3 4.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.92 -36.55 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -49.53 -62.92 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -106.75 -54.36 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.48 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 65.4 m-85 -55.46 -30.88 61.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 70.85 27.83 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -68.51 137.48 30.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.5 mt-10 -37.9 154.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.06 112.57 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.82 173.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p -170.9 129.7 0.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.895 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.1 m -157.83 175.61 13.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.96 -174.71 45.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.479 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 m -142.88 175.06 10.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 110.86 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 p -173.29 132.81 0.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.67 52.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -140.57 125.86 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.331 . . . . 0.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 10' ' ' PHE . 1.7 p30 -80.01 145.79 32.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.452 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.8 OUTLIER -34.27 -62.19 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.15 138.17 0.57 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.573 0.702 . . . . 0.0 110.901 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 164.63 33.81 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -164.75 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.703 2.269 . . . . 0.0 112.35 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -106.57 132.83 52.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.522 HH21 ' ND2' ' A' ' 17' ' ' ASN . 19.3 ttp180 -162.69 127.72 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -89.42 89.43 7.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.522 ' ND2' HH21 ' A' ' 15' ' ' ARG . 1.5 m-20 -84.43 41.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.449 ' CZ3' ' HG2' ' A' ' 73' ' ' LYS . 8.4 t-105 -95.61 42.67 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.22 113.85 25.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 m -139.98 158.59 43.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -118.75 40.21 3.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.413 ' C ' ' HG2' ' A' ' 25' ' ' MET . 4.2 m-85 -119.59 -11.98 9.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -71.24 115.65 10.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.849 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.83 28.24 61.27 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.413 ' HG2' ' C ' ' A' ' 22' ' ' TYR . 32.4 mmm -110.84 147.31 36.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.539 0.685 . . . . 0.0 110.895 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 126.85 13.79 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.693 2.262 . . . . 0.0 112.321 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.5 tp -53.06 -39.79 63.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -55.21 -29.4 57.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.17 -40.85 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.55 -44.04 88.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 m -81.42 173.45 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 p -111.75 143.71 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.63 3.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.22 -43.47 98.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -131.68 106.17 14.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.54 0.686 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -35.44 12.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.623 2.215 . . . . 0.0 112.347 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.84 130.03 79.7 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.723 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.77 68.41 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.448 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.87 -47.97 78.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -45.34 -63.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.0 t -48.45 -53.77 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 150' ' ' TYR . 15.3 mm-40 -48.95 -55.84 10.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 50.6 mmtt -50.51 -41.16 53.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.8 m -63.56 -43.55 96.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 150' ' ' TYR . 44.4 t -66.64 -61.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 47' ' ' PHE . 10.6 pt-20 -53.11 -47.51 68.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.414 ' N ' ' CG ' ' A' ' 46' ' ' GLU . 60.4 t80 -48.26 -64.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mt -38.55 -62.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -45.9 -47.83 16.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -56.46 -47.21 79.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -84.76 29.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.12 141.26 6.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -106.49 -14.32 15.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.7 p -84.48 34.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 56' ' ' GLU . 36.7 m -68.73 157.05 37.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 55' ' ' THR . 1.8 mp0 -100.89 147.86 25.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' C ' ' HG2' ' A' ' 60' ' ' ARG . . . 48.01 75.87 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.48 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.413 ' CD2' ' HB ' ' A' ' 55' ' ' THR . 4.5 mm? -95.0 122.79 38.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 63.32 26.49 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 57' ' ' GLY . 7.0 ptm180 -127.24 -10.16 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.4 t -97.91 140.71 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 t -40.1 -59.44 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.41 118.73 1.27 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.473 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -55.28 123.48 13.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -35.16 79.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 m -60.41 -51.88 67.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.2 -46.17 79.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -70.19 -28.68 65.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.944 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.02 -60.96 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.1 p30 -53.92 -36.77 63.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.459 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 50.2 mt -53.39 -56.6 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.55 -52.44 38.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HG2' ' CZ3' ' A' ' 18' ' ' TRP . 30.6 mtpt -53.16 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -68.32 -29.79 68.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -68.66 -49.43 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -63.99 -33.0 74.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -158.67 156.07 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -105.71 -15.4 14.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -80.75 45.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.2 pt -106.0 177.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -142.48 130.04 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.71 -42.44 21.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.82 -44.12 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.7 t -64.95 -28.86 69.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.8 mmm -70.6 -33.61 71.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 62.35 34.59 15.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.82 156.66 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 p -67.66 146.88 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.3 t -53.22 -49.46 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -42.99 -49.94 5.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.4 -62.86 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.5 t -53.79 -50.23 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.137 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.12 59.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.71 -49.29 7.26 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.0 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.71 -45.08 77.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 99' ' ' ALA . 20.9 mtmt -64.08 -53.43 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.01 -44.29 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -54.65 -54.03 46.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -57.07 -39.19 74.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.39 -35.79 82.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 104' ' ' LEU . 9.6 t0 -59.85 -40.45 88.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.9 mt -36.86 143.06 0.34 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.62 154.29 79.49 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.709 . . . . 0.0 110.851 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 108' ' ' LEU . 54.0 Cg_endo -69.78 131.14 20.59 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.37 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 107' ' ' PRO . 26.1 tp -35.73 -38.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -103.12 125.58 34.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 157.08 61.69 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.737 2.291 . . . . 0.0 112.327 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -76.02 -22.1 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.6 m -72.3 -7.18 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -130.27 28.83 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.479 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 2.9 m170 -74.57 -61.97 1.04 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.859 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.6 Cg_endo -69.74 -23.36 30.98 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -67.55 -32.17 72.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.22 -33.53 69.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 121' ' ' ALA . 6.3 mt -81.67 -55.64 4.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.77 -32.62 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.26 -26.8 23.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -79.46 -23.63 42.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -83.03 1.17 41.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.56 129.27 90.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.638 0.733 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -47.05 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.343 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.7 m-20 -61.6 97.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -34.45 -50.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.4 m -55.68 -57.76 10.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -54.87 -44.8 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.83 -54.23 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.7 mt -68.93 -62.21 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -38.68 -43.28 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.41 79.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.31 -23.44 65.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -78.54 -32.64 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -85.34 -34.4 21.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.55 -39.86 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.4 p -62.57 -8.74 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -76.83 -30.35 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.85 -22.98 61.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 141' ' ' HIS . 5.6 m-85 -51.45 133.4 29.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 1.2 t-80 -35.03 141.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.526 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.2 Cg_endo -69.84 -13.12 34.05 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.715 2.276 . . . . 0.0 112.301 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.2 t -95.0 -37.09 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -87.32 -38.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -45.06 -44.94 10.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -61.27 -56.27 22.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.07 -54.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -49.03 -45.52 42.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 149' ' ' ARG . 7.5 mtp-105 -64.2 -49.08 73.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.565 ' CE2' ' OE2' ' A' ' 42' ' ' GLU . 39.1 t80 -52.59 -45.29 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.923 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.03 -57.36 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.135 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.46 ' CG2' ' HA ' ' A' ' 205' ' ' ILE . 70.3 mt -49.66 -48.97 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -47.54 -39.87 17.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -77.57 -31.24 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.03 -45.95 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -54.72 -38.63 67.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.45 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 84.2 mtt180 -65.59 -37.02 85.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.91 -43.25 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.6 p -60.8 -40.08 91.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 34.9 mt-30 -48.13 -37.7 16.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -105.06 32.83 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 166' ' ' LEU . 12.4 p80 -51.19 -38.73 53.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -57.44 -32.49 66.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 52.7 mt -87.81 -58.26 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 55' ' ' THR . 10.6 m-20 -76.08 4.07 9.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 162' ' ' HIS . 13.5 mt 46.15 42.67 10.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 31.2 mmm -144.37 122.59 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.6 p -100.63 156.89 17.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.69 -37.64 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.31 -47.47 64.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -58.49 -38.4 77.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.57 -48.07 61.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.2 p -51.92 -48.76 64.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.0 mt -62.01 -39.4 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.59 -17.07 53.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.424 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 33.0 m-85 -109.43 -10.57 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.571 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -48.76 -46.47 72.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.54 0.686 . . . . 0.0 110.9 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.91 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 180' ' ' LEU . 16.5 m -61.08 -64.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 179' ' ' THR . 59.5 mt -36.96 -62.31 0.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 86.0 mtp -117.1 81.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.481 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 8.3 mmt180 -60.86 -60.1 11.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.613 0.72 . . . . 0.0 110.839 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 54.0 Cg_endo -69.69 164.98 32.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.705 2.27 . . . . 0.0 112.325 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -126.99 118.84 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -111.96 -34.89 5.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -124.83 -174.92 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 16.7 t-20 59.8 52.27 5.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.909 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -70.43 -176.7 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -55.7 -22.39 23.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -81.88 140.94 33.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.0 mt 49.98 47.98 22.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 65.0 m -65.01 -13.9 59.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 39.0 p -86.52 96.25 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 4.0 t -163.99 139.26 6.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.137 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -111.56 36.35 3.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 94.1 mt -95.0 -56.74 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.419 ' CD2' HD22 ' A' ' 118' ' ' LEU . 65.5 m80 -50.78 -72.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -47.85 -51.15 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.6 t -46.12 -42.22 13.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 89.2 t -41.09 -70.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 202' ' ' GLU . 84.2 t -54.86 -59.66 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 201' ' ' VAL . 15.9 tt0 -35.85 -51.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 53.0 m -54.03 -57.9 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -40.09 -34.37 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.46 ' HA ' ' CG2' ' A' ' 152' ' ' ILE . 66.9 mt -75.32 -59.84 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -53.93 -53.43 52.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.63 18.91 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 19.3 t -60.6 -12.01 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 213' ' ' TYR . 14.9 mm-40 -95.96 -57.2 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -40.59 -38.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -49.63 -61.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -107.86 -53.96 2.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 209' ' ' GLN . 53.2 m-85 -58.06 -28.59 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 64.64 42.83 4.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.68 51.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -63.9 134.9 56.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.25 131.73 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.18 163.92 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -169.31 148.54 3.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -157.83 177.33 11.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.06 -176.57 17.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.512 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.2 p -163.64 129.28 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.373 . . . . 0.0 110.866 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 t -165.71 173.48 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.38 127.45 2.59 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -158.14 146.72 18.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.814 0.34 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -164.73 159.26 18.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -169.98 177.86 4.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.1 116.77 1.64 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.2 68.01 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.663 2.242 . . . . 0.0 112.391 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 173.03 11.6 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.668 2.245 . . . . 0.0 112.344 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -136.51 143.39 43.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.68 129.34 11.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -123.48 108.79 13.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -84.67 36.42 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -58.74 98.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -119.12 140.7 49.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -144.65 174.43 10.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -102.73 -48.77 4.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -37.75 -47.74 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 23' ' ' PHE . 1.7 p90 -39.56 119.89 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.14 -43.55 1.65 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.491 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 16.5 mtp -81.88 139.23 46.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.521 0.676 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 159.78 52.15 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.339 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 tp -55.41 -46.0 76.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -48.67 -35.57 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.63 -48.91 17.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.2 mt -56.03 -44.49 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.76 171.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.5 p -108.12 144.03 36.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.94 -37.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.51 -42.19 95.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -128.83 96.47 29.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.703 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -24.65 29.54 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.8 mt -92.95 130.96 34.54 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 122.5 9.16 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -50.67 -27.43 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -62.3 -61.67 2.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -50.02 -50.94 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -51.83 -60.05 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 45.1 mmtt -44.3 -39.33 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 95.2 m -67.5 -45.6 75.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.63 -59.54 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.26 -27.7 16.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -70.83 -54.33 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.8 mt -56.37 -20.5 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -91.06 -22.05 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.33 -17.62 22.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -82.56 18.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.144 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.38 -42.55 2.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.5 tp 64.7 44.0 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.1 p -133.16 30.0 3.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -90.93 127.84 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -60.39 120.76 10.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 48.71 76.04 0.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -89.38 4.36 49.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.934 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.62 -48.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -59.05 -48.15 82.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 t -82.43 146.91 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.2 p -128.26 117.08 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.78 -144.61 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.479 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -64.75 -176.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -107.63 -37.68 6.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 m -53.04 -57.76 9.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.478 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -39.34 -58.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -50.59 -44.57 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.73 -51.0 70.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -50.97 -52.1 45.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.3 mt -43.75 -46.46 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.12 -62.63 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ASP . 48.5 mttt -50.67 -64.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -39.41 -42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -71.66 -38.49 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' LYS . 11.1 t0 -65.33 -41.75 93.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.28 -31.57 71.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -166.89 148.35 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -94.66 -19.55 20.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -78.3 48.47 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 pt -109.98 -176.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.6 125.44 7.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -70.72 -46.69 62.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.01 -48.48 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -59.79 -43.81 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.9 mtp -59.25 -19.39 45.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 47.6 39.42 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.71 164.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 p -74.88 131.89 41.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.3 t -44.36 -48.93 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -46.18 -40.21 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.77 -62.79 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.8 t -52.69 -36.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.85 72.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.57 -54.04 4.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.02 -44.39 61.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.0 tp -45.85 -43.67 13.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.11 -47.12 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -39.38 -45.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.25 -54.18 46.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -49.61 -47.22 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -54.49 -37.69 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.5 mt -41.45 141.01 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.657 0.741 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.13 32.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -133.25 150.6 75.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.881 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.24 37.47 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.336 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.1 tp -43.03 -53.84 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mt -85.42 124.09 72.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.417 ' CG ' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.79 149.02 66.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -70.43 -8.96 54.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.5 m -83.65 -12.46 55.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.848 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.527 HD11 ' CE1' ' A' ' 140' ' ' PHE . 43.0 mt -120.52 26.25 9.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.486 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.4 m170 -71.02 -60.12 3.04 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.78 -20.62 34.49 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.258 . . . . 0.0 112.328 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -70.89 -39.14 72.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.09 -28.72 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.9 mt -83.68 -50.21 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.11 -26.36 11.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.61 -21.75 21.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.27 -15.4 50.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -95.47 10.23 37.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.3 mt -73.51 132.19 81.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.584 0.707 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -45.39 1.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.375 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 105.56 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -41.37 -53.04 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.557 HG21 ' CD2' ' A' ' 131' ' ' HIS . 3.0 m -56.02 -59.72 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -49.22 -39.3 29.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -57.46 -42.79 83.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.6 -54.12 8.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.557 ' CD2' HG21 ' A' ' 127' ' ' THR . 15.6 m-70 -46.76 -44.06 18.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.06 -59.66 4.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.82 -33.75 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -65.68 -34.97 79.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -82.62 -41.38 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.419 ' HA ' ' NZ ' ' A' ' 139' ' ' LYS . 87.8 mt -59.62 -21.14 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.488 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 9.5 p -92.64 -5.91 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -81.02 -35.27 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' A' ' 136' ' ' ILE . 5.8 pttm -80.57 -7.78 59.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.527 ' CE1' HD11 ' A' ' 113' ' ' LEU . 2.7 m-85 -51.4 149.88 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.579 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -41.83 140.64 1.41 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.81 -16.66 37.43 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.653 2.235 . . . . 0.0 112.286 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 91.1 t -96.97 -38.72 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -83.89 -40.23 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 71.4 t80 -46.56 -42.86 16.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -45.18 94.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.1 t -68.33 -61.11 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -44.45 -46.86 9.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.421 ' HB3' ' NH1' ' A' ' 149' ' ' ARG . 7.8 ttp-105 -62.57 -47.97 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.03 -54.19 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 85.0 t -46.4 -65.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.12 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 77.8 mt -44.0 -53.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.9 m -39.77 -36.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -80.36 -43.31 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.5 mt -49.2 -42.99 41.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -52.26 -48.57 65.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -56.91 -29.84 63.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.4 t -80.46 -29.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.093 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 p -75.65 -20.44 58.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.94 -44.37 63.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -97.01 29.48 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.559 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 16.8 p80 -52.48 -39.25 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.559 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 0.8 OUTLIER -59.15 -21.19 58.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 49.6 mt -92.73 -64.96 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -76.08 1.41 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 162' ' ' HIS . 43.5 mt 54.6 46.28 25.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.417 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 21.0 mtp -141.12 112.55 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.445 HG21 ' CG ' ' A' ' 162' ' ' HIS . 33.7 p -98.24 160.63 14.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -45.96 -35.39 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -49.05 62.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.86 -44.17 77.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.77 -44.36 96.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -53.07 -40.31 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.455 HG12 ' NE2' ' A' ' 198' ' ' GLN . 9.6 mt -80.71 -41.21 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.142 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.58 -20.77 66.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -108.75 0.04 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.577 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.13 -45.92 95.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.533 0.682 . . . . 0.0 110.872 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -47.95 -58.54 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.688 2.259 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -69.69 -62.96 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.1 mt -40.52 -52.23 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 16.1 mmm -128.52 123.25 33.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -102.79 105.96 47.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 0.0 110.842 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 147.41 62.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.64 2.227 . . . . 0.0 112.325 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.58 140.2 29.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 185' ' ' PHE . 1.2 p90 -115.48 -44.8 2.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -116.73 29.16 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -132.23 -179.64 5.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.61 120.8 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -106.56 121.5 44.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -110.87 155.0 23.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.7 152.41 37.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.4 t -123.48 58.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.5 m -50.58 -52.54 38.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.168 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 80.7 p -90.57 111.63 23.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -78.08 70.63 4.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 87.0 mt -88.76 -36.64 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -48.74 -71.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.455 ' NE2' HG12 ' A' ' 174' ' ' ILE . 7.1 tt0 -40.7 -53.67 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 t -45.88 -41.96 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.6 t -53.8 -60.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.56 -66.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -38.68 -52.33 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 51.5 m -48.85 -64.6 0.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 203' ' ' THR . 7.4 m-85 -34.16 -48.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 48.3 mt -66.25 -50.37 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -53.86 -45.61 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -110.02 30.42 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.517 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 0.8 OUTLIER -64.12 -15.32 59.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 213' ' ' TYR . 67.6 mm-40 -88.92 -54.47 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 210' ' ' PHE . 0.9 OUTLIER -42.76 -40.46 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -45.91 -63.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -105.54 -53.32 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 209' ' ' GLN . 56.9 m-85 -56.03 -35.2 66.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.931 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 71.02 28.02 3.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.68 -166.41 1.77 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.508 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.84 151.99 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 54.1 mt -76.42 132.05 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 m -110.22 174.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -114.56 138.23 50.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -167.09 107.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.42 55.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.527 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -115.25 176.23 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.872 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.0 p -45.48 111.18 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.51 68.55 0.48 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.02 155.96 16.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.903 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -87.55 -25.05 23.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.896 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -159.14 163.99 35.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.87 132.52 95.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.617 0.722 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 146.74 61.17 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 156.88 62.19 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.625 2.217 . . . . 0.0 112.347 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -111.52 152.85 27.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -138.85 145.77 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -48.02 -54.24 13.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 66.08 25.44 10.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.428 ' CZ3' ' HG2' ' A' ' 73' ' ' LYS . 31.5 t-105 69.96 52.17 0.4 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -114.11 144.95 42.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 m -171.37 167.2 6.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -88.63 -38.11 15.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.479 ' O ' ' C ' ' A' ' 23' ' ' PHE . 73.2 m-85 -38.82 -69.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 22' ' ' TYR . 28.1 m-85 -32.25 96.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.92 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' TYR . . . 107.07 24.87 6.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.504 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.485 ' O ' ' CE ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -109.43 154.94 42.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 149.43 66.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.694 2.263 . . . . 0.0 112.367 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.0 tp -70.6 -39.39 73.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.34 -28.57 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.12 -41.24 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.411 ' CD2' ' HG3' ' A' ' 25' ' ' MET . 14.1 mt -69.37 -39.0 78.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -96.26 164.65 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -107.41 168.49 9.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.49 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -53.52 -46.75 70.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -130.74 103.88 15.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -33.6 16.21 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.644 2.23 . . . . 0.0 112.369 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.436 HG22 ' CG ' ' A' ' 42' ' ' GLU . 29.8 mt -74.68 131.36 79.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.611 0.72 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 147.64 63.68 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.472 ' CD1' ' CG ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.33 -50.03 71.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -42.53 -67.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.0 t -46.93 -54.36 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' CG ' HG22 ' A' ' 37' ' ' ILE . 33.1 mt-10 -47.23 -58.04 4.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.472 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 51.8 mmtt -53.05 -37.56 61.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.4 m -65.22 -43.94 89.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.02 -51.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.27 -45.72 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.477 ' CE1' HG21 ' A' ' 93' ' ' VAL . 33.4 t80 -53.53 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.2 mt -37.48 -56.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -52.06 -48.05 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.05 -44.1 87.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 t -85.87 23.92 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.1 139.65 10.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -110.29 -27.44 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.964 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.9 m -84.48 39.75 0.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 56' ' ' GLU . 11.5 m -82.72 111.67 18.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.4 tt0 -35.97 130.85 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 36.57 77.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mp -60.2 -61.73 2.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.955 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -93.3 -43.45 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -42.54 -49.02 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.12 88.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 t -68.33 -41.8 80.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.48 -116.57 5.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -79.66 172.18 14.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.371 . . . . 0.0 110.873 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -32.02 6.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -49.94 -35.54 24.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -60.84 -53.83 52.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.35 -27.35 65.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.57 -62.89 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 13.4 p30 -61.71 -44.55 96.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.449 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 47.2 mt -43.5 -42.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.52 -54.81 4.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HG2' ' CZ3' ' A' ' 18' ' ' TRP . 10.3 mtpp -51.22 -61.17 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -51.12 -38.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 75' ' ' PHE . 7.7 t80 -62.9 -28.74 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.74 -63.16 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -55.38 -29.31 58.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -131.04 99.05 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -69.92 -17.28 63.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.85 32.62 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.461 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 7.1 tt -73.61 157.22 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.461 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 4.8 t30 -132.35 94.74 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -40.49 -46.58 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.48 -50.65 78.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -55.54 -41.41 73.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.4 mmm -62.09 -33.86 75.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 61.55 46.51 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.7 m -78.75 165.72 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.7 p -67.26 139.44 57.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.9 t -52.82 -55.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -45.92 -44.45 14.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.54 -63.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 47' ' ' PHE . 93.7 t -45.04 -55.55 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.64 -38.7 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.35 -60.82 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.51 -43.92 8.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 tp -47.81 -44.55 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -68.01 -48.09 66.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.14 -38.38 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.068 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.25 -46.45 86.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -61.16 -47.51 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.79 79.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 104' ' ' LEU . 6.7 t70 -59.42 -36.92 76.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' ASP . 96.2 mt -36.78 144.15 0.29 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -22.12 32.73 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.21 153.97 69.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.629 0.728 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 133.03 24.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.4 tp -38.38 -49.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.0 mt -84.2 123.63 75.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 111.162 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.406 ' CG ' HD11 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.79 153.93 68.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.691 2.261 . . . . 0.0 112.318 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.472 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 13.5 m-85 -72.62 -17.5 61.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 m -72.92 -30.45 63.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.406 HD11 ' CG ' ' A' ' 110' ' ' PRO . 19.6 mt -106.39 27.85 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.497 ' CD2' ' CE ' ' A' ' 181' ' ' MET . 4.0 m170 -71.49 -60.16 2.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.601 0.715 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.75 -33.83 15.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.247 . . . . 0.0 112.335 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -59.03 -33.3 70.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.85 -40.28 69.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.2 mt -75.09 -58.57 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -42.71 -29.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.95 -28.4 20.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -76.8 -20.91 55.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -92.14 16.21 11.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 30.8 mt -78.22 132.64 66.01 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.59 0.71 . . . . 0.0 111.135 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -45.39 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.671 2.247 . . . . 0.0 112.349 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 126' ' ' LYS . 75.7 m-20 -66.34 92.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 125' ' ' ASP . 38.1 tttt -34.91 -51.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 42.4 m -53.25 -59.92 3.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' ARG . 45.1 mm-40 -54.83 -52.6 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 128' ' ' GLU . 11.4 ttm180 -36.87 -43.5 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 131' ' ' HIS . 22.8 mt -75.84 -61.56 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 130' ' ' LEU . 11.8 m-70 -36.53 -49.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.1 -55.14 30.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.0 mt -55.9 -41.37 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -56.3 -29.67 61.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -90.37 -46.33 8.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.7 mt -56.43 -29.2 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.521 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 7.8 p -76.15 -15.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -73.37 -25.44 60.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -77.38 -19.13 56.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 7.9 m-85 -50.51 146.98 4.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.569 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.4 t-80 -45.48 141.39 3.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.569 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -21.0 34.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.7 -38.89 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -83.65 -44.06 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 14.1 t80 -40.97 -56.77 2.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -46.9 -34.45 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.38 -58.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.414 ' CZ ' HD13 ' A' ' 152' ' ' ILE . 24.0 t80 -43.17 -41.65 3.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -70.47 -44.79 67.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.42 ' CB ' HD12 ' A' ' 37' ' ' ILE . 76.6 t80 -57.71 -42.37 83.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.414 HD13 ' CZ ' ' A' ' 148' ' ' PHE . 86.0 mt -43.4 -53.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.146 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.8 m -41.25 -34.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -83.61 -39.68 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 92.8 mt -56.2 -45.52 79.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.98 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -50.36 -43.66 54.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -59.86 -30.84 69.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.72 -45.65 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.6 p -57.84 -29.95 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.06 -46.48 88.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -100.86 40.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 166' ' ' LEU . 10.6 p80 -58.54 -41.05 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.403 ' HG2' ' NE2' ' A' ' 162' ' ' HIS . 17.0 mmmt -55.32 -27.57 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 79.9 mt -90.29 -57.07 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.3 OUTLIER -84.17 18.07 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 162' ' ' HIS . 12.1 mt 34.32 52.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 49.1 mmm -146.34 108.73 4.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 169' ' ' ALA . 73.9 p -93.94 151.19 19.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.79 -37.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.89 -49.09 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 168' ' ' THR . 41.1 m-20 -54.54 -42.8 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.43 -48.05 79.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 p -58.55 -39.36 80.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.31 -37.48 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.175 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.91 -15.44 63.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -108.16 -8.43 15.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.556 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -56.73 -47.29 99.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.871 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.2 Cg_exo -48.0 -62.12 0.49 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 180' ' ' LEU . 16.7 m -67.85 -62.97 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.129 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 179' ' ' THR . 48.2 mt -33.2 -44.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.497 ' CE ' ' CD2' ' A' ' 114' ' ' HIS . 31.2 mtp -146.86 140.2 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.426 ' NE ' ' OH ' ' A' ' 111' ' ' TYR . 9.7 ptp180 -52.65 151.94 7.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.827 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 184' ' ' ASP . 53.2 Cg_endo -69.81 117.88 5.35 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.635 2.223 . . . . 0.0 112.333 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' PRO . 8.9 p-10 -35.83 144.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -79.1 -34.29 43.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -41.52 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.44 -27.2 12.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -13.08 51.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -93.79 125.15 38.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.455 ' CD2' ' HG ' ' A' ' 191' ' ' LEU . 36.7 p90 -100.57 -45.79 5.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.455 ' HG ' ' CD2' ' A' ' 190' ' ' PHE . 11.3 mt -85.59 128.14 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.6 t -102.31 89.27 3.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.839 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 22.0 p -78.1 -63.29 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 25.6 m -62.0 119.45 8.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -2.67 14.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 65.3 mt -49.07 -36.24 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -43.03 -69.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -67.16 -39.36 86.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 t -43.45 -40.37 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.823 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 66.4 t -52.58 -58.25 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.16 -39.96 82.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -58.04 -52.4 65.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.4 m -49.51 -61.77 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' A' ' 208' ' ' CYS . 10.0 m-85 -33.83 -52.67 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 38.8 mt -62.61 -47.7 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -55.92 -47.63 77.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.9 mm-40 -109.84 31.67 5.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.518 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 2.4 t -63.55 -21.42 66.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.533 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 10.3 mm-40 -86.53 -51.17 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -45.04 -35.3 2.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.518 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -52.76 -62.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -108.07 -55.06 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.533 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 54.7 m-85 -56.63 -14.57 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 52.37 38.75 25.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.41 150.68 33.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -49.95 153.3 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.915 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.406 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 93.2 mt -73.69 126.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.092 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.2 m -104.81 177.68 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -152.79 166.67 31.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.903 0.382 . . . . 0.0 110.847 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -165.06 169.05 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.823 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.18 -141.23 4.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -143.72 139.47 29.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.838 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.9 m -110.25 168.45 9.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.3 114.47 1.0 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.504 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -174.56 144.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -61.71 106.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -76.76 -45.37 29.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -82.16 137.56 46.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 167.99 22.87 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.678 2.252 . . . . 0.0 112.347 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -179.16 2.73 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.255 . . . . 0.0 112.343 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -129.18 151.67 49.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -95.87 128.48 42.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -92.61 -42.37 9.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 18' ' ' TRP . 11.2 t-20 49.62 35.14 8.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' ASN . 0.0 OUTLIER 34.11 44.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.58 140.22 58.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -152.14 163.83 38.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -83.31 -30.83 27.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 25' ' ' MET . 13.4 m-85 -49.18 -61.9 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.0 m-30 37.11 48.26 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.26 38.26 93.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 22' ' ' TYR . 25.4 mmt -93.87 152.03 40.29 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.613 0.721 . . . . 0.0 110.884 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.444 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 53.5 Cg_endo -69.73 133.77 26.43 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.642 2.228 . . . . 0.0 112.369 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.2 tp -53.22 -53.61 48.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -44.37 -33.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.444 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 11.5 t70 -79.24 -48.8 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.424 HD23 ' CB ' ' A' ' 25' ' ' MET . 41.4 mt -57.03 -43.95 82.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.7 m -82.06 -179.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -117.61 147.52 42.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.14 -45.03 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -52.23 -43.09 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.75 108.37 13.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.552 0.691 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -39.39 6.55 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.455 HG22 ' CG ' ' A' ' 42' ' ' GLU . 22.3 mt -73.99 132.94 79.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.648 0.737 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 0.0 112.363 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.405 HD23 ' CE ' ' A' ' 43' ' ' LYS . 2.2 tm? -45.1 -48.02 12.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.513 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 82.0 t80 -43.2 -70.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.2 t -44.17 -50.48 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.069 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' CG ' HG22 ' A' ' 37' ' ' ILE . 16.6 mt-10 -49.13 -53.89 18.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' CE ' HD23 ' A' ' 39' ' ' LEU . 12.2 mmtp -52.15 -40.76 61.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.0 m -66.53 -47.47 72.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.56 -46.21 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.71 -43.96 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.491 ' CD2' HG23 ' A' ' 93' ' ' VAL . 63.8 t80 -50.78 -63.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.5 mt -39.67 -62.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -49.01 -50.3 36.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.44 -39.0 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.9 p -88.65 25.43 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.29 137.91 1.89 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp -113.47 47.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.773 0.32 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.6 p -132.75 37.45 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -96.72 119.61 35.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.1 tt0 -37.93 123.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.17 73.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.528 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.75 -24.73 63.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -102.59 -57.04 2.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.435 ' CG ' ' HA3' ' A' ' 57' ' ' GLY . 15.7 ptm180 -46.65 -33.06 3.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.7 t -97.25 102.59 13.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.142 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.9 m -61.97 -58.14 9.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.88 -161.5 23.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.497 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.74 161.89 11.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 65' ' ' LYS . 2.2 mppt? -92.63 -52.49 4.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -40.65 -53.23 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.164 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.1 -45.33 32.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -73.9 -30.94 62.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -62.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -50.63 -34.47 26.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.48 -44.6 89.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -79.06 -46.59 17.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 76' ' ' ASP . 93.2 mttt -59.79 -66.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -40.26 -47.01 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 42.9 t80 -64.29 -37.91 89.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 73' ' ' LYS . 37.6 m-20 -68.74 -58.85 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -53.38 -29.25 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.06 149.88 14.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.23 -17.72 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -83.43 50.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 -177.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -149.26 136.31 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.7 mt -81.28 -46.78 14.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.5 t -44.14 -54.16 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.1 t -55.57 -43.28 75.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.7 mmm -55.95 -28.83 58.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 51.97 45.94 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.99 164.84 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 t -75.22 128.16 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.3 t -40.31 -51.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -38.72 -53.01 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.15 -60.93 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.491 HG23 ' CD2' ' A' ' 47' ' ' PHE . 94.4 t -47.26 -51.23 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.75 -45.05 58.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.12 -63.35 3.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.78 -42.15 5.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.884 0.373 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.3 tp -48.69 -45.57 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -69.62 -51.17 37.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -40.26 -39.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -58.99 -47.46 85.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.433 ' CB ' ' CG2' ' A' ' 179' ' ' THR . 51.6 m-85 -62.27 -48.87 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.15 -37.13 71.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -34.8 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -41.65 141.29 1.23 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -19.06 36.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.693 2.262 . . . . 0.0 112.357 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -134.14 152.55 78.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.62 26.02 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.708 2.272 . . . . 0.0 112.342 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.2 tp -44.25 -44.26 7.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.49 123.94 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.617 0.723 . . . . 0.0 111.162 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 146.37 59.92 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.345 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.65 ' CD2' ' CE1' ' A' ' 114' ' ' HIS . 73.7 m-85 -66.26 -32.55 74.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m -61.14 -15.11 30.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.3 mt -122.0 28.47 7.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.65 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 3.9 m170 -73.0 -60.79 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.569 0.7 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.76 -31.82 19.79 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.694 2.263 . . . . 0.0 112.38 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -59.96 -28.86 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.0 -46.66 33.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 121' ' ' ALA . 12.0 mt -65.12 -55.2 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -45.72 -37.19 5.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.53 -21.08 32.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -86.63 -18.44 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -89.81 -8.85 51.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.4 mt -56.81 130.17 78.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 111.141 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -46.08 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.12 116.94 10.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -50.99 -49.55 60.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.41 HG22 ' CD2' ' A' ' 131' ' ' HIS . 99.0 m -53.57 -55.7 23.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -60.38 -38.95 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -57.75 -49.97 74.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.76 -60.52 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.41 ' CD2' HG22 ' A' ' 127' ' ' THR . 15.9 m-70 -43.58 -50.15 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.77 78.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 mt -74.57 -27.26 60.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -78.0 -27.16 48.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.0 pt-20 -86.11 -32.99 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 84.9 mt -74.2 -38.01 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.8 p -62.05 -11.81 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -74.96 -43.09 56.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -61.55 -32.97 73.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -40.52 137.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.573 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -39.33 141.16 0.69 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.849 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.78 -18.99 36.62 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 92.1 t -89.86 -37.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.91 -40.26 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.513 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 6.2 t80 -48.69 -51.69 27.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.92 -51.85 21.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.0 -67.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.551 ' CZ ' HD12 ' A' ' 152' ' ' ILE . 38.5 t80 -40.21 -40.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 4.6 mmp_? -66.39 -45.1 81.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.07 -48.15 77.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.99 -64.75 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.551 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 91.6 mt -42.82 -53.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.3 m -40.26 -36.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.121 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -78.9 -36.89 41.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 152' ' ' ILE . 53.1 mt -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -47.21 -47.37 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -55.57 -37.65 68.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.94 -50.41 54.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.2 p -55.23 -37.8 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -50.7 -39.87 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -108.46 40.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.501 ' CG ' HG23 ' A' ' 168' ' ' THR . 17.9 p80 -58.67 -35.68 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -58.16 -31.99 67.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.55 -57.85 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 166' ' ' LEU . 2.6 m-20 -83.39 17.23 2.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 162' ' ' HIS . 22.0 mt 34.96 50.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 39.4 mmm -146.42 113.83 6.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.501 HG23 ' CG ' ' A' ' 162' ' ' HIS . 9.2 p -95.76 153.36 17.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.97 -49.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.07 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -50.17 74.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -53.34 -44.39 68.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.5 mt -61.69 -41.62 97.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -59.38 -48.9 79.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 42.7 mt -62.74 -34.57 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 40.9 m -69.51 -22.86 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -102.25 -5.77 23.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.583 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -55.1 -46.05 99.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.609 0.718 . . . . 0.0 110.97 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.8 Cg_exo -47.95 -63.12 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 0.0 112.363 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 180' ' ' LEU . 87.1 m -65.44 -61.4 2.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 179' ' ' THR . 78.6 mt -34.24 -42.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 8.7 ptp -166.6 142.24 4.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.846 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -114.69 147.97 39.33 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 133.33 25.27 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.689 2.259 . . . . 0.0 112.311 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.94 116.54 28.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -92.51 -56.7 2.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -35.99 56.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.88 177.46 6.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.7 tpt85 -101.21 9.62 41.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.833 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -47.77 100.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.847 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -46.22 112.65 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.86 114.11 20.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 86.6 p -126.56 134.79 50.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.9 p -105.61 102.77 12.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.125 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 196' ' ' ILE . 58.5 p -142.13 127.75 19.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.155 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 194' ' ' THR . 14.0 ttmm -35.41 -34.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 194' ' ' THR . 51.1 mt -43.88 -65.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 196' ' ' ILE . 39.1 m-70 -35.4 -61.19 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -56.77 -48.1 78.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 m -49.74 -36.97 27.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.21 -70.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.166 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.17 -53.37 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.454 ' C ' ' OE1' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -38.69 -48.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 204' ' ' PHE . 60.8 m -58.79 -62.12 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.1 m-85 -34.41 -40.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 70.6 mt -78.67 -52.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -48.57 -44.92 37.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.6 mm-40 -113.31 35.4 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 6.1 t -64.07 -15.98 60.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.466 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 12.8 mm-40 -89.07 -53.68 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.69 -36.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -53.07 -63.47 1.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -107.53 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.466 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 89.4 m-85 -61.27 -9.98 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 48.5 t30 47.24 43.86 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.63 145.87 28.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.519 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -43.79 143.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.46 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 75.7 mt -63.35 131.15 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.118 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.1 m -112.26 173.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.159 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 219' ' ' GLU . 5.0 tm-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -131.94 125.62 32.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.857 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 t -123.76 159.76 28.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.95 110.14 3.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' SER . 9.1 m -126.35 42.37 3.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' SER . 25.9 t -35.45 104.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.64 150.41 14.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -87.77 119.99 28.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.322 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -100.9 42.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -117.48 112.87 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -108.77 122.81 38.97 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.634 0.73 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 146.93 61.77 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.682 2.255 . . . . 0.0 112.357 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 158.17 57.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.688 2.259 . . . . 0.0 112.33 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 p -63.34 125.49 24.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.126 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 ptt85 -53.64 172.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -72.91 143.68 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -53.3 -45.58 69.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -55.17 99.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.19 159.5 32.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -167.63 163.41 14.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -87.51 -30.17 20.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.562 ' CE1' HD11 ' A' ' 30' ' ' LEU . 9.5 m-85 -85.26 -43.87 13.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 22' ' ' TYR . 47.5 p90 35.55 30.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' TYR . . . 112.5 23.55 5.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.495 ' CE ' ' HD2' ' A' ' 26' ' ' PRO . 61.1 mmm -79.57 137.44 55.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.861 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.495 ' HD2' ' CE ' ' A' ' 25' ' ' MET . 53.4 Cg_endo -69.8 128.48 16.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 0.0 112.334 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.1 tp -52.49 -45.1 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -49.65 -32.04 12.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.96 -41.47 20.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.562 HD11 ' CE1' ' A' ' 22' ' ' TYR . 68.6 mt -63.03 -41.86 99.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 36' ' ' PRO . 23.6 m -85.27 164.8 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 p -110.63 147.91 33.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.57 -45.02 4.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -58.58 -41.14 85.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -130.99 97.62 20.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 53.9 Cg_endo -69.68 -47.44 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.377 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.8 mt -64.09 132.41 95.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.73 . . . . 0.0 111.109 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 140.05 41.67 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -51.32 70.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.42 ' CD1' ' CD2' ' A' ' 75' ' ' PHE . 28.7 t80 -42.13 -64.42 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.7 t -46.6 -54.32 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.122 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -50.3 -55.27 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -47.26 -40.97 17.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 81.8 m -63.62 -46.37 86.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -64.89 -56.35 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.28 -45.38 88.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.555 ' CE2' HG23 ' A' ' 93' ' ' VAL . 63.6 t80 -42.92 -60.17 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.0 mt -51.34 -48.88 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -56.07 -47.74 77.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -44.55 -47.52 10.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.3 p -84.04 29.84 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.21 163.11 9.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 tp -103.03 37.08 2.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.346 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.52 40.68 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.472 HG23 ' CD2' ' A' ' 58' ' ' LEU . 39.6 m -88.88 133.85 34.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.191 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -98.13 110.82 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.37 72.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.472 ' CD2' HG23 ' A' ' 55' ' ' THR . 20.3 mt -114.79 119.62 37.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 62.67 28.96 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -129.9 -36.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.0 t -93.37 131.87 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.8 m -78.69 102.93 8.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.06 154.35 47.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.5 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -55.66 131.58 46.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 110.886 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -57.12 -35.59 69.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -54.03 -41.73 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.162 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.42 -54.04 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -60.54 -32.63 71.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -67.99 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -52.92 -34.72 56.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.494 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 49.0 mt -56.68 -40.47 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -85.34 -59.76 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -46.8 -59.66 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 70' ' ' ASN . 40.1 mm-40 -49.71 -51.58 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CD2' ' CD1' ' A' ' 40' ' ' PHE . 58.2 t80 -58.59 -37.35 75.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.46 -60.1 3.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -58.76 -38.83 79.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.22 111.5 5.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -68.09 -32.41 72.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.4 m-80 -38.88 -36.91 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 80' ' ' ASN . 13.7 tt -34.51 146.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -134.89 100.68 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 82' ' ' ASN . 56.2 mt -34.35 -54.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.18 -47.31 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' ASN . 3.3 t -63.04 -48.1 80.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.7 mmm -57.33 -35.5 69.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 61.33 49.96 5.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.45 171.1 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.114 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.7 p -66.28 123.68 20.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 91.4 t -44.97 -56.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.109 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -37.78 -41.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.51 -60.47 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.555 HG23 ' CE2' ' A' ' 47' ' ' PHE . 99.1 t -45.05 -51.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.9 -44.23 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -50.34 11.68 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.449 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.22 -51.61 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.9 tp -43.77 -44.51 6.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 37.8 mtmt -72.85 -47.7 43.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.15 -45.63 4.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -57.43 -46.92 83.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -57.0 -44.24 82.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.54 90.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -40.48 76.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.4 mt -37.23 145.39 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -18.99 36.38 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.709 2.272 . . . . 0.0 112.306 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.8 152.27 70.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.601 0.715 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.4 Cg_endo -69.77 129.01 16.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 107' ' ' PRO . 11.2 tp -34.45 -45.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.2 mt -96.58 121.7 59.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 111.162 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 151.71 69.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.402 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.97 -22.35 64.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.2 m -68.77 -21.65 64.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 mt -113.89 28.69 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.501 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 3.4 m170 -75.68 -62.94 0.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.81 -23.38 30.64 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.613 2.209 . . . . 0.0 112.334 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.4 -32.48 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.3 mt -75.15 -27.09 59.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.14 -51.02 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.95 -25.9 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -91.94 -29.45 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.08 -21.06 60.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -92.27 20.32 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 87.7 mt -84.33 134.16 43.52 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 111.154 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -44.35 2.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.28 . . . . 0.0 112.381 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 126' ' ' LYS . 24.1 t0 -69.18 95.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 125' ' ' ASP . 44.1 tttp -38.11 -43.67 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.0 m -58.72 -66.65 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -46.23 -43.55 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -48.07 -42.15 27.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.2 mt -73.12 -52.86 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -49.08 -52.71 24.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.4 -57.61 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.25 -35.22 74.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -61.61 -30.8 70.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.14 -44.94 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.59 -32.71 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.1 p -68.6 -16.18 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.121 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -72.1 -32.06 66.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -68.55 -30.3 69.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 141' ' ' HIS . 8.4 m-85 -43.59 138.45 2.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.515 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -37.25 141.37 0.43 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.556 0.693 . . . . 0.0 110.851 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.515 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.3 Cg_endo -69.78 -17.04 37.72 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.71 -32.34 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -86.76 -39.16 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -49.54 -47.7 48.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.57 -54.53 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.71 -56.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.553 ' CZ ' HD13 ' A' ' 152' ' ' ILE . 45.9 t80 -46.76 -48.5 20.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -65.05 -48.51 73.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -54.74 -41.98 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.52 -59.55 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.553 HD13 ' CZ ' ' A' ' 148' ' ' PHE . 73.0 mt -47.67 -53.89 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' ILE . 24.4 m -36.83 -36.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -81.75 -39.41 24.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 152' ' ' ILE . 71.4 mt -56.93 -40.13 75.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.858 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.463 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 43.8 t-20 -56.84 -41.74 78.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.21 -54.07 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.4 p -46.46 -32.78 3.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' A' ' 156' ' ' ASN . 1.5 mt-30 -67.18 -46.65 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -88.15 39.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.424 ' CB ' HG21 ' A' ' 168' ' ' THR . 15.9 p80 -67.91 -20.37 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -68.83 -30.81 69.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 50.4 mt -102.47 -53.72 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.38 -23.43 66.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 34.8 mt 65.01 39.95 5.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 42.4 mmm -150.11 118.98 6.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.424 HG21 ' CB ' ' A' ' 162' ' ' HIS . 74.3 p -98.16 172.67 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.96 -38.48 73.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -59.69 -47.19 86.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -63.28 -39.48 94.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 10.9 mt -66.57 -38.54 87.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 t -61.29 -41.4 96.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.5 mt -77.85 -34.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 42.3 m -68.95 -14.85 63.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.497 ' CE2' ' HG2' ' A' ' 98' ' ' LYS . 13.3 m-85 -111.48 -5.76 14.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.578 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -54.55 -46.33 99.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -47.96 -53.36 6.74 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.306 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 26.2 m -78.77 -68.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 33.0 mt -34.22 -64.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.539 ' HG2' ' CH2' ' A' ' 177' ' ' TRP . 1.0 OUTLIER -112.33 96.9 6.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.453 ' CG ' ' HD2' ' A' ' 183' ' ' PRO . 33.6 ttm-85 -37.31 141.41 0.44 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.633 0.73 . . . . 0.0 110.865 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 182' ' ' ARG . 53.5 Cg_endo -69.72 135.75 31.34 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 0.0 112.347 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.15 120.86 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -56.14 -53.62 54.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -88.91 115.62 26.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -145.96 105.79 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -80.05 136.11 36.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -138.39 112.98 8.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 191' ' ' LEU . 50.4 p90 -72.02 -51.19 22.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 190' ' ' PHE . 56.5 mt -142.89 163.27 33.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 18.3 m -100.43 39.11 1.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 13.6 t -114.27 38.71 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.091 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 10.0 t -156.97 123.2 4.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.19 41.23 2.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 32.0 mt -67.12 -59.14 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -37.83 -47.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.72 -51.67 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.9 m -40.83 -42.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 57.9 t -40.44 -71.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 202' ' ' GLU . 85.5 t -60.08 -61.11 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 201' ' ' VAL . 20.9 tt0 -35.77 -42.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.3 m -62.72 -59.93 4.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.2 m-85 -33.98 -47.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 47.4 mt -71.66 -48.71 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -51.84 -45.34 63.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.459 ' NE2' ' HA ' ' A' ' 207' ' ' GLN . 6.4 mm-40 -113.74 34.1 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 21.6 t -63.54 -21.85 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.489 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 47.3 mm-40 -84.5 -54.54 4.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -41.13 -34.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 22.3 m-85 -52.62 -63.4 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -106.11 -56.35 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.489 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 72.1 m-85 -56.92 -17.16 8.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.915 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 51.67 40.1 26.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.925 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.07 135.77 15.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -42.5 137.08 2.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 0.0 110.936 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 68.1 mt -48.43 127.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.42 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t -148.54 155.25 40.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 110.849 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 p -151.7 175.53 12.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.89 168.47 27.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.477 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.6 p -119.59 159.58 24.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 110.85 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.6 m -89.26 -56.25 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.58 -119.81 5.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp 55.98 42.85 28.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.803 0.335 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -99.37 135.72 40.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -125.44 177.67 6.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.426 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 7.6 t30 -168.51 140.42 2.26 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.607 0.718 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 54.3 Cg_endo -69.72 153.07 69.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.665 2.243 . . . . 0.0 112.411 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 162.49 41.9 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.635 2.223 . . . . 0.0 112.361 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.9 p -98.63 113.56 25.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.184 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -105.81 157.97 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 17' ' ' ASN . 12.2 tpp180 -83.81 155.05 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ARG . 98.0 m-20 -35.08 -44.38 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -163.89 116.99 1.45 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 20' ' ' SER . 0.7 OUTLIER -110.85 140.83 44.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.407 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 75.3 m -135.1 176.2 8.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.848 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -102.86 -35.45 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -81.56 -51.48 8.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 22' ' ' TYR . 42.3 p90 45.85 43.64 10.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.22 29.88 4.37 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.9 mtp -113.31 147.38 37.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.572 0.701 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 153.98 68.03 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.7 2.266 . . . . 0.0 112.312 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.44 -45.61 92.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -46.79 -31.57 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.97 -44.05 27.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.14 -42.09 96.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.81 158.21 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -100.48 150.53 22.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -45.89 -46.17 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -53.7 -40.32 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 15.2 mmtp -133.75 94.73 18.45 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.7 Cg_endo -69.76 -35.95 11.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.704 2.269 . . . . 0.0 112.365 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.407 HG21 ' CG ' ' A' ' 42' ' ' GLU . 18.9 mt -74.22 131.33 80.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 111.113 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 121.56 8.26 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.713 2.276 . . . . 0.0 112.345 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.465 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -44.67 -53.88 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -38.72 -68.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.2 t -45.41 -54.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' CG ' HG21 ' A' ' 37' ' ' ILE . 88.5 mt-10 -45.94 -60.9 1.99 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.465 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 54.5 mmtt -46.94 -39.29 12.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.6 m -68.64 -52.49 30.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.93 -32.65 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -82.64 -36.29 26.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.506 ' CE1' HG22 ' A' ' 93' ' ' VAL . 6.3 t80 -63.15 -55.87 21.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 51' ' ' THR . 23.1 mt -47.75 -52.47 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -70.94 -24.32 62.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.84 -17.71 59.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 48' ' ' ILE . 8.4 t -91.98 26.33 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.54 -34.4 3.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 tp 68.21 53.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.3 p -114.65 -25.33 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -42.74 129.52 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 57' ' ' GLY . 7.3 mp0 -74.21 140.96 45.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 33.93 37.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.2 pp -38.22 -32.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -82.03 -61.83 1.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -55.33 -14.02 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.46 108.53 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 77.4 p -79.76 -46.09 17.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.54 -125.03 8.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.509 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -99.75 136.69 39.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.467 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 1.4 mptm? -63.92 -47.48 80.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m -46.25 -43.68 15.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.13 -58.65 6.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.823 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.467 ' NE2' ' HA ' ' A' ' 65' ' ' LYS . 1.2 mp0 -58.19 -34.95 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -50.56 -62.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.3 p30 -58.9 -41.26 86.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.49 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 70.7 mt -46.61 -41.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.56 -57.7 2.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -49.09 -56.24 9.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -54.39 -46.54 73.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -62.38 -35.16 78.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.85 -53.31 52.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -74.42 -24.82 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -130.6 89.62 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.6 -34.63 75.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.68 39.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.417 HG12 ' N ' ' A' ' 82' ' ' ASN . 9.6 tt -79.99 154.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' ND2' ' HB ' ' A' ' 84' ' ' VAL . 5.0 t30 -124.79 94.56 4.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -41.15 -49.12 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.955 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 63.3 t -47.41 -44.62 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 t -60.18 -40.49 90.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 77.9 mtp -63.14 -37.97 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 62.95 47.4 4.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.0 m -84.76 171.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.7 p -68.71 118.96 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.9 t -36.56 -54.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -40.04 -47.78 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 -63.08 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.506 HG22 ' CE1' ' A' ' 47' ' ' PHE . 90.4 t -50.05 -46.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.84 -50.66 33.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -54.16 6.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.64 -40.85 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.1 tp -53.24 -56.31 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.463 ' CG ' ' CE2' ' A' ' 176' ' ' PHE . 6.1 mtmp? -60.34 -46.27 90.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.33 -46.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 7.3 t80 -57.41 -53.19 60.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -51.46 -41.01 60.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.53 -36.47 81.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -62.23 -38.75 90.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' ASP . 95.9 mt -34.89 144.64 0.21 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 110.934 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.28 36.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -139.26 153.82 71.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.77 128.65 16.32 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 2.263 . . . . 0.0 112.357 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 107' ' ' PRO . 23.8 tp -34.97 -39.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.9 mt -98.46 121.41 56.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 144.19 53.21 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 23.6 m-85 -59.38 -30.76 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.9 p -61.36 -16.35 45.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.45 29.92 7.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.51 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 3.1 m170 -76.39 -63.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.74 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.2 Cg_endo -69.73 -20.54 34.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.724 2.283 . . . . 0.0 112.364 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.6 -34.02 71.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mt -73.36 -37.09 66.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 121' ' ' ALA . 5.1 mt -77.49 -53.21 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -43.8 -32.37 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.42 -31.74 21.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -71.72 -19.74 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -92.92 26.25 2.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.949 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.1 mt -92.53 129.87 39.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.606 0.717 . . . . 0.0 111.138 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -44.36 2.11 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.63 2.22 . . . . 0.0 112.35 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.448 ' HB2' ' CG ' ' A' ' 128' ' ' GLU . 0.6 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -37.36 -57.99 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.9 m -46.66 -47.85 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.448 ' CG ' ' HB2' ' A' ' 125' ' ' ASP . 37.5 mm-40 -64.38 -48.61 74.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -45.97 -57.46 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.457 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 16.3 mt -63.33 -67.12 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 130' ' ' LEU . 9.3 m-70 -34.38 -40.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.12 -63.25 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.61 -30.27 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -65.96 -32.77 74.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -87.93 -47.65 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.3 mt -57.55 -26.07 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.174 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.7 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -76.39 -34.75 58.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -64.07 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.936 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.2 m-85 -40.7 129.73 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.577 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -33.95 141.11 0.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.7 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.577 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.75 -13.75 35.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.725 2.283 . . . . 0.0 112.352 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 95.4 t -97.84 -35.83 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.071 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.53 -39.61 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 1.4 t80 -47.22 -47.87 24.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.81 66.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.4 t -70.14 -57.99 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.557 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 41.3 t80 -48.4 -46.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -62.06 -51.18 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -53.66 -47.73 70.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.8 t -54.77 -58.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.557 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 86.3 mt -46.78 -52.09 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.6 m -41.36 -37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -80.72 -35.13 33.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 152' ' ' ILE . 97.0 mt -57.81 -42.99 85.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -52.6 -44.52 66.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -55.3 -43.4 74.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.35 -42.32 95.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 p -67.53 -27.11 66.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -69.97 -40.42 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -102.14 50.38 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.464 ' CB ' HG22 ' A' ' 168' ' ' THR . 0.6 OUTLIER -80.15 41.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.833 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -122.21 -43.47 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 mt -87.91 -40.97 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.158 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.84 -23.69 18.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 mt 63.99 48.27 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 37.8 mmm -132.2 97.14 4.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.464 HG22 ' CB ' ' A' ' 162' ' ' HIS . 72.3 p -85.36 167.85 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -52.32 -41.33 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.054 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.53 -56.42 20.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -50.69 -42.73 57.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.09 -43.95 97.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.6 t -57.9 -46.07 85.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.49 -35.16 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.9 t -68.59 -26.17 65.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 98' ' ' LYS . 16.7 m-85 -101.18 -6.58 24.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.589 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -54.61 -45.8 99.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.562 0.696 . . . . 0.0 110.907 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.1 Cg_exo -48.01 -50.18 12.39 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.268 . . . . 0.0 112.304 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 180' ' ' LEU . 20.8 m -81.87 -65.55 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 26.0 mt -33.45 -59.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.558 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 1.4 ttm -114.58 116.62 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -56.4 130.59 75.97 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 117.93 5.37 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.372 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -102.38 169.79 8.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -95.4 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -130.0 123.76 31.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.59 137.85 50.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -113.61 163.15 15.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -140.0 123.51 17.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.429 ' O ' ' C ' ' A' ' 191' ' ' LEU . 12.6 t80 -131.4 123.75 28.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 190' ' ' PHE . 0.1 OUTLIER -36.08 -47.07 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.91 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.2 t -83.12 149.14 27.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.8 m -63.32 120.12 10.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 2.9 m -78.96 -67.84 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.173 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 15.8 pttm 43.78 33.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 82.3 mt -84.65 -59.96 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -40.37 -51.65 2.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.15 -55.05 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 m -45.32 -38.62 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 94.0 t -45.17 -70.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.9 t -64.74 -60.37 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 201' ' ' VAL . 22.9 tt0 -34.59 -45.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 84.2 m -60.16 -59.15 5.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.2 m-85 -34.62 -54.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 50.5 mt -62.66 -55.52 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -46.28 -54.99 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.935 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 16.5 mm-40 -99.26 27.25 5.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.592 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 3.5 t -61.37 -14.42 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' TYR . 20.9 mm-40 -95.32 -57.53 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.49 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.6 t80 -39.67 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -52.9 -62.29 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -128.2 -26.78 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 215' ' ' GLY . 27.7 m-85 -83.21 30.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 213' ' ' TYR . 27.5 m-20 33.64 33.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -57.26 146.27 36.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.34 133.28 34.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.464 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 85.5 mt -48.29 122.82 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.1 m -111.49 166.31 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m 51.79 45.27 28.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -127.92 153.97 46.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.871 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.25 156.04 17.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.0 p -153.89 147.75 25.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -114.61 -61.57 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.12 157.86 33.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -136.97 167.38 21.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -139.2 176.37 8.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -133.82 175.03 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -89.12 122.17 68.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.608 0.718 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 150.99 69.02 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.631 2.221 . . . . 0.0 112.357 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -177.7 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.352 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -103.61 151.15 23.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.101 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -84.87 27.82 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -112.93 160.67 17.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -80.77 -42.8 21.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.413 ' CH2' ' HG3' ' A' ' 73' ' ' LYS . 4.7 m95 -132.29 125.79 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -148.37 126.13 11.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.496 ' O ' ' CE2' ' A' ' 23' ' ' PHE . 4.1 t -172.97 175.8 3.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.851 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -97.27 -23.9 15.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -59.72 -50.21 74.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -57.35 123.68 16.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.09 -41.87 2.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 8.4 mtt -84.07 145.14 45.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 110.82 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 147.62 62.99 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.633 2.222 . . . . 0.0 112.337 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.72 -52.4 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.954 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -44.9 -30.13 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.99 -45.03 15.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.05 -44.76 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 m -83.0 164.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -114.2 164.7 13.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.21 63.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -51.66 -54.13 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 mmtp -119.69 96.41 49.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -35.94 11.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.238 . . . . 0.0 112.328 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.5 mt -85.73 134.71 39.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.77 150.48 68.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -68.66 -47.2 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -40.79 -58.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.8 t -55.28 -62.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -45.8 -62.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -50.74 -37.25 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 68.8 m -69.86 -31.98 70.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.4 t -78.68 -60.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.46 -40.72 60.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.615 ' CE1' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -51.04 -41.1 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mt -59.9 -64.13 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -33.7 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.58 -24.64 56.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.1 p -107.7 29.23 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.08 134.66 5.21 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.58 -10.65 14.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.931 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.0 m -91.68 40.9 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 56' ' ' GLU . 6.0 m -92.45 113.78 26.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.7 tt0 -33.98 121.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.27 69.3 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -66.49 -9.56 35.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.93 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CD2' HD21 ' A' ' 58' ' ' LEU . 8.9 m-85 -122.75 -37.75 2.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -74.1 -40.2 62.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.41 137.1 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 91' ' ' ASN . 63.5 m -131.93 -41.23 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.84 -72.09 0.76 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -117.38 165.52 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.936 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -108.91 -39.02 5.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 69' ' ' ASP . 45.4 m -38.26 -53.74 1.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -35.72 -59.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -52.65 -38.4 60.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.9 t70 -47.84 -56.69 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.8 p30 -68.94 -36.08 77.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.458 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 57.8 mt -51.09 -42.36 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -82.92 -54.01 5.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HG3' ' CH2' ' A' ' 18' ' ' TRP . 5.6 mtpm? -54.39 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -45.04 -46.02 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.58 -31.37 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.15 -48.05 38.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.35 -30.15 65.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.1 93.18 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.89 37.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tt -76.58 153.13 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 83' ' ' LEU . 6.0 t30 -124.62 83.87 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 82' ' ' ASN . 26.4 mt -34.35 -47.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.22 -54.79 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -52.35 -42.01 63.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 75.2 mtp -60.9 -36.39 79.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 59.4 45.0 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 160.97 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.183 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 p -56.12 118.18 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.1 t -41.52 -54.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -43.23 -35.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.1 -59.3 4.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.615 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 89.6 t -50.39 -51.03 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.39 -45.34 35.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.32 -55.39 18.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.469 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.8 -40.77 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 14.5 tp -48.75 -39.95 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.505 ' CG ' ' CE1' ' A' ' 176' ' ' PHE . 42.6 mtmt -74.41 -45.95 43.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.13 -34.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 6.9 t80 -68.48 -48.09 65.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -56.66 -41.29 76.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.44 86.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.44 -35.4 73.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.3 mt -39.2 144.56 0.44 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -29.12 24.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.91 154.14 81.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 143.8 51.97 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.569 HD22 ' CD1' ' A' ' 148' ' ' PHE . 13.5 tp -48.16 -58.46 4.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.95 131.17 54.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.656 0.741 . . . . 0.0 111.106 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.404 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.77 162.09 43.41 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.317 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.538 ' CD2' ' CE1' ' A' ' 114' ' ' HIS . 52.8 m-85 -79.87 -25.78 40.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -69.74 -17.03 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.489 ' O ' ' CD1' ' A' ' 117' ' ' LEU . 43.3 mt -122.42 31.92 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.538 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 3.9 m170 -74.28 -61.76 1.14 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.582 0.706 . . . . 0.0 110.828 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.5 Cg_endo -69.77 -10.73 29.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -68.01 -44.03 77.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' A' ' 113' ' ' LEU . 4.3 mp -67.23 -34.93 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.528 HD11 ' CE1' ' A' ' 197' ' ' HIS . 9.6 mt -77.45 -58.5 3.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -42.76 -30.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.46 -31.76 18.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.451 ' CB ' HG23 ' A' ' 200' ' ' VAL . . . -69.08 -21.98 64.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -90.21 19.06 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.8 mt -85.53 132.71 43.85 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -44.57 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.319 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.3 m-20 -64.36 95.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.1 ttpt -35.58 -53.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 131' ' ' HIS . 55.4 m -57.34 -61.37 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.121 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -46.38 -46.23 18.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.863 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -48.35 -51.99 23.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.55 -60.1 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.532 ' CD2' HG22 ' A' ' 127' ' ' THR . 14.9 m-70 -40.96 -53.85 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.73 -49.57 65.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.05 -28.02 69.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -74.66 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -86.1 -32.43 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.66 -21.71 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.9 -7.72 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -77.04 -38.6 52.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -12.8 60.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.443 ' O ' ' C ' ' A' ' 141' ' ' HIS . 2.8 m-85 -53.68 135.92 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.2 t-80 -34.49 141.51 0.25 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.572 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.77 -14.53 36.18 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.665 2.244 . . . . 0.0 112.383 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.7 t -95.36 -25.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.105 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -94.84 -34.59 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -64.87 -54.42 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -45.52 -45.39 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 148' ' ' PHE . 11.7 t -77.16 -63.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.569 ' CD1' HD22 ' A' ' 108' ' ' LEU . 27.8 t80 -37.23 -41.4 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -64.77 -54.35 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -53.31 -51.14 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.6 t -48.11 -56.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 89.0 mt -55.83 -49.25 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.7 m -42.88 -31.03 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -85.17 -42.99 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 83.0 mt -54.93 -46.58 74.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -51.76 -48.3 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -53.55 -38.22 63.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.15 -45.67 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.165 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.2 p -58.35 -21.51 50.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -51.62 -53.75 35.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -102.32 37.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.506 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 24.5 p80 -49.97 -27.67 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.506 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 3.9 mmmp? -70.12 -32.58 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 92.2 mt -82.66 -65.32 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -2.3 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.5 mt 55.25 46.81 22.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 25.6 mtp -144.69 116.92 8.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.844 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.446 HG23 ' CG ' ' A' ' 162' ' ' HIS . 39.1 p -101.15 159.16 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.107 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.29 -35.03 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.77 -48.97 57.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -55.22 -36.11 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 14.0 mt -72.56 -43.3 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -58.11 -36.91 73.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.467 HG12 ' NE2' ' A' ' 198' ' ' GLN . 17.6 mt -77.8 -35.85 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.6 -18.47 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.505 ' CE1' ' CG ' ' A' ' 98' ' ' LYS . 11.6 m-85 -108.71 -8.83 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.571 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -54.34 -46.42 99.0 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.566 0.698 . . . . 0.0 110.917 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -47.95 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 3.9 m -69.1 -59.45 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 56.7 mt -33.83 -47.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 34.3 mmm -143.0 136.53 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -39.08 159.52 0.1 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 136.73 33.76 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.655 2.237 . . . . 0.0 112.373 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -47.79 163.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -119.96 -44.01 2.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -153.4 141.02 19.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.887 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -63.47 155.14 30.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -82.67 140.46 33.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -97.64 -177.0 3.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 28.1 t80 42.49 37.77 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 34.3 mt -154.53 129.78 9.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.4 m -78.04 -56.49 4.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.4 m -111.52 91.64 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 10.0 t -99.94 34.92 2.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -103.32 37.2 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 197' ' ' HIS . 96.8 mt -74.22 -43.61 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.528 ' CE1' HD11 ' A' ' 118' ' ' LEU . 53.1 m-70 -36.74 -62.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.526 ' OE1' ' CD1' ' A' ' 177' ' ' TRP . 18.2 mm100 -43.64 -54.17 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 m -50.61 -36.94 37.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' A' ' 117' ' ' LEU . 23.2 t -54.81 -71.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.09 -54.27 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -45.6 -51.77 11.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 204' ' ' PHE . 93.3 m -50.06 -63.02 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.4 m-85 -34.25 -53.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.11 -54.87 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -49.06 -57.55 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 10.3 mm-40 -96.52 28.48 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.491 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 3.1 t -61.86 -20.66 63.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 213' ' ' TYR . 10.9 mm-40 -88.57 -51.44 5.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -44.75 -37.97 4.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -48.88 -63.07 1.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -104.05 -54.29 2.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 209' ' ' GLN . 60.2 m-85 -56.82 -36.18 69.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.7 t30 73.25 36.23 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.21 174.72 49.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.98 142.71 53.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.455 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 92.9 mt -68.25 137.87 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.62 168.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.3 p -171.9 156.11 4.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.878 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 m -147.22 168.6 21.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.817 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.08 122.65 7.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.498 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.2 m -148.14 172.28 14.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -63.97 168.43 5.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.824 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.84 97.57 0.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.541 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -73.44 159.19 33.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -83.35 54.82 2.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 52.38 45.87 27.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.411 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 8.7 t30 -139.82 140.14 23.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 53.6 Cg_endo -69.73 151.21 69.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.36 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 146.82 61.29 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.724 2.283 . . . . 0.0 112.35 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.7 p -54.19 125.47 19.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -68.46 120.49 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 17' ' ' ASN . 19.1 ptp180 -94.26 -43.9 8.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 16' ' ' ARG . 13.8 p30 48.1 25.69 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.481 ' CG ' ' O ' ' A' ' 18' ' ' TRP . 34.3 t90 -118.89 3.82 11.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -52.4 156.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -129.59 178.67 6.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 22' ' ' TYR . 11.8 m120 -77.98 -43.99 28.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.585 ' CZ ' ' CE1' ' A' ' 23' ' ' PHE . 1.1 p90 -36.92 -37.54 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.585 ' CE1' ' CZ ' ' A' ' 22' ' ' TYR . 12.8 m-85 -49.5 108.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.78 -34.68 4.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -81.92 139.43 46.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.716 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 158.53 56.71 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.67 2.246 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.1 tp -54.6 -43.82 72.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -51.06 -37.35 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.19 -49.71 26.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.3 -46.43 79.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.08 168.41 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.5 p -112.33 162.88 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.72 -43.94 73.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.3 -45.46 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -128.93 86.15 58.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -34.34 14.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.39 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.1 mt -78.73 129.2 74.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 111.143 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.658 2.239 . . . . 0.0 112.334 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.471 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -47.69 -48.61 29.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -41.13 -66.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' CD1' ' A' ' 97' ' ' LEU . 41.8 t -45.84 -61.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -40.23 -61.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.471 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 43.2 mmtt -46.39 -41.27 13.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 86.7 m -68.69 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.79 -61.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -53.62 -35.94 61.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.544 ' CE2' HG22 ' A' ' 93' ' ' VAL . 30.3 t80 -56.72 -49.23 75.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.0 mt -61.67 -20.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -89.75 -14.1 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -95.44 -20.41 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -85.16 23.88 1.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.01 -29.79 3.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.477 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp 63.25 52.05 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.926 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 16.7 p -133.35 31.61 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 m -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.152 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.09 114.39 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.76 90.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.54 -30.13 12.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.98 -47.62 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -59.59 -15.96 22.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.94 101.97 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -66.11 -55.99 13.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.35 -101.55 2.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -116.48 158.24 23.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 66' ' ' THR . 1.6 tmtp? -95.62 -53.11 3.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' ASP . 91.5 m -38.1 -58.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 19.3 m-20 -39.13 -49.34 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.49 -29.41 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 66' ' ' THR . 8.5 t0 -59.39 -54.32 48.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 67' ' ' ASP . 20.2 p30 -54.72 -39.26 68.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.436 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 58.2 mt -49.03 -39.53 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -91.25 -55.1 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HA ' ' CZ2' ' A' ' 18' ' ' TRP . 50.1 mtmt -46.29 -48.09 18.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -66.31 -56.64 10.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -40.0 -43.42 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.88 -53.09 52.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -56.5 -40.06 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -149.86 134.33 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -91.01 -20.2 22.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -81.13 45.21 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 pt -106.12 -178.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -145.18 154.53 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.3 mt -89.24 -34.24 16.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.83 -56.63 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -52.32 -31.14 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.5 mmm -69.58 -27.8 65.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 59.13 48.16 10.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.45 162.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' VAL . 58.9 p -69.85 121.18 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' THR . 88.4 t -37.07 -55.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.09 -47.14 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.52 -62.75 1.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.544 HG22 ' CE2' ' A' ' 47' ' ' PHE . 97.2 t -44.41 -43.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.9 78.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -55.28 26.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -44.96 35.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 111.121 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.457 ' CD1' HG13 ' A' ' 41' ' ' VAL . 26.7 tp -44.11 -43.84 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -75.8 -46.57 29.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.09 -43.06 3.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -56.79 -46.58 81.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -60.53 -50.22 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.37 -39.88 73.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.57 -39.87 71.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.2 mt -39.02 143.36 0.48 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.711 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.62 31.8 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -133.49 154.83 81.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.731 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.03 68.23 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 148' ' ' PHE . 11.1 tp -62.63 -40.67 97.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 117' ' ' LEU . 65.1 mt -95.51 128.34 38.49 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 111.127 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 160.48 49.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.344 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.54 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 30.6 m-85 -75.45 -36.18 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.5 t -56.19 -14.57 2.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.445 HD12 ' CE1' ' A' ' 140' ' ' PHE . 23.1 mt -127.73 32.0 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.54 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.2 m170 -75.88 -63.15 0.66 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.822 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.71 -11.46 30.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.327 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.92 -32.94 57.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.437 ' CD1' HG21 ' A' ' 109' ' ' ILE . 2.5 mt -70.39 -45.77 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.7 mt -68.09 -55.04 13.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -47.88 -29.35 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.15 -24.89 26.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -81.06 -32.19 34.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -75.75 -1.29 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.0 mt -62.43 130.76 93.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.639 0.733 . . . . 0.0 111.151 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.58 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.38 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.25 110.81 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -46.07 -54.96 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.2 m -50.98 -56.81 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -56.25 -38.06 70.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -55.25 -46.54 76.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 131' ' ' HIS . 13.1 mt -70.76 -66.51 0.6 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' LEU . 12.7 m-70 -35.69 -51.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.09 -57.51 9.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 9.3 mt -59.47 -20.52 55.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -81.65 -34.11 30.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -80.69 -28.61 36.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.4 mt -72.58 -34.59 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.097 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.562 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 9.5 p -73.0 -0.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -79.07 -42.92 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 18.91 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.562 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 2.7 m-85 -77.67 143.43 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -37.16 141.13 0.43 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.526 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.73 -25.6 28.58 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.323 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.3 t -92.18 -35.39 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.422 ' OD1' ' CG ' ' A' ' 141' ' ' HIS . 17.6 m120 -81.42 -45.78 15.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.554 ' CE1' ' HD3' ' A' ' 149' ' ' ARG . 4.3 t80 -43.38 -48.53 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -56.25 -59.8 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.7 -63.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.552 ' CD1' HD22 ' A' ' 108' ' ' LEU . 30.0 t80 -43.97 -44.44 7.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.554 ' HD3' ' CE1' ' A' ' 145' ' ' TYR . 8.2 ttp85 -62.14 -49.04 77.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -59.33 -53.96 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -45.49 -59.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.545 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 75.0 mt -52.08 -52.67 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 m -41.51 -29.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -88.44 -42.37 12.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.599 ' CD2' ' CE2' ' A' ' 176' ' ' PHE . 89.8 mt -54.53 -46.84 73.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -51.35 -40.95 60.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -61.3 -41.49 97.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.74 -42.92 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.7 p -61.8 -19.67 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -58.05 -53.2 60.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -99.76 37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.497 ' CG ' HG22 ' A' ' 168' ' ' THR . 19.7 p80 -53.43 -28.25 28.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -67.31 -27.26 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 79.3 mt -89.46 -59.03 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' LEU . 3.5 p30 -81.49 15.48 2.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 165' ' ' ASN . 27.3 mt 36.82 50.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 64.3 mmm -145.06 115.24 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.497 HG22 ' CG ' ' A' ' 162' ' ' HIS . 66.1 p -101.19 167.44 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.67 -40.39 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -58.26 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -58.65 -55.67 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.76 -21.73 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.435 ' HB2' ' N ' ' A' ' 202' ' ' GLU . 4.7 p -82.92 -39.16 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 49.4 mt -75.75 -25.1 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.3 p -79.39 -36.92 38.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.599 ' CE2' ' CD2' ' A' ' 155' ' ' LEU . 7.2 m-85 -85.24 -38.71 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.608 ' O ' ' CE3' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -39.26 -57.14 2.37 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.546 0.689 . . . . 0.0 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.533 ' HD3' ' CD1' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -48.07 -65.89 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.662 2.242 . . . . 0.0 112.317 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.489 ' O ' ' C ' ' A' ' 180' ' ' LEU . 94.6 m -54.39 -55.47 28.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.489 ' C ' ' O ' ' A' ' 179' ' ' THR . 32.8 mt -30.24 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.485 ' N ' ' O ' ' A' ' 179' ' ' THR . 2.5 ptt? -175.65 143.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -98.8 148.46 34.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 122.4 9.08 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 186' ' ' GLU . 11.3 t0 -72.75 153.1 41.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 184' ' ' ASP . 0.8 OUTLIER 33.24 34.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 184' ' ' ASP . 5.9 pt-20 -35.6 111.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -56.77 172.74 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -54.93 178.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -53.86 114.79 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 190' ' ' PHE . 3.8 p90 -114.02 160.17 19.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 9.5 mt -156.19 107.08 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 47.4 m -144.43 153.81 42.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 14.6 t -83.08 39.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 64.6 p -96.3 93.72 7.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -90.41 40.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.56 -58.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.108 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -41.74 -52.54 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.903 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -63.11 -46.11 88.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.6 t -55.0 -40.93 70.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 79.1 t -37.62 -67.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.5 t -63.9 -51.72 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.435 ' N ' ' HB2' ' A' ' 173' ' ' SER . 15.6 tt0 -37.37 -53.93 1.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.6 m -56.3 -57.26 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 10.7 m-85 -42.62 -36.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 86.0 mt -71.73 -58.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.448 ' HB3' ' CG2' ' A' ' 218' ' ' VAL . 11.3 mt-30 -54.96 -54.76 38.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.401 ' HG3' ' CD1' ' A' ' 130' ' ' LEU . 61.6 mm-40 -86.44 24.2 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.73 -18.62 62.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 213' ' ' TYR . 18.2 mm-40 -91.6 -51.14 5.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -45.24 -38.49 5.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -50.3 -63.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -106.68 -54.79 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 209' ' ' GLN . 71.4 m-85 -59.62 -16.95 29.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 48.28 47.07 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -90.04 165.6 31.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.89 132.87 42.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 93.4 mt -58.63 106.84 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 206' ' ' GLN . 30.1 m -64.01 168.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 t -158.58 150.46 21.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 t -112.21 -55.57 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 37.98 -122.25 1.1 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.492 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 p -38.84 137.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.8 t -106.91 118.1 35.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.04 63.35 0.32 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -157.81 156.82 32.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.3 . . . . 0.0 110.923 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -94.09 148.49 22.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -170.48 115.58 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.429 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 24.5 t-20 -87.78 140.61 31.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 0.0 110.878 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 53.5 Cg_endo -69.77 154.34 67.81 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.346 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 162.08 43.46 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.694 2.262 . . . . 0.0 112.333 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 t -169.41 157.77 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.13 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.71 151.6 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -109.66 -44.04 3.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 36.94 39.64 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -87.34 42.57 1.04 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -100.55 128.43 46.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.45 ' HB2' ' CD1' ' A' ' 22' ' ' TYR . 1.6 m -117.28 -6.63 11.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.827 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 58.14 40.69 24.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.45 ' CD1' ' HB2' ' A' ' 20' ' ' SER . 4.2 p90 -127.4 -44.76 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' N ' ' CG ' ' A' ' 22' ' ' TYR . 30.5 p90 -51.41 112.15 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.849 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.47 -38.66 3.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.509 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.0 mmt -80.39 152.67 73.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.508 0.671 . . . . 0.0 110.866 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 154.38 67.74 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.1 tp -61.0 -42.69 98.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.51 -29.23 24.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.81 -48.74 12.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.37 -45.18 84.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.2 168.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -107.64 146.83 31.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.79 -40.97 6.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.103 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.02 -44.48 82.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -131.02 99.57 17.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.617 0.722 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -35.51 12.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.343 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.71 129.36 74.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 117.37 5.05 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.459 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -40.09 -46.3 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -44.69 -64.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.0 t -43.16 -59.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.168 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -45.1 -61.34 1.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.459 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 49.0 mmtt -46.09 -43.17 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 90.1 m -65.29 -30.33 71.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.493 HG11 ' CG ' ' A' ' 154' ' ' HIS . 95.6 t -79.27 -54.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.04 -43.04 86.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 48' ' ' ILE . 3.2 t80 -49.59 -60.27 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 76.8 mt -45.11 -44.64 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HG2' ' NH2' ' A' ' 157' ' ' ARG . 64.7 mt-10 -63.03 -45.65 91.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.02 -42.3 94.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.6 p -85.89 29.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.147 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.71 153.9 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -120.28 38.96 3.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.6 p -117.49 42.3 2.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -97.86 133.51 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.04 120.95 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.51 80.07 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.0 -49.69 69.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 20.1 m-85 -99.49 -48.96 4.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -38.04 -42.03 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.68 137.95 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.0 p -121.01 144.15 48.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.91 -133.55 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.76 166.94 16.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 110.89 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -39.13 18.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -44.36 -54.19 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -45.77 -52.72 10.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.828 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -67.89 -32.18 72.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.32 -67.9 0.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -49.12 -42.13 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.0 mt -50.22 -40.81 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -81.27 -57.08 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -50.98 -59.67 3.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -49.09 -47.78 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -61.77 -41.39 97.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.31 -48.09 82.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.1 -29.65 61.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -132.53 93.14 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.802 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -60.57 -34.34 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.17 36.6 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.1 tt -77.53 156.16 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' SER . 2.9 t30 -122.04 87.82 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 82' ' ' ASN . 60.0 mt -37.27 -49.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.438 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 50.1 t -50.05 -42.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ASN . 45.6 t -59.96 -35.14 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.7 mmm -68.99 -34.17 74.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 59.22 50.15 8.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -84.79 172.24 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 90' ' ' VAL . 37.1 p -75.04 117.14 16.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 89' ' ' THR . 75.4 t -36.68 -52.89 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 90' ' ' VAL . 2.6 t-20 -37.16 -46.38 0.7 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.08 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.447 HG23 ' CE1' ' A' ' 47' ' ' PHE . 81.5 t -43.66 -46.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.095 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -51.88 -48.57 64.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.95 -62.71 4.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.82 -42.57 5.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 111.066 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.8 tp -52.04 -46.91 65.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 99' ' ' ALA . 42.3 mtmt -69.29 -47.92 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.5 -41.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.73 -55.22 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -54.16 -52.78 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.46 ' CA ' HG22 ' A' ' 179' ' ' THR . . . -54.28 -42.2 69.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.78 -35.57 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -42.47 141.42 1.5 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -19.49 35.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.642 2.228 . . . . 0.0 112.375 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 155.18 73.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.571 0.701 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 151.07 68.73 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.66 2.24 . . . . 0.0 112.376 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 tp -52.46 -51.39 59.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.447 HG22 ' CD1' ' A' ' 117' ' ' LEU . 29.1 mt -83.42 132.31 50.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 0.0 111.129 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.463 ' CG ' HD11 ' A' ' 113' ' ' LEU . 53.9 Cg_endo -69.71 146.76 61.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.369 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.517 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 20.9 m-85 -60.55 -26.0 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE2' ' A' ' 116' ' ' GLU . 33.1 m -65.57 -35.85 82.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.563 HD13 ' CE1' ' A' ' 140' ' ' PHE . 65.4 mt -92.17 35.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.517 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 4.1 m170 -77.56 -60.02 0.77 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.3 Cg_endo -69.79 -58.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.504 ' OE1' ' CD2' ' A' ' 113' ' ' LEU . 5.2 pt-20 -44.57 -38.13 4.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 113' ' ' LEU . 10.8 mt -66.64 -38.48 86.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.468 ' CD2' ' HA ' ' A' ' 197' ' ' HIS . 6.9 mt -76.65 -56.27 4.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.91 -28.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -81.74 -31.12 32.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.073 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -78.15 -31.9 49.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -82.94 16.77 2.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 73.5 mt -79.03 129.86 71.68 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.638 0.733 . . . . 0.0 111.16 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.93 2.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 126' ' ' LYS . 31.7 m-20 -67.21 95.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 125' ' ' ASP . 27.5 ttpt -33.49 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.5 m -57.49 -61.76 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.149 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -44.74 -56.47 4.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -37.75 -52.23 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.459 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 22.2 mt -64.87 -66.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 130' ' ' LEU . 20.1 m-70 -34.56 -45.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.61 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.9 mt -51.65 -27.53 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -75.18 -37.87 61.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.9 -26.11 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.449 ' O ' ' CD ' ' A' ' 139' ' ' LYS . 36.2 mt -75.33 -36.33 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.564 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 8.5 p -69.83 -0.41 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -82.01 -29.61 31.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' CD ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -97.18 14.17 26.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.3 m-85 -75.11 140.59 43.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 4.4 t-80 -34.39 141.05 0.26 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.74 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.275 . . . . 0.0 112.355 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.8 -33.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -83.26 -47.78 11.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -42.68 -44.88 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.2 -55.49 34.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.33 -60.1 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 20.8 t80 -38.43 -42.02 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -72.32 -49.52 33.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -52.51 -45.13 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.57 -64.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.481 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 82.1 mt -43.4 -51.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.7 m -43.37 -35.44 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.493 ' CG ' HG11 ' A' ' 45' ' ' VAL . 77.2 t60 -83.36 -37.56 23.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 98.8 mt -56.37 -46.32 80.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -51.69 -41.97 61.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.451 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 2.6 mtp-105 -57.12 -35.56 69.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 -42.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.5 p -64.86 -34.53 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 36.2 mt-30 -54.18 -42.25 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.29 37.35 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 166' ' ' LEU . 29.8 p80 -53.96 -34.07 58.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -55.93 -31.22 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 74.2 mt -89.75 -58.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.178 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -76.89 7.56 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 162' ' ' HIS . 34.7 mt 40.85 53.38 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 75.4 mmm -152.29 119.85 6.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 169' ' ' ALA . 69.2 p -102.01 153.13 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.173 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.82 -44.29 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.105 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -61.81 -50.87 70.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -53.57 -39.91 65.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 38.9 mt -67.31 -44.35 79.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t -53.59 -50.1 66.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.98 -41.28 89.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.12 -30.66 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.58 -2.27 54.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.582 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.86 -45.95 92.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.96 -53.94 5.92 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.721 2.281 . . . . 0.0 112.296 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.46 HG22 ' CA ' ' A' ' 102' ' ' ALA . 20.5 m -76.28 -67.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 179' ' ' THR . 24.8 mt -34.29 -48.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 4.4 mmm -136.44 120.98 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.905 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -45.08 142.66 2.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.526 0.679 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 133.35 25.35 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.69 140.23 58.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -60.48 -49.44 77.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.819 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.0 -55.71 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.5 t30 45.01 42.55 6.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -127.8 142.52 51.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.88 119.58 32.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -81.63 -54.14 5.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.2 mt -153.41 168.47 25.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.8 m 39.35 45.36 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -40.02 120.56 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.143 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 11.5 t -90.55 143.91 26.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -130.54 33.65 4.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 197' ' ' HIS . 72.7 mt -78.23 -56.61 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.107 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 51.2 m80 -36.18 -50.67 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.05 -47.35 71.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.2 m -47.4 -36.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.6 t -48.18 -50.46 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 202' ' ' GLU . 45.2 t -65.69 -59.65 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' VAL . 65.4 tt0 -34.48 -64.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 205' ' ' ILE . 38.2 m -41.49 -66.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.8 m-85 -35.43 -33.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 203' ' ' THR . 82.3 mt -84.64 -46.52 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 203' ' ' THR . 5.6 mm-40 -56.27 -59.28 5.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 6.5 mm-40 -94.61 31.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.5 t -58.64 -21.55 54.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.576 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 5.8 mm-40 -86.24 -54.67 4.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -40.03 -35.77 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -54.71 -63.19 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -107.73 -56.51 2.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.576 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 63.1 m-85 -60.06 -11.55 6.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 46.18 43.65 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.89 168.83 53.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.92 141.89 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.464 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.9 mt -73.91 133.42 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.416 ' N ' HG21 ' A' ' 217' ' ' ILE . 29.6 m -109.8 170.97 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.13 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.8 p -173.02 177.91 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.367 . . . . 0.0 110.836 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 t -134.43 175.78 9.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.03 163.07 29.65 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -172.49 -178.88 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.852 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 p -161.94 171.49 17.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.9 -179.43 26.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -165.37 128.03 2.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -142.77 162.67 34.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -169.05 165.8 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -162.08 146.69 9.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.641 0.734 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 169.16 19.53 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.715 2.277 . . . . 0.0 112.344 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 132.14 22.71 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.7 2.267 . . . . 0.0 112.348 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.447 HG21 ' N ' ' A' ' 15' ' ' ARG . 48.9 m -153.9 147.64 25.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.127 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.447 ' N ' HG21 ' A' ' 14' ' ' THR . 17.6 mmt180 -35.56 115.64 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -75.63 133.28 40.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -86.2 48.04 1.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.569 ' CZ3' ' HA ' ' A' ' 73' ' ' LYS . 9.3 t-105 -104.42 84.78 2.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -89.48 174.62 7.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -146.54 137.03 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -125.92 45.78 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' PHE . 5.4 p90 -126.27 -41.1 1.93 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.2 m-85 35.39 47.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.56 33.42 7.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.463 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 19.2 mmt -100.44 138.33 20.15 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.581 0.705 . . . . 0.0 110.902 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 151.89 69.44 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.375 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.0 tp -46.91 -40.89 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' CB ' HG22 ' A' ' 143' ' ' VAL . 4.8 pt20 -50.81 -44.65 59.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.95 -46.24 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -57.52 -37.28 72.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 m -89.67 164.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 35' ' ' LYS . 20.4 p -106.53 133.18 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -34.68 -44.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -58.13 -47.68 82.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' THR . 33.1 mmtm -124.75 96.65 40.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.549 0.69 . . . . 0.0 110.862 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -40.35 5.35 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.452 ' CG1' ' OD2' ' A' ' 146' ' ' ASP . 15.7 mt -80.51 130.73 63.75 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.673 0.749 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 54.1 Cg_endo -69.71 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.36 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -38.29 -54.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -39.25 -63.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.442 ' CG2' ' HG2' ' A' ' 38' ' ' PRO . 43.1 t -44.31 -52.67 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -53.7 -61.25 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.463 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 48.3 mmtt -44.16 -33.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 87.8 m -76.04 -50.44 14.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG11 ' CG ' ' A' ' 154' ' ' HIS . 96.6 t -58.61 -39.66 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -78.1 -26.36 48.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 47' ' ' PHE . 1.1 t80 -79.26 -33.76 43.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.5 mt -66.93 -34.24 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -84.36 -33.98 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.83 -24.62 52.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.6 p -84.3 28.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.104 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.64 -32.02 4.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.469 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 tp 70.45 27.54 3.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.807 0.337 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.56 44.65 1.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -101.17 135.59 42.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 57' ' ' GLY . 4.0 mt-10 -65.43 115.62 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.56 68.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.439 ' CD1' ' CG ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -62.48 -15.58 50.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CG ' ' CD1' ' A' ' 58' ' ' LEU . 20.0 m-85 -98.22 -56.11 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -15.53 18.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.83 103.23 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.5 p -60.76 125.42 23.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.82 157.87 20.73 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.451 ' ND2' ' HB ' ' A' ' 66' ' ' THR . 53.1 t30 -41.04 146.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -78.78 -42.5 27.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.451 ' HB ' ' ND2' ' A' ' 64' ' ' ASN . 6.4 m -51.04 -45.38 61.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.171 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.469 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 5.1 m-20 -57.81 -58.29 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -50.23 -28.34 7.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -60.37 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -57.47 -45.55 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 79.3 mt -47.1 -42.82 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -83.74 -64.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.569 ' HA ' ' CZ3' ' A' ' 18' ' ' TRP . 46.3 mttm -41.72 -54.0 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.401 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 31.6 mm-40 -58.85 -40.22 83.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 78' ' ' ASP . 65.2 t80 -64.73 -61.15 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.32 -57.09 9.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -52.0 -26.63 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' CG ' ' O ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -162.23 116.22 1.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -71.61 -33.31 68.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -41.07 -46.23 2.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.46 HG12 ' N ' ' A' ' 82' ' ' ASN . 1.8 tt -45.85 145.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' N ' HG12 ' A' ' 81' ' ' ILE . 56.3 t30 -128.71 119.32 24.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 mt -47.96 -52.94 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.75 -48.27 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -62.9 -44.69 95.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.6 mtp -52.17 -33.9 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 57.72 49.74 11.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -84.5 171.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.3 p -70.96 116.49 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.4 t -39.55 -45.69 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -48.85 -41.92 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB2' ' CB ' ' A' ' 67' ' ' ASP . . . -62.73 -63.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.498 HG21 ' CE1' ' A' ' 47' ' ' PHE . 87.0 t -50.33 -51.59 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.73 -36.79 5.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.76 -57.21 3.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.02 -41.72 3.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.088 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -49.33 -53.76 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -64.46 -43.92 92.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.79 -50.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -55.04 -57.87 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.471 ' HB3' ' CG2' ' A' ' 179' ' ' THR . 34.3 m-85 -50.65 -39.3 50.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.13 80.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.28 -33.99 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.0 mt -40.29 141.44 0.84 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.937 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.39 32.22 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.248 . . . . 0.0 112.388 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.59 155.81 75.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 141.22 44.56 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.553 HD22 ' CD1' ' A' ' 148' ' ' PHE . 15.4 tp -43.62 -51.6 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 91.2 mt -82.09 128.97 66.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 158.84 55.58 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.34 -29.05 47.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -65.48 -5.33 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.566 HD13 ' CE1' ' A' ' 140' ' ' PHE . 13.6 mt -133.46 22.09 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.485 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.4 m170 -70.79 -60.17 3.19 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.892 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.2 Cg_endo -69.77 -16.39 37.5 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 0.0 112.309 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.29 -36.8 63.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.7 mt -71.79 -26.33 62.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.72 -48.47 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -53.59 -31.4 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.17 -25.43 25.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.454 ' CB ' HG21 ' A' ' 200' ' ' VAL . . . -78.87 -21.33 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -89.47 11.2 20.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' A' ' 124' ' ' PRO . 85.9 mt -76.62 138.52 66.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.654 0.74 . . . . 0.0 111.151 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 123' ' ' ILE . 53.6 Cg_endo -69.8 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.276 . . . . 0.0 112.299 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.35 101.27 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -44.01 -48.73 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.555 HG22 ' CD2' ' A' ' 131' ' ' HIS . 89.6 m -56.93 -60.8 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -49.94 -48.07 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -45.47 -51.53 11.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.0 mt -65.79 -53.7 36.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.555 ' CD2' HG22 ' A' ' 127' ' ' THR . 12.0 m-70 -45.48 -55.97 5.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.2 -54.87 17.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.5 mt -55.53 -36.69 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -68.16 -22.45 64.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -89.27 -48.32 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.426 ' O ' ' CD1' ' A' ' 140' ' ' PHE . 19.0 mt -56.61 -34.47 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.492 ' O ' ' CE1' ' A' ' 145' ' ' TYR . 7.1 p -71.25 -6.75 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -87.51 -37.91 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 23.2 1.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 113' ' ' LEU . 2.3 m-30 -81.79 175.2 10.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.886 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -65.3 141.14 98.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.584 0.707 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.572 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.8 -15.6 37.01 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.266 . . . . 0.0 112.32 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.461 HG22 ' CB ' ' A' ' 28' ' ' GLN . 69.6 t -99.21 -25.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -93.98 -33.46 13.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CE1' ' O ' ' A' ' 137' ' ' VAL . 83.1 t80 -65.21 -56.77 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.452 ' OD2' ' CG1' ' A' ' 37' ' ' ILE . 4.6 p-10 -42.86 -49.42 5.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.46 -55.89 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.553 ' CD1' HD22 ' A' ' 108' ' ' LEU . 17.4 t80 -42.49 -41.69 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.468 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 19.4 mtp180 -59.8 -59.89 4.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -54.05 -34.63 60.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.8 t -59.39 -63.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.529 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 21.5 mt -53.01 -53.25 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -39.82 -33.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.463 ' CG ' HG11 ' A' ' 45' ' ' VAL . 74.0 t60 -84.36 -41.86 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 76.0 mt -50.83 -48.75 59.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 205' ' ' ILE . 3.9 t-20 -49.33 -45.84 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.45 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 57.5 mtt-85 -53.57 -38.67 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.5 t -74.77 -43.39 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 26.2 p -60.67 -25.22 66.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 41.2 mt-30 -65.55 -37.03 85.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -105.72 36.35 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.545 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 17.5 p80 -55.0 -38.3 67.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.545 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 18.0 mmmt -59.46 -36.72 76.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.53 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -73.31 2.17 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 162' ' ' HIS . 28.3 mt 49.8 42.82 24.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.7 mmm -141.88 112.02 6.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.3 p -94.11 155.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -41.06 -36.37 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.66 -52.57 50.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -57.44 -45.03 85.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.5 mt -62.46 -46.52 88.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -57.53 -24.23 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.82 -39.44 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 8.4 p -63.35 -32.67 74.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.418 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.4 m-85 -90.02 -12.98 36.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -48.76 -46.57 72.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -48.01 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 101' ' ' PHE . 40.0 m -64.41 -59.89 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 179' ' ' THR . 70.2 mt -33.72 -48.15 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.524 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 13.2 ptm -159.06 150.82 20.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -70.8 145.34 91.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.61 0.719 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 134.54 28.23 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.56 41.55 3.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -76.41 48.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -112.77 38.82 2.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -152.67 141.0 20.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -54.38 150.25 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -92.03 -175.07 3.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -138.44 174.36 10.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 0.1 OUTLIER -96.29 -58.84 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 73.8 m -43.4 -69.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 33.4 p -118.3 125.01 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 12.0 t -145.15 148.72 33.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm 63.7 46.08 4.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 81.1 mt -74.2 -46.8 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -43.32 -44.82 5.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.18 -54.41 47.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 t -52.81 -40.42 63.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.454 HG21 ' CB ' ' A' ' 121' ' ' ALA . 85.3 t -47.1 -69.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.157 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 202' ' ' GLU . 83.1 t -58.14 -60.28 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 201' ' ' VAL . 66.6 tt0 -37.62 -43.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 56.9 m -59.46 -55.38 35.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 208' ' ' CYS . 9.4 m-85 -38.73 -58.22 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.501 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 63.2 mt -55.56 -50.75 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -53.69 -60.13 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.417 ' OE1' ' CB ' ' A' ' 210' ' ' PHE . 11.0 mm-40 -92.52 25.57 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.926 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 1.8 t -60.4 -14.82 21.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' TYR . 14.0 mm-40 -95.86 -57.91 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.471 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.8 t80 -39.76 -30.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.4 m-85 -52.6 -61.87 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -127.02 -28.33 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 209' ' ' GLN . 26.2 m-85 -83.99 26.82 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' TYR . 75.9 m-20 33.48 34.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -59.08 145.87 43.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.12 129.93 35.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 53.3 mt -41.32 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.08 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.26 163.96 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 m -137.95 160.36 39.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 m -152.19 127.6 9.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.5 127.35 9.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 t -81.84 115.09 20.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 110.843 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.7 m -130.72 121.81 26.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.83 44.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.533 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm 56.9 41.56 27.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -78.06 -25.67 47.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -87.14 -60.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.18 158.25 38.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.86 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 168.27 22.13 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.647 2.232 . . . . 0.0 112.292 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 154.92 67.13 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 p -117.6 170.26 8.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -65.59 166.45 10.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.62 147.58 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -118.83 40.09 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 57.32 41.75 26.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.82 105.32 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -121.25 119.25 31.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -86.81 29.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -122.34 -41.63 2.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.918 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -53.38 123.91 13.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.29 25.26 75.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.6 mmm -119.73 150.15 49.78 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.504 0.669 . . . . 0.0 110.91 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 54.2 Cg_endo -69.72 123.46 10.14 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.383 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.0 tp -49.39 -49.87 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.85 -34.66 5.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 33.2 t70 -77.28 -45.81 25.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.9 mt -59.45 -46.04 89.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.3 m -88.27 163.22 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.9 p -108.87 149.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.105 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.73 -46.94 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -50.14 -44.45 52.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.923 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -132.66 99.17 15.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.606 0.717 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -41.17 4.47 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.692 2.261 . . . . 0.0 112.344 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.1 mt -74.84 134.81 74.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.584 0.707 . . . . 0.0 111.164 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.32 64.65 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.643 2.228 . . . . 0.0 112.356 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.48 HD12 ' CE ' ' A' ' 43' ' ' LYS . 1.1 tm? -65.12 -59.36 4.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' LEU . 24.9 t80 -36.09 -64.86 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.2 t -46.67 -63.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -40.53 -56.01 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.48 ' CE ' HD12 ' A' ' 39' ' ' LEU . 64.2 mmtt -53.92 -39.43 65.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 80.7 m -65.23 -41.88 93.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.66 -43.86 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -70.45 -38.76 74.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.498 ' CE1' HG23 ' A' ' 93' ' ' VAL . 11.0 t80 -56.58 -50.15 72.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 mt -48.83 -68.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 50' ' ' ASP . 2.7 pp20? -55.18 -53.19 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 21.1 t70 -45.46 -42.89 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 p -88.66 29.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 108.65 1.45 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.22 51.41 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 0.0 110.953 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 80.4 m -132.7 30.88 4.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 7.5 m -66.54 122.33 17.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.15 130.38 42.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 45.18 87.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.492 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 4.6 mp -83.16 143.61 30.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.353 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 58' ' ' LEU . 2.6 m-85 47.87 27.88 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 tpp85 -123.41 -46.84 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t -100.37 145.05 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.4 t -171.45 148.05 2.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.5 -52.83 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -71.09 91.28 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.23 -34.58 78.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -52.87 -36.31 58.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.156 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.96 -58.27 8.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -58.91 -33.88 71.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.95 -66.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -57.19 -37.85 72.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.496 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 38.7 mt -52.25 -37.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -90.63 -55.65 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.04 -54.87 20.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -54.04 -43.84 70.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -57.38 -40.68 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.29 -62.0 2.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -58.94 -28.65 66.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -129.67 103.98 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -76.33 -27.24 56.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -96.23 37.21 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.1 tt -80.69 153.77 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -123.0 94.78 4.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -37.23 -50.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.4 t -43.66 -46.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -57.88 -46.41 84.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.0 mtp -56.16 -38.11 70.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 62.05 50.12 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.02 178.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 p -75.63 117.76 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -42.08 -51.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -40.39 -49.48 2.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 71' ' ' ILE . . . -47.45 -56.15 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 47' ' ' PHE . 98.3 t -46.65 -55.24 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -47.07 -45.36 21.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.49 -60.27 5.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.31 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.9 tp -47.98 -42.94 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -64.96 -43.33 93.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.912 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.94 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -60.54 -35.87 77.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -82.15 -41.0 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.861 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.4 -41.71 98.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -57.28 -40.17 77.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.442 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 47.7 mt -36.56 146.98 0.21 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.602 0.715 . . . . 0.0 110.946 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -27.46 26.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 153.98 81.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.64 0.733 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 156.58 63.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.337 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.67 -45.91 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.3 mt -95.93 117.65 66.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 111.146 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 137.69 36.12 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.662 2.242 . . . . 0.0 112.323 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.573 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 6.0 m-85 -53.05 -36.47 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -54.91 -23.52 19.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.426 HD13 ' CE1' ' A' ' 140' ' ' PHE . 60.8 mt -112.97 30.81 6.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.858 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.573 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.6 m170 -74.3 -61.8 1.13 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 110.847 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.1 Cg_endo -69.73 -40.32 5.5 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -47.09 -33.55 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.62 -43.02 66.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 121' ' ' ALA . 6.3 mt -69.1 -57.95 4.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -43.05 -25.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.06 -27.72 15.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.74 -31.72 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -74.1 -15.55 61.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 90.4 mt -50.26 129.35 24.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -46.94 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.252 . . . . 0.0 112.372 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -59.04 106.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -46.94 -46.49 21.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.488 HG23 ' CD2' ' A' ' 131' ' ' HIS . 70.6 m -59.78 -67.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 129' ' ' ARG . 58.0 mm-40 -46.6 -51.76 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 128' ' ' GLU . 12.2 ttm180 -36.79 -48.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.472 ' CD2' ' HG2' ' A' ' 207' ' ' GLN . 23.0 mt -73.26 -66.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.488 ' CD2' HG23 ' A' ' 127' ' ' THR . 29.9 m-70 -34.14 -49.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.864 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.92 -59.94 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.84 -40.01 59.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -63.45 -26.47 68.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.44 -39.79 13.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.47 -41.56 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 140' ' ' PHE . 12.9 p -58.75 -24.9 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -60.04 -32.28 70.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -60.42 -34.88 74.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 141' ' ' HIS . 22.6 m-85 -44.91 132.34 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.565 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.1 t-80 -33.99 141.85 0.23 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -9.55 26.38 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.369 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.6 t -98.83 -38.99 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -84.28 -38.17 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.505 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 35.5 t80 -51.71 -43.75 62.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.93 -45.71 82.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.23 -59.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.529 ' CE2' HD11 ' A' ' 152' ' ' ILE . 41.0 t80 -47.92 -42.92 28.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.505 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 14.0 mmm180 -65.87 -38.76 89.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -65.28 -45.71 83.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.67 -60.35 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.529 HD11 ' CE2' ' A' ' 148' ' ' PHE . 84.7 mt -46.97 -48.58 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.3 m -44.09 -36.21 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -80.79 -36.39 31.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.92 -47.0 87.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -49.04 -43.08 40.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.462 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 26.8 mtp85 -61.79 -38.08 86.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.23 -47.51 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.2 p -56.63 -36.4 69.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.2 mt-30 -53.01 -42.04 65.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.928 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -110.66 35.93 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 166' ' ' LEU . 22.5 p80 -47.35 -35.78 8.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 24.3 mmtp -57.71 -33.82 68.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 92.9 mt -80.13 -59.7 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.145 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -81.99 13.04 3.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 162' ' ' HIS . 16.7 mt 39.53 54.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.465 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 18.0 mmm -154.47 116.06 4.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 p -93.5 154.86 17.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -40.02 -42.73 1.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.101 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -63.64 -52.48 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -52.63 -48.21 66.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.41 -44.94 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 71.2 p -63.39 -42.42 98.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.04 -33.59 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 m -72.95 -18.85 61.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -104.25 -9.58 18.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.562 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -50.23 -46.73 83.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.567 0.699 . . . . 0.0 110.909 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.9 Cg_exo -47.97 -59.78 1.12 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.665 2.243 . . . . 0.0 112.334 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 180' ' ' LEU . 25.5 m -69.42 -64.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 179' ' ' THR . 85.2 mt -33.28 -50.18 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 19.4 ptm -157.17 131.26 8.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -86.78 139.88 33.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.845 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 157.32 60.73 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.84 138.29 55.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.65 -52.15 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.77 95.37 5.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 187' ' ' ASN . 0.0 OUTLIER -122.35 30.91 6.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 187' ' ' ASN . 13.4 tpp180 -35.31 144.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -74.44 100.48 3.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -115.33 -58.47 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 26.9 mt -127.96 87.65 2.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.3 m -147.1 105.5 3.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 34.8 p -125.05 38.45 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.128 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 1.8 t -173.65 128.62 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -88.68 80.68 7.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 197' ' ' HIS . 40.6 mt -98.01 -49.99 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.454 ' C ' ' O ' ' A' ' 196' ' ' ILE . 94.7 m-70 -34.2 -38.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 196' ' ' ILE . 75.5 mt-30 -80.72 -50.6 9.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.2 p -54.65 -24.89 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.97 -66.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.53 -37.41 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -55.24 -45.51 76.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.9 m -60.07 -53.87 52.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -39.15 -38.86 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.439 ' HA ' ' CG2' ' A' ' 152' ' ' ILE . 60.5 mt -74.56 -65.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -45.39 -52.55 9.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.472 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 24.1 mp0 -94.2 29.35 2.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.438 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 35.7 t -67.0 -29.62 69.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 213' ' ' TYR . 9.6 mm-40 -81.85 -45.14 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -48.93 -37.57 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.438 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -49.47 -63.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -105.21 -55.76 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 209' ' ' GLN . 80.7 m-85 -57.41 -23.97 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.922 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 59.86 39.76 20.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.851 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -72.92 -177.9 33.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.64 145.44 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.66 116.35 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.0 m -91.56 174.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.0 m -119.21 102.84 9.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 0.0 110.843 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -92.13 -56.15 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.63 80.72 0.18 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.514 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.9 p -125.25 90.98 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.935 0.398 . . . . 0.0 110.873 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -79.88 171.54 14.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.23 44.18 0.49 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.472 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -150.2 118.13 6.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -66.34 91.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -90.86 42.61 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -152.36 150.64 25.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 147.61 63.13 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.697 2.265 . . . . 0.0 112.298 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 178.34 4.64 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.712 2.274 . . . . 0.0 112.359 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.509 HG22 ' CB ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -71.98 0.3 9.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 53.15 26.39 4.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.509 ' CB ' HG22 ' A' ' 14' ' ' THR . 13.9 tpt180 -127.91 160.5 31.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.97 36.22 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 18' ' ' TRP . 2.7 m95 -74.75 99.89 3.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -129.69 111.95 13.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.472 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 6.1 t -167.43 142.54 3.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -84.31 -7.64 59.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 2.7 t80 -77.92 -39.07 44.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -73.39 -23.51 60.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.856 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.68 20.15 51.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 14.6 mmt -121.97 157.52 57.46 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.612 0.72 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.49 68.9 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.343 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.0 tp -60.36 -49.04 79.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -47.46 -28.24 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -45.54 14.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' A' ' 22' ' ' TYR . 49.6 mt -60.76 -44.93 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 m -91.2 167.14 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -113.44 167.69 10.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.08 -48.45 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.24 -54.77 43.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -115.3 85.23 12.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -31.71 19.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.0 mt -80.87 130.17 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 111.134 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.09 47.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -67.19 -31.77 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 100' ' ' PHE . 42.0 t80 -56.38 -48.47 76.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.538 HG23 ' CE1' ' A' ' 101' ' ' PHE . 19.7 t -65.12 -50.68 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.074 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -58.48 -60.99 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -46.3 -30.37 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 40' ' ' PHE . 65.6 m -76.72 -34.37 58.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.2 t -76.78 -60.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -54.54 -39.9 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.442 ' CZ ' HG23 ' A' ' 51' ' ' THR . 20.3 t80 -53.24 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mt -46.05 -52.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.22 -52.41 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.19 -33.54 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.442 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 82.1 p -91.92 23.66 3.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.09 154.69 24.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.501 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.78 47.73 2.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.0 p -132.39 40.32 3.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -97.84 130.88 44.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -67.14 127.22 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.59 77.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.533 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.27 -66.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.96 -37.11 22.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -50.34 -47.56 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.3 t -108.93 131.34 59.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.0 m -110.15 144.19 39.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.94 -166.17 42.1 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -49.5 139.68 11.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -67.9 -28.04 67.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m -53.97 -39.33 65.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.83 -47.38 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -65.43 -20.82 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.14 -69.87 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.2 p30 -47.49 -39.25 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.498 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 50.1 mt -47.15 -42.54 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.97 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -45.98 -58.4 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -54.2 -58.18 8.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -55.39 -27.91 50.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.55 -57.33 7.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -73.09 -23.61 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -124.38 120.37 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -95.06 -14.01 24.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -104.55 31.18 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 3.2 tt -76.27 158.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.509 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 7.0 t30 -126.24 94.72 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.9 mt -44.87 -45.71 10.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -48.68 -36.81 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.2 t -66.59 -39.24 88.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.7 mmm -69.06 -28.9 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 55.83 35.86 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.2 m -66.67 148.72 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.8 p -55.63 129.91 40.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.43 -41.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -52.34 -39.22 60.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.47 -59.76 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.0 -53.31 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.59 -33.62 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 -57.7 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.463 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.4 -31.59 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 46.1 tp -56.39 -47.96 77.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -64.37 -34.43 78.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.31 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.439 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . 7.3 t80 -67.08 -24.96 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.538 ' CE1' HG23 ' A' ' 41' ' ' VAL . 51.9 m-85 -90.11 -28.6 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.14 -34.66 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.0 -36.23 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.4 mt -38.56 142.55 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.925 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.24 32.31 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.23 157.37 76.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.85 26.59 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.338 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.401 HD23 ' CD1' ' A' ' 148' ' ' PHE . 16.8 tp -40.59 -42.54 1.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.41 130.02 36.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 111.136 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 159.36 53.67 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.665 2.243 . . . . 0.0 112.343 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.31 -20.64 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.3 t -76.58 -1.51 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.827 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.457 HD12 ' CE1' ' A' ' 140' ' ' PHE . 18.3 mt -134.78 17.72 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.466 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 3.8 m170 -61.47 -60.49 10.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.606 0.717 . . . . 0.0 110.832 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.76 -36.57 10.55 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.691 2.261 . . . . 0.0 112.375 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -51.86 -32.03 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.429 HD22 ' CG1' ' A' ' 200' ' ' VAL . 3.2 mt -73.28 -23.87 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.961 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 121' ' ' ALA . 19.1 mt -94.65 -59.25 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -45.03 -24.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.414 ' CB ' ' HB1' ' A' ' 132' ' ' ALA . . . -96.04 -27.33 15.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -79.65 -18.29 51.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -86.31 -0.63 56.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 79.6 mt -66.37 129.85 94.18 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.631 0.729 . . . . 0.0 111.107 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.0 2.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.4 t70 -61.65 94.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 125' ' ' ASP . 3.4 ttmt -34.88 -39.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.6 m -65.16 -67.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -49.07 -48.55 44.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -45.0 -55.16 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 18.7 mt -65.92 -58.74 4.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.65 -43.37 2.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.414 ' HB1' ' CB ' ' A' ' 120' ' ' ALA . . . -59.69 -45.51 91.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mt -69.07 -25.59 64.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -76.25 -30.51 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 0.5 OUTLIER -88.71 -30.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.415 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 54.9 mt -71.83 -25.12 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.35 -7.58 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -81.89 -31.24 31.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -88.94 14.05 11.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.457 ' CE1' HD12 ' A' ' 113' ' ' LEU . 3.0 m-85 -77.84 166.88 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.524 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.9 t-80 -54.96 140.85 60.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.597 0.713 . . . . 0.0 110.88 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.524 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.71 -24.31 30.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.703 2.269 . . . . 0.0 112.334 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.2 t -91.11 -40.84 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 145' ' ' TYR . 28.8 m120 -77.7 -48.99 15.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CZ ' ' HD2' ' A' ' 149' ' ' ARG . 19.7 t80 -37.39 -56.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -49.18 -65.26 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.1 t -49.75 -59.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.401 ' CD1' HD23 ' A' ' 108' ' ' LEU . 39.3 t80 -43.26 -45.78 5.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.495 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 5.3 mtt-85 -63.3 -56.48 16.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -46.04 -45.2 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -56.09 -62.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.2 mt -48.02 -50.93 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -42.18 -38.78 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -79.74 -35.73 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 95.6 mt -57.29 -44.02 83.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 205' ' ' ILE . 8.5 t-20 -52.1 -46.55 65.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.45 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 44.2 mtt-85 -57.14 -42.39 80.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.32 -47.24 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.6 p -59.3 -40.16 85.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.8 mt-30 -49.7 -44.2 47.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -100.29 54.17 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.471 ' CG ' HG23 ' A' ' 168' ' ' THR . 2.3 p80 -84.58 29.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -110.17 -36.76 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.7 mt -92.27 -47.32 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -88.33 -6.8 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.8 mt 49.44 50.34 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 74.1 mmm -127.6 85.62 2.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.471 HG23 ' CG ' ' A' ' 162' ' ' HIS . 71.0 p -77.77 153.24 33.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.14 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -39.03 -36.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -66.96 -48.72 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -61.76 -40.34 94.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 13.1 mt -65.49 -47.73 75.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.7 p -55.61 -48.37 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.2 mt -65.67 -38.97 83.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.7 m -63.08 -9.73 11.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.408 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.8 m-85 -118.27 -9.48 10.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.581 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -50.64 -46.0 85.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.556 0.694 . . . . 0.0 110.942 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.6 Cg_exo -47.98 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.651 2.234 . . . . 0.0 112.37 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.455 ' CG2' ' HB3' ' A' ' 101' ' ' PHE . 52.9 m -63.95 -63.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 179' ' ' THR . 45.6 mt -34.3 -60.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 7.4 ptp -139.11 127.63 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 148.53 55.66 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.596 0.712 . . . . 0.0 110.854 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -164.26 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.233 . . . . 0.0 112.31 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 t70 50.2 38.3 16.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 186' ' ' GLU . 18.3 t80 -95.06 43.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 185' ' ' PHE . 46.3 mt-10 -34.36 103.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -111.17 168.07 9.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -45.97 121.48 3.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 191' ' ' LEU . 13.0 mt-10 -106.68 20.8 18.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.864 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.52 ' CZ ' ' CD1' ' A' ' 191' ' ' LEU . 2.5 p90 -37.5 -32.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 190' ' ' PHE . 8.8 mt -105.17 173.71 6.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 193' ' ' THR . 79.5 p -132.82 168.07 19.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.816 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 192' ' ' SER . 28.8 p 34.85 45.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.179 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.7 95.08 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.158 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -72.74 65.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 51.5 mt -80.57 -45.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -42.05 -55.46 3.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -40.97 72.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.7 t -50.19 -36.76 31.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.429 ' CG1' HD22 ' A' ' 117' ' ' LEU . 93.4 t -53.47 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.122 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.98 -52.7 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -46.83 -45.88 20.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.4 m -55.77 -57.24 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 208' ' ' CYS . 12.7 m-85 -38.97 -52.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.418 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 68.6 mt -58.54 -53.86 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -52.76 -55.2 24.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 10.2 mm-40 -93.36 24.68 3.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.562 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 13.2 t -63.37 -7.3 6.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 213' ' ' TYR . 5.8 mm-40 -103.44 -60.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.465 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 4.0 t80 -40.02 -27.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -56.09 -61.97 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -125.88 -26.86 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.501 ' O ' ' N ' ' A' ' 215' ' ' GLY . 32.1 m-85 -83.94 25.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' TYR . 0.4 OUTLIER 34.4 32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -61.7 175.86 5.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -110.06 146.29 35.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.882 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.454 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 89.8 mt -65.42 111.51 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.28 168.24 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.425 ' C ' ' CD ' ' A' ' 219' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -166.61 165.71 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.875 0.369 . . . . 0.0 110.85 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 t -174.77 177.32 2.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.86 178.75 44.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.493 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -172.58 177.58 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 0.0 110.855 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 m -144.89 174.38 11.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.31 161.29 30.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' C ' ' CG ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER -115.98 172.72 6.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.924 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -162.24 172.3 15.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 9' ' ' ASN . 70.2 m-85 -159.87 162.99 34.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.848 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -155.86 123.81 2.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.658 0.742 . . . . 0.0 110.903 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 167.26 24.99 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.732 2.288 . . . . 0.0 112.289 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 137.96 36.72 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 m -89.29 24.08 2.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -84.96 153.07 23.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -103.4 105.51 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -105.47 33.97 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.817 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -54.47 93.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -136.1 116.93 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 m -123.45 91.31 3.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -59.17 -11.65 4.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 25' ' ' MET . 20.7 m-85 -59.08 -45.79 89.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -44.12 -27.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' N ' ' CD1' ' A' ' 23' ' ' PHE . . . -81.66 -33.39 27.81 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.441 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 22' ' ' TYR . 8.0 mtt -89.03 142.26 30.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.599 0.714 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 153.44 68.83 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.65 2.234 . . . . 0.0 112.313 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.1 tp -47.3 -56.35 6.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.437 ' CB ' HG23 ' A' ' 143' ' ' VAL . 7.4 pt20 -44.22 -32.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.81 -49.4 18.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.63 -42.09 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.3 m -89.33 156.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.8 p -103.65 159.85 15.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.65 -44.82 63.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -57.36 -46.5 83.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -126.48 88.28 54.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.859 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -36.13 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.98 131.29 63.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.721 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 120.98 7.68 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.403 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.43 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -43.89 -50.08 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.493 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 84.7 t80 -42.58 -66.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.5 t -42.72 -57.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -48.56 -57.7 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 47.6 mmtt -46.77 -39.81 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 88.7 m -67.01 -36.8 82.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.2 t -72.44 -53.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -60.63 -35.87 77.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 50' ' ' ASP . 65.6 t80 -60.77 -65.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -37.2 -39.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.57 -41.68 60.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 47' ' ' PHE . 5.4 m-20 -62.18 -43.73 98.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -79.57 -29.82 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.144 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.04 119.7 1.09 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.495 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -94.62 -32.86 13.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.43 39.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 56' ' ' GLU . 24.3 m -87.16 112.47 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.3 tt0 -37.01 125.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.19 89.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -106.03 -36.88 6.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.819 0.342 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -84.13 -61.23 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -12.02 2.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.39 113.02 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.9 t -166.61 123.19 1.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.5 -69.84 0.19 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -50.49 146.19 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -113.64 -40.02 3.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -46.69 -49.82 18.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -43.26 -49.69 6.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -63.75 -29.45 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.3 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 20.8 p30 -50.52 -43.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.46 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 81.1 mt -51.05 -42.52 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -78.51 -57.29 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.93 -67.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -38.74 -52.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 86.2 t80 -54.16 -55.59 26.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.98 -46.47 71.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -60.83 -33.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.28 141.88 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -93.33 -18.7 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -78.32 46.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.7 pt -109.25 175.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -142.16 117.53 10.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.97 -43.09 83.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.11 -42.24 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 t -60.55 -43.57 97.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 mtp -60.54 -29.82 69.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.811 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.11 43.42 29.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.58 168.36 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 p -65.9 118.16 9.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -38.72 -47.29 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -46.31 -42.97 15.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.39 -59.91 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 47' ' ' PHE . 58.7 t -51.59 -59.68 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.78 -38.88 0.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.113 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.3 -58.72 2.69 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.44 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.36 -39.99 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 111.091 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.4 tp -52.23 -51.21 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -67.26 -41.19 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.88 -39.87 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.61 -52.55 64.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.414 ' CB ' ' CG2' ' A' ' 179' ' ' THR . 49.4 m-85 -60.34 -43.66 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.32 -41.26 79.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -35.56 65.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.0 mt -39.24 143.9 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.652 0.739 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.61 34.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.706 2.271 . . . . 0.0 112.326 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 156.85 68.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 140.39 42.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.371 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -43.91 -49.48 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.422 HG23 ' CD1' ' A' ' 117' ' ' LEU . 55.7 mt -87.45 125.02 66.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.609 0.719 . . . . 0.0 111.142 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 150.61 68.42 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -67.03 -25.59 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 t -65.14 -15.94 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.555 HD13 ' CE1' ' A' ' 140' ' ' PHE . 21.5 mt -118.55 26.0 9.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.485 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.8 m170 -71.63 -60.22 2.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.598 0.713 . . . . 0.0 110.903 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.74 -25.56 28.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.27 . . . . 0.0 112.326 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -68.16 -35.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.422 ' CD1' HG23 ' A' ' 109' ' ' ILE . 7.5 mt -72.52 -25.68 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 121' ' ' ALA . 9.8 mt -88.75 -58.65 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -39.47 -30.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.68 -37.68 20.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -65.54 -17.77 64.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.095 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -96.79 26.42 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.98 131.48 39.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.649 0.737 . . . . 0.0 111.139 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -45.78 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.2 m-20 -70.92 95.53 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -35.61 -54.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.9 m -51.64 -51.95 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.85 -45.46 90.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -50.11 -44.46 52.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.25 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -43.15 -50.35 6.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.61 -60.21 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 22.8 mt -52.04 -38.12 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -62.93 -26.4 68.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 -42.06 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.409 ' O ' ' CE1' ' A' ' 140' ' ' PHE . 86.4 mt -64.5 -18.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.51 -6.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -78.95 -39.03 35.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -76.02 -1.93 28.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -64.67 137.05 57.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.528 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -38.69 141.73 0.56 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.599 0.714 . . . . 0.0 110.86 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.528 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.7 -15.98 37.58 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.437 HG23 ' CB ' ' A' ' 28' ' ' GLN . 21.4 t -96.04 -39.0 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -76.33 -41.97 46.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 3.1 t80 -56.58 -59.45 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 145' ' ' TYR . 3.4 t0 -35.69 -45.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 49.0 t -76.5 -44.21 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.54 ' CZ ' HD13 ' A' ' 152' ' ' ILE . 31.2 t80 -52.86 -46.13 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -66.28 -48.11 71.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -56.28 -44.7 80.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.74 -64.23 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.181 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.54 HD13 ' CZ ' ' A' ' 148' ' ' PHE . 78.1 mt -45.46 -52.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.122 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.8 m -41.04 -38.31 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -78.81 -39.45 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 98.7 mt -56.58 -47.1 80.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.79 -44.76 39.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.457 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 22.4 mtt-85 -60.38 -28.03 67.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.04 -40.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 84.2 p -64.0 -26.36 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 40.1 mt-30 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.424 ' OE1' ' C ' ' A' ' 160' ' ' GLN . 2.1 mm100 -103.38 32.43 3.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.543 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 11.5 p80 -52.73 -43.43 65.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.543 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 14.3 mmtp -59.54 -28.55 67.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 82.2 mt -83.09 -55.92 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 166' ' ' LEU . 1.3 m-20 -92.4 22.1 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 162' ' ' HIS . 11.5 mt 35.18 53.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.5 mmm -148.64 110.39 4.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ALA . 61.2 p -96.59 154.01 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.08 -41.6 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.95 -50.04 65.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 168' ' ' THR . 38.8 m-20 -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.65 -42.43 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 t -60.27 -27.95 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 47.5 mt -83.43 -35.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.98 -21.33 64.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -104.5 -11.32 17.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.22 -46.45 93.93 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.598 0.713 . . . . 0.0 110.933 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.4 Cg_exo -48.0 -57.4 2.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 0.0 112.346 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 180' ' ' LEU . 59.8 m -73.35 -61.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 80.7 mt -32.54 -48.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.479 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 14.1 ptm -158.29 141.97 15.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.829 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -66.95 149.92 98.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.848 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 156.04 64.2 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.684 2.256 . . . . 0.0 112.292 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.07 -178.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -84.9 15.76 3.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -78.57 92.83 4.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -90.76 -63.38 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -60.88 157.41 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.34 118.48 24.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -111.62 163.48 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 192' ' ' SER . 40.6 mt -41.16 155.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 191' ' ' LEU . 98.3 p -35.81 104.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.2 m -84.19 124.97 31.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.188 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 76.3 p -40.24 133.58 1.77 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.153 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.439 ' CD ' ' O ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -85.28 30.62 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.23 -45.28 99.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -47.84 -58.76 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.84 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -53.36 -50.32 65.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 m -50.1 -41.48 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 66.8 t -44.07 -71.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 202' ' ' GLU . 95.3 t -61.1 -59.68 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 201' ' ' VAL . 10.1 tt0 -34.16 -47.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -60.0 -57.04 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -39.12 -34.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.401 ' HA ' ' CG2' ' A' ' 152' ' ' ILE . 95.2 mt -80.81 -62.0 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -47.91 -51.94 21.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 207' ' ' GLN . 26.5 mp0 -95.42 30.6 2.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.485 ' NE2' ' CD2' ' A' ' 213' ' ' TYR . 6.1 mm-40 -84.65 -53.88 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -40.45 -37.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -53.06 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.21 -55.29 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.485 ' CD2' ' NE2' ' A' ' 209' ' ' GLN . 69.9 m-85 -60.34 -9.96 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.959 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 t30 49.07 37.19 10.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -68.66 172.05 36.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.71 154.86 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.16 132.57 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.85 177.98 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 p -88.7 -57.8 2.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -173.12 173.15 3.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.26 -158.14 7.62 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.2 p -168.2 139.97 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 m -171.46 166.69 6.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.826 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.05 64.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.486 ' HE3' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -80.42 166.16 21.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.888 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -141.25 121.18 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CD1' ' O ' ' A' ' 10' ' ' PHE . 53.1 p90 -136.45 124.8 23.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -102.5 147.98 34.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.654 0.74 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 155.13 66.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.676 2.251 . . . . 0.0 112.328 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 139.66 40.79 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.666 2.244 . . . . 0.0 112.376 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 t -168.69 153.36 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 1.7 mpt_? -91.09 107.22 19.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 17' ' ' ASN . 29.7 ptt180 -62.54 -51.47 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.424 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 17.5 t30 54.75 35.75 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.563 ' CZ2' ' HA ' ' A' ' 73' ' ' LYS . 53.6 t90 -131.75 13.06 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -176.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.495 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 42.2 p -144.0 163.99 31.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.904 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -98.2 -26.83 14.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -58.94 -44.44 91.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 20' ' ' SER . 1.1 p90 -45.69 -34.71 3.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.48 ' N ' ' CD1' ' A' ' 23' ' ' PHE . . . -73.1 -36.9 56.2 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 10.6 mmt -80.98 148.83 65.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 147.25 62.81 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.704 2.269 . . . . 0.0 112.37 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.1 tp -45.03 -55.37 5.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.564 ' NE2' ' CE1' ' A' ' 141' ' ' HIS . 5.2 pt20 -46.46 -36.16 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.63 -39.95 61.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.19 -44.84 82.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -93.37 171.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 p -111.53 147.95 34.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.56 -45.12 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -54.59 -45.44 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -129.34 93.42 35.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 110.948 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -38.92 7.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.732 2.288 . . . . 0.0 112.346 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.451 HD11 ' CB ' ' A' ' 150' ' ' TYR . 27.8 mt -78.2 128.46 78.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.664 0.745 . . . . 0.0 111.089 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.87 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.699 2.266 . . . . 0.0 112.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.447 HD12 ' CG ' ' A' ' 43' ' ' LYS . 2.4 tm? -99.13 -49.21 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -46.53 -50.32 17.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.5 t -57.51 -58.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.091 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -46.45 -56.21 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CG ' HD12 ' A' ' 39' ' ' LEU . 12.0 mmtp -43.97 -44.53 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 85.3 m -66.76 -62.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -45.36 -47.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.12 -37.17 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.562 ' CD1' HG21 ' A' ' 93' ' ' VAL . 4.9 t80 -55.61 -59.19 5.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 47' ' ' PHE . 10.7 mt -34.82 -68.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.96 -45.71 89.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -40.13 -50.49 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -87.26 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 48' ' ' ILE . . . 149.15 156.21 7.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.506 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.05 41.45 3.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.307 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 p -129.92 41.85 3.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.4 m -95.96 116.25 28.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -39.12 116.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 72.37 0.56 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.506 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -41.73 -45.33 3.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 110.948 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.442 ' O ' ' C ' ' A' ' 60' ' ' ARG . 6.5 m-85 -117.9 -41.69 2.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 59' ' ' TYR . 16.8 tpp85 -34.7 -47.22 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t -93.14 115.3 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -175.09 120.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.42 -53.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.436 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -38.6 -39.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 48.86 25.04 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.6 m -98.12 -27.56 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.01 -50.47 19.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.97 -39.08 84.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -46.3 -53.2 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.0 p30 -66.03 -38.2 87.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.5 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 68.6 mt -51.42 -39.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -87.06 -60.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HA ' ' CZ2' ' A' ' 18' ' ' TRP . 24.4 mtpt -46.83 -35.63 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 70' ' ' ASN . 52.1 mm-40 -77.7 -43.31 31.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -53.47 -28.81 32.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -75.71 -60.68 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -61.52 -25.84 67.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -130.62 107.07 8.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -79.68 -25.41 41.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -97.35 36.56 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.0 tt -79.83 147.46 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -124.86 102.87 7.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -44.65 -50.22 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.5 t -46.46 -50.1 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -56.5 -46.47 80.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.3 mmm -60.03 -26.8 66.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 51.96 51.45 16.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -85.36 160.2 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 p -56.13 125.18 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.2 t -43.48 -46.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.147 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -51.73 -35.72 44.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.69 -58.44 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.562 HG21 ' CD1' ' A' ' 47' ' ' PHE . 78.4 t -58.49 -37.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.22 88.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.076 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.16 -45.89 7.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.39 -46.71 73.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.2 tp -46.06 -44.19 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 30.9 mtmt -71.25 -42.06 69.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.33 -48.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 4.6 t80 -58.47 -48.61 80.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.446 ' CB ' HG22 ' A' ' 179' ' ' THR . 16.9 m-85 -53.95 -47.62 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.457 ' N ' HG23 ' A' ' 179' ' ' THR . . . -59.1 -41.46 88.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -53.18 -34.63 57.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -39.26 147.47 0.3 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -25.02 28.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.377 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -135.48 155.82 78.2 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 136.57 33.3 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.717 2.278 . . . . 0.0 112.38 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.549 HD23 ' CD1' ' A' ' 148' ' ' PHE . 24.1 tp -43.55 -41.3 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.2 mt -95.05 123.88 55.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.702 . . . . 0.0 111.139 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 140.85 43.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.248 . . . . 0.0 112.323 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 6.3 m-85 -62.75 -22.4 66.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -66.81 -22.19 66.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.4 mt -116.58 32.11 6.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.549 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.3 m170 -74.62 -61.48 1.11 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 0.0 110.832 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.72 -27.18 26.96 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.688 2.259 . . . . 0.0 112.325 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -63.77 -33.99 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -73.42 -41.54 63.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 121' ' ' ALA . 8.8 mt -69.82 -57.2 5.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -43.82 -35.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.437 ' CB ' ' HB1' ' A' ' 132' ' ' ALA . . . -81.7 -26.79 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.081 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.9 -30.4 50.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -77.56 -10.99 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 55.4 mt -51.85 132.61 38.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.16 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -65.63 113.7 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -52.09 -50.89 60.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.8 m -54.59 -65.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.172 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -43.45 -52.81 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -41.01 -52.56 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.5 mt -60.47 -57.22 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 120' ' ' ALA . . . -48.34 -51.64 25.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.01 -24.6 67.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -77.71 -33.04 53.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.1 pt-20 -83.69 -35.46 24.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.467 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 54.3 mt -69.2 -36.57 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.16 -21.13 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -72.09 -39.48 68.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -59.62 -33.52 71.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -41.98 145.82 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.564 ' CE1' ' NE2' ' A' ' 28' ' ' GLN . 2.4 t-80 -43.25 142.18 1.68 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.816 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.84 -6.4 18.54 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.413 HG21 ' CB ' ' A' ' 28' ' ' GLN . 48.8 t -99.19 -45.9 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -79.22 -38.06 36.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.3 t80 -42.74 -47.92 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -52.42 65.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -55.93 -64.12 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.561 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 31.3 t80 -43.55 -49.37 7.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 mtp85 -60.5 -47.06 87.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.451 ' CB ' HD11 ' A' ' 37' ' ' ILE . 71.8 t80 -59.13 -44.28 92.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 70.9 t -56.93 -60.53 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.561 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 56.3 mt -48.5 -50.14 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.6 m -40.4 -32.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.6 -36.83 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 152' ' ' ILE . 75.1 mt -55.96 -46.81 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -49.28 -41.68 38.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 23.3 mtp85 -60.63 -32.84 71.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.72 -39.4 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 p -66.22 -28.05 68.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.3 mt-30 -63.33 -37.35 86.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.473 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 16.2 mm-40 -98.3 32.31 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.448 ' HB2' ' CG2' ' A' ' 168' ' ' THR . 7.8 p80 -57.13 -21.32 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -82.96 -17.56 43.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 60.2 mt -100.12 -63.93 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.73 22.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 165' ' ' ASN . 22.8 mt 33.12 54.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 38.1 mmm -142.68 105.82 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 169' ' ' ALA . 72.4 p -94.7 150.05 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -33.81 -50.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -55.04 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -55.16 -38.81 68.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -71.67 -34.65 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.5 ' CD1' ' OE1' ' A' ' 198' ' ' GLN . 27.5 mt -80.7 -28.39 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.9 m -75.9 -21.21 57.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.559 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 14.3 m-85 -103.7 -8.74 19.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.568 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.5 OUTLIER -54.37 -46.92 98.88 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.52 0.676 . . . . 0.0 110.902 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.7 Cg_exo -48.02 -48.64 15.84 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.457 HG23 ' N ' ' A' ' 102' ' ' ALA . 39.7 m -81.83 -59.13 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 58.9 mt -33.17 -69.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.565 ' HG2' ' CH2' ' A' ' 177' ' ' TRP . 3.2 ttp -121.01 118.75 30.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.471 ' HD3' ' N ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -40.92 130.65 1.92 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.585 0.707 . . . . 0.0 110.872 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.471 ' N ' ' HD3' ' A' ' 182' ' ' ARG . 54.3 Cg_endo -69.67 122.12 8.83 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.403 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.64 110.81 10.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.882 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.416 ' O ' ' C ' ' A' ' 186' ' ' GLU . 45.4 m-85 -97.43 -50.45 4.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 185' ' ' PHE . 48.5 mp0 -36.42 -56.44 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -48.48 118.8 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -99.37 159.23 15.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -140.84 177.66 7.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.21 -60.28 3.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 191' ' ' LEU . 3.8 mm? -89.94 125.18 35.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 96.9 p -44.79 -34.65 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 13.2 t -174.31 150.89 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.105 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 9.0 t -150.85 155.44 39.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.13 29.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 81.8 mt -89.95 -44.34 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.408 ' CD2' HD21 ' A' ' 118' ' ' LEU . 6.0 m80 -50.81 -60.16 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.5 ' OE1' ' CD1' ' A' ' 174' ' ' ILE . 70.1 mt-30 -57.2 -43.94 83.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 t -55.92 -39.34 71.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 92.8 t -46.7 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.124 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.42 -55.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.147 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -40.62 -40.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 204' ' ' PHE . 49.5 m -58.98 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 208' ' ' CYS . 10.7 m-85 -36.08 -56.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 60.7 mt -59.56 -46.43 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -55.57 -58.03 9.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -99.72 28.98 4.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.554 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -57.91 -27.48 63.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -82.34 -54.55 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.18 -36.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.554 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -50.54 -63.17 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -104.61 -55.74 2.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -55.0 -35.63 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 71.28 39.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -75.53 178.04 48.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.48 137.14 47.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 77.7 mt -59.16 125.92 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.28 170.31 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.166 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.94 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.7 p -145.12 112.77 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -138.07 144.49 40.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.12 165.18 12.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.52 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -131.32 135.73 47.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -102.36 -59.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.39 84.34 0.43 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -44.3 -47.2 9.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.1 t30 49.95 43.06 25.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -95.49 134.44 38.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -129.88 140.23 38.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.623 0.725 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 158.53 56.66 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 150.77 68.48 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.709 2.272 . . . . 0.0 112.372 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.7 p -107.4 141.14 39.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -142.28 144.79 33.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -53.47 121.83 8.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -88.65 43.53 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -130.89 84.93 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -147.39 118.86 7.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -165.58 179.88 5.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.857 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -105.58 -37.33 6.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -38.86 -48.06 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -63.24 121.64 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.63 -43.28 1.7 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.495 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.8 mmt -79.9 159.83 70.27 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.569 0.7 . . . . 0.0 110.872 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 160.25 50.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.736 2.291 . . . . 0.0 112.369 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.8 tp -78.74 -45.51 20.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -48.15 -28.12 2.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -78.02 -45.66 23.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.5 mt -66.16 -42.78 88.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.3 m -87.77 155.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -103.68 157.78 16.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.05 -44.19 30.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -58.74 -48.84 79.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -121.63 87.6 45.99 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.54 0.686 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.17 9.57 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.656 2.237 . . . . 0.0 112.364 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -77.35 132.95 68.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.643 0.735 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 140.02 41.44 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.26 . . . . 0.0 112.316 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.528 ' CD1' ' CG ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -55.24 -54.07 48.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 39' ' ' LEU . 82.4 t80 -38.17 -69.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.0 t -42.79 -55.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -50.29 -57.84 6.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.528 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 36.2 mmtt -46.74 -39.13 11.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.01 -44.73 75.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.67 -53.09 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.8 -45.37 94.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.547 ' CD1' HD13 ' A' ' 83' ' ' LEU . 57.8 t80 -43.06 -63.21 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -53.88 -57.3 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -40.85 -53.37 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -59.7 -39.72 85.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -86.37 26.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.148 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.48 172.55 48.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.469 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.66 37.36 3.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.6 p -116.63 29.68 7.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.46 ' O ' ' CD2' ' A' ' 58' ' ' LEU . 77.9 m -68.81 114.23 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.182 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.03 114.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.43 96.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.46 ' CD2' ' O ' ' A' ' 55' ' ' THR . 1.8 mm? -90.08 112.29 23.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.348 . . . . 0.0 110.917 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 72.29 33.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -126.63 -38.02 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.45 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 21.3 t -85.99 124.79 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 t -72.26 115.56 11.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.6 164.66 25.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.526 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -52.13 169.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.366 . . . . 0.0 110.922 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -100.47 -39.36 7.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.2 m -50.22 -30.97 12.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.2 -55.9 7.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -59.46 -21.36 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.93 -61.41 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.7 p30 -61.46 -41.0 96.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.476 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 80.9 mt -52.34 -43.11 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -81.88 -53.88 5.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ASP . 50.9 mttt -54.62 -65.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -40.94 -44.33 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.5 -35.9 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.9 t0 -66.98 -55.48 14.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -54.72 -34.53 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -158.12 151.81 23.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.15 -19.07 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -80.81 49.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.57 -177.78 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.471 ' ND2' ' HB ' ' A' ' 84' ' ' VAL . 4.9 t30 -145.72 139.82 26.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.547 HD13 ' CD1' ' A' ' 47' ' ' PHE . 14.7 mt -84.25 -41.25 17.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.471 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 88.4 t -48.55 -50.22 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -57.53 -41.59 81.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 mtp -61.27 -26.43 67.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 54.08 45.81 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.6 151.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.107 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 p -60.83 129.77 43.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.5 t -42.83 -52.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.45 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 9.9 m120 -40.82 -48.07 3.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.5 -62.86 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.468 HG23 ' CE2' ' A' ' 47' ' ' PHE . 65.6 t -48.7 -54.03 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.46 -41.39 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.78 -60.16 4.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.67 -41.29 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.7 tp -49.64 -49.92 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 101' ' ' PHE . 32.5 mtmt -68.22 -47.46 67.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.13 -33.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -65.38 -47.12 77.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 98' ' ' LYS . 41.5 m-85 -57.04 -44.49 82.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.49 -39.6 88.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.49 -37.99 82.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -37.78 141.6 0.47 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -24.12 29.74 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.232 . . . . 0.0 112.343 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.68 153.83 77.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.655 0.74 . . . . 0.0 110.838 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 134.77 28.76 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.351 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.532 HD22 ' CD1' ' A' ' 148' ' ' PHE . 19.1 tp -38.95 -52.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.3 mt -87.35 124.35 68.27 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 0.0 111.155 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.422 ' CG ' HD13 ' A' ' 113' ' ' LEU . 54.1 Cg_endo -69.77 154.82 67.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.69 2.26 . . . . 0.0 112.352 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.528 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 21.7 m-85 -68.85 -26.47 65.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 m -65.71 -25.41 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.863 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.422 HD13 ' CG ' ' A' ' 110' ' ' PRO . 25.6 mt -111.58 36.66 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.967 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.552 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 2.7 m170 -77.94 -65.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.561 0.696 . . . . 0.0 110.829 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.71 -21.44 33.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.739 2.293 . . . . 0.0 112.344 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.64 -28.55 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -79.91 -36.6 36.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.6 -46.47 25.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.95 -31.79 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.84 -29.25 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.7 -21.17 59.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -91.97 22.04 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.07 130.07 45.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -44.83 1.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 102.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -40.18 -60.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.444 HG22 ' CD2' ' A' ' 131' ' ' HIS . 98.7 m -50.04 -57.09 8.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -50.27 -56.51 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -41.59 -57.15 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.468 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 52.7 mt -58.26 -54.18 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.444 ' CD2' HG22 ' A' ' 127' ' ' THR . 10.2 m-70 -47.0 -50.58 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.14 -44.45 64.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.5 mt -71.02 -29.9 65.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -74.07 -30.18 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -87.32 -36.87 17.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.7 mt -69.89 -37.71 73.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 5.2 p -63.7 -7.73 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -77.61 -38.65 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.934 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -64.87 -29.88 70.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.1 m-85 -43.68 128.34 5.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.574 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -34.09 141.49 0.24 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.574 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.72 -10.11 27.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.09 -40.38 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -83.44 -35.12 25.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 4.4 t80 -57.0 -43.43 81.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.66 -49.31 70.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.96 -50.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.532 ' CD1' HD22 ' A' ' 108' ' ' LEU . 37.4 t80 -54.13 -45.69 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -65.37 -47.15 77.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -59.27 -46.07 89.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 85.0 t -53.19 -59.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.162 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.516 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 73.6 mt -48.88 -52.01 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.074 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.1 m -39.52 -34.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -83.44 -35.67 24.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.529 HD23 ' CE2' ' A' ' 176' ' ' PHE . 68.9 mt -61.48 -49.53 76.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -50.01 -49.8 49.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -53.64 -43.36 68.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.8 -50.05 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.8 p -52.5 -21.64 3.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -58.18 -44.13 87.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.466 ' NE2' HD13 ' A' ' 164' ' ' ILE . 24.8 mt-30 -101.25 30.3 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.424 ' HA ' ' ND2' ' A' ' 165' ' ' ASN . 7.4 p80 -45.48 -25.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -74.91 -36.61 62.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.466 HD13 ' NE2' ' A' ' 161' ' ' GLN . 77.0 mt -84.29 -56.41 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -81.08 16.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 165' ' ' ASN . 11.2 mt 34.49 54.78 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 7.7 mmm -150.12 108.39 3.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.409 HG21 ' ND1' ' A' ' 162' ' ' HIS . 72.4 p -94.09 157.76 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -38.67 -43.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -62.72 -58.73 6.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -45.6 -51.66 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.52 -30.78 70.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -75.69 -32.87 60.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.488 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 62.5 mt -78.24 -31.04 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.3 m -75.26 -34.05 61.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.529 ' CE2' HD23 ' A' ' 155' ' ' LEU . 12.0 m-85 -89.09 -40.75 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.623 ' O ' ' CE3' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.01 -56.81 0.7 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 0.0 110.948 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.527 ' HD3' ' CD1' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.02 -63.7 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.487 ' O ' ' C ' ' A' ' 180' ' ' LEU . 28.6 m -59.37 -56.09 26.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 179' ' ' THR . 83.3 mt -31.34 -59.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.453 ' O ' ' C ' ' A' ' 182' ' ' ARG . 4.0 ttp -125.94 117.72 23.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 181' ' ' MET . 17.3 ttm180 -34.15 133.91 0.38 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 159.21 54.2 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.245 . . . . 0.0 112.359 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -51.52 149.37 4.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.569 ' CD2' ' HG3' ' A' ' 186' ' ' GLU . 9.6 p90 -84.9 -48.8 8.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.569 ' HG3' ' CD2' ' A' ' 185' ' ' PHE . 10.2 mt-10 -140.21 136.48 33.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -151.74 122.17 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 -24.39 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -82.35 107.21 14.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 190' ' ' PHE . 26.7 p90 -114.07 80.17 1.35 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 14.5 mt -150.25 134.21 16.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 m 47.71 44.45 17.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 95.7 m -76.46 90.8 3.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 78.4 p -60.47 131.08 49.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -86.45 44.76 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 74.4 mt -80.38 -34.44 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.104 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -50.58 -50.82 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.21 -44.35 72.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.0 m -54.02 -48.31 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 74.2 t -38.69 -56.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.54 -50.03 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -46.71 -45.38 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 204' ' ' PHE . 97.7 m -57.93 -61.77 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.8 m-85 -35.04 -47.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 68.6 mt -67.64 -58.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.422 ' NE2' ' O ' ' A' ' 219' ' ' GLU . 18.2 mt-30 -46.37 -41.39 13.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.468 ' HG3' ' CD1' ' A' ' 130' ' ' LEU . 7.1 mm-40 -116.28 34.9 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.567 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -68.38 -22.77 64.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -85.38 -55.35 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -39.95 -34.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.567 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.0 m-85 -51.81 -63.18 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.864 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -104.98 -55.86 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -58.01 -22.53 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.929 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 57.35 38.12 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.18 143.4 23.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -41.98 145.04 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.908 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.36 143.56 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.26 170.32 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.422 ' O ' ' NE2' ' A' ' 206' ' ' GLN . 12.7 tm-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -108.97 177.34 4.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.4 t -132.69 86.56 2.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.62 132.21 2.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.463 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.2 m -67.11 122.25 17.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.823 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.0 t -136.77 110.91 8.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.87 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.97 -163.17 10.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -70.58 118.57 13.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -96.73 131.49 43.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 11' ' ' ASN . 10.8 p90 -174.16 179.06 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' PHE . 30.8 m-20 -36.35 143.88 0.28 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.634 0.73 . . . . 0.0 110.874 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 148.54 65.41 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.665 2.244 . . . . 0.0 112.357 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 177.62 5.41 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.712 2.274 . . . . 0.0 112.317 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -109.4 140.14 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -82.72 139.32 33.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 18' ' ' TRP . 6.2 tpt180 -86.28 -53.37 5.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ARG . 5.4 p-10 36.91 32.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.438 ' N ' ' O ' ' A' ' 16' ' ' ARG . 64.3 t-105 -130.19 59.39 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -54.04 111.82 0.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.602 ' O ' ' CE1' ' A' ' 23' ' ' PHE . 58.5 p -134.65 132.85 39.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.36 -5.11 6.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.52 ' CD2' ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -76.24 -60.62 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.602 ' CE1' ' O ' ' A' ' 20' ' ' SER . 21.6 m-85 46.99 30.44 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.36 47.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 15.2 mtm -91.21 144.97 30.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.59 0.71 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 151.9 69.32 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.384 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.53 -53.86 26.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -46.21 -32.01 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -40.68 30.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.01 -43.79 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.9 m -90.98 172.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.0 p -112.03 161.61 16.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.38 -44.78 72.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.39 -45.2 80.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -127.21 95.37 36.55 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -38.03 8.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.2 mt -75.04 136.56 72.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.666 0.746 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 169.51 18.72 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.706 2.27 . . . . 0.0 112.333 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.42 HD13 ' C ' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -84.69 -46.07 11.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.923 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -48.19 -64.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 44' ' ' CYS . 55.4 t -43.94 -65.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -39.77 -53.61 2.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -56.48 -37.19 70.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.41 ' N ' ' O ' ' A' ' 41' ' ' VAL . 69.4 m -69.16 -45.52 69.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.01 -49.1 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.96 -43.37 83.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.495 ' CE1' HG22 ' A' ' 93' ' ' VAL . 13.2 t80 -56.52 -61.39 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.8 mt -41.05 -44.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -64.39 -42.32 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.19 -35.19 79.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 p -90.98 29.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.64 150.66 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -120.74 -34.51 3.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.916 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.1 p -56.36 -14.7 3.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.4 m -40.95 105.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -44.51 111.38 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.73 105.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mp -105.88 -33.62 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -104.74 -55.63 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' HD3' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -59.37 -34.82 72.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.482 ' CG2' ' HD3' ' A' ' 60' ' ' ARG . 3.2 t -103.02 109.48 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 p -137.58 122.86 19.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.818 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.09 -130.33 1.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.529 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -40.91 156.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -103.93 -46.81 4.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.902 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ASP . 87.3 m -39.04 -42.79 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -41.92 -49.96 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -67.58 -28.83 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.0 t70 -53.23 -53.61 48.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.6 p30 -60.14 -38.8 84.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.42 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 54.4 mt -49.92 -50.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.49 -61.01 2.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -46.04 -58.99 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -53.42 -42.04 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -64.66 -37.75 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.06 -49.13 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -76.81 -24.93 52.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -133.31 99.66 4.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -72.32 -29.32 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -91.49 34.91 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.1 tt -77.98 150.13 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -118.38 93.61 4.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -44.51 -42.08 6.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -52.81 -44.02 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 t -65.69 -27.71 68.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.6 mtp -70.96 -38.15 72.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 60.18 49.53 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 m -84.49 162.52 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' VAL . 66.8 p -67.23 115.18 6.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' THR . 60.9 t -33.65 -54.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.154 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -37.16 -49.33 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.05 -60.37 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.495 HG22 ' CE1' ' A' ' 47' ' ' PHE . 77.2 t -48.08 -62.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -41.28 -35.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.15 -57.43 2.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.517 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.1 -43.66 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 111.066 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.3 tp -43.41 -45.29 6.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.557 ' HG2' ' CE1' ' A' ' 176' ' ' PHE . 28.5 mtmt -65.06 -46.82 79.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.67 -34.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -65.93 -38.76 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.84 -36.35 50.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.06 -39.31 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -59.95 -37.52 79.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -40.42 146.39 0.44 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 -21.67 32.99 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.336 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -142.82 155.07 63.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.542 0.687 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.74 48.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.423 HD22 ' CD1' ' A' ' 148' ' ' PHE . 9.0 tp -43.66 -40.85 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mt -83.37 128.7 63.35 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.676 0.75 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 147.05 62.09 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.722 2.282 . . . . 0.0 112.318 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.554 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 4.7 m-85 -64.66 -37.85 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.3 m -55.91 -15.11 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.566 HD12 ' CE1' ' A' ' 140' ' ' PHE . 31.8 mt -128.44 35.64 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.554 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.2 m170 -76.08 -63.32 0.62 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 0.0 110.859 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.69 -10.3 28.27 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -74.7 -33.78 62.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.18 -36.15 66.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.91 -54.3 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -49.53 -33.06 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.43 ' HB3' ' CB ' ' A' ' 132' ' ' ALA . . . -82.66 -22.46 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.75 -33.81 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -71.45 -10.23 59.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.44 127.92 85.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.622 0.725 . . . . 0.0 111.137 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -44.77 1.88 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.667 2.244 . . . . 0.0 112.351 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.77 108.64 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -46.66 -55.99 6.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 m -57.34 -65.26 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -42.42 -56.35 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -38.62 -46.14 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.7 mt -69.27 -58.47 3.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -44.8 -51.85 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 120' ' ' ALA . . . -49.97 -46.23 52.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 20.0 mt -68.53 -28.27 66.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -75.13 -32.54 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.04 -31.29 25.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 74.8 mt -75.26 -32.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.434 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.8 p -76.03 0.35 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.141 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -82.33 -41.13 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.25 22.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.566 ' CE1' HD12 ' A' ' 113' ' ' LEU . 2.3 m-85 -80.1 141.44 35.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.7 t-80 -39.91 141.94 0.73 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.604 0.716 . . . . 0.0 110.833 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.8 Cg_endo -69.81 -8.06 22.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 74.3 t -99.19 -48.33 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -73.47 -43.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -48.51 -42.19 32.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.95 -56.22 23.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.63 -62.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.168 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.552 ' CZ ' HD12 ' A' ' 152' ' ' ILE . 26.3 t80 -39.43 -39.94 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -70.43 -46.33 64.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.29 -36.66 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.0 t -63.1 -64.69 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.078 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.552 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 80.2 mt -47.98 -52.1 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -40.94 -35.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.149 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -83.26 -40.91 18.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 97.5 mt -54.47 -44.45 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -50.88 -45.34 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.449 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 72.0 mtt85 -55.77 -39.26 70.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 76.3 t -69.12 -38.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 p -64.32 -35.34 80.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.449 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 38.7 mt-30 -54.51 -38.0 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.49 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 21.4 mm-40 -99.1 28.77 4.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.516 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 9.8 p80 -54.6 -31.71 57.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 20.5 mmtp -73.54 -21.69 60.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.455 ' CD1' ' OE1' ' A' ' 161' ' ' GLN . 74.3 mt -95.37 -57.59 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -89.86 26.24 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 165' ' ' ASN . 14.2 mt 32.56 41.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 9.7 mmm -128.72 104.5 7.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.453 ' CG2' ' HB2' ' A' ' 162' ' ' HIS . 60.8 p -96.57 150.67 20.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -36.16 -33.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 168' ' ' THR . 10.0 t70 -63.84 -57.43 9.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -51.4 -57.15 9.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 10.6 mt -53.67 -29.01 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.0 t -81.13 -37.36 28.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 70.1 mt -74.51 -24.78 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -75.27 -39.07 60.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.557 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 9.6 m-85 -88.99 -38.81 14.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.626 ' O ' ' CE3' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.78 -56.7 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.563 0.696 . . . . 0.0 110.906 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.501 ' CD ' ' O ' ' A' ' 174' ' ' ILE . 65.7 Cg_exo -48.04 -52.37 8.37 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 180' ' ' LEU . 58.7 m -70.42 -62.0 1.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 95.9 mt -34.05 -45.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 13.6 mtm -145.5 133.32 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.469 ' CG ' ' HD2' ' A' ' 183' ' ' PRO . 27.7 ttp180 -41.27 139.91 1.29 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 110.884 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.514 ' HA ' ' CZ2' ' A' ' 177' ' ' TRP . 53.9 Cg_endo -69.77 132.62 23.7 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.708 2.272 . . . . 0.0 112.349 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -160.86 137.68 8.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -112.53 50.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -97.64 98.0 9.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -165.34 159.58 17.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.45 ' NE ' ' HG2' ' A' ' 189' ' ' GLU . 3.3 ppt_? -124.57 -22.36 4.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.45 ' HG2' ' NE ' ' A' ' 188' ' ' ARG . 8.8 mm-40 -80.02 107.75 13.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 194' ' ' THR . 53.4 t80 -120.17 -54.19 2.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 90.6 mt -43.85 -59.92 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 78.5 p -56.29 -56.61 18.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 194' ' ' THR . 27.6 m -140.21 143.64 36.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.182 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.464 ' N ' HG23 ' A' ' 193' ' ' THR . 82.1 p -112.38 147.43 36.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.166 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 49.68 46.09 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 197' ' ' HIS . 91.0 mt -48.76 -55.32 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 196' ' ' ILE . 60.0 m-70 -35.79 -48.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -68.3 -60.14 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 200' ' ' VAL . 21.1 m -43.28 -41.47 3.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 199' ' ' SER . 99.5 t -36.75 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' GLU . 90.6 t -68.86 -55.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -34.24 -49.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.5 m -55.68 -62.9 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 11.7 m-85 -35.71 -51.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 85.8 mt -60.48 -57.35 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -49.43 -52.31 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.9 mm-40 -101.72 30.69 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 1.4 t -65.34 -19.45 65.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 213' ' ' TYR . 32.7 mm-40 -87.9 -45.89 9.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -37.17 20.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -50.71 -63.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -104.77 -55.45 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 209' ' ' GLN . 52.2 m-85 -58.25 -25.1 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 57.47 45.21 20.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -83.73 -179.04 52.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.64 147.93 44.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.445 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 45.8 mt -75.13 139.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.145 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.05 177.68 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.3 m -144.43 161.97 37.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.3 p -171.5 173.37 4.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.82 167.61 39.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.454 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.5 p -168.39 177.6 5.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.897 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.6 p -154.04 169.15 24.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.97 147.11 5.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.485 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -166.4 159.85 15.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -161.35 138.77 8.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 10' ' ' PHE . 34.0 p90 -88.96 86.2 6.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -155.0 134.26 7.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 152.1 69.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.684 2.256 . . . . 0.0 112.317 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 150.34 67.91 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.649 2.233 . . . . 0.0 112.324 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.3 p -119.48 163.18 17.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -128.86 -1.53 5.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -157.11 118.92 3.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -109.37 30.28 6.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -125.58 43.09 3.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -123.83 173.36 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.5 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 63.7 m -134.25 178.96 6.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -103.93 -33.9 8.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -53.76 -41.41 67.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' CD1' ' O ' ' A' ' 20' ' ' SER . 1.6 p90 -52.26 -26.2 11.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.66 -39.23 8.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.9 mmt -89.39 154.81 48.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.573 0.701 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 158.58 56.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.326 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.8 tp -72.39 -48.47 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.47 ' CB ' HG23 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -48.7 -25.27 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.49 -49.4 12.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.29 -43.81 97.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.9 m -94.98 156.43 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.4 p -105.25 162.5 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.58 -39.02 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -63.45 -45.62 90.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -128.17 81.74 69.87 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -31.33 20.75 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.712 2.275 . . . . 0.0 112.359 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -82.4 127.82 69.49 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.563 0.696 . . . . 0.0 111.139 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 161.67 45.03 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.683 2.256 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.514 ' CD1' ' CG ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.63 -56.33 5.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -38.6 -63.83 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.1 t -44.95 -58.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -48.79 -59.93 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.514 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 51.3 mmtt -43.52 -39.8 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.84 -48.87 57.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.2 t -58.71 -45.59 90.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' CD ' ' HA ' ' A' ' 43' ' ' LYS . 11.7 pt-20 -67.22 -41.31 85.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.563 ' CE1' HG22 ' A' ' 93' ' ' VAL . 17.7 t80 -53.02 -63.39 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 98.1 mt -39.98 -48.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.05 -43.52 98.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.23 -41.03 96.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 t -85.66 28.55 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.141 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.52 165.07 24.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.42 41.52 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 p -129.12 43.36 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -95.09 136.52 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.176 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -81.42 117.88 22.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.4 99.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.13 -0.41 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CD1' ' HE2' ' A' ' 98' ' ' LYS . 15.7 m-85 -123.11 -38.31 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -85.0 -29.3 25.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 62' ' ' SER . 99.0 t -89.47 132.99 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.405 ' N ' HG13 ' A' ' 61' ' ' VAL . 16.5 p -93.61 -68.72 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.73 -103.91 2.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.474 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -100.28 -44.73 5.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.368 . . . . 0.0 110.895 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt 57.05 25.25 10.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.3 m -91.54 -30.66 16.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 51.4 m-20 -60.6 -53.36 58.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.424 ' OE1' ' N ' ' A' ' 96' ' ' ALA . 44.2 mt-30 -49.12 -40.73 33.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.52 -68.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 24.8 p30 -59.82 -39.5 85.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.501 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 45.4 mt -43.93 -44.15 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -77.45 -46.28 23.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 18' ' ' TRP . 6.3 mtpp -56.95 -63.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -43.2 -44.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.13 -42.12 97.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.08 -46.25 88.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -61.63 -36.22 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -158.34 154.78 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.6 m170 -102.06 -20.69 14.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.47 54.85 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 pt -118.78 -178.8 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -144.69 145.12 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.4 mt -89.15 -42.59 11.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.01 -53.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -50.33 -46.58 55.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.6 mtp -52.97 -28.53 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 53.23 41.45 32.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.66 163.95 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.8 t -70.91 149.38 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.6 t -59.98 -54.41 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -40.19 -39.52 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.471 ' CB ' ' HB2' ' A' ' 67' ' ' ASP . . . -62.1 -64.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.563 HG22 ' CE1' ' A' ' 47' ' ' PHE . 94.1 t -45.28 -50.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -43.89 -51.89 7.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.408 ' C ' ' OE1' ' A' ' 68' ' ' GLN . . . -65.19 -47.31 82.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.424 ' N ' ' OE1' ' A' ' 68' ' ' GLN . . . -46.32 -48.84 18.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.064 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.2 tp -48.84 -50.01 36.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.502 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 43.9 mtmt -65.61 -46.76 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.56 -47.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.66 -53.29 60.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -53.5 -50.25 65.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.436 ' N ' HG22 ' A' ' 179' ' ' THR . . . -52.85 -42.76 65.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.437 ' OD1' ' CB ' ' A' ' 23' ' ' PHE . 13.1 t0 -52.51 -42.13 64.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 103' ' ' ASP . 80.5 mt -36.62 141.04 0.39 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -18.89 36.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.79 152.68 56.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.674 0.75 . . . . 0.0 110.859 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.73 134.82 28.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 107' ' ' PRO . 5.4 tp -33.95 -52.87 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.0 mt -73.86 127.0 89.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.634 0.731 . . . . 0.0 111.161 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 143.93 52.4 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.272 . . . . 0.0 112.331 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.538 ' CD1' ' CE1' ' A' ' 114' ' ' HIS . 4.1 m-85 -59.71 -32.16 70.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 t -59.29 -24.07 62.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.586 HD13 ' CE1' ' A' ' 140' ' ' PHE . 18.1 mt -117.64 30.21 7.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.538 ' CE1' ' CD1' ' A' ' 111' ' ' TYR . 3.6 m170 -75.03 -62.42 0.87 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.642 0.734 . . . . 0.0 110.849 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.4 Cg_endo -69.78 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -81.04 -30.76 34.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.467 HD22 ' CG1' ' A' ' 200' ' ' VAL . 3.0 mt -74.22 -38.15 63.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 197' ' ' HIS . 10.2 mt -75.39 -59.81 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -40.35 -33.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -84.27 -33.99 23.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.076 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -67.16 -26.39 66.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -87.0 26.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 95.3 mt -95.64 130.76 30.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 111.182 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -46.63 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 0.0 112.372 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 61.9 m-20 -60.39 91.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 125' ' ' ASP . 32.8 tttt -34.7 -56.49 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.0 m -53.1 -58.58 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.65 -57.73 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -39.92 -56.96 1.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.2 mt -55.76 -56.77 16.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -48.64 -38.48 21.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.03 96.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.5 mt -77.19 -24.35 51.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -81.67 -23.62 36.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.04 -33.9 16.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.468 ' O ' ' CE1' ' A' ' 140' ' ' PHE . 48.5 mt -74.83 -26.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.59 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.1 p -77.93 -11.16 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -74.74 -41.7 59.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -81.39 19.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.1 m-85 -80.73 138.03 36.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.561 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.6 t-80 -38.06 142.64 0.45 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.561 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.75 -7.72 21.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.362 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.47 HG23 ' CB ' ' A' ' 28' ' ' GLN . 92.8 t -99.75 -39.11 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.77 -46.48 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.467 ' CE2' ' O ' ' A' ' 137' ' ' VAL . 1.3 t80 -41.83 -54.56 3.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.34 -65.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.3 t -50.52 -40.58 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.564 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 3.9 t80 -51.07 -48.54 61.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -58.14 -58.35 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -52.58 -45.06 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.51 -66.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.564 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 64.3 mt -54.22 -56.16 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.9 m -41.09 -34.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -76.89 -42.73 38.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 30.5 mt -60.81 -51.83 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -45.12 -44.27 10.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 56.7 mtt-85 -56.96 -50.47 72.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.23 -50.17 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 p -51.58 -29.67 18.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 157' ' ' ARG . 35.2 mm-40 -46.51 -57.39 4.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -100.58 41.63 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 167' ' ' MET . 27.3 p80 -57.81 -21.44 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -71.06 -34.15 70.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.83 -58.76 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.088 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -79.58 12.84 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 15.2 mt 38.11 53.86 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.435 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 19.7 mmm -148.53 108.05 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 30.5 p -92.22 166.77 12.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.167 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -53.27 -34.25 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' CG ' ' HG3' ' A' ' 202' ' ' GLU . 1.1 m-20 -70.38 -48.49 56.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -55.82 -35.9 66.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.8 -46.9 64.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.2 t -53.9 -38.96 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 15.7 mt -78.95 -33.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.6 m -70.58 -25.6 63.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.502 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 21.4 m-85 -97.72 -16.8 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.564 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -46.69 -47.16 50.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.567 0.699 . . . . 0.0 110.901 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.1 Cg_exo -48.03 -48.6 15.95 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.692 2.262 . . . . 0.0 112.31 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 102' ' ' ALA . 76.0 m -84.02 -64.48 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 179' ' ' THR . 49.8 mt -34.61 -63.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 46.2 mmm -111.16 117.37 33.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -42.55 132.18 2.86 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 0.0 110.874 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 120.49 7.27 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.668 2.245 . . . . 0.0 112.373 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.58 130.89 38.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -78.58 -52.12 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.77 93.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -118.54 150.04 40.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -155.21 145.59 22.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -153.53 168.25 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -164.65 118.49 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 62.7 mt 38.59 42.32 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 67.1 m -150.38 153.21 35.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 8.2 t -90.05 -23.04 21.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.168 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 21.5 m 43.06 42.73 3.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -92.97 39.64 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 36.5 mt -86.4 -56.79 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.557 ' CE1' HD12 ' A' ' 118' ' ' LEU . 53.3 m-70 -42.58 -60.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -49.64 -44.52 47.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.0 m -60.64 -42.71 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.467 ' CG1' HD22 ' A' ' 117' ' ' LEU . 90.9 t -38.08 -69.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 202' ' ' GLU . 60.3 t -62.32 -55.88 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.419 ' HG3' ' CG ' ' A' ' 170' ' ' ASP . 2.1 tm-20 -37.88 -40.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 204' ' ' PHE . 65.8 m -64.9 -60.87 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.12 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' CYS . 12.3 m-85 -34.11 -54.11 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.85 -56.59 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.155 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -46.38 -49.65 17.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.465 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.7 mm-40 -109.51 34.19 3.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.549 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 4.2 t -65.79 -19.72 65.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.889 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 209' ' ' GLN . 3.7 mm-40 -84.94 -54.98 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.87 -38.63 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.549 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -47.47 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.13 -53.7 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -58.5 -25.12 62.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 58.68 43.15 19.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -87.36 144.17 19.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 215' ' ' GLY . 10.1 mm-40 -35.14 149.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.465 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.6 mt -74.29 133.81 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.176 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.5 172.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 t -168.25 147.95 4.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.872 0.367 . . . . 0.0 110.85 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.0 p -148.13 179.7 7.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.8 -153.78 6.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 t -169.73 175.9 5.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 110.867 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 t -159.44 178.39 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.49 170.22 29.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.502 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.9 138.28 6.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 10' ' ' PHE . 5.8 p-10 -120.69 141.6 50.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 9' ' ' ASN . 15.5 m-85 -167.7 116.74 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.841 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -116.43 143.59 31.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.649 0.738 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 161.26 46.63 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.637 2.225 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 153.34 69.04 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.701 2.268 . . . . 0.0 112.313 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -127.03 155.12 43.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -75.63 -179.56 4.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -61.7 109.22 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -104.74 31.5 4.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -88.02 49.55 1.82 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.952 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -113.09 107.15 15.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -119.39 175.68 5.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -132.06 33.25 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.532 ' CD2' HD23 ' A' ' 30' ' ' LEU . 5.6 m-85 -104.74 -39.16 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CG ' ' N ' ' A' ' 24' ' ' GLY . 11.4 p90 -52.77 -41.35 64.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' PHE . . . -67.59 -41.29 90.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.06 145.84 61.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.548 0.69 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 154.12 67.79 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.659 2.24 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 tp -47.54 -46.81 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -53.07 -30.4 35.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -46.02 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.532 HD23 ' CD2' ' A' ' 22' ' ' TYR . 20.8 mt -59.83 -44.11 94.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 m -90.43 171.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 p -118.95 156.26 29.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -46.9 -45.97 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -59.66 -46.21 89.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -126.58 86.73 57.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -29.89 22.91 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.684 2.256 . . . . 0.0 112.361 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.8 mt -84.16 134.51 43.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 111.154 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 146.81 61.62 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.435 ' CD1' ' CG ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -67.17 -40.81 86.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -51.6 -60.88 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.1 t -49.24 -63.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -40.61 -55.43 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 40.9 mmtt -55.87 -41.21 74.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.5 m -61.33 -40.71 95.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.449 ' CG1' ' CG ' ' A' ' 154' ' ' HIS . 25.2 t -71.22 -54.85 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -50.33 -33.69 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.42 ' CE2' HG21 ' A' ' 93' ' ' VAL . 19.5 t80 -60.74 -62.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.8 mt -47.34 -43.04 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.14 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.95 -26.51 59.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.35 -22.4 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -110.75 11.62 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 164.02 6.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.83 75.15 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -25.08 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -51.34 117.22 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.33 117.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.7 94.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.471 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.75 -34.73 9.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.7 -63.96 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HB2' ' NH1' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -53.34 -16.22 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.2 t -101.57 120.28 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.4 p -98.44 120.76 39.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.19 -161.06 10.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.459 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -80.18 126.92 31.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.918 0.39 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.455 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 36.3 tptt -43.96 -29.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -57.46 -43.44 83.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -54.66 -60.49 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -59.92 -44.78 94.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -41.62 -49.5 4.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 16.1 p30 -73.17 -34.78 66.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.453 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 52.1 mt -55.4 -45.97 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -79.57 -48.63 13.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -57.46 -59.27 5.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -50.26 -48.24 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.4 ' O ' ' O ' ' A' ' 78' ' ' ASP . 40.8 t80 -50.01 -56.05 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -54.59 -33.11 59.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -81.72 -18.41 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 75' ' ' PHE . 5.2 t0 -149.53 118.87 6.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -83.75 -24.23 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -98.57 36.38 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 tt -79.73 151.76 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -124.24 94.53 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.7 mt -40.55 -44.39 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.0 t -49.05 -47.88 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 t -58.11 -43.22 87.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 85.4 mtp -59.03 -36.13 74.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 59.28 44.75 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -80.18 173.84 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.9 p -69.11 111.88 5.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.5 t -37.44 -50.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -45.36 -45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.37 -63.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' A' ' 47' ' ' PHE . 95.5 t -45.83 -44.85 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.95 -38.59 67.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.58 -56.29 3.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.87 -36.92 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 111.099 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.8 tp -60.08 -47.39 86.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -65.96 -38.73 89.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.44 -36.87 55.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.093 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -62.9 -40.69 98.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.02 -41.68 99.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.07 80.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -34.31 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -41.48 147.4 0.48 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -28.71 24.8 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.94 139.47 16.07 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.605 0.717 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.9 Cg_endo -69.77 136.51 33.16 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.674 2.249 . . . . 0.0 112.321 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.44 HD23 ' CD1' ' A' ' 148' ' ' PHE . 5.5 mp -34.97 -49.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.2 mt -91.51 107.41 21.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 0.0 111.133 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 149.42 67.15 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.407 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.427 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 0.7 OUTLIER -62.48 -27.42 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 m -66.02 -8.19 21.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.527 HD12 ' CE1' ' A' ' 140' ' ' PHE . 70.4 mt -128.39 21.7 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.487 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.1 m170 -67.93 -60.13 5.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 0.0 110.81 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.78 -25.15 28.8 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.93 -27.35 67.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.77 -18.71 53.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.422 HD23 ' CD2' ' A' ' 197' ' ' HIS . 10.6 mt -92.56 -47.83 6.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -48.29 -40.37 24.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -83.73 -20.47 33.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.61 -21.79 51.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -93.8 17.87 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 96.5 mt -81.73 129.58 64.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 111.145 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -44.79 1.87 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.317 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.2 t70 -67.02 94.08 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.838 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.0 tptp -34.64 -50.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.2 m -52.5 -57.76 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -56.74 -49.18 75.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -45.74 -53.98 8.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.437 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 37.3 mt -65.57 -62.24 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -41.82 -28.65 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.414 ' HB1' ' CB ' ' A' ' 120' ' ' ALA . . . -75.52 -50.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 13.5 mt -65.77 -22.81 66.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -81.94 -30.61 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.926 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -85.89 -29.75 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.464 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 11.1 p -86.66 -6.48 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -77.78 -41.57 36.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -16.06 62.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.527 ' CE1' HD12 ' A' ' 113' ' ' LEU . 3.1 m-85 -46.82 151.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.539 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.9 t-80 -42.46 138.32 2.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.539 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.74 -20.72 34.59 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.35 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.27 -44.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -73.9 -48.06 33.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -39.24 -53.71 1.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -47.65 -48.93 28.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 30.5 t -69.26 -57.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.159 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.44 ' CD1' HD23 ' A' ' 108' ' ' LEU . 10.7 t80 -42.24 -45.5 4.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -60.85 -53.59 55.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -54.57 -43.83 72.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 82.0 t -52.61 -62.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.154 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.423 HD13 ' CZ ' ' A' ' 148' ' ' PHE . 3.3 mt -46.49 -51.13 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.4 m -40.93 -37.91 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.449 ' CG ' ' CG1' ' A' ' 45' ' ' VAL . 84.6 t60 -80.26 -39.2 29.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.52 -45.85 73.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -51.22 -49.82 60.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -51.79 -53.24 42.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.24 -35.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.8 p -66.24 -22.34 66.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -73.98 -31.59 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.426 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 3.1 mm100 -95.78 27.7 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.516 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 11.1 p80 -60.11 -16.47 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.827 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 14.0 mmmt -86.5 -5.53 59.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.33 -60.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.37 9.31 11.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.8 mt 47.46 43.95 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.405 ' HE1' ' CD2' ' A' ' 172' ' ' LEU . 23.2 mtp -129.96 106.26 8.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ALA . 78.1 p -97.57 151.24 20.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.77 -35.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 168' ' ' THR . 2.1 t70 -66.04 -60.45 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -47.81 -49.07 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.405 ' CD2' ' HE1' ' A' ' 167' ' ' MET . 7.4 mt -62.13 -49.06 77.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 t -51.71 -43.57 62.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -77.0 -38.01 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.19 -16.0 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -107.16 -11.72 15.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.565 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.23 -46.77 93.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.526 0.679 . . . . 0.0 110.896 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.0 -63.59 0.3 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 180' ' ' LEU . 28.9 m -67.04 -57.97 5.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 179' ' ' THR . 39.9 mt -34.22 -51.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.432 ' SD ' ' CZ2' ' A' ' 177' ' ' TRP . 0.6 OUTLIER -152.52 119.2 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.424 ' CG ' ' HD2' ' A' ' 183' ' ' PRO . 42.7 ttm-85 -61.4 138.18 94.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 182' ' ' ARG . 54.1 Cg_endo -69.73 142.57 48.44 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.676 2.25 . . . . 0.0 112.36 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -42.4 147.53 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -38.21 -43.2 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -146.56 147.84 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -115.3 121.7 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 154.45 39.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -94.64 106.09 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -146.15 161.6 39.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 61.1 mt -44.11 112.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 56.9 p -87.28 51.91 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 16.6 p -80.28 -53.44 6.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 10.8 t -79.56 117.22 20.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -119.25 73.48 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 71.4 mt -92.82 -37.99 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.422 ' CD2' HD23 ' A' ' 118' ' ' LEU . 32.8 m80 -41.35 -47.95 3.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -73.43 -56.24 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.0 m -42.09 -39.34 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.2 t -46.6 -72.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' PHE . 68.9 t -55.04 -57.34 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -39.84 -36.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 60.3 m -69.86 -39.05 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.189 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' VAL . 12.2 m-85 -55.53 -41.79 73.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.15 -54.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.06 -56.17 25.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.437 ' HG3' ' CD2' ' A' ' 130' ' ' LEU . 38.4 mm-40 -81.9 16.9 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.571 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 18.2 t -58.55 -22.74 56.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.92 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.582 ' N ' ' CD ' ' A' ' 209' ' ' GLN . 0.2 OUTLIER -78.59 -62.51 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -39.5 -39.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 17.4 m-30 -52.2 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -107.57 -52.17 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 209' ' ' GLN . 65.4 m-85 -62.22 -11.71 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 61.3 t30 45.78 41.04 7.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -70.46 -151.35 0.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.435 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.07 165.98 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.0 mt -75.56 121.57 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.9 175.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 p -143.68 135.63 26.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.888 0.375 . . . . 0.0 110.85 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 t -158.79 127.27 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.93 88.37 1.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.1 t -47.27 126.45 9.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.843 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.0 p -130.78 171.99 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.24 119.22 0.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -45.22 139.11 3.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -93.31 159.0 15.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 11' ' ' ASN . 1.9 p90 -120.47 173.32 7.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.411 ' O ' ' CD2' ' A' ' 10' ' ' PHE . 16.4 m120 -86.27 142.08 35.38 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.674 0.75 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 169.5 18.84 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -174.33 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.385 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.2 p -81.15 89.46 6.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -164.49 145.45 8.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.5 ttp-105 -138.12 161.92 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -123.05 27.01 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -115.69 94.02 4.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.73 124.45 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -118.57 -7.75 10.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 60.3 43.76 13.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 23' ' ' PHE . 4.2 p90 -134.95 -44.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' N ' ' CG ' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -67.87 125.86 27.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.896 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.81 -37.08 3.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.8 mmt -84.42 154.23 62.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.581 0.705 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 148.63 65.44 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.681 2.254 . . . . 0.0 112.327 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.78 -49.25 71.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.956 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -43.87 -37.2 2.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.91 -50.58 33.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.26 -45.49 83.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -91.74 171.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.1 p -120.28 158.06 27.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.21 -46.27 45.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.51 -44.28 72.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -132.1 90.4 35.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.97 8.45 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.7 mt -72.8 130.25 85.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 39' ' ' LEU . 54.0 Cg_endo -69.79 108.8 2.16 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.316 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.469 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -36.04 -57.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 39' ' ' LEU . 31.0 t80 -34.21 -64.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.409 ' CG2' ' HG2' ' A' ' 38' ' ' PRO . 79.7 t -43.82 -59.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -42.91 -61.94 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 64.0 mmtt -43.53 -41.09 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.9 m -68.35 -41.35 80.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -65.94 -51.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.67 -45.28 93.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 93' ' ' VAL . 32.5 t80 -45.69 -57.14 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.8 mt -45.27 -44.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -62.4 -57.41 11.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.65 -39.38 35.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -84.51 29.93 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.44 164.19 21.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.486 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.6 tp -126.81 41.04 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.748 0.309 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -124.38 37.99 4.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.6 m -98.75 128.38 44.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.36 145.75 29.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.75 45.24 4.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.535 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 59' ' ' TYR . 2.2 pt? -58.41 -37.96 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.437 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 60.7 m-85 -99.18 -51.95 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -44.03 -54.24 5.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 62' ' ' SER . 79.4 t -69.79 135.64 27.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.18 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.444 ' N ' HG13 ' A' ' 61' ' ' VAL . 59.8 p -79.84 -44.85 19.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.76 -163.15 53.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -59.52 178.22 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.956 0.408 . . . . 0.0 110.871 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -119.3 -46.84 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.7 m -47.67 -63.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.505 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 2.5 m-20 -41.26 -61.23 1.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -40.8 -40.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -67.17 -50.41 61.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -50.29 -47.22 55.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.4 mt -44.77 -43.9 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -82.82 -52.26 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -52.85 -62.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.27 -45.65 34.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.57 -44.23 97.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -63.32 -53.3 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -52.25 -39.27 60.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.23 152.58 22.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.78 -22.19 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.84 51.73 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.0 pt -107.19 -174.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 0.3 OUTLIER -151.03 119.32 6.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.26 -50.87 64.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.54 -40.92 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 68.6 m -60.39 -45.49 93.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.3 mtp -52.74 -32.44 43.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 60.86 45.66 9.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.01 168.87 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 90' ' ' VAL . 24.9 p -75.29 116.33 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 89' ' ' THR . 85.2 t -33.75 -54.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.092 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -36.12 -57.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -39.04 -59.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.55 HG22 ' CE1' ' A' ' 47' ' ' PHE . 96.9 t -46.01 -55.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.17 -44.48 16.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.24 -60.26 6.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.511 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.05 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.5 tp -53.47 -48.94 68.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 101' ' ' PHE . 29.7 mtmt -69.26 -52.5 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.8 -42.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.123 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -59.16 -47.74 84.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' LYS . 16.2 m-85 -56.18 -51.45 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.48 71.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 104' ' ' LEU . 64.4 m-20 -51.3 -42.77 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.6 mt -34.22 142.26 0.23 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -22.89 31.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -134.7 152.93 78.5 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.582 0.706 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 132.06 22.47 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.34 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -38.47 -47.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 mt -91.87 121.31 67.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 0.0 111.15 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.63 40.86 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.571 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 8.7 m-85 -54.68 -34.31 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE1' ' A' ' 116' ' ' GLU . 22.2 m -55.56 -29.15 58.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.571 HD13 ' CE1' ' A' ' 140' ' ' PHE . 32.2 mt -110.8 36.16 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.571 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 2.1 m170 -79.13 -65.49 0.3 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.632 0.73 . . . . 0.0 110.879 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.544 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.3 Cg_endo -69.74 -31.89 19.72 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.382 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 112' ' ' SER . 24.5 mp0 -60.47 -35.38 75.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.14 -39.46 68.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD22 ' CG ' ' A' ' 197' ' ' HIS . 4.9 mt -70.45 -55.48 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -46.82 -36.22 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.488 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -75.99 -25.78 56.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.413 ' CB ' HG23 ' A' ' 200' ' ' VAL . . . -78.15 -28.68 48.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -90.47 27.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 89.0 mt -89.5 135.18 31.26 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.654 0.74 . . . . 0.0 111.109 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -48.64 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.647 2.231 . . . . 0.0 112.345 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -66.15 95.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 125' ' ' ASP . 14.1 tptm -36.82 -53.44 0.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.503 HG22 ' CD2' ' A' ' 131' ' ' HIS . 50.7 m -52.23 -51.32 59.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -60.31 -49.05 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -47.2 -49.7 22.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.93 -62.65 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.503 ' CD2' HG22 ' A' ' 127' ' ' THR . 11.9 m-70 -40.43 -50.84 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.29 48.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.03 -34.12 76.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -68.32 -35.93 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 4.0 pt-20 -81.8 -32.7 31.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.462 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 51.0 mt -73.2 -34.77 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.35 -18.6 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.88 -34.48 75.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -66.95 -34.97 78.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.571 ' CE1' HD13 ' A' ' 113' ' ' LEU . 11.8 m-85 -42.66 132.39 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -33.47 142.68 0.19 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.523 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.82 -16.94 37.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 91.9 t -90.94 -39.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.15 -38.26 24.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.407 ' CZ ' ' HD3' ' A' ' 149' ' ' ARG . 46.3 t80 -52.47 -42.26 64.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.97 -42.44 80.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.84 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.439 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 98.9 t -74.31 -44.37 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.566 ' CZ ' HD12 ' A' ' 152' ' ' ILE . 26.2 t80 -58.76 -40.92 85.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.854 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 145' ' ' TYR . 47.2 ttp180 -67.62 -49.95 60.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -60.8 -47.66 85.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 147' ' ' VAL . 93.2 t -50.83 -65.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.139 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.566 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 75.8 mt -41.97 -50.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -40.51 -40.8 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -73.46 -40.14 64.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.65 -44.03 93.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.441 ' HA ' ' CG2' ' A' ' 205' ' ' ILE . 52.4 t-20 -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -58.93 -48.22 82.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.5 t -55.04 -46.86 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.3 p -56.57 -29.43 62.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -47.48 -56.35 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -100.45 33.73 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.573 ' CE1' ' HD3' ' A' ' 163' ' ' LYS . 7.3 p80 -51.62 -19.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.573 ' HD3' ' CE1' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -55.31 -34.68 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.49 -56.46 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -27.16 68.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 162' ' ' HIS . 75.8 mt 64.12 39.4 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.6 mmm -131.52 82.75 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.499 HG21 ' CG ' ' A' ' 162' ' ' HIS . 32.8 p -71.99 163.43 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.14 -46.74 5.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -60.25 -59.61 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -47.53 -50.01 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.35 -47.75 78.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.6 t -59.1 -44.58 91.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 57.9 mt -70.25 -31.49 47.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 48.9 t -70.79 -34.8 72.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.444 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 22.7 m-85 -90.23 -15.55 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.563 ' CZ3' ' HG2' ' A' ' 181' ' ' MET . 0.8 OUTLIER -47.55 -46.67 60.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.926 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.3 Cg_exo -48.04 -51.66 9.58 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.461 ' O ' ' C ' ' A' ' 180' ' ' LEU . 89.6 m -76.44 -63.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 179' ' ' THR . 87.4 mt -33.49 -70.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.563 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 2.3 ttm -100.03 112.04 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 183' ' ' PRO . 38.0 ttm-85 -112.7 103.34 55.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 182' ' ' ARG . 53.3 Cg_endo -69.8 134.63 28.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 0.0 112.343 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 185' ' ' PHE . 4.9 m-20 -107.02 100.62 10.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 184' ' ' ASP . 4.7 t80 37.17 39.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -146.47 136.66 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.855 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -130.3 173.25 10.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -97.25 126.49 42.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -40.91 125.1 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -47.14 127.37 10.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.4 mt -152.08 176.39 11.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 193' ' ' THR . 39.8 t -49.18 153.08 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 192' ' ' SER . 4.0 t -34.06 117.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 23.9 m -117.19 89.21 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -101.98 33.42 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 75.9 mt -83.89 -50.79 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.455 ' CG ' HD22 ' A' ' 118' ' ' LEU . 61.0 m80 -39.08 -63.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -51.91 -58.08 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.3 m -43.37 -44.16 5.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.413 HG23 ' CB ' ' A' ' 121' ' ' ALA . 48.1 t -46.25 -68.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.53 -47.32 93.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -46.32 -48.71 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.1 m -57.42 -57.87 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.457 ' C ' ' O ' ' A' ' 203' ' ' THR . 10.2 m-85 -33.98 -49.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' A' ' 156' ' ' ASN . 49.9 mt -70.39 -50.67 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -48.5 -45.45 37.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.42 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 9.4 mm-40 -117.44 36.92 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 22.9 t -64.1 -30.74 71.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -75.13 -51.67 12.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -43.82 -37.04 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -51.19 -63.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -101.25 -56.7 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -56.26 -38.04 70.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 73.18 42.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.3 169.29 53.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -58.82 136.05 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.42 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 66.3 mt -61.39 121.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -94.15 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.954 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.861 0.276 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.627 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.4 tp -51.1 -42.6 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.25 -31.78 22.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -85.51 -44.63 12.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.84 -46.84 84.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 27' ' ' LEU . 17.7 m -88.05 171.54 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 p -124.15 165.64 17.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.37 65.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.49 -47.82 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -126.82 91.74 46.38 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.6 0.714 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -30.53 21.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.686 2.257 . . . . 0.0 112.329 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.526 HG23 ' HD2' ' A' ' 38' ' ' PRO . 14.7 mt -84.3 135.22 41.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.63 0.729 . . . . 0.0 111.129 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 130.32 19.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.635 HD21 ' HE2' ' A' ' 43' ' ' LYS . 5.4 tp -52.2 -53.19 46.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' LEU . 16.8 t80 -36.27 -56.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 HD11 ' A' ' 97' ' ' LEU . 53.0 t -54.45 -62.63 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -47.68 -59.74 3.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.635 ' HE2' HD21 ' A' ' 39' ' ' LEU . 24.5 mmtm -44.43 -36.59 2.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.3 m -75.24 -38.38 60.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -72.9 -60.12 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -54.02 -32.9 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -63.28 -57.67 9.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.9 mt -50.35 -53.54 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.42 -45.04 85.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.58 -41.23 97.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.7 p -89.05 23.35 2.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.65 135.43 4.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.456 ' CD2' ' HB3' ' A' ' 157' ' ' ARG . 15.1 tp -103.72 35.48 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.7 ' HB2' HG21 ' A' ' 164' ' ' ILE . 15.1 p -121.63 40.34 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.625 HG21 ' HB ' ' A' ' 90' ' ' VAL . 18.4 m -92.28 112.31 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.7 tt0 -34.76 120.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.14 77.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.613 HD21 HG11 ' A' ' 158' ' ' VAL . 1.6 pt? -61.25 -29.05 69.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -108.41 -49.62 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -49.63 -49.78 45.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.9 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.809 0.337 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -51.0 -45.74 61.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.605 ' HA ' HD12 ' A' ' 71' ' ' ILE . 64.2 mt-30 -65.11 -35.03 79.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.93 -58.4 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.0 p30 -64.35 -36.05 82.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 68' ' ' GLN . 57.4 mt -54.3 -47.35 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -78.25 -40.08 38.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -64.7 -67.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -44.99 -45.65 10.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.87 -34.92 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.9 -52.04 48.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.57 -21.56 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -145.47 113.82 6.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -84.6 -3.23 58.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -101.91 23.53 11.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.458 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 6.0 tt -68.97 156.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.458 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 2.5 t-20 -125.94 91.63 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASN . 84.3 mt -36.94 -48.06 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -51.47 -48.71 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -54.39 -39.57 67.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.406 ' HB3' HG13 ' A' ' 88' ' ' VAL . 40.8 mmm -66.97 -32.44 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 56.94 47.22 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' A' ' 86' ' ' MET . 31.6 m -81.45 179.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.599 HG23 ' H ' ' A' ' 92' ' ' ALA . 9.2 t -87.55 127.42 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.625 ' HB ' HG21 ' A' ' 55' ' ' THR . 93.9 t -40.19 -47.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -48.31 -40.47 25.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.599 ' H ' HG23 ' A' ' 89' ' ' THR . . . -62.76 -61.99 2.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.6 -38.28 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' LEU . . . -57.75 -50.09 74.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.19 -49.81 64.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.21 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HG13 ' A' ' 41' ' ' VAL . 34.2 tp -58.86 -46.56 87.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' ALA . 30.0 mtmt -67.24 -52.01 46.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.45 -45.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -53.45 -53.42 51.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CB ' HG21 ' A' ' 179' ' ' THR . 34.9 m-85 -58.15 -33.61 69.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -28.58 64.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LEU . 1.9 t70 -75.22 -31.57 60.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' ASP . 67.2 mt -35.72 143.51 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.743 2.295 . . . . 0.0 112.283 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -139.05 154.28 72.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.639 0.733 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.6 Cg_endo -69.82 130.09 18.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.309 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.434 HD21 ' CD1' ' A' ' 148' ' ' PHE . 12.0 tp -35.73 -51.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -91.95 126.33 53.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.669 0.747 . . . . 0.0 111.155 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.466 ' CG ' HD12 ' A' ' 113' ' ' LEU . 53.2 Cg_endo -69.81 161.49 45.75 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -78.95 -11.49 60.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.429 ' O ' HD23 ' A' ' 113' ' ' LEU . 30.9 t -88.67 5.45 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 117' ' ' LEU . 80.0 mt -133.96 19.85 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.5 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.2 m170 -71.09 -60.11 3.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.56 0.695 . . . . 0.0 110.855 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.76 -27.13 26.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.363 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.79 -32.14 72.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.4 mt -77.27 -34.38 55.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 197' ' ' HIS . 9.6 mt -78.95 -44.04 23.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.2 -23.66 62.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.64 -9.48 29.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.486 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -95.18 -28.79 14.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -80.98 -3.44 51.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.652 HG23 ' HD2' ' A' ' 124' ' ' PRO . 67.4 mt -56.37 138.29 75.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.652 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.84 -50.71 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.649 2.232 . . . . 0.0 112.324 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.99 107.36 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -46.32 -52.21 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -55.09 -61.39 2.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.29 -45.87 17.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -50.18 -42.58 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.406 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 43.7 mt -70.75 -42.34 70.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -60.66 -54.52 44.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.88 62.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.68 -24.89 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -78.26 -30.06 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.7 -31.48 18.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -38.11 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.089 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.23 -8.69 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -76.06 -28.85 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -73.04 -19.32 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -53.53 137.54 36.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.537 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.8 t-80 -38.69 141.58 0.57 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 110.896 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.77 -8.81 24.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 0.0 112.374 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.505 HG12 HD23 ' A' ' 27' ' ' LEU . 20.3 t -99.12 -42.25 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -85.56 -29.85 23.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -52.41 -48.79 65.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.32 -50.96 69.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.407 HG22 ' HD2' ' A' ' 38' ' ' PRO . 61.2 t -60.46 -59.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 13.5 t80 -40.4 -40.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -69.74 -48.19 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.18 -48.91 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.54 -64.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.905 HG23 HG12 ' A' ' 205' ' ' ILE . 92.0 mt -48.52 -49.21 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.0 m -40.45 -34.87 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.423 ' CE1' HD11 ' A' ' 53' ' ' LEU . 40.2 t60 -80.1 -45.95 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.634 HD12 ' HA ' ' A' ' 152' ' ' ILE . 59.1 mt -49.58 -49.17 47.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -48.26 -41.09 26.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.456 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 98.7 mtt180 -64.34 -36.81 85.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.613 HG11 HD21 ' A' ' 58' ' ' LEU . 59.5 t -68.47 -42.48 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.6 p -62.64 -30.74 71.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -60.84 -50.32 73.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -98.01 38.96 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.549 ' CE1' ' HD2' ' A' ' 163' ' ' LYS . 2.1 p80 -56.04 -31.65 63.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.549 ' HD2' ' CE1' ' A' ' 162' ' ' HIS . 12.5 mptt -53.74 -22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.7 HG21 ' HB2' ' A' ' 54' ' ' CYS . 15.6 mt -100.65 -58.69 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -80.08 11.57 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 162' ' ' HIS . 6.6 mt 34.71 46.35 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.9 mmm -142.58 120.93 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.6 p -105.47 177.32 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.03 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -46.55 66.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -59.58 -46.97 87.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.62 -41.22 98.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.444 ' OG ' ' NE2' ' A' ' 198' ' ' GLN . 45.6 p -58.75 -28.52 65.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.2 mt -86.81 -42.25 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.31 -16.93 57.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.414 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 14.3 m-85 -107.95 -7.13 16.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.576 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.2 t90 -51.68 -45.45 91.55 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.939 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -48.0 -65.44 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.552 HG21 ' CB ' ' A' ' 101' ' ' PHE . 8.4 m -61.17 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 179' ' ' THR . 86.9 mt -34.35 -44.61 0.2 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 3.9 mtt -146.91 119.9 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.841 -179.923 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 200' ' ' VAL . 30.7 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.857 0.36 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.566 ' CD2' HD21 ' A' ' 118' ' ' LEU . 13.7 m80 -47.8 -66.42 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.444 ' NE2' ' OG ' ' A' ' 173' ' ' SER . 2.4 tm0? -37.42 -48.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.4 t -55.26 -48.19 74.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.851 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.486 HG22 ' CB ' ' A' ' 121' ' ' ALA . 23.1 t -45.49 -69.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.82 -61.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -44.0 -47.55 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 204' ' ' PHE . 70.7 m -54.16 -62.71 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' CYS . 14.1 m-85 -34.66 -52.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.905 HG12 HG23 ' A' ' 152' ' ' ILE . 61.1 mt -60.6 -59.97 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -45.88 -48.92 15.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.443 ' NE2' ' HA ' ' A' ' 207' ' ' GLN . 8.8 mm-40 -106.2 31.4 5.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.561 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 6.4 t -67.26 -21.15 65.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.48 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 74.4 mm-40 -87.07 -54.3 4.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.92 -36.55 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -49.53 -62.92 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -106.75 -54.36 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.48 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 65.4 m-85 -55.46 -30.88 61.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 70.85 27.83 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -68.51 137.48 30.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.5 mt-10 -37.9 154.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.06 112.57 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.82 173.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.841 0.267 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' O ' HG22 ' A' ' 31' ' ' VAL . 22.5 tp -53.06 -39.79 63.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.469 ' HB3' HG21 ' A' ' 143' ' ' VAL . 13.9 pt20 -55.21 -29.4 57.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.17 -40.85 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.55 -44.04 88.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 27' ' ' LEU . 21.2 m -81.42 173.45 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 p -111.75 143.71 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.63 3.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.22 -43.47 98.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -131.68 106.17 14.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.54 0.686 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.405 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.8 Cg_endo -69.77 -35.44 12.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.623 2.215 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.84 130.03 79.7 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.723 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.77 68.41 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.473 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.87 -47.97 78.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -45.34 -63.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.0 t -48.45 -53.77 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 150' ' ' TYR . 15.3 mm-40 -48.95 -55.84 10.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 50.6 mmtt -50.51 -41.16 53.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.8 m -63.56 -43.55 96.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 150' ' ' TYR . 44.4 t -66.64 -61.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 47' ' ' PHE . 10.6 pt-20 -53.11 -47.51 68.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.666 ' CE2' HG21 ' A' ' 93' ' ' VAL . 60.4 t80 -48.26 -64.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mt -38.55 -62.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -45.9 -47.83 16.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -56.46 -47.21 79.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -84.76 29.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.12 141.26 6.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -106.49 -14.32 15.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.7 p -84.48 34.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.896 ' HB ' HD21 ' A' ' 58' ' ' LEU . 36.7 m -68.73 157.05 37.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' N ' HG22 ' A' ' 55' ' ' THR . 1.8 mp0 -100.89 147.86 25.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' C ' ' HG2' ' A' ' 60' ' ' ARG . . . 48.01 75.87 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.48 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.896 HD21 ' HB ' ' A' ' 55' ' ' THR . 4.5 mm? -95.0 122.79 38.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.609 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 26.7 m-85 63.32 26.49 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HG2' ' C ' ' A' ' 57' ' ' GLY . 7.0 ptm180 -127.24 -10.16 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.2 -46.17 79.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 71' ' ' ILE . 43.5 mt-30 -70.19 -28.68 65.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.944 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.02 -60.96 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.1 p30 -53.92 -36.77 63.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 68' ' ' GLN . 50.2 mt -53.39 -56.6 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.55 -52.44 38.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -53.16 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -68.32 -29.79 68.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -68.66 -49.43 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -63.99 -33.0 74.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -158.67 156.07 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -105.71 -15.4 14.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -80.75 45.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.2 pt -106.0 177.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -142.48 130.04 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.71 -42.44 21.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.82 -44.12 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.7 t -64.95 -28.86 69.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.8 mmm -70.6 -33.61 71.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 62.35 34.59 15.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.82 156.66 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 p -67.66 146.88 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.3 t -53.22 -49.46 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -42.99 -49.94 5.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.4 -62.86 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.666 HG21 ' CE2' ' A' ' 47' ' ' PHE . 67.5 t -53.79 -50.23 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -52.79 -37.12 59.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.71 -49.29 7.26 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.0 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.71 -45.08 77.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 99' ' ' ALA . 20.9 mtmt -64.08 -53.43 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.01 -44.29 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -54.65 -54.03 46.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -57.07 -39.19 74.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.39 -35.79 82.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 104' ' ' LEU . 9.6 t0 -59.85 -40.45 88.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.9 mt -36.86 143.06 0.34 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.62 154.29 79.49 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.709 . . . . 0.0 110.851 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 108' ' ' LEU . 54.0 Cg_endo -69.78 131.14 20.59 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.37 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 107' ' ' PRO . 26.1 tp -35.73 -38.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -103.12 125.58 34.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 157.08 61.69 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.737 2.291 . . . . 0.0 112.327 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -76.02 -22.1 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.6 m -72.3 -7.18 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -130.27 28.83 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.479 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -74.57 -61.97 1.04 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.859 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.6 Cg_endo -69.74 -23.36 30.98 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -67.55 -32.17 72.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.22 -33.53 69.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.525 HD23 HG21 ' A' ' 200' ' ' VAL . 6.3 mt -81.67 -55.64 4.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.77 -32.62 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.26 -26.8 23.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -79.46 -23.63 42.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -83.03 1.17 41.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 128' ' ' GLU . 91.7 mt -70.56 129.27 90.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.638 0.733 . . . . 0.0 111.113 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -47.05 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.343 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.7 m-20 -61.6 97.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -34.45 -50.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.4 m -55.68 -57.76 10.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.52 ' HB2' HG21 ' A' ' 123' ' ' ILE . 15.6 mt-10 -54.87 -44.8 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.83 -54.23 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 207' ' ' GLN . 21.7 mt -68.93 -62.21 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -38.68 -43.28 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.41 79.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.553 HD22 ' HE1' ' A' ' 204' ' ' PHE . 12.6 mt -67.31 -23.44 65.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.428 ' O ' HG12 ' A' ' 137' ' ' VAL . 4.2 ttpm? -78.54 -32.64 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -85.34 -34.4 21.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.55 -39.86 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 134' ' ' LYS . 5.4 p -62.57 -8.74 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -76.83 -30.35 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.85 -22.98 61.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 141' ' ' HIS . 5.6 m-85 -51.45 133.4 29.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 5.5 t60 -35.03 141.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.2 Cg_endo -69.84 -13.12 34.05 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.715 2.276 . . . . 0.0 112.301 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 28' ' ' GLN . 26.2 t -95.0 -37.09 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -87.32 -38.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -45.06 -44.94 10.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -61.27 -56.27 22.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.07 -54.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.846 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 24.8 t80 -49.03 -45.52 42.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.484 ' CZ ' ' HB3' ' A' ' 149' ' ' ARG . 7.5 mtp-105 -64.2 -49.08 73.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.565 ' CE2' ' OE2' ' A' ' 42' ' ' GLU . 39.1 t80 -52.59 -45.29 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.923 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.03 -57.36 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.135 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.846 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 70.3 mt -49.66 -48.97 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -47.54 -39.87 17.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.521 ' O ' HG23 ' A' ' 158' ' ' VAL . 36.3 t-80 -77.57 -31.24 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 152' ' ' ILE . 97.9 mt -66.03 -45.95 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -54.72 -38.63 67.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -65.59 -37.02 85.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 154' ' ' HIS . 46.5 t -68.91 -43.25 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.6 p -60.8 -40.08 91.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -48.13 -37.7 16.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.413 ' HB3' HD12 ' A' ' 164' ' ' ILE . 6.0 mm-40 -105.06 32.83 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 166' ' ' LEU . 12.4 p80 -51.19 -38.73 53.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 21.1 mmtp -57.44 -32.49 66.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 161' ' ' GLN . 52.7 mt -87.81 -58.26 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 55' ' ' THR . 10.6 m-20 -76.08 4.07 9.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 162' ' ' HIS . 13.5 mt 46.15 42.67 10.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 31.2 mmm -144.37 122.59 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.6 p -100.63 156.89 17.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.69 -37.64 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.31 -47.47 64.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -58.49 -38.4 77.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.57 -48.07 61.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.2 p -51.92 -48.76 64.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.0 mt -62.01 -39.4 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.59 -17.07 53.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.437 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 33.0 m-85 -109.43 -10.57 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.571 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -48.76 -46.47 72.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.54 0.686 . . . . 0.0 110.9 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.91 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 180' ' ' LEU . 16.5 m -61.08 -64.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 179' ' ' THR . 59.5 mt -36.96 -62.31 0.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 86.0 mtp -117.1 81.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.613 0.72 . . . . 0.0 110.839 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.75 ' O ' HG23 ' A' ' 200' ' ' VAL . 94.1 mt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -50.78 -72.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -47.85 -51.15 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.6 t -46.12 -42.22 13.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 196' ' ' ILE . 89.2 t -41.09 -70.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 202' ' ' GLU . 84.2 t -54.86 -59.66 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 201' ' ' VAL . 15.9 tt0 -35.85 -51.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 53.0 m -54.03 -57.9 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.671 ' HB3' HD13 ' A' ' 152' ' ' ILE . 8.1 m-85 -40.09 -34.37 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.553 ' HA ' HG23 ' A' ' 152' ' ' ILE . 66.9 mt -75.32 -59.84 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -53.93 -53.43 52.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.598 ' OE1' HG22 ' A' ' 218' ' ' VAL . 1.0 OUTLIER -84.63 18.91 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 19.3 t -60.6 -12.01 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.479 ' NE2' ' CD2' ' A' ' 213' ' ' TYR . 11.2 mm100 -95.96 -57.2 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -40.59 -38.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -49.63 -61.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -107.86 -53.96 2.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.479 ' CD2' ' NE2' ' A' ' 209' ' ' GLN . 53.2 m-85 -58.06 -28.59 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 64.64 42.83 4.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.68 51.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -63.9 134.9 56.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.25 131.73 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.598 HG22 ' OE1' ' A' ' 207' ' ' GLN . 27.0 m -116.18 163.92 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.847 0.269 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 tp -55.41 -46.0 76.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -48.67 -35.57 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.63 -48.91 17.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.2 mt -56.03 -44.49 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 36' ' ' PRO . 4.5 m -90.76 171.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.5 p -108.12 144.03 36.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.94 -37.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.51 -42.19 95.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 17.7 mmtp -128.83 96.47 29.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.703 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HA ' HG21 ' A' ' 31' ' ' VAL . 54.0 Cg_endo -69.74 -24.65 29.54 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.8 mt -92.95 130.96 34.54 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 122.5 9.16 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -50.67 -27.43 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -62.3 -61.67 2.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.805 HG13 HD11 ' A' ' 97' ' ' LEU . 42.3 t -50.02 -50.94 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -51.83 -60.05 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 45.1 mmtt -44.3 -39.33 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HB2' HD13 ' A' ' 97' ' ' LEU . 95.2 m -67.5 -45.6 75.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.509 HG13 ' CG ' ' A' ' 154' ' ' HIS . 60.6 t -62.63 -59.54 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.26 -27.7 16.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -70.83 -54.33 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.466 HG22 ' CD1' ' A' ' 53' ' ' LEU . 42.8 mt -56.37 -20.5 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -91.06 -22.05 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.33 -17.62 22.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -82.56 18.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.144 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.38 -42.55 2.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.698 HD11 HG22 ' A' ' 158' ' ' VAL . 12.5 tp 64.7 44.0 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.1 p -133.16 30.0 3.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -90.93 127.84 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -60.39 120.76 10.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 48.71 76.04 0.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 58' ' ' LEU . 1.2 pt? -89.38 4.36 49.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.934 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.62 -48.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -59.05 -48.15 82.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.791 0.329 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.487 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -39.34 -58.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -50.59 -44.57 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.73 -51.0 70.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -50.97 -52.1 45.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 93' ' ' VAL . 85.3 mt -43.75 -46.46 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.12 -62.63 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ASP . 48.5 mttt -50.67 -64.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -39.41 -42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -71.66 -38.49 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' LYS . 11.1 t0 -65.33 -41.75 93.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.28 -31.57 71.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -166.89 148.35 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -94.66 -19.55 20.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -78.3 48.47 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 pt -109.98 -176.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -154.6 125.44 7.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -70.72 -46.69 62.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.01 -48.48 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -59.79 -43.81 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.474 ' HB3' HG13 ' A' ' 88' ' ' VAL . 89.9 mtp -59.25 -19.39 45.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 47.6 39.42 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' A' ' 86' ' ' MET . 31.3 m -72.71 164.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 p -74.88 131.89 41.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.3 t -44.36 -48.93 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -46.18 -40.21 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.77 -62.79 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.516 ' HA ' HD13 ' A' ' 71' ' ' ILE . 72.8 t -52.69 -36.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.85 72.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.57 -54.04 4.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.02 -44.39 61.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.805 HD11 HG13 ' A' ' 41' ' ' VAL . 34.0 tp -45.85 -43.67 13.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.11 -47.12 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -39.38 -45.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.25 -54.18 46.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.596 ' HB2' HG21 ' A' ' 179' ' ' THR . 76.3 m-85 -49.61 -47.22 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -54.49 -37.69 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.5 mt -41.45 141.01 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.657 0.741 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.13 32.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -133.25 150.6 75.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.881 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.24 37.47 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.336 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.1 tp -43.03 -53.84 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mt -85.42 124.09 72.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.559 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.79 149.02 66.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -70.43 -8.96 54.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.5 m -83.65 -12.46 55.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.848 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.628 HD13 ' CE1' ' A' ' 140' ' ' PHE . 43.0 mt -120.52 26.25 9.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.5 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.4 m170 -71.02 -60.12 3.04 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.78 -20.62 34.49 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.258 . . . . 0.0 112.328 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.404 ' O ' HD13 ' A' ' 136' ' ' ILE . 12.0 mp0 -70.89 -39.14 72.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.515 ' HB3' HG11 ' A' ' 200' ' ' VAL . 12.8 mt -72.09 -28.72 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.637 HD11 ' CE1' ' A' ' 197' ' ' HIS . 21.9 mt -83.68 -50.21 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.11 -26.36 11.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.61 -21.75 21.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -83.27 -15.4 50.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -95.47 10.23 37.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.3 mt -73.51 132.19 81.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.584 0.707 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -45.39 1.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.375 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 105.56 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HD3' HG21 ' A' ' 217' ' ' ILE . 6.9 ttmt -41.37 -53.04 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.625 HG22 ' CD2' ' A' ' 131' ' ' HIS . 3.0 m -56.02 -59.72 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -49.22 -39.3 29.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -57.46 -42.79 83.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.6 -54.12 8.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.625 ' CD2' HG22 ' A' ' 127' ' ' THR . 15.6 m-70 -46.76 -44.06 18.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.06 -59.66 4.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.533 HD22 ' HE1' ' A' ' 204' ' ' PHE . 16.1 mt -53.82 -33.75 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 137' ' ' VAL . 57.4 tttt -65.68 -34.97 79.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -82.62 -41.38 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 139' ' ' LYS . 87.8 mt -59.62 -21.14 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 134' ' ' LYS . 9.5 p -92.64 -5.91 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -81.02 -35.27 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 136' ' ' ILE . 5.8 pttm -80.57 -7.78 59.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.628 ' CE1' HD13 ' A' ' 113' ' ' LEU . 2.7 m-85 -51.4 149.88 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.599 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -41.83 140.64 1.41 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.81 -16.66 37.43 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.653 2.235 . . . . 0.0 112.286 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 91.1 t -96.97 -38.72 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -83.89 -40.23 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 71.4 t80 -46.56 -42.86 16.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -45.18 94.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.1 t -68.33 -61.11 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -44.45 -46.86 9.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.434 ' HB3' ' NH1' ' A' ' 149' ' ' ARG . 7.8 ttp-105 -62.57 -47.97 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.03 -54.19 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 85.0 t -46.4 -65.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.12 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.485 ' HA ' HD12 ' A' ' 155' ' ' LEU . 77.8 mt -44.0 -53.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.9 m -39.77 -36.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.509 ' CG ' HG13 ' A' ' 45' ' ' VAL . 15.1 t60 -80.36 -43.31 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 205' ' ' ILE . 96.5 mt -49.2 -42.99 41.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -52.26 -48.57 65.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -56.91 -29.84 63.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.698 HG22 HD11 ' A' ' 53' ' ' LEU . 42.4 t -80.46 -29.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.093 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 p -75.65 -20.44 58.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.94 -44.37 63.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.715 ' HB3' HD12 ' A' ' 164' ' ' ILE . 1.7 mm100 -97.01 29.48 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.574 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 16.8 p80 -52.48 -39.25 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.574 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 0.8 OUTLIER -59.15 -21.19 58.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 161' ' ' GLN . 49.6 mt -92.73 -64.96 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -76.08 1.41 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 162' ' ' HIS . 43.5 mt 54.6 46.28 25.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.417 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 21.0 mtp -141.12 112.55 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.46 HG22 ' CG ' ' A' ' 162' ' ' HIS . 33.7 p -98.24 160.63 14.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -45.96 -35.39 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -49.05 62.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.86 -44.17 77.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.77 -44.36 96.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -53.07 -40.31 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.6 mt -80.71 -41.21 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.142 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.58 -20.77 66.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -108.75 0.04 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.577 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.13 -45.92 95.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.533 0.682 . . . . 0.0 110.872 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -47.95 -58.54 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.688 2.259 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.596 HG21 ' HB2' ' A' ' 101' ' ' PHE . 18.2 m -69.69 -62.96 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.1 mt -40.52 -52.23 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 16.1 mmm -128.52 123.25 33.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 0.0 110.842 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 200' ' ' VAL . 87.0 mt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.849 0.357 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.637 ' CE1' HD11 ' A' ' 118' ' ' LEU . 12.8 m80 -48.74 -71.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -40.7 -53.67 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 t -45.88 -41.96 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 196' ' ' ILE . 29.6 t -53.8 -60.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.56 -66.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -38.68 -52.33 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 51.5 m -48.85 -64.6 0.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.533 ' HE1' HD22 ' A' ' 133' ' ' LEU . 7.4 m-85 -34.16 -48.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 155' ' ' LEU . 48.3 mt -66.25 -50.37 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -53.86 -45.61 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -110.02 30.42 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.527 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 0.8 OUTLIER -64.12 -15.32 59.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 213' ' ' TYR . 67.6 mm-40 -88.92 -54.47 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 210' ' ' PHE . 0.9 OUTLIER -42.76 -40.46 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -45.91 -63.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -105.54 -53.32 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 209' ' ' GLN . 56.9 m-85 -56.03 -35.2 66.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.931 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 71.02 28.02 3.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.68 -166.41 1.77 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.508 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.84 151.99 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.593 HG21 ' HD3' ' A' ' 126' ' ' LYS . 54.1 mt -76.42 132.05 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 m -110.22 174.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.814 0.256 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.665 ' O ' HG22 ' A' ' 31' ' ' VAL . 30.0 tp -70.6 -39.39 73.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.443 ' HB3' HG21 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -52.34 -28.57 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.12 -41.24 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.37 -39.0 78.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 27' ' ' LEU . 34.6 m -96.26 164.65 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -107.41 168.49 9.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.49 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -53.52 -46.75 70.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 24.4 mmtm -130.74 103.88 15.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.51 ' O ' HG11 ' A' ' 31' ' ' VAL . 54.0 Cg_endo -69.77 -33.6 16.21 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.644 2.23 . . . . 0.0 112.369 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.455 HG22 ' HG3' ' A' ' 42' ' ' GLU . 29.8 mt -74.68 131.36 79.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.611 0.72 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' HD21 ' A' ' 27' ' ' LEU . 54.2 Cg_endo -69.7 147.64 63.68 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.483 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.33 -50.03 71.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -42.53 -67.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.753 HG13 HD11 ' A' ' 97' ' ' LEU . 75.0 t -46.93 -54.36 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' HG3' HG22 ' A' ' 37' ' ' ILE . 33.1 mt-10 -47.23 -58.04 4.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 51.8 mmtt -53.05 -37.56 61.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.427 ' O ' HD12 ' A' ' 48' ' ' ILE . 78.4 m -65.22 -43.94 89.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.02 -51.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.27 -45.72 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 93' ' ' VAL . 33.4 t80 -53.53 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 44' ' ' CYS . 41.2 mt -37.48 -56.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -52.06 -48.05 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.05 -44.1 87.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 t -85.87 23.92 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.1 139.65 10.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.434 ' O ' HD11 ' A' ' 58' ' ' LEU . 16.0 tp -110.29 -27.44 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.964 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.9 m -84.48 39.75 0.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.708 ' O ' HD12 ' A' ' 58' ' ' LEU . 11.5 m -82.72 111.67 18.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.4 tt0 -35.97 130.85 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 36.57 77.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 55' ' ' THR . 3.0 mp -60.2 -61.73 2.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.955 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.674 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 59.4 m-85 -93.3 -43.45 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -42.54 -49.02 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.096 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.776 0.322 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -60.84 -53.83 52.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.35 -27.35 65.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.57 -62.89 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 13.4 p30 -61.71 -44.55 96.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.449 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 47.2 mt -43.5 -42.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.52 -54.81 4.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -51.22 -61.17 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -51.12 -38.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HA ' HG21 ' A' ' 81' ' ' ILE . 7.7 t80 -62.9 -28.74 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.74 -63.16 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -55.38 -29.31 58.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -131.04 99.05 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -69.92 -17.28 63.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.85 32.62 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.525 HG21 ' HA ' ' A' ' 75' ' ' PHE . 7.1 tt -73.61 157.22 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.461 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 1.9 t-20 -132.35 94.74 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -40.49 -46.58 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.48 -50.65 78.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -55.54 -41.41 73.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.427 ' HB3' HG13 ' A' ' 88' ' ' VAL . 22.4 mmm -62.09 -33.86 75.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 61.55 46.51 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 86' ' ' MET . 33.7 m -78.75 165.72 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.7 p -67.26 139.44 57.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.9 t -52.82 -55.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -45.92 -44.45 14.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.54 -63.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 47' ' ' PHE . 93.7 t -45.04 -55.55 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.674 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -48.64 -38.7 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.35 -60.82 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.51 -43.92 8.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.753 HD11 HG13 ' A' ' 41' ' ' VAL . 23.8 tp -47.81 -44.55 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -68.01 -48.09 66.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.14 -38.38 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.068 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.25 -46.45 86.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -61.16 -47.51 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.511 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -59.74 -37.79 79.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 104' ' ' LEU . 6.7 t70 -59.42 -36.92 76.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' ASP . 96.2 mt -36.78 144.15 0.29 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -22.12 32.73 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.21 153.97 69.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.629 0.728 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 133.03 24.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.483 HD12 HD22 ' A' ' 144' ' ' ASN . 11.4 tp -38.38 -49.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.0 mt -84.2 123.63 75.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 111.162 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 153.93 68.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.691 2.261 . . . . 0.0 112.318 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.483 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 13.5 m-85 -72.62 -17.5 61.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 m -72.92 -30.45 63.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.39 27.85 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.498 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.0 m170 -71.49 -60.16 2.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.601 0.715 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.75 -33.83 15.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.247 . . . . 0.0 112.335 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.526 ' O ' HD13 ' A' ' 136' ' ' ILE . 1.3 mp0 -59.03 -33.3 70.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.44 ' HB3' HG11 ' A' ' 200' ' ' VAL . 12.8 mt -71.85 -40.28 69.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.2 mt -75.09 -58.57 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -42.71 -29.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.95 -28.4 20.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -76.8 -20.91 55.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -92.14 16.21 11.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 30.8 mt -78.22 132.64 66.01 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.59 0.71 . . . . 0.0 111.135 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -45.39 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.671 2.247 . . . . 0.0 112.349 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 126' ' ' LYS . 75.7 m-20 -66.34 92.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 125' ' ' ASP . 38.1 tttt -34.91 -51.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 42.4 m -53.25 -59.92 3.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' ARG . 45.1 mm-40 -54.83 -52.6 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 128' ' ' GLU . 11.4 ttm180 -36.87 -43.5 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 133' ' ' LEU . 22.8 mt -75.84 -61.56 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 130' ' ' LEU . 11.8 m-70 -36.53 -49.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.1 -55.14 30.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.589 HD22 ' HE1' ' A' ' 204' ' ' PHE . 11.0 mt -55.9 -41.37 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -56.3 -29.67 61.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -90.37 -46.33 8.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 116' ' ' GLU . 56.7 mt -56.43 -29.2 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.528 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 7.8 p -76.15 -15.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -73.37 -25.44 60.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -77.38 -19.13 56.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 7.9 m-85 -50.51 146.98 4.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.586 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.4 t-80 -45.48 141.39 3.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.586 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -21.0 34.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 28' ' ' GLN . 84.6 t -89.7 -38.89 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.483 HD22 HD12 ' A' ' 108' ' ' LEU . 2.9 m120 -83.65 -44.06 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 14.1 t80 -40.97 -56.77 2.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -46.9 -34.45 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.38 -58.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 24.0 t80 -43.17 -41.65 3.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -70.47 -44.79 67.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -57.71 -42.37 83.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.466 ' HA ' HD12 ' A' ' 155' ' ' LEU . 86.0 mt -43.4 -53.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.146 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.8 m -41.25 -34.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -83.61 -39.68 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 152' ' ' ILE . 92.8 mt -56.2 -45.52 79.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.98 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -50.36 -43.66 54.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.407 ' HB3' HD21 ' A' ' 53' ' ' LEU . 22.6 mtp85 -59.86 -30.84 69.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.72 -45.65 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.6 p -57.84 -29.95 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.06 -46.48 88.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -100.86 40.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 166' ' ' LEU . 10.6 p80 -58.54 -41.05 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.414 ' HG2' ' NE2' ' A' ' 162' ' ' HIS . 17.0 mmmt -55.32 -27.57 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 79.9 mt -90.29 -57.07 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.3 OUTLIER -84.17 18.07 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 162' ' ' HIS . 12.1 mt 34.32 52.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 49.1 mmm -146.34 108.73 4.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.437 HG22 ' ND1' ' A' ' 162' ' ' HIS . 73.9 p -93.94 151.19 19.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.79 -37.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.89 -49.09 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 168' ' ' THR . 41.1 m-20 -54.54 -42.8 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.43 -48.05 79.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 p -58.55 -39.36 80.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.31 -37.48 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.175 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.91 -15.44 63.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -108.16 -8.43 15.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.556 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -56.73 -47.29 99.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.871 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.2 Cg_exo -48.0 -62.12 0.49 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.511 HG23 ' CA ' ' A' ' 102' ' ' ALA . 16.7 m -67.85 -62.97 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.129 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 179' ' ' THR . 48.2 mt -33.2 -44.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.497 ' CE ' ' CD2' ' A' ' 114' ' ' HIS . 31.2 mtp -146.86 140.2 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.426 ' NE ' ' OH ' ' A' ' 111' ' ' TYR . 9.7 ptp180 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.827 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 200' ' ' VAL . 65.3 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.831 0.348 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -43.03 -69.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -67.16 -39.36 86.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 t -43.45 -40.37 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.823 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 196' ' ' ILE . 66.4 t -52.58 -58.25 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.16 -39.96 82.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -58.04 -52.4 65.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.4 m -49.51 -61.77 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.589 ' HE1' HD22 ' A' ' 133' ' ' LEU . 10.0 m-85 -33.83 -52.67 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.435 HG12 HG23 ' A' ' 152' ' ' ILE . 38.8 mt -62.61 -47.7 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -55.92 -47.63 77.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.9 mm-40 -109.84 31.67 5.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 2.4 t -63.55 -21.42 66.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.683 ' NE2' ' CD2' ' A' ' 213' ' ' TYR . 7.8 mm100 -86.53 -51.17 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -45.04 -35.3 2.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -52.76 -62.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -108.07 -55.06 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.683 ' CD2' ' NE2' ' A' ' 209' ' ' GLN . 54.7 m-85 -56.63 -14.57 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 52.37 38.75 25.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.41 150.68 33.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 216' ' ' GLU . 2.8 mp0 -49.95 153.3 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.915 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.419 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 93.2 mt -73.69 126.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.092 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.2 m -104.81 177.68 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 53.5 Cg_endo . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.802 0.251 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.434 ' O ' HG22 ' A' ' 31' ' ' VAL . 26.2 tp -53.22 -53.61 48.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HA ' HG11 ' A' ' 143' ' ' VAL . 18.5 pt20 -44.37 -33.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 11.5 t70 -79.24 -48.8 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.4 mt -57.03 -43.95 82.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' LEU . 20.7 m -82.06 -179.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -117.61 147.52 42.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.14 -45.03 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -52.23 -43.09 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.75 108.37 13.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.552 0.691 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -39.39 6.55 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HD2' ' A' ' 38' ' ' PRO . 22.3 mt -73.99 132.94 79.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.648 0.737 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.76 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 0.0 112.363 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.621 HD11 ' HE3' ' A' ' 43' ' ' LYS . 2.2 tm? -45.1 -48.02 12.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.511 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 82.0 t80 -43.2 -70.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.932 HG13 HD11 ' A' ' 97' ' ' LEU . 66.2 t -44.17 -50.48 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.069 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -49.13 -53.89 18.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.621 ' HE3' HD11 ' A' ' 39' ' ' LEU . 12.2 mmtp -52.15 -40.76 61.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.0 m -66.53 -47.47 72.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.56 -46.21 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.71 -43.96 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 93' ' ' VAL . 63.8 t80 -50.78 -63.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.5 mt -39.67 -62.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -49.01 -50.3 36.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.44 -39.0 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.9 p -88.65 25.43 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.29 137.91 1.89 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.508 HD11 HG22 ' A' ' 158' ' ' VAL . 6.1 tp -113.47 47.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.773 0.32 . . . . 0.0 110.874 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.6 p -132.75 37.45 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -96.72 119.61 35.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.1 tt0 -37.93 123.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 60' ' ' ARG . . . 34.17 73.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.528 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.75 -24.73 63.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -102.59 -57.04 2.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HG3' HG23 ' A' ' 61' ' ' VAL . 15.7 ptm180 -46.65 -33.06 3.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.614 HG23 ' HG3' ' A' ' 60' ' ' ARG . 48.7 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.142 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.795 0.331 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.1 -45.33 32.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -73.9 -30.94 62.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -62.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -50.63 -34.47 26.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.48 -44.6 89.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -79.06 -46.59 17.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 76' ' ' ASP . 93.2 mttt -59.79 -66.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -40.26 -47.01 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 42.9 t80 -64.29 -37.91 89.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 73' ' ' LYS . 37.6 m-20 -68.74 -58.85 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -53.38 -29.25 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.06 149.88 14.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.23 -17.72 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -83.43 50.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 -177.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -149.26 136.31 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.7 mt -81.28 -46.78 14.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.5 t -44.14 -54.16 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.1 t -55.57 -43.28 75.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.7 mmm -55.95 -28.83 58.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 51.97 45.94 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.99 164.84 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 t -75.22 128.16 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.3 t -40.31 -51.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -38.72 -53.01 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.15 -60.93 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.506 HG21 ' CD2' ' A' ' 47' ' ' PHE . 94.4 t -47.26 -51.23 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.75 -45.05 58.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.12 -63.35 3.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.78 -42.15 5.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.884 0.373 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.932 HD11 HG13 ' A' ' 41' ' ' VAL . 43.3 tp -48.69 -45.57 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -69.62 -51.17 37.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -40.26 -39.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -58.99 -47.46 85.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.771 ' HB2' HG21 ' A' ' 179' ' ' THR . 51.6 m-85 -62.27 -48.87 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.428 ' N ' HG23 ' A' ' 179' ' ' THR . . . -57.15 -37.13 71.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -34.8 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -41.65 141.29 1.23 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -19.06 36.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.693 2.262 . . . . 0.0 112.357 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -134.14 152.55 78.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.62 26.02 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.708 2.272 . . . . 0.0 112.342 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.2 tp -44.25 -44.26 7.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.49 123.94 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.617 0.723 . . . . 0.0 111.162 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.699 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.8 Cg_endo -69.77 146.37 59.92 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.345 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.449 ' CD2' ' NE2' ' A' ' 114' ' ' HIS . 73.7 m-85 -66.26 -32.55 74.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m -61.14 -15.11 30.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.699 HD12 ' HG2' ' A' ' 110' ' ' PRO . 27.3 mt -122.0 28.47 7.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.476 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -73.0 -60.79 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.569 0.7 . . . . 0.0 110.826 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.76 -31.82 19.79 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.694 2.263 . . . . 0.0 112.38 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -59.96 -28.86 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.0 -46.66 33.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 121' ' ' ALA . 12.0 mt -65.12 -55.2 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -45.72 -37.19 5.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.53 -21.08 32.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -86.63 -18.44 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -89.81 -8.85 51.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 128' ' ' GLU . 82.4 mt -56.81 130.17 78.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 111.141 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -46.08 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.12 116.94 10.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.44 ' HG2' HG21 ' A' ' 217' ' ' ILE . 7.4 tppt? -50.99 -49.55 60.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.0 m -53.57 -55.7 23.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.53 ' HB2' HG21 ' A' ' 123' ' ' ILE . 14.2 mt-10 -60.38 -38.95 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -57.75 -49.97 74.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.76 -60.52 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -43.58 -50.15 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.77 78.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 mt -74.57 -27.26 60.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -78.0 -27.16 48.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.0 pt-20 -86.11 -32.99 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.418 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 84.9 mt -74.2 -38.01 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.8 p -62.05 -11.81 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -74.96 -43.09 56.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -61.55 -32.97 73.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -40.52 137.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.513 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 4.7 t60 -39.33 141.16 0.69 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.849 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.513 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.78 -18.99 36.62 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 28' ' ' GLN . 92.1 t -89.86 -37.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.91 -40.26 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.525 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 6.2 t80 -48.69 -51.69 27.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.92 -51.85 21.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.0 -67.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 38.5 t80 -40.21 -40.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.525 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 4.6 mmp_? -66.39 -45.1 81.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.07 -48.15 77.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.99 -64.75 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.751 ' HA ' HD12 ' A' ' 155' ' ' LEU . 91.6 mt -42.82 -53.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.3 m -40.26 -36.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.121 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -78.9 -36.89 41.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.751 HD12 ' HA ' ' A' ' 152' ' ' ILE . 53.1 mt -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -47.21 -47.37 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -55.57 -37.65 68.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.549 HG11 HD21 ' A' ' 172' ' ' LEU . 75.7 t -68.94 -50.41 54.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.2 p -55.23 -37.8 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -50.7 -39.87 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -108.46 40.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 167' ' ' MET . 17.9 p80 -58.67 -35.68 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -58.16 -31.99 67.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.55 -57.85 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 166' ' ' LEU . 2.6 m-20 -83.39 17.23 2.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 162' ' ' HIS . 22.0 mt 34.96 50.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.695 ' CE ' HD23 ' A' ' 172' ' ' LEU . 39.4 mmm -146.42 113.83 6.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 169' ' ' ALA . 9.2 p -95.76 153.36 17.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.97 -49.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.07 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -50.17 74.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -53.34 -44.39 68.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.695 HD23 ' CE ' ' A' ' 167' ' ' MET . 16.5 mt -61.69 -41.62 97.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -59.38 -48.9 79.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 42.7 mt -62.74 -34.57 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 40.9 m -69.51 -22.86 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -102.25 -5.77 23.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.583 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -55.1 -46.05 99.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.609 0.718 . . . . 0.0 110.97 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.8 Cg_exo -47.95 -63.12 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 0.0 112.363 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.771 HG21 ' HB2' ' A' ' 101' ' ' PHE . 87.1 m -65.44 -61.4 2.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 179' ' ' THR . 78.6 mt -34.24 -42.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 8.7 ptp -166.6 142.24 4.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.846 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.88 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 197' ' ' HIS . 51.1 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.814 0.34 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 196' ' ' ILE . 39.1 m-70 -35.4 -61.19 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -56.77 -48.1 78.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 m -49.74 -36.97 27.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.21 -70.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.166 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.17 -53.37 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.512 ' CD ' HE21 ' A' ' 206' ' ' GLN . 0.0 OUTLIER -38.69 -48.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 204' ' ' PHE . 60.8 m -58.79 -62.12 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.1 m-85 -34.41 -40.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 152' ' ' ILE . 70.6 mt -78.67 -52.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.512 HE21 ' CD ' ' A' ' 202' ' ' GLU . 7.5 mt-30 -48.57 -44.92 37.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.6 mm-40 -113.31 35.4 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 6.1 t -64.07 -15.98 60.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.466 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 12.8 mm-40 -89.07 -53.68 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.69 -36.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -53.07 -63.47 1.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -107.53 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.466 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 89.4 m-85 -61.27 -9.98 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 48.5 t30 47.24 43.86 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.63 145.87 28.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.519 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -43.79 143.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.471 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 75.7 mt -63.35 131.15 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.118 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.1 m -112.26 173.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.159 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 219' ' ' GLU . 5.0 tm-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.851 0.271 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' HG22 ' A' ' 31' ' ' VAL . 17.1 tp -52.49 -45.1 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.492 ' HB3' HG21 ' A' ' 143' ' ' VAL . 15.1 pt20 -49.65 -32.04 12.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.96 -41.47 20.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -63.03 -41.86 99.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.771 HG11 ' O ' ' A' ' 36' ' ' PRO . 23.6 m -85.27 164.8 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 p -110.63 147.91 33.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.57 -45.02 4.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -58.58 -41.14 85.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -130.99 97.62 20.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.771 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.9 Cg_endo -69.68 -47.44 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.377 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.425 HG23 ' HD2' ' A' ' 38' ' ' PRO . 43.8 mt -64.09 132.41 95.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.73 . . . . 0.0 111.109 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 147' ' ' VAL . 53.2 Cg_endo -69.78 140.05 41.67 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -57.76 -51.32 70.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.42 ' CD1' ' CD2' ' A' ' 75' ' ' PHE . 28.7 t80 -42.13 -64.42 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 97' ' ' LEU . 71.7 t -46.6 -54.32 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.122 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -50.3 -55.27 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.55 ' HG2' HD13 ' A' ' 39' ' ' LEU . 38.1 mmtt -47.26 -40.97 17.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.464 ' HB2' HD13 ' A' ' 97' ' ' LEU . 81.8 m -63.62 -46.37 86.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 ' CG ' ' A' ' 154' ' ' HIS . 35.1 t -64.89 -56.35 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.28 -45.38 88.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 93' ' ' VAL . 63.6 t80 -42.92 -60.17 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.0 mt -51.34 -48.88 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -56.07 -47.74 77.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -44.55 -47.52 10.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.3 p -84.04 29.84 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.21 163.11 9.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.403 HD21 ' C ' ' A' ' 157' ' ' ARG . 3.6 tp -103.03 37.08 2.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.346 . . . . 0.0 110.939 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.52 40.68 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.448 HG21 HD21 ' A' ' 58' ' ' LEU . 39.6 m -88.88 133.85 34.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.191 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -98.13 110.82 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.37 72.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 55' ' ' THR . 20.3 mt -114.79 119.62 37.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 62.67 28.96 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB2' ' HE1' ' A' ' 167' ' ' MET . 19.4 ttm-85 -129.9 -36.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.815 0.34 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.42 -54.04 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.709 ' HA ' HD12 ' A' ' 71' ' ' ILE . 29.5 mt-30 -60.54 -32.63 71.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -67.99 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -52.92 -34.72 56.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 68' ' ' GLN . 49.0 mt -56.68 -40.47 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -85.34 -59.76 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -46.8 -59.66 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.448 ' CB ' HD12 ' A' ' 81' ' ' ILE . 40.1 mm-40 -49.71 -51.58 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CD2' ' CD1' ' A' ' 40' ' ' PHE . 58.2 t80 -58.59 -37.35 75.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.46 -60.1 3.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -58.76 -38.83 79.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.22 111.5 5.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -32.41 72.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.4 m-80 -38.88 -36.91 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.448 HD12 ' CB ' ' A' ' 74' ' ' GLN . 13.7 tt -34.51 146.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 83' ' ' LEU . 6.6 t-20 -134.89 100.68 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 82' ' ' ASN . 56.2 mt -34.35 -54.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.18 -47.31 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' ASN . 3.3 t -63.04 -48.1 80.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.448 ' HB3' HG13 ' A' ' 88' ' ' VAL . 7.7 mmm -57.33 -35.5 69.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 61.33 49.96 5.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 86' ' ' MET . 35.5 m -83.45 171.1 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.114 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.7 p -66.28 123.68 20.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 55' ' ' THR . 91.4 t -44.97 -56.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.109 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -37.78 -41.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.51 -60.47 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 47' ' ' PHE . 99.1 t -45.05 -51.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.9 -44.23 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -50.34 11.68 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.449 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.22 -51.61 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.53 HD11 HG13 ' A' ' 41' ' ' VAL . 32.9 tp -43.77 -44.51 6.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 37.8 mtmt -72.85 -47.7 43.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.15 -45.63 4.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -57.43 -46.92 83.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -57.0 -44.24 82.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.54 90.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -40.48 76.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.4 mt -37.23 145.39 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -18.99 36.38 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.709 2.272 . . . . 0.0 112.306 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.8 152.27 70.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.601 0.715 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.4 Cg_endo -69.77 129.01 16.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 107' ' ' PRO . 11.2 tp -34.45 -45.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.2 mt -96.58 121.7 59.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 111.162 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 151.71 69.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.402 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.97 -22.35 64.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.2 m -68.77 -21.65 64.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 mt -113.89 28.69 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.501 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -75.68 -62.94 0.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.81 -23.38 30.64 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.613 2.209 . . . . 0.0 112.334 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.4 -32.48 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.3 mt -75.15 -27.09 59.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.14 -51.02 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.95 -25.9 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.407 ' HA ' HD11 ' A' ' 123' ' ' ILE . . . -91.94 -29.45 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -73.08 -21.06 60.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -92.27 20.32 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 124' ' ' PRO . 87.7 mt -84.33 134.16 43.52 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 111.154 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 123' ' ' ILE . 54.1 Cg_endo -69.71 -44.35 2.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.28 . . . . 0.0 112.381 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 126' ' ' LYS . 24.1 t0 -69.18 95.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.604 ' HE3' HG21 ' A' ' 217' ' ' ILE . 44.1 tttp -38.11 -43.67 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.0 m -58.72 -66.65 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -46.23 -43.55 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 123' ' ' ILE . 20.6 ttp180 -48.07 -42.15 27.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.2 mt -73.12 -52.86 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -49.08 -52.71 24.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.4 -57.61 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.435 HD22 ' HE1' ' A' ' 204' ' ' PHE . 11.9 mt -60.25 -35.22 74.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 137' ' ' VAL . 29.3 tttm -61.61 -30.8 70.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.14 -44.94 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.59 -32.71 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 134' ' ' LYS . 10.1 p -68.6 -16.18 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -72.1 -32.06 66.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -68.55 -30.3 69.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 141' ' ' HIS . 8.4 m-85 -43.59 138.45 2.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -37.25 141.37 0.43 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.556 0.693 . . . . 0.0 110.851 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.3 Cg_endo -69.78 -17.04 37.72 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 28' ' ' GLN . 60.4 t -97.71 -32.34 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -86.76 -39.16 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -49.54 -47.7 48.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.57 -54.53 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 151' ' ' VAL . 61.1 t -60.71 -56.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 45.9 t80 -46.76 -48.5 20.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -65.05 -48.51 73.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -54.74 -41.98 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 147' ' ' VAL . 62.6 t -59.52 -59.55 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.936 HG23 HG12 ' A' ' 205' ' ' ILE . 73.0 mt -47.67 -53.89 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' ILE . 24.4 m -36.83 -36.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.495 ' CG ' HG13 ' A' ' 45' ' ' VAL . 69.2 t60 -81.75 -39.41 24.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 152' ' ' ILE . 71.4 mt -56.93 -40.13 75.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.858 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.463 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 43.8 t-20 -56.84 -41.74 78.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.403 ' C ' HD21 ' A' ' 53' ' ' LEU . 23.1 mtp180 -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.528 HG13 HD22 ' A' ' 165' ' ' ASN . 67.2 t -65.21 -54.07 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.4 p -46.46 -32.78 3.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' A' ' 156' ' ' ASN . 1.5 mt-30 -67.18 -46.65 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -88.15 39.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -67.91 -20.37 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -68.83 -30.81 69.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 50.4 mt -102.47 -53.72 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.528 HD22 HG13 ' A' ' 158' ' ' VAL . 1.5 m-20 -66.38 -23.43 66.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 34.8 mt 65.01 39.95 5.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.426 ' HE1' ' HB2' ' A' ' 60' ' ' ARG . 42.4 mmm -150.11 118.98 6.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.3 p -98.16 172.67 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -56.96 -38.48 73.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -59.69 -47.19 86.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -63.28 -39.48 94.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 169' ' ' ALA . 10.9 mt -66.57 -38.54 87.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 t -61.29 -41.4 96.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.5 mt -77.85 -34.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 42.3 m -68.95 -14.85 63.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.513 ' CE2' ' HG2' ' A' ' 98' ' ' LYS . 13.3 m-85 -111.48 -5.76 14.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.578 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -54.55 -46.33 99.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -47.96 -53.36 6.74 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.306 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 26.2 m -78.77 -68.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 33.0 mt -34.22 -64.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.554 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 1.0 OUTLIER -112.33 96.9 6.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 181' ' ' MET . 33.6 ttm-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.633 0.73 . . . . 0.0 110.865 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 200' ' ' VAL . 32.0 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.881 0.372 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -37.83 -47.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.72 -51.67 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.9 m -40.83 -42.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 121' ' ' ALA . 57.9 t -40.44 -71.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 202' ' ' GLU . 85.5 t -60.08 -61.11 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 201' ' ' VAL . 20.9 tt0 -35.77 -42.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.3 m -62.72 -59.93 4.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.2 m-85 -33.98 -47.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.936 HG12 HG23 ' A' ' 152' ' ' ILE . 47.4 mt -71.66 -48.71 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -51.84 -45.34 63.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.469 ' NE2' ' HB2' ' A' ' 210' ' ' PHE . 6.4 mm100 -113.74 34.1 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.539 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 21.6 t -63.54 -21.85 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.489 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 47.3 mm-40 -84.5 -54.54 4.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.469 ' HB2' ' NE2' ' A' ' 207' ' ' GLN . 1.4 t80 -41.13 -34.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.539 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 22.3 m-85 -52.62 -63.4 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -106.11 -56.35 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.489 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 72.1 m-85 -56.92 -17.16 8.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.915 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 51.67 40.1 26.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.925 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.07 135.77 15.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -42.5 137.08 2.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 0.0 110.936 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.604 HG21 ' HE3' ' A' ' 126' ' ' LYS . 68.1 mt -48.43 127.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.409 HG22 ' OE1' ' A' ' 207' ' ' GLN . 35.8 m -89.42 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.798 0.249 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' VAL . 27.8 tp -62.44 -45.61 92.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.593 ' HA ' HG11 ' A' ' 143' ' ' VAL . 4.9 pt20 -46.79 -31.57 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.97 -44.05 27.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.14 -42.09 96.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 27' ' ' LEU . 32.8 m -90.81 158.21 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -100.48 150.53 22.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -45.89 -46.17 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -53.7 -40.32 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 15.2 mmtp -133.75 94.73 18.45 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.7 Cg_endo -69.76 -35.95 11.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.704 2.269 . . . . 0.0 112.365 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 ' HG3' ' A' ' 42' ' ' GLU . 18.9 mt -74.22 131.33 80.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 111.113 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' HG22 ' A' ' 147' ' ' VAL . 53.9 Cg_endo -69.71 121.56 8.26 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.713 2.276 . . . . 0.0 112.345 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.491 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -44.67 -53.88 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -38.72 -68.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.885 HG13 HD11 ' A' ' 97' ' ' LEU . 79.2 t -45.41 -54.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HG3' HG22 ' A' ' 37' ' ' ILE . 88.5 mt-10 -45.94 -60.9 1.99 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 54.5 mmtt -46.94 -39.29 12.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.543 ' HB2' HD13 ' A' ' 97' ' ' LEU . 94.6 m -68.64 -52.49 30.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.93 -32.65 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -82.64 -36.29 26.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -63.15 -55.87 21.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.98 ' O ' HG22 ' A' ' 51' ' ' THR . 23.1 mt -47.75 -52.47 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -70.94 -24.32 62.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.84 -17.71 59.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.98 HG22 ' O ' ' A' ' 48' ' ' ILE . 8.4 t -91.98 26.33 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.54 -34.4 3.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 48' ' ' ILE . 4.7 tp 68.21 53.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.3 p -114.65 -25.33 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -42.74 129.52 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 57' ' ' GLY . 7.3 mp0 -74.21 140.96 45.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 33.93 37.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 59' ' ' TYR . 1.2 pp -38.22 -32.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.765 ' N ' HD12 ' A' ' 58' ' ' LEU . 15.1 m-85 -82.03 -61.83 1.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG3' HG23 ' A' ' 61' ' ' VAL . 11.5 ptm180 -55.33 -14.02 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 60' ' ' ARG . 88.4 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.854 0.359 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.13 -58.65 6.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.823 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.809 ' HA ' HD12 ' A' ' 71' ' ' ILE . 1.2 mp0 -58.19 -34.95 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -50.56 -62.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.3 p30 -58.9 -41.26 86.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 68' ' ' GLN . 70.7 mt -46.61 -41.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.56 -57.7 2.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -49.09 -56.24 9.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -54.39 -46.54 73.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -62.38 -35.16 78.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.85 -53.31 52.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -74.42 -24.82 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -130.6 89.62 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.6 -34.63 75.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.68 39.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.724 HD11 ' SD ' ' A' ' 86' ' ' MET . 9.6 tt -79.99 154.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 81' ' ' ILE . 1.9 t-20 -124.79 94.56 4.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -41.15 -49.12 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.955 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.3 t -47.41 -44.62 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 t -60.18 -40.49 90.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.724 ' SD ' HD11 ' A' ' 81' ' ' ILE . 77.9 mtp -63.14 -37.97 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 62.95 47.4 4.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.0 m -84.76 171.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.7 p -68.71 118.96 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.9 t -36.56 -54.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -40.04 -47.78 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 -63.08 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.4 t -50.05 -46.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.84 -50.66 33.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -54.16 6.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.64 -40.85 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.885 HD11 HG13 ' A' ' 41' ' ' VAL . 11.1 tp -53.24 -56.31 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.463 ' CG ' ' CE2' ' A' ' 176' ' ' PHE . 6.1 mtmp? -60.34 -46.27 90.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.33 -46.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 7.3 t80 -57.41 -53.19 60.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -51.46 -41.01 60.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.53 -36.47 81.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -62.23 -38.75 90.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' ASP . 95.9 mt -34.89 144.64 0.21 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 110.934 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.28 36.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -139.26 153.82 71.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.77 128.65 16.32 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 2.263 . . . . 0.0 112.357 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 107' ' ' PRO . 23.8 tp -34.97 -39.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.9 mt -98.46 121.41 56.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.77 144.19 53.21 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -59.38 -30.76 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.9 p -61.36 -16.35 45.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 117' ' ' LEU . 58.1 mt -119.45 29.92 7.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.51 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -76.39 -63.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.74 . . . . 0.0 110.855 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.2 Cg_endo -69.73 -20.54 34.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.724 2.283 . . . . 0.0 112.364 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.6 -34.02 71.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 113' ' ' LEU . 3.1 mt -73.36 -37.09 66.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 121' ' ' ALA . 5.1 mt -77.49 -53.21 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -43.8 -32.37 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.42 -31.74 21.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -71.72 -19.74 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -92.92 26.25 2.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.949 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 128' ' ' GLU . 72.1 mt -92.53 129.87 39.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.606 0.717 . . . . 0.0 111.138 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -44.36 2.11 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.63 2.22 . . . . 0.0 112.35 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.459 ' HB2' ' CG ' ' A' ' 128' ' ' GLU . 0.6 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -37.36 -57.99 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.9 m -46.66 -47.85 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.595 ' HB2' HG21 ' A' ' 123' ' ' ILE . 37.5 mm-40 -64.38 -48.61 74.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -45.97 -57.46 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.583 HD13 ' OE1' ' A' ' 207' ' ' GLN . 16.3 mt -63.33 -67.12 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 130' ' ' LEU . 21.1 m80 -34.38 -40.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.12 -63.25 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.61 -30.27 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.644 ' O ' HG12 ' A' ' 137' ' ' VAL . 64.8 tttt -65.96 -32.77 74.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -87.93 -47.65 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.3 mt -57.55 -26.07 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.174 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 134' ' ' LYS . 13.5 p -71.7 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -76.39 -34.75 58.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -64.07 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.936 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.2 m-85 -40.7 129.73 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.596 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -33.95 141.11 0.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.7 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.596 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.75 -13.75 35.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.725 2.283 . . . . 0.0 112.352 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 28' ' ' GLN . 95.4 t -97.84 -35.83 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.071 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.53 -39.61 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 1.4 t80 -47.22 -47.87 24.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.81 66.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 151' ' ' VAL . 83.4 t -70.14 -57.99 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 41.3 t80 -48.4 -46.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -62.06 -51.18 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -53.66 -47.73 70.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 147' ' ' VAL . 97.8 t -54.77 -58.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.64 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 86.3 mt -46.78 -52.09 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.6 m -41.36 -37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -80.72 -35.13 33.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.728 HD13 HD11 ' A' ' 205' ' ' ILE . 97.0 mt -57.81 -42.99 85.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -44.52 66.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -55.3 -43.4 74.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.656 HG11 HD21 ' A' ' 172' ' ' LEU . 84.5 t -63.35 -42.32 95.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 p -67.53 -27.11 66.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -69.97 -40.42 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -102.14 50.38 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.469 ' CD2' HG22 ' A' ' 168' ' ' THR . 0.6 OUTLIER -80.15 41.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.833 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -122.21 -43.47 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 mt -87.91 -40.97 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.158 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.84 -23.69 18.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 mt 63.99 48.27 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 37.8 mmm -132.2 97.14 4.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.469 HG22 ' CD2' ' A' ' 162' ' ' HIS . 72.3 p -85.36 167.85 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -52.32 -41.33 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.054 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.53 -56.42 20.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -50.69 -42.73 57.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 169' ' ' ALA . 7.4 mt -63.09 -43.95 97.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.6 t -57.9 -46.07 85.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.49 -35.16 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.9 t -68.59 -26.17 65.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 98' ' ' LYS . 16.7 m-85 -101.18 -6.58 24.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.589 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -54.61 -45.8 99.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.562 0.696 . . . . 0.0 110.907 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.1 Cg_exo -48.01 -50.18 12.39 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.268 . . . . 0.0 112.304 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 180' ' ' LEU . 20.8 m -81.87 -65.55 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 26.0 mt -33.45 -59.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.565 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 1.4 ttm -114.58 116.62 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.868 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 200' ' ' VAL . 82.3 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.821 0.343 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -40.37 -51.65 2.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.15 -55.05 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 m -45.32 -38.62 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 196' ' ' ILE . 94.0 t -45.17 -70.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.102 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.9 t -64.74 -60.37 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 201' ' ' VAL . 22.9 tt0 -34.59 -45.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 84.2 m -60.16 -59.15 5.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.2 m-85 -34.62 -54.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.728 HD11 HD13 ' A' ' 155' ' ' LEU . 50.5 mt -62.66 -55.52 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -46.28 -54.99 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.935 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.583 ' OE1' HD13 ' A' ' 130' ' ' LEU . 16.5 mm-40 -99.26 27.25 5.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.599 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 3.5 t -61.37 -14.42 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' TYR . 20.9 mm-40 -95.32 -57.53 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.495 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.6 t80 -39.67 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.599 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -52.9 -62.29 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -128.2 -26.78 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 215' ' ' GLY . 27.7 m-85 -83.21 30.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 213' ' ' TYR . 27.5 m-20 33.64 33.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -57.26 146.27 36.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.34 133.28 34.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.48 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 85.5 mt -48.29 122.82 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.1 m -111.49 166.31 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.811 0.255 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.72 -52.4 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.954 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.675 ' CB ' HG21 ' A' ' 143' ' ' VAL . 21.0 pt20 -44.9 -30.13 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.99 -45.03 15.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.05 -44.76 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 36' ' ' PRO . 12.2 m -83.0 164.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -114.2 164.7 13.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.21 63.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -51.66 -54.13 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 23.1 mmtp -119.69 96.41 49.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 0.0 110.883 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.464 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.1 Cg_endo -69.79 -35.94 11.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.238 . . . . 0.0 112.328 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.52 HG23 ' HD2' ' A' ' 38' ' ' PRO . 36.5 mt -85.73 134.71 39.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 0.0 111.161 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.0 Cg_endo -69.77 150.48 68.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -68.66 -47.2 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -40.79 -58.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 97' ' ' LEU . 96.8 t -55.28 -62.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -45.8 -62.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -50.74 -37.25 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 68.8 m -69.86 -31.98 70.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG13 ' CG ' ' A' ' 154' ' ' HIS . 84.4 t -78.68 -60.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.46 -40.72 60.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.783 ' CE1' HG21 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -51.04 -41.1 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mt -59.9 -64.13 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -33.7 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.58 -24.64 56.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.1 p -107.7 29.23 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.08 134.66 5.21 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.58 -10.65 14.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.931 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.0 m -91.68 40.9 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 56' ' ' GLU . 6.0 m -92.45 113.78 26.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.7 tt0 -33.98 121.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.27 69.3 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.901 ' O ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -66.49 -9.56 35.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.93 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.685 ' CE2' HD21 ' A' ' 58' ' ' LEU . 8.9 m-85 -122.75 -37.75 2.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -74.1 -40.2 62.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 69' ' ' ASP . 45.4 m . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.788 0.328 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -35.72 -59.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 71' ' ' ILE . 36.3 mt-30 -52.65 -38.4 60.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.9 t70 -47.84 -56.69 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.8 p30 -68.94 -36.08 77.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 68' ' ' GLN . 57.8 mt -51.09 -42.36 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -82.92 -54.01 5.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -54.39 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -45.04 -46.02 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.58 -31.37 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.15 -48.05 38.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.35 -30.15 65.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.1 93.18 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.89 37.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.84 HD11 ' SD ' ' A' ' 86' ' ' MET . 10.6 tt -76.58 153.13 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 83' ' ' LEU . 2.3 t-20 -124.62 83.87 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 82' ' ' ASN . 26.4 mt -34.35 -47.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.22 -54.79 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -52.35 -42.01 63.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.84 ' SD ' HD11 ' A' ' 81' ' ' ILE . 75.2 mtp -60.9 -36.39 79.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 59.4 45.0 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 160.97 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.183 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 29.0 p -56.12 118.18 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.121 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.1 t -41.52 -54.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -43.23 -35.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 71' ' ' ILE . . . -55.1 -59.3 4.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.783 HG21 ' CE1' ' A' ' 47' ' ' PHE . 89.6 t -50.39 -51.03 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -48.39 -45.34 35.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.32 -55.39 18.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.469 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.8 -40.77 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 41' ' ' VAL . 14.5 tp -48.75 -39.95 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.505 ' CG ' ' CE1' ' A' ' 176' ' ' PHE . 42.6 mtmt -74.41 -45.95 43.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.13 -34.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 6.9 t80 -68.48 -48.09 65.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -56.66 -41.29 76.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.43 ' HB2' HG23 ' A' ' 179' ' ' THR . . . -65.75 -37.44 86.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.44 -35.4 73.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.3 mt -39.2 144.56 0.44 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -29.12 24.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.91 154.14 81.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 143.8 51.97 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.5 tp -48.16 -58.46 4.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.95 131.17 54.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.656 0.741 . . . . 0.0 111.106 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 162.09 43.41 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.317 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -79.87 -25.78 40.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -69.74 -17.03 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 117' ' ' LEU . 43.3 mt -122.42 31.92 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.474 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -74.28 -61.76 1.14 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.582 0.706 . . . . 0.0 110.828 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.5 Cg_endo -69.77 -10.73 29.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -68.01 -44.03 77.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 113' ' ' LEU . 4.3 mp -67.23 -34.93 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.545 HD11 ' CE1' ' A' ' 197' ' ' HIS . 9.6 mt -77.45 -58.5 3.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -42.76 -30.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.46 -31.76 18.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -69.08 -21.98 64.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -90.21 19.06 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.4 HG23 ' HD2' ' A' ' 124' ' ' PRO . 66.8 mt -85.53 132.71 43.85 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 0.0 111.099 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.79 -44.57 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.319 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.3 m-20 -64.36 95.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.1 ttpt -35.58 -53.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.4 m -57.34 -61.37 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.121 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -46.38 -46.23 18.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.863 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -48.35 -51.99 23.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.55 -60.1 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -40.96 -53.85 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.73 -49.57 65.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.05 -28.02 69.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 137' ' ' VAL . 44.4 tttt -74.66 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -86.1 -32.43 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.66 -21.71 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 134' ' ' LYS . 10.8 p -87.9 -7.72 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -77.04 -38.6 52.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -12.8 60.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.68 ' HZ ' HD11 ' A' ' 117' ' ' LEU . 2.8 m-85 -53.68 135.92 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.594 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.2 t-80 -34.49 141.51 0.25 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.594 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.77 -14.53 36.18 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.665 2.244 . . . . 0.0 112.383 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.675 HG21 ' CB ' ' A' ' 28' ' ' GLN . 96.7 t -95.36 -25.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.105 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -94.84 -34.59 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -64.87 -54.42 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.475 ' O ' HD11 ' A' ' 37' ' ' ILE . 6.7 p-10 -45.52 -45.39 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.511 HG22 HG12 ' A' ' 37' ' ' ILE . 11.7 t -77.16 -63.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.574 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 27.8 t80 -37.23 -41.4 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -64.77 -54.35 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -53.31 -51.14 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.6 t -48.11 -56.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.684 HG23 HG12 ' A' ' 205' ' ' ILE . 89.0 mt -55.83 -49.25 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.7 m -42.88 -31.03 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.526 ' CG ' HG13 ' A' ' 45' ' ' VAL . 86.5 t60 -85.17 -42.99 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 152' ' ' ILE . 83.0 mt -54.93 -46.58 74.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -51.76 -48.3 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -53.55 -38.22 63.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.15 -45.67 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.165 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.2 p -58.35 -21.51 50.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -51.62 -53.75 35.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.483 ' HB3' HD12 ' A' ' 164' ' ' ILE . 10.8 mm100 -102.32 37.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.508 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 24.5 p80 -49.97 -27.67 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.508 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 3.9 mmmp? -70.12 -32.58 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 161' ' ' GLN . 92.2 mt -82.66 -65.32 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -2.3 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.5 mt 55.25 46.81 22.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 25.6 mtp -144.69 116.92 8.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.844 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.456 HG22 ' CG ' ' A' ' 162' ' ' HIS . 39.1 p -101.15 159.16 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.107 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.29 -35.03 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.77 -48.97 57.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -55.22 -36.11 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 14.0 mt -72.56 -43.3 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -58.11 -36.91 73.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.6 mt -77.8 -35.85 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.6 -18.47 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.505 ' CE1' ' CG ' ' A' ' 98' ' ' LYS . 11.6 m-85 -108.71 -8.83 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.676 ' CD1' ' NE2' ' A' ' 198' ' ' GLN . 0.4 OUTLIER -54.34 -46.42 99.0 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.566 0.698 . . . . 0.0 110.917 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -47.95 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 3.9 m -69.1 -59.45 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 56.7 mt -33.83 -47.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 34.3 mmm -143.0 136.53 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.851 -179.91 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 197' ' ' HIS . 96.8 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.851 0.358 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.545 ' CE1' HD11 ' A' ' 118' ' ' LEU . 53.1 m-70 -36.74 -62.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.676 ' NE2' ' CD1' ' A' ' 177' ' ' TRP . 83.9 mm-40 -43.64 -54.17 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 m -50.61 -36.94 37.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' A' ' 117' ' ' LEU . 23.2 t -54.81 -71.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.09 -54.27 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -45.6 -51.77 11.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 204' ' ' PHE . 93.3 m -50.06 -63.02 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.4 m-85 -34.25 -53.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.684 HG12 HG23 ' A' ' 152' ' ' ILE . 67.1 mt -62.11 -54.87 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -49.06 -57.55 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.465 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 10.3 mm-40 -96.52 28.48 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.503 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 3.1 t -61.86 -20.66 63.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 213' ' ' TYR . 7.6 mm100 -88.57 -51.44 5.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -44.75 -37.97 4.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -48.88 -63.07 1.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -104.05 -54.29 2.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 209' ' ' GLN . 60.2 m-85 -56.82 -36.18 69.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.7 t30 73.25 36.23 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.21 174.72 49.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.98 142.71 53.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.465 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 92.9 mt -68.25 137.87 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.62 168.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.22 0 CA-C-O 120.821 0.259 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' VAL . 21.1 tp -54.6 -43.82 72.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.785 ' HA ' HG11 ' A' ' 143' ' ' VAL . 3.4 pt20 -51.06 -37.35 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.19 -49.71 26.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.3 -46.43 79.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 27' ' ' LEU . 5.2 m -91.08 168.41 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.5 p -112.33 162.88 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.72 -43.94 73.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.3 -45.46 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -128.93 86.15 58.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -34.34 14.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.39 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.1 mt -78.73 129.2 74.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 111.143 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.658 2.239 . . . . 0.0 112.334 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.495 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -47.69 -48.61 29.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.409 ' CZ ' HG22 ' A' ' 71' ' ' ILE . 90.4 t80 -41.13 -66.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.802 HG13 HD11 ' A' ' 97' ' ' LEU . 41.8 t -45.84 -61.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -40.23 -61.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 43.2 mmtt -46.39 -41.27 13.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 86.7 m -68.69 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.579 HG13 ' CG ' ' A' ' 154' ' ' HIS . 71.7 t -71.79 -61.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -53.62 -35.94 61.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.538 ' CD2' HG11 ' A' ' 93' ' ' VAL . 30.3 t80 -56.72 -49.23 75.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.679 HG22 HD12 ' A' ' 53' ' ' LEU . 17.0 mt -61.67 -20.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -89.75 -14.1 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -95.44 -20.41 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -85.16 23.88 1.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.01 -29.79 3.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.477 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.756 HD11 HG22 ' A' ' 158' ' ' VAL . 6.1 tp 63.25 52.05 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.926 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 16.7 p -133.35 31.61 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 m -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.152 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.09 114.39 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.76 90.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -99.54 -30.13 12.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.98 -47.62 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.71 ' HG3' HG23 ' A' ' 61' ' ' VAL . 14.0 ptt180 -59.59 -15.96 22.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.71 HG23 ' HG3' ' A' ' 60' ' ' ARG . 79.0 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' ASP . 91.5 m . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 19.3 m-20 -39.13 -49.34 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HA ' HD12 ' A' ' 71' ' ' ILE . 35.9 mt-30 -72.49 -29.41 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 66' ' ' THR . 8.5 t0 -59.39 -54.32 48.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 67' ' ' ASP . 20.2 p30 -54.72 -39.26 68.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.436 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 58.2 mt -49.03 -39.53 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -91.25 -55.1 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' HE2' ' CG ' ' A' ' 69' ' ' ASP . 50.1 mtmt -46.29 -48.09 18.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -66.31 -56.64 10.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -40.0 -43.42 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.88 -53.09 52.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -56.5 -40.06 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -149.86 134.33 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -91.01 -20.2 22.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -81.13 45.21 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 pt -106.12 -178.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -145.18 154.53 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.3 mt -89.24 -34.24 16.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.83 -56.63 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -52.32 -31.14 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.471 ' HB3' HG13 ' A' ' 88' ' ' VAL . 9.5 mmm -69.58 -27.8 65.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 59.13 48.16 10.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 86' ' ' MET . 34.5 m -84.45 162.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' VAL . 58.9 p -69.85 121.18 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' THR . 88.4 t -37.07 -55.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.09 -47.14 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.52 -62.75 1.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.538 HG11 ' CD2' ' A' ' 47' ' ' PHE . 97.2 t -44.41 -43.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' LEU . . . -65.19 -46.9 78.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -55.28 26.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -44.96 35.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 111.121 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.802 HD11 HG13 ' A' ' 41' ' ' VAL . 26.7 tp -44.11 -43.84 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -75.8 -46.57 29.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.09 -43.06 3.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -56.79 -46.58 81.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -60.53 -50.22 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.501 ' HB2' HG23 ' A' ' 179' ' ' THR . . . -56.37 -39.88 73.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.57 -39.87 71.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.2 mt -39.02 143.36 0.48 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.711 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.62 31.8 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -133.49 154.83 81.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.731 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.03 68.23 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 148' ' ' PHE . 11.1 tp -62.63 -40.67 97.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.564 HD12 ' HE2' ' A' ' 181' ' ' MET . 65.1 mt -95.51 128.34 38.49 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 111.127 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.9 Cg_endo -69.78 160.48 49.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.344 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.429 ' HA ' ' CG ' ' A' ' 114' ' ' HIS . 30.6 m-85 -75.45 -36.18 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.5 t -56.19 -14.57 2.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.467 HD21 ' HG3' ' A' ' 139' ' ' LYS . 23.1 mt -127.73 32.0 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.504 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -75.88 -63.15 0.66 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.822 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.71 -11.46 30.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.327 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.92 -32.94 57.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.524 ' CD1' HD13 ' A' ' 109' ' ' ILE . 2.5 mt -70.39 -45.77 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.7 mt -68.09 -55.04 13.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -47.88 -29.35 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.15 -24.89 26.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -81.06 -32.19 34.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -75.75 -1.29 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 128' ' ' GLU . 53.0 mt -62.43 130.76 93.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.639 0.733 . . . . 0.0 111.151 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.58 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.38 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.25 110.81 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -46.07 -54.96 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.2 m -50.98 -56.81 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.516 ' HB2' HG21 ' A' ' 123' ' ' ILE . 63.7 mm-40 -56.25 -38.06 70.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -55.25 -46.54 76.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 207' ' ' GLN . 13.1 mt -70.76 -66.51 0.6 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' LEU . 12.7 m-70 -35.69 -51.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.09 -57.51 9.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 9.3 mt -59.47 -20.52 55.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.533 ' O ' HG12 ' A' ' 137' ' ' VAL . 4.6 ttpm? -81.65 -34.11 30.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 4.5 pt-20 -80.69 -28.61 36.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.545 HG22 ' HE1' ' A' ' 140' ' ' PHE . 39.4 mt -72.58 -34.59 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.097 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.57 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 9.5 p -73.0 -0.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -79.07 -42.92 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.467 ' HG3' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -85.81 18.91 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.57 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 2.7 m-85 -77.67 143.43 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -37.16 141.13 0.43 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.73 -25.6 28.58 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.323 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.785 HG11 ' HA ' ' A' ' 28' ' ' GLN . 40.3 t -92.18 -35.39 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.422 ' OD1' ' CG ' ' A' ' 141' ' ' HIS . 17.6 m120 -81.42 -45.78 15.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.564 ' CE1' ' HD3' ' A' ' 149' ' ' ARG . 4.3 t80 -43.38 -48.53 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -56.25 -59.8 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.7 -63.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.595 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 30.0 t80 -43.97 -44.44 7.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.564 ' HD3' ' CE1' ' A' ' 145' ' ' TYR . 8.2 ttp85 -62.14 -49.04 77.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -59.33 -53.96 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -45.49 -59.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.595 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 75.0 mt -52.08 -52.67 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 m -41.51 -29.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.579 ' CG ' HG13 ' A' ' 45' ' ' VAL . 28.7 t60 -88.44 -42.37 12.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 1.003 HD21 ' CE2' ' A' ' 176' ' ' PHE . 89.8 mt -54.53 -46.84 73.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -51.35 -40.95 60.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -61.3 -41.49 97.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.756 HG22 HD11 ' A' ' 53' ' ' LEU . 76.2 t -60.74 -42.92 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.7 p -61.8 -19.67 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -58.05 -53.2 60.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.474 ' HB3' HD12 ' A' ' 164' ' ' ILE . 8.5 mm100 -99.76 37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.483 ' CG ' HG22 ' A' ' 168' ' ' THR . 19.7 p80 -53.43 -28.25 28.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -67.31 -27.26 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 161' ' ' GLN . 79.3 mt -89.46 -59.03 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' LEU . 3.5 p30 -81.49 15.48 2.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 165' ' ' ASN . 27.3 mt 36.82 50.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 64.3 mmm -145.06 115.24 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.483 HG22 ' CG ' ' A' ' 162' ' ' HIS . 66.1 p -101.19 167.44 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.67 -40.39 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -58.26 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -58.65 -55.67 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.76 -21.73 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.452 ' HB2' ' N ' ' A' ' 202' ' ' GLU . 4.7 p -82.92 -39.16 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 49.4 mt -75.75 -25.1 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.3 p -79.39 -36.92 38.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 1.003 ' CE2' HD21 ' A' ' 155' ' ' LEU . 7.2 m-85 -85.24 -38.71 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.864 ' HA ' HD12 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -39.26 -57.14 2.37 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.546 0.689 . . . . 0.0 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.521 ' HD3' ' CG ' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -48.07 -65.89 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.662 2.242 . . . . 0.0 112.317 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 102' ' ' ALA . 94.6 m -54.39 -55.47 28.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 177' ' ' TRP . 32.8 mt -30.24 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.564 ' HE2' HD12 ' A' ' 109' ' ' ILE . 2.5 ptt? -175.65 143.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.89 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 200' ' ' VAL . 88.4 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.828 0.346 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -41.74 -52.54 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.903 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -63.11 -46.11 88.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.6 t -55.0 -40.93 70.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.445 ' CG1' HD22 ' A' ' 117' ' ' LEU . 79.1 t -37.62 -67.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.5 t -63.9 -51.72 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.452 ' N ' ' HB2' ' A' ' 173' ' ' SER . 15.6 tt0 -37.37 -53.93 1.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.6 m -56.3 -57.26 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 10.7 m-85 -42.62 -36.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 86.0 mt -71.73 -58.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.452 ' HB3' ' CG2' ' A' ' 218' ' ' VAL . 11.3 mt-30 -54.96 -54.76 38.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.497 ' HG3' HD13 ' A' ' 130' ' ' LEU . 61.6 mm-40 -86.44 24.2 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.73 -18.62 62.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 213' ' ' TYR . 18.2 mm-40 -91.6 -51.14 5.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -45.24 -38.49 5.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -50.3 -63.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -106.68 -54.79 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 209' ' ' GLN . 71.4 m-85 -59.62 -16.95 29.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 20.7 m120 48.28 47.07 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -90.04 165.6 31.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.89 132.87 42.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 93.4 mt -58.63 106.84 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 206' ' ' GLN . 30.1 m -64.01 168.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.807 0.253 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 31' ' ' VAL . 20.1 tp -61.0 -42.69 98.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.921 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.477 ' HA ' HG11 ' A' ' 143' ' ' VAL . 3.5 pt20 -52.51 -29.23 24.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.81 -48.74 12.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.37 -45.18 84.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 27' ' ' LEU . 5.8 m -87.2 168.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -107.64 146.83 31.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.79 -40.97 6.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.103 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.02 -44.48 82.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 4.5 mmmm -131.02 99.57 17.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.617 0.722 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 54.0 Cg_endo -69.72 -35.51 12.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.343 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.71 129.36 74.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 117.37 5.05 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.527 HD11 ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -40.09 -46.3 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -44.69 -64.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.458 HG13 HD11 ' A' ' 97' ' ' LEU . 21.0 t -43.16 -59.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.168 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -45.1 -61.34 1.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HE2' HD11 ' A' ' 39' ' ' LEU . 49.0 mmtt -46.09 -43.17 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.618 ' HB2' HD13 ' A' ' 97' ' ' LEU . 90.1 m -65.29 -30.33 71.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.503 HG13 ' CG ' ' A' ' 154' ' ' HIS . 95.6 t -79.27 -54.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.04 -43.04 86.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.791 ' CE1' HG21 ' A' ' 93' ' ' VAL . 3.2 t80 -49.59 -60.27 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 76.8 mt -45.11 -44.64 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -63.03 -45.65 91.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.02 -42.3 94.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.6 p -85.89 29.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.147 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.71 153.9 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -120.28 38.96 3.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.478 ' HB2' HG21 ' A' ' 164' ' ' ILE . 19.6 p -117.49 42.3 2.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -97.86 133.51 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.04 120.95 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.51 80.07 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.0 -49.69 69.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.851 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 20.1 m-85 -99.49 -48.96 4.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -38.04 -42.03 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.998 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.807 0.337 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -45.77 -52.72 10.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.828 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.861 ' HA ' HD12 ' A' ' 71' ' ' ILE . 7.0 mt-30 -67.89 -32.18 72.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.32 -67.9 0.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -49.12 -42.13 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 68' ' ' GLN . 65.0 mt -50.22 -40.81 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -81.27 -57.08 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -50.98 -59.67 3.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HB3' HD12 ' A' ' 81' ' ' ILE . 32.2 mm-40 -49.09 -47.78 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -61.77 -41.39 97.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.31 -48.09 82.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.1 -29.65 61.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -132.53 93.14 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.802 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -60.57 -34.34 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.17 36.6 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 74' ' ' GLN . 13.1 tt -77.53 156.16 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' SER . 2.0 t-20 -122.04 87.82 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 82' ' ' ASN . 60.0 mt -37.27 -49.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.1 t -50.05 -42.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ASN . 45.6 t -59.96 -35.14 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.7 mmm -68.99 -34.17 74.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 59.22 50.15 8.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -84.79 172.24 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 90' ' ' VAL . 37.1 p -75.04 117.14 16.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 89' ' ' THR . 75.4 t -36.68 -52.89 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 90' ' ' VAL . 2.6 t-20 -37.16 -46.38 0.7 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.08 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.791 HG21 ' CE1' ' A' ' 47' ' ' PHE . 81.5 t -43.66 -46.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.095 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.851 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -51.88 -48.57 64.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.95 -62.71 4.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -43.82 -42.57 5.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 111.066 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.618 HD13 ' HB2' ' A' ' 44' ' ' CYS . 34.8 tp -52.04 -46.91 65.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 99' ' ' ALA . 42.3 mtmt -69.29 -47.92 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.5 -41.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.73 -55.22 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 147' ' ' VAL . 17.3 m-85 -54.16 -52.78 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.474 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -54.28 -42.2 69.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.78 -35.57 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -42.47 141.42 1.5 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -19.49 35.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.642 2.228 . . . . 0.0 112.375 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 155.18 73.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.571 0.701 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 151.07 68.73 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.66 2.24 . . . . 0.0 112.376 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 148' ' ' PHE . 10.2 tp -52.46 -51.39 59.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.493 HG21 ' CD1' ' A' ' 117' ' ' LEU . 29.1 mt -83.42 132.31 50.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 0.0 111.129 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.55 ' CG ' HD12 ' A' ' 113' ' ' LEU . 53.9 Cg_endo -69.71 146.76 61.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.369 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.528 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 20.9 m-85 -60.55 -26.0 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE2' ' A' ' 116' ' ' GLU . 33.1 m -65.57 -35.85 82.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.891 HD23 ' CD ' ' A' ' 116' ' ' GLU . 65.4 mt -92.17 35.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.528 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 4.1 m170 -77.56 -60.02 0.77 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.3 Cg_endo -69.79 -58.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.891 ' CD ' HD23 ' A' ' 113' ' ' LEU . 5.2 pt-20 -44.57 -38.13 4.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 113' ' ' LEU . 10.8 mt -66.64 -38.48 86.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.472 ' CD2' ' HA ' ' A' ' 197' ' ' HIS . 6.9 mt -76.65 -56.27 4.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.91 -28.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -81.74 -31.12 32.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.073 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -78.15 -31.9 49.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -82.94 16.77 2.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 129' ' ' ARG . 73.5 mt -79.03 129.86 71.68 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.638 0.733 . . . . 0.0 111.16 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.93 2.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 126' ' ' LYS . 31.7 m-20 -67.21 95.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 125' ' ' ASP . 27.5 ttpt -33.49 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.413 HG22 ' CD2' ' A' ' 131' ' ' HIS . 86.5 m -57.49 -61.76 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.455 ' CB ' HG21 ' A' ' 123' ' ' ILE . 12.4 mt-10 -44.74 -56.47 4.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 123' ' ' ILE . 7.3 ttm180 -37.75 -52.23 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.466 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 22.2 mt -64.87 -66.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 130' ' ' LEU . 20.1 m-70 -34.56 -45.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.404 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . . . -57.61 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.424 ' CD1' HG21 ' A' ' 203' ' ' THR . 18.9 mt -51.65 -27.53 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 137' ' ' VAL . 49.1 tttp -75.18 -37.87 61.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.9 -26.11 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.568 HG22 ' HE1' ' A' ' 140' ' ' PHE . 36.2 mt -75.33 -36.33 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.574 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 8.5 p -69.83 -0.41 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -82.01 -29.61 31.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' CD ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -97.18 14.17 26.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.833 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.3 m-85 -75.11 140.59 43.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.54 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 4.4 t-80 -34.39 141.05 0.26 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.74 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.275 . . . . 0.0 112.355 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 28' ' ' GLN . 39.7 t -88.8 -33.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -83.26 -47.78 11.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -42.68 -44.88 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.2 -55.49 34.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 101' ' ' PHE . 87.2 t -64.33 -60.1 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD1' HD23 ' A' ' 108' ' ' LEU . 20.8 t80 -38.43 -42.02 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -72.32 -49.52 33.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -52.51 -45.13 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.57 -64.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.538 HG23 HG12 ' A' ' 205' ' ' ILE . 82.1 mt -43.4 -51.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.7 m -43.37 -35.44 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.503 ' CG ' HG13 ' A' ' 45' ' ' VAL . 77.2 t60 -83.36 -37.56 23.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 152' ' ' ILE . 98.8 mt -56.37 -46.32 80.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.417 HD21 ' C ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER -51.69 -41.97 61.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -57.12 -35.56 69.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 -42.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.5 p -64.86 -34.53 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -54.18 -42.25 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.29 37.35 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 166' ' ' LEU . 29.8 p80 -53.96 -34.07 58.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -55.93 -31.22 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 54' ' ' CYS . 74.2 mt -89.75 -58.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.178 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -76.89 7.56 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 162' ' ' HIS . 34.7 mt 40.85 53.38 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 75.4 mmm -152.29 119.85 6.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 169' ' ' ALA . 69.2 p -102.01 153.13 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.173 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.82 -44.29 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.105 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -61.81 -50.87 70.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -53.57 -39.91 65.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 38.9 mt -67.31 -44.35 79.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t -53.59 -50.1 66.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.98 -41.28 89.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.12 -30.66 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.58 -2.27 54.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.582 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.86 -45.95 92.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.96 -53.94 5.92 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.721 2.281 . . . . 0.0 112.296 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.474 HG23 ' CA ' ' A' ' 102' ' ' ALA . 20.5 m -76.28 -67.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 179' ' ' THR . 24.8 mt -34.29 -48.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 4.4 mmm -136.44 120.98 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.905 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.526 0.679 . . . . 0.0 110.905 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 197' ' ' HIS . 72.7 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.89 0.376 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.472 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 51.2 m80 -36.18 -50.67 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.05 -47.35 71.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.2 m -47.4 -36.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.6 t -48.18 -50.46 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 202' ' ' GLU . 45.2 t -65.69 -59.65 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' VAL . 65.4 tt0 -34.48 -64.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 205' ' ' ILE . 38.2 m -41.49 -66.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.8 m-85 -35.43 -33.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.538 HG12 HG23 ' A' ' 152' ' ' ILE . 82.3 mt -84.64 -46.52 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 203' ' ' THR . 8.5 mm100 -56.27 -59.28 5.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.476 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 6.5 mm-40 -94.61 31.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.5 t -58.64 -21.55 54.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.728 ' NE2' ' CD2' ' A' ' 213' ' ' TYR . 7.1 mm100 -86.24 -54.67 4.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -40.03 -35.77 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -54.71 -63.19 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -107.73 -56.51 2.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.728 ' CD2' ' NE2' ' A' ' 209' ' ' GLN . 63.1 m-85 -60.06 -11.55 6.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 46.18 43.65 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.89 168.83 53.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.92 141.89 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.476 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.9 mt -73.91 133.42 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.6 m -109.8 170.97 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.13 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.769 0.237 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.74 HD13 HD21 ' A' ' 104' ' ' LEU . 24.0 tp -46.91 -40.89 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.718 ' HB3' HG21 ' A' ' 143' ' ' VAL . 4.8 pt20 -50.81 -44.65 59.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.95 -46.24 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -57.52 -37.28 72.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 36' ' ' PRO . 10.3 m -89.67 164.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 35' ' ' LYS . 20.4 p -106.53 133.18 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -34.68 -44.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -58.13 -47.68 82.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' THR . 33.1 mmtm -124.75 96.65 40.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.549 0.69 . . . . 0.0 110.862 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.506 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.4 Cg_endo -69.81 -40.35 5.35 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.553 HG12 HG22 ' A' ' 147' ' ' VAL . 15.7 mt -80.51 130.73 63.75 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.673 0.749 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 54.1 Cg_endo -69.71 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.36 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.487 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -38.29 -54.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.415 ' CZ ' ' HG2' ' A' ' 72' ' ' GLN . 25.1 t80 -39.25 -63.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.468 ' CG2' ' HG2' ' A' ' 38' ' ' PRO . 43.1 t -44.31 -52.67 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -53.7 -61.25 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 48.3 mmtt -44.16 -33.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 87.8 m -76.04 -50.44 14.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.613 HG13 ' CG ' ' A' ' 154' ' ' HIS . 96.6 t -58.61 -39.66 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -78.1 -26.36 48.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 47' ' ' PHE . 1.1 t80 -79.26 -33.76 43.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG2' HD22 ' A' ' 58' ' ' LEU . 21.5 mt -66.93 -34.24 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -84.36 -33.98 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.83 -24.62 52.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.47 HG21 HG22 ' A' ' 90' ' ' VAL . 47.6 p -84.3 28.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.104 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.64 -32.02 4.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.469 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.517 HD11 HG22 ' A' ' 158' ' ' VAL . 14.2 tp 70.45 27.54 3.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.807 0.337 . . . . 0.0 110.922 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.56 44.65 1.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -101.17 135.59 42.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 57' ' ' GLY . 4.0 mt-10 -65.43 115.62 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.56 68.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.774 HD12 ' N ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -62.48 -15.58 50.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.774 ' N ' HD12 ' A' ' 58' ' ' LEU . 20.0 m-85 -98.22 -56.11 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -59.55 -15.53 18.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.44 HG23 ' CD ' ' A' ' 60' ' ' ARG . 39.0 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.771 0.319 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.481 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 5.1 m-20 -57.81 -58.29 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.436 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 25.3 mt-30 -50.23 -28.34 7.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -60.37 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -57.47 -45.55 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 79.3 mt -47.1 -42.82 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 40' ' ' PHE . 39.1 mt-30 -83.74 -64.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -41.72 -54.0 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.497 ' HB3' HD12 ' A' ' 81' ' ' ILE . 31.6 mm-40 -58.85 -40.22 83.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 65.2 t80 -64.73 -61.15 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.32 -57.09 9.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -52.0 -26.63 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.836 ' O ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -162.23 116.22 1.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -71.61 -33.31 68.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -41.07 -46.23 2.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.888 HD11 ' SD ' ' A' ' 86' ' ' MET . 1.8 tt -45.85 145.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.48 ' N ' HG12 ' A' ' 81' ' ' ILE . 56.3 t30 -128.71 119.32 24.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.45 HD22 HG23 ' A' ' 71' ' ' ILE . 64.5 mt -47.96 -52.94 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.75 -48.27 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -62.9 -44.69 95.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.888 ' SD ' HD11 ' A' ' 81' ' ' ILE . 25.6 mtp -52.17 -33.9 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 57.72 49.74 11.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 86' ' ' MET . 33.0 m -84.5 171.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.3 p -70.96 116.49 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 51' ' ' THR . 58.4 t -39.55 -45.69 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -48.85 -41.92 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.73 -63.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.42 HG21 ' CE1' ' A' ' 47' ' ' PHE . 87.0 t -50.33 -51.59 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.73 -36.79 5.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.76 -57.21 3.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -43.02 -41.72 3.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.088 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -49.33 -53.76 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -64.46 -43.92 92.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.79 -50.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -55.04 -57.87 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.509 ' CB ' HG21 ' A' ' 179' ' ' THR . 34.3 m-85 -50.65 -39.3 50.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.13 80.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.28 -33.99 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.74 HD21 HD13 ' A' ' 27' ' ' LEU . 95.0 mt -40.29 141.44 0.84 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.39 32.22 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.248 . . . . 0.0 112.388 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.59 155.81 75.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 141.22 44.56 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.485 HD12 HD22 ' A' ' 144' ' ' ASN . 15.4 tp -43.62 -51.6 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 91.2 mt -82.09 128.97 66.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.722 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.6 Cg_endo -69.77 158.84 55.58 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.34 -29.05 47.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -65.48 -5.33 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.862 HD13 ' CD1' ' A' ' 140' ' ' PHE . 13.6 mt -133.46 22.09 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.497 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -70.79 -60.17 3.19 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.892 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.628 ' HA ' HD12 ' A' ' 118' ' ' LEU . 53.2 Cg_endo -69.77 -16.39 37.5 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 0.0 112.309 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.29 -36.8 63.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.416 HD11 ' HZ ' ' A' ' 140' ' ' PHE . 14.7 mt -71.79 -26.33 62.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 115' ' ' PRO . 5.4 mt -84.72 -48.47 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -53.59 -31.4 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.17 -25.43 25.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -78.87 -21.33 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -89.47 11.2 20.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.659 HG23 ' HD2' ' A' ' 124' ' ' PRO . 85.9 mt -76.62 138.52 66.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.654 0.74 . . . . 0.0 111.151 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.659 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.6 Cg_endo -69.8 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.276 . . . . 0.0 112.299 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.35 101.27 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.718 ' HE3' HD13 ' A' ' 217' ' ' ILE . 33.6 ttpt -44.01 -48.73 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -56.93 -60.8 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -49.94 -48.07 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -45.47 -51.53 11.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.594 HD13 ' HG3' ' A' ' 207' ' ' GLN . 26.0 mt -65.79 -53.7 36.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -45.48 -55.97 5.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.2 -54.87 17.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 130' ' ' LEU . 10.5 mt -55.53 -36.69 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -68.16 -22.45 64.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -89.27 -48.32 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.629 HG22 ' HE1' ' A' ' 140' ' ' PHE . 19.0 mt -56.61 -34.47 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.492 ' O ' ' CE1' ' A' ' 145' ' ' TYR . 7.1 p -71.25 -6.75 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -87.51 -37.91 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 23.2 1.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.862 ' CD1' HD13 ' A' ' 113' ' ' LEU . 2.3 m-30 -81.79 175.2 10.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.886 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.59 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -65.3 141.14 98.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.584 0.707 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.8 -15.6 37.01 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.266 . . . . 0.0 112.32 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 28' ' ' GLN . 69.6 t -99.21 -25.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.485 HD22 HD12 ' A' ' 108' ' ' LEU . 34.8 m120 -93.98 -33.46 13.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CE1' ' O ' ' A' ' 137' ' ' VAL . 83.1 t80 -65.21 -56.77 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.452 ' OD2' ' CG1' ' A' ' 37' ' ' ILE . 4.6 p-10 -42.86 -49.42 5.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 151' ' ' VAL . 20.0 t -72.46 -55.89 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.747 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 17.4 t80 -42.49 -41.69 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.472 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 19.4 mtp180 -59.8 -59.89 4.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -54.05 -34.63 60.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 147' ' ' VAL . 62.8 t -59.39 -63.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.747 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 21.5 mt -53.01 -53.25 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -39.82 -33.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.613 ' CG ' HG13 ' A' ' 45' ' ' VAL . 74.0 t60 -84.36 -41.86 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 152' ' ' ILE . 76.0 mt -50.83 -48.75 59.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.33 -45.84 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -53.57 -38.67 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 53' ' ' LEU . 39.5 t -74.77 -43.39 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 26.2 p -60.67 -25.22 66.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -65.55 -37.03 85.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -105.72 36.35 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.485 ' CD2' HG22 ' A' ' 168' ' ' THR . 56.0 p-80 -55.0 -38.3 67.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -59.46 -36.72 76.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.53 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -73.31 2.17 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 162' ' ' HIS . 28.3 mt 49.8 42.82 24.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.7 mmm -141.88 112.02 6.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.485 HG22 ' CD2' ' A' ' 162' ' ' HIS . 44.3 p -94.11 155.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -41.06 -36.37 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.66 -52.57 50.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -57.44 -45.03 85.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.5 mt -62.46 -46.52 88.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -57.53 -24.23 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.82 -39.44 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 8.4 p -63.35 -32.67 74.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.431 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.4 m-85 -90.02 -12.98 36.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -48.76 -46.57 72.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -48.01 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.509 HG21 ' CB ' ' A' ' 101' ' ' PHE . 40.0 m -64.41 -59.89 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 179' ' ' THR . 70.2 mt -33.72 -48.15 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.548 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 13.2 ptm -159.06 150.82 20.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.61 0.719 . . . . 0.0 110.853 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 200' ' ' VAL . 81.1 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.841 0.353 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.416 ' H ' ' CD2' ' A' ' 197' ' ' HIS . 39.6 m-70 -43.32 -44.82 5.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.18 -54.41 47.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 t -52.81 -40.42 63.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 121' ' ' ALA . 85.3 t -47.1 -69.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.157 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 202' ' ' GLU . 83.1 t -58.14 -60.28 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 201' ' ' VAL . 66.6 tt0 -37.62 -43.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 56.9 m -59.46 -55.38 35.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.547 ' HB3' HD13 ' A' ' 152' ' ' ILE . 9.4 m-85 -38.73 -58.22 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 63.2 mt -55.56 -50.75 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -53.69 -60.13 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.594 ' HG3' HD13 ' A' ' 130' ' ' LEU . 11.0 mm-40 -92.52 25.57 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.926 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.581 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 1.8 t -60.4 -14.82 21.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' TYR . 10.6 mm100 -95.86 -57.91 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.473 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.8 t80 -39.76 -30.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.4 m-85 -52.6 -61.87 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -127.02 -28.33 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 209' ' ' GLN . 26.2 m-85 -83.99 26.82 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' TYR . 75.9 m-20 33.48 34.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -59.08 145.87 43.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.12 129.93 35.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.718 HD13 ' HE3' ' A' ' 126' ' ' LYS . 53.3 mt -41.32 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.26 163.96 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.837 0.265 . . . . 0.0 112.383 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 31' ' ' VAL . 14.0 tp -49.39 -49.87 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.679 ' HA ' HG11 ' A' ' 143' ' ' VAL . 17.6 pt20 -46.85 -34.66 5.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.446 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 33.2 t70 -77.28 -45.81 25.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.9 mt -59.45 -46.04 89.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 27' ' ' LEU . 33.3 m -88.27 163.22 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.9 p -108.87 149.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.105 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.73 -46.94 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -50.14 -44.45 52.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.923 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 30.0 mmtt -132.66 99.17 15.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.606 0.717 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.7 Cg_endo -69.79 -41.17 4.47 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.692 2.261 . . . . 0.0 112.344 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.513 HG23 ' HD2' ' A' ' 38' ' ' PRO . 34.1 mt -74.84 134.81 74.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.584 0.707 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 148.32 64.65 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.643 2.228 . . . . 0.0 112.356 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.483 ' CD1' ' HG3' ' A' ' 43' ' ' LYS . 1.1 tm? -65.12 -59.36 4.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' LEU . 24.9 t80 -36.09 -64.86 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.915 HG13 HD11 ' A' ' 97' ' ' LEU . 90.2 t -46.67 -63.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -40.53 -56.01 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG3' ' CD1' ' A' ' 39' ' ' LEU . 64.2 mmtt -53.92 -39.43 65.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 80.7 m -65.23 -41.88 93.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.66 -43.86 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -70.45 -38.76 74.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 93' ' ' VAL . 11.0 t80 -56.58 -50.15 72.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 mt -48.83 -68.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 50' ' ' ASP . 2.7 pp20? -55.18 -53.19 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 21.1 t70 -45.46 -42.89 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 p -88.66 29.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 108.65 1.45 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.22 51.41 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 0.0 110.953 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 80.4 m -132.7 30.88 4.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.436 ' O ' HD12 ' A' ' 58' ' ' LEU . 7.5 m -66.54 122.33 17.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.15 130.38 42.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 45.18 87.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 4.6 mp -83.16 143.61 30.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.353 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.647 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 2.6 m-85 47.87 27.88 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HB2' ' HE1' ' A' ' 167' ' ' MET . 15.4 tpp85 -123.41 -46.84 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.926 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.807 0.337 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.96 -58.27 8.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -58.91 -33.88 71.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.95 -66.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -57.19 -37.85 72.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.496 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 38.7 mt -52.25 -37.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -90.63 -55.65 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.04 -54.87 20.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -54.04 -43.84 70.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -57.38 -40.68 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.29 -62.0 2.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -58.94 -28.65 66.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -129.67 103.98 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -76.33 -27.24 56.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -96.23 37.21 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.608 HD11 ' SD ' ' A' ' 86' ' ' MET . 9.1 tt -80.69 153.77 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.402 ' N ' HG12 ' A' ' 81' ' ' ILE . 4.8 t-20 -123.0 94.78 4.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -37.23 -50.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.4 t -43.66 -46.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -57.88 -46.41 84.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.608 ' SD ' HD11 ' A' ' 81' ' ' ILE . 82.0 mtp -56.16 -38.11 70.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 62.05 50.12 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.02 178.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 p -75.63 117.76 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -42.08 -51.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -40.39 -49.48 2.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.45 -56.15 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 47' ' ' PHE . 98.3 t -46.65 -55.24 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.647 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -47.07 -45.36 21.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.49 -60.27 5.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.31 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.915 HD11 HG13 ' A' ' 41' ' ' VAL . 20.9 tp -47.98 -42.94 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -64.96 -43.33 93.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.912 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.94 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -60.54 -35.87 77.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -82.15 -41.0 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.861 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.4 -41.71 98.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -57.28 -40.17 77.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.442 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 47.7 mt -36.56 146.98 0.21 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.602 0.715 . . . . 0.0 110.946 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -27.46 26.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 153.98 81.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.64 0.733 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 156.58 63.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.337 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.67 -45.91 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.3 mt -95.93 117.65 66.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 111.146 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.449 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.74 137.69 36.12 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.662 2.242 . . . . 0.0 112.323 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -53.05 -36.47 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -54.91 -23.52 19.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 117' ' ' LEU . 60.8 mt -112.97 30.81 6.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.858 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -74.3 -61.8 1.13 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 110.847 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.589 ' HA ' HD12 ' A' ' 118' ' ' LEU . 54.1 Cg_endo -69.73 -40.32 5.5 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -47.09 -33.55 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.8 mt -71.62 -43.02 66.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 115' ' ' PRO . 6.3 mt -69.1 -57.95 4.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -43.05 -25.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.06 -27.72 15.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.74 -31.72 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -74.1 -15.55 61.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 90.4 mt -50.26 129.35 24.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -46.94 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.252 . . . . 0.0 112.372 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -59.04 106.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -46.94 -46.49 21.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.6 m -59.78 -67.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 129' ' ' ARG . 58.0 mm-40 -46.6 -51.76 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 128' ' ' GLU . 12.2 ttm180 -36.79 -48.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.47 ' CD2' ' HG2' ' A' ' 207' ' ' GLN . 23.0 mt -73.26 -66.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 130' ' ' LEU . 29.9 m-70 -34.14 -49.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.864 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.92 -59.94 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.84 -40.01 59.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -63.45 -26.47 68.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.44 -39.79 13.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.47 -41.56 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 12.9 p -58.75 -24.9 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -60.04 -32.28 70.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -60.42 -34.88 74.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 141' ' ' HIS . 22.6 m-85 -44.91 132.34 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.537 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.9 t60 -33.99 141.85 0.23 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -9.55 26.38 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.369 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 28' ' ' GLN . 97.6 t -98.83 -38.99 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -84.28 -38.17 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.515 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 35.5 t80 -51.71 -43.75 62.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.93 -45.71 82.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.23 -59.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 41.0 t80 -47.92 -42.92 28.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.515 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 14.0 mmm180 -65.87 -38.76 89.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -65.28 -45.71 83.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.67 -60.35 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 84.7 mt -46.97 -48.58 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.3 m -44.09 -36.21 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -80.79 -36.39 31.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 152' ' ' ILE . 77.9 mt -59.92 -47.0 87.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -43.08 40.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.8 mtp85 -61.79 -38.08 86.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.23 -47.51 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.2 p -56.63 -36.4 69.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -53.01 -42.04 65.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.928 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.676 ' HB3' HD12 ' A' ' 164' ' ' ILE . 12.7 mm100 -110.66 35.93 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 166' ' ' LEU . 22.5 p80 -47.35 -35.78 8.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 24.3 mmtp -57.71 -33.82 68.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.676 HD12 ' HB3' ' A' ' 161' ' ' GLN . 92.9 mt -80.13 -59.7 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.145 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -81.99 13.04 3.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 162' ' ' HIS . 16.7 mt 39.53 54.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.465 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 18.0 mmm -154.47 116.06 4.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.441 HG22 ' CG ' ' A' ' 162' ' ' HIS . 68.9 p -93.5 154.86 17.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -40.02 -42.73 1.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.101 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.417 ' CG ' ' HG1' ' A' ' 168' ' ' THR . 1.2 p-10 -63.64 -52.48 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -52.63 -48.21 66.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.41 -44.94 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 71.2 p -63.39 -42.42 98.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.04 -33.59 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 m -72.95 -18.85 61.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 9.6 m-85 -104.25 -9.58 18.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.562 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -50.23 -46.73 83.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.567 0.699 . . . . 0.0 110.909 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.9 Cg_exo -47.97 -59.78 1.12 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.665 2.243 . . . . 0.0 112.334 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 180' ' ' LEU . 25.5 m -69.42 -64.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 179' ' ' THR . 85.2 mt -33.28 -50.18 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 19.4 ptm -157.17 131.26 8.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.845 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 200' ' ' VAL . 40.6 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.473 ' ND1' HD21 ' A' ' 118' ' ' LEU . 94.7 m-70 -34.2 -38.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 196' ' ' ILE . 75.5 mt-30 -80.72 -50.6 9.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.2 p -54.65 -24.89 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 196' ' ' ILE . 92.6 t -58.97 -66.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.53 -37.41 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -55.24 -45.51 76.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.9 m -60.07 -53.87 52.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.401 ' HB3' HD13 ' A' ' 152' ' ' ILE . 6.1 m-85 -39.15 -38.86 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 152' ' ' ILE . 60.5 mt -74.56 -65.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.42 ' HB3' HG23 ' A' ' 218' ' ' VAL . 36.7 mt-30 -45.39 -52.55 9.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.47 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 24.1 mp0 -94.2 29.35 2.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.449 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 35.7 t -67.0 -29.62 69.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 213' ' ' TYR . 7.0 mm100 -81.85 -45.14 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -48.93 -37.57 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -49.47 -63.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -105.21 -55.76 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 209' ' ' GLN . 80.7 m-85 -57.41 -23.97 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.922 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 59.86 39.76 20.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.851 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -72.92 -177.9 33.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.64 145.44 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.66 116.35 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.42 HG23 ' HB3' ' A' ' 206' ' ' GLN . 30.0 m -91.56 174.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.808 0.253 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 147' ' ' VAL . 31.0 tp -60.36 -49.04 79.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.667 ' CB ' HG21 ' A' ' 143' ' ' VAL . 16.6 pt20 -47.46 -28.24 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -45.54 14.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.76 -44.93 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 27' ' ' LEU . 20.0 m -91.2 167.14 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -113.44 167.69 10.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.08 -48.45 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.24 -54.77 43.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -115.3 85.23 12.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.446 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.4 Cg_endo -69.79 -31.71 19.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.0 mt -80.87 130.17 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 111.134 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.09 47.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.442 HD21 ' HE2' ' A' ' 43' ' ' LYS . 5.3 tp -67.19 -31.77 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' A' ' 100' ' ' PHE . 42.0 t80 -56.38 -48.47 76.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 97' ' ' LEU . 19.7 t -65.12 -50.68 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.074 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -58.48 -60.99 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HE2' HD21 ' A' ' 39' ' ' LEU . 17.7 mmtt -46.3 -30.37 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.6 m -76.72 -34.37 58.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.535 HG13 ' CG ' ' A' ' 154' ' ' HIS . 93.2 t -76.78 -60.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -54.54 -39.9 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 51' ' ' THR . 20.3 t80 -53.24 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mt -46.05 -52.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.22 -52.41 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.19 -33.54 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.497 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 82.1 p -91.92 23.66 3.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.09 154.69 24.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.501 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.78 47.73 2.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.0 p -132.39 40.32 3.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -97.84 130.88 44.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -67.14 127.22 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.59 77.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.533 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.27 -66.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.96 -37.11 22.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -50.34 -47.56 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.83 -47.38 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.741 ' HA ' HD12 ' A' ' 71' ' ' ILE . 7.4 mt-30 -65.43 -20.82 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.14 -69.87 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.2 p30 -47.49 -39.25 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 68' ' ' GLN . 50.1 mt -47.15 -42.54 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.97 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -45.98 -58.4 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -54.2 -58.18 8.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -55.39 -27.91 50.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.55 -57.33 7.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -73.09 -23.61 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -124.38 120.37 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.06 -14.01 24.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -104.55 31.18 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 3.2 tt -76.27 158.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.509 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 2.6 t-20 -126.24 94.72 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.9 mt -44.87 -45.71 10.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -48.68 -36.81 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.2 t -66.59 -39.24 88.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.525 ' HB3' HG13 ' A' ' 88' ' ' VAL . 6.7 mmm -69.06 -28.9 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 55.83 35.86 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 86' ' ' MET . 16.2 m -66.67 148.72 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.8 p -55.63 129.91 40.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.43 -41.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -52.34 -39.22 60.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.47 -59.76 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.0 -53.31 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.59 -33.62 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 -57.7 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.463 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.4 -31.59 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 41' ' ' VAL . 46.1 tp -56.39 -47.96 77.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -64.37 -34.43 78.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.31 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . 7.3 t80 -67.08 -24.96 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.624 ' HB2' HG21 ' A' ' 179' ' ' THR . 51.9 m-85 -90.11 -28.6 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.14 -34.66 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.0 -36.23 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.4 mt -38.56 142.55 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.925 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.24 32.31 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.23 157.37 76.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.85 26.59 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.338 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp -40.59 -42.54 1.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.41 130.02 36.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 111.136 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 159.36 53.67 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.665 2.243 . . . . 0.0 112.343 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.31 -20.64 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.623 ' O ' HD23 ' A' ' 113' ' ' LEU . 21.3 t -76.58 -1.51 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.827 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.633 HD22 ' HE2' ' A' ' 139' ' ' LYS . 18.3 mt -134.78 17.72 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.477 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -61.47 -60.49 10.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.606 0.717 . . . . 0.0 110.832 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.76 -36.57 10.55 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.691 2.261 . . . . 0.0 112.375 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -51.86 -32.03 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mt -73.28 -23.87 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 121' ' ' ALA . 19.1 mt -94.65 -59.25 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -45.03 -24.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.502 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -96.04 -27.33 15.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -79.65 -18.29 51.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -86.31 -0.63 56.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.554 HG21 ' HB2' ' A' ' 128' ' ' GLU . 79.6 mt -66.37 129.85 94.18 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.631 0.729 . . . . 0.0 111.107 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.0 2.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.4 t70 -61.65 94.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.527 ' HD3' HG21 ' A' ' 217' ' ' ILE . 3.4 ttmt -34.88 -39.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.6 m -65.16 -67.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.554 ' HB2' HG21 ' A' ' 123' ' ' ILE . 8.3 mt-10 -49.07 -48.55 44.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -45.0 -55.16 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.63 HD22 ' HG3' ' A' ' 207' ' ' GLN . 18.7 mt -65.92 -58.74 4.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.65 -43.37 2.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.502 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -59.69 -45.51 91.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 130' ' ' LEU . 8.3 mt -69.07 -25.59 64.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -76.25 -30.51 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 0.5 OUTLIER -88.71 -30.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.404 ' O ' ' CD1' ' A' ' 140' ' ' PHE . 54.9 mt -71.83 -25.12 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.35 -7.58 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -81.89 -31.24 31.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.633 ' HE2' HD22 ' A' ' 113' ' ' LEU . 12.1 pttt -88.94 14.05 11.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.632 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.0 m-85 -77.84 166.88 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.9 t-80 -54.96 140.85 60.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.597 0.713 . . . . 0.0 110.88 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.71 -24.31 30.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.703 2.269 . . . . 0.0 112.334 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.667 HG21 ' CB ' ' A' ' 28' ' ' GLN . 17.2 t -91.11 -40.84 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 145' ' ' TYR . 28.8 m120 -77.7 -48.99 15.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.482 ' CZ ' ' HD2' ' A' ' 149' ' ' ARG . 19.7 t80 -37.39 -56.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -49.18 -65.26 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 27' ' ' LEU . 44.1 t -49.75 -59.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -43.26 -45.78 5.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.482 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 5.3 mtt-85 -63.3 -56.48 16.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -46.04 -45.2 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -56.09 -62.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.559 HG22 ' SG ' ' A' ' 208' ' ' CYS . 5.2 mt -48.02 -50.93 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -42.18 -38.78 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.535 ' CG ' HG13 ' A' ' 45' ' ' VAL . 56.0 t60 -79.74 -35.73 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 152' ' ' ILE . 95.6 mt -57.29 -44.02 83.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.1 -46.55 65.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 44.2 mtt-85 -57.14 -42.39 80.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.785 HG11 HD21 ' A' ' 172' ' ' LEU . 89.9 t -64.32 -47.24 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.6 p -59.3 -40.16 85.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -49.7 -44.2 47.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.485 ' OE1' HD12 ' A' ' 164' ' ' ILE . 6.2 mm-40 -100.29 54.17 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.493 ' CG ' HG22 ' A' ' 168' ' ' THR . 2.3 p80 -84.58 29.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -110.17 -36.76 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.485 HD12 ' OE1' ' A' ' 161' ' ' GLN . 24.7 mt -92.27 -47.32 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -88.33 -6.8 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.8 mt 49.44 50.34 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 74.1 mmm -127.6 85.62 2.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.493 HG22 ' CG ' ' A' ' 162' ' ' HIS . 71.0 p -77.77 153.24 33.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.14 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -39.03 -36.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -66.96 -48.72 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -61.76 -40.34 94.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.785 HD21 HG11 ' A' ' 158' ' ' VAL . 13.1 mt -65.49 -47.73 75.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.7 p -55.61 -48.37 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.2 mt -65.67 -38.97 83.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.7 m -63.08 -9.73 11.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.422 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.8 m-85 -118.27 -9.48 10.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.581 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -50.64 -46.0 85.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.556 0.694 . . . . 0.0 110.942 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.6 Cg_exo -47.98 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.651 2.234 . . . . 0.0 112.37 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 101' ' ' PHE . 52.9 m -63.95 -63.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 179' ' ' THR . 45.6 mt -34.3 -60.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 7.4 ptp -139.11 127.63 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.444 HH22 ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.596 0.712 . . . . 0.0 110.854 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 200' ' ' VAL . 51.5 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.908 0.385 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -42.05 -55.46 3.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -40.97 72.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.7 t -50.19 -36.76 31.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.529 HG22 ' CB ' ' A' ' 121' ' ' ALA . 93.4 t -53.47 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.122 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.98 -52.7 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -46.83 -45.88 20.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.4 m -55.77 -57.24 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.542 ' HB3' HD13 ' A' ' 152' ' ' ILE . 12.7 m-85 -38.97 -52.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.421 HD11 HD13 ' A' ' 155' ' ' LEU . 68.6 mt -58.54 -53.86 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -52.76 -55.2 24.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.63 ' HG3' HD22 ' A' ' 130' ' ' LEU . 10.2 mm-40 -93.36 24.68 3.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.569 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 13.2 t -63.37 -7.3 6.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.605 ' NE2' ' CG ' ' A' ' 213' ' ' TYR . 4.6 mm100 -103.44 -60.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.471 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 4.0 t80 -40.02 -27.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -56.09 -61.97 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -125.88 -26.86 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.605 ' CG ' ' NE2' ' A' ' 209' ' ' GLN . 32.1 m-85 -83.94 25.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' TYR . 0.4 OUTLIER 34.4 32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -61.7 175.86 5.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -110.06 146.29 35.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.882 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.527 HG21 ' HD3' ' A' ' 126' ' ' LYS . 89.8 mt -65.42 111.51 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.28 168.24 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.425 ' C ' ' CD ' ' A' ' 219' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.82 0.258 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 31' ' ' VAL . 21.1 tp -47.3 -56.35 6.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.849 ' HA ' HG11 ' A' ' 143' ' ' VAL . 7.4 pt20 -44.22 -32.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.81 -49.4 18.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.63 -42.09 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 27' ' ' LEU . 28.3 m -89.33 156.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.8 p -103.65 159.85 15.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.65 -44.82 63.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -57.36 -46.5 83.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -126.48 88.28 54.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.859 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.419 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.5 Cg_endo -69.76 -36.13 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.98 131.29 63.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.721 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 120.98 7.68 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.403 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -43.89 -50.08 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.498 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 84.7 t80 -42.58 -66.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.425 HG13 HD11 ' A' ' 97' ' ' LEU . 37.5 t -42.72 -57.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -48.56 -57.7 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 47.6 mmtt -46.77 -39.81 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 88.7 m -67.01 -36.8 82.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG13 ' CG ' ' A' ' 154' ' ' HIS . 99.2 t -72.44 -53.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -60.63 -35.87 77.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.675 ' CE2' HG21 ' A' ' 93' ' ' VAL . 65.6 t80 -60.77 -65.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -37.2 -39.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.57 -41.68 60.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 47' ' ' PHE . 5.4 m-20 -62.18 -43.73 98.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -79.57 -29.82 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.144 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.04 119.7 1.09 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.495 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -94.62 -32.86 13.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.43 39.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 56' ' ' GLU . 24.3 m -87.16 112.47 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.3 tt0 -37.01 125.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.19 89.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 58' ' ' LEU . 1.6 pt? -106.03 -36.88 6.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.819 0.342 . . . . 0.0 110.907 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 10.8 m-85 -84.13 -61.23 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.555 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -57.65 -12.02 2.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.555 HG23 ' CD ' ' A' ' 60' ' ' ARG . 38.5 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.738 0.304 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -43.26 -49.69 6.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.574 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 14.2 mt-30 -63.75 -29.45 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.3 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 20.8 p30 -50.52 -43.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.46 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 81.1 mt -51.05 -42.52 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -78.51 -57.29 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.93 -67.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -38.74 -52.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 86.2 t80 -54.16 -55.59 26.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.98 -46.47 71.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -60.83 -33.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.28 141.88 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -93.33 -18.7 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -78.32 46.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.7 pt -109.25 175.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -142.16 117.53 10.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.97 -43.09 83.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.11 -42.24 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 t -60.55 -43.57 97.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 mtp -60.54 -29.82 69.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.811 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.11 43.42 29.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.58 168.36 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 p -65.9 118.16 9.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -38.72 -47.29 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -46.31 -42.97 15.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.39 -59.91 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.675 HG21 ' CE2' ' A' ' 47' ' ' PHE . 58.7 t -51.59 -59.68 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.78 -38.88 0.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.113 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.3 -58.72 2.69 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.44 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -42.36 -39.99 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 111.091 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.425 HD11 HG13 ' A' ' 41' ' ' VAL . 16.4 tp -52.23 -51.21 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -67.26 -41.19 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.88 -39.87 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.61 -52.55 64.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.691 ' HB2' HG21 ' A' ' 179' ' ' THR . 49.4 m-85 -60.34 -43.66 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.32 -41.26 79.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -35.56 65.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.0 mt -39.24 143.9 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.652 0.739 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.61 34.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.706 2.271 . . . . 0.0 112.326 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 156.85 68.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 140.39 42.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.371 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -43.91 -49.48 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.7 mt -87.45 125.02 66.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.609 0.719 . . . . 0.0 111.142 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.731 ' HG2' HD12 ' A' ' 113' ' ' LEU . 54.0 Cg_endo -69.76 150.61 68.42 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -67.03 -25.59 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 t -65.14 -15.94 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.94 HD13 ' CE1' ' A' ' 140' ' ' PHE . 21.5 mt -118.55 26.0 9.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.497 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.3 OUTLIER -71.63 -60.22 2.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.598 0.713 . . . . 0.0 110.903 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.74 -25.56 28.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.27 . . . . 0.0 112.326 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.521 ' O ' HD13 ' A' ' 136' ' ' ILE . 51.3 mm-40 -68.16 -35.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.489 ' HB3' HG11 ' A' ' 200' ' ' VAL . 7.5 mt -72.52 -25.68 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 121' ' ' ALA . 9.8 mt -88.75 -58.65 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -39.47 -30.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.68 -37.68 20.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -65.54 -17.77 64.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.095 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -96.79 26.42 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.98 131.48 39.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.649 0.737 . . . . 0.0 111.139 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -45.78 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.2 m-20 -70.92 95.53 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -35.61 -54.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.9 m -51.64 -51.95 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.85 -45.46 90.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -50.11 -44.46 52.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.25 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -43.15 -50.35 6.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.61 -60.21 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 22.8 mt -52.04 -38.12 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 137' ' ' VAL . 27.5 tttm -62.93 -26.4 68.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 -42.06 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 116' ' ' GLU . 86.4 mt -64.5 -18.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 134' ' ' LYS . 7.6 p -90.51 -6.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -78.95 -39.03 35.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -76.02 -1.93 28.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.94 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -64.67 137.05 57.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.534 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -38.69 141.73 0.56 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.599 0.714 . . . . 0.0 110.86 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.7 -15.98 37.58 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.849 HG11 ' HA ' ' A' ' 28' ' ' GLN . 21.4 t -96.04 -39.0 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -76.33 -41.97 46.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 3.1 t80 -56.58 -59.45 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 145' ' ' TYR . 3.4 t0 -35.69 -45.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 151' ' ' VAL . 49.0 t -76.5 -44.21 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.567 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 31.2 t80 -52.86 -46.13 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -66.28 -48.11 71.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -56.28 -44.7 80.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 147' ' ' VAL . 58.2 t -58.74 -64.23 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.181 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.585 HG23 HG12 ' A' ' 205' ' ' ILE . 78.1 mt -45.46 -52.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.122 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.8 m -41.04 -38.31 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.424 ' CG ' HG13 ' A' ' 45' ' ' VAL . 19.3 t60 -78.81 -39.45 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 152' ' ' ILE . 98.7 mt -56.58 -47.1 80.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.79 -44.76 39.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 22.4 mtt-85 -60.38 -28.03 67.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.04 -40.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 84.2 p -64.0 -26.36 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 40.1 mt-30 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.566 ' HB3' HD12 ' A' ' 164' ' ' ILE . 2.1 mm100 -103.38 32.43 3.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.621 ' CD2' HG22 ' A' ' 168' ' ' THR . 51.5 p-80 -52.73 -43.43 65.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -59.54 -28.55 67.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 161' ' ' GLN . 82.2 mt -83.09 -55.92 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 166' ' ' LEU . 1.3 m-20 -92.4 22.1 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 162' ' ' HIS . 11.5 mt 35.18 53.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.5 mmm -148.64 110.39 4.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.621 HG22 ' CD2' ' A' ' 162' ' ' HIS . 61.2 p -96.59 154.01 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.08 -41.6 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.95 -50.04 65.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 168' ' ' THR . 38.8 m-20 -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.65 -42.43 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 t -60.27 -27.95 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 47.5 mt -83.43 -35.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.98 -21.33 64.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -104.5 -11.32 17.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.22 -46.45 93.93 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.598 0.713 . . . . 0.0 110.933 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.4 Cg_exo -48.0 -57.4 2.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 0.0 112.346 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 101' ' ' PHE . 59.8 m -73.35 -61.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 80.7 mt -32.54 -48.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.484 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 14.1 ptm -158.29 141.97 15.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.829 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.848 -179.88 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 200' ' ' VAL . 96.1 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.487 ' ND1' HD21 ' A' ' 118' ' ' LEU . 51.8 m-70 -47.84 -58.76 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.84 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -53.36 -50.32 65.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 m -50.1 -41.48 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 196' ' ' ILE . 66.8 t -44.07 -71.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 202' ' ' GLU . 95.3 t -61.1 -59.68 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 201' ' ' VAL . 10.1 tt0 -34.16 -47.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -60.0 -57.04 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -39.12 -34.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.585 HG12 HG23 ' A' ' 152' ' ' ILE . 95.2 mt -80.81 -62.0 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -47.91 -51.94 21.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 207' ' ' GLN . 26.5 mp0 -95.42 30.6 2.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.404 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 8.8 t -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.56 ' NE2' ' CG ' ' A' ' 213' ' ' TYR . 8.5 mm100 -84.65 -53.88 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -40.45 -37.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 19.2 m-85 -53.06 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.21 -55.29 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.56 ' CG ' ' NE2' ' A' ' 209' ' ' GLN . 69.9 m-85 -60.34 -9.96 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.959 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 t30 49.07 37.19 10.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -68.66 172.05 36.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.71 154.86 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.16 132.57 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.85 177.98 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.761 0.234 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.1 tp -45.03 -55.37 5.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.88 ' HA ' HG11 ' A' ' 143' ' ' VAL . 19.9 pt20 -46.46 -36.16 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.63 -39.95 61.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.19 -44.84 82.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -93.37 171.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 p -111.53 147.95 34.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.56 -45.12 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -54.59 -45.44 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 29.8 mmtt -129.34 93.42 35.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 110.948 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.3 Cg_endo -69.73 -38.92 7.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.732 2.288 . . . . 0.0 112.346 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 mt -78.2 128.46 78.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.664 0.745 . . . . 0.0 111.089 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.87 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.699 2.266 . . . . 0.0 112.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.663 HD11 ' HE3' ' A' ' 43' ' ' LYS . 2.4 tm? -99.13 -49.21 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -46.53 -50.32 17.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 97' ' ' LEU . 43.5 t -57.51 -58.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.091 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -46.45 -56.21 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.663 ' HE3' HD11 ' A' ' 39' ' ' LEU . 12.0 mmtp -43.97 -44.53 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 85.3 m -66.76 -62.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -45.36 -47.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.12 -37.17 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.707 ' CD1' HG21 ' A' ' 93' ' ' VAL . 4.9 t80 -55.61 -59.19 5.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 47' ' ' PHE . 10.7 mt -34.82 -68.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.96 -45.71 89.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -40.13 -50.49 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -87.26 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 48' ' ' ILE . . . 149.15 156.21 7.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.506 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.71 HD11 HG22 ' A' ' 158' ' ' VAL . 11.2 tp -126.05 41.45 3.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.307 . . . . 0.0 110.902 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 p -129.92 41.85 3.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 58' ' ' LEU . 50.4 m -95.96 116.25 28.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -39.12 116.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 72.37 0.56 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.506 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.616 HD22 ' O ' ' A' ' 55' ' ' THR . 4.1 mm? -41.73 -45.33 3.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 110.948 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CE2' ' HB1' ' A' ' 94' ' ' ALA . 6.5 m-85 -117.9 -41.69 2.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 59' ' ' TYR . 16.8 tpp85 -34.7 -47.22 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.8 0.333 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.01 -50.47 19.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -59.97 -39.08 84.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -46.3 -53.2 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.0 p30 -66.03 -38.2 87.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 68' ' ' GLN . 68.6 mt -51.42 -39.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -87.06 -60.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -46.83 -35.63 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 70' ' ' ASN . 52.1 mm-40 -77.7 -43.31 31.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -53.47 -28.81 32.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -75.71 -60.68 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -61.52 -25.84 67.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -130.62 107.07 8.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -79.68 -25.41 41.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -97.35 36.56 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.0 tt -79.83 147.46 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -124.86 102.87 7.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -44.65 -50.22 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.5 t -46.46 -50.1 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -56.5 -46.47 80.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.417 ' HB3' HG13 ' A' ' 88' ' ' VAL . 22.3 mmm -60.03 -26.8 66.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 51.96 51.45 16.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 86' ' ' MET . 34.1 m -85.36 160.2 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 p -56.13 125.18 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.2 t -43.48 -46.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.147 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -51.73 -35.72 44.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.69 -58.44 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.707 HG21 ' CD1' ' A' ' 47' ' ' PHE . 78.4 t -58.49 -37.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB1' ' CE2' ' A' ' 59' ' ' TYR . . . -58.84 -42.22 88.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.076 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.16 -45.89 7.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.39 -46.71 73.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 41' ' ' VAL . 23.2 tp -46.06 -44.19 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.564 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 30.9 mtmt -71.25 -42.06 69.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.33 -48.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 4.6 t80 -58.47 -48.61 80.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -53.95 -47.62 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.432 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -59.1 -41.46 88.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -53.18 -34.63 57.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -39.26 147.47 0.3 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -25.02 28.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.377 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -135.48 155.82 78.2 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.427 ' HG3' ' CE1' ' A' ' 111' ' ' TYR . 53.6 Cg_endo -69.77 136.57 33.3 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.717 2.278 . . . . 0.0 112.38 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.463 HD21 ' CD1' ' A' ' 148' ' ' PHE . 24.1 tp -43.55 -41.3 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.2 mt -95.05 123.88 55.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.702 . . . . 0.0 111.139 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 140.85 43.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.248 . . . . 0.0 112.323 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.427 ' CE1' ' HG3' ' A' ' 107' ' ' PRO . 6.3 m-85 -62.75 -22.4 66.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -66.81 -22.19 66.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 117' ' ' LEU . 41.4 mt -116.58 32.11 6.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.469 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -74.62 -61.48 1.11 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 0.0 110.832 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.72 -27.18 26.96 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.688 2.259 . . . . 0.0 112.325 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -63.77 -33.99 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.5 mt -73.42 -41.54 63.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.565 HD23 HG21 ' A' ' 200' ' ' VAL . 8.8 mt -69.82 -57.2 5.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -43.82 -35.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.7 -26.79 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.081 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.9 -30.4 50.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -77.56 -10.99 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 55.4 mt -51.85 132.61 38.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.16 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -65.63 113.7 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.752 ' HD3' HG21 ' A' ' 217' ' ' ILE . 17.8 ttmt -52.09 -50.89 60.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.8 m -54.59 -65.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.172 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -43.45 -52.81 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -41.01 -52.56 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.5 mt -60.47 -57.22 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.34 -51.64 25.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.01 -24.6 67.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.525 ' O ' HG12 ' A' ' 137' ' ' VAL . 32.4 tttm -77.71 -33.04 53.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.1 pt-20 -83.69 -35.46 24.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.496 HG23 ' HZ2' ' A' ' 139' ' ' LYS . 54.3 mt -69.2 -36.57 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 134' ' ' LYS . 8.8 p -65.16 -21.13 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -72.09 -39.48 68.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.496 ' HZ2' HG23 ' A' ' 136' ' ' ILE . 4.6 mttp -59.62 -33.52 71.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -41.98 145.82 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.546 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.4 t-80 -43.25 142.18 1.68 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.816 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.84 -6.4 18.54 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 28' ' ' GLN . 48.8 t -99.19 -45.9 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -79.22 -38.06 36.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.3 t80 -42.74 -47.92 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -52.42 65.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -55.93 -64.12 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.587 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 31.3 t80 -43.55 -49.37 7.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 mtp85 -60.5 -47.06 87.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.13 -44.28 92.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 70.9 t -56.93 -60.53 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.67 HG23 HG12 ' A' ' 205' ' ' ILE . 56.3 mt -48.5 -50.14 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.6 m -40.4 -32.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.6 -36.83 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 152' ' ' ILE . 75.1 mt -55.96 -46.81 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.428 ' C ' HD21 ' A' ' 156' ' ' ASN . 0.2 OUTLIER -49.28 -41.68 38.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mtp85 -60.63 -32.84 71.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 53' ' ' LEU . 47.0 t -73.72 -39.4 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 p -66.22 -28.05 68.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -63.33 -37.35 86.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.664 ' OE1' HD12 ' A' ' 164' ' ' ILE . 16.2 mm-40 -98.3 32.31 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.561 ' HB2' HG22 ' A' ' 168' ' ' THR . 7.8 p80 -57.13 -21.32 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -82.96 -17.56 43.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.664 HD12 ' OE1' ' A' ' 161' ' ' GLN . 60.2 mt -100.12 -63.93 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.73 22.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 165' ' ' ASN . 22.8 mt 33.12 54.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 38.1 mmm -142.68 105.82 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.561 HG22 ' HB2' ' A' ' 162' ' ' HIS . 72.4 p -94.7 150.05 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -33.81 -50.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -55.04 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -55.16 -38.81 68.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.519 HD11 ' HB ' ' A' ' 158' ' ' VAL . 79.5 mt -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -71.67 -34.65 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.699 HD11 ' OE1' ' A' ' 198' ' ' GLN . 27.5 mt -80.7 -28.39 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.9 m -75.9 -21.21 57.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.564 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 14.3 m-85 -103.7 -8.74 19.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.568 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.5 OUTLIER -54.37 -46.92 98.88 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.52 0.676 . . . . 0.0 110.902 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.7 Cg_exo -48.02 -48.64 15.84 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 180' ' ' LEU . 39.7 m -81.83 -59.13 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 58.9 mt -33.17 -69.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.566 ' HG2' ' CH2' ' A' ' 177' ' ' TRP . 3.2 ttp -121.01 118.75 30.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.402 ' C ' ' HD3' ' A' ' 182' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.585 0.707 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.749 ' O ' HG23 ' A' ' 200' ' ' VAL . 81.8 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.861 0.362 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -50.81 -60.16 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.699 ' OE1' HD11 ' A' ' 174' ' ' ILE . 70.1 mt-30 -57.2 -43.94 83.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 t -55.92 -39.34 71.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 196' ' ' ILE . 92.8 t -46.7 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.124 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.42 -55.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.147 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -40.62 -40.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 204' ' ' PHE . 49.5 m -58.98 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 208' ' ' CYS . 10.7 m-85 -36.08 -56.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.67 HG12 HG23 ' A' ' 152' ' ' ILE . 60.7 mt -59.56 -46.43 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -55.57 -58.03 9.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -99.72 28.98 4.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.564 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -57.91 -27.48 63.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -82.34 -54.55 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.18 -36.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -50.54 -63.17 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -104.61 -55.74 2.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -55.0 -35.63 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 71.28 39.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -75.53 178.04 48.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.48 137.14 47.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.752 HG21 ' HD3' ' A' ' 126' ' ' LYS . 77.7 mt -59.16 125.92 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.28 170.31 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.166 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.94 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.21 0 CA-C-O 120.789 0.245 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 31' ' ' VAL . 17.8 tp -78.74 -45.51 20.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.733 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -48.15 -28.12 2.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -78.02 -45.66 23.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.5 mt -66.16 -42.78 88.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 27' ' ' LEU . 18.3 m -87.77 155.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -103.68 157.78 16.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.05 -44.19 30.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -58.74 -48.84 79.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -121.63 87.6 45.99 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.54 0.686 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.17 9.57 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.656 2.237 . . . . 0.0 112.364 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.434 HG23 ' HD2' ' A' ' 38' ' ' PRO . 72.1 mt -77.35 132.95 68.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.643 0.735 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.82 140.02 41.44 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.26 . . . . 0.0 112.316 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -55.24 -54.07 48.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 39' ' ' LEU . 82.4 t80 -38.17 -69.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.563 HG13 HD11 ' A' ' 97' ' ' LEU . 53.0 t -42.79 -55.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -50.29 -57.84 6.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HG2' HD13 ' A' ' 39' ' ' LEU . 36.2 mmtt -46.74 -39.13 11.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.431 ' HB2' HD13 ' A' ' 97' ' ' LEU . 73.0 m -68.01 -44.73 75.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.67 -53.09 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.8 -45.37 94.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 83' ' ' LEU . 57.8 t80 -43.06 -63.21 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -53.88 -57.3 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -40.85 -53.37 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -59.7 -39.72 85.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -86.37 26.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.148 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.48 172.55 48.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.469 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.66 37.36 3.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.6 p -116.63 29.68 7.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.732 ' O ' HD22 ' A' ' 58' ' ' LEU . 77.9 m -68.81 114.23 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.182 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.03 114.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.43 96.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 55' ' ' THR . 1.8 mm? -90.08 112.29 23.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.348 . . . . 0.0 110.917 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 22.0 m-85 72.29 33.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -126.63 -38.02 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.46 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 21.3 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.838 0.351 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.2 -55.9 7.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HA ' HD12 ' A' ' 71' ' ' ILE . 18.9 mt-30 -59.46 -21.36 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.93 -61.41 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.7 p30 -61.46 -41.0 96.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.476 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 80.9 mt -52.34 -43.11 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -81.88 -53.88 5.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ASP . 50.9 mttt -54.62 -65.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -40.94 -44.33 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.5 -35.9 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.9 t0 -66.98 -55.48 14.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -54.72 -34.53 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -158.12 151.81 23.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.15 -19.07 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -80.81 49.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.57 -177.78 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -145.72 139.82 26.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . 14.7 mt -84.25 -41.25 17.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.4 t -48.55 -50.22 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -57.53 -41.59 81.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 mtp -61.27 -26.43 67.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 54.08 45.81 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.6 151.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.107 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 p -60.83 129.77 43.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.5 t -42.83 -52.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.46 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 9.9 m120 -40.82 -48.07 3.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.5 -62.86 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.415 HG21 ' CE2' ' A' ' 47' ' ' PHE . 65.6 t -48.7 -54.03 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -46.46 -41.39 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.78 -60.16 4.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.67 -41.29 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.563 HD11 HG13 ' A' ' 41' ' ' VAL . 15.7 tp -49.64 -49.92 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 101' ' ' PHE . 32.5 mtmt -68.22 -47.46 67.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.13 -33.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -65.38 -47.12 77.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 151' ' ' VAL . 41.5 m-85 -57.04 -44.49 82.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.49 -39.6 88.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.49 -37.99 82.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -37.78 141.6 0.47 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -24.12 29.74 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.232 . . . . 0.0 112.343 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.68 153.83 77.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.655 0.74 . . . . 0.0 110.838 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 134.77 28.76 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.351 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' A' ' 148' ' ' PHE . 19.1 tp -38.95 -52.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.3 mt -87.35 124.35 68.27 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 0.0 111.155 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 154.82 67.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.69 2.26 . . . . 0.0 112.352 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -68.85 -26.47 65.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 m -65.71 -25.41 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.863 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.6 mt -111.58 36.66 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.967 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.651 ' CE1' ' SD ' ' A' ' 181' ' ' MET . 0.1 OUTLIER -77.94 -65.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.561 0.696 . . . . 0.0 110.829 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.71 -21.44 33.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.739 2.293 . . . . 0.0 112.344 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.64 -28.55 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.536 HD22 ' CG1' ' A' ' 200' ' ' VAL . 2.5 mt -79.91 -36.6 36.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.6 -46.47 25.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.95 -31.79 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 132' ' ' ALA . . . -86.84 -29.25 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.7 -21.17 59.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -91.97 22.04 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.07 130.07 45.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -44.83 1.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 102.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -40.18 -60.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 98.7 m -50.04 -57.09 8.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -50.27 -56.51 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -41.59 -57.15 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.472 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 52.7 mt -58.26 -54.18 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -47.0 -50.58 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.497 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . . . -52.14 -44.45 64.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.5 mt -71.02 -29.9 65.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -74.07 -30.18 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 7.2 pt-20 -87.32 -36.87 17.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.411 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 88.7 mt -69.89 -37.71 73.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.453 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 5.2 p -63.7 -7.73 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -77.61 -38.65 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.934 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -64.87 -29.88 70.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.1 m-85 -43.68 128.34 5.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.595 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -34.09 141.49 0.24 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.72 -10.11 27.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.733 HG11 ' HA ' ' A' ' 28' ' ' GLN . 41.8 t -99.09 -40.38 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -83.44 -35.12 25.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 4.4 t80 -57.0 -43.43 81.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.66 -49.31 70.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 151' ' ' VAL . 69.3 t -66.96 -50.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.532 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 37.4 t80 -54.13 -45.69 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -65.37 -47.15 77.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -59.27 -46.07 89.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 147' ' ' VAL . 85.0 t -53.19 -59.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.646 ' HA ' HD12 ' A' ' 155' ' ' LEU . 73.6 mt -48.88 -52.01 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.074 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.1 m -39.52 -34.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -83.44 -35.67 24.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 152' ' ' ILE . 68.9 mt -61.48 -49.53 76.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -50.01 -49.8 49.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -53.64 -43.36 68.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.8 -50.05 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.8 p -52.5 -21.64 3.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -58.18 -44.13 87.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.648 ' HB2' HD22 ' A' ' 165' ' ' ASN . 51.6 mt-30 -101.25 30.3 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.665 ' ND1' HG22 ' A' ' 168' ' ' THR . 7.4 p80 -45.48 -25.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -74.91 -36.61 62.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 161' ' ' GLN . 77.0 mt -84.29 -56.41 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.648 HD22 ' HB2' ' A' ' 161' ' ' GLN . 0.6 OUTLIER -81.08 16.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 165' ' ' ASN . 11.2 mt 34.49 54.78 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 7.7 mmm -150.12 108.39 3.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.665 HG22 ' ND1' ' A' ' 162' ' ' HIS . 72.4 p -94.09 157.76 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -38.67 -43.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -62.72 -58.73 6.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -45.6 -51.66 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.52 -30.78 70.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -75.69 -32.87 60.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.488 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 62.5 mt -78.24 -31.04 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.3 m -75.26 -34.05 61.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.606 ' CE2' HD21 ' A' ' 155' ' ' LEU . 12.0 m-85 -89.09 -40.75 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.623 ' O ' ' CE3' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.01 -56.81 0.7 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 0.0 110.948 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.513 ' HD3' ' CD1' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.02 -63.7 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.487 ' O ' ' C ' ' A' ' 180' ' ' LEU . 28.6 m -59.37 -56.09 26.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 177' ' ' TRP . 83.3 mt -31.34 -59.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.651 ' SD ' ' CE1' ' A' ' 114' ' ' HIS . 4.0 ttp -125.94 117.72 23.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 181' ' ' MET . 17.3 ttm180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.857 ' O ' HG23 ' A' ' 200' ' ' VAL . 74.4 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.795 0.331 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -50.58 -50.82 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.21 -44.35 72.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.0 m -54.02 -48.31 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 196' ' ' ILE . 74.2 t -38.69 -56.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.54 -50.03 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -46.71 -45.38 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 204' ' ' PHE . 97.7 m -57.93 -61.77 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.8 m-85 -35.04 -47.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 152' ' ' ILE . 68.6 mt -67.64 -58.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 219' ' ' GLU . 18.2 mt-30 -46.37 -41.39 13.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.472 ' HG3' ' CD1' ' A' ' 130' ' ' LEU . 7.1 mm-40 -116.28 34.9 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.578 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -68.38 -22.77 64.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -85.38 -55.35 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -39.95 -34.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.0 m-85 -51.81 -63.18 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.864 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -104.98 -55.86 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -58.01 -22.53 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.929 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 57.35 38.12 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.18 143.4 23.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 216' ' ' GLU . 7.5 mp0 -41.98 145.04 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.36 143.56 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.26 170.32 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.417 ' CD ' ' O ' ' A' ' 219' ' ' GLU . 12.7 tm-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.834 0.264 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.53 -53.86 26.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.476 ' CB ' HG21 ' A' ' 143' ' ' VAL . 2.7 pt20 -46.21 -32.01 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -40.68 30.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.01 -43.79 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 36' ' ' PRO . 20.9 m -90.98 172.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.0 p -112.03 161.61 16.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.38 -44.78 72.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.39 -45.2 80.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -127.21 95.37 36.55 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' O ' HG21 ' A' ' 31' ' ' VAL . 54.2 Cg_endo -69.72 -38.03 8.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.577 HG23 ' HD2' ' A' ' 38' ' ' PRO . 10.2 mt -75.04 136.56 72.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.666 0.746 . . . . 0.0 111.114 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.73 169.51 18.72 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.706 2.27 . . . . 0.0 112.333 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.636 HD11 ' HE2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -84.69 -46.07 11.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.923 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -48.19 -64.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 97' ' ' LEU . 55.4 t -43.94 -65.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -39.77 -53.61 2.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HE2' HD11 ' A' ' 39' ' ' LEU . 48.7 mmtt -56.48 -37.19 70.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.692 ' HB2' HD13 ' A' ' 97' ' ' LEU . 69.4 m -69.16 -45.52 69.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.444 HG13 ' CG ' ' A' ' 154' ' ' HIS . 46.4 t -64.01 -49.1 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.96 -43.37 83.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CZ ' HG21 ' A' ' 51' ' ' THR . 13.2 t80 -56.52 -61.39 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 44' ' ' CYS . 19.8 mt -41.05 -44.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' OE1' HD13 ' A' ' 53' ' ' LEU . 7.4 mm-40 -64.39 -42.32 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.19 -35.19 79.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.756 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 22.1 p -90.98 29.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.64 150.66 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 158' ' ' VAL . 11.9 tp -120.74 -34.51 3.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.916 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.1 p -56.36 -14.7 3.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.4 m -40.95 105.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -44.51 111.38 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.73 105.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 4.7 mp -105.88 -33.62 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -104.74 -55.63 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.969 ' HD3' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -59.37 -34.82 72.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.969 HG23 ' HD3' ' A' ' 60' ' ' ARG . 3.2 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ASP . 87.3 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -41.92 -49.96 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.67 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 8.1 mt-30 -67.58 -28.83 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.0 t70 -53.23 -53.61 48.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.6 p30 -60.14 -38.8 84.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 68' ' ' GLN . 54.4 mt -49.92 -50.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.49 -61.01 2.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -46.04 -58.99 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -53.42 -42.04 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -64.66 -37.75 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.06 -49.13 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -76.81 -24.93 52.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -133.31 99.66 4.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -72.32 -29.32 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -91.49 34.91 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.761 HD11 ' SD ' ' A' ' 86' ' ' MET . 10.1 tt -77.98 150.13 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -118.38 93.61 4.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -44.51 -42.08 6.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -52.81 -44.02 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 t -65.69 -27.71 68.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.761 ' SD ' HD11 ' A' ' 81' ' ' ILE . 62.6 mtp -70.96 -38.15 72.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 60.18 49.53 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 m -84.49 162.52 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' VAL . 66.8 p -67.23 115.18 6.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 51' ' ' THR . 60.9 t -33.65 -54.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.154 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -37.16 -49.33 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.468 ' HB1' ' HG3' ' A' ' 68' ' ' GLN . . . -55.05 -60.37 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.626 HG21 ' CE1' ' A' ' 47' ' ' PHE . 77.2 t -48.08 -62.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 58' ' ' LEU . . . -41.28 -35.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.15 -57.43 2.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.517 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.67 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -45.1 -43.66 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 111.066 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.692 HD13 ' HB2' ' A' ' 44' ' ' CYS . 34.3 tp -43.41 -45.29 6.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.582 ' HG2' ' CE1' ' A' ' 176' ' ' PHE . 28.5 mtmt -65.06 -46.82 79.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.67 -34.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -65.93 -38.76 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.84 -36.35 50.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.06 -39.31 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -59.95 -37.52 79.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -40.42 146.39 0.44 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 -21.67 32.99 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.336 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -142.82 155.07 63.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.542 0.687 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.74 48.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 148' ' ' PHE . 9.0 tp -43.66 -40.85 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mt -83.37 128.7 63.35 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.676 0.75 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 147.05 62.09 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.722 2.282 . . . . 0.0 112.318 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -64.66 -37.85 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.3 m -55.91 -15.11 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.8 mt -128.44 35.64 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.504 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -76.08 -63.32 0.62 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 0.0 110.859 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.69 -10.3 28.27 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -74.7 -33.78 62.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.18 -36.15 66.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 115' ' ' PRO . 6.1 mt -73.91 -54.3 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -49.53 -33.06 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.66 -22.46 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.75 -33.81 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -71.45 -10.23 59.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.44 127.92 85.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.622 0.725 . . . . 0.0 111.137 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -44.77 1.88 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.667 2.244 . . . . 0.0 112.351 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.77 108.64 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -46.66 -55.99 6.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.411 HG22 ' ND1' ' A' ' 131' ' ' HIS . 2.6 m -57.34 -65.26 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -42.42 -56.35 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -38.62 -46.14 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.7 mt -69.27 -58.47 3.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.411 ' ND1' HG22 ' A' ' 127' ' ' THR . 63.7 m80 -44.8 -51.85 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.97 -46.23 52.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 20.0 mt -68.53 -28.27 66.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -75.13 -32.54 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 5.2 pt-20 -84.04 -31.29 25.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 74.8 mt -75.26 -32.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.444 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.8 p -76.03 0.35 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.141 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -82.33 -41.13 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.25 22.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 2.3 m-85 -80.1 141.44 35.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.54 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.7 t-80 -39.91 141.94 0.73 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.604 0.716 . . . . 0.0 110.833 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.8 Cg_endo -69.81 -8.06 22.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.476 HG21 ' CB ' ' A' ' 28' ' ' GLN . 74.3 t -99.19 -48.33 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 141' ' ' HIS . 59.6 m-80 -73.47 -43.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -48.51 -42.19 32.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.95 -56.22 23.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 151' ' ' VAL . 63.8 t -63.63 -62.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.168 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.568 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 26.3 t80 -39.43 -39.94 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -70.43 -46.33 64.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.29 -36.66 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 147' ' ' VAL . 35.0 t -63.1 -64.69 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.078 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.719 HG23 HG12 ' A' ' 205' ' ' ILE . 80.2 mt -47.98 -52.1 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -40.94 -35.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.149 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.444 ' CG ' HG13 ' A' ' 45' ' ' VAL . 23.0 t60 -83.26 -40.91 18.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 176' ' ' PHE . 97.5 mt -54.47 -44.45 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -50.88 -45.34 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -55.77 -39.26 70.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.711 HG11 HD21 ' A' ' 172' ' ' LEU . 76.3 t -69.12 -38.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 p -64.32 -35.34 80.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -54.51 -38.0 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.693 ' OE1' HD12 ' A' ' 164' ' ' ILE . 21.4 mm-40 -99.1 28.77 4.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.597 ' CD2' HG22 ' A' ' 168' ' ' THR . 48.1 p-80 -54.6 -31.71 57.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -73.54 -21.69 60.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.693 HD12 ' OE1' ' A' ' 161' ' ' GLN . 74.3 mt -95.37 -57.59 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -89.86 26.24 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 165' ' ' ASN . 14.2 mt 32.56 41.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 9.7 mmm -128.72 104.5 7.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.597 HG22 ' CD2' ' A' ' 162' ' ' HIS . 60.8 p -96.57 150.67 20.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -36.16 -33.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 168' ' ' THR . 10.0 t70 -63.84 -57.43 9.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -51.4 -57.15 9.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.711 HD21 HG11 ' A' ' 158' ' ' VAL . 10.6 mt -53.67 -29.01 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.0 t -81.13 -37.36 28.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 70.1 mt -74.51 -24.78 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -75.27 -39.07 60.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.582 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 9.6 m-85 -88.99 -38.81 14.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.626 ' O ' ' CE3' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.78 -56.7 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.563 0.696 . . . . 0.0 110.906 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.501 ' CD ' ' O ' ' A' ' 174' ' ' ILE . 65.7 Cg_exo -48.04 -52.37 8.37 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 180' ' ' LEU . 58.7 m -70.42 -62.0 1.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 95.9 mt -34.05 -45.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 13.6 mtm -145.5 133.32 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 110.884 -179.941 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 200' ' ' VAL . 91.0 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.864 0.364 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 196' ' ' ILE . 60.0 m-70 -35.79 -48.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -68.3 -60.14 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 200' ' ' VAL . 21.1 m -43.28 -41.47 3.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 196' ' ' ILE . 99.5 t -36.75 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' GLU . 90.6 t -68.86 -55.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -34.24 -49.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.5 m -55.68 -62.9 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 11.7 m-85 -35.71 -51.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.719 HG12 HG23 ' A' ' 152' ' ' ILE . 85.8 mt -60.48 -57.35 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.132 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.434 ' HB3' HG23 ' A' ' 218' ' ' VAL . 5.5 mt-30 -49.43 -52.31 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.9 mm-40 -101.72 30.69 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.486 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 1.4 t -65.34 -19.45 65.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 213' ' ' TYR . 32.7 mm-40 -87.9 -45.89 9.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -37.17 20.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.486 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -50.71 -63.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -104.77 -55.45 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 209' ' ' GLN . 52.2 m-85 -58.25 -25.1 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 57.47 45.21 20.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -83.73 -179.04 52.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.64 147.93 44.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.457 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 45.8 mt -75.13 139.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.145 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 206' ' ' GLN . 27.2 m -124.05 177.68 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.817 0.257 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.473 ' O ' HG22 ' A' ' 31' ' ' VAL . 9.8 tp -72.39 -48.47 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.799 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -48.7 -25.27 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.49 -49.4 12.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.29 -43.81 97.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 27' ' ' LEU . 19.9 m -94.98 156.43 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.4 p -105.25 162.5 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.58 -39.02 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -63.45 -45.62 90.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -128.17 81.74 69.87 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -31.33 20.75 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.712 2.275 . . . . 0.0 112.359 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 147' ' ' VAL . 62.1 mt -82.4 127.82 69.49 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.563 0.696 . . . . 0.0 111.139 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 161.67 45.03 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.683 2.256 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.595 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.63 -56.33 5.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -38.6 -63.83 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.729 HG13 HD11 ' A' ' 97' ' ' LEU . 55.1 t -44.95 -58.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -48.79 -59.93 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HG2' HD13 ' A' ' 39' ' ' LEU . 51.3 mmtt -43.52 -39.8 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.84 -48.87 57.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 150' ' ' TYR . 64.2 t -58.71 -45.59 90.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CD ' ' HA ' ' A' ' 43' ' ' LYS . 11.7 pt-20 -67.22 -41.31 85.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 1.025 ' CE1' HG21 ' A' ' 93' ' ' VAL . 17.7 t80 -53.02 -63.39 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 94' ' ' ALA . 98.1 mt -39.98 -48.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.05 -43.52 98.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.23 -41.03 96.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 90' ' ' VAL . 13.2 t -85.66 28.55 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.141 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.52 165.07 24.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.42 41.52 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 p -129.12 43.36 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -95.09 136.52 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.176 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -81.42 117.88 22.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.4 99.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.837 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.13 -0.41 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 15.7 m-85 -123.11 -38.31 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -85.0 -29.3 25.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.3 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.786 0.326 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.489 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 51.4 m-20 -60.6 -53.36 58.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.68 ' HA ' HD12 ' A' ' 71' ' ' ILE . 44.2 mt-30 -49.12 -40.73 33.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.52 -68.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 24.8 p30 -59.82 -39.5 85.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 68' ' ' GLN . 45.4 mt -43.93 -44.15 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -77.45 -46.28 23.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -56.95 -63.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -43.2 -44.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.13 -42.12 97.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.08 -46.25 88.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -61.63 -36.22 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -158.34 154.78 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -102.06 -20.69 14.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.47 54.85 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 pt -118.78 -178.8 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -144.69 145.12 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.4 mt -89.15 -42.59 11.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.01 -53.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -50.33 -46.58 55.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.6 mtp -52.97 -28.53 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 53.23 41.45 32.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.66 163.95 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.567 HG23 ' H ' ' A' ' 92' ' ' ALA . 13.8 t -70.91 149.38 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.425 HG22 HG21 ' A' ' 51' ' ' THR . 75.6 t -59.98 -54.41 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -40.19 -39.52 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.567 ' H ' HG23 ' A' ' 89' ' ' THR . . . -62.1 -64.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.025 HG21 ' CE1' ' A' ' 47' ' ' PHE . 94.1 t -45.28 -50.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -43.89 -51.89 7.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.408 ' C ' ' OE1' ' A' ' 68' ' ' GLN . . . -65.19 -47.31 82.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.678 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -46.32 -48.84 18.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.064 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.729 HD11 HG13 ' A' ' 41' ' ' VAL . 8.2 tp -48.84 -50.01 36.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 43.9 mtmt -65.61 -46.76 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.56 -47.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.66 -53.29 60.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -53.5 -50.25 65.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.85 -42.76 65.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 104' ' ' LEU . 13.1 t0 -52.51 -42.13 64.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 103' ' ' ASP . 80.5 mt -36.62 141.04 0.39 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -18.89 36.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.79 152.68 56.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.674 0.75 . . . . 0.0 110.859 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.73 134.82 28.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 107' ' ' PRO . 5.4 tp -33.95 -52.87 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.0 mt -73.86 127.0 89.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.634 0.731 . . . . 0.0 111.161 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.571 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.6 Cg_endo -69.76 143.93 52.4 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.272 . . . . 0.0 112.331 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.498 ' HA ' ' CG ' ' A' ' 114' ' ' HIS . 4.1 m-85 -59.71 -32.16 70.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 t -59.29 -24.07 62.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.571 HD12 ' HG2' ' A' ' 110' ' ' PRO . 18.1 mt -117.64 30.21 7.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.498 ' CG ' ' HA ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -75.03 -62.42 0.87 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.642 0.734 . . . . 0.0 110.849 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.4 Cg_endo -69.78 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -81.04 -30.76 34.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mt -74.22 -38.15 63.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.544 HD23 HG21 ' A' ' 200' ' ' VAL . 10.2 mt -75.39 -59.81 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -40.35 -33.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.509 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -84.27 -33.99 23.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.076 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -67.16 -26.39 66.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -87.0 26.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 95.3 mt -95.64 130.76 30.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 111.182 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -46.63 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 0.0 112.372 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 61.9 m-20 -60.39 91.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 125' ' ' ASP . 32.8 tttt -34.7 -56.49 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.0 m -53.1 -58.58 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.65 -57.73 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -39.92 -56.96 1.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.2 mt -55.76 -56.77 16.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -48.64 -38.48 21.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.509 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -63.34 -40.03 96.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.5 mt -77.19 -24.35 51.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 138' ' ' LYS . 40.1 tttp -81.67 -23.62 36.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.04 -33.9 16.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.546 HG22 ' HE1' ' A' ' 140' ' ' PHE . 48.5 mt -74.83 -26.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.602 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.1 p -77.93 -11.16 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 134' ' ' LYS . 27.9 mttm -74.74 -41.7 59.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -81.39 19.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.1 m-85 -80.73 138.03 36.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.6 t-80 -38.06 142.64 0.45 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.75 -7.72 21.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.362 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 28' ' ' GLN . 92.8 t -99.75 -39.11 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.77 -46.48 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.467 ' CE2' ' O ' ' A' ' 137' ' ' VAL . 1.3 t80 -41.83 -54.56 3.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.34 -65.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 151' ' ' VAL . 66.3 t -50.52 -40.58 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.575 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 3.9 t80 -51.07 -48.54 61.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -58.14 -58.35 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.429 ' CE2' HG21 ' A' ' 45' ' ' VAL . 37.8 t80 -52.58 -45.06 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 147' ' ' VAL . 94.8 t -56.51 -66.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.66 HG23 HG12 ' A' ' 205' ' ' ILE . 64.3 mt -54.22 -56.16 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.9 m -41.09 -34.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -76.89 -42.73 38.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.632 HD13 HD11 ' A' ' 205' ' ' ILE . 30.5 mt -60.81 -51.83 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -45.12 -44.27 10.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 56.7 mtt-85 -56.96 -50.47 72.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.23 -50.17 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 p -51.58 -29.67 18.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 157' ' ' ARG . 35.2 mm-40 -46.51 -57.39 4.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -100.58 41.63 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.511 ' ND1' HG22 ' A' ' 168' ' ' THR . 27.3 p80 -57.81 -21.44 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -71.06 -34.15 70.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.83 -58.76 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.088 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -79.58 12.84 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 15.2 mt 38.11 53.86 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.435 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 19.7 mmm -148.53 108.05 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.511 HG22 ' ND1' ' A' ' 162' ' ' HIS . 30.5 p -92.22 166.77 12.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -53.27 -34.25 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.439 ' CG ' ' HG3' ' A' ' 202' ' ' GLU . 1.1 m-20 -70.38 -48.49 56.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -55.82 -35.9 66.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 169' ' ' ALA . 8.6 mt -69.8 -46.9 64.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.2 t -53.9 -38.96 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.403 HG12 ' CD ' ' A' ' 198' ' ' GLN . 15.7 mt -78.95 -33.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.6 m -70.58 -25.6 63.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.51 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 21.4 m-85 -97.72 -16.8 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.564 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -46.69 -47.16 50.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.567 0.699 . . . . 0.0 110.901 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.1 Cg_exo -48.03 -48.6 15.95 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.692 2.262 . . . . 0.0 112.31 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 180' ' ' LEU . 76.0 m -84.02 -64.48 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 179' ' ' THR . 49.8 mt -34.61 -63.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 46.2 mmm -111.16 117.37 33.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 0.0 110.874 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 36.5 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.858 0.361 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.452 ' ND1' HD21 ' A' ' 118' ' ' LEU . 53.3 m-70 -42.58 -60.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.403 ' CD ' HG12 ' A' ' 174' ' ' ILE . 93.2 mt-30 -49.64 -44.52 47.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.0 m -60.64 -42.71 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.544 HG21 HD23 ' A' ' 118' ' ' LEU . 90.9 t -38.08 -69.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 202' ' ' GLU . 60.3 t -62.32 -55.88 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.439 ' HG3' ' CG ' ' A' ' 170' ' ' ASP . 2.1 tm-20 -37.88 -40.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 204' ' ' PHE . 65.8 m -64.9 -60.87 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.12 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' CYS . 12.3 m-85 -34.11 -54.11 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.66 HG12 HG23 ' A' ' 152' ' ' ILE . 68.0 mt -61.85 -56.59 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -46.38 -49.65 17.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.7 mm-40 -109.51 34.19 3.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 4.2 t -65.79 -19.72 65.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.889 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -84.94 -54.98 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.87 -38.63 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -47.47 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.13 -53.7 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -58.5 -25.12 62.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 58.68 43.15 19.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -87.36 144.17 19.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 215' ' ' GLY . 10.1 mm-40 -35.14 149.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.474 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.6 mt -74.29 133.81 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.176 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.5 172.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.825 0.261 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 tp -47.54 -46.81 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.86 ' HB3' HG21 ' A' ' 143' ' ' VAL . 6.3 pt20 -53.07 -30.4 35.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -46.02 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.8 mt -59.83 -44.11 94.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG11 ' O ' ' A' ' 36' ' ' PRO . 5.2 m -90.43 171.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 p -118.95 156.26 29.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -46.9 -45.97 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -59.66 -46.21 89.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -126.58 86.73 57.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.551 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.3 Cg_endo -69.81 -29.89 22.91 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.684 2.256 . . . . 0.0 112.361 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.492 HG23 ' HD2' ' A' ' 38' ' ' PRO . 7.8 mt -84.16 134.51 43.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 111.154 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.71 146.81 61.62 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.538 HD11 ' CE ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -67.17 -40.81 86.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -51.6 -60.88 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG13 HD11 ' A' ' 97' ' ' LEU . 74.1 t -49.24 -63.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -40.61 -55.43 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.538 ' CE ' HD11 ' A' ' 39' ' ' LEU . 40.9 mmtt -55.87 -41.21 74.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.683 ' HB2' HD13 ' A' ' 97' ' ' LEU . 94.5 m -61.33 -40.71 95.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.656 HG13 ' CG ' ' A' ' 154' ' ' HIS . 25.2 t -71.22 -54.85 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -50.33 -33.69 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' A' ' 93' ' ' VAL . 19.5 t80 -60.74 -62.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.8 mt -47.34 -43.04 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.14 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.95 -26.51 59.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.35 -22.4 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -110.75 11.62 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 164.02 6.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HG ' HG22 ' A' ' 158' ' ' VAL . 1.7 mm? -107.83 75.15 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -25.08 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -51.34 117.22 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.33 117.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.7 94.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.471 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -101.75 -34.73 9.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.7 -63.96 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.618 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.34 -16.22 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.618 HG23 ' CD ' ' A' ' 60' ' ' ARG . 76.2 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.766 0.317 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . 6.2 m-20 -54.66 -60.49 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.845 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -59.92 -44.78 94.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -41.62 -49.5 4.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 16.1 p30 -73.17 -34.78 66.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 68' ' ' GLN . 52.1 mt -55.4 -45.97 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -79.57 -48.63 13.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -57.46 -59.27 5.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -50.26 -48.24 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.4 ' O ' ' O ' ' A' ' 78' ' ' ASP . 40.8 t80 -50.01 -56.05 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -54.59 -33.11 59.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -81.72 -18.41 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 75' ' ' PHE . 5.2 t0 -149.53 118.87 6.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -83.75 -24.23 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -98.57 36.38 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.771 HD11 ' SD ' ' A' ' 86' ' ' MET . 6.0 tt -79.73 151.76 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -124.24 94.53 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.7 mt -40.55 -44.39 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.0 t -49.05 -47.88 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 t -58.11 -43.22 87.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.771 ' SD ' HD11 ' A' ' 81' ' ' ILE . 85.4 mtp -59.03 -36.13 74.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 59.28 44.75 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -80.18 173.84 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.9 p -69.11 111.88 5.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.5 t -37.44 -50.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -45.36 -45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 67' ' ' ASP . . . -52.37 -63.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 47' ' ' PHE . 95.5 t -45.83 -44.85 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.95 -38.59 67.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.58 -56.29 3.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 68' ' ' GLN . . . -45.87 -36.92 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 111.099 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 44' ' ' CYS . 16.8 tp -60.08 -47.39 86.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -65.96 -38.73 89.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.44 -36.87 55.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.093 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -62.9 -40.69 98.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.53 ' HB2' HG21 ' A' ' 179' ' ' THR . 5.1 m-85 -63.02 -41.68 99.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.07 80.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -34.31 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -41.48 147.4 0.48 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -28.71 24.8 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.94 139.47 16.07 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.605 0.717 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.9 Cg_endo -69.77 136.51 33.16 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.674 2.249 . . . . 0.0 112.321 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.45 HD23 ' CD1' ' A' ' 148' ' ' PHE . 5.5 mp -34.97 -49.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.2 mt -91.51 107.41 21.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 0.0 111.133 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.497 ' HG2' HD12 ' A' ' 113' ' ' LEU . 54.1 Cg_endo -69.72 149.42 67.15 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.407 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.48 -27.42 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 m -66.02 -8.19 21.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.497 HD12 ' HG2' ' A' ' 110' ' ' PRO . 70.4 mt -128.39 21.7 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.501 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -67.93 -60.13 5.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 0.0 110.81 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.516 ' HA ' HD12 ' A' ' 118' ' ' LEU . 53.7 Cg_endo -69.78 -25.15 28.8 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.93 -27.35 67.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.778 ' HB3' HG11 ' A' ' 200' ' ' VAL . 3.4 mt -78.77 -18.71 53.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.941 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.532 HD23 HG21 ' A' ' 200' ' ' VAL . 10.6 mt -92.56 -47.83 6.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -48.29 -40.37 24.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.599 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -83.73 -20.47 33.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -77.61 -21.79 51.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -93.8 17.87 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 128' ' ' GLU . 96.5 mt -81.73 129.58 64.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 111.145 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -44.79 1.87 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.317 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.2 t70 -67.02 94.08 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.838 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.0 tptp -34.64 -50.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.2 m -52.5 -57.76 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.498 ' HB2' HG21 ' A' ' 123' ' ' ILE . 17.8 mm-40 -56.74 -49.18 75.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -45.74 -53.98 8.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.431 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 37.3 mt -65.57 -62.24 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -41.82 -28.65 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.599 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -75.52 -50.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 13.5 mt -65.77 -22.81 66.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 137' ' ' VAL . 39.7 tttp -81.94 -30.61 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.926 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -85.89 -29.75 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.478 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 11.1 p -86.66 -6.48 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -77.78 -41.57 36.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -16.06 62.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.1 m-85 -46.82 151.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.9 t-80 -42.46 138.32 2.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.74 -20.72 34.59 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.35 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.86 HG21 ' HB3' ' A' ' 28' ' ' GLN . 43.4 t -92.27 -44.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.406 HD22 HD12 ' A' ' 108' ' ' LEU . 2.7 m120 -73.9 -48.06 33.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -39.24 -53.71 1.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -47.65 -48.93 28.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 151' ' ' VAL . 30.5 t -69.26 -57.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.159 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.488 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 10.7 t80 -42.24 -45.5 4.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -60.85 -53.59 55.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -54.57 -43.83 72.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 147' ' ' VAL . 82.0 t -52.61 -62.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.154 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.49 ' HA ' HD12 ' A' ' 155' ' ' LEU . 3.3 mt -46.49 -51.13 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.4 m -40.93 -37.91 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.656 ' CG ' HG13 ' A' ' 45' ' ' VAL . 84.6 t60 -80.26 -39.2 29.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.575 HD21 ' CE2' ' A' ' 176' ' ' PHE . 96.6 mt -54.52 -45.85 73.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.22 -49.82 60.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -51.79 -53.24 42.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.43 HG22 ' HG ' ' A' ' 53' ' ' LEU . 41.0 t -60.24 -35.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.8 p -66.24 -22.34 66.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -73.98 -31.59 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.476 HE21 HD12 ' A' ' 164' ' ' ILE . 3.1 mm100 -95.78 27.7 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.519 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 11.1 p80 -60.11 -16.47 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.827 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 14.0 mmmt -86.5 -5.53 59.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.476 HD12 HE21 ' A' ' 161' ' ' GLN . 26.2 mt -115.33 -60.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.37 9.31 11.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.8 mt 47.46 43.95 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 23.2 mtp -129.96 106.26 8.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.473 HG22 ' CG ' ' A' ' 162' ' ' HIS . 78.1 p -97.57 151.24 20.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.77 -35.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 168' ' ' THR . 2.1 t70 -66.04 -60.45 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -47.81 -49.07 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 7.4 mt -62.13 -49.06 77.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 t -51.71 -43.57 62.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -77.0 -38.01 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.19 -16.0 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.575 ' CE2' HD21 ' A' ' 155' ' ' LEU . 9.9 m-85 -107.16 -11.72 15.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.565 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.23 -46.77 93.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.526 0.679 . . . . 0.0 110.896 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.0 -63.59 0.3 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.53 HG21 ' HB2' ' A' ' 101' ' ' PHE . 28.9 m -67.04 -57.97 5.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 179' ' ' THR . 39.9 mt -34.22 -51.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.432 ' SD ' ' CZ2' ' A' ' 177' ' ' TRP . 0.6 OUTLIER -152.52 119.2 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 42.7 ttm-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.884 -179.949 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 200' ' ' VAL . 71.4 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.847 0.356 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.475 ' HA ' HD21 ' A' ' 118' ' ' LEU . 32.8 m80 -41.35 -47.95 3.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -73.43 -56.24 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.0 m -42.09 -39.34 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 196' ' ' ILE . 58.2 t -46.6 -72.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' PHE . 68.9 t -55.04 -57.34 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -39.84 -36.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 60.3 m -69.86 -39.05 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.189 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' VAL . 12.2 m-85 -55.53 -41.79 73.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.15 -54.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.06 -56.17 25.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.431 ' HG3' ' CD2' ' A' ' 130' ' ' LEU . 38.4 mm-40 -81.9 16.9 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.583 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 18.2 t -58.55 -22.74 56.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.92 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.582 ' N ' ' CD ' ' A' ' 209' ' ' GLN . 0.2 OUTLIER -78.59 -62.51 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -39.5 -39.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 17.4 m-30 -52.2 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -107.57 -52.17 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 209' ' ' GLN . 65.4 m-85 -62.22 -11.71 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 61.3 t30 45.78 41.04 7.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -70.46 -151.35 0.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.435 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.07 165.98 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.0 mt -75.56 121.57 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.9 175.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.813 0.256 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' VAL . 18.3 tp -64.78 -49.25 71.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HA ' HG11 ' A' ' 143' ' ' VAL . 11.1 pt20 -43.87 -37.2 2.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.91 -50.58 33.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.26 -45.49 83.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 27' ' ' LEU . 33.8 m -91.74 171.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.1 p -120.28 158.06 27.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.21 -46.27 45.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.51 -44.28 72.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -132.1 90.4 35.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.97 8.45 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.7 mt -72.8 130.25 85.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 147' ' ' VAL . 54.0 Cg_endo -69.79 108.8 2.16 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.316 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.492 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -36.04 -57.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 39' ' ' LEU . 31.0 t80 -34.21 -64.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 HD11 ' A' ' 97' ' ' LEU . 79.7 t -43.82 -59.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -42.91 -61.94 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 64.0 mmtt -43.53 -41.09 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.9 m -68.35 -41.35 80.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.487 HG13 ' CG ' ' A' ' 154' ' ' HIS . 76.3 t -65.94 -51.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.67 -45.28 93.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' A' ' 93' ' ' VAL . 32.5 t80 -45.69 -57.14 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.8 mt -45.27 -44.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.546 ' OE1' HD13 ' A' ' 53' ' ' LEU . 19.0 mm-40 -62.4 -57.41 11.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.65 -39.38 35.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -84.51 29.93 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.44 164.19 21.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.486 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.546 HD13 ' OE1' ' A' ' 49' ' ' GLU . 11.6 tp -126.81 41.04 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.748 0.309 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -124.38 37.99 4.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.6 m -98.75 128.38 44.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.36 145.75 29.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.75 45.24 4.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.535 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.509 ' H ' HD23 ' A' ' 58' ' ' LEU . 2.2 pt? -58.41 -37.96 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.45 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 60.7 m-85 -99.18 -51.95 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -44.03 -54.24 5.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.18 179.925 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.762 0.315 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.512 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 2.5 m-20 -41.26 -61.23 1.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.863 ' HA ' HD12 ' A' ' 71' ' ' ILE . 11.9 mt-30 -40.8 -40.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -67.17 -50.41 61.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -50.29 -47.22 55.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.863 HD12 ' HA ' ' A' ' 68' ' ' GLN . 28.4 mt -44.77 -43.9 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.118 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -82.82 -52.26 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -52.85 -62.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.27 -45.65 34.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.57 -44.23 97.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -63.32 -53.3 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -52.25 -39.27 60.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.23 152.58 22.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.78 -22.19 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.84 51.73 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.0 pt -107.19 -174.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 2.1 t-20 -151.03 119.32 6.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.26 -50.87 64.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.54 -40.92 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 68.6 m -60.39 -45.49 93.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.3 mtp -52.74 -32.44 43.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 60.86 45.66 9.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.01 168.87 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 90' ' ' VAL . 24.9 p -75.29 116.33 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 89' ' ' THR . 85.2 t -33.75 -54.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.092 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -36.12 -57.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -39.04 -59.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 47' ' ' PHE . 96.9 t -46.01 -55.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -46.17 -44.48 16.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.24 -60.26 6.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.511 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.05 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HG13 ' A' ' 41' ' ' VAL . 23.5 tp -53.47 -48.94 68.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 101' ' ' PHE . 29.7 mtmt -69.26 -52.5 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.8 -42.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.123 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -59.16 -47.74 84.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' LYS . 16.2 m-85 -56.18 -51.45 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.48 71.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 104' ' ' LEU . 64.4 m-20 -51.3 -42.77 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.6 mt -34.22 142.26 0.23 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -22.89 31.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -134.7 152.93 78.5 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.582 0.706 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 132.06 22.47 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.34 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -38.47 -47.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 mt -91.87 121.31 67.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 0.0 111.15 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.63 40.86 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -54.68 -34.31 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE1' ' A' ' 116' ' ' GLU . 22.2 m -55.56 -29.15 58.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.2 mt -110.8 36.16 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.544 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -79.13 -65.49 0.3 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.632 0.73 . . . . 0.0 110.879 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.679 ' HA ' HD12 ' A' ' 118' ' ' LEU . 54.3 Cg_endo -69.74 -31.89 19.72 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.382 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 112' ' ' SER . 24.5 mp0 -60.47 -35.38 75.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.544 HD11 ' HZ ' ' A' ' 140' ' ' PHE . 12.1 mt -72.14 -39.46 68.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.679 HD12 ' HA ' ' A' ' 115' ' ' PRO . 4.9 mt -70.45 -55.48 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 13.6 pt-20 -46.82 -36.22 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -75.99 -25.78 56.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -78.15 -28.68 48.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 119' ' ' GLU . 2.4 pttt -90.47 27.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.525 HG23 ' HD2' ' A' ' 124' ' ' PRO . 89.0 mt -89.5 135.18 31.26 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.654 0.74 . . . . 0.0 111.109 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.525 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.82 -48.64 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.647 2.231 . . . . 0.0 112.345 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -66.15 95.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 125' ' ' ASP . 14.1 tptm -36.82 -53.44 0.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 50.7 m -52.23 -51.32 59.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -60.31 -49.05 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -47.2 -49.7 22.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.93 -62.65 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -40.43 -50.84 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.29 48.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.03 -34.12 76.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.55 ' O ' HG12 ' A' ' 137' ' ' VAL . 23.0 tttm -68.32 -35.93 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 4.0 pt-20 -81.8 -32.7 31.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.474 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 51.0 mt -73.2 -34.77 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 134' ' ' LYS . 8.4 p -67.35 -18.6 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.88 -34.48 75.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -66.95 -34.97 78.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.544 ' HZ ' HD11 ' A' ' 117' ' ' LEU . 11.8 m-85 -42.66 132.39 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -33.47 142.68 0.19 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.82 -16.94 37.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 28' ' ' GLN . 91.9 t -90.94 -39.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.15 -38.26 24.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.418 ' CZ ' ' HD3' ' A' ' 149' ' ' ARG . 46.3 t80 -52.47 -42.26 64.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.97 -42.44 80.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.84 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 151' ' ' VAL . 98.9 t -74.31 -44.37 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.581 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 26.2 t80 -58.76 -40.92 85.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.854 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.418 ' HD3' ' CZ ' ' A' ' 145' ' ' TYR . 47.2 ttp180 -67.62 -49.95 60.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -60.8 -47.66 85.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 147' ' ' VAL . 93.2 t -50.83 -65.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.139 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.839 HG23 HG12 ' A' ' 205' ' ' ILE . 75.8 mt -41.97 -50.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -40.51 -40.8 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.487 ' CG ' HG13 ' A' ' 45' ' ' VAL . 85.7 t60 -73.46 -40.14 64.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 152' ' ' ILE . 51.1 mt -59.65 -44.03 93.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.454 ' HB2' HG23 ' A' ' 205' ' ' ILE . 0.4 OUTLIER -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -58.93 -48.22 82.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.5 t -55.04 -46.86 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.3 p -56.57 -29.43 62.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -47.48 -56.35 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -100.45 33.73 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.598 ' CE1' ' HD3' ' A' ' 163' ' ' LYS . 7.3 p80 -51.62 -19.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.598 ' HD3' ' CE1' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -55.31 -34.68 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.49 -56.46 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -27.16 68.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 75.8 mt 64.12 39.4 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.6 mmm -131.52 82.75 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 32.8 p -71.99 163.43 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.14 -46.74 5.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.437 ' OD1' HD11 ' A' ' 174' ' ' ILE . 6.7 t70 -60.25 -59.61 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -47.53 -50.01 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.35 -47.75 78.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.6 t -59.1 -44.58 91.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.437 HD11 ' OD1' ' A' ' 170' ' ' ASP . 57.9 mt -70.25 -31.49 47.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 48.9 t -70.79 -34.8 72.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.483 ' CE1' HD21 ' A' ' 155' ' ' LEU . 22.7 m-85 -90.23 -15.55 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.559 ' CZ3' ' HG2' ' A' ' 181' ' ' MET . 0.8 OUTLIER -47.55 -46.67 60.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.926 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.3 Cg_exo -48.04 -51.66 9.58 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.461 ' O ' ' C ' ' A' ' 180' ' ' LEU . 89.6 m -76.44 -63.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 179' ' ' THR . 87.4 mt -33.49 -70.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.559 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 2.3 ttm -100.03 112.04 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.812 -179.896 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 200' ' ' VAL . 75.9 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.834 0.35 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.457 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 48.4 m-70 -39.08 -63.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -51.91 -58.08 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.3 m -43.37 -44.16 5.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 196' ' ' ILE . 48.1 t -46.25 -68.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.53 -47.32 93.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -46.32 -48.71 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.1 m -57.42 -57.87 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.457 ' C ' ' O ' ' A' ' 203' ' ' THR . 10.2 m-85 -33.98 -49.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.839 HG12 HG23 ' A' ' 152' ' ' ILE . 49.9 mt -70.39 -50.67 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -48.5 -45.45 37.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 9.4 mm-40 -117.44 36.92 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.572 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 22.9 t -64.1 -30.74 71.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -75.13 -51.67 12.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -43.82 -37.04 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -51.19 -63.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -101.25 -56.7 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -56.26 -38.04 70.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 73.18 42.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.886 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.3 169.29 53.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -58.82 136.05 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.429 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 66.3 mt -61.39 121.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -94.15 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.954 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m 61.11 45.57 8.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m -90.94 101.26 14.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.839 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.69 141.05 14.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 m -97.14 162.63 13.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.1 p -116.11 -24.35 8.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.2 -157.79 15.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.485 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.61 153.92 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.845 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -137.93 153.98 49.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -174.02 170.37 3.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -129.78 140.78 39.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.612 0.72 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 153.82 68.31 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.698 2.266 . . . . 0.0 112.308 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -168.17 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 p -87.99 174.84 8.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -144.49 128.03 17.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 18' ' ' TRP . 4.8 ptm180 -111.19 -179.27 3.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 16' ' ' ARG . 10.0 p-10 -35.42 -34.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.441 ' N ' ' O ' ' A' ' 16' ' ' ARG . 54.5 t-105 -174.17 164.41 4.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -138.53 105.32 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 t -168.95 143.54 3.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.2 11.09 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.482 ' CD2' HD22 ' A' ' 30' ' ' LEU . 7.4 m-85 -100.44 -47.76 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.577 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -46.83 -43.67 18.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' N ' ' CD1' ' A' ' 23' ' ' PHE . . . -64.69 -37.72 94.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 15.0 mmt -85.89 146.17 42.78 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.568 0.699 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 156.91 62.06 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.627 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.4 tp -51.1 -42.6 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.25 -31.78 22.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -85.51 -44.63 12.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.482 HD22 ' CD2' ' A' ' 22' ' ' TYR . 11.1 mt -57.84 -46.84 84.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 27' ' ' LEU . 17.7 m -88.05 171.54 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 p -124.15 165.64 17.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.37 65.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.49 -47.82 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -126.82 91.74 46.38 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.6 0.714 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -30.53 21.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.686 2.257 . . . . 0.0 112.329 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.526 HG23 ' HD2' ' A' ' 38' ' ' PRO . 14.7 mt -84.3 135.22 41.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.63 0.729 . . . . 0.0 111.129 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 130.32 19.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.635 HD21 ' HE2' ' A' ' 43' ' ' LYS . 5.4 tp -52.2 -53.19 46.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' LEU . 16.8 t80 -36.27 -56.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 HD11 ' A' ' 97' ' ' LEU . 53.0 t -54.45 -62.63 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -47.68 -59.74 3.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.635 ' HE2' HD21 ' A' ' 39' ' ' LEU . 24.5 mmtm -44.43 -36.59 2.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.3 m -75.24 -38.38 60.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -72.9 -60.12 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -54.02 -32.9 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -63.28 -57.67 9.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.9 mt -50.35 -53.54 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.42 -45.04 85.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.58 -41.23 97.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.7 p -89.05 23.35 2.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.65 135.43 4.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.456 ' CD2' ' HB3' ' A' ' 157' ' ' ARG . 15.1 tp -103.72 35.48 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.7 ' HB2' HG21 ' A' ' 164' ' ' ILE . 15.1 p -121.63 40.34 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.625 HG21 ' HB ' ' A' ' 90' ' ' VAL . 18.4 m -92.28 112.31 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.7 tt0 -34.76 120.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.14 77.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.613 HD21 HG11 ' A' ' 158' ' ' VAL . 1.6 pt? -61.25 -29.05 69.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -108.41 -49.62 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -49.63 -49.78 45.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.9 t -107.89 123.26 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.6 m -106.7 -37.06 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.83 -99.76 2.24 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -93.66 154.7 17.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -105.47 -37.71 6.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 m -46.55 -40.02 11.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.165 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -51.0 -45.74 61.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.605 ' HA ' HD12 ' A' ' 71' ' ' ILE . 64.2 mt-30 -65.11 -35.03 79.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.93 -58.4 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.0 p30 -64.35 -36.05 82.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 68' ' ' GLN . 57.4 mt -54.3 -47.35 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -78.25 -40.08 38.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -64.7 -67.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -44.99 -45.65 10.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.87 -34.92 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.9 -52.04 48.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.57 -21.56 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -145.47 113.82 6.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -84.6 -3.23 58.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -101.91 23.53 11.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.458 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 6.0 tt -68.97 156.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.458 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 2.5 t-20 -125.94 91.63 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASN . 84.3 mt -36.94 -48.06 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -51.47 -48.71 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -54.39 -39.57 67.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.406 ' HB3' HG13 ' A' ' 88' ' ' VAL . 40.8 mmm -66.97 -32.44 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 56.94 47.22 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' A' ' 86' ' ' MET . 31.6 m -81.45 179.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.599 HG23 ' H ' ' A' ' 92' ' ' ALA . 9.2 t -87.55 127.42 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.625 ' HB ' HG21 ' A' ' 55' ' ' THR . 93.9 t -40.19 -47.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -48.31 -40.47 25.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.599 ' H ' HG23 ' A' ' 89' ' ' THR . . . -62.76 -61.99 2.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.6 -38.28 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' LEU . . . -57.75 -50.09 74.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.19 -49.81 64.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.21 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HG13 ' A' ' 41' ' ' VAL . 34.2 tp -58.86 -46.56 87.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' ALA . 30.0 mtmt -67.24 -52.01 46.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.45 -45.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -53.45 -53.42 51.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CB ' HG21 ' A' ' 179' ' ' THR . 34.9 m-85 -58.15 -33.61 69.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -28.58 64.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LEU . 1.9 t70 -75.22 -31.57 60.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' ASP . 67.2 mt -35.72 143.51 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.743 2.295 . . . . 0.0 112.283 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -139.05 154.28 72.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.639 0.733 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.6 Cg_endo -69.82 130.09 18.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.309 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.434 HD21 ' CD1' ' A' ' 148' ' ' PHE . 12.0 tp -35.73 -51.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -91.95 126.33 53.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.669 0.747 . . . . 0.0 111.155 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.466 ' CG ' HD12 ' A' ' 113' ' ' LEU . 53.2 Cg_endo -69.81 161.49 45.75 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -78.95 -11.49 60.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.429 ' O ' HD23 ' A' ' 113' ' ' LEU . 30.9 t -88.67 5.45 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 117' ' ' LEU . 80.0 mt -133.96 19.85 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.5 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.2 m170 -71.09 -60.11 3.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.56 0.695 . . . . 0.0 110.855 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.76 -27.13 26.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.363 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.79 -32.14 72.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.4 mt -77.27 -34.38 55.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 197' ' ' HIS . 9.6 mt -78.95 -44.04 23.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.2 -23.66 62.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.64 -9.48 29.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.486 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -95.18 -28.79 14.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -80.98 -3.44 51.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.652 HG23 ' HD2' ' A' ' 124' ' ' PRO . 67.4 mt -56.37 138.29 75.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.652 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.84 -50.71 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.649 2.232 . . . . 0.0 112.324 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.99 107.36 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -46.32 -52.21 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -55.09 -61.39 2.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.29 -45.87 17.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -50.18 -42.58 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.406 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 43.7 mt -70.75 -42.34 70.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -60.66 -54.52 44.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.88 62.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.68 -24.89 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -78.26 -30.06 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.7 -31.48 18.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -38.11 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.089 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.23 -8.69 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -76.06 -28.85 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -73.04 -19.32 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -53.53 137.54 36.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.537 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.8 t-80 -38.69 141.58 0.57 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 110.896 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.77 -8.81 24.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 0.0 112.374 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.505 HG12 HD23 ' A' ' 27' ' ' LEU . 20.3 t -99.12 -42.25 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -85.56 -29.85 23.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -52.41 -48.79 65.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.32 -50.96 69.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.407 HG22 ' HD2' ' A' ' 38' ' ' PRO . 61.2 t -60.46 -59.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 13.5 t80 -40.4 -40.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -69.74 -48.19 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.18 -48.91 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.54 -64.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.905 HG23 HG12 ' A' ' 205' ' ' ILE . 92.0 mt -48.52 -49.21 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.0 m -40.45 -34.87 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.423 ' CE1' HD11 ' A' ' 53' ' ' LEU . 40.2 t60 -80.1 -45.95 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.634 HD12 ' HA ' ' A' ' 152' ' ' ILE . 59.1 mt -49.58 -49.17 47.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -48.26 -41.09 26.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.456 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 98.7 mtt180 -64.34 -36.81 85.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.613 HG11 HD21 ' A' ' 58' ' ' LEU . 59.5 t -68.47 -42.48 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.6 p -62.64 -30.74 71.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -60.84 -50.32 73.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -98.01 38.96 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.549 ' CE1' ' HD2' ' A' ' 163' ' ' LYS . 2.1 p80 -56.04 -31.65 63.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.549 ' HD2' ' CE1' ' A' ' 162' ' ' HIS . 12.5 mptt -53.74 -22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.7 HG21 ' HB2' ' A' ' 54' ' ' CYS . 15.6 mt -100.65 -58.69 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -80.08 11.57 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 162' ' ' HIS . 6.6 mt 34.71 46.35 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.9 mmm -142.58 120.93 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.6 p -105.47 177.32 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.03 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -46.55 66.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -59.58 -46.97 87.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.62 -41.22 98.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.444 ' OG ' ' NE2' ' A' ' 198' ' ' GLN . 45.6 p -58.75 -28.52 65.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.2 mt -86.81 -42.25 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.31 -16.93 57.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.414 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 14.3 m-85 -107.95 -7.13 16.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.576 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.2 t90 -51.68 -45.45 91.55 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.939 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -48.0 -65.44 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.552 HG21 ' CB ' ' A' ' 101' ' ' PHE . 8.4 m -61.17 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 179' ' ' THR . 86.9 mt -34.35 -44.61 0.2 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 3.9 mtt -146.91 119.9 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -117.73 78.24 11.96 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.841 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -174.6 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.498 ' OD1' ' CD1' ' A' ' 185' ' ' PHE . 3.2 t70 -88.29 139.09 30.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.498 ' CD1' ' OD1' ' A' ' 184' ' ' ASP . 15.0 p90 -44.3 -35.1 2.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.44 64.76 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -90.85 0.46 57.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -107.46 1.26 23.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.53 -21.92 60.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 191' ' ' LEU . 5.1 t80 -127.8 171.69 11.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' PHE . 3.9 mm? -36.2 139.55 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.915 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.0 t -106.86 126.03 51.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.0 m -98.04 153.2 18.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 196' ' ' ILE . 17.3 m -48.93 147.02 2.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -64.18 74.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 194' ' ' THR . 30.7 mt -92.64 -32.86 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.566 ' CD2' HD21 ' A' ' 118' ' ' LEU . 13.7 m80 -47.8 -66.42 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.444 ' NE2' ' OG ' ' A' ' 173' ' ' SER . 2.4 tm0? -37.42 -48.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.4 t -55.26 -48.19 74.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.851 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.486 HG22 ' CB ' ' A' ' 121' ' ' ALA . 23.1 t -45.49 -69.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.82 -61.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -44.0 -47.55 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 204' ' ' PHE . 70.7 m -54.16 -62.71 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' CYS . 14.1 m-85 -34.66 -52.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.905 HG12 HG23 ' A' ' 152' ' ' ILE . 61.1 mt -60.6 -59.97 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -45.88 -48.92 15.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.443 ' NE2' ' HA ' ' A' ' 207' ' ' GLN . 8.8 mm-40 -106.2 31.4 5.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.561 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 6.4 t -67.26 -21.15 65.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.48 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 74.4 mm-40 -87.07 -54.3 4.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.92 -36.55 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -49.53 -62.92 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -106.75 -54.36 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.48 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 65.4 m-85 -55.46 -30.88 61.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 70.85 27.83 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -68.51 137.48 30.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.5 mt-10 -37.9 154.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.06 112.57 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.82 173.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p -170.9 129.7 0.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.895 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.1 m -157.83 175.61 13.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.96 -174.71 45.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.479 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 m -142.88 175.06 10.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 110.86 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 p -173.29 132.81 0.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.67 52.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -140.57 125.86 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.331 . . . . 0.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 10' ' ' PHE . 1.6 p-10 -80.01 145.79 32.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.452 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.8 OUTLIER -34.27 -62.19 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.15 138.17 0.57 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.573 0.702 . . . . 0.0 110.901 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 164.63 33.81 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -164.75 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.703 2.269 . . . . 0.0 112.35 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -106.57 132.83 52.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.542 HH21 ' ND2' ' A' ' 17' ' ' ASN . 19.3 ttp180 -162.69 127.72 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -89.42 89.43 7.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.542 ' ND2' HH21 ' A' ' 15' ' ' ARG . 1.5 m-20 -84.43 41.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.46 ' CZ3' ' HG2' ' A' ' 73' ' ' LYS . 8.4 t-105 -95.61 42.67 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.22 113.85 25.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 m -139.98 158.59 43.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -118.75 40.21 3.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' C ' ' HG2' ' A' ' 25' ' ' MET . 4.2 m-85 -119.59 -11.98 9.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -71.24 115.65 10.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.849 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.83 28.24 61.27 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.457 ' HB2' HD21 ' A' ' 30' ' ' LEU . 32.4 mmm -110.84 147.31 36.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.539 0.685 . . . . 0.0 110.895 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 126.85 13.79 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.693 2.262 . . . . 0.0 112.321 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' O ' HG22 ' A' ' 31' ' ' VAL . 22.5 tp -53.06 -39.79 63.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.469 ' HB3' HG21 ' A' ' 143' ' ' VAL . 13.9 pt20 -55.21 -29.4 57.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.17 -40.85 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 25' ' ' MET . 15.2 mt -65.55 -44.04 88.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 27' ' ' LEU . 21.2 m -81.42 173.45 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 p -111.75 143.71 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.63 3.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.22 -43.47 98.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -131.68 106.17 14.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.54 0.686 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.8 Cg_endo -69.77 -35.44 12.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.623 2.215 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.84 130.03 79.7 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.723 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.77 68.41 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.473 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.87 -47.97 78.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -45.34 -63.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.0 t -48.45 -53.77 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 150' ' ' TYR . 15.3 mm-40 -48.95 -55.84 10.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 50.6 mmtt -50.51 -41.16 53.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.8 m -63.56 -43.55 96.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 150' ' ' TYR . 44.4 t -66.64 -61.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 47' ' ' PHE . 10.6 pt-20 -53.11 -47.51 68.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.666 ' CE2' HG21 ' A' ' 93' ' ' VAL . 60.4 t80 -48.26 -64.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mt -38.55 -62.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -45.9 -47.83 16.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -56.46 -47.21 79.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -84.76 29.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.12 141.26 6.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -106.49 -14.32 15.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.7 p -84.48 34.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.896 ' HB ' HD21 ' A' ' 58' ' ' LEU . 36.7 m -68.73 157.05 37.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' N ' HG22 ' A' ' 55' ' ' THR . 1.8 mp0 -100.89 147.86 25.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' C ' ' HG2' ' A' ' 60' ' ' ARG . . . 48.01 75.87 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.48 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.896 HD21 ' HB ' ' A' ' 55' ' ' THR . 4.5 mm? -95.0 122.79 38.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.609 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 26.7 m-85 63.32 26.49 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HG2' ' C ' ' A' ' 57' ' ' GLY . 7.0 ptm180 -127.24 -10.16 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.4 t -97.91 140.71 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 t -40.1 -59.44 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.41 118.73 1.27 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.473 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -55.28 123.48 13.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -35.16 79.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 m -60.41 -51.88 67.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.2 -46.17 79.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 71' ' ' ILE . 43.5 mt-30 -70.19 -28.68 65.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.944 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.02 -60.96 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.1 p30 -53.92 -36.77 63.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 68' ' ' GLN . 50.2 mt -53.39 -56.6 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.55 -52.44 38.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HG2' ' CZ3' ' A' ' 18' ' ' TRP . 30.6 mtpt -53.16 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -68.32 -29.79 68.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -68.66 -49.43 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -63.99 -33.0 74.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -158.67 156.07 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -105.71 -15.4 14.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -80.75 45.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.2 pt -106.0 177.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -142.48 130.04 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.71 -42.44 21.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.82 -44.12 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.7 t -64.95 -28.86 69.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.8 mmm -70.6 -33.61 71.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 62.35 34.59 15.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.82 156.66 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 p -67.66 146.88 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.3 t -53.22 -49.46 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -42.99 -49.94 5.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.4 -62.86 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.666 HG21 ' CE2' ' A' ' 47' ' ' PHE . 67.5 t -53.79 -50.23 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -52.79 -37.12 59.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.71 -49.29 7.26 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.0 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.71 -45.08 77.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 99' ' ' ALA . 20.9 mtmt -64.08 -53.43 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.01 -44.29 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -54.65 -54.03 46.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -57.07 -39.19 74.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.39 -35.79 82.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 104' ' ' LEU . 9.6 t0 -59.85 -40.45 88.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.9 mt -36.86 143.06 0.34 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.62 154.29 79.49 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.709 . . . . 0.0 110.851 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 108' ' ' LEU . 54.0 Cg_endo -69.78 131.14 20.59 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.37 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 107' ' ' PRO . 26.1 tp -35.73 -38.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -103.12 125.58 34.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 157.08 61.69 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.737 2.291 . . . . 0.0 112.327 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -76.02 -22.1 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.6 m -72.3 -7.18 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -130.27 28.83 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.479 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -74.57 -61.97 1.04 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.859 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.6 Cg_endo -69.74 -23.36 30.98 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -67.55 -32.17 72.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.22 -33.53 69.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.525 HD23 HG21 ' A' ' 200' ' ' VAL . 6.3 mt -81.67 -55.64 4.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.77 -32.62 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.26 -26.8 23.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -79.46 -23.63 42.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -83.03 1.17 41.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 128' ' ' GLU . 91.7 mt -70.56 129.27 90.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.638 0.733 . . . . 0.0 111.113 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -47.05 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.343 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.7 m-20 -61.6 97.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -34.45 -50.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.4 m -55.68 -57.76 10.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.52 ' HB2' HG21 ' A' ' 123' ' ' ILE . 15.6 mt-10 -54.87 -44.8 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.83 -54.23 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 207' ' ' GLN . 21.7 mt -68.93 -62.21 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -38.68 -43.28 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.41 79.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.553 HD22 ' HE1' ' A' ' 204' ' ' PHE . 12.6 mt -67.31 -23.44 65.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.428 ' O ' HG12 ' A' ' 137' ' ' VAL . 4.2 ttpm? -78.54 -32.64 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -85.34 -34.4 21.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.55 -39.86 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 134' ' ' LYS . 5.4 p -62.57 -8.74 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -76.83 -30.35 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.85 -22.98 61.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 141' ' ' HIS . 5.6 m-85 -51.45 133.4 29.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 5.5 t60 -35.03 141.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.2 Cg_endo -69.84 -13.12 34.05 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.715 2.276 . . . . 0.0 112.301 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 28' ' ' GLN . 26.2 t -95.0 -37.09 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -87.32 -38.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -45.06 -44.94 10.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -61.27 -56.27 22.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.07 -54.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.846 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 24.8 t80 -49.03 -45.52 42.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.484 ' CZ ' ' HB3' ' A' ' 149' ' ' ARG . 7.5 mtp-105 -64.2 -49.08 73.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.565 ' CE2' ' OE2' ' A' ' 42' ' ' GLU . 39.1 t80 -52.59 -45.29 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.923 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.03 -57.36 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.135 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.846 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 70.3 mt -49.66 -48.97 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -47.54 -39.87 17.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.521 ' O ' HG23 ' A' ' 158' ' ' VAL . 36.3 t-80 -77.57 -31.24 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 152' ' ' ILE . 97.9 mt -66.03 -45.95 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -54.72 -38.63 67.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -65.59 -37.02 85.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 154' ' ' HIS . 46.5 t -68.91 -43.25 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.6 p -60.8 -40.08 91.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -48.13 -37.7 16.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.413 ' HB3' HD12 ' A' ' 164' ' ' ILE . 6.0 mm-40 -105.06 32.83 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 166' ' ' LEU . 12.4 p80 -51.19 -38.73 53.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 21.1 mmtp -57.44 -32.49 66.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 161' ' ' GLN . 52.7 mt -87.81 -58.26 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 55' ' ' THR . 10.6 m-20 -76.08 4.07 9.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 162' ' ' HIS . 13.5 mt 46.15 42.67 10.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 31.2 mmm -144.37 122.59 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.6 p -100.63 156.89 17.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.69 -37.64 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.31 -47.47 64.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -58.49 -38.4 77.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.57 -48.07 61.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.2 p -51.92 -48.76 64.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.0 mt -62.01 -39.4 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.59 -17.07 53.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.437 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 33.0 m-85 -109.43 -10.57 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.571 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -48.76 -46.47 72.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.54 0.686 . . . . 0.0 110.9 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.91 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 180' ' ' LEU . 16.5 m -61.08 -64.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 179' ' ' THR . 59.5 mt -36.96 -62.31 0.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 86.0 mtp -117.1 81.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 8.3 mmt180 -60.86 -60.1 11.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.613 0.72 . . . . 0.0 110.839 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 54.0 Cg_endo -69.69 164.98 32.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.705 2.27 . . . . 0.0 112.325 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -126.99 118.84 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -111.96 -34.89 5.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -124.83 -174.92 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.411 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 16.7 t-20 59.8 52.27 5.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.909 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -70.43 -176.7 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -55.7 -22.39 23.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -81.88 140.94 33.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.0 mt 49.98 47.98 22.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 65.0 m -65.01 -13.9 59.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 39.0 p -86.52 96.25 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 4.0 t -163.99 139.26 6.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.137 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -111.56 36.35 3.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.75 ' O ' HG23 ' A' ' 200' ' ' VAL . 94.1 mt -95.0 -56.74 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' A' ' 187' ' ' ASN . 65.5 m80 -50.78 -72.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -47.85 -51.15 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.6 t -46.12 -42.22 13.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 196' ' ' ILE . 89.2 t -41.09 -70.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 202' ' ' GLU . 84.2 t -54.86 -59.66 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 201' ' ' VAL . 15.9 tt0 -35.85 -51.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 53.0 m -54.03 -57.9 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.671 ' HB3' HD13 ' A' ' 152' ' ' ILE . 8.1 m-85 -40.09 -34.37 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.553 ' HA ' HG23 ' A' ' 152' ' ' ILE . 66.9 mt -75.32 -59.84 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -53.93 -53.43 52.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.598 ' OE1' HG22 ' A' ' 218' ' ' VAL . 1.0 OUTLIER -84.63 18.91 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 19.3 t -60.6 -12.01 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.479 ' NE2' ' CD2' ' A' ' 213' ' ' TYR . 11.2 mm100 -95.96 -57.2 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -40.59 -38.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -49.63 -61.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -107.86 -53.96 2.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.479 ' CD2' ' NE2' ' A' ' 209' ' ' GLN . 53.2 m-85 -58.06 -28.59 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 64.64 42.83 4.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.68 51.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -63.9 134.9 56.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.25 131.73 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.598 HG22 ' OE1' ' A' ' 207' ' ' GLN . 27.0 m -116.18 163.92 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -169.31 148.54 3.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -157.83 177.33 11.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.06 -176.57 17.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.512 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.2 p -163.64 129.28 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.373 . . . . 0.0 110.866 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 t -165.71 173.48 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.38 127.45 2.59 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -158.14 146.72 18.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.814 0.34 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -164.73 159.26 18.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -169.98 177.86 4.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.1 116.77 1.64 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.2 68.01 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.663 2.242 . . . . 0.0 112.391 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 173.03 11.6 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.668 2.245 . . . . 0.0 112.344 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -136.51 143.39 43.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.68 129.34 11.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -123.48 108.79 13.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -84.67 36.42 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -58.74 98.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -119.12 140.7 49.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -144.65 174.43 10.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -102.73 -48.77 4.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -37.75 -47.74 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 23' ' ' PHE . 1.7 p90 -39.56 119.89 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.14 -43.55 1.65 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.491 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 16.5 mtp -81.88 139.23 46.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.521 0.676 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 159.78 52.15 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.339 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 tp -55.41 -46.0 76.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -48.67 -35.57 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.63 -48.91 17.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.2 mt -56.03 -44.49 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 36' ' ' PRO . 4.5 m -90.76 171.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.5 p -108.12 144.03 36.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.94 -37.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.51 -42.19 95.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 17.7 mmtp -128.83 96.47 29.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.703 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HA ' HG21 ' A' ' 31' ' ' VAL . 54.0 Cg_endo -69.74 -24.65 29.54 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.8 mt -92.95 130.96 34.54 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 122.5 9.16 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -50.67 -27.43 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -62.3 -61.67 2.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.805 HG13 HD11 ' A' ' 97' ' ' LEU . 42.3 t -50.02 -50.94 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -51.83 -60.05 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 45.1 mmtt -44.3 -39.33 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HB2' HD13 ' A' ' 97' ' ' LEU . 95.2 m -67.5 -45.6 75.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.509 HG13 ' CG ' ' A' ' 154' ' ' HIS . 60.6 t -62.63 -59.54 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.26 -27.7 16.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -70.83 -54.33 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.466 HG22 ' CD1' ' A' ' 53' ' ' LEU . 42.8 mt -56.37 -20.5 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -91.06 -22.05 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.33 -17.62 22.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -82.56 18.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.144 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.38 -42.55 2.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.698 HD11 HG22 ' A' ' 158' ' ' VAL . 12.5 tp 64.7 44.0 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.1 p -133.16 30.0 3.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -90.93 127.84 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -60.39 120.76 10.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 48.71 76.04 0.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 58' ' ' LEU . 1.2 pt? -89.38 4.36 49.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.934 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.62 -48.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -59.05 -48.15 82.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 t -82.43 146.91 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.2 p -128.26 117.08 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.78 -144.61 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.479 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -64.75 -176.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -107.63 -37.68 6.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 m -53.04 -57.76 9.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.487 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -39.34 -58.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -50.59 -44.57 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.73 -51.0 70.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -50.97 -52.1 45.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 93' ' ' VAL . 85.3 mt -43.75 -46.46 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.12 -62.63 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ASP . 48.5 mttt -50.67 -64.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -39.41 -42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -71.66 -38.49 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' LYS . 11.1 t0 -65.33 -41.75 93.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.28 -31.57 71.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -166.89 148.35 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -94.66 -19.55 20.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -78.3 48.47 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 pt -109.98 -176.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -154.6 125.44 7.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -70.72 -46.69 62.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.01 -48.48 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -59.79 -43.81 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.474 ' HB3' HG13 ' A' ' 88' ' ' VAL . 89.9 mtp -59.25 -19.39 45.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 47.6 39.42 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' A' ' 86' ' ' MET . 31.3 m -72.71 164.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 p -74.88 131.89 41.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.3 t -44.36 -48.93 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -46.18 -40.21 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.77 -62.79 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.516 ' HA ' HD13 ' A' ' 71' ' ' ILE . 72.8 t -52.69 -36.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.85 72.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.57 -54.04 4.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.02 -44.39 61.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.805 HD11 HG13 ' A' ' 41' ' ' VAL . 34.0 tp -45.85 -43.67 13.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.11 -47.12 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -39.38 -45.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.25 -54.18 46.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.596 ' HB2' HG21 ' A' ' 179' ' ' THR . 76.3 m-85 -49.61 -47.22 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -54.49 -37.69 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.5 mt -41.45 141.01 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.657 0.741 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.13 32.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -133.25 150.6 75.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.881 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.24 37.47 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.336 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.1 tp -43.03 -53.84 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mt -85.42 124.09 72.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.559 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.79 149.02 66.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -70.43 -8.96 54.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.5 m -83.65 -12.46 55.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.848 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.628 HD13 ' CE1' ' A' ' 140' ' ' PHE . 43.0 mt -120.52 26.25 9.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.5 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.4 m170 -71.02 -60.12 3.04 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.78 -20.62 34.49 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.258 . . . . 0.0 112.328 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.404 ' O ' HD13 ' A' ' 136' ' ' ILE . 12.0 mp0 -70.89 -39.14 72.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.515 ' HB3' HG11 ' A' ' 200' ' ' VAL . 12.8 mt -72.09 -28.72 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.637 HD11 ' CE1' ' A' ' 197' ' ' HIS . 21.9 mt -83.68 -50.21 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.11 -26.36 11.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.61 -21.75 21.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -83.27 -15.4 50.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -95.47 10.23 37.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.3 mt -73.51 132.19 81.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.584 0.707 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -45.39 1.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.375 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 105.56 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HD3' HG21 ' A' ' 217' ' ' ILE . 6.9 ttmt -41.37 -53.04 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.625 HG22 ' CD2' ' A' ' 131' ' ' HIS . 3.0 m -56.02 -59.72 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -49.22 -39.3 29.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -57.46 -42.79 83.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.6 -54.12 8.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.625 ' CD2' HG22 ' A' ' 127' ' ' THR . 15.6 m-70 -46.76 -44.06 18.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.06 -59.66 4.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.533 HD22 ' HE1' ' A' ' 204' ' ' PHE . 16.1 mt -53.82 -33.75 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 137' ' ' VAL . 57.4 tttt -65.68 -34.97 79.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -82.62 -41.38 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 139' ' ' LYS . 87.8 mt -59.62 -21.14 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 134' ' ' LYS . 9.5 p -92.64 -5.91 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -81.02 -35.27 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 136' ' ' ILE . 5.8 pttm -80.57 -7.78 59.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.628 ' CE1' HD13 ' A' ' 113' ' ' LEU . 2.7 m-85 -51.4 149.88 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.599 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -41.83 140.64 1.41 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.81 -16.66 37.43 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.653 2.235 . . . . 0.0 112.286 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 91.1 t -96.97 -38.72 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -83.89 -40.23 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 71.4 t80 -46.56 -42.86 16.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -45.18 94.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.1 t -68.33 -61.11 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -44.45 -46.86 9.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.434 ' HB3' ' NH1' ' A' ' 149' ' ' ARG . 7.8 ttp-105 -62.57 -47.97 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.03 -54.19 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 85.0 t -46.4 -65.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.12 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.485 ' HA ' HD12 ' A' ' 155' ' ' LEU . 77.8 mt -44.0 -53.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.9 m -39.77 -36.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.509 ' CG ' HG13 ' A' ' 45' ' ' VAL . 15.1 t60 -80.36 -43.31 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 205' ' ' ILE . 96.5 mt -49.2 -42.99 41.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -52.26 -48.57 65.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -56.91 -29.84 63.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.698 HG22 HD11 ' A' ' 53' ' ' LEU . 42.4 t -80.46 -29.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.093 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 p -75.65 -20.44 58.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.94 -44.37 63.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.715 ' HB3' HD12 ' A' ' 164' ' ' ILE . 1.7 mm100 -97.01 29.48 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.574 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 16.8 p80 -52.48 -39.25 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.574 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 0.8 OUTLIER -59.15 -21.19 58.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 161' ' ' GLN . 49.6 mt -92.73 -64.96 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -76.08 1.41 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 162' ' ' HIS . 43.5 mt 54.6 46.28 25.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.417 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 21.0 mtp -141.12 112.55 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.46 HG22 ' CG ' ' A' ' 162' ' ' HIS . 33.7 p -98.24 160.63 14.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -45.96 -35.39 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -49.05 62.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.86 -44.17 77.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.77 -44.36 96.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -53.07 -40.31 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.6 mt -80.71 -41.21 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.142 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.58 -20.77 66.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -108.75 0.04 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.577 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.13 -45.92 95.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.533 0.682 . . . . 0.0 110.872 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -47.95 -58.54 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.688 2.259 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.596 HG21 ' HB2' ' A' ' 101' ' ' PHE . 18.2 m -69.69 -62.96 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.1 mt -40.52 -52.23 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 16.1 mmm -128.52 123.25 33.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -102.79 105.96 47.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 0.0 110.842 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 147.41 62.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.64 2.227 . . . . 0.0 112.325 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.58 140.2 29.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 185' ' ' PHE . 1.2 p90 -115.48 -44.8 2.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -116.73 29.16 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -132.23 -179.64 5.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.61 120.8 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -106.56 121.5 44.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -110.87 155.0 23.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -75.7 152.41 37.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.4 t -123.48 58.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.5 m -50.58 -52.54 38.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.168 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 80.7 p -90.57 111.63 23.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -78.08 70.63 4.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 200' ' ' VAL . 87.0 mt -88.76 -36.64 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.637 ' CE1' HD11 ' A' ' 118' ' ' LEU . 12.8 m80 -48.74 -71.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -40.7 -53.67 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 t -45.88 -41.96 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 196' ' ' ILE . 29.6 t -53.8 -60.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.56 -66.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -38.68 -52.33 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 51.5 m -48.85 -64.6 0.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.533 ' HE1' HD22 ' A' ' 133' ' ' LEU . 7.4 m-85 -34.16 -48.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 155' ' ' LEU . 48.3 mt -66.25 -50.37 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -53.86 -45.61 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -110.02 30.42 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.527 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 0.8 OUTLIER -64.12 -15.32 59.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 213' ' ' TYR . 67.6 mm-40 -88.92 -54.47 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 210' ' ' PHE . 0.9 OUTLIER -42.76 -40.46 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -45.91 -63.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -105.54 -53.32 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 209' ' ' GLN . 56.9 m-85 -56.03 -35.2 66.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.931 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 71.02 28.02 3.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.68 -166.41 1.77 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.508 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.84 151.99 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.593 HG21 ' HD3' ' A' ' 126' ' ' LYS . 54.1 mt -76.42 132.05 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 m -110.22 174.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -114.56 138.23 50.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -167.09 107.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.42 55.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.527 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -115.25 176.23 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.872 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.0 p -45.48 111.18 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.51 68.55 0.48 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.02 155.96 16.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.903 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -87.55 -25.05 23.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.896 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -159.14 163.99 35.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.87 132.52 95.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.617 0.722 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 146.74 61.17 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 156.88 62.19 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.625 2.217 . . . . 0.0 112.347 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -111.52 152.85 27.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -138.85 145.77 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -48.02 -54.24 13.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 66.08 25.44 10.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CZ3' ' HG2' ' A' ' 73' ' ' LYS . 31.5 t-105 69.96 52.17 0.4 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -114.11 144.95 42.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 m -171.37 167.2 6.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -88.63 -38.11 15.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.479 ' O ' ' C ' ' A' ' 23' ' ' PHE . 73.2 m-85 -38.82 -69.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 22' ' ' TYR . 28.1 m-85 -32.25 96.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.92 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' TYR . . . 107.07 24.87 6.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.504 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.862 ' HG3' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -109.43 154.94 42.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 149.43 66.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.694 2.263 . . . . 0.0 112.367 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.665 ' O ' HG22 ' A' ' 31' ' ' VAL . 30.0 tp -70.6 -39.39 73.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.443 ' HB3' HG21 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -52.34 -28.57 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.12 -41.24 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.862 HD21 ' HG3' ' A' ' 25' ' ' MET . 14.1 mt -69.37 -39.0 78.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 27' ' ' LEU . 34.6 m -96.26 164.65 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -107.41 168.49 9.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.49 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -53.52 -46.75 70.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 24.4 mmtm -130.74 103.88 15.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.51 ' O ' HG11 ' A' ' 31' ' ' VAL . 54.0 Cg_endo -69.77 -33.6 16.21 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.644 2.23 . . . . 0.0 112.369 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.455 HG22 ' HG3' ' A' ' 42' ' ' GLU . 29.8 mt -74.68 131.36 79.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.611 0.72 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' HD21 ' A' ' 27' ' ' LEU . 54.2 Cg_endo -69.7 147.64 63.68 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.483 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.33 -50.03 71.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -42.53 -67.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.753 HG13 HD11 ' A' ' 97' ' ' LEU . 75.0 t -46.93 -54.36 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' HG3' HG22 ' A' ' 37' ' ' ILE . 33.1 mt-10 -47.23 -58.04 4.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 51.8 mmtt -53.05 -37.56 61.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.427 ' O ' HD12 ' A' ' 48' ' ' ILE . 78.4 m -65.22 -43.94 89.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.02 -51.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.27 -45.72 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 93' ' ' VAL . 33.4 t80 -53.53 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 44' ' ' CYS . 41.2 mt -37.48 -56.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -52.06 -48.05 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.05 -44.1 87.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 t -85.87 23.92 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.1 139.65 10.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.434 ' O ' HD11 ' A' ' 58' ' ' LEU . 16.0 tp -110.29 -27.44 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.964 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.9 m -84.48 39.75 0.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.708 ' O ' HD12 ' A' ' 58' ' ' LEU . 11.5 m -82.72 111.67 18.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.4 tt0 -35.97 130.85 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 36.57 77.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 55' ' ' THR . 3.0 mp -60.2 -61.73 2.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.955 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.674 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 59.4 m-85 -93.3 -43.45 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -42.54 -49.02 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.12 88.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 t -68.33 -41.8 80.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.48 -116.57 5.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -79.66 172.18 14.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.371 . . . . 0.0 110.873 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -32.02 6.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -49.94 -35.54 24.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -60.84 -53.83 52.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.35 -27.35 65.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.57 -62.89 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 13.4 p30 -61.71 -44.55 96.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.449 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 47.2 mt -43.5 -42.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.52 -54.81 4.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HG2' ' CZ3' ' A' ' 18' ' ' TRP . 10.3 mtpp -51.22 -61.17 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -51.12 -38.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HA ' HG21 ' A' ' 81' ' ' ILE . 7.7 t80 -62.9 -28.74 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.74 -63.16 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -55.38 -29.31 58.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -131.04 99.05 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -69.92 -17.28 63.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.85 32.62 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.525 HG21 ' HA ' ' A' ' 75' ' ' PHE . 7.1 tt -73.61 157.22 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.461 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 1.9 t-20 -132.35 94.74 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -40.49 -46.58 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.48 -50.65 78.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -55.54 -41.41 73.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.427 ' HB3' HG13 ' A' ' 88' ' ' VAL . 22.4 mmm -62.09 -33.86 75.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 61.55 46.51 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 86' ' ' MET . 33.7 m -78.75 165.72 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.7 p -67.26 139.44 57.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.9 t -52.82 -55.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -45.92 -44.45 14.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.54 -63.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 47' ' ' PHE . 93.7 t -45.04 -55.55 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.674 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -48.64 -38.7 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.35 -60.82 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.51 -43.92 8.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.753 HD11 HG13 ' A' ' 41' ' ' VAL . 23.8 tp -47.81 -44.55 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -68.01 -48.09 66.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.14 -38.38 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.068 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.25 -46.45 86.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -61.16 -47.51 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.511 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -59.74 -37.79 79.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 104' ' ' LEU . 6.7 t70 -59.42 -36.92 76.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' ASP . 96.2 mt -36.78 144.15 0.29 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -22.12 32.73 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.21 153.97 69.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.629 0.728 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 133.03 24.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.483 HD12 HD22 ' A' ' 144' ' ' ASN . 11.4 tp -38.38 -49.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.0 mt -84.2 123.63 75.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 111.162 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 153.93 68.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.691 2.261 . . . . 0.0 112.318 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.483 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 13.5 m-85 -72.62 -17.5 61.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 m -72.92 -30.45 63.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.39 27.85 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.498 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.0 m170 -71.49 -60.16 2.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.601 0.715 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.75 -33.83 15.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.247 . . . . 0.0 112.335 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.526 ' O ' HD13 ' A' ' 136' ' ' ILE . 1.3 mp0 -59.03 -33.3 70.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.44 ' HB3' HG11 ' A' ' 200' ' ' VAL . 12.8 mt -71.85 -40.28 69.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.2 mt -75.09 -58.57 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -42.71 -29.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.95 -28.4 20.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -76.8 -20.91 55.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -92.14 16.21 11.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 30.8 mt -78.22 132.64 66.01 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.59 0.71 . . . . 0.0 111.135 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -45.39 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.671 2.247 . . . . 0.0 112.349 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 126' ' ' LYS . 75.7 m-20 -66.34 92.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 125' ' ' ASP . 38.1 tttt -34.91 -51.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 42.4 m -53.25 -59.92 3.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' ARG . 45.1 mm-40 -54.83 -52.6 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 128' ' ' GLU . 11.4 ttm180 -36.87 -43.5 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 133' ' ' LEU . 22.8 mt -75.84 -61.56 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 130' ' ' LEU . 11.8 m-70 -36.53 -49.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.1 -55.14 30.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.589 HD22 ' HE1' ' A' ' 204' ' ' PHE . 11.0 mt -55.9 -41.37 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -56.3 -29.67 61.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -90.37 -46.33 8.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 116' ' ' GLU . 56.7 mt -56.43 -29.2 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.528 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 7.8 p -76.15 -15.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -73.37 -25.44 60.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -77.38 -19.13 56.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 7.9 m-85 -50.51 146.98 4.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.586 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.4 t-80 -45.48 141.39 3.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.586 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -21.0 34.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 28' ' ' GLN . 84.6 t -89.7 -38.89 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.483 HD22 HD12 ' A' ' 108' ' ' LEU . 2.9 m120 -83.65 -44.06 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 14.1 t80 -40.97 -56.77 2.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -46.9 -34.45 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.38 -58.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 24.0 t80 -43.17 -41.65 3.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -70.47 -44.79 67.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -57.71 -42.37 83.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.466 ' HA ' HD12 ' A' ' 155' ' ' LEU . 86.0 mt -43.4 -53.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.146 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.8 m -41.25 -34.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -83.61 -39.68 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 152' ' ' ILE . 92.8 mt -56.2 -45.52 79.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.98 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -50.36 -43.66 54.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.407 ' HB3' HD21 ' A' ' 53' ' ' LEU . 22.6 mtp85 -59.86 -30.84 69.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.72 -45.65 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.6 p -57.84 -29.95 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.06 -46.48 88.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -100.86 40.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 166' ' ' LEU . 10.6 p80 -58.54 -41.05 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.414 ' HG2' ' NE2' ' A' ' 162' ' ' HIS . 17.0 mmmt -55.32 -27.57 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 79.9 mt -90.29 -57.07 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.3 OUTLIER -84.17 18.07 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 162' ' ' HIS . 12.1 mt 34.32 52.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 49.1 mmm -146.34 108.73 4.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.437 HG22 ' ND1' ' A' ' 162' ' ' HIS . 73.9 p -93.94 151.19 19.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.79 -37.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.89 -49.09 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 168' ' ' THR . 41.1 m-20 -54.54 -42.8 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.43 -48.05 79.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 p -58.55 -39.36 80.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.31 -37.48 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.175 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.91 -15.44 63.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -108.16 -8.43 15.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.556 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -56.73 -47.29 99.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.871 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.2 Cg_exo -48.0 -62.12 0.49 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.511 HG23 ' CA ' ' A' ' 102' ' ' ALA . 16.7 m -67.85 -62.97 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.129 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 179' ' ' THR . 48.2 mt -33.2 -44.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.497 ' CE ' ' CD2' ' A' ' 114' ' ' HIS . 31.2 mtp -146.86 140.2 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.426 ' NE ' ' OH ' ' A' ' 111' ' ' TYR . 9.7 ptp180 -52.65 151.94 7.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.827 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 184' ' ' ASP . 53.2 Cg_endo -69.81 117.88 5.35 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.635 2.223 . . . . 0.0 112.333 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' PRO . 8.9 p-10 -35.83 144.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -79.1 -34.29 43.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -41.52 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.44 -27.2 12.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -13.08 51.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -93.79 125.15 38.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.467 ' CD2' ' HG ' ' A' ' 191' ' ' LEU . 36.7 p90 -100.57 -45.79 5.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 190' ' ' PHE . 11.3 mt -85.59 128.14 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.6 t -102.31 89.27 3.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.839 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 22.0 p -78.1 -63.29 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 25.6 m -62.0 119.45 8.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -2.67 14.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 200' ' ' VAL . 65.3 mt -49.07 -36.24 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -43.03 -69.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -67.16 -39.36 86.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 t -43.45 -40.37 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.823 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 196' ' ' ILE . 66.4 t -52.58 -58.25 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.16 -39.96 82.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -58.04 -52.4 65.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.4 m -49.51 -61.77 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.589 ' HE1' HD22 ' A' ' 133' ' ' LEU . 10.0 m-85 -33.83 -52.67 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.435 HG12 HG23 ' A' ' 152' ' ' ILE . 38.8 mt -62.61 -47.7 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -55.92 -47.63 77.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.9 mm-40 -109.84 31.67 5.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 2.4 t -63.55 -21.42 66.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.683 ' NE2' ' CD2' ' A' ' 213' ' ' TYR . 7.8 mm100 -86.53 -51.17 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -45.04 -35.3 2.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -52.76 -62.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -108.07 -55.06 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.683 ' CD2' ' NE2' ' A' ' 209' ' ' GLN . 54.7 m-85 -56.63 -14.57 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 52.37 38.75 25.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.41 150.68 33.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 216' ' ' GLU . 2.8 mp0 -49.95 153.3 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.915 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.419 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 93.2 mt -73.69 126.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.092 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.2 m -104.81 177.68 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -152.79 166.67 31.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.903 0.382 . . . . 0.0 110.847 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -165.06 169.05 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.823 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.18 -141.23 4.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -143.72 139.47 29.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.838 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.9 m -110.25 168.45 9.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.3 114.47 1.0 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.504 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -174.56 144.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -61.71 106.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -76.76 -45.37 29.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -82.16 137.56 46.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 167.99 22.87 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.678 2.252 . . . . 0.0 112.347 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -179.16 2.73 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.255 . . . . 0.0 112.343 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -129.18 151.67 49.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -95.87 128.48 42.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -92.61 -42.37 9.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 18' ' ' TRP . 11.2 t-20 49.62 35.14 8.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' ASN . 0.0 OUTLIER 34.11 44.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.58 140.22 58.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -152.14 163.83 38.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -83.31 -30.83 27.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 25' ' ' MET . 13.4 m-85 -49.18 -61.9 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.0 m-30 37.11 48.26 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.26 38.26 93.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.47 ' HB2' HD21 ' A' ' 30' ' ' LEU . 25.4 mmt -93.87 152.03 40.29 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.613 0.721 . . . . 0.0 110.884 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 53.5 Cg_endo -69.73 133.77 26.43 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.642 2.228 . . . . 0.0 112.369 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.434 ' O ' HG22 ' A' ' 31' ' ' VAL . 26.2 tp -53.22 -53.61 48.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HA ' HG11 ' A' ' 143' ' ' VAL . 18.5 pt20 -44.37 -33.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 11.5 t70 -79.24 -48.8 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 25' ' ' MET . 41.4 mt -57.03 -43.95 82.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' LEU . 20.7 m -82.06 -179.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -117.61 147.52 42.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.14 -45.03 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -52.23 -43.09 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.75 108.37 13.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.552 0.691 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -39.39 6.55 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HD2' ' A' ' 38' ' ' PRO . 22.3 mt -73.99 132.94 79.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.648 0.737 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.76 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 0.0 112.363 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.621 HD11 ' HE3' ' A' ' 43' ' ' LYS . 2.2 tm? -45.1 -48.02 12.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.511 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 82.0 t80 -43.2 -70.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.932 HG13 HD11 ' A' ' 97' ' ' LEU . 66.2 t -44.17 -50.48 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.069 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -49.13 -53.89 18.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.621 ' HE3' HD11 ' A' ' 39' ' ' LEU . 12.2 mmtp -52.15 -40.76 61.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.0 m -66.53 -47.47 72.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.56 -46.21 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.71 -43.96 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 93' ' ' VAL . 63.8 t80 -50.78 -63.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.5 mt -39.67 -62.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -49.01 -50.3 36.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.44 -39.0 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.9 p -88.65 25.43 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.29 137.91 1.89 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.508 HD11 HG22 ' A' ' 158' ' ' VAL . 6.1 tp -113.47 47.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.773 0.32 . . . . 0.0 110.874 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.6 p -132.75 37.45 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -96.72 119.61 35.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.1 tt0 -37.93 123.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 60' ' ' ARG . . . 34.17 73.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.528 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.75 -24.73 63.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -102.59 -57.04 2.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HG3' HG23 ' A' ' 61' ' ' VAL . 15.7 ptm180 -46.65 -33.06 3.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.614 HG23 ' HG3' ' A' ' 60' ' ' ARG . 48.7 t -97.25 102.59 13.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.142 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.9 m -61.97 -58.14 9.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.88 -161.5 23.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.497 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.74 161.89 11.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HD3' ' N ' ' A' ' 65' ' ' LYS . 2.2 mppt? -92.63 -52.49 4.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -40.65 -53.23 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.164 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.1 -45.33 32.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -73.9 -30.94 62.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -62.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -50.63 -34.47 26.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.48 -44.6 89.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -79.06 -46.59 17.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 76' ' ' ASP . 93.2 mttt -59.79 -66.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -40.26 -47.01 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 42.9 t80 -64.29 -37.91 89.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 73' ' ' LYS . 37.6 m-20 -68.74 -58.85 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -53.38 -29.25 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.06 149.88 14.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.23 -17.72 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -83.43 50.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 -177.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -149.26 136.31 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.7 mt -81.28 -46.78 14.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.5 t -44.14 -54.16 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.1 t -55.57 -43.28 75.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.7 mmm -55.95 -28.83 58.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 51.97 45.94 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.99 164.84 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 t -75.22 128.16 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.3 t -40.31 -51.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -38.72 -53.01 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.15 -60.93 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.506 HG21 ' CD2' ' A' ' 47' ' ' PHE . 94.4 t -47.26 -51.23 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.75 -45.05 58.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.12 -63.35 3.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.78 -42.15 5.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.884 0.373 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.932 HD11 HG13 ' A' ' 41' ' ' VAL . 43.3 tp -48.69 -45.57 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -69.62 -51.17 37.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -40.26 -39.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -58.99 -47.46 85.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.771 ' HB2' HG21 ' A' ' 179' ' ' THR . 51.6 m-85 -62.27 -48.87 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.428 ' N ' HG23 ' A' ' 179' ' ' THR . . . -57.15 -37.13 71.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -34.8 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -41.65 141.29 1.23 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -19.06 36.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.693 2.262 . . . . 0.0 112.357 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -134.14 152.55 78.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.62 26.02 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.708 2.272 . . . . 0.0 112.342 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.2 tp -44.25 -44.26 7.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.49 123.94 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.617 0.723 . . . . 0.0 111.162 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.699 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.8 Cg_endo -69.77 146.37 59.92 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.345 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.449 ' CD2' ' NE2' ' A' ' 114' ' ' HIS . 73.7 m-85 -66.26 -32.55 74.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m -61.14 -15.11 30.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.699 HD12 ' HG2' ' A' ' 110' ' ' PRO . 27.3 mt -122.0 28.47 7.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.476 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -73.0 -60.79 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.569 0.7 . . . . 0.0 110.826 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.76 -31.82 19.79 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.694 2.263 . . . . 0.0 112.38 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -59.96 -28.86 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.0 -46.66 33.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 121' ' ' ALA . 12.0 mt -65.12 -55.2 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -45.72 -37.19 5.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.53 -21.08 32.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -86.63 -18.44 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -89.81 -8.85 51.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 128' ' ' GLU . 82.4 mt -56.81 130.17 78.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 111.141 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -46.08 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.12 116.94 10.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.44 ' HG2' HG21 ' A' ' 217' ' ' ILE . 7.4 tppt? -50.99 -49.55 60.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.0 m -53.57 -55.7 23.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.53 ' HB2' HG21 ' A' ' 123' ' ' ILE . 14.2 mt-10 -60.38 -38.95 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -57.75 -49.97 74.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.76 -60.52 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -43.58 -50.15 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.77 78.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 mt -74.57 -27.26 60.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -78.0 -27.16 48.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.0 pt-20 -86.11 -32.99 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.418 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 84.9 mt -74.2 -38.01 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.8 p -62.05 -11.81 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -74.96 -43.09 56.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -61.55 -32.97 73.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -40.52 137.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.513 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 4.7 t60 -39.33 141.16 0.69 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.849 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.513 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.78 -18.99 36.62 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 28' ' ' GLN . 92.1 t -89.86 -37.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.91 -40.26 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.525 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 6.2 t80 -48.69 -51.69 27.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.92 -51.85 21.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.0 -67.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 38.5 t80 -40.21 -40.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.525 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 4.6 mmp_? -66.39 -45.1 81.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.07 -48.15 77.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.99 -64.75 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.751 ' HA ' HD12 ' A' ' 155' ' ' LEU . 91.6 mt -42.82 -53.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.3 m -40.26 -36.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.121 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -78.9 -36.89 41.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.751 HD12 ' HA ' ' A' ' 152' ' ' ILE . 53.1 mt -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -47.21 -47.37 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -55.57 -37.65 68.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.549 HG11 HD21 ' A' ' 172' ' ' LEU . 75.7 t -68.94 -50.41 54.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.2 p -55.23 -37.8 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -50.7 -39.87 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -108.46 40.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 167' ' ' MET . 17.9 p80 -58.67 -35.68 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -58.16 -31.99 67.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.55 -57.85 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 166' ' ' LEU . 2.6 m-20 -83.39 17.23 2.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 162' ' ' HIS . 22.0 mt 34.96 50.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.695 ' CE ' HD23 ' A' ' 172' ' ' LEU . 39.4 mmm -146.42 113.83 6.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 169' ' ' ALA . 9.2 p -95.76 153.36 17.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.97 -49.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.07 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -50.17 74.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -53.34 -44.39 68.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.695 HD23 ' CE ' ' A' ' 167' ' ' MET . 16.5 mt -61.69 -41.62 97.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -59.38 -48.9 79.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 42.7 mt -62.74 -34.57 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 40.9 m -69.51 -22.86 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -102.25 -5.77 23.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.583 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -55.1 -46.05 99.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.609 0.718 . . . . 0.0 110.97 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.8 Cg_exo -47.95 -63.12 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 0.0 112.363 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.771 HG21 ' HB2' ' A' ' 101' ' ' PHE . 87.1 m -65.44 -61.4 2.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 179' ' ' THR . 78.6 mt -34.24 -42.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 8.7 ptp -166.6 142.24 4.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.846 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -114.69 147.97 39.33 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 133.33 25.27 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.689 2.259 . . . . 0.0 112.311 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.94 116.54 28.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -92.51 -56.7 2.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -35.99 56.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.88 177.46 6.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.7 tpt85 -101.21 9.62 41.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.833 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -47.77 100.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.847 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -46.22 112.65 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -82.86 114.11 20.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.937 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 86.6 p -126.56 134.79 50.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.9 p -105.61 102.77 12.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.125 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 196' ' ' ILE . 58.5 p -142.13 127.75 19.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.155 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 194' ' ' THR . 14.0 ttmm -35.41 -34.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 194' ' ' THR . 51.1 mt -43.88 -65.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 196' ' ' ILE . 39.1 m-70 -35.4 -61.19 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -56.77 -48.1 78.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 m -49.74 -36.97 27.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.21 -70.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.166 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.17 -53.37 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.512 ' CD ' HE21 ' A' ' 206' ' ' GLN . 0.0 OUTLIER -38.69 -48.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 204' ' ' PHE . 60.8 m -58.79 -62.12 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.1 m-85 -34.41 -40.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 152' ' ' ILE . 70.6 mt -78.67 -52.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.512 HE21 ' CD ' ' A' ' 202' ' ' GLU . 7.5 mt-30 -48.57 -44.92 37.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.6 mm-40 -113.31 35.4 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 6.1 t -64.07 -15.98 60.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.466 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 12.8 mm-40 -89.07 -53.68 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.69 -36.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -53.07 -63.47 1.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -107.53 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.466 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 89.4 m-85 -61.27 -9.98 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 48.5 t30 47.24 43.86 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.63 145.87 28.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.519 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -43.79 143.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.471 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 75.7 mt -63.35 131.15 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.118 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.1 m -112.26 173.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.159 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 219' ' ' GLU . 5.0 tm-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -131.94 125.62 32.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.857 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 t -123.76 159.76 28.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.95 110.14 3.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' SER . 9.1 m -126.35 42.37 3.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' SER . 25.9 t -35.45 104.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.64 150.41 14.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -87.77 119.99 28.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.322 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -100.9 42.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -117.48 112.87 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -108.77 122.81 38.97 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.634 0.73 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 146.93 61.77 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.682 2.255 . . . . 0.0 112.357 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 158.17 57.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.688 2.259 . . . . 0.0 112.33 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 p -63.34 125.49 24.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.126 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 ptt85 -53.64 172.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -72.91 143.68 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -53.3 -45.58 69.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -55.17 99.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.19 159.5 32.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -167.63 163.41 14.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -87.51 -30.17 20.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 24' ' ' GLY . 9.5 m-85 -85.26 -43.87 13.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 22' ' ' TYR . 47.5 p90 35.55 30.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' TYR . . . 112.5 23.55 5.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.509 ' HE3' ' HD2' ' A' ' 26' ' ' PRO . 61.1 mmm -79.57 137.44 55.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.861 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.509 ' HD2' ' HE3' ' A' ' 25' ' ' MET . 53.4 Cg_endo -69.8 128.48 16.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 0.0 112.334 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' HG22 ' A' ' 31' ' ' VAL . 17.1 tp -52.49 -45.1 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.492 ' HB3' HG21 ' A' ' 143' ' ' VAL . 15.1 pt20 -49.65 -32.04 12.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.96 -41.47 20.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -63.03 -41.86 99.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.771 HG11 ' O ' ' A' ' 36' ' ' PRO . 23.6 m -85.27 164.8 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 p -110.63 147.91 33.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.57 -45.02 4.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -58.58 -41.14 85.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -130.99 97.62 20.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.771 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.9 Cg_endo -69.68 -47.44 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.377 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.425 HG23 ' HD2' ' A' ' 38' ' ' PRO . 43.8 mt -64.09 132.41 95.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.73 . . . . 0.0 111.109 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 147' ' ' VAL . 53.2 Cg_endo -69.78 140.05 41.67 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -57.76 -51.32 70.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.42 ' CD1' ' CD2' ' A' ' 75' ' ' PHE . 28.7 t80 -42.13 -64.42 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 97' ' ' LEU . 71.7 t -46.6 -54.32 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.122 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -50.3 -55.27 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.55 ' HG2' HD13 ' A' ' 39' ' ' LEU . 38.1 mmtt -47.26 -40.97 17.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.464 ' HB2' HD13 ' A' ' 97' ' ' LEU . 81.8 m -63.62 -46.37 86.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 ' CG ' ' A' ' 154' ' ' HIS . 35.1 t -64.89 -56.35 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.28 -45.38 88.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 93' ' ' VAL . 63.6 t80 -42.92 -60.17 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.0 mt -51.34 -48.88 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -56.07 -47.74 77.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -44.55 -47.52 10.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.3 p -84.04 29.84 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.21 163.11 9.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.403 HD21 ' C ' ' A' ' 157' ' ' ARG . 3.6 tp -103.03 37.08 2.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.346 . . . . 0.0 110.939 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.52 40.68 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.448 HG21 HD21 ' A' ' 58' ' ' LEU . 39.6 m -88.88 133.85 34.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.191 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -98.13 110.82 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.37 72.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 55' ' ' THR . 20.3 mt -114.79 119.62 37.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 62.67 28.96 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB2' ' HE1' ' A' ' 167' ' ' MET . 19.4 ttm-85 -129.9 -36.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.0 t -93.37 131.87 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.8 m -78.69 102.93 8.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.06 154.35 47.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.5 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -55.66 131.58 46.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 110.886 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -57.12 -35.59 69.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -54.03 -41.73 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.162 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.42 -54.04 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.709 ' HA ' HD12 ' A' ' 71' ' ' ILE . 29.5 mt-30 -60.54 -32.63 71.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -67.99 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -52.92 -34.72 56.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 68' ' ' GLN . 49.0 mt -56.68 -40.47 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -85.34 -59.76 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -46.8 -59.66 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.448 ' CB ' HD12 ' A' ' 81' ' ' ILE . 40.1 mm-40 -49.71 -51.58 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CD2' ' CD1' ' A' ' 40' ' ' PHE . 58.2 t80 -58.59 -37.35 75.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.46 -60.1 3.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -58.76 -38.83 79.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.22 111.5 5.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -32.41 72.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.4 m-80 -38.88 -36.91 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.448 HD12 ' CB ' ' A' ' 74' ' ' GLN . 13.7 tt -34.51 146.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 83' ' ' LEU . 6.6 t-20 -134.89 100.68 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 82' ' ' ASN . 56.2 mt -34.35 -54.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.18 -47.31 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' ASN . 3.3 t -63.04 -48.1 80.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.448 ' HB3' HG13 ' A' ' 88' ' ' VAL . 7.7 mmm -57.33 -35.5 69.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 61.33 49.96 5.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 86' ' ' MET . 35.5 m -83.45 171.1 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.114 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.7 p -66.28 123.68 20.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 55' ' ' THR . 91.4 t -44.97 -56.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.109 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -37.78 -41.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.51 -60.47 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 47' ' ' PHE . 99.1 t -45.05 -51.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.9 -44.23 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -50.34 11.68 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.449 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.22 -51.61 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.53 HD11 HG13 ' A' ' 41' ' ' VAL . 32.9 tp -43.77 -44.51 6.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 37.8 mtmt -72.85 -47.7 43.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.15 -45.63 4.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -57.43 -46.92 83.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -57.0 -44.24 82.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.54 90.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -40.48 76.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.4 mt -37.23 145.39 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -18.99 36.38 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.709 2.272 . . . . 0.0 112.306 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.8 152.27 70.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.601 0.715 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.4 Cg_endo -69.77 129.01 16.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 107' ' ' PRO . 11.2 tp -34.45 -45.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.2 mt -96.58 121.7 59.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 111.162 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 151.71 69.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.402 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.97 -22.35 64.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.2 m -68.77 -21.65 64.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 mt -113.89 28.69 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.501 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -75.68 -62.94 0.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.81 -23.38 30.64 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.613 2.209 . . . . 0.0 112.334 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.4 -32.48 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.3 mt -75.15 -27.09 59.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.14 -51.02 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.95 -25.9 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.407 ' HA ' HD11 ' A' ' 123' ' ' ILE . . . -91.94 -29.45 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -73.08 -21.06 60.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -92.27 20.32 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 124' ' ' PRO . 87.7 mt -84.33 134.16 43.52 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 111.154 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 123' ' ' ILE . 54.1 Cg_endo -69.71 -44.35 2.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.28 . . . . 0.0 112.381 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 126' ' ' LYS . 24.1 t0 -69.18 95.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.604 ' HE3' HG21 ' A' ' 217' ' ' ILE . 44.1 tttp -38.11 -43.67 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.0 m -58.72 -66.65 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -46.23 -43.55 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 123' ' ' ILE . 20.6 ttp180 -48.07 -42.15 27.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.2 mt -73.12 -52.86 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -49.08 -52.71 24.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.4 -57.61 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.435 HD22 ' HE1' ' A' ' 204' ' ' PHE . 11.9 mt -60.25 -35.22 74.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 137' ' ' VAL . 29.3 tttm -61.61 -30.8 70.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.14 -44.94 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.59 -32.71 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 134' ' ' LYS . 10.1 p -68.6 -16.18 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -72.1 -32.06 66.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -68.55 -30.3 69.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 141' ' ' HIS . 8.4 m-85 -43.59 138.45 2.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -37.25 141.37 0.43 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.556 0.693 . . . . 0.0 110.851 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.3 Cg_endo -69.78 -17.04 37.72 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 28' ' ' GLN . 60.4 t -97.71 -32.34 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -86.76 -39.16 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -49.54 -47.7 48.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.57 -54.53 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 151' ' ' VAL . 61.1 t -60.71 -56.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 45.9 t80 -46.76 -48.5 20.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -65.05 -48.51 73.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -54.74 -41.98 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 147' ' ' VAL . 62.6 t -59.52 -59.55 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.936 HG23 HG12 ' A' ' 205' ' ' ILE . 73.0 mt -47.67 -53.89 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' ILE . 24.4 m -36.83 -36.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.495 ' CG ' HG13 ' A' ' 45' ' ' VAL . 69.2 t60 -81.75 -39.41 24.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 152' ' ' ILE . 71.4 mt -56.93 -40.13 75.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.858 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.463 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 43.8 t-20 -56.84 -41.74 78.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.403 ' C ' HD21 ' A' ' 53' ' ' LEU . 23.1 mtp180 -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.528 HG13 HD22 ' A' ' 165' ' ' ASN . 67.2 t -65.21 -54.07 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.4 p -46.46 -32.78 3.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' A' ' 156' ' ' ASN . 1.5 mt-30 -67.18 -46.65 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -88.15 39.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -67.91 -20.37 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -68.83 -30.81 69.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 50.4 mt -102.47 -53.72 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.528 HD22 HG13 ' A' ' 158' ' ' VAL . 1.5 m-20 -66.38 -23.43 66.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 34.8 mt 65.01 39.95 5.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.426 ' HE1' ' HB2' ' A' ' 60' ' ' ARG . 42.4 mmm -150.11 118.98 6.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.3 p -98.16 172.67 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -56.96 -38.48 73.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -59.69 -47.19 86.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -63.28 -39.48 94.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 169' ' ' ALA . 10.9 mt -66.57 -38.54 87.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 t -61.29 -41.4 96.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.5 mt -77.85 -34.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 42.3 m -68.95 -14.85 63.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.513 ' CE2' ' HG2' ' A' ' 98' ' ' LYS . 13.3 m-85 -111.48 -5.76 14.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.578 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -54.55 -46.33 99.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -47.96 -53.36 6.74 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.306 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 26.2 m -78.77 -68.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 33.0 mt -34.22 -64.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.554 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 1.0 OUTLIER -112.33 96.9 6.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.446 ' CG ' ' HD2' ' A' ' 183' ' ' PRO . 33.6 ttm-85 -37.31 141.41 0.44 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.633 0.73 . . . . 0.0 110.865 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 182' ' ' ARG . 53.5 Cg_endo -69.72 135.75 31.34 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 0.0 112.347 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.15 120.86 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -56.14 -53.62 54.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -88.91 115.62 26.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -145.96 105.79 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -80.05 136.11 36.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -138.39 112.98 8.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 191' ' ' LEU . 50.4 p90 -72.02 -51.19 22.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 190' ' ' PHE . 56.5 mt -142.89 163.27 33.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 18.3 m -100.43 39.11 1.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 193' ' ' THR . 13.6 t -114.27 38.71 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.091 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 194' ' ' THR . 10.0 t -156.97 123.2 4.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.19 41.23 2.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 200' ' ' VAL . 32.0 mt -67.12 -59.14 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -37.83 -47.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.72 -51.67 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.9 m -40.83 -42.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 121' ' ' ALA . 57.9 t -40.44 -71.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 202' ' ' GLU . 85.5 t -60.08 -61.11 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 201' ' ' VAL . 20.9 tt0 -35.77 -42.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.3 m -62.72 -59.93 4.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.2 m-85 -33.98 -47.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.936 HG12 HG23 ' A' ' 152' ' ' ILE . 47.4 mt -71.66 -48.71 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -51.84 -45.34 63.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.469 ' NE2' ' HB2' ' A' ' 210' ' ' PHE . 6.4 mm100 -113.74 34.1 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.539 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 21.6 t -63.54 -21.85 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.489 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 47.3 mm-40 -84.5 -54.54 4.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.469 ' HB2' ' NE2' ' A' ' 207' ' ' GLN . 1.4 t80 -41.13 -34.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.539 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 22.3 m-85 -52.62 -63.4 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -106.11 -56.35 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.489 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 72.1 m-85 -56.92 -17.16 8.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.915 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 51.67 40.1 26.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.925 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.07 135.77 15.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -42.5 137.08 2.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 0.0 110.936 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.604 HG21 ' HE3' ' A' ' 126' ' ' LYS . 68.1 mt -48.43 127.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.409 HG22 ' OE1' ' A' ' 207' ' ' GLN . 35.8 m -89.42 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t -148.54 155.25 40.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 110.849 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 p -151.7 175.53 12.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.89 168.47 27.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.477 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.6 p -119.59 159.58 24.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 110.85 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.6 m -89.26 -56.25 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.58 -119.81 5.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp 55.98 42.85 28.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.803 0.335 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -99.37 135.72 40.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -125.44 177.67 6.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.432 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 7.6 t30 -168.51 140.42 2.26 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.607 0.718 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 54.3 Cg_endo -69.72 153.07 69.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.665 2.243 . . . . 0.0 112.411 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 162.49 41.9 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.635 2.223 . . . . 0.0 112.361 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.9 p -98.63 113.56 25.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.184 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -105.81 157.97 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 17' ' ' ASN . 12.2 tpp180 -83.81 155.05 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ARG . 98.0 m-20 -35.08 -44.38 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -163.89 116.99 1.45 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 20' ' ' SER . 0.7 OUTLIER -110.85 140.83 44.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.415 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 75.3 m -135.1 176.2 8.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.848 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -102.86 -35.45 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.671 ' HB3' HD21 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -81.56 -51.48 8.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 22' ' ' TYR . 42.3 p90 45.85 43.64 10.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.22 29.88 4.37 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.9 mtp -113.31 147.38 37.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.572 0.701 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 153.98 68.03 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.7 2.266 . . . . 0.0 112.312 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' VAL . 27.8 tp -62.44 -45.61 92.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.593 ' HA ' HG11 ' A' ' 143' ' ' VAL . 4.9 pt20 -46.79 -31.57 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.97 -44.05 27.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 22' ' ' TYR . 28.0 mt -64.14 -42.09 96.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 27' ' ' LEU . 32.8 m -90.81 158.21 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -100.48 150.53 22.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -45.89 -46.17 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -53.7 -40.32 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 15.2 mmtp -133.75 94.73 18.45 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.7 Cg_endo -69.76 -35.95 11.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.704 2.269 . . . . 0.0 112.365 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 ' HG3' ' A' ' 42' ' ' GLU . 18.9 mt -74.22 131.33 80.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 111.113 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' HG22 ' A' ' 147' ' ' VAL . 53.9 Cg_endo -69.71 121.56 8.26 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.713 2.276 . . . . 0.0 112.345 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.491 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -44.67 -53.88 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -38.72 -68.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.885 HG13 HD11 ' A' ' 97' ' ' LEU . 79.2 t -45.41 -54.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HG3' HG22 ' A' ' 37' ' ' ILE . 88.5 mt-10 -45.94 -60.9 1.99 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 54.5 mmtt -46.94 -39.29 12.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.543 ' HB2' HD13 ' A' ' 97' ' ' LEU . 94.6 m -68.64 -52.49 30.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.93 -32.65 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -82.64 -36.29 26.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -63.15 -55.87 21.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.98 ' O ' HG22 ' A' ' 51' ' ' THR . 23.1 mt -47.75 -52.47 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -70.94 -24.32 62.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.84 -17.71 59.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.98 HG22 ' O ' ' A' ' 48' ' ' ILE . 8.4 t -91.98 26.33 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.54 -34.4 3.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 48' ' ' ILE . 4.7 tp 68.21 53.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.3 p -114.65 -25.33 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -42.74 129.52 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 57' ' ' GLY . 7.3 mp0 -74.21 140.96 45.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 33.93 37.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 59' ' ' TYR . 1.2 pp -38.22 -32.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.765 ' N ' HD12 ' A' ' 58' ' ' LEU . 15.1 m-85 -82.03 -61.83 1.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG3' HG23 ' A' ' 61' ' ' VAL . 11.5 ptm180 -55.33 -14.02 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 60' ' ' ARG . 88.4 t -117.46 108.53 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 77.4 p -79.76 -46.09 17.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.54 -125.03 8.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.509 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -99.75 136.69 39.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.477 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 1.4 mptm? -63.92 -47.48 80.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m -46.25 -43.68 15.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.13 -58.65 6.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.823 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.809 ' HA ' HD12 ' A' ' 71' ' ' ILE . 1.2 mp0 -58.19 -34.95 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -50.56 -62.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.3 p30 -58.9 -41.26 86.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 68' ' ' GLN . 70.7 mt -46.61 -41.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.56 -57.7 2.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -49.09 -56.24 9.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -54.39 -46.54 73.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -62.38 -35.16 78.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.85 -53.31 52.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -74.42 -24.82 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -130.6 89.62 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.6 -34.63 75.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.68 39.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.724 HD11 ' SD ' ' A' ' 86' ' ' MET . 9.6 tt -79.99 154.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 81' ' ' ILE . 1.9 t-20 -124.79 94.56 4.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -41.15 -49.12 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.955 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.3 t -47.41 -44.62 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 t -60.18 -40.49 90.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.724 ' SD ' HD11 ' A' ' 81' ' ' ILE . 77.9 mtp -63.14 -37.97 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 62.95 47.4 4.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.0 m -84.76 171.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.7 p -68.71 118.96 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.9 t -36.56 -54.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -40.04 -47.78 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 -63.08 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.4 t -50.05 -46.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.84 -50.66 33.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -54.16 6.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.64 -40.85 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.885 HD11 HG13 ' A' ' 41' ' ' VAL . 11.1 tp -53.24 -56.31 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.463 ' CG ' ' CE2' ' A' ' 176' ' ' PHE . 6.1 mtmp? -60.34 -46.27 90.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.33 -46.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 7.3 t80 -57.41 -53.19 60.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -51.46 -41.01 60.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.53 -36.47 81.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -62.23 -38.75 90.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' ASP . 95.9 mt -34.89 144.64 0.21 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 110.934 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.28 36.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -139.26 153.82 71.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.77 128.65 16.32 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 2.263 . . . . 0.0 112.357 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 107' ' ' PRO . 23.8 tp -34.97 -39.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.9 mt -98.46 121.41 56.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.77 144.19 53.21 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -59.38 -30.76 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.9 p -61.36 -16.35 45.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 117' ' ' LEU . 58.1 mt -119.45 29.92 7.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.51 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -76.39 -63.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.74 . . . . 0.0 110.855 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.2 Cg_endo -69.73 -20.54 34.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.724 2.283 . . . . 0.0 112.364 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.6 -34.02 71.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 113' ' ' LEU . 3.1 mt -73.36 -37.09 66.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 121' ' ' ALA . 5.1 mt -77.49 -53.21 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -43.8 -32.37 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.42 -31.74 21.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -71.72 -19.74 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -92.92 26.25 2.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.949 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 128' ' ' GLU . 72.1 mt -92.53 129.87 39.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.606 0.717 . . . . 0.0 111.138 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -44.36 2.11 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.63 2.22 . . . . 0.0 112.35 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.459 ' HB2' ' CG ' ' A' ' 128' ' ' GLU . 0.6 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -37.36 -57.99 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.9 m -46.66 -47.85 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.595 ' HB2' HG21 ' A' ' 123' ' ' ILE . 37.5 mm-40 -64.38 -48.61 74.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -45.97 -57.46 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.583 HD13 ' OE1' ' A' ' 207' ' ' GLN . 16.3 mt -63.33 -67.12 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 130' ' ' LEU . 21.1 m80 -34.38 -40.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.12 -63.25 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.61 -30.27 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.644 ' O ' HG12 ' A' ' 137' ' ' VAL . 64.8 tttt -65.96 -32.77 74.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -87.93 -47.65 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.3 mt -57.55 -26.07 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.174 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 134' ' ' LYS . 13.5 p -71.7 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -76.39 -34.75 58.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -64.07 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.936 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.2 m-85 -40.7 129.73 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.596 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -33.95 141.11 0.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.7 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.596 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.75 -13.75 35.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.725 2.283 . . . . 0.0 112.352 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 28' ' ' GLN . 95.4 t -97.84 -35.83 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.071 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.53 -39.61 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 1.4 t80 -47.22 -47.87 24.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.81 66.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 151' ' ' VAL . 83.4 t -70.14 -57.99 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 41.3 t80 -48.4 -46.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -62.06 -51.18 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -53.66 -47.73 70.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 147' ' ' VAL . 97.8 t -54.77 -58.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.64 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 86.3 mt -46.78 -52.09 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.6 m -41.36 -37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -80.72 -35.13 33.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.728 HD13 HD11 ' A' ' 205' ' ' ILE . 97.0 mt -57.81 -42.99 85.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -44.52 66.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -55.3 -43.4 74.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.656 HG11 HD21 ' A' ' 172' ' ' LEU . 84.5 t -63.35 -42.32 95.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 p -67.53 -27.11 66.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -69.97 -40.42 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -102.14 50.38 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.469 ' CD2' HG22 ' A' ' 168' ' ' THR . 0.6 OUTLIER -80.15 41.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.833 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -122.21 -43.47 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 mt -87.91 -40.97 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.158 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.84 -23.69 18.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 mt 63.99 48.27 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 37.8 mmm -132.2 97.14 4.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.469 HG22 ' CD2' ' A' ' 162' ' ' HIS . 72.3 p -85.36 167.85 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -52.32 -41.33 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.054 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.53 -56.42 20.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -50.69 -42.73 57.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 169' ' ' ALA . 7.4 mt -63.09 -43.95 97.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.6 t -57.9 -46.07 85.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.49 -35.16 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.9 t -68.59 -26.17 65.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 98' ' ' LYS . 16.7 m-85 -101.18 -6.58 24.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.589 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -54.61 -45.8 99.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.562 0.696 . . . . 0.0 110.907 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.1 Cg_exo -48.01 -50.18 12.39 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.268 . . . . 0.0 112.304 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 180' ' ' LEU . 20.8 m -81.87 -65.55 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 26.0 mt -33.45 -59.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.565 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 1.4 ttm -114.58 116.62 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -56.4 130.59 75.97 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 117.93 5.37 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.372 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -102.38 169.79 8.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -95.4 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -130.0 123.76 31.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.59 137.85 50.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -113.61 163.15 15.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -140.0 123.51 17.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.429 ' O ' ' C ' ' A' ' 191' ' ' LEU . 12.6 t80 -131.4 123.75 28.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -36.08 -47.07 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.91 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.2 t -83.12 149.14 27.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.8 m -63.32 120.12 10.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.429 HG22 HG13 ' A' ' 196' ' ' ILE . 2.9 m -78.96 -67.84 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 15.8 pttm 43.78 33.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 200' ' ' VAL . 82.3 mt -84.65 -59.96 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -40.37 -51.65 2.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.15 -55.05 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 m -45.32 -38.62 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 196' ' ' ILE . 94.0 t -45.17 -70.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.102 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.9 t -64.74 -60.37 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 201' ' ' VAL . 22.9 tt0 -34.59 -45.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 84.2 m -60.16 -59.15 5.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.2 m-85 -34.62 -54.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.728 HD11 HD13 ' A' ' 155' ' ' LEU . 50.5 mt -62.66 -55.52 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -46.28 -54.99 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.935 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.583 ' OE1' HD13 ' A' ' 130' ' ' LEU . 16.5 mm-40 -99.26 27.25 5.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.599 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 3.5 t -61.37 -14.42 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' TYR . 20.9 mm-40 -95.32 -57.53 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.495 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.6 t80 -39.67 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.599 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -52.9 -62.29 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -128.2 -26.78 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 215' ' ' GLY . 27.7 m-85 -83.21 30.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 213' ' ' TYR . 27.5 m-20 33.64 33.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -57.26 146.27 36.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.34 133.28 34.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.48 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 85.5 mt -48.29 122.82 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.1 m -111.49 166.31 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m 51.79 45.27 28.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -127.92 153.97 46.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.871 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.25 156.04 17.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.0 p -153.89 147.75 25.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -114.61 -61.57 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.12 157.86 33.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -136.97 167.38 21.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -139.2 176.37 8.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -133.82 175.03 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -89.12 122.17 68.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.608 0.718 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 150.99 69.02 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.631 2.221 . . . . 0.0 112.357 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -177.7 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.352 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -103.61 151.15 23.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.101 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -84.87 27.82 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -112.93 160.67 17.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -80.77 -42.8 21.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.431 ' CH2' ' HG3' ' A' ' 73' ' ' LYS . 4.7 m95 -132.29 125.79 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -148.37 126.13 11.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.496 ' O ' ' CE2' ' A' ' 23' ' ' PHE . 4.1 t -172.97 175.8 3.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.851 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -97.27 -23.9 15.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -59.72 -50.21 74.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -57.35 123.68 16.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.09 -41.87 2.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 8.4 mtt -84.07 145.14 45.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 110.82 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 147.62 62.99 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.633 2.222 . . . . 0.0 112.337 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.72 -52.4 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.954 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.675 ' CB ' HG21 ' A' ' 143' ' ' VAL . 21.0 pt20 -44.9 -30.13 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.99 -45.03 15.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.05 -44.76 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 36' ' ' PRO . 12.2 m -83.0 164.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -114.2 164.7 13.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.21 63.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -51.66 -54.13 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 23.1 mmtp -119.69 96.41 49.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 0.0 110.883 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.1 Cg_endo -69.79 -35.94 11.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.238 . . . . 0.0 112.328 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.52 HG23 ' HD2' ' A' ' 38' ' ' PRO . 36.5 mt -85.73 134.71 39.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 0.0 111.161 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.0 Cg_endo -69.77 150.48 68.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -68.66 -47.2 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -40.79 -58.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 97' ' ' LEU . 96.8 t -55.28 -62.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -45.8 -62.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -50.74 -37.25 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 68.8 m -69.86 -31.98 70.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG13 ' CG ' ' A' ' 154' ' ' HIS . 84.4 t -78.68 -60.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.46 -40.72 60.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.783 ' CE1' HG21 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -51.04 -41.1 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mt -59.9 -64.13 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -33.7 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.58 -24.64 56.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.1 p -107.7 29.23 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.08 134.66 5.21 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.58 -10.65 14.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.931 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.0 m -91.68 40.9 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 56' ' ' GLU . 6.0 m -92.45 113.78 26.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.7 tt0 -33.98 121.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.27 69.3 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.901 ' O ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -66.49 -9.56 35.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.93 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.685 ' CE2' HD21 ' A' ' 58' ' ' LEU . 8.9 m-85 -122.75 -37.75 2.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -74.1 -40.2 62.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.41 137.1 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.411 ' HA ' ' CB ' ' A' ' 91' ' ' ASN . 63.5 m -131.93 -41.23 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.84 -72.09 0.76 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -117.38 165.52 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.936 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -108.91 -39.02 5.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 69' ' ' ASP . 45.4 m -38.26 -53.74 1.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -35.72 -59.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 71' ' ' ILE . 36.3 mt-30 -52.65 -38.4 60.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.9 t70 -47.84 -56.69 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.8 p30 -68.94 -36.08 77.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 68' ' ' GLN . 57.8 mt -51.09 -42.36 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -82.92 -54.01 5.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' HG3' ' CH2' ' A' ' 18' ' ' TRP . 5.6 mtpm? -54.39 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -45.04 -46.02 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.58 -31.37 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.15 -48.05 38.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.35 -30.15 65.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.1 93.18 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.89 37.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.84 HD11 ' SD ' ' A' ' 86' ' ' MET . 10.6 tt -76.58 153.13 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 83' ' ' LEU . 2.3 t-20 -124.62 83.87 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 82' ' ' ASN . 26.4 mt -34.35 -47.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.22 -54.79 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -52.35 -42.01 63.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.84 ' SD ' HD11 ' A' ' 81' ' ' ILE . 75.2 mtp -60.9 -36.39 79.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 59.4 45.0 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 160.97 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.183 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 29.0 p -56.12 118.18 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.121 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.1 t -41.52 -54.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -43.23 -35.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 71' ' ' ILE . . . -55.1 -59.3 4.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.783 HG21 ' CE1' ' A' ' 47' ' ' PHE . 89.6 t -50.39 -51.03 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -48.39 -45.34 35.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.32 -55.39 18.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.469 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.8 -40.77 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 41' ' ' VAL . 14.5 tp -48.75 -39.95 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.505 ' CG ' ' CE1' ' A' ' 176' ' ' PHE . 42.6 mtmt -74.41 -45.95 43.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.13 -34.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 6.9 t80 -68.48 -48.09 65.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -56.66 -41.29 76.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' HB2' HG23 ' A' ' 179' ' ' THR . . . -65.75 -37.44 86.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.44 -35.4 73.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.3 mt -39.2 144.56 0.44 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -29.12 24.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.91 154.14 81.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 143.8 51.97 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.5 tp -48.16 -58.46 4.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.95 131.17 54.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.656 0.741 . . . . 0.0 111.106 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 162.09 43.41 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.317 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -79.87 -25.78 40.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -69.74 -17.03 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 117' ' ' LEU . 43.3 mt -122.42 31.92 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.474 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -74.28 -61.76 1.14 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.582 0.706 . . . . 0.0 110.828 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.5 Cg_endo -69.77 -10.73 29.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -68.01 -44.03 77.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 113' ' ' LEU . 4.3 mp -67.23 -34.93 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.545 HD11 ' CE1' ' A' ' 197' ' ' HIS . 9.6 mt -77.45 -58.5 3.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -42.76 -30.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.46 -31.76 18.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -69.08 -21.98 64.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -90.21 19.06 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.4 HG23 ' HD2' ' A' ' 124' ' ' PRO . 66.8 mt -85.53 132.71 43.85 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 0.0 111.099 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.79 -44.57 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.319 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.3 m-20 -64.36 95.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.1 ttpt -35.58 -53.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.4 m -57.34 -61.37 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.121 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -46.38 -46.23 18.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.863 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -48.35 -51.99 23.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.55 -60.1 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -40.96 -53.85 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.73 -49.57 65.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.05 -28.02 69.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 137' ' ' VAL . 44.4 tttt -74.66 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -86.1 -32.43 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.66 -21.71 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 134' ' ' LYS . 10.8 p -87.9 -7.72 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -77.04 -38.6 52.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -12.8 60.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.68 ' HZ ' HD11 ' A' ' 117' ' ' LEU . 2.8 m-85 -53.68 135.92 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.594 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.2 t-80 -34.49 141.51 0.25 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.594 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.77 -14.53 36.18 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.665 2.244 . . . . 0.0 112.383 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.675 HG21 ' CB ' ' A' ' 28' ' ' GLN . 96.7 t -95.36 -25.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.105 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -94.84 -34.59 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -64.87 -54.42 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.475 ' O ' HD11 ' A' ' 37' ' ' ILE . 6.7 p-10 -45.52 -45.39 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.511 HG22 HG12 ' A' ' 37' ' ' ILE . 11.7 t -77.16 -63.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.574 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 27.8 t80 -37.23 -41.4 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -64.77 -54.35 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -53.31 -51.14 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.6 t -48.11 -56.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.684 HG23 HG12 ' A' ' 205' ' ' ILE . 89.0 mt -55.83 -49.25 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.7 m -42.88 -31.03 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.526 ' CG ' HG13 ' A' ' 45' ' ' VAL . 86.5 t60 -85.17 -42.99 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 152' ' ' ILE . 83.0 mt -54.93 -46.58 74.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -51.76 -48.3 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -53.55 -38.22 63.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.15 -45.67 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.165 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.2 p -58.35 -21.51 50.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -51.62 -53.75 35.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.483 ' HB3' HD12 ' A' ' 164' ' ' ILE . 10.8 mm100 -102.32 37.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.508 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 24.5 p80 -49.97 -27.67 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.508 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 3.9 mmmp? -70.12 -32.58 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 161' ' ' GLN . 92.2 mt -82.66 -65.32 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -2.3 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.5 mt 55.25 46.81 22.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 25.6 mtp -144.69 116.92 8.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.844 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.456 HG22 ' CG ' ' A' ' 162' ' ' HIS . 39.1 p -101.15 159.16 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.107 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.29 -35.03 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.77 -48.97 57.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -55.22 -36.11 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 14.0 mt -72.56 -43.3 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -58.11 -36.91 73.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.6 mt -77.8 -35.85 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.6 -18.47 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.505 ' CE1' ' CG ' ' A' ' 98' ' ' LYS . 11.6 m-85 -108.71 -8.83 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.676 ' CD1' ' NE2' ' A' ' 198' ' ' GLN . 0.4 OUTLIER -54.34 -46.42 99.0 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.566 0.698 . . . . 0.0 110.917 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -47.95 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 3.9 m -69.1 -59.45 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 56.7 mt -33.83 -47.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 34.3 mmm -143.0 136.53 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -39.08 159.52 0.1 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 136.73 33.76 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.655 2.237 . . . . 0.0 112.373 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -47.79 163.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -119.96 -44.01 2.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -153.4 141.02 19.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.887 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -63.47 155.14 30.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.451 ' HG2' HD12 ' A' ' 191' ' ' LEU . 9.2 tpp180 -82.67 140.46 33.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -97.64 -177.0 3.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 28.1 t80 42.49 37.77 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.451 HD12 ' HG2' ' A' ' 188' ' ' ARG . 34.3 mt -154.53 129.78 9.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.4 m -78.04 -56.49 4.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.4 m -111.52 91.64 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 10.0 t -99.94 34.92 2.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -103.32 37.2 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 197' ' ' HIS . 96.8 mt -74.22 -43.61 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.545 ' CE1' HD11 ' A' ' 118' ' ' LEU . 53.1 m-70 -36.74 -62.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.676 ' NE2' ' CD1' ' A' ' 177' ' ' TRP . 83.9 mm-40 -43.64 -54.17 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 m -50.61 -36.94 37.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' A' ' 117' ' ' LEU . 23.2 t -54.81 -71.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.09 -54.27 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -45.6 -51.77 11.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 204' ' ' PHE . 93.3 m -50.06 -63.02 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.4 m-85 -34.25 -53.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.684 HG12 HG23 ' A' ' 152' ' ' ILE . 67.1 mt -62.11 -54.87 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -49.06 -57.55 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.465 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 10.3 mm-40 -96.52 28.48 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.503 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 3.1 t -61.86 -20.66 63.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 213' ' ' TYR . 7.6 mm100 -88.57 -51.44 5.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -44.75 -37.97 4.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -48.88 -63.07 1.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -104.05 -54.29 2.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 209' ' ' GLN . 60.2 m-85 -56.82 -36.18 69.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.7 t30 73.25 36.23 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.21 174.72 49.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.98 142.71 53.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.465 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 92.9 mt -68.25 137.87 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.62 168.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.3 p -171.9 156.11 4.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.878 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 m -147.22 168.6 21.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.817 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.08 122.65 7.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.498 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.2 m -148.14 172.28 14.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -63.97 168.43 5.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.824 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.84 97.57 0.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.541 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -73.44 159.19 33.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -83.35 54.82 2.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 52.38 45.87 27.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.417 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 8.7 t30 -139.82 140.14 23.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 53.6 Cg_endo -69.73 151.21 69.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.36 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 146.82 61.29 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.724 2.283 . . . . 0.0 112.35 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.7 p -54.19 125.47 19.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -68.46 120.49 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 17' ' ' ASN . 19.1 ptp180 -94.26 -43.9 8.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.3 OUTLIER 48.1 25.69 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.481 ' CG ' ' O ' ' A' ' 18' ' ' TRP . 34.3 t90 -118.89 3.82 11.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -52.4 156.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -129.59 178.67 6.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 22' ' ' TYR . 11.8 m120 -77.98 -43.99 28.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.585 ' CZ ' ' CE1' ' A' ' 23' ' ' PHE . 1.1 p90 -36.92 -37.54 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.585 ' CE1' ' CZ ' ' A' ' 22' ' ' TYR . 12.8 m-85 -49.5 108.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.78 -34.68 4.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -81.92 139.43 46.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.716 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 158.53 56.71 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.67 2.246 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' VAL . 21.1 tp -54.6 -43.82 72.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.785 ' HA ' HG11 ' A' ' 143' ' ' VAL . 3.4 pt20 -51.06 -37.35 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.19 -49.71 26.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.3 -46.43 79.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 27' ' ' LEU . 5.2 m -91.08 168.41 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.5 p -112.33 162.88 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.72 -43.94 73.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.3 -45.46 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -128.93 86.15 58.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -34.34 14.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.39 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.1 mt -78.73 129.2 74.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 111.143 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.658 2.239 . . . . 0.0 112.334 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.495 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -47.69 -48.61 29.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.409 ' CZ ' HG22 ' A' ' 71' ' ' ILE . 90.4 t80 -41.13 -66.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.802 HG13 HD11 ' A' ' 97' ' ' LEU . 41.8 t -45.84 -61.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -40.23 -61.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 43.2 mmtt -46.39 -41.27 13.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 86.7 m -68.69 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.579 HG13 ' CG ' ' A' ' 154' ' ' HIS . 71.7 t -71.79 -61.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -53.62 -35.94 61.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.538 ' CD2' HG11 ' A' ' 93' ' ' VAL . 30.3 t80 -56.72 -49.23 75.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.679 HG22 HD12 ' A' ' 53' ' ' LEU . 17.0 mt -61.67 -20.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -89.75 -14.1 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -95.44 -20.41 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -85.16 23.88 1.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.01 -29.79 3.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.477 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.756 HD11 HG22 ' A' ' 158' ' ' VAL . 6.1 tp 63.25 52.05 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.926 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 16.7 p -133.35 31.61 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 m -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.152 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.09 114.39 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.76 90.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -99.54 -30.13 12.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.98 -47.62 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.71 ' HG3' HG23 ' A' ' 61' ' ' VAL . 14.0 ptt180 -59.59 -15.96 22.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.71 HG23 ' HG3' ' A' ' 60' ' ' ARG . 79.0 t -119.94 101.97 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -66.11 -55.99 13.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.35 -101.55 2.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -116.48 158.24 23.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 66' ' ' THR . 1.6 tmtp? -95.62 -53.11 3.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' ASP . 91.5 m -38.1 -58.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 19.3 m-20 -39.13 -49.34 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HA ' HD12 ' A' ' 71' ' ' ILE . 35.9 mt-30 -72.49 -29.41 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 66' ' ' THR . 8.5 t0 -59.39 -54.32 48.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 67' ' ' ASP . 20.2 p30 -54.72 -39.26 68.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.436 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 58.2 mt -49.03 -39.53 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -91.25 -55.1 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 18' ' ' TRP . 50.1 mtmt -46.29 -48.09 18.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -66.31 -56.64 10.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -40.0 -43.42 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.88 -53.09 52.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -56.5 -40.06 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -149.86 134.33 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -91.01 -20.2 22.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -81.13 45.21 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 pt -106.12 -178.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -145.18 154.53 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.3 mt -89.24 -34.24 16.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.83 -56.63 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -52.32 -31.14 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.471 ' HB3' HG13 ' A' ' 88' ' ' VAL . 9.5 mmm -69.58 -27.8 65.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 59.13 48.16 10.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 86' ' ' MET . 34.5 m -84.45 162.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' VAL . 58.9 p -69.85 121.18 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' THR . 88.4 t -37.07 -55.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.09 -47.14 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.52 -62.75 1.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.538 HG11 ' CD2' ' A' ' 47' ' ' PHE . 97.2 t -44.41 -43.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' LEU . . . -65.19 -46.9 78.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -55.28 26.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -44.96 35.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 111.121 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.802 HD11 HG13 ' A' ' 41' ' ' VAL . 26.7 tp -44.11 -43.84 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -75.8 -46.57 29.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.09 -43.06 3.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -56.79 -46.58 81.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -60.53 -50.22 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.501 ' HB2' HG23 ' A' ' 179' ' ' THR . . . -56.37 -39.88 73.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.57 -39.87 71.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.2 mt -39.02 143.36 0.48 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.711 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.62 31.8 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -133.49 154.83 81.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.731 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.03 68.23 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 148' ' ' PHE . 11.1 tp -62.63 -40.67 97.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.564 HD12 ' HE2' ' A' ' 181' ' ' MET . 65.1 mt -95.51 128.34 38.49 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 111.127 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.9 Cg_endo -69.78 160.48 49.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.344 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.429 ' HA ' ' CG ' ' A' ' 114' ' ' HIS . 30.6 m-85 -75.45 -36.18 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.5 t -56.19 -14.57 2.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.467 HD21 ' HG3' ' A' ' 139' ' ' LYS . 23.1 mt -127.73 32.0 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.504 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -75.88 -63.15 0.66 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.822 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.71 -11.46 30.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.327 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.92 -32.94 57.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.524 ' CD1' HD13 ' A' ' 109' ' ' ILE . 2.5 mt -70.39 -45.77 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.7 mt -68.09 -55.04 13.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -47.88 -29.35 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.15 -24.89 26.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -81.06 -32.19 34.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -75.75 -1.29 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 128' ' ' GLU . 53.0 mt -62.43 130.76 93.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.639 0.733 . . . . 0.0 111.151 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.58 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.38 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.25 110.81 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -46.07 -54.96 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.2 m -50.98 -56.81 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.516 ' HB2' HG21 ' A' ' 123' ' ' ILE . 63.7 mm-40 -56.25 -38.06 70.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -55.25 -46.54 76.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 207' ' ' GLN . 13.1 mt -70.76 -66.51 0.6 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' LEU . 12.7 m-70 -35.69 -51.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.09 -57.51 9.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 9.3 mt -59.47 -20.52 55.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.533 ' O ' HG12 ' A' ' 137' ' ' VAL . 4.6 ttpm? -81.65 -34.11 30.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 4.5 pt-20 -80.69 -28.61 36.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.545 HG22 ' HE1' ' A' ' 140' ' ' PHE . 39.4 mt -72.58 -34.59 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.097 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.57 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 9.5 p -73.0 -0.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -79.07 -42.92 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.467 ' HG3' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -85.81 18.91 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.57 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 2.7 m-85 -77.67 143.43 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -37.16 141.13 0.43 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.73 -25.6 28.58 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.323 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.785 HG11 ' HA ' ' A' ' 28' ' ' GLN . 40.3 t -92.18 -35.39 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.422 ' OD1' ' CG ' ' A' ' 141' ' ' HIS . 17.6 m120 -81.42 -45.78 15.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.564 ' CE1' ' HD3' ' A' ' 149' ' ' ARG . 4.3 t80 -43.38 -48.53 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -56.25 -59.8 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.7 -63.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.595 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 30.0 t80 -43.97 -44.44 7.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.564 ' HD3' ' CE1' ' A' ' 145' ' ' TYR . 8.2 ttp85 -62.14 -49.04 77.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -59.33 -53.96 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -45.49 -59.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.595 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 75.0 mt -52.08 -52.67 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 m -41.51 -29.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.579 ' CG ' HG13 ' A' ' 45' ' ' VAL . 28.7 t60 -88.44 -42.37 12.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 1.003 HD21 ' CE2' ' A' ' 176' ' ' PHE . 89.8 mt -54.53 -46.84 73.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -51.35 -40.95 60.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -61.3 -41.49 97.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.756 HG22 HD11 ' A' ' 53' ' ' LEU . 76.2 t -60.74 -42.92 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.7 p -61.8 -19.67 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -58.05 -53.2 60.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.474 ' HB3' HD12 ' A' ' 164' ' ' ILE . 8.5 mm100 -99.76 37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.483 ' CG ' HG22 ' A' ' 168' ' ' THR . 19.7 p80 -53.43 -28.25 28.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -67.31 -27.26 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 161' ' ' GLN . 79.3 mt -89.46 -59.03 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' LEU . 3.5 p30 -81.49 15.48 2.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 165' ' ' ASN . 27.3 mt 36.82 50.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 64.3 mmm -145.06 115.24 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.483 HG22 ' CG ' ' A' ' 162' ' ' HIS . 66.1 p -101.19 167.44 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.67 -40.39 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -58.26 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -58.65 -55.67 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.76 -21.73 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.452 ' HB2' ' N ' ' A' ' 202' ' ' GLU . 4.7 p -82.92 -39.16 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 49.4 mt -75.75 -25.1 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.3 p -79.39 -36.92 38.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 1.003 ' CE2' HD21 ' A' ' 155' ' ' LEU . 7.2 m-85 -85.24 -38.71 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.864 ' HA ' HD12 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -39.26 -57.14 2.37 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.546 0.689 . . . . 0.0 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.521 ' HD3' ' CG ' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -48.07 -65.89 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.662 2.242 . . . . 0.0 112.317 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 102' ' ' ALA . 94.6 m -54.39 -55.47 28.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 177' ' ' TRP . 32.8 mt -30.24 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.564 ' HE2' HD12 ' A' ' 109' ' ' ILE . 2.5 ptt? -175.65 143.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -98.8 148.46 34.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 122.4 9.08 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 186' ' ' GLU . 11.3 t0 -72.75 153.1 41.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 184' ' ' ASP . 0.8 OUTLIER 33.24 34.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 184' ' ' ASP . 5.9 pt-20 -35.6 111.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -56.77 172.74 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -54.93 178.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -53.86 114.79 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 190' ' ' PHE . 3.8 p90 -114.02 160.17 19.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 9.5 mt -156.19 107.08 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 47.4 m -144.43 153.81 42.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 193' ' ' THR . 14.6 t -83.08 39.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 64.6 p -96.3 93.72 7.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -90.41 40.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 200' ' ' VAL . 88.4 mt -85.56 -58.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.108 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -41.74 -52.54 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.903 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -63.11 -46.11 88.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.6 t -55.0 -40.93 70.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.445 ' CG1' HD22 ' A' ' 117' ' ' LEU . 79.1 t -37.62 -67.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.5 t -63.9 -51.72 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.452 ' N ' ' HB2' ' A' ' 173' ' ' SER . 15.6 tt0 -37.37 -53.93 1.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.6 m -56.3 -57.26 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 10.7 m-85 -42.62 -36.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 86.0 mt -71.73 -58.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.452 ' HB3' ' CG2' ' A' ' 218' ' ' VAL . 11.3 mt-30 -54.96 -54.76 38.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.497 ' HG3' HD13 ' A' ' 130' ' ' LEU . 61.6 mm-40 -86.44 24.2 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.73 -18.62 62.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 213' ' ' TYR . 18.2 mm-40 -91.6 -51.14 5.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -45.24 -38.49 5.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -50.3 -63.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -106.68 -54.79 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 209' ' ' GLN . 71.4 m-85 -59.62 -16.95 29.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 20.7 m120 48.28 47.07 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -90.04 165.6 31.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.89 132.87 42.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 93.4 mt -58.63 106.84 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 206' ' ' GLN . 30.1 m -64.01 168.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 t -158.58 150.46 21.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 t -112.21 -55.57 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 37.98 -122.25 1.1 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.492 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 p -38.84 137.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.8 t -106.91 118.1 35.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.04 63.35 0.32 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -157.81 156.82 32.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.3 . . . . 0.0 110.923 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -94.09 148.49 22.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -170.48 115.58 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.427 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 24.5 t-20 -87.78 140.61 31.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 0.0 110.878 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 53.5 Cg_endo -69.77 154.34 67.81 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.346 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 162.08 43.46 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.694 2.262 . . . . 0.0 112.333 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 t -169.41 157.77 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.13 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.71 151.6 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -109.66 -44.04 3.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 36.94 39.64 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -87.34 42.57 1.04 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -100.55 128.43 46.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.475 ' HB2' ' CD1' ' A' ' 22' ' ' TYR . 1.6 m -117.28 -6.63 11.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.827 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 58.14 40.69 24.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.475 ' CD1' ' HB2' ' A' ' 20' ' ' SER . 4.2 p90 -127.4 -44.76 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' N ' ' CG ' ' A' ' 22' ' ' TYR . 30.5 p90 -51.41 112.15 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.849 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.47 -38.66 3.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.509 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.0 mmt -80.39 152.67 73.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.508 0.671 . . . . 0.0 110.866 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 154.38 67.74 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 31' ' ' VAL . 20.1 tp -61.0 -42.69 98.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.921 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.477 ' HA ' HG11 ' A' ' 143' ' ' VAL . 3.5 pt20 -52.51 -29.23 24.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.81 -48.74 12.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.37 -45.18 84.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 27' ' ' LEU . 5.8 m -87.2 168.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -107.64 146.83 31.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.79 -40.97 6.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.103 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.02 -44.48 82.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 4.5 mmmm -131.02 99.57 17.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.617 0.722 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 54.0 Cg_endo -69.72 -35.51 12.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.343 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.71 129.36 74.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 117.37 5.05 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.527 HD11 ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -40.09 -46.3 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -44.69 -64.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.458 HG13 HD11 ' A' ' 97' ' ' LEU . 21.0 t -43.16 -59.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.168 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -45.1 -61.34 1.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HE2' HD11 ' A' ' 39' ' ' LEU . 49.0 mmtt -46.09 -43.17 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.618 ' HB2' HD13 ' A' ' 97' ' ' LEU . 90.1 m -65.29 -30.33 71.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.503 HG13 ' CG ' ' A' ' 154' ' ' HIS . 95.6 t -79.27 -54.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.04 -43.04 86.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.791 ' CE1' HG21 ' A' ' 93' ' ' VAL . 3.2 t80 -49.59 -60.27 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 76.8 mt -45.11 -44.64 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -63.03 -45.65 91.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.02 -42.3 94.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.6 p -85.89 29.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.147 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.71 153.9 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -120.28 38.96 3.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.478 ' HB2' HG21 ' A' ' 164' ' ' ILE . 19.6 p -117.49 42.3 2.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -97.86 133.51 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.04 120.95 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.51 80.07 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.0 -49.69 69.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.851 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 20.1 m-85 -99.49 -48.96 4.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -38.04 -42.03 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.68 137.95 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.0 p -121.01 144.15 48.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.91 -133.55 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.76 166.94 16.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 110.89 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -39.13 18.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -44.36 -54.19 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -45.77 -52.72 10.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.828 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.861 ' HA ' HD12 ' A' ' 71' ' ' ILE . 7.0 mt-30 -67.89 -32.18 72.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.32 -67.9 0.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -49.12 -42.13 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 68' ' ' GLN . 65.0 mt -50.22 -40.81 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -81.27 -57.08 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -50.98 -59.67 3.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HB3' HD12 ' A' ' 81' ' ' ILE . 32.2 mm-40 -49.09 -47.78 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -61.77 -41.39 97.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.31 -48.09 82.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.1 -29.65 61.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -132.53 93.14 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.802 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -60.57 -34.34 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.17 36.6 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 74' ' ' GLN . 13.1 tt -77.53 156.16 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' SER . 2.0 t-20 -122.04 87.82 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 82' ' ' ASN . 60.0 mt -37.27 -49.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.1 t -50.05 -42.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ASN . 45.6 t -59.96 -35.14 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.7 mmm -68.99 -34.17 74.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 59.22 50.15 8.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -84.79 172.24 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 90' ' ' VAL . 37.1 p -75.04 117.14 16.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 89' ' ' THR . 75.4 t -36.68 -52.89 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 90' ' ' VAL . 2.6 t-20 -37.16 -46.38 0.7 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.08 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.791 HG21 ' CE1' ' A' ' 47' ' ' PHE . 81.5 t -43.66 -46.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.095 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.851 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -51.88 -48.57 64.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.95 -62.71 4.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -43.82 -42.57 5.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 111.066 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.618 HD13 ' HB2' ' A' ' 44' ' ' CYS . 34.8 tp -52.04 -46.91 65.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 99' ' ' ALA . 42.3 mtmt -69.29 -47.92 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.5 -41.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.73 -55.22 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 147' ' ' VAL . 17.3 m-85 -54.16 -52.78 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.474 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -54.28 -42.2 69.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.78 -35.57 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -42.47 141.42 1.5 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -19.49 35.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.642 2.228 . . . . 0.0 112.375 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 155.18 73.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.571 0.701 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 151.07 68.73 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.66 2.24 . . . . 0.0 112.376 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 148' ' ' PHE . 10.2 tp -52.46 -51.39 59.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.493 HG21 ' CD1' ' A' ' 117' ' ' LEU . 29.1 mt -83.42 132.31 50.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 0.0 111.129 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.55 ' CG ' HD12 ' A' ' 113' ' ' LEU . 53.9 Cg_endo -69.71 146.76 61.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.369 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.528 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 20.9 m-85 -60.55 -26.0 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE2' ' A' ' 116' ' ' GLU . 33.1 m -65.57 -35.85 82.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.891 HD23 ' CD ' ' A' ' 116' ' ' GLU . 65.4 mt -92.17 35.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.528 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 4.1 m170 -77.56 -60.02 0.77 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.3 Cg_endo -69.79 -58.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.891 ' CD ' HD23 ' A' ' 113' ' ' LEU . 5.2 pt-20 -44.57 -38.13 4.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 113' ' ' LEU . 10.8 mt -66.64 -38.48 86.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.472 ' CD2' ' HA ' ' A' ' 197' ' ' HIS . 6.9 mt -76.65 -56.27 4.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.91 -28.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -81.74 -31.12 32.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.073 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -78.15 -31.9 49.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -82.94 16.77 2.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 129' ' ' ARG . 73.5 mt -79.03 129.86 71.68 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.638 0.733 . . . . 0.0 111.16 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.93 2.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 126' ' ' LYS . 31.7 m-20 -67.21 95.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 125' ' ' ASP . 27.5 ttpt -33.49 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.413 HG22 ' CD2' ' A' ' 131' ' ' HIS . 86.5 m -57.49 -61.76 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.455 ' CB ' HG21 ' A' ' 123' ' ' ILE . 12.4 mt-10 -44.74 -56.47 4.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 123' ' ' ILE . 7.3 ttm180 -37.75 -52.23 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.466 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 22.2 mt -64.87 -66.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 130' ' ' LEU . 20.1 m-70 -34.56 -45.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.404 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . . . -57.61 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.424 ' CD1' HG21 ' A' ' 203' ' ' THR . 18.9 mt -51.65 -27.53 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 137' ' ' VAL . 49.1 tttp -75.18 -37.87 61.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.9 -26.11 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.568 HG22 ' HE1' ' A' ' 140' ' ' PHE . 36.2 mt -75.33 -36.33 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.574 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 8.5 p -69.83 -0.41 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -82.01 -29.61 31.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' CD ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -97.18 14.17 26.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.833 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.3 m-85 -75.11 140.59 43.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.54 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 4.4 t-80 -34.39 141.05 0.26 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.74 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.275 . . . . 0.0 112.355 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 28' ' ' GLN . 39.7 t -88.8 -33.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -83.26 -47.78 11.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -42.68 -44.88 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.2 -55.49 34.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 101' ' ' PHE . 87.2 t -64.33 -60.1 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD1' HD23 ' A' ' 108' ' ' LEU . 20.8 t80 -38.43 -42.02 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -72.32 -49.52 33.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -52.51 -45.13 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.57 -64.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.538 HG23 HG12 ' A' ' 205' ' ' ILE . 82.1 mt -43.4 -51.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.7 m -43.37 -35.44 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.503 ' CG ' HG13 ' A' ' 45' ' ' VAL . 77.2 t60 -83.36 -37.56 23.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 152' ' ' ILE . 98.8 mt -56.37 -46.32 80.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.417 HD21 ' C ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER -51.69 -41.97 61.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -57.12 -35.56 69.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 -42.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.5 p -64.86 -34.53 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -54.18 -42.25 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.29 37.35 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 166' ' ' LEU . 29.8 p80 -53.96 -34.07 58.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -55.93 -31.22 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 54' ' ' CYS . 74.2 mt -89.75 -58.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.178 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -76.89 7.56 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 162' ' ' HIS . 34.7 mt 40.85 53.38 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 75.4 mmm -152.29 119.85 6.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 169' ' ' ALA . 69.2 p -102.01 153.13 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.173 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.82 -44.29 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.105 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -61.81 -50.87 70.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -53.57 -39.91 65.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 38.9 mt -67.31 -44.35 79.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t -53.59 -50.1 66.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.98 -41.28 89.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.12 -30.66 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.58 -2.27 54.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.582 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.86 -45.95 92.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.96 -53.94 5.92 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.721 2.281 . . . . 0.0 112.296 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.474 HG23 ' CA ' ' A' ' 102' ' ' ALA . 20.5 m -76.28 -67.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 179' ' ' THR . 24.8 mt -34.29 -48.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 4.4 mmm -136.44 120.98 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.905 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -45.08 142.66 2.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.526 0.679 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 133.35 25.35 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.69 140.23 58.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -60.48 -49.44 77.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.819 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.0 -55.71 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.5 t30 45.01 42.55 6.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -127.8 142.52 51.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.88 119.58 32.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -81.63 -54.14 5.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.2 mt -153.41 168.47 25.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.8 m 39.35 45.36 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -40.02 120.56 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.143 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 11.5 t -90.55 143.91 26.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -130.54 33.65 4.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 197' ' ' HIS . 72.7 mt -78.23 -56.61 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.107 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.472 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 51.2 m80 -36.18 -50.67 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.05 -47.35 71.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.2 m -47.4 -36.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.6 t -48.18 -50.46 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 202' ' ' GLU . 45.2 t -65.69 -59.65 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' VAL . 65.4 tt0 -34.48 -64.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 205' ' ' ILE . 38.2 m -41.49 -66.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.8 m-85 -35.43 -33.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.538 HG12 HG23 ' A' ' 152' ' ' ILE . 82.3 mt -84.64 -46.52 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 203' ' ' THR . 8.5 mm100 -56.27 -59.28 5.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.476 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 6.5 mm-40 -94.61 31.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.5 t -58.64 -21.55 54.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.728 ' NE2' ' CD2' ' A' ' 213' ' ' TYR . 7.1 mm100 -86.24 -54.67 4.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -40.03 -35.77 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -54.71 -63.19 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -107.73 -56.51 2.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.728 ' CD2' ' NE2' ' A' ' 209' ' ' GLN . 63.1 m-85 -60.06 -11.55 6.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 46.18 43.65 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.89 168.83 53.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.92 141.89 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.476 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.9 mt -73.91 133.42 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.6 m -109.8 170.97 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.13 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.8 p -173.02 177.91 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.367 . . . . 0.0 110.836 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 t -134.43 175.78 9.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.03 163.07 29.65 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -172.49 -178.88 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.852 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 p -161.94 171.49 17.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.9 -179.43 26.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -165.37 128.03 2.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -142.77 162.67 34.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -169.05 165.8 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -162.08 146.69 9.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.641 0.734 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 169.16 19.53 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.715 2.277 . . . . 0.0 112.344 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 132.14 22.71 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.7 2.267 . . . . 0.0 112.348 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 15' ' ' ARG . 48.9 m -153.9 147.64 25.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.127 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 14' ' ' THR . 17.6 mmt180 -35.56 115.64 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -75.63 133.28 40.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -86.2 48.04 1.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.576 ' CZ3' ' HA ' ' A' ' 73' ' ' LYS . 9.3 t-105 -104.42 84.78 2.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -89.48 174.62 7.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -146.54 137.03 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -125.92 45.78 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.558 ' HB2' HD21 ' A' ' 30' ' ' LEU . 5.4 p90 -126.27 -41.1 1.93 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.2 m-85 35.39 47.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.56 33.42 7.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.463 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.401 ' SD ' ' HD2' ' A' ' 26' ' ' PRO . 19.2 mmt -100.44 138.33 20.15 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.581 0.705 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HD2' ' SD ' ' A' ' 25' ' ' MET . 53.9 Cg_endo -69.71 151.89 69.44 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.375 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.74 HD13 HD21 ' A' ' 104' ' ' LEU . 24.0 tp -46.91 -40.89 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.718 ' HB3' HG21 ' A' ' 143' ' ' VAL . 4.8 pt20 -50.81 -44.65 59.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.95 -46.24 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' A' ' 22' ' ' TYR . 24.8 mt -57.52 -37.28 72.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 36' ' ' PRO . 10.3 m -89.67 164.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 35' ' ' LYS . 20.4 p -106.53 133.18 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -34.68 -44.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -58.13 -47.68 82.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' THR . 33.1 mmtm -124.75 96.65 40.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.549 0.69 . . . . 0.0 110.862 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.4 Cg_endo -69.81 -40.35 5.35 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.553 HG12 HG22 ' A' ' 147' ' ' VAL . 15.7 mt -80.51 130.73 63.75 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.673 0.749 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 54.1 Cg_endo -69.71 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.36 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -38.29 -54.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.415 ' CZ ' ' HG2' ' A' ' 72' ' ' GLN . 25.1 t80 -39.25 -63.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.468 ' CG2' ' HG2' ' A' ' 38' ' ' PRO . 43.1 t -44.31 -52.67 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -53.7 -61.25 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 48.3 mmtt -44.16 -33.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 87.8 m -76.04 -50.44 14.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.613 HG13 ' CG ' ' A' ' 154' ' ' HIS . 96.6 t -58.61 -39.66 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -78.1 -26.36 48.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 47' ' ' PHE . 1.1 t80 -79.26 -33.76 43.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG2' HD22 ' A' ' 58' ' ' LEU . 21.5 mt -66.93 -34.24 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -84.36 -33.98 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.83 -24.62 52.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.47 HG21 HG22 ' A' ' 90' ' ' VAL . 47.6 p -84.3 28.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.104 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.64 -32.02 4.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.469 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.517 HD11 HG22 ' A' ' 158' ' ' VAL . 14.2 tp 70.45 27.54 3.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.807 0.337 . . . . 0.0 110.922 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.56 44.65 1.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -101.17 135.59 42.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 57' ' ' GLY . 4.0 mt-10 -65.43 115.62 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.56 68.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.774 HD12 ' N ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -62.48 -15.58 50.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.774 ' N ' HD12 ' A' ' 58' ' ' LEU . 20.0 m-85 -98.22 -56.11 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -59.55 -15.53 18.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG23 ' CD ' ' A' ' 60' ' ' ARG . 39.0 t -96.83 103.23 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.5 p -60.76 125.42 23.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.82 157.87 20.73 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.459 ' ND2' ' HB ' ' A' ' 66' ' ' THR . 53.1 t30 -41.04 146.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -78.78 -42.5 27.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.459 ' HB ' ' ND2' ' A' ' 64' ' ' ASN . 6.4 m -51.04 -45.38 61.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.171 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.481 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 5.1 m-20 -57.81 -58.29 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.436 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 25.3 mt-30 -50.23 -28.34 7.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -60.37 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -57.47 -45.55 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 79.3 mt -47.1 -42.82 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 40' ' ' PHE . 39.1 mt-30 -83.74 -64.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.576 ' HA ' ' CZ3' ' A' ' 18' ' ' TRP . 46.3 mttm -41.72 -54.0 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.497 ' HB3' HD12 ' A' ' 81' ' ' ILE . 31.6 mm-40 -58.85 -40.22 83.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 65.2 t80 -64.73 -61.15 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.32 -57.09 9.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -52.0 -26.63 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.836 ' O ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -162.23 116.22 1.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -71.61 -33.31 68.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -41.07 -46.23 2.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.888 HD11 ' SD ' ' A' ' 86' ' ' MET . 1.8 tt -45.85 145.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.48 ' N ' HG12 ' A' ' 81' ' ' ILE . 56.3 t30 -128.71 119.32 24.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD22 HG23 ' A' ' 71' ' ' ILE . 64.5 mt -47.96 -52.94 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.75 -48.27 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -62.9 -44.69 95.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.888 ' SD ' HD11 ' A' ' 81' ' ' ILE . 25.6 mtp -52.17 -33.9 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 57.72 49.74 11.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 86' ' ' MET . 33.0 m -84.5 171.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.3 p -70.96 116.49 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 51' ' ' THR . 58.4 t -39.55 -45.69 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -48.85 -41.92 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.73 -63.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.42 HG21 ' CE1' ' A' ' 47' ' ' PHE . 87.0 t -50.33 -51.59 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.73 -36.79 5.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.76 -57.21 3.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -43.02 -41.72 3.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.088 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -49.33 -53.76 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -64.46 -43.92 92.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.79 -50.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -55.04 -57.87 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.509 ' CB ' HG21 ' A' ' 179' ' ' THR . 34.3 m-85 -50.65 -39.3 50.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.13 80.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.28 -33.99 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.74 HD21 HD13 ' A' ' 27' ' ' LEU . 95.0 mt -40.29 141.44 0.84 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.39 32.22 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.248 . . . . 0.0 112.388 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.59 155.81 75.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 141.22 44.56 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.485 HD12 HD22 ' A' ' 144' ' ' ASN . 15.4 tp -43.62 -51.6 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 91.2 mt -82.09 128.97 66.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.722 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.6 Cg_endo -69.77 158.84 55.58 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.34 -29.05 47.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -65.48 -5.33 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.862 HD13 ' CD1' ' A' ' 140' ' ' PHE . 13.6 mt -133.46 22.09 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.497 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -70.79 -60.17 3.19 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.892 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.628 ' HA ' HD12 ' A' ' 118' ' ' LEU . 53.2 Cg_endo -69.77 -16.39 37.5 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 0.0 112.309 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.29 -36.8 63.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.416 HD11 ' HZ ' ' A' ' 140' ' ' PHE . 14.7 mt -71.79 -26.33 62.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 115' ' ' PRO . 5.4 mt -84.72 -48.47 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -53.59 -31.4 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.17 -25.43 25.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -78.87 -21.33 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -89.47 11.2 20.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.659 HG23 ' HD2' ' A' ' 124' ' ' PRO . 85.9 mt -76.62 138.52 66.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.654 0.74 . . . . 0.0 111.151 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.659 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.6 Cg_endo -69.8 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.276 . . . . 0.0 112.299 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.35 101.27 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.718 ' HE3' HD13 ' A' ' 217' ' ' ILE . 33.6 ttpt -44.01 -48.73 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -56.93 -60.8 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -49.94 -48.07 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -45.47 -51.53 11.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.594 HD13 ' HG3' ' A' ' 207' ' ' GLN . 26.0 mt -65.79 -53.7 36.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -45.48 -55.97 5.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.2 -54.87 17.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 130' ' ' LEU . 10.5 mt -55.53 -36.69 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -68.16 -22.45 64.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -89.27 -48.32 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.629 HG22 ' HE1' ' A' ' 140' ' ' PHE . 19.0 mt -56.61 -34.47 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.492 ' O ' ' CE1' ' A' ' 145' ' ' TYR . 7.1 p -71.25 -6.75 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -87.51 -37.91 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 23.2 1.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.862 ' CD1' HD13 ' A' ' 113' ' ' LEU . 2.3 m-30 -81.79 175.2 10.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.886 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.59 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -65.3 141.14 98.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.584 0.707 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.8 -15.6 37.01 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.266 . . . . 0.0 112.32 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 28' ' ' GLN . 69.6 t -99.21 -25.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.485 HD22 HD12 ' A' ' 108' ' ' LEU . 34.8 m120 -93.98 -33.46 13.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CE1' ' O ' ' A' ' 137' ' ' VAL . 83.1 t80 -65.21 -56.77 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.452 ' OD2' ' CG1' ' A' ' 37' ' ' ILE . 4.6 p-10 -42.86 -49.42 5.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 151' ' ' VAL . 20.0 t -72.46 -55.89 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.747 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 17.4 t80 -42.49 -41.69 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.472 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 19.4 mtp180 -59.8 -59.89 4.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -54.05 -34.63 60.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 147' ' ' VAL . 62.8 t -59.39 -63.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.747 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 21.5 mt -53.01 -53.25 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -39.82 -33.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.613 ' CG ' HG13 ' A' ' 45' ' ' VAL . 74.0 t60 -84.36 -41.86 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 152' ' ' ILE . 76.0 mt -50.83 -48.75 59.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.33 -45.84 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -53.57 -38.67 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 53' ' ' LEU . 39.5 t -74.77 -43.39 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 26.2 p -60.67 -25.22 66.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -65.55 -37.03 85.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -105.72 36.35 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.485 ' CD2' HG22 ' A' ' 168' ' ' THR . 56.0 p-80 -55.0 -38.3 67.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -59.46 -36.72 76.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.53 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -73.31 2.17 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 162' ' ' HIS . 28.3 mt 49.8 42.82 24.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.7 mmm -141.88 112.02 6.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.485 HG22 ' CD2' ' A' ' 162' ' ' HIS . 44.3 p -94.11 155.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -41.06 -36.37 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.66 -52.57 50.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -57.44 -45.03 85.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.5 mt -62.46 -46.52 88.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -57.53 -24.23 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.82 -39.44 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 8.4 p -63.35 -32.67 74.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.431 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.4 m-85 -90.02 -12.98 36.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -48.76 -46.57 72.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -48.01 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.509 HG21 ' CB ' ' A' ' 101' ' ' PHE . 40.0 m -64.41 -59.89 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 179' ' ' THR . 70.2 mt -33.72 -48.15 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.548 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 13.2 ptm -159.06 150.82 20.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -70.8 145.34 91.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.61 0.719 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 134.54 28.23 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.56 41.55 3.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -76.41 48.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -112.77 38.82 2.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -152.67 141.0 20.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -54.38 150.25 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -92.03 -175.07 3.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -138.44 174.36 10.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 191' ' ' LEU . 0.1 OUTLIER -96.29 -58.84 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 73.8 m -43.4 -69.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 33.4 p -118.3 125.01 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 12.0 t -145.15 148.72 33.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm 63.7 46.08 4.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 200' ' ' VAL . 81.1 mt -74.2 -46.8 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.416 ' H ' ' CD2' ' A' ' 197' ' ' HIS . 39.6 m-70 -43.32 -44.82 5.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.18 -54.41 47.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 t -52.81 -40.42 63.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 121' ' ' ALA . 85.3 t -47.1 -69.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.157 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 202' ' ' GLU . 83.1 t -58.14 -60.28 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 201' ' ' VAL . 66.6 tt0 -37.62 -43.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 56.9 m -59.46 -55.38 35.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.547 ' HB3' HD13 ' A' ' 152' ' ' ILE . 9.4 m-85 -38.73 -58.22 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 63.2 mt -55.56 -50.75 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -53.69 -60.13 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.594 ' HG3' HD13 ' A' ' 130' ' ' LEU . 11.0 mm-40 -92.52 25.57 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.926 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.581 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 1.8 t -60.4 -14.82 21.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' TYR . 10.6 mm100 -95.86 -57.91 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.473 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.8 t80 -39.76 -30.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.4 m-85 -52.6 -61.87 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -127.02 -28.33 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 209' ' ' GLN . 26.2 m-85 -83.99 26.82 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' TYR . 75.9 m-20 33.48 34.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -59.08 145.87 43.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.12 129.93 35.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.718 HD13 ' HE3' ' A' ' 126' ' ' LYS . 53.3 mt -41.32 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.26 163.96 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 m -137.95 160.36 39.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 m -152.19 127.6 9.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.5 127.35 9.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 t -81.84 115.09 20.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 110.843 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.7 m -130.72 121.81 26.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.83 44.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.533 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm 56.9 41.56 27.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -78.06 -25.67 47.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -87.14 -60.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.18 158.25 38.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.86 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 168.27 22.13 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.647 2.232 . . . . 0.0 112.292 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 154.92 67.13 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 p -117.6 170.26 8.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -65.59 166.45 10.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.62 147.58 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -118.83 40.09 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 57.32 41.75 26.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.82 105.32 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -121.25 119.25 31.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -86.81 29.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -122.34 -41.63 2.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.918 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -53.38 123.91 13.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.29 25.26 75.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.479 ' HB2' HD21 ' A' ' 30' ' ' LEU . 63.6 mmm -119.73 150.15 49.78 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.504 0.669 . . . . 0.0 110.91 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 54.2 Cg_endo -69.72 123.46 10.14 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.383 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 31' ' ' VAL . 14.0 tp -49.39 -49.87 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.679 ' HA ' HG11 ' A' ' 143' ' ' VAL . 17.6 pt20 -46.85 -34.66 5.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.446 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 33.2 t70 -77.28 -45.81 25.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 25' ' ' MET . 36.9 mt -59.45 -46.04 89.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 27' ' ' LEU . 33.3 m -88.27 163.22 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.9 p -108.87 149.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.105 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.73 -46.94 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -50.14 -44.45 52.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.923 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 30.0 mmtt -132.66 99.17 15.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.606 0.717 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.7 Cg_endo -69.79 -41.17 4.47 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.692 2.261 . . . . 0.0 112.344 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.513 HG23 ' HD2' ' A' ' 38' ' ' PRO . 34.1 mt -74.84 134.81 74.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.584 0.707 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 148.32 64.65 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.643 2.228 . . . . 0.0 112.356 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.483 ' CD1' ' HG3' ' A' ' 43' ' ' LYS . 1.1 tm? -65.12 -59.36 4.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' LEU . 24.9 t80 -36.09 -64.86 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.915 HG13 HD11 ' A' ' 97' ' ' LEU . 90.2 t -46.67 -63.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -40.53 -56.01 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG3' ' CD1' ' A' ' 39' ' ' LEU . 64.2 mmtt -53.92 -39.43 65.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 80.7 m -65.23 -41.88 93.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.66 -43.86 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -70.45 -38.76 74.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 93' ' ' VAL . 11.0 t80 -56.58 -50.15 72.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 mt -48.83 -68.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 50' ' ' ASP . 2.7 pp20? -55.18 -53.19 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 21.1 t70 -45.46 -42.89 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 p -88.66 29.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 108.65 1.45 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.22 51.41 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 0.0 110.953 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 80.4 m -132.7 30.88 4.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.436 ' O ' HD12 ' A' ' 58' ' ' LEU . 7.5 m -66.54 122.33 17.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.15 130.38 42.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 45.18 87.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 4.6 mp -83.16 143.61 30.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.353 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.647 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 2.6 m-85 47.87 27.88 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HB2' ' HE1' ' A' ' 167' ' ' MET . 15.4 tpp85 -123.41 -46.84 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t -100.37 145.05 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.4 t -171.45 148.05 2.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.5 -52.83 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -71.09 91.28 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 0.7 OUTLIER -66.23 -34.58 78.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -52.87 -36.31 58.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.156 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.96 -58.27 8.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.404 ' NE2' ' HA ' ' A' ' 65' ' ' LYS . 1.3 mp0 -58.91 -33.88 71.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.95 -66.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -57.19 -37.85 72.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.496 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 38.7 mt -52.25 -37.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -90.63 -55.65 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.04 -54.87 20.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -54.04 -43.84 70.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -57.38 -40.68 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.29 -62.0 2.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -58.94 -28.65 66.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -129.67 103.98 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -76.33 -27.24 56.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -96.23 37.21 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.608 HD11 ' SD ' ' A' ' 86' ' ' MET . 9.1 tt -80.69 153.77 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.402 ' N ' HG12 ' A' ' 81' ' ' ILE . 4.8 t-20 -123.0 94.78 4.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -37.23 -50.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.4 t -43.66 -46.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -57.88 -46.41 84.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.608 ' SD ' HD11 ' A' ' 81' ' ' ILE . 82.0 mtp -56.16 -38.11 70.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 62.05 50.12 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.02 178.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 p -75.63 117.76 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -42.08 -51.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -40.39 -49.48 2.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.45 -56.15 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 47' ' ' PHE . 98.3 t -46.65 -55.24 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.647 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -47.07 -45.36 21.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.49 -60.27 5.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.31 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.915 HD11 HG13 ' A' ' 41' ' ' VAL . 20.9 tp -47.98 -42.94 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -64.96 -43.33 93.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.912 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.94 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -60.54 -35.87 77.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -82.15 -41.0 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.861 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.4 -41.71 98.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -57.28 -40.17 77.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.442 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 47.7 mt -36.56 146.98 0.21 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.602 0.715 . . . . 0.0 110.946 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -27.46 26.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 153.98 81.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.64 0.733 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 156.58 63.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.337 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.67 -45.91 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.3 mt -95.93 117.65 66.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 111.146 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.449 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.74 137.69 36.12 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.662 2.242 . . . . 0.0 112.323 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -53.05 -36.47 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -54.91 -23.52 19.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 117' ' ' LEU . 60.8 mt -112.97 30.81 6.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.858 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -74.3 -61.8 1.13 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 110.847 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.589 ' HA ' HD12 ' A' ' 118' ' ' LEU . 54.1 Cg_endo -69.73 -40.32 5.5 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -47.09 -33.55 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.8 mt -71.62 -43.02 66.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 115' ' ' PRO . 6.3 mt -69.1 -57.95 4.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -43.05 -25.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.06 -27.72 15.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.74 -31.72 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -74.1 -15.55 61.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 90.4 mt -50.26 129.35 24.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -46.94 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.252 . . . . 0.0 112.372 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -59.04 106.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -46.94 -46.49 21.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.6 m -59.78 -67.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 129' ' ' ARG . 58.0 mm-40 -46.6 -51.76 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 128' ' ' GLU . 12.2 ttm180 -36.79 -48.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.47 ' CD2' ' HG2' ' A' ' 207' ' ' GLN . 23.0 mt -73.26 -66.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 130' ' ' LEU . 29.9 m-70 -34.14 -49.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.864 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.92 -59.94 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.84 -40.01 59.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -63.45 -26.47 68.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.44 -39.79 13.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.47 -41.56 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 12.9 p -58.75 -24.9 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -60.04 -32.28 70.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -60.42 -34.88 74.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 141' ' ' HIS . 22.6 m-85 -44.91 132.34 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.537 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.9 t60 -33.99 141.85 0.23 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -9.55 26.38 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.369 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 28' ' ' GLN . 97.6 t -98.83 -38.99 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -84.28 -38.17 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.515 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 35.5 t80 -51.71 -43.75 62.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.93 -45.71 82.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.23 -59.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 41.0 t80 -47.92 -42.92 28.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.515 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 14.0 mmm180 -65.87 -38.76 89.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -65.28 -45.71 83.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.67 -60.35 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 84.7 mt -46.97 -48.58 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.3 m -44.09 -36.21 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -80.79 -36.39 31.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 152' ' ' ILE . 77.9 mt -59.92 -47.0 87.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -43.08 40.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.8 mtp85 -61.79 -38.08 86.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.23 -47.51 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.2 p -56.63 -36.4 69.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -53.01 -42.04 65.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.928 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.676 ' HB3' HD12 ' A' ' 164' ' ' ILE . 12.7 mm100 -110.66 35.93 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 166' ' ' LEU . 22.5 p80 -47.35 -35.78 8.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 24.3 mmtp -57.71 -33.82 68.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.676 HD12 ' HB3' ' A' ' 161' ' ' GLN . 92.9 mt -80.13 -59.7 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.145 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -81.99 13.04 3.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 162' ' ' HIS . 16.7 mt 39.53 54.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.465 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 18.0 mmm -154.47 116.06 4.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.441 HG22 ' CG ' ' A' ' 162' ' ' HIS . 68.9 p -93.5 154.86 17.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -40.02 -42.73 1.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.101 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.417 ' CG ' ' HG1' ' A' ' 168' ' ' THR . 1.2 p-10 -63.64 -52.48 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -52.63 -48.21 66.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.41 -44.94 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 71.2 p -63.39 -42.42 98.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.04 -33.59 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 m -72.95 -18.85 61.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.4 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 9.6 m-85 -104.25 -9.58 18.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.562 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -50.23 -46.73 83.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.567 0.699 . . . . 0.0 110.909 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.9 Cg_exo -47.97 -59.78 1.12 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.665 2.243 . . . . 0.0 112.334 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 180' ' ' LEU . 25.5 m -69.42 -64.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 179' ' ' THR . 85.2 mt -33.28 -50.18 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 19.4 ptm -157.17 131.26 8.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -86.78 139.88 33.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.845 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 157.32 60.73 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.84 138.29 55.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.65 -52.15 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.77 95.37 5.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 187' ' ' ASN . 1.2 p-10 -122.35 30.91 6.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 187' ' ' ASN . 13.4 tpp180 -35.31 144.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 189' ' ' GLU . 5.3 mp0 -74.44 100.48 3.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -115.33 -58.47 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 26.9 mt -127.96 87.65 2.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.3 m -147.1 105.5 3.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 34.8 p -125.05 38.45 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.128 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 1.8 t -173.65 128.62 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -88.68 80.68 7.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 200' ' ' VAL . 40.6 mt -98.01 -49.99 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.473 ' ND1' HD21 ' A' ' 118' ' ' LEU . 94.7 m-70 -34.2 -38.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 196' ' ' ILE . 75.5 mt-30 -80.72 -50.6 9.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.2 p -54.65 -24.89 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 196' ' ' ILE . 92.6 t -58.97 -66.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.53 -37.41 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -55.24 -45.51 76.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.9 m -60.07 -53.87 52.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.401 ' HB3' HD13 ' A' ' 152' ' ' ILE . 6.1 m-85 -39.15 -38.86 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 152' ' ' ILE . 60.5 mt -74.56 -65.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.42 ' HB3' HG23 ' A' ' 218' ' ' VAL . 36.7 mt-30 -45.39 -52.55 9.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.47 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 24.1 mp0 -94.2 29.35 2.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.449 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 35.7 t -67.0 -29.62 69.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 213' ' ' TYR . 7.0 mm100 -81.85 -45.14 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -48.93 -37.57 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -49.47 -63.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -105.21 -55.76 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 209' ' ' GLN . 80.7 m-85 -57.41 -23.97 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.922 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 59.86 39.76 20.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.851 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -72.92 -177.9 33.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.64 145.44 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.66 116.35 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.42 HG23 ' HB3' ' A' ' 206' ' ' GLN . 30.0 m -91.56 174.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.0 m -119.21 102.84 9.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 0.0 110.843 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -92.13 -56.15 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.63 80.72 0.18 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.514 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.9 p -125.25 90.98 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.935 0.398 . . . . 0.0 110.873 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -79.88 171.54 14.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.23 44.18 0.49 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.472 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -150.2 118.13 6.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -66.34 91.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -90.86 42.61 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -152.36 150.64 25.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 147.61 63.13 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.697 2.265 . . . . 0.0 112.298 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 178.34 4.64 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.712 2.274 . . . . 0.0 112.359 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.539 HG23 ' CB ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -71.98 0.3 9.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 53.15 26.39 4.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.539 ' CB ' HG23 ' A' ' 14' ' ' THR . 13.9 tpt180 -127.91 160.5 31.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.97 36.22 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.417 ' CE3' ' HA ' ' A' ' 18' ' ' TRP . 2.7 m95 -74.75 99.89 3.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -129.69 111.95 13.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.472 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 6.1 t -167.43 142.54 3.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -84.31 -7.64 59.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.836 ' CZ ' HD13 ' A' ' 30' ' ' LEU . 2.7 t80 -77.92 -39.07 44.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -73.39 -23.51 60.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.856 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.68 20.15 51.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 14.6 mmt -121.97 157.52 57.46 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.612 0.72 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.49 68.9 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.343 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 147' ' ' VAL . 31.0 tp -60.36 -49.04 79.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.667 ' CB ' HG21 ' A' ' 143' ' ' VAL . 16.6 pt20 -47.46 -28.24 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -45.54 14.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.836 HD13 ' CZ ' ' A' ' 22' ' ' TYR . 49.6 mt -60.76 -44.93 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 27' ' ' LEU . 20.0 m -91.2 167.14 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -113.44 167.69 10.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.08 -48.45 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.24 -54.77 43.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -115.3 85.23 12.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.446 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.4 Cg_endo -69.79 -31.71 19.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.0 mt -80.87 130.17 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 111.134 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.09 47.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.442 HD21 ' HE2' ' A' ' 43' ' ' LYS . 5.3 tp -67.19 -31.77 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' A' ' 100' ' ' PHE . 42.0 t80 -56.38 -48.47 76.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 97' ' ' LEU . 19.7 t -65.12 -50.68 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.074 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -58.48 -60.99 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HE2' HD21 ' A' ' 39' ' ' LEU . 17.7 mmtt -46.3 -30.37 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.6 m -76.72 -34.37 58.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.535 HG13 ' CG ' ' A' ' 154' ' ' HIS . 93.2 t -76.78 -60.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -54.54 -39.9 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 51' ' ' THR . 20.3 t80 -53.24 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mt -46.05 -52.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.22 -52.41 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.19 -33.54 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.497 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 82.1 p -91.92 23.66 3.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.09 154.69 24.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.501 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.78 47.73 2.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.0 p -132.39 40.32 3.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -97.84 130.88 44.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -67.14 127.22 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.59 77.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.533 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.27 -66.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.96 -37.11 22.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -50.34 -47.56 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.3 t -108.93 131.34 59.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.0 m -110.15 144.19 39.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.94 -166.17 42.1 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -49.5 139.68 11.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -67.9 -28.04 67.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m -53.97 -39.33 65.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.83 -47.38 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.741 ' HA ' HD12 ' A' ' 71' ' ' ILE . 7.4 mt-30 -65.43 -20.82 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.14 -69.87 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.2 p30 -47.49 -39.25 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 68' ' ' GLN . 50.1 mt -47.15 -42.54 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.97 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -45.98 -58.4 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -54.2 -58.18 8.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -55.39 -27.91 50.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.55 -57.33 7.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -73.09 -23.61 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -124.38 120.37 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.06 -14.01 24.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -104.55 31.18 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 3.2 tt -76.27 158.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.509 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 2.6 t-20 -126.24 94.72 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.9 mt -44.87 -45.71 10.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -48.68 -36.81 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.2 t -66.59 -39.24 88.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.525 ' HB3' HG13 ' A' ' 88' ' ' VAL . 6.7 mmm -69.06 -28.9 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 55.83 35.86 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 86' ' ' MET . 16.2 m -66.67 148.72 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.8 p -55.63 129.91 40.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.43 -41.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -52.34 -39.22 60.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.47 -59.76 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.0 -53.31 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.59 -33.62 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 -57.7 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.463 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.4 -31.59 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 41' ' ' VAL . 46.1 tp -56.39 -47.96 77.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -64.37 -34.43 78.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.31 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . 7.3 t80 -67.08 -24.96 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.624 ' HB2' HG21 ' A' ' 179' ' ' THR . 51.9 m-85 -90.11 -28.6 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.14 -34.66 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.0 -36.23 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.4 mt -38.56 142.55 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.925 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.24 32.31 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.23 157.37 76.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.85 26.59 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.338 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp -40.59 -42.54 1.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.41 130.02 36.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 111.136 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 159.36 53.67 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.665 2.243 . . . . 0.0 112.343 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.31 -20.64 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.623 ' O ' HD23 ' A' ' 113' ' ' LEU . 21.3 t -76.58 -1.51 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.827 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.633 HD22 ' HE2' ' A' ' 139' ' ' LYS . 18.3 mt -134.78 17.72 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.477 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -61.47 -60.49 10.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.606 0.717 . . . . 0.0 110.832 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.76 -36.57 10.55 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.691 2.261 . . . . 0.0 112.375 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -51.86 -32.03 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mt -73.28 -23.87 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 121' ' ' ALA . 19.1 mt -94.65 -59.25 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -45.03 -24.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.502 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -96.04 -27.33 15.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -79.65 -18.29 51.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -86.31 -0.63 56.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.554 HG21 ' HB2' ' A' ' 128' ' ' GLU . 79.6 mt -66.37 129.85 94.18 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.631 0.729 . . . . 0.0 111.107 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.0 2.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.4 t70 -61.65 94.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.527 ' HD3' HG21 ' A' ' 217' ' ' ILE . 3.4 ttmt -34.88 -39.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.6 m -65.16 -67.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.554 ' HB2' HG21 ' A' ' 123' ' ' ILE . 8.3 mt-10 -49.07 -48.55 44.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -45.0 -55.16 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.63 HD22 ' HG3' ' A' ' 207' ' ' GLN . 18.7 mt -65.92 -58.74 4.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.65 -43.37 2.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.502 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -59.69 -45.51 91.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 130' ' ' LEU . 8.3 mt -69.07 -25.59 64.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -76.25 -30.51 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 0.5 OUTLIER -88.71 -30.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.404 ' O ' ' CD1' ' A' ' 140' ' ' PHE . 54.9 mt -71.83 -25.12 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.35 -7.58 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -81.89 -31.24 31.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.633 ' HE2' HD22 ' A' ' 113' ' ' LEU . 12.1 pttt -88.94 14.05 11.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.632 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.0 m-85 -77.84 166.88 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.9 t-80 -54.96 140.85 60.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.597 0.713 . . . . 0.0 110.88 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.71 -24.31 30.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.703 2.269 . . . . 0.0 112.334 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.667 HG21 ' CB ' ' A' ' 28' ' ' GLN . 17.2 t -91.11 -40.84 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 145' ' ' TYR . 28.8 m120 -77.7 -48.99 15.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.482 ' CZ ' ' HD2' ' A' ' 149' ' ' ARG . 19.7 t80 -37.39 -56.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -49.18 -65.26 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 27' ' ' LEU . 44.1 t -49.75 -59.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -43.26 -45.78 5.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.482 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 5.3 mtt-85 -63.3 -56.48 16.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -46.04 -45.2 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -56.09 -62.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.559 HG22 ' SG ' ' A' ' 208' ' ' CYS . 5.2 mt -48.02 -50.93 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -42.18 -38.78 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.535 ' CG ' HG13 ' A' ' 45' ' ' VAL . 56.0 t60 -79.74 -35.73 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 152' ' ' ILE . 95.6 mt -57.29 -44.02 83.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.1 -46.55 65.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 44.2 mtt-85 -57.14 -42.39 80.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.785 HG11 HD21 ' A' ' 172' ' ' LEU . 89.9 t -64.32 -47.24 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.6 p -59.3 -40.16 85.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -49.7 -44.2 47.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.485 ' OE1' HD12 ' A' ' 164' ' ' ILE . 6.2 mm-40 -100.29 54.17 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.493 ' CG ' HG22 ' A' ' 168' ' ' THR . 2.3 p80 -84.58 29.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -110.17 -36.76 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.485 HD12 ' OE1' ' A' ' 161' ' ' GLN . 24.7 mt -92.27 -47.32 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -88.33 -6.8 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.8 mt 49.44 50.34 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 74.1 mmm -127.6 85.62 2.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.493 HG22 ' CG ' ' A' ' 162' ' ' HIS . 71.0 p -77.77 153.24 33.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.14 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -39.03 -36.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -66.96 -48.72 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -61.76 -40.34 94.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.785 HD21 HG11 ' A' ' 158' ' ' VAL . 13.1 mt -65.49 -47.73 75.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.7 p -55.61 -48.37 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.2 mt -65.67 -38.97 83.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.7 m -63.08 -9.73 11.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.422 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.8 m-85 -118.27 -9.48 10.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.581 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -50.64 -46.0 85.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.556 0.694 . . . . 0.0 110.942 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.6 Cg_exo -47.98 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.651 2.234 . . . . 0.0 112.37 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 101' ' ' PHE . 52.9 m -63.95 -63.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 179' ' ' THR . 45.6 mt -34.3 -60.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 7.4 ptp -139.11 127.63 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.444 HH22 ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -57.59 148.53 55.66 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.596 0.712 . . . . 0.0 110.854 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -164.26 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.233 . . . . 0.0 112.31 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 t70 50.2 38.3 16.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 186' ' ' GLU . 18.3 t80 -95.06 43.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 185' ' ' PHE . 46.3 mt-10 -34.36 103.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -111.17 168.07 9.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -45.97 121.48 3.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 191' ' ' LEU . 13.0 mt-10 -106.68 20.8 18.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.864 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.94 ' CZ ' HD12 ' A' ' 191' ' ' LEU . 2.5 p90 -37.5 -32.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.94 HD12 ' CZ ' ' A' ' 190' ' ' PHE . 8.8 mt -105.17 173.71 6.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 193' ' ' THR . 79.5 p -132.82 168.07 19.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.816 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 192' ' ' SER . 28.8 p 34.85 45.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.179 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.7 95.08 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.158 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -72.74 65.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 200' ' ' VAL . 51.5 mt -80.57 -45.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -42.05 -55.46 3.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -40.97 72.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.7 t -50.19 -36.76 31.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.529 HG22 ' CB ' ' A' ' 121' ' ' ALA . 93.4 t -53.47 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.122 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.98 -52.7 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -46.83 -45.88 20.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.4 m -55.77 -57.24 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.542 ' HB3' HD13 ' A' ' 152' ' ' ILE . 12.7 m-85 -38.97 -52.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.421 HD11 HD13 ' A' ' 155' ' ' LEU . 68.6 mt -58.54 -53.86 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -52.76 -55.2 24.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.63 ' HG3' HD22 ' A' ' 130' ' ' LEU . 10.2 mm-40 -93.36 24.68 3.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.569 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 13.2 t -63.37 -7.3 6.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.605 ' NE2' ' CG ' ' A' ' 213' ' ' TYR . 4.6 mm100 -103.44 -60.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.471 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 4.0 t80 -40.02 -27.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -56.09 -61.97 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -125.88 -26.86 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.605 ' CG ' ' NE2' ' A' ' 209' ' ' GLN . 32.1 m-85 -83.94 25.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' TYR . 0.4 OUTLIER 34.4 32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -61.7 175.86 5.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -110.06 146.29 35.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.882 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.527 HG21 ' HD3' ' A' ' 126' ' ' LYS . 89.8 mt -65.42 111.51 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.28 168.24 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.425 ' C ' ' CD ' ' A' ' 219' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -166.61 165.71 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.875 0.369 . . . . 0.0 110.85 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 t -174.77 177.32 2.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.86 178.75 44.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.493 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -172.58 177.58 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 0.0 110.855 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 m -144.89 174.38 11.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.31 161.29 30.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' C ' ' CG ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER -115.98 172.72 6.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.924 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -162.24 172.3 15.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 9' ' ' ASN . 70.2 m-85 -159.87 162.99 34.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.848 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -155.86 123.81 2.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.658 0.742 . . . . 0.0 110.903 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 167.26 24.99 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.732 2.288 . . . . 0.0 112.289 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 137.96 36.72 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 14' ' ' THR . 8.8 m -89.29 24.08 2.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -84.96 153.07 23.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -103.4 105.51 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -105.47 33.97 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.817 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -54.47 93.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -136.1 116.93 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 m -123.45 91.31 3.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -59.17 -11.65 4.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 25' ' ' MET . 20.7 m-85 -59.08 -45.79 89.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -44.12 -27.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' N ' ' CD1' ' A' ' 23' ' ' PHE . . . -81.66 -33.39 27.81 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.441 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 22' ' ' TYR . 8.0 mtt -89.03 142.26 30.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.599 0.714 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 153.44 68.83 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.65 2.234 . . . . 0.0 112.313 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 31' ' ' VAL . 21.1 tp -47.3 -56.35 6.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.849 ' HA ' HG11 ' A' ' 143' ' ' VAL . 7.4 pt20 -44.22 -32.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.81 -49.4 18.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.63 -42.09 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 27' ' ' LEU . 28.3 m -89.33 156.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.8 p -103.65 159.85 15.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.65 -44.82 63.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -57.36 -46.5 83.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -126.48 88.28 54.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.859 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.5 Cg_endo -69.76 -36.13 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.98 131.29 63.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.721 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 120.98 7.68 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.403 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -43.89 -50.08 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.498 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 84.7 t80 -42.58 -66.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.425 HG13 HD11 ' A' ' 97' ' ' LEU . 37.5 t -42.72 -57.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -48.56 -57.7 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 47.6 mmtt -46.77 -39.81 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 88.7 m -67.01 -36.8 82.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG13 ' CG ' ' A' ' 154' ' ' HIS . 99.2 t -72.44 -53.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -60.63 -35.87 77.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.675 ' CE2' HG21 ' A' ' 93' ' ' VAL . 65.6 t80 -60.77 -65.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -37.2 -39.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.57 -41.68 60.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 47' ' ' PHE . 5.4 m-20 -62.18 -43.73 98.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -79.57 -29.82 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.144 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.04 119.7 1.09 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.495 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -94.62 -32.86 13.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.43 39.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 56' ' ' GLU . 24.3 m -87.16 112.47 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.3 tt0 -37.01 125.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.19 89.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 58' ' ' LEU . 1.6 pt? -106.03 -36.88 6.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.819 0.342 . . . . 0.0 110.907 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 10.8 m-85 -84.13 -61.23 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.555 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -57.65 -12.02 2.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.555 HG23 ' CD ' ' A' ' 60' ' ' ARG . 38.5 t -106.39 113.02 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.9 t -166.61 123.19 1.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.5 -69.84 0.19 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -50.49 146.19 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -113.64 -40.02 3.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -46.69 -49.82 18.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -43.26 -49.69 6.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.574 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 14.2 mt-30 -63.75 -29.45 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.3 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 20.8 p30 -50.52 -43.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.46 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 81.1 mt -51.05 -42.52 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -78.51 -57.29 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.93 -67.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -38.74 -52.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 86.2 t80 -54.16 -55.59 26.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.98 -46.47 71.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -60.83 -33.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.28 141.88 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -93.33 -18.7 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -78.32 46.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.7 pt -109.25 175.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -142.16 117.53 10.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.97 -43.09 83.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.11 -42.24 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 t -60.55 -43.57 97.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 mtp -60.54 -29.82 69.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.811 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.11 43.42 29.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.58 168.36 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 p -65.9 118.16 9.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -38.72 -47.29 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -46.31 -42.97 15.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.39 -59.91 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.675 HG21 ' CE2' ' A' ' 47' ' ' PHE . 58.7 t -51.59 -59.68 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.78 -38.88 0.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.113 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.3 -58.72 2.69 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.44 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -42.36 -39.99 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 111.091 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.425 HD11 HG13 ' A' ' 41' ' ' VAL . 16.4 tp -52.23 -51.21 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -67.26 -41.19 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.88 -39.87 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.61 -52.55 64.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.691 ' HB2' HG21 ' A' ' 179' ' ' THR . 49.4 m-85 -60.34 -43.66 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.32 -41.26 79.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -35.56 65.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.0 mt -39.24 143.9 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.652 0.739 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.61 34.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.706 2.271 . . . . 0.0 112.326 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 156.85 68.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 140.39 42.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.371 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -43.91 -49.48 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.7 mt -87.45 125.02 66.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.609 0.719 . . . . 0.0 111.142 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.731 ' HG2' HD12 ' A' ' 113' ' ' LEU . 54.0 Cg_endo -69.76 150.61 68.42 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -67.03 -25.59 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 t -65.14 -15.94 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.94 HD13 ' CE1' ' A' ' 140' ' ' PHE . 21.5 mt -118.55 26.0 9.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.497 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.3 OUTLIER -71.63 -60.22 2.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.598 0.713 . . . . 0.0 110.903 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.74 -25.56 28.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.27 . . . . 0.0 112.326 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.521 ' O ' HD13 ' A' ' 136' ' ' ILE . 51.3 mm-40 -68.16 -35.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.489 ' HB3' HG11 ' A' ' 200' ' ' VAL . 7.5 mt -72.52 -25.68 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 121' ' ' ALA . 9.8 mt -88.75 -58.65 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -39.47 -30.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.68 -37.68 20.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -65.54 -17.77 64.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.095 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -96.79 26.42 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.98 131.48 39.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.649 0.737 . . . . 0.0 111.139 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -45.78 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.2 m-20 -70.92 95.53 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -35.61 -54.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.9 m -51.64 -51.95 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.85 -45.46 90.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -50.11 -44.46 52.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.25 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -43.15 -50.35 6.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.61 -60.21 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 22.8 mt -52.04 -38.12 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 137' ' ' VAL . 27.5 tttm -62.93 -26.4 68.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 -42.06 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 116' ' ' GLU . 86.4 mt -64.5 -18.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 134' ' ' LYS . 7.6 p -90.51 -6.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -78.95 -39.03 35.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -76.02 -1.93 28.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.94 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -64.67 137.05 57.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.534 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -38.69 141.73 0.56 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.599 0.714 . . . . 0.0 110.86 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.7 -15.98 37.58 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.849 HG11 ' HA ' ' A' ' 28' ' ' GLN . 21.4 t -96.04 -39.0 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -76.33 -41.97 46.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 3.1 t80 -56.58 -59.45 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 145' ' ' TYR . 3.4 t0 -35.69 -45.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 151' ' ' VAL . 49.0 t -76.5 -44.21 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.567 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 31.2 t80 -52.86 -46.13 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -66.28 -48.11 71.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -56.28 -44.7 80.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 147' ' ' VAL . 58.2 t -58.74 -64.23 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.181 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.585 HG23 HG12 ' A' ' 205' ' ' ILE . 78.1 mt -45.46 -52.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.122 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.8 m -41.04 -38.31 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.424 ' CG ' HG13 ' A' ' 45' ' ' VAL . 19.3 t60 -78.81 -39.45 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 152' ' ' ILE . 98.7 mt -56.58 -47.1 80.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.79 -44.76 39.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 22.4 mtt-85 -60.38 -28.03 67.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.04 -40.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 84.2 p -64.0 -26.36 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 40.1 mt-30 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.566 ' HB3' HD12 ' A' ' 164' ' ' ILE . 2.1 mm100 -103.38 32.43 3.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.621 ' CD2' HG22 ' A' ' 168' ' ' THR . 51.5 p-80 -52.73 -43.43 65.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -59.54 -28.55 67.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 161' ' ' GLN . 82.2 mt -83.09 -55.92 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 166' ' ' LEU . 1.3 m-20 -92.4 22.1 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 162' ' ' HIS . 11.5 mt 35.18 53.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.5 mmm -148.64 110.39 4.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.621 HG22 ' CD2' ' A' ' 162' ' ' HIS . 61.2 p -96.59 154.01 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.08 -41.6 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.95 -50.04 65.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 168' ' ' THR . 38.8 m-20 -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.65 -42.43 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 t -60.27 -27.95 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 47.5 mt -83.43 -35.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.98 -21.33 64.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -104.5 -11.32 17.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.22 -46.45 93.93 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.598 0.713 . . . . 0.0 110.933 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.4 Cg_exo -48.0 -57.4 2.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 0.0 112.346 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 101' ' ' PHE . 59.8 m -73.35 -61.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 80.7 mt -32.54 -48.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.484 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 14.1 ptm -158.29 141.97 15.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.829 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -66.95 149.92 98.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.848 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 156.04 64.2 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.684 2.256 . . . . 0.0 112.292 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.07 -178.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -84.9 15.76 3.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -78.57 92.83 4.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -90.76 -63.38 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -60.88 157.41 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.34 118.48 24.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -111.62 163.48 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 192' ' ' SER . 40.6 mt -41.16 155.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 191' ' ' LEU . 98.3 p -35.81 104.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.2 m -84.19 124.97 31.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.188 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 76.3 p -40.24 133.58 1.77 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.153 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.439 ' CD ' ' O ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -85.28 30.62 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 200' ' ' VAL . 96.1 mt -62.23 -45.28 99.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.487 ' ND1' HD21 ' A' ' 118' ' ' LEU . 51.8 m-70 -47.84 -58.76 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.84 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -53.36 -50.32 65.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 m -50.1 -41.48 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 196' ' ' ILE . 66.8 t -44.07 -71.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 202' ' ' GLU . 95.3 t -61.1 -59.68 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 201' ' ' VAL . 10.1 tt0 -34.16 -47.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -60.0 -57.04 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -39.12 -34.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.585 HG12 HG23 ' A' ' 152' ' ' ILE . 95.2 mt -80.81 -62.0 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -47.91 -51.94 21.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 207' ' ' GLN . 26.5 mp0 -95.42 30.6 2.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.404 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 8.8 t -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.56 ' NE2' ' CG ' ' A' ' 213' ' ' TYR . 8.5 mm100 -84.65 -53.88 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -40.45 -37.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 19.2 m-85 -53.06 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.21 -55.29 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.56 ' CG ' ' NE2' ' A' ' 209' ' ' GLN . 69.9 m-85 -60.34 -9.96 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.959 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 t30 49.07 37.19 10.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -68.66 172.05 36.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.71 154.86 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.16 132.57 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.85 177.98 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 p -88.7 -57.8 2.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -173.12 173.15 3.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.26 -158.14 7.62 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.2 p -168.2 139.97 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 m -171.46 166.69 6.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.826 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.05 64.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.496 ' HE3' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -80.42 166.16 21.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.888 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -141.25 121.18 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CD1' ' O ' ' A' ' 10' ' ' PHE . 53.1 p90 -136.45 124.8 23.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -102.5 147.98 34.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.654 0.74 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 155.13 66.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.676 2.251 . . . . 0.0 112.328 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 139.66 40.79 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.666 2.244 . . . . 0.0 112.376 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 t -168.69 153.36 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 1.7 mpt_? -91.09 107.22 19.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 17' ' ' ASN . 29.7 ptt180 -62.54 -51.47 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.436 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 17.5 t30 54.75 35.75 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.571 ' CZ2' ' HA ' ' A' ' 73' ' ' LYS . 53.6 t90 -131.75 13.06 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -176.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.495 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 42.2 p -144.0 163.99 31.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.904 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -98.2 -26.83 14.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -58.94 -44.44 91.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 20' ' ' SER . 1.1 p90 -45.69 -34.71 3.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.48 ' N ' ' CD1' ' A' ' 23' ' ' PHE . . . -73.1 -36.9 56.2 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 10.6 mmt -80.98 148.83 65.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 147.25 62.81 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.704 2.269 . . . . 0.0 112.37 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.1 tp -45.03 -55.37 5.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.88 ' HA ' HG11 ' A' ' 143' ' ' VAL . 19.9 pt20 -46.46 -36.16 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.63 -39.95 61.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.19 -44.84 82.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -93.37 171.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 p -111.53 147.95 34.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.56 -45.12 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -54.59 -45.44 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 29.8 mmtt -129.34 93.42 35.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 110.948 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.3 Cg_endo -69.73 -38.92 7.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.732 2.288 . . . . 0.0 112.346 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 mt -78.2 128.46 78.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.664 0.745 . . . . 0.0 111.089 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.87 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.699 2.266 . . . . 0.0 112.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.663 HD11 ' HE3' ' A' ' 43' ' ' LYS . 2.4 tm? -99.13 -49.21 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -46.53 -50.32 17.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 97' ' ' LEU . 43.5 t -57.51 -58.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.091 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -46.45 -56.21 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.663 ' HE3' HD11 ' A' ' 39' ' ' LEU . 12.0 mmtp -43.97 -44.53 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 85.3 m -66.76 -62.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -45.36 -47.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.12 -37.17 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.707 ' CD1' HG21 ' A' ' 93' ' ' VAL . 4.9 t80 -55.61 -59.19 5.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 47' ' ' PHE . 10.7 mt -34.82 -68.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.96 -45.71 89.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -40.13 -50.49 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -87.26 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 48' ' ' ILE . . . 149.15 156.21 7.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.506 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.71 HD11 HG22 ' A' ' 158' ' ' VAL . 11.2 tp -126.05 41.45 3.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.307 . . . . 0.0 110.902 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 p -129.92 41.85 3.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 58' ' ' LEU . 50.4 m -95.96 116.25 28.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -39.12 116.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 72.37 0.56 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.506 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.616 HD22 ' O ' ' A' ' 55' ' ' THR . 4.1 mm? -41.73 -45.33 3.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 110.948 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CE2' ' HB1' ' A' ' 94' ' ' ALA . 6.5 m-85 -117.9 -41.69 2.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 59' ' ' TYR . 16.8 tpp85 -34.7 -47.22 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t -93.14 115.3 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -175.09 120.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.42 -53.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.436 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -38.6 -39.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 48.86 25.04 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.6 m -98.12 -27.56 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.01 -50.47 19.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -59.97 -39.08 84.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -46.3 -53.2 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.0 p30 -66.03 -38.2 87.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 68' ' ' GLN . 68.6 mt -51.42 -39.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -87.06 -60.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.571 ' HA ' ' CZ2' ' A' ' 18' ' ' TRP . 24.4 mtpt -46.83 -35.63 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 70' ' ' ASN . 52.1 mm-40 -77.7 -43.31 31.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -53.47 -28.81 32.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -75.71 -60.68 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -61.52 -25.84 67.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -130.62 107.07 8.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -79.68 -25.41 41.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -97.35 36.56 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.0 tt -79.83 147.46 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -124.86 102.87 7.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -44.65 -50.22 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.5 t -46.46 -50.1 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -56.5 -46.47 80.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.417 ' HB3' HG13 ' A' ' 88' ' ' VAL . 22.3 mmm -60.03 -26.8 66.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 51.96 51.45 16.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 86' ' ' MET . 34.1 m -85.36 160.2 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 p -56.13 125.18 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.2 t -43.48 -46.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.147 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -51.73 -35.72 44.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.69 -58.44 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.707 HG21 ' CD1' ' A' ' 47' ' ' PHE . 78.4 t -58.49 -37.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB1' ' CE2' ' A' ' 59' ' ' TYR . . . -58.84 -42.22 88.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.076 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.16 -45.89 7.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.39 -46.71 73.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 41' ' ' VAL . 23.2 tp -46.06 -44.19 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.564 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 30.9 mtmt -71.25 -42.06 69.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.33 -48.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 4.6 t80 -58.47 -48.61 80.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -53.95 -47.62 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.432 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -59.1 -41.46 88.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -53.18 -34.63 57.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -39.26 147.47 0.3 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -25.02 28.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.377 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -135.48 155.82 78.2 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.427 ' HG3' ' CE1' ' A' ' 111' ' ' TYR . 53.6 Cg_endo -69.77 136.57 33.3 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.717 2.278 . . . . 0.0 112.38 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.463 HD21 ' CD1' ' A' ' 148' ' ' PHE . 24.1 tp -43.55 -41.3 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.2 mt -95.05 123.88 55.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.702 . . . . 0.0 111.139 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 140.85 43.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.248 . . . . 0.0 112.323 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.427 ' CE1' ' HG3' ' A' ' 107' ' ' PRO . 6.3 m-85 -62.75 -22.4 66.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -66.81 -22.19 66.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 117' ' ' LEU . 41.4 mt -116.58 32.11 6.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.469 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -74.62 -61.48 1.11 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 0.0 110.832 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.72 -27.18 26.96 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.688 2.259 . . . . 0.0 112.325 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -63.77 -33.99 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.5 mt -73.42 -41.54 63.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.565 HD23 HG21 ' A' ' 200' ' ' VAL . 8.8 mt -69.82 -57.2 5.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -43.82 -35.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.7 -26.79 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.081 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.9 -30.4 50.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -77.56 -10.99 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 55.4 mt -51.85 132.61 38.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.16 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -65.63 113.7 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.752 ' HD3' HG21 ' A' ' 217' ' ' ILE . 17.8 ttmt -52.09 -50.89 60.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.8 m -54.59 -65.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.172 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -43.45 -52.81 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -41.01 -52.56 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.5 mt -60.47 -57.22 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.34 -51.64 25.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.01 -24.6 67.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.525 ' O ' HG12 ' A' ' 137' ' ' VAL . 32.4 tttm -77.71 -33.04 53.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.1 pt-20 -83.69 -35.46 24.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.496 HG23 ' HZ2' ' A' ' 139' ' ' LYS . 54.3 mt -69.2 -36.57 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 134' ' ' LYS . 8.8 p -65.16 -21.13 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -72.09 -39.48 68.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.496 ' HZ2' HG23 ' A' ' 136' ' ' ILE . 4.6 mttp -59.62 -33.52 71.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -41.98 145.82 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.546 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.4 t-80 -43.25 142.18 1.68 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.816 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.84 -6.4 18.54 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 28' ' ' GLN . 48.8 t -99.19 -45.9 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -79.22 -38.06 36.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.3 t80 -42.74 -47.92 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -52.42 65.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -55.93 -64.12 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.587 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 31.3 t80 -43.55 -49.37 7.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 mtp85 -60.5 -47.06 87.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.13 -44.28 92.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 70.9 t -56.93 -60.53 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.67 HG23 HG12 ' A' ' 205' ' ' ILE . 56.3 mt -48.5 -50.14 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.6 m -40.4 -32.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.6 -36.83 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 152' ' ' ILE . 75.1 mt -55.96 -46.81 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.428 ' C ' HD21 ' A' ' 156' ' ' ASN . 0.2 OUTLIER -49.28 -41.68 38.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mtp85 -60.63 -32.84 71.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 53' ' ' LEU . 47.0 t -73.72 -39.4 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 p -66.22 -28.05 68.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -63.33 -37.35 86.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.664 ' OE1' HD12 ' A' ' 164' ' ' ILE . 16.2 mm-40 -98.3 32.31 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.561 ' HB2' HG22 ' A' ' 168' ' ' THR . 7.8 p80 -57.13 -21.32 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -82.96 -17.56 43.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.664 HD12 ' OE1' ' A' ' 161' ' ' GLN . 60.2 mt -100.12 -63.93 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.73 22.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 165' ' ' ASN . 22.8 mt 33.12 54.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 38.1 mmm -142.68 105.82 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.561 HG22 ' HB2' ' A' ' 162' ' ' HIS . 72.4 p -94.7 150.05 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -33.81 -50.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -55.04 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -55.16 -38.81 68.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.519 HD11 ' HB ' ' A' ' 158' ' ' VAL . 79.5 mt -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -71.67 -34.65 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.699 HD11 ' OE1' ' A' ' 198' ' ' GLN . 27.5 mt -80.7 -28.39 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.9 m -75.9 -21.21 57.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.564 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 14.3 m-85 -103.7 -8.74 19.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.568 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.5 OUTLIER -54.37 -46.92 98.88 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.52 0.676 . . . . 0.0 110.902 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.7 Cg_exo -48.02 -48.64 15.84 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 180' ' ' LEU . 39.7 m -81.83 -59.13 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 58.9 mt -33.17 -69.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.566 ' HG2' ' CH2' ' A' ' 177' ' ' TRP . 3.2 ttp -121.01 118.75 30.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.47 ' HD3' ' N ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -40.92 130.65 1.92 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.585 0.707 . . . . 0.0 110.872 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.47 ' N ' ' HD3' ' A' ' 182' ' ' ARG . 54.3 Cg_endo -69.67 122.12 8.83 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.403 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.64 110.81 10.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.882 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.416 ' O ' ' C ' ' A' ' 186' ' ' GLU . 45.4 m-85 -97.43 -50.45 4.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 185' ' ' PHE . 48.5 mp0 -36.42 -56.44 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -48.48 118.8 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -99.37 159.23 15.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -140.84 177.66 7.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.617 ' HD2' HD23 ' A' ' 191' ' ' LEU . 0.7 OUTLIER -50.21 -60.28 3.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.617 HD23 ' HD2' ' A' ' 190' ' ' PHE . 3.8 mm? -89.94 125.18 35.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 96.9 p -44.79 -34.65 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 13.2 t -174.31 150.89 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.105 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.411 HG21 HD12 ' A' ' 196' ' ' ILE . 9.0 t -150.85 155.44 39.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.13 29.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.749 ' O ' HG23 ' A' ' 200' ' ' VAL . 81.8 mt -89.95 -44.34 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -50.81 -60.16 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.699 ' OE1' HD11 ' A' ' 174' ' ' ILE . 70.1 mt-30 -57.2 -43.94 83.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 t -55.92 -39.34 71.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 196' ' ' ILE . 92.8 t -46.7 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.124 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.42 -55.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.147 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -40.62 -40.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 204' ' ' PHE . 49.5 m -58.98 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 208' ' ' CYS . 10.7 m-85 -36.08 -56.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.67 HG12 HG23 ' A' ' 152' ' ' ILE . 60.7 mt -59.56 -46.43 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -55.57 -58.03 9.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -99.72 28.98 4.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.564 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -57.91 -27.48 63.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -82.34 -54.55 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.18 -36.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -50.54 -63.17 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -104.61 -55.74 2.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -55.0 -35.63 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 71.28 39.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -75.53 178.04 48.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.48 137.14 47.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.752 HG21 ' HD3' ' A' ' 126' ' ' LYS . 77.7 mt -59.16 125.92 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.28 170.31 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.166 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.94 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.7 p -145.12 112.77 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -138.07 144.49 40.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.12 165.18 12.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.52 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -131.32 135.73 47.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -102.36 -59.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.39 84.34 0.43 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -44.3 -47.2 9.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.1 t30 49.95 43.06 25.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -95.49 134.44 38.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.404 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 4.9 t30 -129.88 140.23 38.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.623 0.725 . . . . 0.0 110.881 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 53.5 Cg_endo -69.75 158.53 56.66 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 150.77 68.48 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.709 2.272 . . . . 0.0 112.372 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.7 p -107.4 141.14 39.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -142.28 144.79 33.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -53.47 121.83 8.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -88.65 43.53 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -130.89 84.93 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -147.39 118.86 7.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -165.58 179.88 5.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.857 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -105.58 -37.33 6.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -38.86 -48.06 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -63.24 121.64 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.63 -43.28 1.7 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.495 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.4 ' SD ' ' HD2' ' A' ' 26' ' ' PRO . 22.8 mmt -79.9 159.83 70.27 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.569 0.7 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD2' ' SD ' ' A' ' 25' ' ' MET . 53.9 Cg_endo -69.71 160.25 50.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.736 2.291 . . . . 0.0 112.369 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 31' ' ' VAL . 17.8 tp -78.74 -45.51 20.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.733 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -48.15 -28.12 2.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -78.02 -45.66 23.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.5 mt -66.16 -42.78 88.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 27' ' ' LEU . 18.3 m -87.77 155.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -103.68 157.78 16.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.05 -44.19 30.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -58.74 -48.84 79.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -121.63 87.6 45.99 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.54 0.686 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.17 9.57 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.656 2.237 . . . . 0.0 112.364 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.434 HG23 ' HD2' ' A' ' 38' ' ' PRO . 72.1 mt -77.35 132.95 68.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.643 0.735 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.82 140.02 41.44 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.26 . . . . 0.0 112.316 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -55.24 -54.07 48.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 39' ' ' LEU . 82.4 t80 -38.17 -69.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.563 HG13 HD11 ' A' ' 97' ' ' LEU . 53.0 t -42.79 -55.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -50.29 -57.84 6.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HG2' HD13 ' A' ' 39' ' ' LEU . 36.2 mmtt -46.74 -39.13 11.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.431 ' HB2' HD13 ' A' ' 97' ' ' LEU . 73.0 m -68.01 -44.73 75.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.67 -53.09 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.8 -45.37 94.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 83' ' ' LEU . 57.8 t80 -43.06 -63.21 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -53.88 -57.3 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -40.85 -53.37 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -59.7 -39.72 85.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -86.37 26.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.148 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.48 172.55 48.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.469 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.66 37.36 3.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.6 p -116.63 29.68 7.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.732 ' O ' HD22 ' A' ' 58' ' ' LEU . 77.9 m -68.81 114.23 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.182 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.03 114.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.43 96.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 55' ' ' THR . 1.8 mm? -90.08 112.29 23.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.348 . . . . 0.0 110.917 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 22.0 m-85 72.29 33.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -126.63 -38.02 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.46 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 21.3 t -85.99 124.79 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 t -72.26 115.56 11.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.6 164.66 25.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.526 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -52.13 169.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.366 . . . . 0.0 110.922 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -100.47 -39.36 7.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.2 m -50.22 -30.97 12.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.2 -55.9 7.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HA ' HD12 ' A' ' 71' ' ' ILE . 18.9 mt-30 -59.46 -21.36 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.93 -61.41 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.7 p30 -61.46 -41.0 96.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.476 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 80.9 mt -52.34 -43.11 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -81.88 -53.88 5.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ASP . 50.9 mttt -54.62 -65.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -40.94 -44.33 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.5 -35.9 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.9 t0 -66.98 -55.48 14.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -54.72 -34.53 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -158.12 151.81 23.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.15 -19.07 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -80.81 49.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.57 -177.78 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -145.72 139.82 26.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . 14.7 mt -84.25 -41.25 17.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.4 t -48.55 -50.22 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -57.53 -41.59 81.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 mtp -61.27 -26.43 67.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 54.08 45.81 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.6 151.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.107 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 p -60.83 129.77 43.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.5 t -42.83 -52.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.46 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 9.9 m120 -40.82 -48.07 3.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.5 -62.86 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.415 HG21 ' CE2' ' A' ' 47' ' ' PHE . 65.6 t -48.7 -54.03 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -46.46 -41.39 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.78 -60.16 4.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.67 -41.29 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.563 HD11 HG13 ' A' ' 41' ' ' VAL . 15.7 tp -49.64 -49.92 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 101' ' ' PHE . 32.5 mtmt -68.22 -47.46 67.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.13 -33.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -65.38 -47.12 77.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 151' ' ' VAL . 41.5 m-85 -57.04 -44.49 82.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.49 -39.6 88.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.49 -37.99 82.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -37.78 141.6 0.47 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -24.12 29.74 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.232 . . . . 0.0 112.343 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.68 153.83 77.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.655 0.74 . . . . 0.0 110.838 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 134.77 28.76 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.351 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' A' ' 148' ' ' PHE . 19.1 tp -38.95 -52.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.3 mt -87.35 124.35 68.27 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 0.0 111.155 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 154.82 67.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.69 2.26 . . . . 0.0 112.352 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -68.85 -26.47 65.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 m -65.71 -25.41 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.863 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.6 mt -111.58 36.66 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.967 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.651 ' CE1' ' SD ' ' A' ' 181' ' ' MET . 0.1 OUTLIER -77.94 -65.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.561 0.696 . . . . 0.0 110.829 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.71 -21.44 33.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.739 2.293 . . . . 0.0 112.344 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.64 -28.55 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.536 HD22 ' CG1' ' A' ' 200' ' ' VAL . 2.5 mt -79.91 -36.6 36.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.6 -46.47 25.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.95 -31.79 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 132' ' ' ALA . . . -86.84 -29.25 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.7 -21.17 59.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -91.97 22.04 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.07 130.07 45.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -44.83 1.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 102.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -40.18 -60.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 98.7 m -50.04 -57.09 8.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -50.27 -56.51 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -41.59 -57.15 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.472 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 52.7 mt -58.26 -54.18 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -47.0 -50.58 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.497 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . . . -52.14 -44.45 64.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.5 mt -71.02 -29.9 65.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -74.07 -30.18 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 7.2 pt-20 -87.32 -36.87 17.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.411 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 88.7 mt -69.89 -37.71 73.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.453 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 5.2 p -63.7 -7.73 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -77.61 -38.65 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.934 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -64.87 -29.88 70.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.1 m-85 -43.68 128.34 5.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.595 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -34.09 141.49 0.24 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.72 -10.11 27.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.733 HG11 ' HA ' ' A' ' 28' ' ' GLN . 41.8 t -99.09 -40.38 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -83.44 -35.12 25.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 4.4 t80 -57.0 -43.43 81.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.66 -49.31 70.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 151' ' ' VAL . 69.3 t -66.96 -50.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.532 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 37.4 t80 -54.13 -45.69 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -65.37 -47.15 77.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -59.27 -46.07 89.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 147' ' ' VAL . 85.0 t -53.19 -59.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.646 ' HA ' HD12 ' A' ' 155' ' ' LEU . 73.6 mt -48.88 -52.01 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.074 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.1 m -39.52 -34.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -83.44 -35.67 24.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 152' ' ' ILE . 68.9 mt -61.48 -49.53 76.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -50.01 -49.8 49.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -53.64 -43.36 68.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.8 -50.05 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.8 p -52.5 -21.64 3.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -58.18 -44.13 87.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.648 ' HB2' HD22 ' A' ' 165' ' ' ASN . 51.6 mt-30 -101.25 30.3 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.665 ' ND1' HG22 ' A' ' 168' ' ' THR . 7.4 p80 -45.48 -25.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -74.91 -36.61 62.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 161' ' ' GLN . 77.0 mt -84.29 -56.41 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.648 HD22 ' HB2' ' A' ' 161' ' ' GLN . 0.6 OUTLIER -81.08 16.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 165' ' ' ASN . 11.2 mt 34.49 54.78 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 7.7 mmm -150.12 108.39 3.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.665 HG22 ' ND1' ' A' ' 162' ' ' HIS . 72.4 p -94.09 157.76 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -38.67 -43.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -62.72 -58.73 6.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -45.6 -51.66 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.52 -30.78 70.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -75.69 -32.87 60.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.488 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 62.5 mt -78.24 -31.04 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.3 m -75.26 -34.05 61.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.606 ' CE2' HD21 ' A' ' 155' ' ' LEU . 12.0 m-85 -89.09 -40.75 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.623 ' O ' ' CE3' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.01 -56.81 0.7 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 0.0 110.948 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.513 ' HD3' ' CD1' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.02 -63.7 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.487 ' O ' ' C ' ' A' ' 180' ' ' LEU . 28.6 m -59.37 -56.09 26.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 177' ' ' TRP . 83.3 mt -31.34 -59.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.651 ' SD ' ' CE1' ' A' ' 114' ' ' HIS . 4.0 ttp -125.94 117.72 23.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 181' ' ' MET . 17.3 ttm180 -34.15 133.91 0.38 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 159.21 54.2 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.245 . . . . 0.0 112.359 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -51.52 149.37 4.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.572 ' CD2' ' HG3' ' A' ' 186' ' ' GLU . 9.6 p90 -84.9 -48.8 8.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.572 ' HG3' ' CD2' ' A' ' 185' ' ' PHE . 10.2 mt-10 -140.21 136.48 33.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -151.74 122.17 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 -24.39 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -82.35 107.21 14.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 190' ' ' PHE . 26.7 p90 -114.07 80.17 1.35 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 14.5 mt -150.25 134.21 16.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 m 47.71 44.45 17.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 95.7 m -76.46 90.8 3.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 78.4 p -60.47 131.08 49.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -86.45 44.76 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.857 ' O ' HG23 ' A' ' 200' ' ' VAL . 74.4 mt -80.38 -34.44 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.104 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -50.58 -50.82 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.21 -44.35 72.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.0 m -54.02 -48.31 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 196' ' ' ILE . 74.2 t -38.69 -56.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.54 -50.03 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -46.71 -45.38 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 204' ' ' PHE . 97.7 m -57.93 -61.77 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.8 m-85 -35.04 -47.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 152' ' ' ILE . 68.6 mt -67.64 -58.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 219' ' ' GLU . 18.2 mt-30 -46.37 -41.39 13.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.472 ' HG3' ' CD1' ' A' ' 130' ' ' LEU . 7.1 mm-40 -116.28 34.9 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.578 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -68.38 -22.77 64.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -85.38 -55.35 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -39.95 -34.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.0 m-85 -51.81 -63.18 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.864 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -104.98 -55.86 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -58.01 -22.53 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.929 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 57.35 38.12 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.18 143.4 23.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 216' ' ' GLU . 7.5 mp0 -41.98 145.04 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.36 143.56 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.26 170.32 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.417 ' CD ' ' O ' ' A' ' 219' ' ' GLU . 12.7 tm-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -108.97 177.34 4.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.4 t -132.69 86.56 2.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.62 132.21 2.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.463 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.2 m -67.11 122.25 17.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.823 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.0 t -136.77 110.91 8.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.87 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.97 -163.17 10.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -70.58 118.57 13.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -96.73 131.49 43.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 11' ' ' ASN . 10.8 p90 -174.16 179.06 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' PHE . 30.8 m-20 -36.35 143.88 0.28 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.634 0.73 . . . . 0.0 110.874 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 148.54 65.41 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.665 2.244 . . . . 0.0 112.357 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 177.62 5.41 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.712 2.274 . . . . 0.0 112.317 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -109.4 140.14 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -82.72 139.32 33.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 18' ' ' TRP . 6.2 tpt180 -86.28 -53.37 5.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ARG . 5.4 p-10 36.91 32.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.438 ' N ' ' O ' ' A' ' 16' ' ' ARG . 64.3 t-105 -130.19 59.39 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -54.04 111.82 0.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.602 ' O ' ' CE1' ' A' ' 23' ' ' PHE . 58.5 p -134.65 132.85 39.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.36 -5.11 6.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.531 ' CD2' ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -76.24 -60.62 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.602 ' CE1' ' O ' ' A' ' 20' ' ' SER . 21.6 m-85 46.99 30.44 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.36 47.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 15.2 mtm -91.21 144.97 30.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.59 0.71 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 151.9 69.32 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.384 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.53 -53.86 26.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.476 ' CB ' HG21 ' A' ' 143' ' ' VAL . 2.7 pt20 -46.21 -32.01 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -40.68 30.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.01 -43.79 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 36' ' ' PRO . 20.9 m -90.98 172.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.0 p -112.03 161.61 16.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.38 -44.78 72.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.39 -45.2 80.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -127.21 95.37 36.55 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' O ' HG21 ' A' ' 31' ' ' VAL . 54.2 Cg_endo -69.72 -38.03 8.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.577 HG23 ' HD2' ' A' ' 38' ' ' PRO . 10.2 mt -75.04 136.56 72.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.666 0.746 . . . . 0.0 111.114 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.73 169.51 18.72 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.706 2.27 . . . . 0.0 112.333 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.636 HD11 ' HE2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -84.69 -46.07 11.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.923 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -48.19 -64.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 97' ' ' LEU . 55.4 t -43.94 -65.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -39.77 -53.61 2.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HE2' HD11 ' A' ' 39' ' ' LEU . 48.7 mmtt -56.48 -37.19 70.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.692 ' HB2' HD13 ' A' ' 97' ' ' LEU . 69.4 m -69.16 -45.52 69.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.444 HG13 ' CG ' ' A' ' 154' ' ' HIS . 46.4 t -64.01 -49.1 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.96 -43.37 83.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CZ ' HG21 ' A' ' 51' ' ' THR . 13.2 t80 -56.52 -61.39 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 44' ' ' CYS . 19.8 mt -41.05 -44.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' OE1' HD13 ' A' ' 53' ' ' LEU . 7.4 mm-40 -64.39 -42.32 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.19 -35.19 79.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.756 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 22.1 p -90.98 29.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.64 150.66 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 158' ' ' VAL . 11.9 tp -120.74 -34.51 3.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.916 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.1 p -56.36 -14.7 3.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.4 m -40.95 105.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -44.51 111.38 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.73 105.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 4.7 mp -105.88 -33.62 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -104.74 -55.63 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.969 ' HD3' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -59.37 -34.82 72.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.969 HG23 ' HD3' ' A' ' 60' ' ' ARG . 3.2 t -103.02 109.48 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 p -137.58 122.86 19.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.818 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.09 -130.33 1.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.529 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -40.91 156.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -103.93 -46.81 4.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.902 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ASP . 87.3 m -39.04 -42.79 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -41.92 -49.96 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.67 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 8.1 mt-30 -67.58 -28.83 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.0 t70 -53.23 -53.61 48.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.6 p30 -60.14 -38.8 84.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 68' ' ' GLN . 54.4 mt -49.92 -50.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.49 -61.01 2.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -46.04 -58.99 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -53.42 -42.04 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -64.66 -37.75 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.06 -49.13 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -76.81 -24.93 52.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -133.31 99.66 4.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -72.32 -29.32 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -91.49 34.91 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.761 HD11 ' SD ' ' A' ' 86' ' ' MET . 10.1 tt -77.98 150.13 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -118.38 93.61 4.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -44.51 -42.08 6.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -52.81 -44.02 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 t -65.69 -27.71 68.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.761 ' SD ' HD11 ' A' ' 81' ' ' ILE . 62.6 mtp -70.96 -38.15 72.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 60.18 49.53 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 m -84.49 162.52 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' VAL . 66.8 p -67.23 115.18 6.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 51' ' ' THR . 60.9 t -33.65 -54.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.154 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -37.16 -49.33 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.468 ' HB1' ' HG3' ' A' ' 68' ' ' GLN . . . -55.05 -60.37 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.626 HG21 ' CE1' ' A' ' 47' ' ' PHE . 77.2 t -48.08 -62.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 58' ' ' LEU . . . -41.28 -35.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.15 -57.43 2.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.517 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.67 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -45.1 -43.66 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 111.066 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.692 HD13 ' HB2' ' A' ' 44' ' ' CYS . 34.3 tp -43.41 -45.29 6.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.582 ' HG2' ' CE1' ' A' ' 176' ' ' PHE . 28.5 mtmt -65.06 -46.82 79.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.67 -34.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -65.93 -38.76 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.84 -36.35 50.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.06 -39.31 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -59.95 -37.52 79.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -40.42 146.39 0.44 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 -21.67 32.99 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.336 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -142.82 155.07 63.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.542 0.687 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.74 48.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 148' ' ' PHE . 9.0 tp -43.66 -40.85 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mt -83.37 128.7 63.35 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.676 0.75 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 147.05 62.09 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.722 2.282 . . . . 0.0 112.318 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -64.66 -37.85 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.3 m -55.91 -15.11 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.8 mt -128.44 35.64 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.504 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -76.08 -63.32 0.62 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 0.0 110.859 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.69 -10.3 28.27 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -74.7 -33.78 62.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.18 -36.15 66.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 115' ' ' PRO . 6.1 mt -73.91 -54.3 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -49.53 -33.06 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.66 -22.46 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.75 -33.81 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -71.45 -10.23 59.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.44 127.92 85.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.622 0.725 . . . . 0.0 111.137 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -44.77 1.88 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.667 2.244 . . . . 0.0 112.351 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.77 108.64 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -46.66 -55.99 6.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.411 HG22 ' ND1' ' A' ' 131' ' ' HIS . 2.6 m -57.34 -65.26 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -42.42 -56.35 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -38.62 -46.14 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.7 mt -69.27 -58.47 3.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.411 ' ND1' HG22 ' A' ' 127' ' ' THR . 63.7 m80 -44.8 -51.85 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.97 -46.23 52.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 20.0 mt -68.53 -28.27 66.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -75.13 -32.54 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 5.2 pt-20 -84.04 -31.29 25.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 74.8 mt -75.26 -32.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.444 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.8 p -76.03 0.35 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.141 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -82.33 -41.13 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.25 22.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 2.3 m-85 -80.1 141.44 35.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.54 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.7 t-80 -39.91 141.94 0.73 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.604 0.716 . . . . 0.0 110.833 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.8 Cg_endo -69.81 -8.06 22.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.476 HG21 ' CB ' ' A' ' 28' ' ' GLN . 74.3 t -99.19 -48.33 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 141' ' ' HIS . 59.6 m-80 -73.47 -43.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -48.51 -42.19 32.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.95 -56.22 23.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 151' ' ' VAL . 63.8 t -63.63 -62.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.168 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.568 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 26.3 t80 -39.43 -39.94 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -70.43 -46.33 64.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.29 -36.66 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 147' ' ' VAL . 35.0 t -63.1 -64.69 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.078 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.719 HG23 HG12 ' A' ' 205' ' ' ILE . 80.2 mt -47.98 -52.1 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -40.94 -35.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.149 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.444 ' CG ' HG13 ' A' ' 45' ' ' VAL . 23.0 t60 -83.26 -40.91 18.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 176' ' ' PHE . 97.5 mt -54.47 -44.45 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -50.88 -45.34 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -55.77 -39.26 70.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.711 HG11 HD21 ' A' ' 172' ' ' LEU . 76.3 t -69.12 -38.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 p -64.32 -35.34 80.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -54.51 -38.0 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.693 ' OE1' HD12 ' A' ' 164' ' ' ILE . 21.4 mm-40 -99.1 28.77 4.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.597 ' CD2' HG22 ' A' ' 168' ' ' THR . 48.1 p-80 -54.6 -31.71 57.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -73.54 -21.69 60.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.693 HD12 ' OE1' ' A' ' 161' ' ' GLN . 74.3 mt -95.37 -57.59 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -89.86 26.24 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 165' ' ' ASN . 14.2 mt 32.56 41.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 9.7 mmm -128.72 104.5 7.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.597 HG22 ' CD2' ' A' ' 162' ' ' HIS . 60.8 p -96.57 150.67 20.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -36.16 -33.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 168' ' ' THR . 10.0 t70 -63.84 -57.43 9.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -51.4 -57.15 9.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.711 HD21 HG11 ' A' ' 158' ' ' VAL . 10.6 mt -53.67 -29.01 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.0 t -81.13 -37.36 28.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 70.1 mt -74.51 -24.78 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -75.27 -39.07 60.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.582 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 9.6 m-85 -88.99 -38.81 14.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.626 ' O ' ' CE3' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.78 -56.7 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.563 0.696 . . . . 0.0 110.906 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.501 ' CD ' ' O ' ' A' ' 174' ' ' ILE . 65.7 Cg_exo -48.04 -52.37 8.37 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 180' ' ' LEU . 58.7 m -70.42 -62.0 1.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 95.9 mt -34.05 -45.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 13.6 mtm -145.5 133.32 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.462 ' CG ' ' HD2' ' A' ' 183' ' ' PRO . 27.7 ttp180 -41.27 139.91 1.29 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 110.884 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.531 ' HA ' ' CZ2' ' A' ' 177' ' ' TRP . 53.9 Cg_endo -69.77 132.62 23.7 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.708 2.272 . . . . 0.0 112.349 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -160.86 137.68 8.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -112.53 50.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -97.64 98.0 9.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -165.34 159.58 17.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.466 ' NE ' ' HG2' ' A' ' 189' ' ' GLU . 3.3 ppt_? -124.57 -22.36 4.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.466 ' HG2' ' NE ' ' A' ' 188' ' ' ARG . 8.8 mm-40 -80.02 107.75 13.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.491 ' CD2' HG22 ' A' ' 194' ' ' THR . 53.4 t80 -120.17 -54.19 2.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 90.6 mt -43.85 -59.92 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 78.5 p -56.29 -56.61 18.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 27.6 m -140.21 143.64 36.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.182 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.491 HG22 ' CD2' ' A' ' 190' ' ' PHE . 82.1 p -112.38 147.43 36.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.166 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 49.68 46.09 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 200' ' ' VAL . 91.0 mt -48.76 -55.32 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 196' ' ' ILE . 60.0 m-70 -35.79 -48.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -68.3 -60.14 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 200' ' ' VAL . 21.1 m -43.28 -41.47 3.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 196' ' ' ILE . 99.5 t -36.75 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' GLU . 90.6 t -68.86 -55.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -34.24 -49.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.5 m -55.68 -62.9 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 11.7 m-85 -35.71 -51.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.719 HG12 HG23 ' A' ' 152' ' ' ILE . 85.8 mt -60.48 -57.35 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.132 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.434 ' HB3' HG23 ' A' ' 218' ' ' VAL . 5.5 mt-30 -49.43 -52.31 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.9 mm-40 -101.72 30.69 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.486 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 1.4 t -65.34 -19.45 65.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 213' ' ' TYR . 32.7 mm-40 -87.9 -45.89 9.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -37.17 20.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.486 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -50.71 -63.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -104.77 -55.45 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 209' ' ' GLN . 52.2 m-85 -58.25 -25.1 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 57.47 45.21 20.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -83.73 -179.04 52.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.64 147.93 44.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.457 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 45.8 mt -75.13 139.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.145 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 206' ' ' GLN . 27.2 m -124.05 177.68 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.3 m -144.43 161.97 37.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.3 p -171.5 173.37 4.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.82 167.61 39.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.454 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.5 p -168.39 177.6 5.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.897 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.6 p -154.04 169.15 24.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.97 147.11 5.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.485 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -166.4 159.85 15.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -161.35 138.77 8.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 10' ' ' PHE . 34.0 p90 -88.96 86.2 6.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -155.0 134.26 7.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 152.1 69.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.684 2.256 . . . . 0.0 112.317 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 150.34 67.91 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.649 2.233 . . . . 0.0 112.324 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.3 p -119.48 163.18 17.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -128.86 -1.53 5.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -157.11 118.92 3.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -109.37 30.28 6.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.524 ' CZ2' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -125.58 43.09 3.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -123.83 173.36 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.5 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 63.7 m -134.25 178.96 6.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -103.93 -33.9 8.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -53.76 -41.41 67.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' CD1' ' O ' ' A' ' 20' ' ' SER . 1.6 p90 -52.26 -26.2 11.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.66 -39.23 8.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.9 mmt -89.39 154.81 48.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.573 0.701 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 158.58 56.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.326 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.473 ' O ' HG22 ' A' ' 31' ' ' VAL . 9.8 tp -72.39 -48.47 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.799 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -48.7 -25.27 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.49 -49.4 12.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.29 -43.81 97.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 27' ' ' LEU . 19.9 m -94.98 156.43 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.4 p -105.25 162.5 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.58 -39.02 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -63.45 -45.62 90.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -128.17 81.74 69.87 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -31.33 20.75 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.712 2.275 . . . . 0.0 112.359 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 147' ' ' VAL . 62.1 mt -82.4 127.82 69.49 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.563 0.696 . . . . 0.0 111.139 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 161.67 45.03 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.683 2.256 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.595 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.63 -56.33 5.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -38.6 -63.83 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.729 HG13 HD11 ' A' ' 97' ' ' LEU . 55.1 t -44.95 -58.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -48.79 -59.93 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HG2' HD13 ' A' ' 39' ' ' LEU . 51.3 mmtt -43.52 -39.8 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.84 -48.87 57.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 150' ' ' TYR . 64.2 t -58.71 -45.59 90.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CD ' ' HA ' ' A' ' 43' ' ' LYS . 11.7 pt-20 -67.22 -41.31 85.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 1.025 ' CE1' HG21 ' A' ' 93' ' ' VAL . 17.7 t80 -53.02 -63.39 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 94' ' ' ALA . 98.1 mt -39.98 -48.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.05 -43.52 98.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.23 -41.03 96.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 90' ' ' VAL . 13.2 t -85.66 28.55 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.141 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.52 165.07 24.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.42 41.52 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 p -129.12 43.36 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -95.09 136.52 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.176 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -81.42 117.88 22.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.4 99.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.837 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.13 -0.41 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 15.7 m-85 -123.11 -38.31 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -85.0 -29.3 25.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.47 132.99 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.5 p -93.61 -68.72 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.73 -103.91 2.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.474 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -100.28 -44.73 5.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.368 . . . . 0.0 110.895 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt 57.05 25.25 10.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.3 m -91.54 -30.66 16.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.489 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 51.4 m-20 -60.6 -53.36 58.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.68 ' HA ' HD12 ' A' ' 71' ' ' ILE . 44.2 mt-30 -49.12 -40.73 33.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.52 -68.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 24.8 p30 -59.82 -39.5 85.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 68' ' ' GLN . 45.4 mt -43.93 -44.15 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -77.45 -46.28 23.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.524 ' HG3' ' CZ2' ' A' ' 18' ' ' TRP . 6.3 mtpp -56.95 -63.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -43.2 -44.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.13 -42.12 97.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.08 -46.25 88.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -61.63 -36.22 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -158.34 154.78 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -102.06 -20.69 14.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.47 54.85 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 pt -118.78 -178.8 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -144.69 145.12 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.4 mt -89.15 -42.59 11.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.01 -53.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -50.33 -46.58 55.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.6 mtp -52.97 -28.53 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 53.23 41.45 32.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.66 163.95 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.567 HG23 ' H ' ' A' ' 92' ' ' ALA . 13.8 t -70.91 149.38 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.425 HG22 HG21 ' A' ' 51' ' ' THR . 75.6 t -59.98 -54.41 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -40.19 -39.52 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.567 ' H ' HG23 ' A' ' 89' ' ' THR . . . -62.1 -64.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.025 HG21 ' CE1' ' A' ' 47' ' ' PHE . 94.1 t -45.28 -50.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -43.89 -51.89 7.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.408 ' C ' ' OE1' ' A' ' 68' ' ' GLN . . . -65.19 -47.31 82.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.678 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -46.32 -48.84 18.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.064 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.729 HD11 HG13 ' A' ' 41' ' ' VAL . 8.2 tp -48.84 -50.01 36.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 43.9 mtmt -65.61 -46.76 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.56 -47.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.66 -53.29 60.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -53.5 -50.25 65.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.85 -42.76 65.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.437 ' OD1' ' CB ' ' A' ' 23' ' ' PHE . 13.1 t0 -52.51 -42.13 64.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 103' ' ' ASP . 80.5 mt -36.62 141.04 0.39 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -18.89 36.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.79 152.68 56.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.674 0.75 . . . . 0.0 110.859 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.73 134.82 28.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 107' ' ' PRO . 5.4 tp -33.95 -52.87 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.0 mt -73.86 127.0 89.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.634 0.731 . . . . 0.0 111.161 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.571 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.6 Cg_endo -69.76 143.93 52.4 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.272 . . . . 0.0 112.331 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.498 ' HA ' ' CG ' ' A' ' 114' ' ' HIS . 4.1 m-85 -59.71 -32.16 70.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 t -59.29 -24.07 62.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.571 HD12 ' HG2' ' A' ' 110' ' ' PRO . 18.1 mt -117.64 30.21 7.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.498 ' CG ' ' HA ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -75.03 -62.42 0.87 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.642 0.734 . . . . 0.0 110.849 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.4 Cg_endo -69.78 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -81.04 -30.76 34.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mt -74.22 -38.15 63.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.544 HD23 HG21 ' A' ' 200' ' ' VAL . 10.2 mt -75.39 -59.81 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -40.35 -33.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.509 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -84.27 -33.99 23.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.076 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -67.16 -26.39 66.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -87.0 26.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 95.3 mt -95.64 130.76 30.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 111.182 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -46.63 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 0.0 112.372 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 61.9 m-20 -60.39 91.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 125' ' ' ASP . 32.8 tttt -34.7 -56.49 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.0 m -53.1 -58.58 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.65 -57.73 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -39.92 -56.96 1.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.2 mt -55.76 -56.77 16.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -48.64 -38.48 21.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.509 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -63.34 -40.03 96.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.5 mt -77.19 -24.35 51.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 138' ' ' LYS . 40.1 tttp -81.67 -23.62 36.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.04 -33.9 16.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.546 HG22 ' HE1' ' A' ' 140' ' ' PHE . 48.5 mt -74.83 -26.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.602 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.1 p -77.93 -11.16 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 134' ' ' LYS . 27.9 mttm -74.74 -41.7 59.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -81.39 19.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.1 m-85 -80.73 138.03 36.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.6 t-80 -38.06 142.64 0.45 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.75 -7.72 21.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.362 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 28' ' ' GLN . 92.8 t -99.75 -39.11 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.77 -46.48 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.467 ' CE2' ' O ' ' A' ' 137' ' ' VAL . 1.3 t80 -41.83 -54.56 3.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.34 -65.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 151' ' ' VAL . 66.3 t -50.52 -40.58 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.575 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 3.9 t80 -51.07 -48.54 61.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -58.14 -58.35 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.429 ' CE2' HG21 ' A' ' 45' ' ' VAL . 37.8 t80 -52.58 -45.06 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 147' ' ' VAL . 94.8 t -56.51 -66.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.66 HG23 HG12 ' A' ' 205' ' ' ILE . 64.3 mt -54.22 -56.16 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.9 m -41.09 -34.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -76.89 -42.73 38.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.632 HD13 HD11 ' A' ' 205' ' ' ILE . 30.5 mt -60.81 -51.83 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -45.12 -44.27 10.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 56.7 mtt-85 -56.96 -50.47 72.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.23 -50.17 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 p -51.58 -29.67 18.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 157' ' ' ARG . 35.2 mm-40 -46.51 -57.39 4.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -100.58 41.63 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.511 ' ND1' HG22 ' A' ' 168' ' ' THR . 27.3 p80 -57.81 -21.44 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -71.06 -34.15 70.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.83 -58.76 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.088 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -79.58 12.84 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 15.2 mt 38.11 53.86 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.435 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 19.7 mmm -148.53 108.05 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.511 HG22 ' ND1' ' A' ' 162' ' ' HIS . 30.5 p -92.22 166.77 12.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -53.27 -34.25 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.439 ' CG ' ' HG3' ' A' ' 202' ' ' GLU . 1.1 m-20 -70.38 -48.49 56.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -55.82 -35.9 66.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 169' ' ' ALA . 8.6 mt -69.8 -46.9 64.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.2 t -53.9 -38.96 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.403 HG12 ' CD ' ' A' ' 198' ' ' GLN . 15.7 mt -78.95 -33.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.6 m -70.58 -25.6 63.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.51 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 21.4 m-85 -97.72 -16.8 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.564 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -46.69 -47.16 50.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.567 0.699 . . . . 0.0 110.901 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.1 Cg_exo -48.03 -48.6 15.95 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.692 2.262 . . . . 0.0 112.31 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 180' ' ' LEU . 76.0 m -84.02 -64.48 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 179' ' ' THR . 49.8 mt -34.61 -63.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 46.2 mmm -111.16 117.37 33.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.4 ' HD3' ' N ' ' A' ' 183' ' ' PRO . 1.3 tmt_? -42.55 132.18 2.86 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.4 ' N ' ' HD3' ' A' ' 182' ' ' ARG . 53.7 Cg_endo -69.74 120.49 7.27 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.668 2.245 . . . . 0.0 112.373 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.58 130.89 38.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -78.58 -52.12 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.77 93.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -118.54 150.04 40.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -155.21 145.59 22.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -153.53 168.25 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -164.65 118.49 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 62.7 mt 38.59 42.32 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 67.1 m -150.38 153.21 35.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 8.2 t -90.05 -23.04 21.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.168 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 194' ' ' THR . 21.5 m 43.06 42.73 3.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -92.97 39.64 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 36.5 mt -86.4 -56.79 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.452 ' ND1' HD21 ' A' ' 118' ' ' LEU . 53.3 m-70 -42.58 -60.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.403 ' CD ' HG12 ' A' ' 174' ' ' ILE . 93.2 mt-30 -49.64 -44.52 47.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.0 m -60.64 -42.71 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.544 HG21 HD23 ' A' ' 118' ' ' LEU . 90.9 t -38.08 -69.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 202' ' ' GLU . 60.3 t -62.32 -55.88 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.439 ' HG3' ' CG ' ' A' ' 170' ' ' ASP . 2.1 tm-20 -37.88 -40.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 204' ' ' PHE . 65.8 m -64.9 -60.87 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.12 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' CYS . 12.3 m-85 -34.11 -54.11 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.66 HG12 HG23 ' A' ' 152' ' ' ILE . 68.0 mt -61.85 -56.59 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -46.38 -49.65 17.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.7 mm-40 -109.51 34.19 3.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 4.2 t -65.79 -19.72 65.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.889 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -84.94 -54.98 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.87 -38.63 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -47.47 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.13 -53.7 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -58.5 -25.12 62.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 58.68 43.15 19.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -87.36 144.17 19.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 215' ' ' GLY . 10.1 mm-40 -35.14 149.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.474 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.6 mt -74.29 133.81 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.176 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.5 172.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 t -168.25 147.95 4.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.872 0.367 . . . . 0.0 110.85 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.0 p -148.13 179.7 7.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.8 -153.78 6.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 t -169.73 175.9 5.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 110.867 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 t -159.44 178.39 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.49 170.22 29.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.502 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.9 138.28 6.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 10' ' ' PHE . 5.8 p-10 -120.69 141.6 50.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 9' ' ' ASN . 15.5 m-85 -167.7 116.74 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.841 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -116.43 143.59 31.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.649 0.738 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 161.26 46.63 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.637 2.225 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 153.34 69.04 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.701 2.268 . . . . 0.0 112.313 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -127.03 155.12 43.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -75.63 -179.56 4.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -61.7 109.22 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -104.74 31.5 4.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -88.02 49.55 1.82 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.952 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -113.09 107.15 15.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -119.39 175.68 5.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.06 33.25 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.646 ' CD2' HD22 ' A' ' 30' ' ' LEU . 5.6 m-85 -104.74 -39.16 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CG ' ' N ' ' A' ' 24' ' ' GLY . 11.4 p90 -52.77 -41.35 64.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' PHE . . . -67.59 -41.29 90.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.06 145.84 61.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.548 0.69 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 154.12 67.79 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.659 2.24 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 tp -47.54 -46.81 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.86 ' HB3' HG21 ' A' ' 143' ' ' VAL . 6.3 pt20 -53.07 -30.4 35.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -46.02 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.646 HD22 ' CD2' ' A' ' 22' ' ' TYR . 20.8 mt -59.83 -44.11 94.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG11 ' O ' ' A' ' 36' ' ' PRO . 5.2 m -90.43 171.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 p -118.95 156.26 29.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -46.9 -45.97 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -59.66 -46.21 89.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -126.58 86.73 57.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.551 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.3 Cg_endo -69.81 -29.89 22.91 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.684 2.256 . . . . 0.0 112.361 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.492 HG23 ' HD2' ' A' ' 38' ' ' PRO . 7.8 mt -84.16 134.51 43.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 111.154 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.71 146.81 61.62 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.538 HD11 ' CE ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -67.17 -40.81 86.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -51.6 -60.88 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG13 HD11 ' A' ' 97' ' ' LEU . 74.1 t -49.24 -63.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -40.61 -55.43 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.538 ' CE ' HD11 ' A' ' 39' ' ' LEU . 40.9 mmtt -55.87 -41.21 74.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.683 ' HB2' HD13 ' A' ' 97' ' ' LEU . 94.5 m -61.33 -40.71 95.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.656 HG13 ' CG ' ' A' ' 154' ' ' HIS . 25.2 t -71.22 -54.85 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -50.33 -33.69 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' A' ' 93' ' ' VAL . 19.5 t80 -60.74 -62.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.8 mt -47.34 -43.04 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.14 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.95 -26.51 59.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.35 -22.4 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -110.75 11.62 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 164.02 6.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HG ' HG22 ' A' ' 158' ' ' VAL . 1.7 mm? -107.83 75.15 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -25.08 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -51.34 117.22 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.33 117.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.7 94.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.471 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -101.75 -34.73 9.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.7 -63.96 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.618 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.34 -16.22 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.618 HG23 ' CD ' ' A' ' 60' ' ' ARG . 76.2 t -101.57 120.28 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.4 p -98.44 120.76 39.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.19 -161.06 10.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.459 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -80.18 126.92 31.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.918 0.39 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 36.3 tptt -43.96 -29.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -57.46 -43.44 83.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . 6.2 m-20 -54.66 -60.49 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.845 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -59.92 -44.78 94.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -41.62 -49.5 4.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 16.1 p30 -73.17 -34.78 66.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 68' ' ' GLN . 52.1 mt -55.4 -45.97 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -79.57 -48.63 13.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -57.46 -59.27 5.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -50.26 -48.24 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.4 ' O ' ' O ' ' A' ' 78' ' ' ASP . 40.8 t80 -50.01 -56.05 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -54.59 -33.11 59.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -81.72 -18.41 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 75' ' ' PHE . 5.2 t0 -149.53 118.87 6.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -83.75 -24.23 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -98.57 36.38 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.771 HD11 ' SD ' ' A' ' 86' ' ' MET . 6.0 tt -79.73 151.76 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -124.24 94.53 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.7 mt -40.55 -44.39 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.0 t -49.05 -47.88 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 t -58.11 -43.22 87.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.771 ' SD ' HD11 ' A' ' 81' ' ' ILE . 85.4 mtp -59.03 -36.13 74.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 59.28 44.75 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -80.18 173.84 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.9 p -69.11 111.88 5.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.5 t -37.44 -50.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -45.36 -45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 67' ' ' ASP . . . -52.37 -63.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 47' ' ' PHE . 95.5 t -45.83 -44.85 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.95 -38.59 67.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.58 -56.29 3.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 68' ' ' GLN . . . -45.87 -36.92 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 111.099 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 44' ' ' CYS . 16.8 tp -60.08 -47.39 86.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -65.96 -38.73 89.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.44 -36.87 55.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.093 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -62.9 -40.69 98.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.53 ' HB2' HG21 ' A' ' 179' ' ' THR . 5.1 m-85 -63.02 -41.68 99.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.07 80.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -34.31 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -41.48 147.4 0.48 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -28.71 24.8 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.94 139.47 16.07 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.605 0.717 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.9 Cg_endo -69.77 136.51 33.16 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.674 2.249 . . . . 0.0 112.321 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.45 HD23 ' CD1' ' A' ' 148' ' ' PHE . 5.5 mp -34.97 -49.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.2 mt -91.51 107.41 21.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 0.0 111.133 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.497 ' HG2' HD12 ' A' ' 113' ' ' LEU . 54.1 Cg_endo -69.72 149.42 67.15 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.407 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.48 -27.42 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 m -66.02 -8.19 21.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.497 HD12 ' HG2' ' A' ' 110' ' ' PRO . 70.4 mt -128.39 21.7 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.501 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -67.93 -60.13 5.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 0.0 110.81 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.516 ' HA ' HD12 ' A' ' 118' ' ' LEU . 53.7 Cg_endo -69.78 -25.15 28.8 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.93 -27.35 67.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.778 ' HB3' HG11 ' A' ' 200' ' ' VAL . 3.4 mt -78.77 -18.71 53.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.941 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.532 HD23 HG21 ' A' ' 200' ' ' VAL . 10.6 mt -92.56 -47.83 6.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -48.29 -40.37 24.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.599 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -83.73 -20.47 33.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -77.61 -21.79 51.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -93.8 17.87 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 128' ' ' GLU . 96.5 mt -81.73 129.58 64.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 111.145 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -44.79 1.87 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.317 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.2 t70 -67.02 94.08 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.838 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.0 tptp -34.64 -50.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.2 m -52.5 -57.76 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.498 ' HB2' HG21 ' A' ' 123' ' ' ILE . 17.8 mm-40 -56.74 -49.18 75.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -45.74 -53.98 8.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.431 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 37.3 mt -65.57 -62.24 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -41.82 -28.65 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.599 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -75.52 -50.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 13.5 mt -65.77 -22.81 66.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 137' ' ' VAL . 39.7 tttp -81.94 -30.61 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.926 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -85.89 -29.75 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.478 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 11.1 p -86.66 -6.48 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -77.78 -41.57 36.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -16.06 62.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.1 m-85 -46.82 151.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.9 t-80 -42.46 138.32 2.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.74 -20.72 34.59 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.35 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.86 HG21 ' HB3' ' A' ' 28' ' ' GLN . 43.4 t -92.27 -44.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.406 HD22 HD12 ' A' ' 108' ' ' LEU . 2.7 m120 -73.9 -48.06 33.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -39.24 -53.71 1.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -47.65 -48.93 28.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 151' ' ' VAL . 30.5 t -69.26 -57.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.159 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.488 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 10.7 t80 -42.24 -45.5 4.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -60.85 -53.59 55.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -54.57 -43.83 72.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 147' ' ' VAL . 82.0 t -52.61 -62.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.154 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.49 ' HA ' HD12 ' A' ' 155' ' ' LEU . 3.3 mt -46.49 -51.13 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.4 m -40.93 -37.91 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.656 ' CG ' HG13 ' A' ' 45' ' ' VAL . 84.6 t60 -80.26 -39.2 29.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.575 HD21 ' CE2' ' A' ' 176' ' ' PHE . 96.6 mt -54.52 -45.85 73.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.22 -49.82 60.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -51.79 -53.24 42.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.43 HG22 ' HG ' ' A' ' 53' ' ' LEU . 41.0 t -60.24 -35.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.8 p -66.24 -22.34 66.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -73.98 -31.59 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.476 HE21 HD12 ' A' ' 164' ' ' ILE . 3.1 mm100 -95.78 27.7 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.519 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 11.1 p80 -60.11 -16.47 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.827 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 14.0 mmmt -86.5 -5.53 59.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.476 HD12 HE21 ' A' ' 161' ' ' GLN . 26.2 mt -115.33 -60.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.37 9.31 11.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.8 mt 47.46 43.95 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 23.2 mtp -129.96 106.26 8.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.473 HG22 ' CG ' ' A' ' 162' ' ' HIS . 78.1 p -97.57 151.24 20.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.77 -35.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 168' ' ' THR . 2.1 t70 -66.04 -60.45 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -47.81 -49.07 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 7.4 mt -62.13 -49.06 77.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 t -51.71 -43.57 62.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -77.0 -38.01 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.19 -16.0 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.575 ' CE2' HD21 ' A' ' 155' ' ' LEU . 9.9 m-85 -107.16 -11.72 15.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.565 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.23 -46.77 93.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.526 0.679 . . . . 0.0 110.896 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.0 -63.59 0.3 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.53 HG21 ' HB2' ' A' ' 101' ' ' PHE . 28.9 m -67.04 -57.97 5.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 179' ' ' THR . 39.9 mt -34.22 -51.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.432 ' SD ' ' CZ2' ' A' ' 177' ' ' TRP . 0.6 OUTLIER -152.52 119.2 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.427 ' CG ' ' HD2' ' A' ' 183' ' ' PRO . 42.7 ttm-85 -61.4 138.18 94.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 182' ' ' ARG . 54.1 Cg_endo -69.73 142.57 48.44 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.676 2.25 . . . . 0.0 112.36 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -42.4 147.53 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -38.21 -43.2 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -146.56 147.84 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -115.3 121.7 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 154.45 39.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -94.64 106.09 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -146.15 161.6 39.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 61.1 mt -44.11 112.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 56.9 p -87.28 51.91 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 16.6 p -80.28 -53.44 6.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 194' ' ' THR . 10.8 t -79.56 117.22 20.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -119.25 73.48 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 200' ' ' VAL . 71.4 mt -92.82 -37.99 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.475 ' HA ' HD21 ' A' ' 118' ' ' LEU . 32.8 m80 -41.35 -47.95 3.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -73.43 -56.24 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.0 m -42.09 -39.34 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 196' ' ' ILE . 58.2 t -46.6 -72.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' PHE . 68.9 t -55.04 -57.34 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -39.84 -36.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 60.3 m -69.86 -39.05 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.189 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' VAL . 12.2 m-85 -55.53 -41.79 73.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.15 -54.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.06 -56.17 25.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.431 ' HG3' ' CD2' ' A' ' 130' ' ' LEU . 38.4 mm-40 -81.9 16.9 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.583 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 18.2 t -58.55 -22.74 56.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.92 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.582 ' N ' ' CD ' ' A' ' 209' ' ' GLN . 0.2 OUTLIER -78.59 -62.51 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -39.5 -39.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 17.4 m-30 -52.2 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -107.57 -52.17 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 209' ' ' GLN . 65.4 m-85 -62.22 -11.71 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 61.3 t30 45.78 41.04 7.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -70.46 -151.35 0.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.435 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.07 165.98 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.0 mt -75.56 121.57 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.9 175.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 p -143.68 135.63 26.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.888 0.375 . . . . 0.0 110.85 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 t -158.79 127.27 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.93 88.37 1.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.1 t -47.27 126.45 9.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.843 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.0 p -130.78 171.99 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.24 119.22 0.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -45.22 139.11 3.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -93.31 159.0 15.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 11' ' ' ASN . 1.9 p90 -120.47 173.32 7.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.411 ' O ' ' CD2' ' A' ' 10' ' ' PHE . 16.4 m120 -86.27 142.08 35.38 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.674 0.75 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 169.5 18.84 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -174.33 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.385 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.2 p -81.15 89.46 6.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -164.49 145.45 8.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.5 ttp-105 -138.12 161.92 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -123.05 27.01 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -115.69 94.02 4.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.73 124.45 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -118.57 -7.75 10.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 60.3 43.76 13.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 23' ' ' PHE . 4.2 p90 -134.95 -44.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' N ' ' CG ' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -67.87 125.86 27.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.896 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.81 -37.08 3.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.8 mmt -84.42 154.23 62.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.581 0.705 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 148.63 65.44 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.681 2.254 . . . . 0.0 112.327 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' VAL . 18.3 tp -64.78 -49.25 71.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HA ' HG11 ' A' ' 143' ' ' VAL . 11.1 pt20 -43.87 -37.2 2.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.91 -50.58 33.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.26 -45.49 83.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 27' ' ' LEU . 33.8 m -91.74 171.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.1 p -120.28 158.06 27.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.21 -46.27 45.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.51 -44.28 72.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -132.1 90.4 35.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.97 8.45 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.7 mt -72.8 130.25 85.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 147' ' ' VAL . 54.0 Cg_endo -69.79 108.8 2.16 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.316 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.492 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -36.04 -57.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 39' ' ' LEU . 31.0 t80 -34.21 -64.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 HD11 ' A' ' 97' ' ' LEU . 79.7 t -43.82 -59.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -42.91 -61.94 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 64.0 mmtt -43.53 -41.09 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.9 m -68.35 -41.35 80.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.487 HG13 ' CG ' ' A' ' 154' ' ' HIS . 76.3 t -65.94 -51.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.67 -45.28 93.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' A' ' 93' ' ' VAL . 32.5 t80 -45.69 -57.14 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.8 mt -45.27 -44.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.546 ' OE1' HD13 ' A' ' 53' ' ' LEU . 19.0 mm-40 -62.4 -57.41 11.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.65 -39.38 35.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -84.51 29.93 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.44 164.19 21.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.486 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.546 HD13 ' OE1' ' A' ' 49' ' ' GLU . 11.6 tp -126.81 41.04 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.748 0.309 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -124.38 37.99 4.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.6 m -98.75 128.38 44.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.36 145.75 29.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.75 45.24 4.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.535 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.509 ' H ' HD23 ' A' ' 58' ' ' LEU . 2.2 pt? -58.41 -37.96 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.45 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 60.7 m-85 -99.18 -51.95 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -44.03 -54.24 5.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.4 t -69.79 135.64 27.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.18 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.8 p -79.84 -44.85 19.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.76 -163.15 53.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -59.52 178.22 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.956 0.408 . . . . 0.0 110.871 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -119.3 -46.84 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.7 m -47.67 -63.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.512 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 2.5 m-20 -41.26 -61.23 1.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.863 ' HA ' HD12 ' A' ' 71' ' ' ILE . 11.9 mt-30 -40.8 -40.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -67.17 -50.41 61.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -50.29 -47.22 55.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.863 HD12 ' HA ' ' A' ' 68' ' ' GLN . 28.4 mt -44.77 -43.9 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.118 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -82.82 -52.26 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -52.85 -62.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.27 -45.65 34.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.57 -44.23 97.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -63.32 -53.3 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -52.25 -39.27 60.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.23 152.58 22.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.78 -22.19 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.84 51.73 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.0 pt -107.19 -174.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 2.1 t-20 -151.03 119.32 6.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.26 -50.87 64.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.54 -40.92 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 68.6 m -60.39 -45.49 93.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.3 mtp -52.74 -32.44 43.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 60.86 45.66 9.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.01 168.87 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 90' ' ' VAL . 24.9 p -75.29 116.33 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 89' ' ' THR . 85.2 t -33.75 -54.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.092 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -36.12 -57.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -39.04 -59.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 47' ' ' PHE . 96.9 t -46.01 -55.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -46.17 -44.48 16.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.24 -60.26 6.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.511 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.05 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HG13 ' A' ' 41' ' ' VAL . 23.5 tp -53.47 -48.94 68.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 101' ' ' PHE . 29.7 mtmt -69.26 -52.5 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.8 -42.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.123 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -59.16 -47.74 84.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' LYS . 16.2 m-85 -56.18 -51.45 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.48 71.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 104' ' ' LEU . 64.4 m-20 -51.3 -42.77 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.6 mt -34.22 142.26 0.23 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -22.89 31.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -134.7 152.93 78.5 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.582 0.706 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 132.06 22.47 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.34 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -38.47 -47.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 mt -91.87 121.31 67.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 0.0 111.15 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.63 40.86 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -54.68 -34.31 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE1' ' A' ' 116' ' ' GLU . 22.2 m -55.56 -29.15 58.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.2 mt -110.8 36.16 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.544 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -79.13 -65.49 0.3 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.632 0.73 . . . . 0.0 110.879 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.679 ' HA ' HD12 ' A' ' 118' ' ' LEU . 54.3 Cg_endo -69.74 -31.89 19.72 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.382 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 112' ' ' SER . 24.5 mp0 -60.47 -35.38 75.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.544 HD11 ' HZ ' ' A' ' 140' ' ' PHE . 12.1 mt -72.14 -39.46 68.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.679 HD12 ' HA ' ' A' ' 115' ' ' PRO . 4.9 mt -70.45 -55.48 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 13.6 pt-20 -46.82 -36.22 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -75.99 -25.78 56.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -78.15 -28.68 48.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 119' ' ' GLU . 2.4 pttt -90.47 27.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.525 HG23 ' HD2' ' A' ' 124' ' ' PRO . 89.0 mt -89.5 135.18 31.26 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.654 0.74 . . . . 0.0 111.109 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.525 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.82 -48.64 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.647 2.231 . . . . 0.0 112.345 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -66.15 95.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 125' ' ' ASP . 14.1 tptm -36.82 -53.44 0.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 50.7 m -52.23 -51.32 59.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -60.31 -49.05 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -47.2 -49.7 22.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.93 -62.65 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -40.43 -50.84 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.29 48.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.03 -34.12 76.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.55 ' O ' HG12 ' A' ' 137' ' ' VAL . 23.0 tttm -68.32 -35.93 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 4.0 pt-20 -81.8 -32.7 31.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.474 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 51.0 mt -73.2 -34.77 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 134' ' ' LYS . 8.4 p -67.35 -18.6 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.88 -34.48 75.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -66.95 -34.97 78.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.544 ' HZ ' HD11 ' A' ' 117' ' ' LEU . 11.8 m-85 -42.66 132.39 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -33.47 142.68 0.19 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.82 -16.94 37.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 28' ' ' GLN . 91.9 t -90.94 -39.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.15 -38.26 24.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.418 ' CZ ' ' HD3' ' A' ' 149' ' ' ARG . 46.3 t80 -52.47 -42.26 64.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.97 -42.44 80.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.84 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 151' ' ' VAL . 98.9 t -74.31 -44.37 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.581 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 26.2 t80 -58.76 -40.92 85.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.854 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.418 ' HD3' ' CZ ' ' A' ' 145' ' ' TYR . 47.2 ttp180 -67.62 -49.95 60.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -60.8 -47.66 85.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 147' ' ' VAL . 93.2 t -50.83 -65.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.139 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.839 HG23 HG12 ' A' ' 205' ' ' ILE . 75.8 mt -41.97 -50.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -40.51 -40.8 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.487 ' CG ' HG13 ' A' ' 45' ' ' VAL . 85.7 t60 -73.46 -40.14 64.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 152' ' ' ILE . 51.1 mt -59.65 -44.03 93.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.454 ' HB2' HG23 ' A' ' 205' ' ' ILE . 0.4 OUTLIER -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -58.93 -48.22 82.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.5 t -55.04 -46.86 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.3 p -56.57 -29.43 62.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -47.48 -56.35 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -100.45 33.73 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.598 ' CE1' ' HD3' ' A' ' 163' ' ' LYS . 7.3 p80 -51.62 -19.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.598 ' HD3' ' CE1' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -55.31 -34.68 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.49 -56.46 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -27.16 68.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 75.8 mt 64.12 39.4 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.6 mmm -131.52 82.75 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 32.8 p -71.99 163.43 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.14 -46.74 5.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.437 ' OD1' HD11 ' A' ' 174' ' ' ILE . 6.7 t70 -60.25 -59.61 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -47.53 -50.01 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.35 -47.75 78.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.6 t -59.1 -44.58 91.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.437 HD11 ' OD1' ' A' ' 170' ' ' ASP . 57.9 mt -70.25 -31.49 47.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 48.9 t -70.79 -34.8 72.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.483 ' CE1' HD21 ' A' ' 155' ' ' LEU . 22.7 m-85 -90.23 -15.55 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.559 ' CZ3' ' HG2' ' A' ' 181' ' ' MET . 0.8 OUTLIER -47.55 -46.67 60.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.926 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.3 Cg_exo -48.04 -51.66 9.58 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.461 ' O ' ' C ' ' A' ' 180' ' ' LEU . 89.6 m -76.44 -63.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 179' ' ' THR . 87.4 mt -33.49 -70.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.559 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 2.3 ttm -100.03 112.04 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.433 ' HA ' ' HD2' ' A' ' 183' ' ' PRO . 38.0 ttm-85 -112.7 103.34 55.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 182' ' ' ARG . 53.3 Cg_endo -69.8 134.63 28.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 0.0 112.343 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 185' ' ' PHE . 4.9 m-20 -107.02 100.62 10.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 184' ' ' ASP . 4.7 t80 37.17 39.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -146.47 136.66 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.855 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -130.3 173.25 10.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -97.25 126.49 42.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -40.91 125.1 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -47.14 127.37 10.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.4 mt -152.08 176.39 11.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 193' ' ' THR . 39.8 t -49.18 153.08 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 192' ' ' SER . 4.0 t -34.06 117.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 23.9 m -117.19 89.21 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -101.98 33.42 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 200' ' ' VAL . 75.9 mt -83.89 -50.79 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.457 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 48.4 m-70 -39.08 -63.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -51.91 -58.08 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.3 m -43.37 -44.16 5.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 196' ' ' ILE . 48.1 t -46.25 -68.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.53 -47.32 93.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -46.32 -48.71 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.1 m -57.42 -57.87 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.457 ' C ' ' O ' ' A' ' 203' ' ' THR . 10.2 m-85 -33.98 -49.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.839 HG12 HG23 ' A' ' 152' ' ' ILE . 49.9 mt -70.39 -50.67 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -48.5 -45.45 37.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 9.4 mm-40 -117.44 36.92 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.572 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 22.9 t -64.1 -30.74 71.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -75.13 -51.67 12.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -43.82 -37.04 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -51.19 -63.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -101.25 -56.7 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -56.26 -38.04 70.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 73.18 42.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.886 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.3 169.29 53.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -58.82 136.05 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.429 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 66.3 mt -61.39 121.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -94.15 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.861 0.276 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.627 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.4 tp -51.1 -42.6 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.25 -31.78 22.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -85.51 -44.63 12.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.84 -46.84 84.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 27' ' ' LEU . 17.7 m -88.05 171.54 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 p -124.15 165.64 17.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.37 65.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.49 -47.82 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -126.82 91.74 46.38 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.6 0.714 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -30.53 21.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.686 2.257 . . . . 0.0 112.329 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.526 HG23 ' HD2' ' A' ' 38' ' ' PRO . 14.7 mt -84.3 135.22 41.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.63 0.729 . . . . 0.0 111.129 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 130.32 19.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.635 HD21 ' HE2' ' A' ' 43' ' ' LYS . 5.4 tp -52.2 -53.19 46.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' LEU . 16.8 t80 -36.27 -56.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 HD11 ' A' ' 97' ' ' LEU . 53.0 t -54.45 -62.63 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -47.68 -59.74 3.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.635 ' HE2' HD21 ' A' ' 39' ' ' LEU . 24.5 mmtm -44.43 -36.59 2.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.3 m -75.24 -38.38 60.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -72.9 -60.12 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -54.02 -32.9 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -63.28 -57.67 9.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.9 mt -50.35 -53.54 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.42 -45.04 85.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.58 -41.23 97.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.7 p -89.05 23.35 2.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.65 135.43 4.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.456 ' CD2' ' HB3' ' A' ' 157' ' ' ARG . 15.1 tp -103.72 35.48 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.7 ' HB2' HG21 ' A' ' 164' ' ' ILE . 15.1 p -121.63 40.34 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.625 HG21 ' HB ' ' A' ' 90' ' ' VAL . 18.4 m -92.28 112.31 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.7 tt0 -34.76 120.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.14 77.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.613 HD21 HG11 ' A' ' 158' ' ' VAL . 1.6 pt? -61.25 -29.05 69.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -108.41 -49.62 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -49.63 -49.78 45.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.9 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.809 0.337 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -51.0 -45.74 61.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.605 ' HA ' HD12 ' A' ' 71' ' ' ILE . 64.2 mt-30 -65.11 -35.03 79.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.93 -58.4 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.0 p30 -64.35 -36.05 82.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 68' ' ' GLN . 57.4 mt -54.3 -47.35 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -78.25 -40.08 38.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -64.7 -67.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -44.99 -45.65 10.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.87 -34.92 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.9 -52.04 48.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.57 -21.56 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -145.47 113.82 6.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -84.6 -3.23 58.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -101.91 23.53 11.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.458 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 6.0 tt -68.97 156.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.458 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 6.6 t30 -125.94 91.63 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASN . 84.3 mt -36.94 -48.06 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -51.47 -48.71 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -54.39 -39.57 67.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.406 ' HB3' HG13 ' A' ' 88' ' ' VAL . 40.8 mmm -66.97 -32.44 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 56.94 47.22 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' A' ' 86' ' ' MET . 31.6 m -81.45 179.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.599 HG23 ' H ' ' A' ' 92' ' ' ALA . 9.2 t -87.55 127.42 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.625 ' HB ' HG21 ' A' ' 55' ' ' THR . 93.9 t -40.19 -47.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -48.31 -40.47 25.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.599 ' H ' HG23 ' A' ' 89' ' ' THR . . . -62.76 -61.99 2.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.6 -38.28 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' LEU . . . -57.75 -50.09 74.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.19 -49.81 64.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.21 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HG13 ' A' ' 41' ' ' VAL . 34.2 tp -58.86 -46.56 87.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' ALA . 30.0 mtmt -67.24 -52.01 46.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.45 -45.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -53.45 -53.42 51.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CB ' HG21 ' A' ' 179' ' ' THR . 34.9 m-85 -58.15 -33.61 69.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -28.58 64.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LEU . 1.9 t70 -75.22 -31.57 60.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' ASP . 67.2 mt -35.72 143.51 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.743 2.295 . . . . 0.0 112.283 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -139.05 154.28 72.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.639 0.733 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.6 Cg_endo -69.82 130.09 18.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.309 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.434 HD21 ' CD1' ' A' ' 148' ' ' PHE . 12.0 tp -35.73 -51.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -91.95 126.33 53.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.669 0.747 . . . . 0.0 111.155 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.466 ' CG ' HD12 ' A' ' 113' ' ' LEU . 53.2 Cg_endo -69.81 161.49 45.75 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -78.95 -11.49 60.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.429 ' O ' HD23 ' A' ' 113' ' ' LEU . 30.9 t -88.67 5.45 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 117' ' ' LEU . 80.0 mt -133.96 19.85 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.5 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.2 m170 -71.09 -60.11 3.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.56 0.695 . . . . 0.0 110.855 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.76 -27.13 26.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.363 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.79 -32.14 72.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.4 mt -77.27 -34.38 55.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.456 HD21 ' CG ' ' A' ' 197' ' ' HIS . 9.6 mt -78.95 -44.04 23.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.2 -23.66 62.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.64 -9.48 29.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.486 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -95.18 -28.79 14.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -80.98 -3.44 51.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.652 HG23 ' HD2' ' A' ' 124' ' ' PRO . 67.4 mt -56.37 138.29 75.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.652 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.84 -50.71 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.649 2.232 . . . . 0.0 112.324 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.99 107.36 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -46.32 -52.21 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -55.09 -61.39 2.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.29 -45.87 17.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -50.18 -42.58 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.406 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 43.7 mt -70.75 -42.34 70.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -60.66 -54.52 44.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.88 62.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.68 -24.89 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -78.26 -30.06 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.7 -31.48 18.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -38.11 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.089 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.23 -8.69 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -76.06 -28.85 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -73.04 -19.32 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -53.53 137.54 36.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.537 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.8 t-80 -38.69 141.58 0.57 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 110.896 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.77 -8.81 24.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 0.0 112.374 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.505 HG12 HD23 ' A' ' 27' ' ' LEU . 20.3 t -99.12 -42.25 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -85.56 -29.85 23.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -52.41 -48.79 65.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.32 -50.96 69.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.407 HG22 ' HD2' ' A' ' 38' ' ' PRO . 61.2 t -60.46 -59.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 13.5 t80 -40.4 -40.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -69.74 -48.19 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.18 -48.91 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.54 -64.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.905 HG23 HG12 ' A' ' 205' ' ' ILE . 92.0 mt -48.52 -49.21 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.0 m -40.45 -34.87 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.423 ' CE1' HD11 ' A' ' 53' ' ' LEU . 40.2 t60 -80.1 -45.95 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.634 HD12 ' HA ' ' A' ' 152' ' ' ILE . 59.1 mt -49.58 -49.17 47.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -48.26 -41.09 26.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.456 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 98.7 mtt180 -64.34 -36.81 85.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.613 HG11 HD21 ' A' ' 58' ' ' LEU . 59.5 t -68.47 -42.48 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.6 p -62.64 -30.74 71.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -60.84 -50.32 73.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -98.01 38.96 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.549 ' CE1' ' HD2' ' A' ' 163' ' ' LYS . 2.1 p80 -56.04 -31.65 63.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.549 ' HD2' ' CE1' ' A' ' 162' ' ' HIS . 12.5 mptt -53.74 -22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.7 HG21 ' HB2' ' A' ' 54' ' ' CYS . 15.6 mt -100.65 -58.69 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -80.08 11.57 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 162' ' ' HIS . 6.6 mt 34.71 46.35 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.9 mmm -142.58 120.93 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.6 p -105.47 177.32 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.03 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -46.55 66.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -59.58 -46.97 87.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.62 -41.22 98.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.6 p -58.75 -28.52 65.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.2 mt -86.81 -42.25 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.31 -16.93 57.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.414 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 14.3 m-85 -107.95 -7.13 16.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.576 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.2 t90 -51.68 -45.45 91.55 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.939 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -48.0 -65.44 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.552 HG21 ' CB ' ' A' ' 101' ' ' PHE . 8.4 m -61.17 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 179' ' ' THR . 86.9 mt -34.35 -44.61 0.2 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 3.9 mtt -146.91 119.9 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.841 -179.923 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 200' ' ' VAL . 30.7 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.857 0.36 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.54 ' H ' ' CD2' ' A' ' 197' ' ' HIS . 16.6 m-70 -47.8 -66.42 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 197' ' ' HIS . 0.6 OUTLIER -37.42 -48.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.4 t -55.26 -48.19 74.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.851 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.486 HG22 ' CB ' ' A' ' 121' ' ' ALA . 23.1 t -45.49 -69.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.82 -61.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -44.0 -47.55 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 204' ' ' PHE . 70.7 m -54.16 -62.71 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' CYS . 14.1 m-85 -34.66 -52.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.905 HG12 HG23 ' A' ' 152' ' ' ILE . 61.1 mt -60.6 -59.97 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -45.88 -48.92 15.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.443 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 8.8 mm-40 -106.2 31.4 5.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.561 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 6.4 t -67.26 -21.15 65.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.48 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 74.4 mm-40 -87.07 -54.3 4.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.92 -36.55 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -49.53 -62.92 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -106.75 -54.36 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.48 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 65.4 m-85 -55.46 -30.88 61.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 70.85 27.83 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -68.51 137.48 30.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.5 mt-10 -37.9 154.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.06 112.57 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.82 173.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.841 0.267 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' O ' HG22 ' A' ' 31' ' ' VAL . 22.5 tp -53.06 -39.79 63.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.469 ' HB3' HG21 ' A' ' 143' ' ' VAL . 9.7 pt20 -55.21 -29.4 57.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.17 -40.85 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.55 -44.04 88.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 27' ' ' LEU . 21.2 m -81.42 173.45 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 p -111.75 143.71 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.63 3.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.22 -43.47 98.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -131.68 106.17 14.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.54 0.686 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.405 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.8 Cg_endo -69.77 -35.44 12.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.623 2.215 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.84 130.03 79.7 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.723 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.77 68.41 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.473 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.87 -47.97 78.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -45.34 -63.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.0 t -48.45 -53.77 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 150' ' ' TYR . 15.3 mm-40 -48.95 -55.84 10.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 50.6 mmtt -50.51 -41.16 53.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.8 m -63.56 -43.55 96.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 150' ' ' TYR . 44.4 t -66.64 -61.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 47' ' ' PHE . 10.6 pt-20 -53.11 -47.51 68.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.666 ' CE2' HG21 ' A' ' 93' ' ' VAL . 60.4 t80 -48.26 -64.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mt -38.55 -62.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -45.9 -47.83 16.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -56.46 -47.21 79.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -84.76 29.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.12 141.26 6.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -106.49 -14.32 15.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.7 p -84.48 34.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.896 ' HB ' HD21 ' A' ' 58' ' ' LEU . 36.7 m -68.73 157.05 37.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' N ' HG22 ' A' ' 55' ' ' THR . 1.8 mp0 -100.89 147.86 25.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' C ' ' HG2' ' A' ' 60' ' ' ARG . . . 48.01 75.87 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.48 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.896 HD21 ' HB ' ' A' ' 55' ' ' THR . 4.5 mm? -95.0 122.79 38.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.609 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 26.7 m-85 63.32 26.49 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HG2' ' C ' ' A' ' 57' ' ' GLY . 7.0 ptm180 -127.24 -10.16 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.2 -46.17 79.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 71' ' ' ILE . 43.5 mt-30 -70.19 -28.68 65.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.944 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.02 -60.96 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.1 p30 -53.92 -36.77 63.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 68' ' ' GLN . 50.2 mt -53.39 -56.6 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.55 -52.44 38.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -53.16 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -68.32 -29.79 68.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -68.66 -49.43 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -63.99 -33.0 74.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -158.67 156.07 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -105.71 -15.4 14.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -80.75 45.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.2 pt -106.0 177.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -142.48 130.04 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.71 -42.44 21.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.82 -44.12 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.7 t -64.95 -28.86 69.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.8 mmm -70.6 -33.61 71.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 62.35 34.59 15.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.82 156.66 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 p -67.66 146.88 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.3 t -53.22 -49.46 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -42.99 -49.94 5.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.4 -62.86 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.666 HG21 ' CE2' ' A' ' 47' ' ' PHE . 67.5 t -53.79 -50.23 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -52.79 -37.12 59.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.71 -49.29 7.26 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.0 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.71 -45.08 77.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 99' ' ' ALA . 20.9 mtmt -64.08 -53.43 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.01 -44.29 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -54.65 -54.03 46.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -57.07 -39.19 74.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.39 -35.79 82.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 104' ' ' LEU . 9.6 t0 -59.85 -40.45 88.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.9 mt -36.86 143.06 0.34 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.62 154.29 79.49 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.709 . . . . 0.0 110.851 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 108' ' ' LEU . 54.0 Cg_endo -69.78 131.14 20.59 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.37 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 107' ' ' PRO . 26.1 tp -35.73 -38.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -103.12 125.58 34.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 157.08 61.69 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.737 2.291 . . . . 0.0 112.327 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.406 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 2.9 m-85 -76.02 -22.1 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.6 m -72.3 -7.18 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -130.27 28.83 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.479 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 2.9 m170 -74.57 -61.97 1.04 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.859 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.6 Cg_endo -69.74 -23.36 30.98 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -67.55 -32.17 72.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.22 -33.53 69.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.525 HD23 HG21 ' A' ' 200' ' ' VAL . 6.3 mt -81.67 -55.64 4.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.77 -32.62 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.26 -26.8 23.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -79.46 -23.63 42.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -83.03 1.17 41.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 128' ' ' GLU . 91.7 mt -70.56 129.27 90.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.638 0.733 . . . . 0.0 111.113 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -47.05 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.343 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.7 m-20 -61.6 97.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -34.45 -50.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.4 m -55.68 -57.76 10.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.52 ' HB2' HG21 ' A' ' 123' ' ' ILE . 15.6 mt-10 -54.87 -44.8 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.83 -54.23 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 207' ' ' GLN . 21.7 mt -68.93 -62.21 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -38.68 -43.28 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.41 79.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.553 HD22 ' HE1' ' A' ' 204' ' ' PHE . 12.6 mt -67.31 -23.44 65.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.428 ' O ' HG12 ' A' ' 137' ' ' VAL . 4.2 ttpm? -78.54 -32.64 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -85.34 -34.4 21.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.55 -39.86 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 134' ' ' LYS . 5.4 p -62.57 -8.74 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -76.83 -30.35 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.85 -22.98 61.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 141' ' ' HIS . 5.6 m-85 -51.45 133.4 29.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 1.2 t-80 -35.03 141.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.2 Cg_endo -69.84 -13.12 34.05 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.715 2.276 . . . . 0.0 112.301 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 28' ' ' GLN . 26.2 t -95.0 -37.09 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -87.32 -38.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -45.06 -44.94 10.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -61.27 -56.27 22.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.07 -54.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.846 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 24.8 t80 -49.03 -45.52 42.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 149' ' ' ARG . 7.5 mtp-105 -64.2 -49.08 73.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.565 ' CE2' ' OE2' ' A' ' 42' ' ' GLU . 39.1 t80 -52.59 -45.29 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.923 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.03 -57.36 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.135 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.846 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 70.3 mt -49.66 -48.97 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -47.54 -39.87 17.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.521 ' O ' HG23 ' A' ' 158' ' ' VAL . 74.6 t60 -77.57 -31.24 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 152' ' ' ILE . 97.9 mt -66.03 -45.95 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -54.72 -38.63 67.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.455 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 84.2 mtt180 -65.59 -37.02 85.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 154' ' ' HIS . 46.5 t -68.91 -43.25 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.6 p -60.8 -40.08 91.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 34.9 mt-30 -48.13 -37.7 16.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.413 ' HB3' HD12 ' A' ' 164' ' ' ILE . 6.0 mm-40 -105.06 32.83 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 166' ' ' LEU . 12.4 p80 -51.19 -38.73 53.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 21.1 mmtp -57.44 -32.49 66.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 161' ' ' GLN . 52.7 mt -87.81 -58.26 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 55' ' ' THR . 10.6 m-20 -76.08 4.07 9.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 162' ' ' HIS . 13.5 mt 46.15 42.67 10.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 31.2 mmm -144.37 122.59 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.6 p -100.63 156.89 17.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.69 -37.64 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.31 -47.47 64.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -58.49 -38.4 77.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.57 -48.07 61.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.2 p -51.92 -48.76 64.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.0 mt -62.01 -39.4 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.59 -17.07 53.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.437 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 33.0 m-85 -109.43 -10.57 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.571 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -48.76 -46.47 72.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.54 0.686 . . . . 0.0 110.9 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.91 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 180' ' ' LEU . 16.5 m -61.08 -64.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 179' ' ' THR . 59.5 mt -36.96 -62.31 0.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 86.0 mtp -117.1 81.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.613 0.72 . . . . 0.0 110.839 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.75 ' O ' HG23 ' A' ' 200' ' ' VAL . 94.1 mt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -50.78 -72.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -47.85 -51.15 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.6 t -46.12 -42.22 13.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 196' ' ' ILE . 89.2 t -41.09 -70.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 202' ' ' GLU . 84.2 t -54.86 -59.66 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 201' ' ' VAL . 15.9 tt0 -35.85 -51.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 53.0 m -54.03 -57.9 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.671 ' HB3' HD13 ' A' ' 152' ' ' ILE . 8.1 m-85 -40.09 -34.37 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.553 ' HA ' HG23 ' A' ' 152' ' ' ILE . 66.9 mt -75.32 -59.84 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -53.93 -53.43 52.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.598 ' OE1' HG22 ' A' ' 218' ' ' VAL . 1.0 OUTLIER -84.63 18.91 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 19.3 t -60.6 -12.01 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 213' ' ' TYR . 14.9 mm-40 -95.96 -57.2 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -40.59 -38.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -49.63 -61.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -107.86 -53.96 2.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 209' ' ' GLN . 53.2 m-85 -58.06 -28.59 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 64.64 42.83 4.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.68 51.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -63.9 134.9 56.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.25 131.73 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.598 HG22 ' OE1' ' A' ' 207' ' ' GLN . 27.0 m -116.18 163.92 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.847 0.269 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 tp -55.41 -46.0 76.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -48.67 -35.57 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.63 -48.91 17.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.2 mt -56.03 -44.49 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 36' ' ' PRO . 4.5 m -90.76 171.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.5 p -108.12 144.03 36.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.94 -37.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.51 -42.19 95.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 17.7 mmtp -128.83 96.47 29.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.703 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HA ' HG21 ' A' ' 31' ' ' VAL . 54.0 Cg_endo -69.74 -24.65 29.54 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.8 mt -92.95 130.96 34.54 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 122.5 9.16 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -50.67 -27.43 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -62.3 -61.67 2.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.805 HG13 HD11 ' A' ' 97' ' ' LEU . 42.3 t -50.02 -50.94 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -51.83 -60.05 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 45.1 mmtt -44.3 -39.33 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HB2' HD13 ' A' ' 97' ' ' LEU . 95.2 m -67.5 -45.6 75.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.509 HG13 ' CG ' ' A' ' 154' ' ' HIS . 60.6 t -62.63 -59.54 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.26 -27.7 16.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -70.83 -54.33 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.466 HG22 ' CD1' ' A' ' 53' ' ' LEU . 42.8 mt -56.37 -20.5 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -91.06 -22.05 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.33 -17.62 22.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -82.56 18.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.144 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.38 -42.55 2.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.698 HD11 HG22 ' A' ' 158' ' ' VAL . 12.5 tp 64.7 44.0 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.1 p -133.16 30.0 3.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -90.93 127.84 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -60.39 120.76 10.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 48.71 76.04 0.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.812 HD23 ' H ' ' A' ' 58' ' ' LEU . 1.2 pt? -89.38 4.36 49.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.934 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.62 -48.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -59.05 -48.15 82.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.791 0.329 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.487 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -39.34 -58.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -50.59 -44.57 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.73 -51.0 70.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -50.97 -52.1 45.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 93' ' ' VAL . 85.3 mt -43.75 -46.46 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.12 -62.63 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ASP . 48.5 mttt -50.67 -64.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -39.41 -42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -71.66 -38.49 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' LYS . 11.1 t0 -65.33 -41.75 93.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.28 -31.57 71.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -166.89 148.35 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -94.66 -19.55 20.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -78.3 48.47 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 pt -109.98 -176.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.6 125.44 7.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -70.72 -46.69 62.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.01 -48.48 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -59.79 -43.81 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.474 ' HB3' HG13 ' A' ' 88' ' ' VAL . 89.9 mtp -59.25 -19.39 45.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 47.6 39.42 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' A' ' 86' ' ' MET . 31.3 m -72.71 164.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 p -74.88 131.89 41.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.3 t -44.36 -48.93 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -46.18 -40.21 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.77 -62.79 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.516 ' HA ' HD13 ' A' ' 71' ' ' ILE . 72.8 t -52.69 -36.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.85 72.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.57 -54.04 4.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.02 -44.39 61.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.805 HD11 HG13 ' A' ' 41' ' ' VAL . 34.0 tp -45.85 -43.67 13.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.11 -47.12 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -39.38 -45.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.25 -54.18 46.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.596 ' HB2' HG21 ' A' ' 179' ' ' THR . 76.3 m-85 -49.61 -47.22 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -54.49 -37.69 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.5 mt -41.45 141.01 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.657 0.741 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.13 32.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -133.25 150.6 75.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.881 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.24 37.47 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.336 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.1 tp -43.03 -53.84 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mt -85.42 124.09 72.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.559 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.79 149.02 66.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -70.43 -8.96 54.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.5 m -83.65 -12.46 55.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.848 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.628 HD13 ' CE1' ' A' ' 140' ' ' PHE . 43.0 mt -120.52 26.25 9.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.5 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.4 m170 -71.02 -60.12 3.04 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.78 -20.62 34.49 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.258 . . . . 0.0 112.328 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.404 ' O ' HD13 ' A' ' 136' ' ' ILE . 12.0 mp0 -70.89 -39.14 72.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.515 ' HB3' HG11 ' A' ' 200' ' ' VAL . 12.8 mt -72.09 -28.72 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.547 HD21 ' CD2' ' A' ' 197' ' ' HIS . 21.9 mt -83.68 -50.21 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.11 -26.36 11.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.61 -21.75 21.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -83.27 -15.4 50.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -95.47 10.23 37.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.3 mt -73.51 132.19 81.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.584 0.707 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -45.39 1.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.375 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 105.56 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HD3' HG21 ' A' ' 217' ' ' ILE . 6.9 ttmt -41.37 -53.04 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.625 HG22 ' CD2' ' A' ' 131' ' ' HIS . 3.0 m -56.02 -59.72 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -49.22 -39.3 29.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -57.46 -42.79 83.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.6 -54.12 8.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.625 ' CD2' HG22 ' A' ' 127' ' ' THR . 15.6 m-70 -46.76 -44.06 18.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.06 -59.66 4.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.533 HD22 ' HE1' ' A' ' 204' ' ' PHE . 16.1 mt -53.82 -33.75 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 137' ' ' VAL . 57.4 tttt -65.68 -34.97 79.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -82.62 -41.38 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 139' ' ' LYS . 87.8 mt -59.62 -21.14 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 134' ' ' LYS . 9.5 p -92.64 -5.91 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -81.02 -35.27 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 136' ' ' ILE . 5.8 pttm -80.57 -7.78 59.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.628 ' CE1' HD13 ' A' ' 113' ' ' LEU . 2.7 m-85 -51.4 149.88 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.599 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -41.83 140.64 1.41 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.81 -16.66 37.43 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.653 2.235 . . . . 0.0 112.286 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 91.1 t -96.97 -38.72 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -83.89 -40.23 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 71.4 t80 -46.56 -42.86 16.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -45.18 94.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.1 t -68.33 -61.11 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -44.45 -46.86 9.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.434 ' HB3' ' NH1' ' A' ' 149' ' ' ARG . 7.8 ttp-105 -62.57 -47.97 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.03 -54.19 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 85.0 t -46.4 -65.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.12 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.485 ' HA ' HD12 ' A' ' 155' ' ' LEU . 77.8 mt -44.0 -53.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.9 m -39.77 -36.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.509 ' CG ' HG13 ' A' ' 45' ' ' VAL . 15.1 t60 -80.36 -43.31 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 205' ' ' ILE . 96.5 mt -49.2 -42.99 41.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -52.26 -48.57 65.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -56.91 -29.84 63.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.698 HG22 HD11 ' A' ' 53' ' ' LEU . 42.4 t -80.46 -29.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.093 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 p -75.65 -20.44 58.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.94 -44.37 63.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.715 ' HB3' HD12 ' A' ' 164' ' ' ILE . 1.7 mm100 -97.01 29.48 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.574 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 16.8 p80 -52.48 -39.25 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.574 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 0.8 OUTLIER -59.15 -21.19 58.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 161' ' ' GLN . 49.6 mt -92.73 -64.96 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -76.08 1.41 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 162' ' ' HIS . 43.5 mt 54.6 46.28 25.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.417 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 21.0 mtp -141.12 112.55 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.46 HG22 ' CG ' ' A' ' 162' ' ' HIS . 33.7 p -98.24 160.63 14.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -45.96 -35.39 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -49.05 62.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.86 -44.17 77.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.77 -44.36 96.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -53.07 -40.31 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.454 HG12 ' NE2' ' A' ' 198' ' ' GLN . 9.6 mt -80.71 -41.21 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.142 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.58 -20.77 66.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -108.75 0.04 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.577 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.13 -45.92 95.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.533 0.682 . . . . 0.0 110.872 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -47.95 -58.54 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.688 2.259 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.596 HG21 ' HB2' ' A' ' 101' ' ' PHE . 18.2 m -69.69 -62.96 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.1 mt -40.52 -52.23 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 16.1 mmm -128.52 123.25 33.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 0.0 110.842 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 200' ' ' VAL . 87.0 mt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.849 0.357 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.547 ' CD2' HD21 ' A' ' 118' ' ' LEU . 9.9 m-70 -48.74 -71.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.454 ' NE2' HG12 ' A' ' 174' ' ' ILE . 7.1 tt0 -40.7 -53.67 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 t -45.88 -41.96 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 196' ' ' ILE . 29.6 t -53.8 -60.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.56 -66.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -38.68 -52.33 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 51.5 m -48.85 -64.6 0.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.533 ' HE1' HD22 ' A' ' 133' ' ' LEU . 7.4 m-85 -34.16 -48.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 155' ' ' LEU . 48.3 mt -66.25 -50.37 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -53.86 -45.61 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -110.02 30.42 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.527 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 0.8 OUTLIER -64.12 -15.32 59.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 213' ' ' TYR . 67.6 mm-40 -88.92 -54.47 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 210' ' ' PHE . 0.9 OUTLIER -42.76 -40.46 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -45.91 -63.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -105.54 -53.32 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 209' ' ' GLN . 56.9 m-85 -56.03 -35.2 66.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.931 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 71.02 28.02 3.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.68 -166.41 1.77 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.508 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.84 151.99 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.593 HG21 ' HD3' ' A' ' 126' ' ' LYS . 54.1 mt -76.42 132.05 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 m -110.22 174.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.814 0.256 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.665 ' O ' HG22 ' A' ' 31' ' ' VAL . 30.0 tp -70.6 -39.39 73.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.443 ' HB3' HG21 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -52.34 -28.57 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.12 -41.24 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.37 -39.0 78.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 27' ' ' LEU . 34.6 m -96.26 164.65 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -107.41 168.49 9.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.49 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -53.52 -46.75 70.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 24.4 mmtm -130.74 103.88 15.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.51 ' O ' HG11 ' A' ' 31' ' ' VAL . 54.0 Cg_endo -69.77 -33.6 16.21 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.644 2.23 . . . . 0.0 112.369 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.455 HG22 ' HG3' ' A' ' 42' ' ' GLU . 29.8 mt -74.68 131.36 79.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.611 0.72 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' HD21 ' A' ' 27' ' ' LEU . 54.2 Cg_endo -69.7 147.64 63.68 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.483 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.33 -50.03 71.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -42.53 -67.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.753 HG13 HD11 ' A' ' 97' ' ' LEU . 75.0 t -46.93 -54.36 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' HG3' HG22 ' A' ' 37' ' ' ILE . 33.1 mt-10 -47.23 -58.04 4.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 51.8 mmtt -53.05 -37.56 61.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.427 ' O ' HD12 ' A' ' 48' ' ' ILE . 78.4 m -65.22 -43.94 89.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.02 -51.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.27 -45.72 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 93' ' ' VAL . 33.4 t80 -53.53 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 44' ' ' CYS . 41.2 mt -37.48 -56.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -52.06 -48.05 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.05 -44.1 87.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 t -85.87 23.92 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.1 139.65 10.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.434 ' O ' HD11 ' A' ' 58' ' ' LEU . 16.0 tp -110.29 -27.44 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.964 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.9 m -84.48 39.75 0.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.708 ' O ' HD12 ' A' ' 58' ' ' LEU . 11.5 m -82.72 111.67 18.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.4 tt0 -35.97 130.85 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 36.57 77.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 55' ' ' THR . 3.0 mp -60.2 -61.73 2.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.955 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.674 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 59.4 m-85 -93.3 -43.45 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -42.54 -49.02 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.096 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.776 0.322 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -60.84 -53.83 52.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.35 -27.35 65.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.57 -62.89 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 13.4 p30 -61.71 -44.55 96.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.449 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 47.2 mt -43.5 -42.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.52 -54.81 4.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -51.22 -61.17 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -51.12 -38.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HA ' HG21 ' A' ' 81' ' ' ILE . 7.7 t80 -62.9 -28.74 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.74 -63.16 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -55.38 -29.31 58.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -131.04 99.05 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -69.92 -17.28 63.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.85 32.62 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.525 HG21 ' HA ' ' A' ' 75' ' ' PHE . 7.1 tt -73.61 157.22 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.461 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 4.8 t30 -132.35 94.74 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -40.49 -46.58 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.48 -50.65 78.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -55.54 -41.41 73.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.427 ' HB3' HG13 ' A' ' 88' ' ' VAL . 22.4 mmm -62.09 -33.86 75.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 61.55 46.51 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 86' ' ' MET . 33.7 m -78.75 165.72 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.7 p -67.26 139.44 57.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.9 t -52.82 -55.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -45.92 -44.45 14.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.54 -63.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 47' ' ' PHE . 93.7 t -45.04 -55.55 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.674 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -48.64 -38.7 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.35 -60.82 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.51 -43.92 8.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.753 HD11 HG13 ' A' ' 41' ' ' VAL . 23.8 tp -47.81 -44.55 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -68.01 -48.09 66.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.14 -38.38 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.068 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.25 -46.45 86.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -61.16 -47.51 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.511 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -59.74 -37.79 79.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 104' ' ' LEU . 6.7 t70 -59.42 -36.92 76.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' ASP . 96.2 mt -36.78 144.15 0.29 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -22.12 32.73 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.21 153.97 69.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.629 0.728 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 133.03 24.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.483 HD12 HD22 ' A' ' 144' ' ' ASN . 11.4 tp -38.38 -49.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.0 mt -84.2 123.63 75.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 111.162 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 153.93 68.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.691 2.261 . . . . 0.0 112.318 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.483 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 13.5 m-85 -72.62 -17.5 61.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 m -72.92 -30.45 63.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.39 27.85 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.498 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.0 m170 -71.49 -60.16 2.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.601 0.715 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.75 -33.83 15.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.247 . . . . 0.0 112.335 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.526 ' O ' HD13 ' A' ' 136' ' ' ILE . 1.3 mp0 -59.03 -33.3 70.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.44 ' HB3' HG11 ' A' ' 200' ' ' VAL . 12.8 mt -71.85 -40.28 69.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.2 mt -75.09 -58.57 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -42.71 -29.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.95 -28.4 20.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -76.8 -20.91 55.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -92.14 16.21 11.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 30.8 mt -78.22 132.64 66.01 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.59 0.71 . . . . 0.0 111.135 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -45.39 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.671 2.247 . . . . 0.0 112.349 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 126' ' ' LYS . 75.7 m-20 -66.34 92.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 125' ' ' ASP . 38.1 tttt -34.91 -51.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 42.4 m -53.25 -59.92 3.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' ARG . 45.1 mm-40 -54.83 -52.6 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 128' ' ' GLU . 11.4 ttm180 -36.87 -43.5 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 133' ' ' LEU . 22.8 mt -75.84 -61.56 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 130' ' ' LEU . 11.8 m-70 -36.53 -49.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.1 -55.14 30.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.589 HD22 ' HE1' ' A' ' 204' ' ' PHE . 11.0 mt -55.9 -41.37 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -56.3 -29.67 61.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -90.37 -46.33 8.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 116' ' ' GLU . 56.7 mt -56.43 -29.2 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.528 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 7.8 p -76.15 -15.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -73.37 -25.44 60.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -77.38 -19.13 56.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 7.9 m-85 -50.51 146.98 4.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.586 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.4 t-80 -45.48 141.39 3.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.586 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -21.0 34.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 28' ' ' GLN . 84.6 t -89.7 -38.89 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.483 HD22 HD12 ' A' ' 108' ' ' LEU . 2.9 m120 -83.65 -44.06 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 14.1 t80 -40.97 -56.77 2.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -46.9 -34.45 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.38 -58.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 24.0 t80 -43.17 -41.65 3.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -70.47 -44.79 67.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -57.71 -42.37 83.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.466 ' HA ' HD12 ' A' ' 155' ' ' LEU . 86.0 mt -43.4 -53.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.146 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.8 m -41.25 -34.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -83.61 -39.68 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 152' ' ' ILE . 92.8 mt -56.2 -45.52 79.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.98 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -50.36 -43.66 54.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.407 ' HB3' HD21 ' A' ' 53' ' ' LEU . 22.6 mtp85 -59.86 -30.84 69.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.72 -45.65 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.6 p -57.84 -29.95 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.06 -46.48 88.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -100.86 40.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 166' ' ' LEU . 10.6 p80 -58.54 -41.05 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.414 ' HG2' ' NE2' ' A' ' 162' ' ' HIS . 17.0 mmmt -55.32 -27.57 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 79.9 mt -90.29 -57.07 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.3 OUTLIER -84.17 18.07 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 162' ' ' HIS . 12.1 mt 34.32 52.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 49.1 mmm -146.34 108.73 4.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.437 HG22 ' ND1' ' A' ' 162' ' ' HIS . 73.9 p -93.94 151.19 19.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.79 -37.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.89 -49.09 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 168' ' ' THR . 41.1 m-20 -54.54 -42.8 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.43 -48.05 79.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 p -58.55 -39.36 80.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.31 -37.48 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.175 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.91 -15.44 63.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -108.16 -8.43 15.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.556 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -56.73 -47.29 99.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.871 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.2 Cg_exo -48.0 -62.12 0.49 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.511 HG23 ' CA ' ' A' ' 102' ' ' ALA . 16.7 m -67.85 -62.97 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.129 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 179' ' ' THR . 48.2 mt -33.2 -44.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.497 ' CE ' ' CD2' ' A' ' 114' ' ' HIS . 31.2 mtp -146.86 140.2 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.426 ' NE ' ' OH ' ' A' ' 111' ' ' TYR . 9.7 ptp180 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.827 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 200' ' ' VAL . 65.3 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.831 0.348 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -43.03 -69.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -67.16 -39.36 86.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 t -43.45 -40.37 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.823 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 196' ' ' ILE . 66.4 t -52.58 -58.25 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.16 -39.96 82.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -58.04 -52.4 65.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.4 m -49.51 -61.77 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.589 ' HE1' HD22 ' A' ' 133' ' ' LEU . 10.0 m-85 -33.83 -52.67 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.435 HG12 HG23 ' A' ' 152' ' ' ILE . 38.8 mt -62.61 -47.7 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -55.92 -47.63 77.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.9 mm-40 -109.84 31.67 5.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 2.4 t -63.55 -21.42 66.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.533 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 10.3 mm-40 -86.53 -51.17 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -45.04 -35.3 2.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -52.76 -62.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -108.07 -55.06 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.533 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 54.7 m-85 -56.63 -14.57 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 52.37 38.75 25.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.41 150.68 33.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 216' ' ' GLU . 2.8 mp0 -49.95 153.3 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.915 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.419 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 93.2 mt -73.69 126.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.092 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.2 m -104.81 177.68 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 53.5 Cg_endo . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.802 0.251 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.434 ' O ' HG22 ' A' ' 31' ' ' VAL . 26.2 tp -53.22 -53.61 48.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HA ' HG11 ' A' ' 143' ' ' VAL . 5.7 pt20 -44.37 -33.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 11.5 t70 -79.24 -48.8 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.4 mt -57.03 -43.95 82.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' LEU . 20.7 m -82.06 -179.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -117.61 147.52 42.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.14 -45.03 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -52.23 -43.09 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.75 108.37 13.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.552 0.691 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -39.39 6.55 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HD2' ' A' ' 38' ' ' PRO . 22.3 mt -73.99 132.94 79.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.648 0.737 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.76 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 0.0 112.363 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.621 HD11 ' HE3' ' A' ' 43' ' ' LYS . 2.2 tm? -45.1 -48.02 12.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.511 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 82.0 t80 -43.2 -70.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.932 HG13 HD11 ' A' ' 97' ' ' LEU . 66.2 t -44.17 -50.48 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.069 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -49.13 -53.89 18.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.621 ' HE3' HD11 ' A' ' 39' ' ' LEU . 12.2 mmtp -52.15 -40.76 61.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.0 m -66.53 -47.47 72.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.56 -46.21 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.71 -43.96 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 93' ' ' VAL . 63.8 t80 -50.78 -63.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.5 mt -39.67 -62.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -49.01 -50.3 36.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.44 -39.0 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.9 p -88.65 25.43 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.29 137.91 1.89 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.508 HD11 HG22 ' A' ' 158' ' ' VAL . 6.1 tp -113.47 47.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.773 0.32 . . . . 0.0 110.874 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.6 p -132.75 37.45 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -96.72 119.61 35.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.1 tt0 -37.93 123.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 60' ' ' ARG . . . 34.17 73.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.528 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.75 -24.73 63.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -102.59 -57.04 2.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HG3' HG23 ' A' ' 61' ' ' VAL . 15.7 ptm180 -46.65 -33.06 3.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.614 HG23 ' HG3' ' A' ' 60' ' ' ARG . 48.7 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.142 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.795 0.331 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.1 -45.33 32.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -73.9 -30.94 62.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -62.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -50.63 -34.47 26.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.48 -44.6 89.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -79.06 -46.59 17.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 76' ' ' ASP . 93.2 mttt -59.79 -66.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -40.26 -47.01 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 42.9 t80 -64.29 -37.91 89.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 73' ' ' LYS . 37.6 m-20 -68.74 -58.85 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -53.38 -29.25 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.06 149.88 14.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.23 -17.72 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -83.43 50.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 -177.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.403 ' ND2' ' HB ' ' A' ' 84' ' ' VAL . 1.9 t30 -149.26 136.31 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.7 mt -81.28 -46.78 14.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.403 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 93.5 t -44.14 -54.16 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.1 t -55.57 -43.28 75.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.7 mmm -55.95 -28.83 58.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 51.97 45.94 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.99 164.84 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 t -75.22 128.16 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.3 t -40.31 -51.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -38.72 -53.01 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.15 -60.93 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.506 HG21 ' CD2' ' A' ' 47' ' ' PHE . 94.4 t -47.26 -51.23 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.75 -45.05 58.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.12 -63.35 3.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.78 -42.15 5.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.884 0.373 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.932 HD11 HG13 ' A' ' 41' ' ' VAL . 43.3 tp -48.69 -45.57 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -69.62 -51.17 37.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -40.26 -39.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -58.99 -47.46 85.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.771 ' HB2' HG21 ' A' ' 179' ' ' THR . 51.6 m-85 -62.27 -48.87 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.428 ' N ' HG23 ' A' ' 179' ' ' THR . . . -57.15 -37.13 71.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -34.8 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -41.65 141.29 1.23 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -19.06 36.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.693 2.262 . . . . 0.0 112.357 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -134.14 152.55 78.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.62 26.02 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.708 2.272 . . . . 0.0 112.342 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.2 tp -44.25 -44.26 7.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.49 123.94 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.617 0.723 . . . . 0.0 111.162 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.699 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.8 Cg_endo -69.77 146.37 59.92 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.345 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.65 ' CD2' ' CE1' ' A' ' 114' ' ' HIS . 73.7 m-85 -66.26 -32.55 74.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m -61.14 -15.11 30.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.699 HD12 ' HG2' ' A' ' 110' ' ' PRO . 27.3 mt -122.0 28.47 7.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.65 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 3.9 m170 -73.0 -60.79 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.569 0.7 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.76 -31.82 19.79 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.694 2.263 . . . . 0.0 112.38 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -59.96 -28.86 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.0 -46.66 33.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 121' ' ' ALA . 12.0 mt -65.12 -55.2 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -45.72 -37.19 5.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.53 -21.08 32.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -86.63 -18.44 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -89.81 -8.85 51.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 128' ' ' GLU . 82.4 mt -56.81 130.17 78.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 111.141 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -46.08 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.12 116.94 10.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.44 ' HG2' HG21 ' A' ' 217' ' ' ILE . 7.4 tppt? -50.99 -49.55 60.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.0 m -53.57 -55.7 23.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.53 ' HB2' HG21 ' A' ' 123' ' ' ILE . 14.2 mt-10 -60.38 -38.95 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -57.75 -49.97 74.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.76 -60.52 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -43.58 -50.15 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.77 78.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 mt -74.57 -27.26 60.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -78.0 -27.16 48.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.0 pt-20 -86.11 -32.99 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.418 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 84.9 mt -74.2 -38.01 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.8 p -62.05 -11.81 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -74.96 -43.09 56.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -61.55 -32.97 73.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -40.52 137.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.59 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -39.33 141.16 0.69 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.849 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.78 -18.99 36.62 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 28' ' ' GLN . 92.1 t -89.86 -37.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.91 -40.26 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.525 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 6.2 t80 -48.69 -51.69 27.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.92 -51.85 21.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.0 -67.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 38.5 t80 -40.21 -40.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.525 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 4.6 mmp_? -66.39 -45.1 81.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.07 -48.15 77.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.99 -64.75 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.751 ' HA ' HD12 ' A' ' 155' ' ' LEU . 91.6 mt -42.82 -53.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.3 m -40.26 -36.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.121 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -78.9 -36.89 41.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.751 HD12 ' HA ' ' A' ' 152' ' ' ILE . 53.1 mt -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -47.21 -47.37 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -55.57 -37.65 68.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.549 HG11 HD21 ' A' ' 172' ' ' LEU . 75.7 t -68.94 -50.41 54.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.2 p -55.23 -37.8 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -50.7 -39.87 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -108.46 40.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 167' ' ' MET . 17.9 p80 -58.67 -35.68 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -58.16 -31.99 67.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.55 -57.85 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 166' ' ' LEU . 2.6 m-20 -83.39 17.23 2.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 162' ' ' HIS . 22.0 mt 34.96 50.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.695 ' CE ' HD23 ' A' ' 172' ' ' LEU . 39.4 mmm -146.42 113.83 6.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 169' ' ' ALA . 9.2 p -95.76 153.36 17.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.97 -49.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.07 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -50.17 74.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -53.34 -44.39 68.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.695 HD23 ' CE ' ' A' ' 167' ' ' MET . 16.5 mt -61.69 -41.62 97.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -59.38 -48.9 79.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 42.7 mt -62.74 -34.57 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 40.9 m -69.51 -22.86 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -102.25 -5.77 23.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.583 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -55.1 -46.05 99.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.609 0.718 . . . . 0.0 110.97 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.8 Cg_exo -47.95 -63.12 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 0.0 112.363 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.771 HG21 ' HB2' ' A' ' 101' ' ' PHE . 87.1 m -65.44 -61.4 2.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 179' ' ' THR . 78.6 mt -34.24 -42.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 8.7 ptp -166.6 142.24 4.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.846 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.88 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 197' ' ' HIS . 51.1 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.814 0.34 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 196' ' ' ILE . 39.1 m-70 -35.4 -61.19 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -56.77 -48.1 78.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 m -49.74 -36.97 27.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.21 -70.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.166 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.17 -53.37 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.454 ' C ' ' OE1' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -38.69 -48.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 204' ' ' PHE . 60.8 m -58.79 -62.12 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.1 m-85 -34.41 -40.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 152' ' ' ILE . 70.6 mt -78.67 -52.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -48.57 -44.92 37.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.6 mm-40 -113.31 35.4 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 6.1 t -64.07 -15.98 60.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.466 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 12.8 mm-40 -89.07 -53.68 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.69 -36.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -53.07 -63.47 1.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -107.53 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.466 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 89.4 m-85 -61.27 -9.98 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 48.5 t30 47.24 43.86 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.63 145.87 28.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.519 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -43.79 143.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.471 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 75.7 mt -63.35 131.15 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.118 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.1 m -112.26 173.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.159 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 219' ' ' GLU . 5.0 tm-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.851 0.271 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' HG22 ' A' ' 31' ' ' VAL . 17.1 tp -52.49 -45.1 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.492 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.1 pt20 -49.65 -32.04 12.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.96 -41.47 20.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -63.03 -41.86 99.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.771 HG11 ' O ' ' A' ' 36' ' ' PRO . 23.6 m -85.27 164.8 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 p -110.63 147.91 33.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.57 -45.02 4.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -58.58 -41.14 85.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -130.99 97.62 20.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.771 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.9 Cg_endo -69.68 -47.44 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.377 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.425 HG23 ' HD2' ' A' ' 38' ' ' PRO . 43.8 mt -64.09 132.41 95.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.73 . . . . 0.0 111.109 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 147' ' ' VAL . 53.2 Cg_endo -69.78 140.05 41.67 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -57.76 -51.32 70.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.42 ' CD1' ' CD2' ' A' ' 75' ' ' PHE . 28.7 t80 -42.13 -64.42 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 97' ' ' LEU . 71.7 t -46.6 -54.32 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.122 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -50.3 -55.27 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.55 ' HG2' HD13 ' A' ' 39' ' ' LEU . 38.1 mmtt -47.26 -40.97 17.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.464 ' HB2' HD13 ' A' ' 97' ' ' LEU . 81.8 m -63.62 -46.37 86.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 ' CG ' ' A' ' 154' ' ' HIS . 35.1 t -64.89 -56.35 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.28 -45.38 88.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 93' ' ' VAL . 63.6 t80 -42.92 -60.17 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.0 mt -51.34 -48.88 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -56.07 -47.74 77.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -44.55 -47.52 10.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.3 p -84.04 29.84 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.21 163.11 9.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.403 HD21 ' C ' ' A' ' 157' ' ' ARG . 3.6 tp -103.03 37.08 2.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.346 . . . . 0.0 110.939 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.52 40.68 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.448 HG21 HD21 ' A' ' 58' ' ' LEU . 39.6 m -88.88 133.85 34.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.191 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -98.13 110.82 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.37 72.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 55' ' ' THR . 20.3 mt -114.79 119.62 37.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 62.67 28.96 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB2' ' HE1' ' A' ' 167' ' ' MET . 19.4 ttm-85 -129.9 -36.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.815 0.34 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.42 -54.04 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.709 ' HA ' HD12 ' A' ' 71' ' ' ILE . 29.5 mt-30 -60.54 -32.63 71.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -67.99 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -52.92 -34.72 56.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 68' ' ' GLN . 49.0 mt -56.68 -40.47 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -85.34 -59.76 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -46.8 -59.66 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.448 ' CB ' HD12 ' A' ' 81' ' ' ILE . 40.1 mm-40 -49.71 -51.58 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CD2' ' CD1' ' A' ' 40' ' ' PHE . 58.2 t80 -58.59 -37.35 75.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.46 -60.1 3.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -58.76 -38.83 79.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.22 111.5 5.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -68.09 -32.41 72.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.4 m-80 -38.88 -36.91 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.448 HD12 ' CB ' ' A' ' 74' ' ' GLN . 13.7 tt -34.51 146.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -134.89 100.68 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 82' ' ' ASN . 56.2 mt -34.35 -54.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.18 -47.31 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' ASN . 3.3 t -63.04 -48.1 80.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.448 ' HB3' HG13 ' A' ' 88' ' ' VAL . 7.7 mmm -57.33 -35.5 69.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 61.33 49.96 5.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 86' ' ' MET . 35.5 m -83.45 171.1 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.114 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.7 p -66.28 123.68 20.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 55' ' ' THR . 91.4 t -44.97 -56.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.109 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -37.78 -41.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.51 -60.47 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 47' ' ' PHE . 99.1 t -45.05 -51.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.9 -44.23 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -50.34 11.68 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.449 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.22 -51.61 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.53 HD11 HG13 ' A' ' 41' ' ' VAL . 32.9 tp -43.77 -44.51 6.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 37.8 mtmt -72.85 -47.7 43.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.15 -45.63 4.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -57.43 -46.92 83.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -57.0 -44.24 82.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.54 90.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -40.48 76.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.4 mt -37.23 145.39 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -18.99 36.38 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.709 2.272 . . . . 0.0 112.306 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.8 152.27 70.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.601 0.715 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.4 Cg_endo -69.77 129.01 16.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 107' ' ' PRO . 11.2 tp -34.45 -45.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.2 mt -96.58 121.7 59.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 111.162 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 151.71 69.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.402 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.97 -22.35 64.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.2 m -68.77 -21.65 64.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 mt -113.89 28.69 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.501 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 3.4 m170 -75.68 -62.94 0.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.81 -23.38 30.64 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.613 2.209 . . . . 0.0 112.334 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.4 -32.48 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.3 mt -75.15 -27.09 59.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.14 -51.02 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.95 -25.9 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.407 ' HA ' HD11 ' A' ' 123' ' ' ILE . . . -91.94 -29.45 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -73.08 -21.06 60.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -92.27 20.32 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 124' ' ' PRO . 87.7 mt -84.33 134.16 43.52 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 111.154 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 123' ' ' ILE . 54.1 Cg_endo -69.71 -44.35 2.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.28 . . . . 0.0 112.381 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 126' ' ' LYS . 24.1 t0 -69.18 95.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.604 ' HE3' HG21 ' A' ' 217' ' ' ILE . 44.1 tttp -38.11 -43.67 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.0 m -58.72 -66.65 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -46.23 -43.55 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 123' ' ' ILE . 20.6 ttp180 -48.07 -42.15 27.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.2 mt -73.12 -52.86 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -49.08 -52.71 24.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.4 -57.61 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.435 HD22 ' HE1' ' A' ' 204' ' ' PHE . 11.9 mt -60.25 -35.22 74.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 137' ' ' VAL . 29.3 tttm -61.61 -30.8 70.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.14 -44.94 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.59 -32.71 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 134' ' ' LYS . 10.1 p -68.6 -16.18 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -72.1 -32.06 66.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -68.55 -30.3 69.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 141' ' ' HIS . 8.4 m-85 -43.59 138.45 2.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -37.25 141.37 0.43 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.556 0.693 . . . . 0.0 110.851 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.3 Cg_endo -69.78 -17.04 37.72 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 28' ' ' GLN . 60.4 t -97.71 -32.34 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -86.76 -39.16 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -49.54 -47.7 48.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.57 -54.53 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 151' ' ' VAL . 61.1 t -60.71 -56.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 45.9 t80 -46.76 -48.5 20.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -65.05 -48.51 73.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -54.74 -41.98 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 147' ' ' VAL . 62.6 t -59.52 -59.55 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.936 HG23 HG12 ' A' ' 205' ' ' ILE . 73.0 mt -47.67 -53.89 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' ILE . 24.4 m -36.83 -36.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.495 ' CG ' HG13 ' A' ' 45' ' ' VAL . 69.2 t60 -81.75 -39.41 24.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 152' ' ' ILE . 71.4 mt -56.93 -40.13 75.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.858 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.463 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 43.8 t-20 -56.84 -41.74 78.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.403 ' C ' HD21 ' A' ' 53' ' ' LEU . 23.1 mtp180 -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.528 HG13 HD22 ' A' ' 165' ' ' ASN . 67.2 t -65.21 -54.07 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.4 p -46.46 -32.78 3.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' A' ' 156' ' ' ASN . 1.5 mt-30 -67.18 -46.65 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.585 HE21 HD12 ' A' ' 164' ' ' ILE . 31.1 mm100 -88.15 39.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -67.91 -20.37 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -68.83 -30.81 69.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.585 HD12 HE21 ' A' ' 161' ' ' GLN . 50.4 mt -102.47 -53.72 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.528 HD22 HG13 ' A' ' 158' ' ' VAL . 1.5 m-20 -66.38 -23.43 66.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 34.8 mt 65.01 39.95 5.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.426 ' HE1' ' HB2' ' A' ' 60' ' ' ARG . 42.4 mmm -150.11 118.98 6.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.3 p -98.16 172.67 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -56.96 -38.48 73.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -59.69 -47.19 86.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -63.28 -39.48 94.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 169' ' ' ALA . 10.9 mt -66.57 -38.54 87.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 t -61.29 -41.4 96.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.5 mt -77.85 -34.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 42.3 m -68.95 -14.85 63.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.513 ' CE2' ' HG2' ' A' ' 98' ' ' LYS . 13.3 m-85 -111.48 -5.76 14.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.578 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -54.55 -46.33 99.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -47.96 -53.36 6.74 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.306 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 26.2 m -78.77 -68.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 33.0 mt -34.22 -64.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.554 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 1.0 OUTLIER -112.33 96.9 6.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 181' ' ' MET . 33.6 ttm-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.633 0.73 . . . . 0.0 110.865 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 200' ' ' VAL . 32.0 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.881 0.372 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -37.83 -47.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.72 -51.67 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.9 m -40.83 -42.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 121' ' ' ALA . 57.9 t -40.44 -71.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 202' ' ' GLU . 85.5 t -60.08 -61.11 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 201' ' ' VAL . 20.9 tt0 -35.77 -42.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.3 m -62.72 -59.93 4.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.2 m-85 -33.98 -47.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.936 HG12 HG23 ' A' ' 152' ' ' ILE . 47.4 mt -71.66 -48.71 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -51.84 -45.34 63.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.57 ' NE2' HG22 ' A' ' 218' ' ' VAL . 6.4 mm-40 -113.74 34.1 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.539 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 21.6 t -63.54 -21.85 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.489 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 47.3 mm-40 -84.5 -54.54 4.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -41.13 -34.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.539 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 22.3 m-85 -52.62 -63.4 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -106.11 -56.35 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.489 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 72.1 m-85 -56.92 -17.16 8.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.915 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 51.67 40.1 26.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.925 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.07 135.77 15.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -42.5 137.08 2.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 0.0 110.936 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.604 HG21 ' HE3' ' A' ' 126' ' ' LYS . 68.1 mt -48.43 127.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.57 HG22 ' NE2' ' A' ' 207' ' ' GLN . 35.8 m -89.42 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.798 0.249 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' VAL . 27.8 tp -62.44 -45.61 92.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.593 ' HA ' HG11 ' A' ' 143' ' ' VAL . 4.9 pt20 -46.79 -31.57 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.97 -44.05 27.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.14 -42.09 96.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 27' ' ' LEU . 32.8 m -90.81 158.21 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -100.48 150.53 22.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -45.89 -46.17 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -53.7 -40.32 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 15.2 mmtp -133.75 94.73 18.45 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.7 Cg_endo -69.76 -35.95 11.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.704 2.269 . . . . 0.0 112.365 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 ' HG3' ' A' ' 42' ' ' GLU . 18.9 mt -74.22 131.33 80.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 111.113 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' HG22 ' A' ' 147' ' ' VAL . 53.9 Cg_endo -69.71 121.56 8.26 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.713 2.276 . . . . 0.0 112.345 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.491 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -44.67 -53.88 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -38.72 -68.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.885 HG13 HD11 ' A' ' 97' ' ' LEU . 79.2 t -45.41 -54.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HG3' HG22 ' A' ' 37' ' ' ILE . 88.5 mt-10 -45.94 -60.9 1.99 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 54.5 mmtt -46.94 -39.29 12.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.543 ' HB2' HD13 ' A' ' 97' ' ' LEU . 94.6 m -68.64 -52.49 30.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.93 -32.65 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -82.64 -36.29 26.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -63.15 -55.87 21.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.98 ' O ' HG22 ' A' ' 51' ' ' THR . 23.1 mt -47.75 -52.47 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -70.94 -24.32 62.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.84 -17.71 59.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.98 HG22 ' O ' ' A' ' 48' ' ' ILE . 8.4 t -91.98 26.33 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.54 -34.4 3.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 48' ' ' ILE . 4.7 tp 68.21 53.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.3 p -114.65 -25.33 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -42.74 129.52 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 57' ' ' GLY . 7.3 mp0 -74.21 140.96 45.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 33.93 37.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 59' ' ' TYR . 1.2 pp -38.22 -32.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.765 ' N ' HD12 ' A' ' 58' ' ' LEU . 15.1 m-85 -82.03 -61.83 1.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG3' HG23 ' A' ' 61' ' ' VAL . 11.5 ptm180 -55.33 -14.02 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 60' ' ' ARG . 88.4 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.854 0.359 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.13 -58.65 6.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.823 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.809 ' HA ' HD12 ' A' ' 71' ' ' ILE . 1.2 mp0 -58.19 -34.95 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -50.56 -62.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.3 p30 -58.9 -41.26 86.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 68' ' ' GLN . 70.7 mt -46.61 -41.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.56 -57.7 2.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -49.09 -56.24 9.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -54.39 -46.54 73.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -62.38 -35.16 78.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.85 -53.31 52.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -74.42 -24.82 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -130.6 89.62 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.6 -34.63 75.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.68 39.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.724 HD11 ' SD ' ' A' ' 86' ' ' MET . 9.6 tt -79.99 154.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 81' ' ' ILE . 5.0 t30 -124.79 94.56 4.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -41.15 -49.12 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.955 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.432 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 63.3 t -47.41 -44.62 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 t -60.18 -40.49 90.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.724 ' SD ' HD11 ' A' ' 81' ' ' ILE . 77.9 mtp -63.14 -37.97 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 62.95 47.4 4.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.0 m -84.76 171.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.7 p -68.71 118.96 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.9 t -36.56 -54.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -40.04 -47.78 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 -63.08 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.4 t -50.05 -46.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.84 -50.66 33.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -54.16 6.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.64 -40.85 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.885 HD11 HG13 ' A' ' 41' ' ' VAL . 11.1 tp -53.24 -56.31 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.463 ' CG ' ' CE2' ' A' ' 176' ' ' PHE . 6.1 mtmp? -60.34 -46.27 90.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.33 -46.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' A' ' 100' ' ' PHE . 7.3 t80 -57.41 -53.19 60.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -51.46 -41.01 60.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.53 -36.47 81.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -62.23 -38.75 90.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' ASP . 95.9 mt -34.89 144.64 0.21 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 110.934 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.28 36.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -139.26 153.82 71.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.77 128.65 16.32 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 2.263 . . . . 0.0 112.357 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 107' ' ' PRO . 23.8 tp -34.97 -39.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.9 mt -98.46 121.41 56.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.77 144.19 53.21 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 23.6 m-85 -59.38 -30.76 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.9 p -61.36 -16.35 45.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 117' ' ' LEU . 58.1 mt -119.45 29.92 7.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.51 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 3.1 m170 -76.39 -63.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.74 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.2 Cg_endo -69.73 -20.54 34.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.724 2.283 . . . . 0.0 112.364 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.6 -34.02 71.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 113' ' ' LEU . 3.1 mt -73.36 -37.09 66.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 121' ' ' ALA . 5.1 mt -77.49 -53.21 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -43.8 -32.37 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.42 -31.74 21.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -71.72 -19.74 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -92.92 26.25 2.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.949 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 128' ' ' GLU . 72.1 mt -92.53 129.87 39.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.606 0.717 . . . . 0.0 111.138 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -44.36 2.11 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.63 2.22 . . . . 0.0 112.35 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.459 ' HB2' ' CG ' ' A' ' 128' ' ' GLU . 0.6 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -37.36 -57.99 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.9 m -46.66 -47.85 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.595 ' HB2' HG21 ' A' ' 123' ' ' ILE . 37.5 mm-40 -64.38 -48.61 74.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -45.97 -57.46 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.583 HD13 ' OE1' ' A' ' 207' ' ' GLN . 16.3 mt -63.33 -67.12 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 130' ' ' LEU . 9.3 m-70 -34.38 -40.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.12 -63.25 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.61 -30.27 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.644 ' O ' HG12 ' A' ' 137' ' ' VAL . 64.8 tttt -65.96 -32.77 74.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -87.93 -47.65 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.3 mt -57.55 -26.07 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.174 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 134' ' ' LYS . 13.5 p -71.7 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -76.39 -34.75 58.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -64.07 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.936 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.2 m-85 -40.7 129.73 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.596 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -33.95 141.11 0.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.7 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.596 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.75 -13.75 35.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.725 2.283 . . . . 0.0 112.352 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 28' ' ' GLN . 95.4 t -97.84 -35.83 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.071 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.53 -39.61 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 1.4 t80 -47.22 -47.87 24.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.81 66.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 151' ' ' VAL . 83.4 t -70.14 -57.99 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 41.3 t80 -48.4 -46.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -62.06 -51.18 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -53.66 -47.73 70.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 147' ' ' VAL . 97.8 t -54.77 -58.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.64 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 86.3 mt -46.78 -52.09 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.6 m -41.36 -37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -80.72 -35.13 33.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.728 HD13 HD11 ' A' ' 205' ' ' ILE . 97.0 mt -57.81 -42.99 85.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -52.6 -44.52 66.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -55.3 -43.4 74.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.656 HG11 HD21 ' A' ' 172' ' ' LEU . 84.5 t -63.35 -42.32 95.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 p -67.53 -27.11 66.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -69.97 -40.42 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -102.14 50.38 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.469 ' CD2' HG22 ' A' ' 168' ' ' THR . 0.6 OUTLIER -80.15 41.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.833 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -122.21 -43.47 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 mt -87.91 -40.97 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.158 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.84 -23.69 18.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 mt 63.99 48.27 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 37.8 mmm -132.2 97.14 4.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.469 HG22 ' CD2' ' A' ' 162' ' ' HIS . 72.3 p -85.36 167.85 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -52.32 -41.33 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.054 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.53 -56.42 20.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -50.69 -42.73 57.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 169' ' ' ALA . 7.4 mt -63.09 -43.95 97.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.6 t -57.9 -46.07 85.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.49 -35.16 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.9 t -68.59 -26.17 65.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 98' ' ' LYS . 16.7 m-85 -101.18 -6.58 24.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.589 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -54.61 -45.8 99.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.562 0.696 . . . . 0.0 110.907 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.1 Cg_exo -48.01 -50.18 12.39 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.268 . . . . 0.0 112.304 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 180' ' ' LEU . 20.8 m -81.87 -65.55 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 26.0 mt -33.45 -59.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.565 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 1.4 ttm -114.58 116.62 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.868 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 200' ' ' VAL . 82.3 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.821 0.343 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -40.37 -51.65 2.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.15 -55.05 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 m -45.32 -38.62 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 196' ' ' ILE . 94.0 t -45.17 -70.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.102 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.9 t -64.74 -60.37 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 201' ' ' VAL . 22.9 tt0 -34.59 -45.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 84.2 m -60.16 -59.15 5.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.2 m-85 -34.62 -54.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.728 HD11 HD13 ' A' ' 155' ' ' LEU . 50.5 mt -62.66 -55.52 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -46.28 -54.99 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.935 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.583 ' OE1' HD13 ' A' ' 130' ' ' LEU . 16.5 mm-40 -99.26 27.25 5.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.599 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 3.5 t -61.37 -14.42 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' TYR . 20.9 mm-40 -95.32 -57.53 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.495 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.6 t80 -39.67 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.599 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -52.9 -62.29 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -128.2 -26.78 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 215' ' ' GLY . 27.7 m-85 -83.21 30.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 213' ' ' TYR . 27.5 m-20 33.64 33.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -57.26 146.27 36.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.34 133.28 34.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.48 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 85.5 mt -48.29 122.82 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.1 m -111.49 166.31 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.811 0.255 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.72 -52.4 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.954 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.675 ' CB ' HG21 ' A' ' 143' ' ' VAL . 7.3 pt20 -44.9 -30.13 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.99 -45.03 15.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.05 -44.76 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 36' ' ' PRO . 12.2 m -83.0 164.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -114.2 164.7 13.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.21 63.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -51.66 -54.13 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 23.1 mmtp -119.69 96.41 49.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 0.0 110.883 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.464 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.1 Cg_endo -69.79 -35.94 11.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.238 . . . . 0.0 112.328 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.52 HG23 ' HD2' ' A' ' 38' ' ' PRO . 36.5 mt -85.73 134.71 39.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 0.0 111.161 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.0 Cg_endo -69.77 150.48 68.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -68.66 -47.2 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -40.79 -58.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 97' ' ' LEU . 96.8 t -55.28 -62.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -45.8 -62.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -50.74 -37.25 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 68.8 m -69.86 -31.98 70.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG13 ' CG ' ' A' ' 154' ' ' HIS . 84.4 t -78.68 -60.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.46 -40.72 60.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.783 ' CE1' HG21 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -51.04 -41.1 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mt -59.9 -64.13 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -33.7 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.58 -24.64 56.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.1 p -107.7 29.23 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.08 134.66 5.21 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.58 -10.65 14.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.931 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.0 m -91.68 40.9 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 56' ' ' GLU . 6.0 m -92.45 113.78 26.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.7 tt0 -33.98 121.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.27 69.3 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.901 HD22 ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -66.49 -9.56 35.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.93 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.685 ' CE2' HD21 ' A' ' 58' ' ' LEU . 8.9 m-85 -122.75 -37.75 2.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -74.1 -40.2 62.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 69' ' ' ASP . 45.4 m . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.788 0.328 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -35.72 -59.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 71' ' ' ILE . 36.3 mt-30 -52.65 -38.4 60.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.9 t70 -47.84 -56.69 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.8 p30 -68.94 -36.08 77.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 68' ' ' GLN . 57.8 mt -51.09 -42.36 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -82.92 -54.01 5.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -54.39 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -45.04 -46.02 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.58 -31.37 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.15 -48.05 38.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.35 -30.15 65.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.1 93.18 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.89 37.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.84 HD11 ' SD ' ' A' ' 86' ' ' MET . 10.6 tt -76.58 153.13 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 83' ' ' LEU . 6.0 t30 -124.62 83.87 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 82' ' ' ASN . 26.4 mt -34.35 -47.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.22 -54.79 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -52.35 -42.01 63.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.84 ' SD ' HD11 ' A' ' 81' ' ' ILE . 75.2 mtp -60.9 -36.39 79.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 59.4 45.0 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 160.97 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.183 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 29.0 p -56.12 118.18 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.121 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.1 t -41.52 -54.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -43.23 -35.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 71' ' ' ILE . . . -55.1 -59.3 4.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.783 HG21 ' CE1' ' A' ' 47' ' ' PHE . 89.6 t -50.39 -51.03 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -48.39 -45.34 35.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.32 -55.39 18.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.469 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.8 -40.77 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 41' ' ' VAL . 14.5 tp -48.75 -39.95 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.505 ' CG ' ' CE1' ' A' ' 176' ' ' PHE . 42.6 mtmt -74.41 -45.95 43.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.13 -34.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 6.9 t80 -68.48 -48.09 65.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -56.66 -41.29 76.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.43 ' HB2' HG23 ' A' ' 179' ' ' THR . . . -65.75 -37.44 86.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.44 -35.4 73.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.3 mt -39.2 144.56 0.44 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -29.12 24.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.91 154.14 81.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 143.8 51.97 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.5 tp -48.16 -58.46 4.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.95 131.17 54.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.656 0.741 . . . . 0.0 111.106 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.404 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.77 162.09 43.41 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.317 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.538 ' CD2' ' CE1' ' A' ' 114' ' ' HIS . 52.8 m-85 -79.87 -25.78 40.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -69.74 -17.03 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 117' ' ' LEU . 43.3 mt -122.42 31.92 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.538 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 3.9 m170 -74.28 -61.76 1.14 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.582 0.706 . . . . 0.0 110.828 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.5 Cg_endo -69.77 -10.73 29.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -68.01 -44.03 77.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 113' ' ' LEU . 4.3 mp -67.23 -34.93 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.545 HD11 ' CE1' ' A' ' 197' ' ' HIS . 9.6 mt -77.45 -58.5 3.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -42.76 -30.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.46 -31.76 18.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -69.08 -21.98 64.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -90.21 19.06 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.4 HG23 ' HD2' ' A' ' 124' ' ' PRO . 66.8 mt -85.53 132.71 43.85 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 0.0 111.099 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.79 -44.57 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.319 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.3 m-20 -64.36 95.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.1 ttpt -35.58 -53.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.4 m -57.34 -61.37 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.121 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -46.38 -46.23 18.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.863 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -48.35 -51.99 23.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.55 -60.1 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -40.96 -53.85 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.73 -49.57 65.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.05 -28.02 69.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 137' ' ' VAL . 44.4 tttt -74.66 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -86.1 -32.43 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.66 -21.71 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 134' ' ' LYS . 10.8 p -87.9 -7.72 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -77.04 -38.6 52.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -12.8 60.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.68 ' HZ ' HD11 ' A' ' 117' ' ' LEU . 2.8 m-85 -53.68 135.92 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.594 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.2 t-80 -34.49 141.51 0.25 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.594 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.77 -14.53 36.18 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.665 2.244 . . . . 0.0 112.383 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.675 HG21 ' CB ' ' A' ' 28' ' ' GLN . 96.7 t -95.36 -25.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.105 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -94.84 -34.59 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -64.87 -54.42 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.475 ' O ' HD11 ' A' ' 37' ' ' ILE . 6.7 p-10 -45.52 -45.39 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.511 HG22 HG12 ' A' ' 37' ' ' ILE . 11.7 t -77.16 -63.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.574 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 27.8 t80 -37.23 -41.4 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -64.77 -54.35 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -53.31 -51.14 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.6 t -48.11 -56.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.684 HG23 HG12 ' A' ' 205' ' ' ILE . 89.0 mt -55.83 -49.25 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.7 m -42.88 -31.03 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.526 ' CG ' HG13 ' A' ' 45' ' ' VAL . 86.5 t60 -85.17 -42.99 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 152' ' ' ILE . 83.0 mt -54.93 -46.58 74.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -51.76 -48.3 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -53.55 -38.22 63.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.15 -45.67 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.165 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.2 p -58.35 -21.51 50.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -51.62 -53.75 35.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.483 ' HB3' HD12 ' A' ' 164' ' ' ILE . 10.8 mm100 -102.32 37.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.508 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 24.5 p80 -49.97 -27.67 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.508 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 3.9 mmmp? -70.12 -32.58 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 161' ' ' GLN . 92.2 mt -82.66 -65.32 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -2.3 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.5 mt 55.25 46.81 22.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 25.6 mtp -144.69 116.92 8.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.844 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.456 HG22 ' CG ' ' A' ' 162' ' ' HIS . 39.1 p -101.15 159.16 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.107 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.29 -35.03 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.77 -48.97 57.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -55.22 -36.11 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 14.0 mt -72.56 -43.3 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -58.11 -36.91 73.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.492 HG12 ' NE2' ' A' ' 198' ' ' GLN . 17.6 mt -77.8 -35.85 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.6 -18.47 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.505 ' CE1' ' CG ' ' A' ' 98' ' ' LYS . 11.6 m-85 -108.71 -8.83 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.571 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -54.34 -46.42 99.0 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.566 0.698 . . . . 0.0 110.917 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -47.95 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 3.9 m -69.1 -59.45 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 56.7 mt -33.83 -47.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 34.3 mmm -143.0 136.53 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.851 -179.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 197' ' ' HIS . 96.8 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.851 0.358 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.545 ' CE1' HD11 ' A' ' 118' ' ' LEU . 53.1 m-70 -36.74 -62.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.526 ' OE1' ' CD1' ' A' ' 177' ' ' TRP . 18.2 mm100 -43.64 -54.17 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 m -50.61 -36.94 37.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' A' ' 117' ' ' LEU . 23.2 t -54.81 -71.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.09 -54.27 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -45.6 -51.77 11.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 204' ' ' PHE . 93.3 m -50.06 -63.02 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.4 m-85 -34.25 -53.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.684 HG12 HG23 ' A' ' 152' ' ' ILE . 67.1 mt -62.11 -54.87 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -49.06 -57.55 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.465 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 10.3 mm-40 -96.52 28.48 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.503 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 3.1 t -61.86 -20.66 63.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 213' ' ' TYR . 10.9 mm-40 -88.57 -51.44 5.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -44.75 -37.97 4.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -48.88 -63.07 1.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -104.05 -54.29 2.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 209' ' ' GLN . 60.2 m-85 -56.82 -36.18 69.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.7 t30 73.25 36.23 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.21 174.72 49.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.98 142.71 53.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.465 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 92.9 mt -68.25 137.87 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.62 168.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.22 0 CA-C-O 120.821 0.259 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' VAL . 21.1 tp -54.6 -43.82 72.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.785 ' HA ' HG11 ' A' ' 143' ' ' VAL . 3.4 pt20 -51.06 -37.35 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.19 -49.71 26.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.3 -46.43 79.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 27' ' ' LEU . 5.2 m -91.08 168.41 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.5 p -112.33 162.88 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.72 -43.94 73.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.3 -45.46 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -128.93 86.15 58.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -34.34 14.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.39 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.1 mt -78.73 129.2 74.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 111.143 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.658 2.239 . . . . 0.0 112.334 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.495 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -47.69 -48.61 29.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.409 ' CZ ' HG22 ' A' ' 71' ' ' ILE . 90.4 t80 -41.13 -66.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.802 HG13 HD11 ' A' ' 97' ' ' LEU . 41.8 t -45.84 -61.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -40.23 -61.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 43.2 mmtt -46.39 -41.27 13.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 86.7 m -68.69 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.579 HG13 ' CG ' ' A' ' 154' ' ' HIS . 71.7 t -71.79 -61.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -53.62 -35.94 61.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.538 ' CD2' HG11 ' A' ' 93' ' ' VAL . 30.3 t80 -56.72 -49.23 75.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.679 HG22 HD12 ' A' ' 53' ' ' LEU . 17.0 mt -61.67 -20.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -89.75 -14.1 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -95.44 -20.41 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -85.16 23.88 1.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.01 -29.79 3.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.477 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.756 HD11 HG22 ' A' ' 158' ' ' VAL . 6.1 tp 63.25 52.05 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.926 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 16.7 p -133.35 31.61 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 m -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.152 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.09 114.39 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.76 90.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.643 HD12 ' H ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -99.54 -30.13 12.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.98 -47.62 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.71 ' HG3' HG23 ' A' ' 61' ' ' VAL . 14.0 ptt180 -59.59 -15.96 22.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.71 HG23 ' HG3' ' A' ' 60' ' ' ARG . 79.0 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' ASP . 91.5 m . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 19.3 m-20 -39.13 -49.34 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HA ' HD12 ' A' ' 71' ' ' ILE . 35.9 mt-30 -72.49 -29.41 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 66' ' ' THR . 8.5 t0 -59.39 -54.32 48.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 67' ' ' ASP . 20.2 p30 -54.72 -39.26 68.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.436 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 58.2 mt -49.03 -39.53 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -91.25 -55.1 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' HE2' ' CG ' ' A' ' 69' ' ' ASP . 50.1 mtmt -46.29 -48.09 18.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -66.31 -56.64 10.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -40.0 -43.42 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.88 -53.09 52.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -56.5 -40.06 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -149.86 134.33 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -91.01 -20.2 22.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -81.13 45.21 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 pt -106.12 -178.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -145.18 154.53 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.3 mt -89.24 -34.24 16.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.83 -56.63 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -52.32 -31.14 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.471 ' HB3' HG13 ' A' ' 88' ' ' VAL . 9.5 mmm -69.58 -27.8 65.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 59.13 48.16 10.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 86' ' ' MET . 34.5 m -84.45 162.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' VAL . 58.9 p -69.85 121.18 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' THR . 88.4 t -37.07 -55.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.09 -47.14 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.52 -62.75 1.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.538 HG11 ' CD2' ' A' ' 47' ' ' PHE . 97.2 t -44.41 -43.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' LEU . . . -65.19 -46.9 78.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -55.28 26.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -44.96 35.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 111.121 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.802 HD11 HG13 ' A' ' 41' ' ' VAL . 26.7 tp -44.11 -43.84 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -75.8 -46.57 29.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.09 -43.06 3.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -56.79 -46.58 81.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -60.53 -50.22 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.501 ' HB2' HG23 ' A' ' 179' ' ' THR . . . -56.37 -39.88 73.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.57 -39.87 71.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.2 mt -39.02 143.36 0.48 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.711 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.62 31.8 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -133.49 154.83 81.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.731 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.03 68.23 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 148' ' ' PHE . 11.1 tp -62.63 -40.67 97.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.564 HD12 ' HE2' ' A' ' 181' ' ' MET . 65.1 mt -95.51 128.34 38.49 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 111.127 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.9 Cg_endo -69.78 160.48 49.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.344 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 30.6 m-85 -75.45 -36.18 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.5 t -56.19 -14.57 2.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.467 HD21 ' HG3' ' A' ' 139' ' ' LYS . 23.1 mt -127.73 32.0 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.549 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.2 m170 -75.88 -63.15 0.66 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.822 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.71 -11.46 30.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.327 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.92 -32.94 57.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.524 ' CD1' HD13 ' A' ' 109' ' ' ILE . 2.5 mt -70.39 -45.77 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.7 mt -68.09 -55.04 13.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -47.88 -29.35 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.15 -24.89 26.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -81.06 -32.19 34.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -75.75 -1.29 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 128' ' ' GLU . 53.0 mt -62.43 130.76 93.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.639 0.733 . . . . 0.0 111.151 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.58 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.38 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.25 110.81 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -46.07 -54.96 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.2 m -50.98 -56.81 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.516 ' HB2' HG21 ' A' ' 123' ' ' ILE . 63.7 mm-40 -56.25 -38.06 70.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -55.25 -46.54 76.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 207' ' ' GLN . 13.1 mt -70.76 -66.51 0.6 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' LEU . 12.7 m-70 -35.69 -51.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.09 -57.51 9.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 9.3 mt -59.47 -20.52 55.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.533 ' O ' HG12 ' A' ' 137' ' ' VAL . 4.6 ttpm? -81.65 -34.11 30.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 4.5 pt-20 -80.69 -28.61 36.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.545 HG22 ' HE1' ' A' ' 140' ' ' PHE . 39.4 mt -72.58 -34.59 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.097 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.57 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 9.5 p -73.0 -0.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -79.07 -42.92 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.467 ' HG3' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -85.81 18.91 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.57 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 2.7 m-85 -77.67 143.43 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -37.16 141.13 0.43 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.73 -25.6 28.58 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.323 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.785 HG11 ' HA ' ' A' ' 28' ' ' GLN . 40.3 t -92.18 -35.39 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.422 ' OD1' ' CG ' ' A' ' 141' ' ' HIS . 17.6 m120 -81.42 -45.78 15.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.564 ' CE1' ' HD3' ' A' ' 149' ' ' ARG . 4.3 t80 -43.38 -48.53 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -56.25 -59.8 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.7 -63.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.595 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 30.0 t80 -43.97 -44.44 7.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.564 ' HD3' ' CE1' ' A' ' 145' ' ' TYR . 8.2 ttp85 -62.14 -49.04 77.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -59.33 -53.96 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -45.49 -59.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.595 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 75.0 mt -52.08 -52.67 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 m -41.51 -29.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.579 ' CG ' HG13 ' A' ' 45' ' ' VAL . 28.7 t60 -88.44 -42.37 12.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 1.003 HD21 ' CE2' ' A' ' 176' ' ' PHE . 89.8 mt -54.53 -46.84 73.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -51.35 -40.95 60.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -61.3 -41.49 97.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.756 HG22 HD11 ' A' ' 53' ' ' LEU . 76.2 t -60.74 -42.92 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.7 p -61.8 -19.67 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -58.05 -53.2 60.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.474 ' HB3' HD12 ' A' ' 164' ' ' ILE . 8.5 mm100 -99.76 37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.483 ' CG ' HG22 ' A' ' 168' ' ' THR . 19.7 p80 -53.43 -28.25 28.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -67.31 -27.26 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 161' ' ' GLN . 79.3 mt -89.46 -59.03 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' LEU . 3.5 p30 -81.49 15.48 2.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 165' ' ' ASN . 27.3 mt 36.82 50.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 64.3 mmm -145.06 115.24 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.483 HG22 ' CG ' ' A' ' 162' ' ' HIS . 66.1 p -101.19 167.44 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.67 -40.39 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -58.26 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -58.65 -55.67 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.76 -21.73 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.452 ' HB2' ' N ' ' A' ' 202' ' ' GLU . 4.7 p -82.92 -39.16 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 49.4 mt -75.75 -25.1 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.3 p -79.39 -36.92 38.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 1.003 ' CE2' HD21 ' A' ' 155' ' ' LEU . 7.2 m-85 -85.24 -38.71 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.864 ' HA ' HD12 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -39.26 -57.14 2.37 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.546 0.689 . . . . 0.0 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.521 ' HD3' ' CG ' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -48.07 -65.89 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.662 2.242 . . . . 0.0 112.317 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 102' ' ' ALA . 94.6 m -54.39 -55.47 28.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 177' ' ' TRP . 32.8 mt -30.24 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.564 ' HE2' HD12 ' A' ' 109' ' ' ILE . 2.5 ptt? -175.65 143.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.89 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 200' ' ' VAL . 88.4 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.828 0.346 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -41.74 -52.54 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.903 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -63.11 -46.11 88.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.6 t -55.0 -40.93 70.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.445 ' CG1' HD22 ' A' ' 117' ' ' LEU . 79.1 t -37.62 -67.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.5 t -63.9 -51.72 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.452 ' N ' ' HB2' ' A' ' 173' ' ' SER . 15.6 tt0 -37.37 -53.93 1.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.6 m -56.3 -57.26 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 10.7 m-85 -42.62 -36.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 86.0 mt -71.73 -58.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.452 ' HB3' ' CG2' ' A' ' 218' ' ' VAL . 11.3 mt-30 -54.96 -54.76 38.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.497 ' HG3' HD13 ' A' ' 130' ' ' LEU . 61.6 mm-40 -86.44 24.2 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.73 -18.62 62.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 213' ' ' TYR . 18.2 mm-40 -91.6 -51.14 5.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -45.24 -38.49 5.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -50.3 -63.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -106.68 -54.79 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 209' ' ' GLN . 71.4 m-85 -59.62 -16.95 29.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 48.28 47.07 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -90.04 165.6 31.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.89 132.87 42.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 93.4 mt -58.63 106.84 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 206' ' ' GLN . 30.1 m -64.01 168.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.807 0.253 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 31' ' ' VAL . 20.1 tp -61.0 -42.69 98.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.921 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.477 ' HA ' HG11 ' A' ' 143' ' ' VAL . 3.5 pt20 -52.51 -29.23 24.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.81 -48.74 12.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.37 -45.18 84.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 27' ' ' LEU . 5.8 m -87.2 168.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -107.64 146.83 31.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.79 -40.97 6.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.103 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.02 -44.48 82.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 4.5 mmmm -131.02 99.57 17.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.617 0.722 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 54.0 Cg_endo -69.72 -35.51 12.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.343 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.71 129.36 74.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 117.37 5.05 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.527 HD11 ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -40.09 -46.3 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -44.69 -64.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.458 HG13 HD11 ' A' ' 97' ' ' LEU . 21.0 t -43.16 -59.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.168 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -45.1 -61.34 1.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HE2' HD11 ' A' ' 39' ' ' LEU . 49.0 mmtt -46.09 -43.17 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.618 ' HB2' HD13 ' A' ' 97' ' ' LEU . 90.1 m -65.29 -30.33 71.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.503 HG13 ' CG ' ' A' ' 154' ' ' HIS . 95.6 t -79.27 -54.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.04 -43.04 86.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.791 ' CE1' HG21 ' A' ' 93' ' ' VAL . 3.2 t80 -49.59 -60.27 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 76.8 mt -45.11 -44.64 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -63.03 -45.65 91.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.02 -42.3 94.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.6 p -85.89 29.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.147 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.71 153.9 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -120.28 38.96 3.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.478 ' HB2' HG21 ' A' ' 164' ' ' ILE . 19.6 p -117.49 42.3 2.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -97.86 133.51 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.04 120.95 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.51 80.07 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.0 -49.69 69.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.851 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 20.1 m-85 -99.49 -48.96 4.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -38.04 -42.03 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.807 0.337 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -45.77 -52.72 10.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.828 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.861 ' HA ' HD12 ' A' ' 71' ' ' ILE . 7.0 mt-30 -67.89 -32.18 72.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.32 -67.9 0.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -49.12 -42.13 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 68' ' ' GLN . 65.0 mt -50.22 -40.81 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -81.27 -57.08 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -50.98 -59.67 3.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HB3' HD12 ' A' ' 81' ' ' ILE . 32.2 mm-40 -49.09 -47.78 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -61.77 -41.39 97.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.31 -48.09 82.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.1 -29.65 61.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -132.53 93.14 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.802 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -60.57 -34.34 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.17 36.6 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 74' ' ' GLN . 13.1 tt -77.53 156.16 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.446 ' ND2' ' HB ' ' A' ' 84' ' ' VAL . 2.9 t30 -122.04 87.82 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 82' ' ' ASN . 60.0 mt -37.27 -49.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.446 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 50.1 t -50.05 -42.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ASN . 45.6 t -59.96 -35.14 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.7 mmm -68.99 -34.17 74.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 59.22 50.15 8.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -84.79 172.24 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 90' ' ' VAL . 37.1 p -75.04 117.14 16.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 89' ' ' THR . 75.4 t -36.68 -52.89 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 90' ' ' VAL . 2.6 t-20 -37.16 -46.38 0.7 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.08 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.791 HG21 ' CE1' ' A' ' 47' ' ' PHE . 81.5 t -43.66 -46.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.095 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.851 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -51.88 -48.57 64.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.95 -62.71 4.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -43.82 -42.57 5.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 111.066 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.618 HD13 ' HB2' ' A' ' 44' ' ' CYS . 34.8 tp -52.04 -46.91 65.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 99' ' ' ALA . 42.3 mtmt -69.29 -47.92 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.5 -41.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.73 -55.22 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 147' ' ' VAL . 17.3 m-85 -54.16 -52.78 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.474 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -54.28 -42.2 69.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.78 -35.57 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -42.47 141.42 1.5 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -19.49 35.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.642 2.228 . . . . 0.0 112.375 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 155.18 73.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.571 0.701 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 151.07 68.73 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.66 2.24 . . . . 0.0 112.376 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 148' ' ' PHE . 10.2 tp -52.46 -51.39 59.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.493 HG21 ' CD1' ' A' ' 117' ' ' LEU . 29.1 mt -83.42 132.31 50.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 0.0 111.129 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.55 ' CG ' HD12 ' A' ' 113' ' ' LEU . 53.9 Cg_endo -69.71 146.76 61.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.369 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.528 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 20.9 m-85 -60.55 -26.0 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE2' ' A' ' 116' ' ' GLU . 33.1 m -65.57 -35.85 82.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.891 HD23 ' CD ' ' A' ' 116' ' ' GLU . 65.4 mt -92.17 35.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.528 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 4.1 m170 -77.56 -60.02 0.77 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.3 Cg_endo -69.79 -58.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.891 ' CD ' HD23 ' A' ' 113' ' ' LEU . 5.2 pt-20 -44.57 -38.13 4.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 113' ' ' LEU . 10.8 mt -66.64 -38.48 86.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.472 ' CD2' ' HA ' ' A' ' 197' ' ' HIS . 6.9 mt -76.65 -56.27 4.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.91 -28.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -81.74 -31.12 32.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.073 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -78.15 -31.9 49.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -82.94 16.77 2.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 129' ' ' ARG . 73.5 mt -79.03 129.86 71.68 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.638 0.733 . . . . 0.0 111.16 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.93 2.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 126' ' ' LYS . 31.7 m-20 -67.21 95.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 125' ' ' ASP . 27.5 ttpt -33.49 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.413 HG22 ' CD2' ' A' ' 131' ' ' HIS . 86.5 m -57.49 -61.76 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.455 ' CB ' HG21 ' A' ' 123' ' ' ILE . 12.4 mt-10 -44.74 -56.47 4.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 123' ' ' ILE . 7.3 ttm180 -37.75 -52.23 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.466 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 22.2 mt -64.87 -66.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 130' ' ' LEU . 20.1 m-70 -34.56 -45.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.404 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . . . -57.61 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.424 ' CD1' HG21 ' A' ' 203' ' ' THR . 18.9 mt -51.65 -27.53 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 137' ' ' VAL . 49.1 tttp -75.18 -37.87 61.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.9 -26.11 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.568 HG22 ' HE1' ' A' ' 140' ' ' PHE . 36.2 mt -75.33 -36.33 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.574 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 8.5 p -69.83 -0.41 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -82.01 -29.61 31.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' CD ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -97.18 14.17 26.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.833 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.3 m-85 -75.11 140.59 43.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.54 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 4.4 t-80 -34.39 141.05 0.26 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.74 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.275 . . . . 0.0 112.355 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 28' ' ' GLN . 39.7 t -88.8 -33.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -83.26 -47.78 11.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -42.68 -44.88 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.2 -55.49 34.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 101' ' ' PHE . 87.2 t -64.33 -60.1 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD1' HD23 ' A' ' 108' ' ' LEU . 20.8 t80 -38.43 -42.02 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -72.32 -49.52 33.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -52.51 -45.13 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.57 -64.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.538 HG23 HG12 ' A' ' 205' ' ' ILE . 82.1 mt -43.4 -51.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.7 m -43.37 -35.44 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.503 ' CG ' HG13 ' A' ' 45' ' ' VAL . 77.2 t60 -83.36 -37.56 23.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 152' ' ' ILE . 98.8 mt -56.37 -46.32 80.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -51.69 -41.97 61.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.455 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 2.6 mtp-105 -57.12 -35.56 69.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 -42.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.5 p -64.86 -34.53 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 36.2 mt-30 -54.18 -42.25 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.29 37.35 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 166' ' ' LEU . 29.8 p80 -53.96 -34.07 58.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -55.93 -31.22 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 54' ' ' CYS . 74.2 mt -89.75 -58.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.178 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -76.89 7.56 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 162' ' ' HIS . 34.7 mt 40.85 53.38 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 75.4 mmm -152.29 119.85 6.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 169' ' ' ALA . 69.2 p -102.01 153.13 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.173 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.82 -44.29 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.105 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -61.81 -50.87 70.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -53.57 -39.91 65.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 38.9 mt -67.31 -44.35 79.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t -53.59 -50.1 66.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.98 -41.28 89.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.12 -30.66 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.58 -2.27 54.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.582 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.86 -45.95 92.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.96 -53.94 5.92 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.721 2.281 . . . . 0.0 112.296 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.474 HG23 ' CA ' ' A' ' 102' ' ' ALA . 20.5 m -76.28 -67.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 179' ' ' THR . 24.8 mt -34.29 -48.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 4.4 mmm -136.44 120.98 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.905 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.526 0.679 . . . . 0.0 110.905 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 197' ' ' HIS . 72.7 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.89 0.376 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.472 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 51.2 m80 -36.18 -50.67 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.05 -47.35 71.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.2 m -47.4 -36.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.6 t -48.18 -50.46 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 202' ' ' GLU . 45.2 t -65.69 -59.65 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' VAL . 65.4 tt0 -34.48 -64.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 205' ' ' ILE . 38.2 m -41.49 -66.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.8 m-85 -35.43 -33.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.538 HG12 HG23 ' A' ' 152' ' ' ILE . 82.3 mt -84.64 -46.52 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 203' ' ' THR . 5.6 mm-40 -56.27 -59.28 5.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.476 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 6.5 mm-40 -94.61 31.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.5 t -58.64 -21.55 54.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.576 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 5.8 mm-40 -86.24 -54.67 4.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -40.03 -35.77 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -54.71 -63.19 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -107.73 -56.51 2.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.576 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 63.1 m-85 -60.06 -11.55 6.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 46.18 43.65 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.89 168.83 53.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.92 141.89 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.476 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.9 mt -73.91 133.42 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.6 m -109.8 170.97 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.13 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.769 0.237 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.74 HD13 HD21 ' A' ' 104' ' ' LEU . 24.0 tp -46.91 -40.89 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.718 ' HB3' HG21 ' A' ' 143' ' ' VAL . 4.8 pt20 -50.81 -44.65 59.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.95 -46.24 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -57.52 -37.28 72.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 36' ' ' PRO . 10.3 m -89.67 164.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 35' ' ' LYS . 20.4 p -106.53 133.18 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -34.68 -44.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -58.13 -47.68 82.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' THR . 33.1 mmtm -124.75 96.65 40.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.549 0.69 . . . . 0.0 110.862 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.506 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.4 Cg_endo -69.81 -40.35 5.35 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.553 HG12 HG22 ' A' ' 147' ' ' VAL . 15.7 mt -80.51 130.73 63.75 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.673 0.749 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 54.1 Cg_endo -69.71 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.36 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.487 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -38.29 -54.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.415 ' CZ ' ' HG2' ' A' ' 72' ' ' GLN . 25.1 t80 -39.25 -63.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.468 ' CG2' ' HG2' ' A' ' 38' ' ' PRO . 43.1 t -44.31 -52.67 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -53.7 -61.25 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 48.3 mmtt -44.16 -33.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 87.8 m -76.04 -50.44 14.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.613 HG13 ' CG ' ' A' ' 154' ' ' HIS . 96.6 t -58.61 -39.66 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -78.1 -26.36 48.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.552 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 1.1 t80 -79.26 -33.76 43.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG2' HD22 ' A' ' 58' ' ' LEU . 21.5 mt -66.93 -34.24 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -84.36 -33.98 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.83 -24.62 52.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.47 HG21 HG22 ' A' ' 90' ' ' VAL . 47.6 p -84.3 28.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.104 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.64 -32.02 4.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.469 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.517 HD11 HG22 ' A' ' 158' ' ' VAL . 14.2 tp 70.45 27.54 3.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.807 0.337 . . . . 0.0 110.922 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.56 44.65 1.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -101.17 135.59 42.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 57' ' ' GLY . 4.0 mt-10 -65.43 115.62 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.56 68.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.774 HD12 ' N ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -62.48 -15.58 50.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.774 ' N ' HD12 ' A' ' 58' ' ' LEU . 20.0 m-85 -98.22 -56.11 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -59.55 -15.53 18.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.44 HG23 ' CD ' ' A' ' 60' ' ' ARG . 39.0 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.771 0.319 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.481 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 5.1 m-20 -57.81 -58.29 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.436 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 25.3 mt-30 -50.23 -28.34 7.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -60.37 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -57.47 -45.55 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 79.3 mt -47.1 -42.82 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 40' ' ' PHE . 39.1 mt-30 -83.74 -64.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -41.72 -54.0 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.497 ' HB3' HD12 ' A' ' 81' ' ' ILE . 31.6 mm-40 -58.85 -40.22 83.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 65.2 t80 -64.73 -61.15 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.32 -57.09 9.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -52.0 -26.63 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.836 ' O ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -162.23 116.22 1.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -71.61 -33.31 68.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -41.07 -46.23 2.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.888 HD11 ' SD ' ' A' ' 86' ' ' MET . 1.8 tt -45.85 145.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.48 ' N ' HG12 ' A' ' 81' ' ' ILE . 56.3 t30 -128.71 119.32 24.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.45 HD22 HG23 ' A' ' 71' ' ' ILE . 64.5 mt -47.96 -52.94 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.75 -48.27 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -62.9 -44.69 95.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.888 ' SD ' HD11 ' A' ' 81' ' ' ILE . 25.6 mtp -52.17 -33.9 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 57.72 49.74 11.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 86' ' ' MET . 33.0 m -84.5 171.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.3 p -70.96 116.49 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 51' ' ' THR . 58.4 t -39.55 -45.69 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -48.85 -41.92 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.73 -63.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.42 HG21 ' CE1' ' A' ' 47' ' ' PHE . 87.0 t -50.33 -51.59 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.73 -36.79 5.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.76 -57.21 3.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -43.02 -41.72 3.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.088 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -49.33 -53.76 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -64.46 -43.92 92.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.79 -50.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -55.04 -57.87 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.509 ' CB ' HG21 ' A' ' 179' ' ' THR . 34.3 m-85 -50.65 -39.3 50.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.13 80.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.28 -33.99 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.74 HD21 HD13 ' A' ' 27' ' ' LEU . 95.0 mt -40.29 141.44 0.84 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.39 32.22 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.248 . . . . 0.0 112.388 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.59 155.81 75.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 141.22 44.56 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.485 HD12 HD22 ' A' ' 144' ' ' ASN . 15.4 tp -43.62 -51.6 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 91.2 mt -82.09 128.97 66.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.722 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.6 Cg_endo -69.77 158.84 55.58 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.34 -29.05 47.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -65.48 -5.33 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.862 HD13 ' CD1' ' A' ' 140' ' ' PHE . 13.6 mt -133.46 22.09 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.497 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.4 m170 -70.79 -60.17 3.19 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.892 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.628 ' HA ' HD12 ' A' ' 118' ' ' LEU . 53.2 Cg_endo -69.77 -16.39 37.5 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 0.0 112.309 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.29 -36.8 63.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.416 HD11 ' HZ ' ' A' ' 140' ' ' PHE . 14.7 mt -71.79 -26.33 62.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 115' ' ' PRO . 5.4 mt -84.72 -48.47 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -53.59 -31.4 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.17 -25.43 25.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -78.87 -21.33 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -89.47 11.2 20.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.659 HG23 ' HD2' ' A' ' 124' ' ' PRO . 85.9 mt -76.62 138.52 66.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.654 0.74 . . . . 0.0 111.151 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.659 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.6 Cg_endo -69.8 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.276 . . . . 0.0 112.299 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.35 101.27 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.718 ' HE3' HD13 ' A' ' 217' ' ' ILE . 33.6 ttpt -44.01 -48.73 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -56.93 -60.8 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -49.94 -48.07 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -45.47 -51.53 11.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.594 HD13 ' HG3' ' A' ' 207' ' ' GLN . 26.0 mt -65.79 -53.7 36.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -45.48 -55.97 5.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.2 -54.87 17.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 130' ' ' LEU . 10.5 mt -55.53 -36.69 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -68.16 -22.45 64.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -89.27 -48.32 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.629 HG22 ' HE1' ' A' ' 140' ' ' PHE . 19.0 mt -56.61 -34.47 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.492 ' O ' ' CE1' ' A' ' 145' ' ' TYR . 7.1 p -71.25 -6.75 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -87.51 -37.91 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 23.2 1.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.862 ' CD1' HD13 ' A' ' 113' ' ' LEU . 2.3 m-30 -81.79 175.2 10.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.886 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.59 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -65.3 141.14 98.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.584 0.707 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.8 -15.6 37.01 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.266 . . . . 0.0 112.32 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 28' ' ' GLN . 69.6 t -99.21 -25.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.485 HD22 HD12 ' A' ' 108' ' ' LEU . 34.8 m120 -93.98 -33.46 13.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CE1' ' O ' ' A' ' 137' ' ' VAL . 83.1 t80 -65.21 -56.77 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.452 ' OD2' ' CG1' ' A' ' 37' ' ' ILE . 4.6 p-10 -42.86 -49.42 5.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 151' ' ' VAL . 20.0 t -72.46 -55.89 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.747 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 17.4 t80 -42.49 -41.69 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.472 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 19.4 mtp180 -59.8 -59.89 4.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -54.05 -34.63 60.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 147' ' ' VAL . 62.8 t -59.39 -63.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.747 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 21.5 mt -53.01 -53.25 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -39.82 -33.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.613 ' CG ' HG13 ' A' ' 45' ' ' VAL . 74.0 t60 -84.36 -41.86 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 152' ' ' ILE . 76.0 mt -50.83 -48.75 59.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 205' ' ' ILE . 3.9 t-20 -49.33 -45.84 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.457 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 57.5 mtt-85 -53.57 -38.67 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 53' ' ' LEU . 39.5 t -74.77 -43.39 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 26.2 p -60.67 -25.22 66.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 41.2 mt-30 -65.55 -37.03 85.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -105.72 36.35 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.549 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 17.5 p80 -55.0 -38.3 67.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.549 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 18.0 mmmt -59.46 -36.72 76.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.53 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -73.31 2.17 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 162' ' ' HIS . 28.3 mt 49.8 42.82 24.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.7 mmm -141.88 112.02 6.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.3 p -94.11 155.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -41.06 -36.37 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.66 -52.57 50.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -57.44 -45.03 85.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.5 mt -62.46 -46.52 88.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -57.53 -24.23 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.82 -39.44 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 8.4 p -63.35 -32.67 74.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.431 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.4 m-85 -90.02 -12.98 36.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -48.76 -46.57 72.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -48.01 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.509 HG21 ' CB ' ' A' ' 101' ' ' PHE . 40.0 m -64.41 -59.89 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 179' ' ' THR . 70.2 mt -33.72 -48.15 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.548 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 13.2 ptm -159.06 150.82 20.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.61 0.719 . . . . 0.0 110.853 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 200' ' ' VAL . 81.1 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.841 0.353 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.416 ' H ' ' CD2' ' A' ' 197' ' ' HIS . 39.6 m-70 -43.32 -44.82 5.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.18 -54.41 47.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 t -52.81 -40.42 63.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 121' ' ' ALA . 85.3 t -47.1 -69.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.157 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 202' ' ' GLU . 83.1 t -58.14 -60.28 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 201' ' ' VAL . 66.6 tt0 -37.62 -43.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 56.9 m -59.46 -55.38 35.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.547 ' HB3' HD13 ' A' ' 152' ' ' ILE . 9.4 m-85 -38.73 -58.22 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.501 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 63.2 mt -55.56 -50.75 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -53.69 -60.13 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.594 ' HG3' HD13 ' A' ' 130' ' ' LEU . 11.0 mm-40 -92.52 25.57 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.926 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.581 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 1.8 t -60.4 -14.82 21.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' TYR . 14.0 mm-40 -95.86 -57.91 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.473 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.8 t80 -39.76 -30.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.4 m-85 -52.6 -61.87 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -127.02 -28.33 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 209' ' ' GLN . 26.2 m-85 -83.99 26.82 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' TYR . 75.9 m-20 33.48 34.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -59.08 145.87 43.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.12 129.93 35.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.718 HD13 ' HE3' ' A' ' 126' ' ' LYS . 53.3 mt -41.32 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.26 163.96 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.837 0.265 . . . . 0.0 112.383 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 31' ' ' VAL . 14.0 tp -49.39 -49.87 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.679 ' HA ' HG11 ' A' ' 143' ' ' VAL . 10.4 pt20 -46.85 -34.66 5.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.446 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 33.2 t70 -77.28 -45.81 25.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.9 mt -59.45 -46.04 89.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 27' ' ' LEU . 33.3 m -88.27 163.22 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.9 p -108.87 149.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.105 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.73 -46.94 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -50.14 -44.45 52.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.923 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 30.0 mmtt -132.66 99.17 15.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.606 0.717 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.7 Cg_endo -69.79 -41.17 4.47 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.692 2.261 . . . . 0.0 112.344 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.513 HG23 ' HD2' ' A' ' 38' ' ' PRO . 34.1 mt -74.84 134.81 74.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.584 0.707 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 148.32 64.65 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.643 2.228 . . . . 0.0 112.356 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.483 ' CD1' ' HG3' ' A' ' 43' ' ' LYS . 1.1 tm? -65.12 -59.36 4.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' LEU . 24.9 t80 -36.09 -64.86 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.915 HG13 HD11 ' A' ' 97' ' ' LEU . 90.2 t -46.67 -63.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -40.53 -56.01 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG3' ' CD1' ' A' ' 39' ' ' LEU . 64.2 mmtt -53.92 -39.43 65.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 80.7 m -65.23 -41.88 93.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.66 -43.86 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -70.45 -38.76 74.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 93' ' ' VAL . 11.0 t80 -56.58 -50.15 72.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 mt -48.83 -68.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 50' ' ' ASP . 2.7 pp20? -55.18 -53.19 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 21.1 t70 -45.46 -42.89 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 p -88.66 29.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 108.65 1.45 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.22 51.41 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 0.0 110.953 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 80.4 m -132.7 30.88 4.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.436 ' O ' HD12 ' A' ' 58' ' ' LEU . 7.5 m -66.54 122.33 17.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.15 130.38 42.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 45.18 87.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 4.6 mp -83.16 143.61 30.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.353 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.647 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 2.6 m-85 47.87 27.88 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HB2' ' HE1' ' A' ' 167' ' ' MET . 15.4 tpp85 -123.41 -46.84 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.926 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.807 0.337 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.96 -58.27 8.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -58.91 -33.88 71.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.95 -66.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -57.19 -37.85 72.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.496 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 38.7 mt -52.25 -37.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -90.63 -55.65 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.04 -54.87 20.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -54.04 -43.84 70.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -57.38 -40.68 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.29 -62.0 2.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -58.94 -28.65 66.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -129.67 103.98 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -76.33 -27.24 56.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -96.23 37.21 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.608 HD11 ' SD ' ' A' ' 86' ' ' MET . 9.1 tt -80.69 153.77 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.402 ' N ' HG12 ' A' ' 81' ' ' ILE . 20.9 t30 -123.0 94.78 4.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -37.23 -50.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.4 t -43.66 -46.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -57.88 -46.41 84.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.608 ' SD ' HD11 ' A' ' 81' ' ' ILE . 82.0 mtp -56.16 -38.11 70.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 62.05 50.12 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.02 178.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 p -75.63 117.76 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -42.08 -51.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -40.39 -49.48 2.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.45 -56.15 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 47' ' ' PHE . 98.3 t -46.65 -55.24 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.647 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -47.07 -45.36 21.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.49 -60.27 5.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.31 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.915 HD11 HG13 ' A' ' 41' ' ' VAL . 20.9 tp -47.98 -42.94 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -64.96 -43.33 93.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.912 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.94 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -60.54 -35.87 77.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -82.15 -41.0 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.861 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.4 -41.71 98.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -57.28 -40.17 77.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.442 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 47.7 mt -36.56 146.98 0.21 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.602 0.715 . . . . 0.0 110.946 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -27.46 26.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 153.98 81.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.64 0.733 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 156.58 63.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.337 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.67 -45.91 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.3 mt -95.93 117.65 66.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 111.146 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.449 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.74 137.69 36.12 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.662 2.242 . . . . 0.0 112.323 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.584 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 6.0 m-85 -53.05 -36.47 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -54.91 -23.52 19.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 117' ' ' LEU . 60.8 mt -112.97 30.81 6.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.858 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.584 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.6 m170 -74.3 -61.8 1.13 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 110.847 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.589 ' HA ' HD12 ' A' ' 118' ' ' LEU . 54.1 Cg_endo -69.73 -40.32 5.5 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -47.09 -33.55 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.8 mt -71.62 -43.02 66.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 115' ' ' PRO . 6.3 mt -69.1 -57.95 4.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -43.05 -25.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.06 -27.72 15.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.74 -31.72 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -74.1 -15.55 61.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 90.4 mt -50.26 129.35 24.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -46.94 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.252 . . . . 0.0 112.372 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -59.04 106.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -46.94 -46.49 21.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.6 m -59.78 -67.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 129' ' ' ARG . 58.0 mm-40 -46.6 -51.76 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 128' ' ' GLU . 12.2 ttm180 -36.79 -48.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.47 ' CD2' ' HG2' ' A' ' 207' ' ' GLN . 23.0 mt -73.26 -66.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 130' ' ' LEU . 29.9 m-70 -34.14 -49.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.864 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.92 -59.94 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.84 -40.01 59.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -63.45 -26.47 68.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.44 -39.79 13.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.47 -41.56 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 12.9 p -58.75 -24.9 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -60.04 -32.28 70.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -60.42 -34.88 74.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 141' ' ' HIS . 22.6 m-85 -44.91 132.34 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.588 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.1 t-80 -33.99 141.85 0.23 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.588 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -9.55 26.38 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.369 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 28' ' ' GLN . 97.6 t -98.83 -38.99 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -84.28 -38.17 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.515 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 35.5 t80 -51.71 -43.75 62.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.93 -45.71 82.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.23 -59.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 41.0 t80 -47.92 -42.92 28.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.515 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 14.0 mmm180 -65.87 -38.76 89.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -65.28 -45.71 83.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.67 -60.35 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 84.7 mt -46.97 -48.58 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.3 m -44.09 -36.21 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -80.79 -36.39 31.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 152' ' ' ILE . 77.9 mt -59.92 -47.0 87.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -49.04 -43.08 40.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.469 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 26.8 mtp85 -61.79 -38.08 86.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.23 -47.51 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.2 p -56.63 -36.4 69.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.2 mt-30 -53.01 -42.04 65.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.928 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.676 ' HB3' HD12 ' A' ' 164' ' ' ILE . 12.7 mm100 -110.66 35.93 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 166' ' ' LEU . 22.5 p80 -47.35 -35.78 8.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 24.3 mmtp -57.71 -33.82 68.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.676 HD12 ' HB3' ' A' ' 161' ' ' GLN . 92.9 mt -80.13 -59.7 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.145 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -81.99 13.04 3.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 162' ' ' HIS . 16.7 mt 39.53 54.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.465 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 18.0 mmm -154.47 116.06 4.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.441 HG22 ' CG ' ' A' ' 162' ' ' HIS . 68.9 p -93.5 154.86 17.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -40.02 -42.73 1.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.101 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.417 ' CG ' ' HG1' ' A' ' 168' ' ' THR . 1.2 p-10 -63.64 -52.48 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -52.63 -48.21 66.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.41 -44.94 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 71.2 p -63.39 -42.42 98.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.04 -33.59 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 m -72.95 -18.85 61.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 9.6 m-85 -104.25 -9.58 18.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.562 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -50.23 -46.73 83.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.567 0.699 . . . . 0.0 110.909 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.9 Cg_exo -47.97 -59.78 1.12 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.665 2.243 . . . . 0.0 112.334 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 180' ' ' LEU . 25.5 m -69.42 -64.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 179' ' ' THR . 85.2 mt -33.28 -50.18 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 19.4 ptm -157.17 131.26 8.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.845 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 200' ' ' VAL . 40.6 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.85 0.357 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.473 ' ND1' HD21 ' A' ' 118' ' ' LEU . 94.7 m-70 -34.2 -38.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 196' ' ' ILE . 75.5 mt-30 -80.72 -50.6 9.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.2 p -54.65 -24.89 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 196' ' ' ILE . 92.6 t -58.97 -66.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.53 -37.41 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -55.24 -45.51 76.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.9 m -60.07 -53.87 52.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.401 ' HB3' HD13 ' A' ' 152' ' ' ILE . 6.1 m-85 -39.15 -38.86 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 152' ' ' ILE . 60.5 mt -74.56 -65.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.42 ' HB3' HG23 ' A' ' 218' ' ' VAL . 36.7 mt-30 -45.39 -52.55 9.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.47 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 24.1 mp0 -94.2 29.35 2.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.449 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 35.7 t -67.0 -29.62 69.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 213' ' ' TYR . 9.6 mm-40 -81.85 -45.14 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -48.93 -37.57 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -49.47 -63.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -105.21 -55.76 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 209' ' ' GLN . 80.7 m-85 -57.41 -23.97 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.922 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 59.86 39.76 20.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.851 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -72.92 -177.9 33.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.64 145.44 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.66 116.35 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.42 HG23 ' HB3' ' A' ' 206' ' ' GLN . 30.0 m -91.56 174.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.808 0.253 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 147' ' ' VAL . 31.0 tp -60.36 -49.04 79.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.667 ' CB ' HG21 ' A' ' 143' ' ' VAL . 3.6 pt20 -47.46 -28.24 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -45.54 14.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.76 -44.93 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 27' ' ' LEU . 20.0 m -91.2 167.14 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -113.44 167.69 10.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.08 -48.45 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.24 -54.77 43.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -115.3 85.23 12.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.446 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.4 Cg_endo -69.79 -31.71 19.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.0 mt -80.87 130.17 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 111.134 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.09 47.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.442 HD21 ' HE2' ' A' ' 43' ' ' LYS . 5.3 tp -67.19 -31.77 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' A' ' 100' ' ' PHE . 42.0 t80 -56.38 -48.47 76.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 97' ' ' LEU . 19.7 t -65.12 -50.68 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.074 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -58.48 -60.99 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HE2' HD21 ' A' ' 39' ' ' LEU . 17.7 mmtt -46.3 -30.37 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.6 m -76.72 -34.37 58.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.535 HG13 ' CG ' ' A' ' 154' ' ' HIS . 93.2 t -76.78 -60.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -54.54 -39.9 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 51' ' ' THR . 20.3 t80 -53.24 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mt -46.05 -52.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.22 -52.41 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.19 -33.54 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.497 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 82.1 p -91.92 23.66 3.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.09 154.69 24.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.501 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.78 47.73 2.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.0 p -132.39 40.32 3.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -97.84 130.88 44.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -67.14 127.22 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.59 77.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.533 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.27 -66.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.96 -37.11 22.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -50.34 -47.56 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.83 -47.38 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.741 ' HA ' HD12 ' A' ' 71' ' ' ILE . 7.4 mt-30 -65.43 -20.82 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.14 -69.87 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.2 p30 -47.49 -39.25 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 68' ' ' GLN . 50.1 mt -47.15 -42.54 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.97 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -45.98 -58.4 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -54.2 -58.18 8.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -55.39 -27.91 50.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.55 -57.33 7.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -73.09 -23.61 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -124.38 120.37 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -95.06 -14.01 24.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -104.55 31.18 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 3.2 tt -76.27 158.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.509 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 7.0 t30 -126.24 94.72 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.9 mt -44.87 -45.71 10.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -48.68 -36.81 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.2 t -66.59 -39.24 88.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.525 ' HB3' HG13 ' A' ' 88' ' ' VAL . 6.7 mmm -69.06 -28.9 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 55.83 35.86 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 86' ' ' MET . 16.2 m -66.67 148.72 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.8 p -55.63 129.91 40.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.43 -41.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -52.34 -39.22 60.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.47 -59.76 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.0 -53.31 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.59 -33.62 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 -57.7 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.463 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.4 -31.59 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 41' ' ' VAL . 46.1 tp -56.39 -47.96 77.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -64.37 -34.43 78.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.31 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . 7.3 t80 -67.08 -24.96 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.624 ' HB2' HG21 ' A' ' 179' ' ' THR . 51.9 m-85 -90.11 -28.6 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.14 -34.66 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.0 -36.23 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.4 mt -38.56 142.55 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.925 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.24 32.31 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.23 157.37 76.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.85 26.59 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.338 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp -40.59 -42.54 1.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.41 130.02 36.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 111.136 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 159.36 53.67 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.665 2.243 . . . . 0.0 112.343 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.31 -20.64 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.623 ' O ' HD23 ' A' ' 113' ' ' LEU . 21.3 t -76.58 -1.51 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.827 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.633 HD22 ' HE2' ' A' ' 139' ' ' LYS . 18.3 mt -134.78 17.72 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.477 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 3.8 m170 -61.47 -60.49 10.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.606 0.717 . . . . 0.0 110.832 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.76 -36.57 10.55 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.691 2.261 . . . . 0.0 112.375 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -51.86 -32.03 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mt -73.28 -23.87 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 121' ' ' ALA . 19.1 mt -94.65 -59.25 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -45.03 -24.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.502 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -96.04 -27.33 15.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -79.65 -18.29 51.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -86.31 -0.63 56.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.554 HG21 ' HB2' ' A' ' 128' ' ' GLU . 79.6 mt -66.37 129.85 94.18 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.631 0.729 . . . . 0.0 111.107 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.0 2.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.4 t70 -61.65 94.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.527 ' HD3' HG21 ' A' ' 217' ' ' ILE . 3.4 ttmt -34.88 -39.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.6 m -65.16 -67.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.554 ' HB2' HG21 ' A' ' 123' ' ' ILE . 8.3 mt-10 -49.07 -48.55 44.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -45.0 -55.16 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.63 HD22 ' HG3' ' A' ' 207' ' ' GLN . 18.7 mt -65.92 -58.74 4.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.65 -43.37 2.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.502 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -59.69 -45.51 91.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 130' ' ' LEU . 8.3 mt -69.07 -25.59 64.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -76.25 -30.51 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 0.5 OUTLIER -88.71 -30.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.404 ' O ' ' CD1' ' A' ' 140' ' ' PHE . 54.9 mt -71.83 -25.12 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.35 -7.58 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -81.89 -31.24 31.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.633 ' HE2' HD22 ' A' ' 113' ' ' LEU . 12.1 pttt -88.94 14.05 11.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.632 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.0 m-85 -77.84 166.88 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.9 t-80 -54.96 140.85 60.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.597 0.713 . . . . 0.0 110.88 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.71 -24.31 30.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.703 2.269 . . . . 0.0 112.334 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.667 HG21 ' CB ' ' A' ' 28' ' ' GLN . 17.2 t -91.11 -40.84 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 145' ' ' TYR . 28.8 m120 -77.7 -48.99 15.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.482 ' CZ ' ' HD2' ' A' ' 149' ' ' ARG . 19.7 t80 -37.39 -56.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -49.18 -65.26 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 27' ' ' LEU . 44.1 t -49.75 -59.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -43.26 -45.78 5.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.482 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 5.3 mtt-85 -63.3 -56.48 16.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -46.04 -45.2 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -56.09 -62.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.559 HG22 ' SG ' ' A' ' 208' ' ' CYS . 5.2 mt -48.02 -50.93 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -42.18 -38.78 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.535 ' CG ' HG13 ' A' ' 45' ' ' VAL . 56.0 t60 -79.74 -35.73 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 152' ' ' ILE . 95.6 mt -57.29 -44.02 83.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 205' ' ' ILE . 8.5 t-20 -52.1 -46.55 65.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.455 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 44.2 mtt-85 -57.14 -42.39 80.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.785 HG11 HD21 ' A' ' 172' ' ' LEU . 89.9 t -64.32 -47.24 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.6 p -59.3 -40.16 85.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.8 mt-30 -49.7 -44.2 47.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.485 ' OE1' HD12 ' A' ' 164' ' ' ILE . 6.2 mm-40 -100.29 54.17 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.493 ' CG ' HG22 ' A' ' 168' ' ' THR . 2.3 p80 -84.58 29.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -110.17 -36.76 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.485 HD12 ' OE1' ' A' ' 161' ' ' GLN . 24.7 mt -92.27 -47.32 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -88.33 -6.8 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.8 mt 49.44 50.34 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 74.1 mmm -127.6 85.62 2.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.493 HG22 ' CG ' ' A' ' 162' ' ' HIS . 71.0 p -77.77 153.24 33.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.14 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -39.03 -36.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -66.96 -48.72 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -61.76 -40.34 94.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.785 HD21 HG11 ' A' ' 158' ' ' VAL . 13.1 mt -65.49 -47.73 75.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.7 p -55.61 -48.37 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.2 mt -65.67 -38.97 83.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.7 m -63.08 -9.73 11.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.422 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.8 m-85 -118.27 -9.48 10.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.581 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -50.64 -46.0 85.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.556 0.694 . . . . 0.0 110.942 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.6 Cg_exo -47.98 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.651 2.234 . . . . 0.0 112.37 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 101' ' ' PHE . 52.9 m -63.95 -63.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 179' ' ' THR . 45.6 mt -34.3 -60.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 7.4 ptp -139.11 127.63 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.596 0.712 . . . . 0.0 110.854 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 200' ' ' VAL . 51.5 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.908 0.385 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -42.05 -55.46 3.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -40.97 72.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.7 t -50.19 -36.76 31.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.529 HG22 ' CB ' ' A' ' 121' ' ' ALA . 93.4 t -53.47 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.122 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.98 -52.7 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -46.83 -45.88 20.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.4 m -55.77 -57.24 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.542 ' HB3' HD13 ' A' ' 152' ' ' ILE . 12.7 m-85 -38.97 -52.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.421 HD11 HD13 ' A' ' 155' ' ' LEU . 68.6 mt -58.54 -53.86 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -52.76 -55.2 24.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.63 ' HG3' HD22 ' A' ' 130' ' ' LEU . 10.2 mm-40 -93.36 24.68 3.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.569 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 13.2 t -63.37 -7.3 6.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 213' ' ' TYR . 5.8 mm-40 -103.44 -60.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.471 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 4.0 t80 -40.02 -27.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -56.09 -61.97 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -125.88 -26.86 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.501 ' O ' ' N ' ' A' ' 215' ' ' GLY . 32.1 m-85 -83.94 25.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' TYR . 0.4 OUTLIER 34.4 32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -61.7 175.86 5.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -110.06 146.29 35.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.882 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.527 HG21 ' HD3' ' A' ' 126' ' ' LYS . 89.8 mt -65.42 111.51 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.28 168.24 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.425 ' C ' ' CD ' ' A' ' 219' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.82 0.258 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 31' ' ' VAL . 21.1 tp -47.3 -56.35 6.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.849 ' HA ' HG11 ' A' ' 143' ' ' VAL . 7.4 pt20 -44.22 -32.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.81 -49.4 18.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.63 -42.09 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 27' ' ' LEU . 28.3 m -89.33 156.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.8 p -103.65 159.85 15.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.65 -44.82 63.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -57.36 -46.5 83.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -126.48 88.28 54.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.859 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.419 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.5 Cg_endo -69.76 -36.13 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.98 131.29 63.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.721 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 120.98 7.68 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.403 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -43.89 -50.08 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.498 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 84.7 t80 -42.58 -66.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.425 HG13 HD11 ' A' ' 97' ' ' LEU . 37.5 t -42.72 -57.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -48.56 -57.7 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 47.6 mmtt -46.77 -39.81 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 88.7 m -67.01 -36.8 82.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG13 ' CG ' ' A' ' 154' ' ' HIS . 99.2 t -72.44 -53.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -60.63 -35.87 77.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.675 ' CE2' HG21 ' A' ' 93' ' ' VAL . 65.6 t80 -60.77 -65.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -37.2 -39.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.57 -41.68 60.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 47' ' ' PHE . 5.4 m-20 -62.18 -43.73 98.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -79.57 -29.82 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.144 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.04 119.7 1.09 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.495 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -94.62 -32.86 13.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.43 39.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 56' ' ' GLU . 24.3 m -87.16 112.47 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.3 tt0 -37.01 125.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.19 89.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 58' ' ' LEU . 1.6 pt? -106.03 -36.88 6.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.819 0.342 . . . . 0.0 110.907 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 10.8 m-85 -84.13 -61.23 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.555 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -57.65 -12.02 2.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.555 HG23 ' CD ' ' A' ' 60' ' ' ARG . 38.5 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.738 0.304 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -43.26 -49.69 6.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.574 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 14.2 mt-30 -63.75 -29.45 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.3 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 20.8 p30 -50.52 -43.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.46 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 81.1 mt -51.05 -42.52 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -78.51 -57.29 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.93 -67.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -38.74 -52.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 86.2 t80 -54.16 -55.59 26.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.98 -46.47 71.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -60.83 -33.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.28 141.88 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -93.33 -18.7 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -78.32 46.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.7 pt -109.25 175.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -142.16 117.53 10.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.97 -43.09 83.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.11 -42.24 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 t -60.55 -43.57 97.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 mtp -60.54 -29.82 69.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.811 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.11 43.42 29.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.58 168.36 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 p -65.9 118.16 9.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -38.72 -47.29 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -46.31 -42.97 15.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.39 -59.91 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.675 HG21 ' CE2' ' A' ' 47' ' ' PHE . 58.7 t -51.59 -59.68 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.78 -38.88 0.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.113 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.3 -58.72 2.69 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.44 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -42.36 -39.99 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 111.091 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.425 HD11 HG13 ' A' ' 41' ' ' VAL . 16.4 tp -52.23 -51.21 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -67.26 -41.19 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.88 -39.87 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.61 -52.55 64.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.691 ' HB2' HG21 ' A' ' 179' ' ' THR . 49.4 m-85 -60.34 -43.66 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.32 -41.26 79.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -35.56 65.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.0 mt -39.24 143.9 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.652 0.739 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.61 34.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.706 2.271 . . . . 0.0 112.326 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 156.85 68.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 140.39 42.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.371 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -43.91 -49.48 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.7 mt -87.45 125.02 66.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.609 0.719 . . . . 0.0 111.142 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.731 ' HG2' HD12 ' A' ' 113' ' ' LEU . 54.0 Cg_endo -69.76 150.61 68.42 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 7.6 m-85 -67.03 -25.59 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 t -65.14 -15.94 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.94 HD13 ' CE1' ' A' ' 140' ' ' PHE . 21.5 mt -118.55 26.0 9.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.497 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.8 m170 -71.63 -60.22 2.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.598 0.713 . . . . 0.0 110.903 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.74 -25.56 28.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.27 . . . . 0.0 112.326 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.521 ' O ' HD13 ' A' ' 136' ' ' ILE . 51.3 mm-40 -68.16 -35.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.489 ' HB3' HG11 ' A' ' 200' ' ' VAL . 7.5 mt -72.52 -25.68 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 121' ' ' ALA . 9.8 mt -88.75 -58.65 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -39.47 -30.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.68 -37.68 20.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -65.54 -17.77 64.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.095 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -96.79 26.42 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.98 131.48 39.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.649 0.737 . . . . 0.0 111.139 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -45.78 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.2 m-20 -70.92 95.53 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -35.61 -54.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.9 m -51.64 -51.95 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.85 -45.46 90.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -50.11 -44.46 52.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.25 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -43.15 -50.35 6.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.61 -60.21 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 22.8 mt -52.04 -38.12 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 137' ' ' VAL . 27.5 tttm -62.93 -26.4 68.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 -42.06 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 116' ' ' GLU . 86.4 mt -64.5 -18.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 134' ' ' LYS . 7.6 p -90.51 -6.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -78.95 -39.03 35.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -76.02 -1.93 28.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.94 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -64.67 137.05 57.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.534 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -38.69 141.73 0.56 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.599 0.714 . . . . 0.0 110.86 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.7 -15.98 37.58 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.849 HG11 ' HA ' ' A' ' 28' ' ' GLN . 21.4 t -96.04 -39.0 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -76.33 -41.97 46.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 3.1 t80 -56.58 -59.45 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 145' ' ' TYR . 3.4 t0 -35.69 -45.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 151' ' ' VAL . 49.0 t -76.5 -44.21 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.567 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 31.2 t80 -52.86 -46.13 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -66.28 -48.11 71.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -56.28 -44.7 80.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 147' ' ' VAL . 58.2 t -58.74 -64.23 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.181 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.585 HG23 HG12 ' A' ' 205' ' ' ILE . 78.1 mt -45.46 -52.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.122 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.8 m -41.04 -38.31 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.424 ' CG ' HG13 ' A' ' 45' ' ' VAL . 19.3 t60 -78.81 -39.45 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 152' ' ' ILE . 98.7 mt -56.58 -47.1 80.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.79 -44.76 39.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 22.4 mtt-85 -60.38 -28.03 67.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.04 -40.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 84.2 p -64.0 -26.36 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 40.1 mt-30 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.566 ' HB3' HD12 ' A' ' 164' ' ' ILE . 2.1 mm100 -103.38 32.43 3.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.562 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 11.5 p80 -52.73 -43.43 65.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.562 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 14.3 mmtp -59.54 -28.55 67.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 161' ' ' GLN . 82.2 mt -83.09 -55.92 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 166' ' ' LEU . 1.3 m-20 -92.4 22.1 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 162' ' ' HIS . 11.5 mt 35.18 53.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.5 mmm -148.64 110.39 4.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ALA . 61.2 p -96.59 154.01 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.08 -41.6 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.95 -50.04 65.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 168' ' ' THR . 38.8 m-20 -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.65 -42.43 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 t -60.27 -27.95 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 47.5 mt -83.43 -35.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.98 -21.33 64.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -104.5 -11.32 17.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.22 -46.45 93.93 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.598 0.713 . . . . 0.0 110.933 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.4 Cg_exo -48.0 -57.4 2.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 0.0 112.346 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 101' ' ' PHE . 59.8 m -73.35 -61.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 80.7 mt -32.54 -48.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.484 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 14.1 ptm -158.29 141.97 15.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.829 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.848 -179.88 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 200' ' ' VAL . 96.1 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.487 ' ND1' HD21 ' A' ' 118' ' ' LEU . 51.8 m-70 -47.84 -58.76 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.84 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -53.36 -50.32 65.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 m -50.1 -41.48 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 196' ' ' ILE . 66.8 t -44.07 -71.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 202' ' ' GLU . 95.3 t -61.1 -59.68 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 201' ' ' VAL . 10.1 tt0 -34.16 -47.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -60.0 -57.04 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -39.12 -34.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.585 HG12 HG23 ' A' ' 152' ' ' ILE . 95.2 mt -80.81 -62.0 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -47.91 -51.94 21.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.474 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 26.5 mp0 -95.42 30.6 2.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.404 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 8.8 t -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.485 ' NE2' ' CD2' ' A' ' 213' ' ' TYR . 6.1 mm-40 -84.65 -53.88 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -40.45 -37.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 19.2 m-85 -53.06 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.21 -55.29 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.485 ' CD2' ' NE2' ' A' ' 209' ' ' GLN . 69.9 m-85 -60.34 -9.96 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.959 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 t30 49.07 37.19 10.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -68.66 172.05 36.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.71 154.86 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.16 132.57 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.85 177.98 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.761 0.234 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.1 tp -45.03 -55.37 5.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.88 ' HA ' HG11 ' A' ' 143' ' ' VAL . 5.2 pt20 -46.46 -36.16 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.63 -39.95 61.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.19 -44.84 82.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -93.37 171.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 p -111.53 147.95 34.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.56 -45.12 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -54.59 -45.44 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 29.8 mmtt -129.34 93.42 35.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 110.948 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.3 Cg_endo -69.73 -38.92 7.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.732 2.288 . . . . 0.0 112.346 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 mt -78.2 128.46 78.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.664 0.745 . . . . 0.0 111.089 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.87 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.699 2.266 . . . . 0.0 112.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.663 HD11 ' HE3' ' A' ' 43' ' ' LYS . 2.4 tm? -99.13 -49.21 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -46.53 -50.32 17.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 97' ' ' LEU . 43.5 t -57.51 -58.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.091 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -46.45 -56.21 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.663 ' HE3' HD11 ' A' ' 39' ' ' LEU . 12.0 mmtp -43.97 -44.53 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 85.3 m -66.76 -62.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -45.36 -47.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.12 -37.17 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.707 ' CD1' HG21 ' A' ' 93' ' ' VAL . 4.9 t80 -55.61 -59.19 5.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 47' ' ' PHE . 10.7 mt -34.82 -68.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.96 -45.71 89.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -40.13 -50.49 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -87.26 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 48' ' ' ILE . . . 149.15 156.21 7.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.506 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.71 HD11 HG22 ' A' ' 158' ' ' VAL . 11.2 tp -126.05 41.45 3.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.307 . . . . 0.0 110.902 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 p -129.92 41.85 3.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 58' ' ' LEU . 50.4 m -95.96 116.25 28.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -39.12 116.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 72.37 0.56 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.506 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.616 HD22 ' O ' ' A' ' 55' ' ' THR . 4.1 mm? -41.73 -45.33 3.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 110.948 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CE2' ' HB1' ' A' ' 94' ' ' ALA . 6.5 m-85 -117.9 -41.69 2.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 59' ' ' TYR . 16.8 tpp85 -34.7 -47.22 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.8 0.333 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.01 -50.47 19.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -59.97 -39.08 84.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -46.3 -53.2 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.0 p30 -66.03 -38.2 87.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 68' ' ' GLN . 68.6 mt -51.42 -39.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -87.06 -60.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -46.83 -35.63 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 70' ' ' ASN . 52.1 mm-40 -77.7 -43.31 31.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -53.47 -28.81 32.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -75.71 -60.68 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -61.52 -25.84 67.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -130.62 107.07 8.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -79.68 -25.41 41.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -97.35 36.56 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.0 tt -79.83 147.46 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -124.86 102.87 7.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -44.65 -50.22 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.5 t -46.46 -50.1 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -56.5 -46.47 80.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.417 ' HB3' HG13 ' A' ' 88' ' ' VAL . 22.3 mmm -60.03 -26.8 66.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 51.96 51.45 16.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 86' ' ' MET . 34.1 m -85.36 160.2 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 p -56.13 125.18 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.2 t -43.48 -46.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.147 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -51.73 -35.72 44.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.69 -58.44 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.707 HG21 ' CD1' ' A' ' 47' ' ' PHE . 78.4 t -58.49 -37.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB1' ' CE2' ' A' ' 59' ' ' TYR . . . -58.84 -42.22 88.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.076 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.16 -45.89 7.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.39 -46.71 73.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 41' ' ' VAL . 23.2 tp -46.06 -44.19 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.564 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 30.9 mtmt -71.25 -42.06 69.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.33 -48.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 4.6 t80 -58.47 -48.61 80.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -53.95 -47.62 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.432 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -59.1 -41.46 88.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -53.18 -34.63 57.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -39.26 147.47 0.3 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -25.02 28.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.377 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -135.48 155.82 78.2 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.427 ' HG3' ' CE1' ' A' ' 111' ' ' TYR . 53.6 Cg_endo -69.77 136.57 33.3 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.717 2.278 . . . . 0.0 112.38 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.463 HD21 ' CD1' ' A' ' 148' ' ' PHE . 24.1 tp -43.55 -41.3 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.2 mt -95.05 123.88 55.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.702 . . . . 0.0 111.139 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 140.85 43.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.248 . . . . 0.0 112.323 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.559 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 6.3 m-85 -62.75 -22.4 66.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -66.81 -22.19 66.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 117' ' ' LEU . 41.4 mt -116.58 32.11 6.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.559 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.3 m170 -74.62 -61.48 1.11 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 0.0 110.832 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.72 -27.18 26.96 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.688 2.259 . . . . 0.0 112.325 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -63.77 -33.99 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.5 mt -73.42 -41.54 63.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.565 HD23 HG21 ' A' ' 200' ' ' VAL . 8.8 mt -69.82 -57.2 5.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -43.82 -35.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.7 -26.79 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.081 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.9 -30.4 50.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -77.56 -10.99 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 55.4 mt -51.85 132.61 38.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.16 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -65.63 113.7 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.752 ' HD3' HG21 ' A' ' 217' ' ' ILE . 17.8 ttmt -52.09 -50.89 60.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.8 m -54.59 -65.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.172 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -43.45 -52.81 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -41.01 -52.56 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.5 mt -60.47 -57.22 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.34 -51.64 25.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.01 -24.6 67.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.525 ' O ' HG12 ' A' ' 137' ' ' VAL . 32.4 tttm -77.71 -33.04 53.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.1 pt-20 -83.69 -35.46 24.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.496 HG23 ' HZ2' ' A' ' 139' ' ' LYS . 54.3 mt -69.2 -36.57 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 134' ' ' LYS . 8.8 p -65.16 -21.13 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -72.09 -39.48 68.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.496 ' HZ2' HG23 ' A' ' 136' ' ' ILE . 4.6 mttp -59.62 -33.52 71.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -41.98 145.82 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.564 ' CE1' ' NE2' ' A' ' 28' ' ' GLN . 2.4 t-80 -43.25 142.18 1.68 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.816 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.84 -6.4 18.54 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 28' ' ' GLN . 48.8 t -99.19 -45.9 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -79.22 -38.06 36.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.3 t80 -42.74 -47.92 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -52.42 65.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -55.93 -64.12 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.587 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 31.3 t80 -43.55 -49.37 7.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 mtp85 -60.5 -47.06 87.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.13 -44.28 92.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 70.9 t -56.93 -60.53 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.67 HG23 HG12 ' A' ' 205' ' ' ILE . 56.3 mt -48.5 -50.14 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.6 m -40.4 -32.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.6 -36.83 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 152' ' ' ILE . 75.1 mt -55.96 -46.81 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -49.28 -41.68 38.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.472 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 23.3 mtp85 -60.63 -32.84 71.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 53' ' ' LEU . 47.0 t -73.72 -39.4 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 p -66.22 -28.05 68.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.3 mt-30 -63.33 -37.35 86.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.664 ' OE1' HD12 ' A' ' 164' ' ' ILE . 16.2 mm-40 -98.3 32.31 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.561 ' HB2' HG22 ' A' ' 168' ' ' THR . 7.8 p80 -57.13 -21.32 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -82.96 -17.56 43.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.664 HD12 ' OE1' ' A' ' 161' ' ' GLN . 60.2 mt -100.12 -63.93 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.73 22.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 165' ' ' ASN . 22.8 mt 33.12 54.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 38.1 mmm -142.68 105.82 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.561 HG22 ' HB2' ' A' ' 162' ' ' HIS . 72.4 p -94.7 150.05 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -33.81 -50.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -55.04 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -55.16 -38.81 68.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.519 HD11 ' HB ' ' A' ' 158' ' ' VAL . 79.5 mt -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -71.67 -34.65 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.699 HD11 ' OE1' ' A' ' 198' ' ' GLN . 27.5 mt -80.7 -28.39 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.9 m -75.9 -21.21 57.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.564 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 14.3 m-85 -103.7 -8.74 19.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.568 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.5 OUTLIER -54.37 -46.92 98.88 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.52 0.676 . . . . 0.0 110.902 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.7 Cg_exo -48.02 -48.64 15.84 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 180' ' ' LEU . 39.7 m -81.83 -59.13 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 58.9 mt -33.17 -69.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.566 ' HG2' ' CH2' ' A' ' 177' ' ' TRP . 3.2 ttp -121.01 118.75 30.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.402 ' C ' ' HD3' ' A' ' 182' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.585 0.707 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.749 ' O ' HG23 ' A' ' 200' ' ' VAL . 81.8 mt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.861 0.362 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.554 ' CD2' HD21 ' A' ' 118' ' ' LEU . 6.0 m80 -50.81 -60.16 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.699 ' OE1' HD11 ' A' ' 174' ' ' ILE . 70.1 mt-30 -57.2 -43.94 83.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 t -55.92 -39.34 71.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 196' ' ' ILE . 92.8 t -46.7 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.124 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.42 -55.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.147 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -40.62 -40.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 204' ' ' PHE . 49.5 m -58.98 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 208' ' ' CYS . 10.7 m-85 -36.08 -56.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.67 HG12 HG23 ' A' ' 152' ' ' ILE . 60.7 mt -59.56 -46.43 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -55.57 -58.03 9.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -99.72 28.98 4.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.564 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -57.91 -27.48 63.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -82.34 -54.55 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.18 -36.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -50.54 -63.17 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -104.61 -55.74 2.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -55.0 -35.63 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 71.28 39.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -75.53 178.04 48.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.48 137.14 47.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.752 HG21 ' HD3' ' A' ' 126' ' ' LYS . 77.7 mt -59.16 125.92 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.28 170.31 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.166 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.94 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.21 0 CA-C-O 120.789 0.245 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 31' ' ' VAL . 17.8 tp -78.74 -45.51 20.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.733 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -48.15 -28.12 2.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -78.02 -45.66 23.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.5 mt -66.16 -42.78 88.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 27' ' ' LEU . 18.3 m -87.77 155.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -103.68 157.78 16.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.05 -44.19 30.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -58.74 -48.84 79.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -121.63 87.6 45.99 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.54 0.686 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.17 9.57 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.656 2.237 . . . . 0.0 112.364 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.434 HG23 ' HD2' ' A' ' 38' ' ' PRO . 72.1 mt -77.35 132.95 68.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.643 0.735 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.82 140.02 41.44 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.26 . . . . 0.0 112.316 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -55.24 -54.07 48.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 39' ' ' LEU . 82.4 t80 -38.17 -69.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.563 HG13 HD11 ' A' ' 97' ' ' LEU . 53.0 t -42.79 -55.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -50.29 -57.84 6.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HG2' HD13 ' A' ' 39' ' ' LEU . 36.2 mmtt -46.74 -39.13 11.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.431 ' HB2' HD13 ' A' ' 97' ' ' LEU . 73.0 m -68.01 -44.73 75.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.67 -53.09 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.8 -45.37 94.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 83' ' ' LEU . 57.8 t80 -43.06 -63.21 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -53.88 -57.3 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -40.85 -53.37 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -59.7 -39.72 85.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -86.37 26.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.148 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.48 172.55 48.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.469 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.66 37.36 3.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.6 p -116.63 29.68 7.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.732 ' O ' HD22 ' A' ' 58' ' ' LEU . 77.9 m -68.81 114.23 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.182 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.03 114.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.43 96.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 55' ' ' THR . 1.8 mm? -90.08 112.29 23.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.348 . . . . 0.0 110.917 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 22.0 m-85 72.29 33.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -126.63 -38.02 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.46 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 21.3 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.838 0.351 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.2 -55.9 7.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HA ' HD12 ' A' ' 71' ' ' ILE . 18.9 mt-30 -59.46 -21.36 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.93 -61.41 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.7 p30 -61.46 -41.0 96.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.476 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 80.9 mt -52.34 -43.11 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -81.88 -53.88 5.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ASP . 50.9 mttt -54.62 -65.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -40.94 -44.33 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.5 -35.9 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.9 t0 -66.98 -55.48 14.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -54.72 -34.53 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -158.12 151.81 23.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.15 -19.07 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -80.81 49.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.57 -177.78 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.479 ' ND2' ' HB ' ' A' ' 84' ' ' VAL . 4.9 t30 -145.72 139.82 26.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . 14.7 mt -84.25 -41.25 17.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.479 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 88.4 t -48.55 -50.22 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -57.53 -41.59 81.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 mtp -61.27 -26.43 67.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 54.08 45.81 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.6 151.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.107 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 p -60.83 129.77 43.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.5 t -42.83 -52.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.46 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 9.9 m120 -40.82 -48.07 3.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.5 -62.86 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.415 HG21 ' CE2' ' A' ' 47' ' ' PHE . 65.6 t -48.7 -54.03 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -46.46 -41.39 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.78 -60.16 4.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.67 -41.29 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.563 HD11 HG13 ' A' ' 41' ' ' VAL . 15.7 tp -49.64 -49.92 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 101' ' ' PHE . 32.5 mtmt -68.22 -47.46 67.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.13 -33.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -65.38 -47.12 77.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 151' ' ' VAL . 41.5 m-85 -57.04 -44.49 82.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.49 -39.6 88.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.49 -37.99 82.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -37.78 141.6 0.47 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -24.12 29.74 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.232 . . . . 0.0 112.343 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.68 153.83 77.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.655 0.74 . . . . 0.0 110.838 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 134.77 28.76 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.351 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' A' ' 148' ' ' PHE . 19.1 tp -38.95 -52.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.3 mt -87.35 124.35 68.27 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 0.0 111.155 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 154.82 67.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.69 2.26 . . . . 0.0 112.352 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.538 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 21.7 m-85 -68.85 -26.47 65.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 m -65.71 -25.41 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.863 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.6 mt -111.58 36.66 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.967 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.552 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 2.7 m170 -77.94 -65.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.561 0.696 . . . . 0.0 110.829 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.71 -21.44 33.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.739 2.293 . . . . 0.0 112.344 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.64 -28.55 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.536 HD22 ' CG1' ' A' ' 200' ' ' VAL . 2.5 mt -79.91 -36.6 36.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.6 -46.47 25.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.95 -31.79 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 132' ' ' ALA . . . -86.84 -29.25 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.7 -21.17 59.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -91.97 22.04 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.07 130.07 45.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -44.83 1.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 102.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -40.18 -60.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 98.7 m -50.04 -57.09 8.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -50.27 -56.51 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -41.59 -57.15 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.472 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 52.7 mt -58.26 -54.18 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -47.0 -50.58 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.497 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . . . -52.14 -44.45 64.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.5 mt -71.02 -29.9 65.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -74.07 -30.18 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 7.2 pt-20 -87.32 -36.87 17.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.411 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 88.7 mt -69.89 -37.71 73.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.453 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 5.2 p -63.7 -7.73 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -77.61 -38.65 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.934 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -64.87 -29.88 70.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.1 m-85 -43.68 128.34 5.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.595 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -34.09 141.49 0.24 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.72 -10.11 27.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.733 HG11 ' HA ' ' A' ' 28' ' ' GLN . 41.8 t -99.09 -40.38 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -83.44 -35.12 25.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 4.4 t80 -57.0 -43.43 81.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.66 -49.31 70.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 151' ' ' VAL . 69.3 t -66.96 -50.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.532 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 37.4 t80 -54.13 -45.69 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -65.37 -47.15 77.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -59.27 -46.07 89.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 147' ' ' VAL . 85.0 t -53.19 -59.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.646 ' HA ' HD12 ' A' ' 155' ' ' LEU . 73.6 mt -48.88 -52.01 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.074 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.1 m -39.52 -34.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -83.44 -35.67 24.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 152' ' ' ILE . 68.9 mt -61.48 -49.53 76.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -50.01 -49.8 49.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -53.64 -43.36 68.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.8 -50.05 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.8 p -52.5 -21.64 3.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -58.18 -44.13 87.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.442 ' NE2' HD12 ' A' ' 164' ' ' ILE . 24.8 mt-30 -101.25 30.3 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.665 ' ND1' HG22 ' A' ' 168' ' ' THR . 7.4 p80 -45.48 -25.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -74.91 -36.61 62.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.442 HD12 ' NE2' ' A' ' 161' ' ' GLN . 77.0 mt -84.29 -56.41 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.47 ' HB2' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -81.08 16.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 165' ' ' ASN . 11.2 mt 34.49 54.78 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 7.7 mmm -150.12 108.39 3.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.665 HG22 ' ND1' ' A' ' 162' ' ' HIS . 72.4 p -94.09 157.76 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -38.67 -43.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -62.72 -58.73 6.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -45.6 -51.66 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.52 -30.78 70.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -75.69 -32.87 60.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.488 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 62.5 mt -78.24 -31.04 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.3 m -75.26 -34.05 61.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.606 ' CE2' HD21 ' A' ' 155' ' ' LEU . 12.0 m-85 -89.09 -40.75 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.623 ' CE3' ' O ' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.01 -56.81 0.7 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 0.0 110.948 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.513 ' HD3' ' CD1' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.02 -63.7 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.487 ' O ' ' C ' ' A' ' 180' ' ' LEU . 28.6 m -59.37 -56.09 26.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 177' ' ' TRP . 83.3 mt -31.34 -59.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.453 ' O ' ' C ' ' A' ' 182' ' ' ARG . 4.0 ttp -125.94 117.72 23.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 181' ' ' MET . 17.3 ttm180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.857 ' O ' HG23 ' A' ' 200' ' ' VAL . 74.4 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.795 0.331 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -50.58 -50.82 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.21 -44.35 72.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.0 m -54.02 -48.31 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 196' ' ' ILE . 74.2 t -38.69 -56.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.54 -50.03 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -46.71 -45.38 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 204' ' ' PHE . 97.7 m -57.93 -61.77 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.8 m-85 -35.04 -47.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 152' ' ' ILE . 68.6 mt -67.64 -58.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 219' ' ' GLU . 18.2 mt-30 -46.37 -41.39 13.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.472 ' HG3' ' CD1' ' A' ' 130' ' ' LEU . 7.1 mm-40 -116.28 34.9 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.578 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -68.38 -22.77 64.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -85.38 -55.35 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -39.95 -34.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.0 m-85 -51.81 -63.18 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.864 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -104.98 -55.86 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -58.01 -22.53 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.929 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 57.35 38.12 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.18 143.4 23.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 216' ' ' GLU . 7.5 mp0 -41.98 145.04 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.36 143.56 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.26 170.32 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.417 ' CD ' ' O ' ' A' ' 219' ' ' GLU . 12.7 tm-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.834 0.264 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.53 -53.86 26.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.476 ' CB ' HG21 ' A' ' 143' ' ' VAL . 2.7 pt20 -46.21 -32.01 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -40.68 30.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.01 -43.79 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 36' ' ' PRO . 20.9 m -90.98 172.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.0 p -112.03 161.61 16.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.38 -44.78 72.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.39 -45.2 80.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -127.21 95.37 36.55 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' O ' HG21 ' A' ' 31' ' ' VAL . 54.2 Cg_endo -69.72 -38.03 8.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.577 HG23 ' HD2' ' A' ' 38' ' ' PRO . 10.2 mt -75.04 136.56 72.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.666 0.746 . . . . 0.0 111.114 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.73 169.51 18.72 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.706 2.27 . . . . 0.0 112.333 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.636 HD11 ' HE2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -84.69 -46.07 11.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.923 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -48.19 -64.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 97' ' ' LEU . 55.4 t -43.94 -65.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -39.77 -53.61 2.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HE2' HD11 ' A' ' 39' ' ' LEU . 48.7 mmtt -56.48 -37.19 70.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.692 ' HB2' HD13 ' A' ' 97' ' ' LEU . 69.4 m -69.16 -45.52 69.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.444 HG13 ' CG ' ' A' ' 154' ' ' HIS . 46.4 t -64.01 -49.1 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.96 -43.37 83.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CZ ' HG21 ' A' ' 51' ' ' THR . 13.2 t80 -56.52 -61.39 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 44' ' ' CYS . 19.8 mt -41.05 -44.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' OE1' HD13 ' A' ' 53' ' ' LEU . 7.4 mm-40 -64.39 -42.32 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.19 -35.19 79.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.756 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 22.1 p -90.98 29.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.64 150.66 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 158' ' ' VAL . 11.9 tp -120.74 -34.51 3.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.916 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.1 p -56.36 -14.7 3.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.4 m -40.95 105.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -44.51 111.38 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.73 105.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 4.7 mp -105.88 -33.62 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -104.74 -55.63 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.969 ' HD3' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -59.37 -34.82 72.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.969 HG23 ' HD3' ' A' ' 60' ' ' ARG . 3.2 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ASP . 87.3 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -41.92 -49.96 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.67 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 8.1 mt-30 -67.58 -28.83 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.0 t70 -53.23 -53.61 48.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.6 p30 -60.14 -38.8 84.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 68' ' ' GLN . 54.4 mt -49.92 -50.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.49 -61.01 2.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -46.04 -58.99 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -53.42 -42.04 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -64.66 -37.75 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.06 -49.13 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -76.81 -24.93 52.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -133.31 99.66 4.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -72.32 -29.32 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -91.49 34.91 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.761 HD11 ' SD ' ' A' ' 86' ' ' MET . 10.1 tt -77.98 150.13 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -118.38 93.61 4.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -44.51 -42.08 6.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -52.81 -44.02 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 t -65.69 -27.71 68.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.761 ' SD ' HD11 ' A' ' 81' ' ' ILE . 62.6 mtp -70.96 -38.15 72.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 60.18 49.53 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 m -84.49 162.52 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' VAL . 66.8 p -67.23 115.18 6.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 51' ' ' THR . 60.9 t -33.65 -54.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.154 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -37.16 -49.33 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.468 ' HB1' ' HG3' ' A' ' 68' ' ' GLN . . . -55.05 -60.37 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.626 HG21 ' CE1' ' A' ' 47' ' ' PHE . 77.2 t -48.08 -62.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 58' ' ' LEU . . . -41.28 -35.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.15 -57.43 2.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.517 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.67 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -45.1 -43.66 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 111.066 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.692 HD13 ' HB2' ' A' ' 44' ' ' CYS . 34.3 tp -43.41 -45.29 6.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.582 ' HG2' ' CE1' ' A' ' 176' ' ' PHE . 28.5 mtmt -65.06 -46.82 79.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.67 -34.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -65.93 -38.76 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.84 -36.35 50.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.06 -39.31 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -59.95 -37.52 79.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -40.42 146.39 0.44 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 -21.67 32.99 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.336 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -142.82 155.07 63.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.542 0.687 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.74 48.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.568 HD12 HD22 ' A' ' 144' ' ' ASN . 9.0 tp -43.66 -40.85 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mt -83.37 128.7 63.35 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.676 0.75 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 147.05 62.09 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.722 2.282 . . . . 0.0 112.318 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.562 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 4.7 m-85 -64.66 -37.85 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.3 m -55.91 -15.11 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.8 mt -128.44 35.64 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.562 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.2 m170 -76.08 -63.32 0.62 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 0.0 110.859 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.69 -10.3 28.27 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -74.7 -33.78 62.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.18 -36.15 66.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 115' ' ' PRO . 6.1 mt -73.91 -54.3 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -49.53 -33.06 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.66 -22.46 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.75 -33.81 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -71.45 -10.23 59.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.44 127.92 85.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.622 0.725 . . . . 0.0 111.137 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -44.77 1.88 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.667 2.244 . . . . 0.0 112.351 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.77 108.64 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -46.66 -55.99 6.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.602 HG22 ' CD2' ' A' ' 131' ' ' HIS . 2.6 m -57.34 -65.26 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -42.42 -56.35 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -38.62 -46.14 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.7 mt -69.27 -58.47 3.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.602 ' CD2' HG22 ' A' ' 127' ' ' THR . 50.7 m-70 -44.8 -51.85 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.97 -46.23 52.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 20.0 mt -68.53 -28.27 66.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -75.13 -32.54 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 5.2 pt-20 -84.04 -31.29 25.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 74.8 mt -75.26 -32.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.444 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.8 p -76.03 0.35 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.141 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -82.33 -41.13 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.25 22.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 2.3 m-85 -80.1 141.44 35.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.54 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.7 t-80 -39.91 141.94 0.73 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.604 0.716 . . . . 0.0 110.833 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.8 Cg_endo -69.81 -8.06 22.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.476 HG21 ' CB ' ' A' ' 28' ' ' GLN . 74.3 t -99.19 -48.33 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.568 HD22 HD12 ' A' ' 108' ' ' LEU . 30.5 m120 -73.47 -43.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -48.51 -42.19 32.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.95 -56.22 23.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 151' ' ' VAL . 63.8 t -63.63 -62.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.168 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.568 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 26.3 t80 -39.43 -39.94 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -70.43 -46.33 64.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.29 -36.66 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 147' ' ' VAL . 35.0 t -63.1 -64.69 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.078 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.719 HG23 HG12 ' A' ' 205' ' ' ILE . 80.2 mt -47.98 -52.1 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -40.94 -35.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.149 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.444 ' CG ' HG13 ' A' ' 45' ' ' VAL . 23.0 t60 -83.26 -40.91 18.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 176' ' ' PHE . 97.5 mt -54.47 -44.45 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -50.88 -45.34 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.457 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 72.0 mtt85 -55.77 -39.26 70.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.711 HG11 HD21 ' A' ' 172' ' ' LEU . 76.3 t -69.12 -38.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 p -64.32 -35.34 80.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 38.7 mt-30 -54.51 -38.0 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.693 ' OE1' HD12 ' A' ' 164' ' ' ILE . 21.4 mm-40 -99.1 28.77 4.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.57 ' HB2' HG22 ' A' ' 168' ' ' THR . 9.8 p80 -54.6 -31.71 57.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.532 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 20.5 mmtp -73.54 -21.69 60.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.693 HD12 ' OE1' ' A' ' 161' ' ' GLN . 74.3 mt -95.37 -57.59 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -89.86 26.24 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 165' ' ' ASN . 14.2 mt 32.56 41.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 9.7 mmm -128.72 104.5 7.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.57 HG22 ' HB2' ' A' ' 162' ' ' HIS . 60.8 p -96.57 150.67 20.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -36.16 -33.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 168' ' ' THR . 10.0 t70 -63.84 -57.43 9.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -51.4 -57.15 9.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.711 HD21 HG11 ' A' ' 158' ' ' VAL . 10.6 mt -53.67 -29.01 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.0 t -81.13 -37.36 28.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 70.1 mt -74.51 -24.78 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -75.27 -39.07 60.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.582 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 9.6 m-85 -88.99 -38.81 14.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.626 ' CE3' ' O ' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.78 -56.7 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.563 0.696 . . . . 0.0 110.906 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.501 ' CD ' ' O ' ' A' ' 174' ' ' ILE . 65.7 Cg_exo -48.04 -52.37 8.37 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 180' ' ' LEU . 58.7 m -70.42 -62.0 1.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 95.9 mt -34.05 -45.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 13.6 mtm -145.5 133.32 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 110.884 -179.941 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 200' ' ' VAL . 91.0 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.864 0.364 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 196' ' ' ILE . 60.0 m-70 -35.79 -48.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -68.3 -60.14 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 200' ' ' VAL . 21.1 m -43.28 -41.47 3.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 196' ' ' ILE . 99.5 t -36.75 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' GLU . 90.6 t -68.86 -55.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -34.24 -49.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.5 m -55.68 -62.9 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 11.7 m-85 -35.71 -51.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.719 HG12 HG23 ' A' ' 152' ' ' ILE . 85.8 mt -60.48 -57.35 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.132 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.434 ' HB3' HG23 ' A' ' 218' ' ' VAL . 5.5 mt-30 -49.43 -52.31 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.9 mm-40 -101.72 30.69 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.486 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 1.4 t -65.34 -19.45 65.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 213' ' ' TYR . 32.7 mm-40 -87.9 -45.89 9.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -37.17 20.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.486 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -50.71 -63.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -104.77 -55.45 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 209' ' ' GLN . 52.2 m-85 -58.25 -25.1 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 57.47 45.21 20.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -83.73 -179.04 52.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.64 147.93 44.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.457 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 45.8 mt -75.13 139.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.145 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 206' ' ' GLN . 27.2 m -124.05 177.68 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.817 0.257 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.473 ' O ' HG22 ' A' ' 31' ' ' VAL . 9.8 tp -72.39 -48.47 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.799 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -48.7 -25.27 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.49 -49.4 12.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.29 -43.81 97.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 27' ' ' LEU . 19.9 m -94.98 156.43 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.4 p -105.25 162.5 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.58 -39.02 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -63.45 -45.62 90.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -128.17 81.74 69.87 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -31.33 20.75 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.712 2.275 . . . . 0.0 112.359 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 147' ' ' VAL . 62.1 mt -82.4 127.82 69.49 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.563 0.696 . . . . 0.0 111.139 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 161.67 45.03 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.683 2.256 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.595 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.63 -56.33 5.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -38.6 -63.83 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.729 HG13 HD11 ' A' ' 97' ' ' LEU . 55.1 t -44.95 -58.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -48.79 -59.93 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HG2' HD13 ' A' ' 39' ' ' LEU . 51.3 mmtt -43.52 -39.8 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.84 -48.87 57.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 150' ' ' TYR . 64.2 t -58.71 -45.59 90.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CD ' ' HA ' ' A' ' 43' ' ' LYS . 11.7 pt-20 -67.22 -41.31 85.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 1.025 ' CE1' HG21 ' A' ' 93' ' ' VAL . 17.7 t80 -53.02 -63.39 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 94' ' ' ALA . 98.1 mt -39.98 -48.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.05 -43.52 98.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.23 -41.03 96.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 90' ' ' VAL . 13.2 t -85.66 28.55 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.141 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.52 165.07 24.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.42 41.52 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 p -129.12 43.36 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -95.09 136.52 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.176 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -81.42 117.88 22.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.4 99.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.837 HD13 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.13 -0.41 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 15.7 m-85 -123.11 -38.31 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -85.0 -29.3 25.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.3 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.786 0.326 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.489 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 51.4 m-20 -60.6 -53.36 58.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.68 ' HA ' HD12 ' A' ' 71' ' ' ILE . 44.2 mt-30 -49.12 -40.73 33.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.52 -68.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 24.8 p30 -59.82 -39.5 85.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 68' ' ' GLN . 45.4 mt -43.93 -44.15 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -77.45 -46.28 23.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -56.95 -63.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -43.2 -44.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.13 -42.12 97.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.08 -46.25 88.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -61.63 -36.22 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -158.34 154.78 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.6 m170 -102.06 -20.69 14.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.47 54.85 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 pt -118.78 -178.8 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -144.69 145.12 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.4 mt -89.15 -42.59 11.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.01 -53.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -50.33 -46.58 55.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.6 mtp -52.97 -28.53 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 53.23 41.45 32.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.66 163.95 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.567 HG23 ' H ' ' A' ' 92' ' ' ALA . 13.8 t -70.91 149.38 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.425 HG22 HG21 ' A' ' 51' ' ' THR . 75.6 t -59.98 -54.41 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -40.19 -39.52 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.567 ' H ' HG23 ' A' ' 89' ' ' THR . . . -62.1 -64.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.025 HG21 ' CE1' ' A' ' 47' ' ' PHE . 94.1 t -45.28 -50.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -43.89 -51.89 7.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.408 ' C ' ' OE1' ' A' ' 68' ' ' GLN . . . -65.19 -47.31 82.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.678 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -46.32 -48.84 18.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.064 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.729 HD11 HG13 ' A' ' 41' ' ' VAL . 8.2 tp -48.84 -50.01 36.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 43.9 mtmt -65.61 -46.76 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.56 -47.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.66 -53.29 60.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -53.5 -50.25 65.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.85 -42.76 65.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 104' ' ' LEU . 13.1 t0 -52.51 -42.13 64.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 103' ' ' ASP . 80.5 mt -36.62 141.04 0.39 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -18.89 36.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.79 152.68 56.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.674 0.75 . . . . 0.0 110.859 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.73 134.82 28.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 107' ' ' PRO . 5.4 tp -33.95 -52.87 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.0 mt -73.86 127.0 89.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.634 0.731 . . . . 0.0 111.161 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.571 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.6 Cg_endo -69.76 143.93 52.4 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.272 . . . . 0.0 112.331 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.538 ' CD1' ' CE1' ' A' ' 114' ' ' HIS . 4.1 m-85 -59.71 -32.16 70.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 t -59.29 -24.07 62.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.571 HD12 ' HG2' ' A' ' 110' ' ' PRO . 18.1 mt -117.64 30.21 7.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.538 ' CE1' ' CD1' ' A' ' 111' ' ' TYR . 3.6 m170 -75.03 -62.42 0.87 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.642 0.734 . . . . 0.0 110.849 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.4 Cg_endo -69.78 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -81.04 -30.76 34.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mt -74.22 -38.15 63.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.544 HD23 HG21 ' A' ' 200' ' ' VAL . 10.2 mt -75.39 -59.81 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -40.35 -33.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.509 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -84.27 -33.99 23.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.076 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -67.16 -26.39 66.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -87.0 26.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 95.3 mt -95.64 130.76 30.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 111.182 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -46.63 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 0.0 112.372 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 61.9 m-20 -60.39 91.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 125' ' ' ASP . 32.8 tttt -34.7 -56.49 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.0 m -53.1 -58.58 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.65 -57.73 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -39.92 -56.96 1.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.2 mt -55.76 -56.77 16.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -48.64 -38.48 21.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.509 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -63.34 -40.03 96.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.5 mt -77.19 -24.35 51.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 138' ' ' LYS . 40.1 tttp -81.67 -23.62 36.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.04 -33.9 16.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.546 HG22 ' HE1' ' A' ' 140' ' ' PHE . 48.5 mt -74.83 -26.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.602 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.1 p -77.93 -11.16 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 134' ' ' LYS . 27.9 mttm -74.74 -41.7 59.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -81.39 19.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.1 m-85 -80.73 138.03 36.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.6 t-80 -38.06 142.64 0.45 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.75 -7.72 21.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.362 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 28' ' ' GLN . 92.8 t -99.75 -39.11 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.77 -46.48 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.467 ' CE2' ' O ' ' A' ' 137' ' ' VAL . 1.3 t80 -41.83 -54.56 3.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.34 -65.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 151' ' ' VAL . 66.3 t -50.52 -40.58 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.575 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 3.9 t80 -51.07 -48.54 61.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -58.14 -58.35 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.429 ' CE2' HG21 ' A' ' 45' ' ' VAL . 37.8 t80 -52.58 -45.06 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 147' ' ' VAL . 94.8 t -56.51 -66.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.66 HG23 HG12 ' A' ' 205' ' ' ILE . 64.3 mt -54.22 -56.16 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.9 m -41.09 -34.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -76.89 -42.73 38.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.632 HD13 HD11 ' A' ' 205' ' ' ILE . 30.5 mt -60.81 -51.83 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -45.12 -44.27 10.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 56.7 mtt-85 -56.96 -50.47 72.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.23 -50.17 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 p -51.58 -29.67 18.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 157' ' ' ARG . 35.2 mm-40 -46.51 -57.39 4.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -100.58 41.63 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.511 ' ND1' HG22 ' A' ' 168' ' ' THR . 27.3 p80 -57.81 -21.44 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -71.06 -34.15 70.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.83 -58.76 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.088 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -79.58 12.84 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 15.2 mt 38.11 53.86 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.435 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 19.7 mmm -148.53 108.05 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.511 HG22 ' ND1' ' A' ' 162' ' ' HIS . 30.5 p -92.22 166.77 12.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -53.27 -34.25 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.439 ' CG ' ' HG3' ' A' ' 202' ' ' GLU . 1.1 m-20 -70.38 -48.49 56.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -55.82 -35.9 66.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 169' ' ' ALA . 8.6 mt -69.8 -46.9 64.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.2 t -53.9 -38.96 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.403 HG12 ' CD ' ' A' ' 198' ' ' GLN . 15.7 mt -78.95 -33.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.6 m -70.58 -25.6 63.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.51 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 21.4 m-85 -97.72 -16.8 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.564 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -46.69 -47.16 50.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.567 0.699 . . . . 0.0 110.901 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.1 Cg_exo -48.03 -48.6 15.95 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.692 2.262 . . . . 0.0 112.31 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 180' ' ' LEU . 76.0 m -84.02 -64.48 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 179' ' ' THR . 49.8 mt -34.61 -63.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 46.2 mmm -111.16 117.37 33.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 0.0 110.874 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 36.5 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.858 0.361 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.452 ' ND1' HD21 ' A' ' 118' ' ' LEU . 53.3 m-70 -42.58 -60.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.403 ' CD ' HG12 ' A' ' 174' ' ' ILE . 93.2 mt-30 -49.64 -44.52 47.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.0 m -60.64 -42.71 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.544 HG21 HD23 ' A' ' 118' ' ' LEU . 90.9 t -38.08 -69.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 202' ' ' GLU . 60.3 t -62.32 -55.88 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.439 ' HG3' ' CG ' ' A' ' 170' ' ' ASP . 2.1 tm-20 -37.88 -40.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 204' ' ' PHE . 65.8 m -64.9 -60.87 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.12 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' CYS . 12.3 m-85 -34.11 -54.11 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.66 HG12 HG23 ' A' ' 152' ' ' ILE . 68.0 mt -61.85 -56.59 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -46.38 -49.65 17.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.7 mm-40 -109.51 34.19 3.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 4.2 t -65.79 -19.72 65.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.889 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.441 ' HA ' ' NE2' ' A' ' 209' ' ' GLN . 3.7 mm-40 -84.94 -54.98 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.87 -38.63 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -47.47 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.13 -53.7 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -58.5 -25.12 62.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 58.68 43.15 19.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -87.36 144.17 19.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 215' ' ' GLY . 10.1 mm-40 -35.14 149.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.474 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.6 mt -74.29 133.81 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.176 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.5 172.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.825 0.261 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 tp -47.54 -46.81 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.86 ' HB3' HG21 ' A' ' 143' ' ' VAL . 6.3 pt20 -53.07 -30.4 35.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -46.02 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.8 mt -59.83 -44.11 94.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG11 ' O ' ' A' ' 36' ' ' PRO . 5.2 m -90.43 171.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 p -118.95 156.26 29.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -46.9 -45.97 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -59.66 -46.21 89.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -126.58 86.73 57.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.551 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.3 Cg_endo -69.81 -29.89 22.91 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.684 2.256 . . . . 0.0 112.361 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.492 HG23 ' HD2' ' A' ' 38' ' ' PRO . 7.8 mt -84.16 134.51 43.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 111.154 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.71 146.81 61.62 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.538 HD11 ' CE ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -67.17 -40.81 86.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -51.6 -60.88 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG13 HD11 ' A' ' 97' ' ' LEU . 74.1 t -49.24 -63.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -40.61 -55.43 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.538 ' CE ' HD11 ' A' ' 39' ' ' LEU . 40.9 mmtt -55.87 -41.21 74.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.683 ' HB2' HD13 ' A' ' 97' ' ' LEU . 94.5 m -61.33 -40.71 95.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.656 HG13 ' CG ' ' A' ' 154' ' ' HIS . 25.2 t -71.22 -54.85 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -50.33 -33.69 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' A' ' 93' ' ' VAL . 19.5 t80 -60.74 -62.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.8 mt -47.34 -43.04 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.14 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.95 -26.51 59.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.35 -22.4 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -110.75 11.62 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 164.02 6.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HG ' HG22 ' A' ' 158' ' ' VAL . 1.7 mm? -107.83 75.15 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -25.08 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -51.34 117.22 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.33 117.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.7 94.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.471 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.643 HD23 ' H ' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -101.75 -34.73 9.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.7 -63.96 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.618 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.34 -16.22 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.618 HG23 ' CD ' ' A' ' 60' ' ' ARG . 76.2 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.766 0.317 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . 6.2 m-20 -54.66 -60.49 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.845 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -59.92 -44.78 94.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -41.62 -49.5 4.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 16.1 p30 -73.17 -34.78 66.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 68' ' ' GLN . 52.1 mt -55.4 -45.97 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -79.57 -48.63 13.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -57.46 -59.27 5.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -50.26 -48.24 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.4 ' O ' ' O ' ' A' ' 78' ' ' ASP . 40.8 t80 -50.01 -56.05 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -54.59 -33.11 59.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -81.72 -18.41 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 75' ' ' PHE . 5.2 t0 -149.53 118.87 6.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -83.75 -24.23 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -98.57 36.38 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.771 HD11 ' SD ' ' A' ' 86' ' ' MET . 6.0 tt -79.73 151.76 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -124.24 94.53 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.7 mt -40.55 -44.39 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.0 t -49.05 -47.88 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 t -58.11 -43.22 87.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.771 ' SD ' HD11 ' A' ' 81' ' ' ILE . 85.4 mtp -59.03 -36.13 74.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 59.28 44.75 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -80.18 173.84 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.9 p -69.11 111.88 5.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.5 t -37.44 -50.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -45.36 -45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 67' ' ' ASP . . . -52.37 -63.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 47' ' ' PHE . 95.5 t -45.83 -44.85 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.95 -38.59 67.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.58 -56.29 3.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 68' ' ' GLN . . . -45.87 -36.92 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 111.099 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 44' ' ' CYS . 16.8 tp -60.08 -47.39 86.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -65.96 -38.73 89.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.44 -36.87 55.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.093 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -62.9 -40.69 98.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.53 ' HB2' HG21 ' A' ' 179' ' ' THR . 5.1 m-85 -63.02 -41.68 99.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.07 80.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -34.31 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -41.48 147.4 0.48 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -28.71 24.8 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.94 139.47 16.07 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.605 0.717 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.9 Cg_endo -69.77 136.51 33.16 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.674 2.249 . . . . 0.0 112.321 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.45 HD23 ' CD1' ' A' ' 148' ' ' PHE . 5.5 mp -34.97 -49.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.2 mt -91.51 107.41 21.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 0.0 111.133 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.497 ' HG2' HD12 ' A' ' 113' ' ' LEU . 54.1 Cg_endo -69.72 149.42 67.15 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.407 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 0.7 OUTLIER -62.48 -27.42 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 m -66.02 -8.19 21.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.497 HD12 ' HG2' ' A' ' 110' ' ' PRO . 70.4 mt -128.39 21.7 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.501 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.1 m170 -67.93 -60.13 5.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 0.0 110.81 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.516 ' HA ' HD12 ' A' ' 118' ' ' LEU . 53.7 Cg_endo -69.78 -25.15 28.8 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.93 -27.35 67.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.778 ' HB3' HG11 ' A' ' 200' ' ' VAL . 3.4 mt -78.77 -18.71 53.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.941 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.532 HD23 HG21 ' A' ' 200' ' ' VAL . 10.6 mt -92.56 -47.83 6.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -48.29 -40.37 24.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.599 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -83.73 -20.47 33.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -77.61 -21.79 51.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -93.8 17.87 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 128' ' ' GLU . 96.5 mt -81.73 129.58 64.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 111.145 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -44.79 1.87 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.317 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.2 t70 -67.02 94.08 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.838 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.0 tptp -34.64 -50.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.2 m -52.5 -57.76 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.498 ' HB2' HG21 ' A' ' 123' ' ' ILE . 17.8 mm-40 -56.74 -49.18 75.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -45.74 -53.98 8.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.431 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 37.3 mt -65.57 -62.24 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -41.82 -28.65 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.599 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -75.52 -50.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 13.5 mt -65.77 -22.81 66.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 137' ' ' VAL . 39.7 tttp -81.94 -30.61 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.926 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -85.89 -29.75 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.478 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 11.1 p -86.66 -6.48 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -77.78 -41.57 36.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -16.06 62.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.1 m-85 -46.82 151.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.9 t-80 -42.46 138.32 2.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.74 -20.72 34.59 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.35 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.86 HG21 ' HB3' ' A' ' 28' ' ' GLN . 43.4 t -92.27 -44.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.406 HD22 HD12 ' A' ' 108' ' ' LEU . 2.7 m120 -73.9 -48.06 33.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -39.24 -53.71 1.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -47.65 -48.93 28.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 151' ' ' VAL . 30.5 t -69.26 -57.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.159 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.488 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 10.7 t80 -42.24 -45.5 4.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -60.85 -53.59 55.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -54.57 -43.83 72.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 147' ' ' VAL . 82.0 t -52.61 -62.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.154 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.49 ' HA ' HD12 ' A' ' 155' ' ' LEU . 3.3 mt -46.49 -51.13 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.4 m -40.93 -37.91 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.656 ' CG ' HG13 ' A' ' 45' ' ' VAL . 84.6 t60 -80.26 -39.2 29.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.575 HD21 ' CE2' ' A' ' 176' ' ' PHE . 96.6 mt -54.52 -45.85 73.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -51.22 -49.82 60.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -51.79 -53.24 42.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.43 HG22 ' HG ' ' A' ' 53' ' ' LEU . 41.0 t -60.24 -35.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.8 p -66.24 -22.34 66.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -73.98 -31.59 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.476 HE21 HD12 ' A' ' 164' ' ' ILE . 3.1 mm100 -95.78 27.7 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.519 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 11.1 p80 -60.11 -16.47 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.827 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 14.0 mmmt -86.5 -5.53 59.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.476 HD12 HE21 ' A' ' 161' ' ' GLN . 26.2 mt -115.33 -60.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.37 9.31 11.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.8 mt 47.46 43.95 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 23.2 mtp -129.96 106.26 8.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.473 HG22 ' CG ' ' A' ' 162' ' ' HIS . 78.1 p -97.57 151.24 20.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.77 -35.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 168' ' ' THR . 2.1 t70 -66.04 -60.45 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -47.81 -49.07 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 7.4 mt -62.13 -49.06 77.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 t -51.71 -43.57 62.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -77.0 -38.01 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.19 -16.0 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.575 ' CE2' HD21 ' A' ' 155' ' ' LEU . 9.9 m-85 -107.16 -11.72 15.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.565 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.23 -46.77 93.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.526 0.679 . . . . 0.0 110.896 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.0 -63.59 0.3 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.53 HG21 ' HB2' ' A' ' 101' ' ' PHE . 28.9 m -67.04 -57.97 5.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 179' ' ' THR . 39.9 mt -34.22 -51.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.432 ' SD ' ' CZ2' ' A' ' 177' ' ' TRP . 0.6 OUTLIER -152.52 119.2 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 42.7 ttm-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.884 -179.949 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 200' ' ' VAL . 71.4 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.847 0.356 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.475 ' HA ' HD21 ' A' ' 118' ' ' LEU . 32.8 m80 -41.35 -47.95 3.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -73.43 -56.24 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.0 m -42.09 -39.34 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 196' ' ' ILE . 58.2 t -46.6 -72.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' PHE . 68.9 t -55.04 -57.34 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -39.84 -36.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 60.3 m -69.86 -39.05 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.189 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' VAL . 12.2 m-85 -55.53 -41.79 73.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.15 -54.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.06 -56.17 25.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.431 ' HG3' ' CD2' ' A' ' 130' ' ' LEU . 38.4 mm-40 -81.9 16.9 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.583 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 18.2 t -58.55 -22.74 56.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.92 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.582 ' N ' ' CD ' ' A' ' 209' ' ' GLN . 0.2 OUTLIER -78.59 -62.51 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -39.5 -39.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 17.4 m-30 -52.2 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -107.57 -52.17 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 209' ' ' GLN . 65.4 m-85 -62.22 -11.71 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 61.3 t30 45.78 41.04 7.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -70.46 -151.35 0.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.435 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.07 165.98 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.0 mt -75.56 121.57 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.9 175.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.813 0.256 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' VAL . 18.3 tp -64.78 -49.25 71.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HA ' HG11 ' A' ' 143' ' ' VAL . 2.9 pt20 -43.87 -37.2 2.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.91 -50.58 33.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.26 -45.49 83.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 27' ' ' LEU . 33.8 m -91.74 171.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.1 p -120.28 158.06 27.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.21 -46.27 45.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.51 -44.28 72.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -132.1 90.4 35.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.97 8.45 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.7 mt -72.8 130.25 85.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 147' ' ' VAL . 54.0 Cg_endo -69.79 108.8 2.16 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.316 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.492 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -36.04 -57.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 39' ' ' LEU . 31.0 t80 -34.21 -64.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 HD11 ' A' ' 97' ' ' LEU . 79.7 t -43.82 -59.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -42.91 -61.94 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 64.0 mmtt -43.53 -41.09 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.9 m -68.35 -41.35 80.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.487 HG13 ' CG ' ' A' ' 154' ' ' HIS . 76.3 t -65.94 -51.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.67 -45.28 93.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' A' ' 93' ' ' VAL . 32.5 t80 -45.69 -57.14 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.8 mt -45.27 -44.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.546 ' OE1' HD13 ' A' ' 53' ' ' LEU . 19.0 mm-40 -62.4 -57.41 11.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.65 -39.38 35.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -84.51 29.93 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.44 164.19 21.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.486 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.546 HD13 ' OE1' ' A' ' 49' ' ' GLU . 11.6 tp -126.81 41.04 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.748 0.309 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -124.38 37.99 4.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.6 m -98.75 128.38 44.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.36 145.75 29.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.75 45.24 4.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.535 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 58' ' ' LEU . 2.2 pt? -58.41 -37.96 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.45 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 60.7 m-85 -99.18 -51.95 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -44.03 -54.24 5.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.18 179.925 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.762 0.315 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.512 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 2.5 m-20 -41.26 -61.23 1.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.863 ' HA ' HD12 ' A' ' 71' ' ' ILE . 11.9 mt-30 -40.8 -40.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -67.17 -50.41 61.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -50.29 -47.22 55.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.863 HD12 ' HA ' ' A' ' 68' ' ' GLN . 28.4 mt -44.77 -43.9 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.118 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -82.82 -52.26 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -52.85 -62.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.27 -45.65 34.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.57 -44.23 97.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -63.32 -53.3 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -52.25 -39.27 60.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.23 152.58 22.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.78 -22.19 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.84 51.73 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.0 pt -107.19 -174.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 0.3 OUTLIER -151.03 119.32 6.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.26 -50.87 64.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.54 -40.92 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 68.6 m -60.39 -45.49 93.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.3 mtp -52.74 -32.44 43.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 60.86 45.66 9.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.01 168.87 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 90' ' ' VAL . 24.9 p -75.29 116.33 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 89' ' ' THR . 85.2 t -33.75 -54.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.092 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -36.12 -57.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -39.04 -59.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 47' ' ' PHE . 96.9 t -46.01 -55.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -46.17 -44.48 16.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.24 -60.26 6.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.511 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.05 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HG13 ' A' ' 41' ' ' VAL . 23.5 tp -53.47 -48.94 68.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 101' ' ' PHE . 29.7 mtmt -69.26 -52.5 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.8 -42.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.123 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -59.16 -47.74 84.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' LYS . 16.2 m-85 -56.18 -51.45 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.48 71.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 104' ' ' LEU . 64.4 m-20 -51.3 -42.77 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.6 mt -34.22 142.26 0.23 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -22.89 31.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -134.7 152.93 78.5 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.582 0.706 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 132.06 22.47 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.34 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -38.47 -47.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 mt -91.87 121.31 67.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 0.0 111.15 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.63 40.86 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.581 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 8.7 m-85 -54.68 -34.31 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE1' ' A' ' 116' ' ' GLU . 22.2 m -55.56 -29.15 58.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.2 mt -110.8 36.16 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.581 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 2.1 m170 -79.13 -65.49 0.3 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.632 0.73 . . . . 0.0 110.879 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.679 ' HA ' HD12 ' A' ' 118' ' ' LEU . 54.3 Cg_endo -69.74 -31.89 19.72 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.382 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 112' ' ' SER . 24.5 mp0 -60.47 -35.38 75.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.544 HD11 ' HZ ' ' A' ' 140' ' ' PHE . 12.1 mt -72.14 -39.46 68.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.679 HD12 ' HA ' ' A' ' 115' ' ' PRO . 4.9 mt -70.45 -55.48 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 13.6 pt-20 -46.82 -36.22 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -75.99 -25.78 56.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -78.15 -28.68 48.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 119' ' ' GLU . 2.4 pttt -90.47 27.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.525 HG23 ' HD2' ' A' ' 124' ' ' PRO . 89.0 mt -89.5 135.18 31.26 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.654 0.74 . . . . 0.0 111.109 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.525 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.82 -48.64 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.647 2.231 . . . . 0.0 112.345 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -66.15 95.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 125' ' ' ASP . 14.1 tptm -36.82 -53.44 0.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 50.7 m -52.23 -51.32 59.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -60.31 -49.05 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -47.2 -49.7 22.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.93 -62.65 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -40.43 -50.84 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.29 48.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.03 -34.12 76.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.55 ' O ' HG12 ' A' ' 137' ' ' VAL . 23.0 tttm -68.32 -35.93 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 4.0 pt-20 -81.8 -32.7 31.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.474 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 51.0 mt -73.2 -34.77 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 134' ' ' LYS . 8.4 p -67.35 -18.6 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.88 -34.48 75.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -66.95 -34.97 78.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.544 ' HZ ' HD11 ' A' ' 117' ' ' LEU . 11.8 m-85 -42.66 132.39 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -33.47 142.68 0.19 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.82 -16.94 37.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 28' ' ' GLN . 91.9 t -90.94 -39.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.15 -38.26 24.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.418 ' CZ ' ' HD3' ' A' ' 149' ' ' ARG . 46.3 t80 -52.47 -42.26 64.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.97 -42.44 80.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.84 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 151' ' ' VAL . 98.9 t -74.31 -44.37 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.581 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 26.2 t80 -58.76 -40.92 85.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.854 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.418 ' HD3' ' CZ ' ' A' ' 145' ' ' TYR . 47.2 ttp180 -67.62 -49.95 60.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -60.8 -47.66 85.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 147' ' ' VAL . 93.2 t -50.83 -65.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.139 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.839 HG23 HG12 ' A' ' 205' ' ' ILE . 75.8 mt -41.97 -50.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -40.51 -40.8 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.487 ' CG ' HG13 ' A' ' 45' ' ' VAL . 85.7 t60 -73.46 -40.14 64.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 152' ' ' ILE . 51.1 mt -59.65 -44.03 93.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.454 ' HB2' HG23 ' A' ' 205' ' ' ILE . 52.4 t-20 -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -58.93 -48.22 82.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.5 t -55.04 -46.86 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.3 p -56.57 -29.43 62.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -47.48 -56.35 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -100.45 33.73 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.598 ' CE1' ' HD3' ' A' ' 163' ' ' LYS . 7.3 p80 -51.62 -19.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.598 ' HD3' ' CE1' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -55.31 -34.68 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.49 -56.46 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -27.16 68.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 75.8 mt 64.12 39.4 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.6 mmm -131.52 82.75 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 32.8 p -71.99 163.43 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.14 -46.74 5.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.437 ' OD1' HD11 ' A' ' 174' ' ' ILE . 6.7 t70 -60.25 -59.61 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -47.53 -50.01 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.35 -47.75 78.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.6 t -59.1 -44.58 91.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.437 HD11 ' OD1' ' A' ' 170' ' ' ASP . 57.9 mt -70.25 -31.49 47.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 48.9 t -70.79 -34.8 72.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.483 ' CE1' HD21 ' A' ' 155' ' ' LEU . 22.7 m-85 -90.23 -15.55 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.559 ' CZ3' ' HG2' ' A' ' 181' ' ' MET . 0.8 OUTLIER -47.55 -46.67 60.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.926 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.3 Cg_exo -48.04 -51.66 9.58 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.461 ' O ' ' C ' ' A' ' 180' ' ' LEU . 89.6 m -76.44 -63.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 179' ' ' THR . 87.4 mt -33.49 -70.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.559 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 2.3 ttm -100.03 112.04 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.812 -179.896 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 200' ' ' VAL . 75.9 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.834 0.35 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.457 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 61.0 m80 -39.08 -63.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -51.91 -58.08 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.3 m -43.37 -44.16 5.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 196' ' ' ILE . 48.1 t -46.25 -68.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.53 -47.32 93.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -46.32 -48.71 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.1 m -57.42 -57.87 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.457 ' C ' ' O ' ' A' ' 203' ' ' THR . 10.2 m-85 -33.98 -49.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.839 HG12 HG23 ' A' ' 152' ' ' ILE . 49.9 mt -70.39 -50.67 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -48.5 -45.45 37.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 9.4 mm-40 -117.44 36.92 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.572 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 22.9 t -64.1 -30.74 71.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -75.13 -51.67 12.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -43.82 -37.04 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -51.19 -63.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -101.25 -56.7 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -56.26 -38.04 70.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 73.18 42.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.3 169.29 53.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -58.82 136.05 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.429 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 66.3 mt -61.39 121.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -94.15 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m 61.11 45.57 8.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m -90.94 101.26 14.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.839 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.69 141.05 14.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 m -97.14 162.63 13.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.1 p -116.11 -24.35 8.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.2 -157.79 15.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.485 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.61 153.92 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.845 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -137.93 153.98 49.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -174.02 170.37 3.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -129.78 140.78 39.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.612 0.72 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 153.82 68.31 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.698 2.266 . . . . 0.0 112.308 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -168.17 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 p -87.99 174.84 8.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -144.49 128.03 17.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 18' ' ' TRP . 4.8 ptm180 -111.19 -179.27 3.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 16' ' ' ARG . 10.0 p-10 -35.42 -34.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.441 ' N ' ' O ' ' A' ' 16' ' ' ARG . 54.5 t-105 -174.17 164.41 4.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -138.53 105.32 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 t -168.95 143.54 3.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -92.2 11.09 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.482 ' CD2' HD22 ' A' ' 30' ' ' LEU . 7.4 m-85 -100.44 -47.76 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.577 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -46.83 -43.67 18.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' N ' ' CD1' ' A' ' 23' ' ' PHE . . . -64.69 -37.72 94.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 15.0 mmt -85.89 146.17 42.78 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.568 0.699 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 156.91 62.06 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.627 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.4 tp -51.1 -42.6 60.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.25 -31.78 22.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -85.51 -44.63 12.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.482 HD22 ' CD2' ' A' ' 22' ' ' TYR . 11.1 mt -57.84 -46.84 84.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 27' ' ' LEU . 17.7 m -88.05 171.54 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 p -124.15 165.64 17.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.37 65.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.49 -47.82 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -126.82 91.74 46.38 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.6 0.714 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -30.53 21.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.686 2.257 . . . . 0.0 112.329 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.526 HG23 ' HD2' ' A' ' 38' ' ' PRO . 14.7 mt -84.3 135.22 41.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.63 0.729 . . . . 0.0 111.129 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 130.32 19.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.635 HD21 ' HE2' ' A' ' 43' ' ' LYS . 5.4 tp -52.2 -53.19 46.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' LEU . 16.8 t80 -36.27 -56.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 HD11 ' A' ' 97' ' ' LEU . 53.0 t -54.45 -62.63 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -47.68 -59.74 3.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.635 ' HE2' HD21 ' A' ' 39' ' ' LEU . 24.5 mmtm -44.43 -36.59 2.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.3 m -75.24 -38.38 60.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -72.9 -60.12 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -54.02 -32.9 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -63.28 -57.67 9.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.9 mt -50.35 -53.54 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.42 -45.04 85.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.58 -41.23 97.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.7 p -89.05 23.35 2.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.65 135.43 4.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.456 ' CD2' ' HB3' ' A' ' 157' ' ' ARG . 15.1 tp -103.72 35.48 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.7 ' HB2' HG21 ' A' ' 164' ' ' ILE . 15.1 p -121.63 40.34 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.625 HG21 ' HB ' ' A' ' 90' ' ' VAL . 18.4 m -92.28 112.31 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.7 tt0 -34.76 120.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.14 77.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.613 HD21 HG11 ' A' ' 158' ' ' VAL . 1.6 pt? -61.25 -29.05 69.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -108.41 -49.62 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -49.63 -49.78 45.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.9 t -107.89 123.26 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.6 m -106.7 -37.06 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.83 -99.76 2.24 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -93.66 154.7 17.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -105.47 -37.71 6.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 m -46.55 -40.02 11.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.165 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -51.0 -45.74 61.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.605 ' HA ' HD12 ' A' ' 71' ' ' ILE . 64.2 mt-30 -65.11 -35.03 79.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.93 -58.4 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.0 p30 -64.35 -36.05 82.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 68' ' ' GLN . 57.4 mt -54.3 -47.35 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -78.25 -40.08 38.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -64.7 -67.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -44.99 -45.65 10.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.87 -34.92 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.9 -52.04 48.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.57 -21.56 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -145.47 113.82 6.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -84.6 -3.23 58.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -101.91 23.53 11.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.458 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 6.0 tt -68.97 156.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.458 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 6.6 t30 -125.94 91.63 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASN . 84.3 mt -36.94 -48.06 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -51.47 -48.71 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -54.39 -39.57 67.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.406 ' HB3' HG13 ' A' ' 88' ' ' VAL . 40.8 mmm -66.97 -32.44 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 56.94 47.22 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' A' ' 86' ' ' MET . 31.6 m -81.45 179.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.599 HG23 ' H ' ' A' ' 92' ' ' ALA . 9.2 t -87.55 127.42 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.625 ' HB ' HG21 ' A' ' 55' ' ' THR . 93.9 t -40.19 -47.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -48.31 -40.47 25.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.599 ' H ' HG23 ' A' ' 89' ' ' THR . . . -62.76 -61.99 2.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -48.6 -38.28 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' LEU . . . -57.75 -50.09 74.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.19 -49.81 64.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.21 46.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HG13 ' A' ' 41' ' ' VAL . 34.2 tp -58.86 -46.56 87.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' ALA . 30.0 mtmt -67.24 -52.01 46.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.45 -45.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -53.45 -53.42 51.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CB ' HG21 ' A' ' 179' ' ' THR . 34.9 m-85 -58.15 -33.61 69.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -28.58 64.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LEU . 1.9 t70 -75.22 -31.57 60.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' ASP . 67.2 mt -35.72 143.51 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.743 2.295 . . . . 0.0 112.283 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -139.05 154.28 72.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.639 0.733 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.6 Cg_endo -69.82 130.09 18.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.309 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.434 HD21 ' CD1' ' A' ' 148' ' ' PHE . 12.0 tp -35.73 -51.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -91.95 126.33 53.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.669 0.747 . . . . 0.0 111.155 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.466 ' CG ' HD12 ' A' ' 113' ' ' LEU . 53.2 Cg_endo -69.81 161.49 45.75 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -78.95 -11.49 60.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.429 ' O ' HD23 ' A' ' 113' ' ' LEU . 30.9 t -88.67 5.45 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 117' ' ' LEU . 80.0 mt -133.96 19.85 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.5 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.2 m170 -71.09 -60.11 3.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.56 0.695 . . . . 0.0 110.855 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.76 -27.13 26.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.363 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.79 -32.14 72.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.4 mt -77.27 -34.38 55.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.456 HD21 ' CG ' ' A' ' 197' ' ' HIS . 9.6 mt -78.95 -44.04 23.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.2 -23.66 62.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.64 -9.48 29.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.486 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -95.18 -28.79 14.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -80.98 -3.44 51.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.652 HG23 ' HD2' ' A' ' 124' ' ' PRO . 67.4 mt -56.37 138.29 75.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.652 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.84 -50.71 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.649 2.232 . . . . 0.0 112.324 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -63.99 107.36 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -46.32 -52.21 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -55.09 -61.39 2.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.29 -45.87 17.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -50.18 -42.58 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.406 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 43.7 mt -70.75 -42.34 70.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -60.66 -54.52 44.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.88 62.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.68 -24.89 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -78.26 -30.06 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.7 -31.48 18.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -38.11 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.089 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.23 -8.69 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -76.06 -28.85 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -73.04 -19.32 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -53.53 137.54 36.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.537 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.8 t-80 -38.69 141.58 0.57 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 110.896 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.77 -8.81 24.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 0.0 112.374 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.505 HG12 HD23 ' A' ' 27' ' ' LEU . 20.3 t -99.12 -42.25 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -85.56 -29.85 23.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -52.41 -48.79 65.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.32 -50.96 69.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.407 HG22 ' HD2' ' A' ' 38' ' ' PRO . 61.2 t -60.46 -59.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 13.5 t80 -40.4 -40.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -69.74 -48.19 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.18 -48.91 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.54 -64.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.905 HG23 HG12 ' A' ' 205' ' ' ILE . 92.0 mt -48.52 -49.21 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.0 m -40.45 -34.87 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.423 ' CE1' HD11 ' A' ' 53' ' ' LEU . 40.2 t60 -80.1 -45.95 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.634 HD12 ' HA ' ' A' ' 152' ' ' ILE . 59.1 mt -49.58 -49.17 47.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -48.26 -41.09 26.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.456 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 98.7 mtt180 -64.34 -36.81 85.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.613 HG11 HD21 ' A' ' 58' ' ' LEU . 59.5 t -68.47 -42.48 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.6 p -62.64 -30.74 71.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -60.84 -50.32 73.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -98.01 38.96 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.549 ' CE1' ' HD2' ' A' ' 163' ' ' LYS . 2.1 p80 -56.04 -31.65 63.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.549 ' HD2' ' CE1' ' A' ' 162' ' ' HIS . 12.5 mptt -53.74 -22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.7 HG21 ' HB2' ' A' ' 54' ' ' CYS . 15.6 mt -100.65 -58.69 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -80.08 11.57 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 162' ' ' HIS . 6.6 mt 34.71 46.35 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.9 mmm -142.58 120.93 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.6 p -105.47 177.32 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.03 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -46.55 66.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -59.58 -46.97 87.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.62 -41.22 98.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.6 p -58.75 -28.52 65.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.2 mt -86.81 -42.25 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.31 -16.93 57.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.414 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 14.3 m-85 -107.95 -7.13 16.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.576 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.2 t90 -51.68 -45.45 91.55 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.939 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -48.0 -65.44 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.552 HG21 ' CB ' ' A' ' 101' ' ' PHE . 8.4 m -61.17 -65.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 179' ' ' THR . 86.9 mt -34.35 -44.61 0.2 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 3.9 mtt -146.91 119.9 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -117.73 78.24 11.96 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.841 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -174.6 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.498 ' OD1' ' CD1' ' A' ' 185' ' ' PHE . 3.2 t70 -88.29 139.09 30.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.498 ' CD1' ' OD1' ' A' ' 184' ' ' ASP . 15.0 p90 -44.3 -35.1 2.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.44 64.76 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -90.85 0.46 57.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -107.46 1.26 23.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.53 -21.92 60.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 191' ' ' LEU . 5.1 t80 -127.8 171.69 11.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' PHE . 3.9 mm? -36.2 139.55 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.915 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.0 t -106.86 126.03 51.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.0 m -98.04 153.2 18.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 196' ' ' ILE . 17.3 m -48.93 147.02 2.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -64.18 74.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 194' ' ' THR . 30.7 mt -92.64 -32.86 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.54 ' H ' ' CD2' ' A' ' 197' ' ' HIS . 16.6 m-70 -47.8 -66.42 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 197' ' ' HIS . 0.6 OUTLIER -37.42 -48.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.4 t -55.26 -48.19 74.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.851 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.486 HG22 ' CB ' ' A' ' 121' ' ' ALA . 23.1 t -45.49 -69.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.82 -61.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -44.0 -47.55 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 204' ' ' PHE . 70.7 m -54.16 -62.71 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' CYS . 14.1 m-85 -34.66 -52.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.905 HG12 HG23 ' A' ' 152' ' ' ILE . 61.1 mt -60.6 -59.97 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -45.88 -48.92 15.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.443 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 8.8 mm-40 -106.2 31.4 5.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.561 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 6.4 t -67.26 -21.15 65.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.48 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 74.4 mm-40 -87.07 -54.3 4.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.92 -36.55 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -49.53 -62.92 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -106.75 -54.36 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.48 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 65.4 m-85 -55.46 -30.88 61.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 70.85 27.83 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -68.51 137.48 30.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.5 mt-10 -37.9 154.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.06 112.57 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 33.6 m -85.82 173.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p -170.9 129.7 0.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.895 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.1 m -157.83 175.61 13.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.96 -174.71 45.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.479 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 m -142.88 175.06 10.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 110.86 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 p -173.29 132.81 0.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.67 52.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -140.57 125.86 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.331 . . . . 0.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 10' ' ' PHE . 1.7 p30 -80.01 145.79 32.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.452 ' C ' ' O ' ' A' ' 9' ' ' ASN . 0.8 OUTLIER -34.27 -62.19 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.15 138.17 0.57 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.573 0.702 . . . . 0.0 110.901 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 164.63 33.81 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -164.75 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.703 2.269 . . . . 0.0 112.35 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -106.57 132.83 52.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.542 HH21 ' ND2' ' A' ' 17' ' ' ASN . 19.3 ttp180 -162.69 127.72 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -89.42 89.43 7.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.542 ' ND2' HH21 ' A' ' 15' ' ' ARG . 1.5 m-20 -84.43 41.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.46 ' CZ3' ' HG2' ' A' ' 73' ' ' LYS . 8.4 t-105 -95.61 42.67 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.22 113.85 25.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 m -139.98 158.59 43.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -118.75 40.21 3.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' C ' ' HG2' ' A' ' 25' ' ' MET . 4.2 m-85 -119.59 -11.98 9.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -71.24 115.65 10.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.849 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.83 28.24 61.27 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.457 ' HB2' HD21 ' A' ' 30' ' ' LEU . 32.4 mmm -110.84 147.31 36.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.539 0.685 . . . . 0.0 110.895 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 126.85 13.79 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.693 2.262 . . . . 0.0 112.321 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' O ' HG22 ' A' ' 31' ' ' VAL . 22.5 tp -53.06 -39.79 63.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.469 ' HB3' HG21 ' A' ' 143' ' ' VAL . 9.7 pt20 -55.21 -29.4 57.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.17 -40.85 19.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 25' ' ' MET . 15.2 mt -65.55 -44.04 88.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 27' ' ' LEU . 21.2 m -81.42 173.45 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 p -111.75 143.71 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.63 3.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.22 -43.47 98.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -131.68 106.17 14.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.54 0.686 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.8 Cg_endo -69.77 -35.44 12.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.623 2.215 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.84 130.03 79.7 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.723 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.77 68.41 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.473 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.87 -47.97 78.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -45.34 -63.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.0 t -48.45 -53.77 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 150' ' ' TYR . 15.3 mm-40 -48.95 -55.84 10.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 50.6 mmtt -50.51 -41.16 53.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.8 m -63.56 -43.55 96.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 150' ' ' TYR . 44.4 t -66.64 -61.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 47' ' ' PHE . 10.6 pt-20 -53.11 -47.51 68.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.666 ' CE2' HG21 ' A' ' 93' ' ' VAL . 60.4 t80 -48.26 -64.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mt -38.55 -62.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -45.9 -47.83 16.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -56.46 -47.21 79.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -84.76 29.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.12 141.26 6.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -106.49 -14.32 15.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.7 p -84.48 34.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.896 ' HB ' HD21 ' A' ' 58' ' ' LEU . 36.7 m -68.73 157.05 37.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' N ' HG22 ' A' ' 55' ' ' THR . 1.8 mp0 -100.89 147.86 25.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' C ' ' HG2' ' A' ' 60' ' ' ARG . . . 48.01 75.87 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.48 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.896 HD21 ' HB ' ' A' ' 55' ' ' THR . 4.5 mm? -95.0 122.79 38.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.609 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 26.7 m-85 63.32 26.49 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HG2' ' C ' ' A' ' 57' ' ' GLY . 7.0 ptm180 -127.24 -10.16 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.4 t -97.91 140.71 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 t -40.1 -59.44 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.41 118.73 1.27 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.473 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -55.28 123.48 13.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -35.16 79.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 m -60.41 -51.88 67.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -56.2 -46.17 79.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 71' ' ' ILE . 43.5 mt-30 -70.19 -28.68 65.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.944 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.02 -60.96 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.1 p30 -53.92 -36.77 63.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 68' ' ' GLN . 50.2 mt -53.39 -56.6 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.55 -52.44 38.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HG2' ' CZ3' ' A' ' 18' ' ' TRP . 30.6 mtpt -53.16 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -44.88 -45.79 10.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -68.32 -29.79 68.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -68.66 -49.43 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -63.99 -33.0 74.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -158.67 156.07 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -105.71 -15.4 14.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -80.75 45.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.2 pt -106.0 177.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -142.48 130.04 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.71 -42.44 21.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.82 -44.12 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.7 t -64.95 -28.86 69.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.8 mmm -70.6 -33.61 71.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 62.35 34.59 15.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.82 156.66 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 p -67.66 146.88 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.3 t -53.22 -49.46 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -42.99 -49.94 5.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.4 -62.86 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.666 HG21 ' CE2' ' A' ' 47' ' ' PHE . 67.5 t -53.79 -50.23 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -52.79 -37.12 59.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.71 -49.29 7.26 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.0 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.71 -45.08 77.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 99' ' ' ALA . 20.9 mtmt -64.08 -53.43 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.01 -44.29 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -54.65 -54.03 46.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -57.07 -39.19 74.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.39 -35.79 82.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 104' ' ' LEU . 9.6 t0 -59.85 -40.45 88.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.9 mt -36.86 143.06 0.34 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -21.47 33.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.62 154.29 79.49 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.709 . . . . 0.0 110.851 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 108' ' ' LEU . 54.0 Cg_endo -69.78 131.14 20.59 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.612 2.208 . . . . 0.0 112.37 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 107' ' ' PRO . 26.1 tp -35.73 -38.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -103.12 125.58 34.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 157.08 61.69 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.737 2.291 . . . . 0.0 112.327 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.406 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 2.9 m-85 -76.02 -22.1 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.6 m -72.3 -7.18 48.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -130.27 28.83 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.479 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 2.9 m170 -74.57 -61.97 1.04 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.859 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.6 Cg_endo -69.74 -23.36 30.98 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -67.55 -32.17 72.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.22 -33.53 69.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.525 HD23 HG21 ' A' ' 200' ' ' VAL . 6.3 mt -81.67 -55.64 4.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.77 -32.62 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.26 -26.8 23.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -79.46 -23.63 42.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -83.03 1.17 41.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 128' ' ' GLU . 91.7 mt -70.56 129.27 90.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.638 0.733 . . . . 0.0 111.113 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -47.05 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.343 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.7 m-20 -61.6 97.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -34.45 -50.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.4 m -55.68 -57.76 10.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.52 ' HB2' HG21 ' A' ' 123' ' ' ILE . 15.6 mt-10 -54.87 -44.8 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -51.83 -54.23 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 207' ' ' GLN . 21.7 mt -68.93 -62.21 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -38.68 -43.28 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.41 79.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.553 HD22 ' HE1' ' A' ' 204' ' ' PHE . 12.6 mt -67.31 -23.44 65.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.428 ' O ' HG12 ' A' ' 137' ' ' VAL . 4.2 ttpm? -78.54 -32.64 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -85.34 -34.4 21.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.55 -39.86 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 134' ' ' LYS . 5.4 p -62.57 -8.74 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -76.83 -30.35 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.85 -22.98 61.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 141' ' ' HIS . 5.6 m-85 -51.45 133.4 29.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 1.2 t-80 -35.03 141.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.2 Cg_endo -69.84 -13.12 34.05 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.715 2.276 . . . . 0.0 112.301 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 28' ' ' GLN . 26.2 t -95.0 -37.09 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -87.32 -38.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -45.06 -44.94 10.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -61.27 -56.27 22.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.07 -54.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.846 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 24.8 t80 -49.03 -45.52 42.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 149' ' ' ARG . 7.5 mtp-105 -64.2 -49.08 73.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.565 ' CE2' ' OE2' ' A' ' 42' ' ' GLU . 39.1 t80 -52.59 -45.29 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.923 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.7 t -62.03 -57.36 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.135 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.846 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 70.3 mt -49.66 -48.97 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -47.54 -39.87 17.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.521 ' O ' HG23 ' A' ' 158' ' ' VAL . 74.6 t60 -77.57 -31.24 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 152' ' ' ILE . 97.9 mt -66.03 -45.95 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -54.72 -38.63 67.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.455 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 84.2 mtt180 -65.59 -37.02 85.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 154' ' ' HIS . 46.5 t -68.91 -43.25 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.6 p -60.8 -40.08 91.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 34.9 mt-30 -48.13 -37.7 16.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.413 ' HB3' HD12 ' A' ' 164' ' ' ILE . 6.0 mm-40 -105.06 32.83 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 166' ' ' LEU . 12.4 p80 -51.19 -38.73 53.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 21.1 mmtp -57.44 -32.49 66.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 161' ' ' GLN . 52.7 mt -87.81 -58.26 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 55' ' ' THR . 10.6 m-20 -76.08 4.07 9.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 162' ' ' HIS . 13.5 mt 46.15 42.67 10.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 31.2 mmm -144.37 122.59 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.6 p -100.63 156.89 17.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.69 -37.64 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.31 -47.47 64.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -58.49 -38.4 77.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.57 -48.07 61.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.2 p -51.92 -48.76 64.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.0 mt -62.01 -39.4 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.59 -17.07 53.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.437 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 33.0 m-85 -109.43 -10.57 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.571 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -48.76 -46.47 72.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.54 0.686 . . . . 0.0 110.9 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.91 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 180' ' ' LEU . 16.5 m -61.08 -64.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 179' ' ' THR . 59.5 mt -36.96 -62.31 0.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 86.0 mtp -117.1 81.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 8.3 mmt180 -60.86 -60.1 11.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.613 0.72 . . . . 0.0 110.839 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 54.0 Cg_endo -69.69 164.98 32.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.705 2.27 . . . . 0.0 112.325 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -126.99 118.84 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -111.96 -34.89 5.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -124.83 -174.92 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.411 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 16.7 t-20 59.8 52.27 5.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.909 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -70.43 -176.7 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -55.7 -22.39 23.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -81.88 140.94 33.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.0 mt 49.98 47.98 22.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 65.0 m -65.01 -13.9 59.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 39.0 p -86.52 96.25 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 4.0 t -163.99 139.26 6.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.137 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -111.56 36.35 3.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.75 ' O ' HG23 ' A' ' 200' ' ' VAL . 94.1 mt -95.0 -56.74 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' A' ' 187' ' ' ASN . 65.5 m80 -50.78 -72.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -47.85 -51.15 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.6 t -46.12 -42.22 13.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 196' ' ' ILE . 89.2 t -41.09 -70.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 202' ' ' GLU . 84.2 t -54.86 -59.66 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 201' ' ' VAL . 15.9 tt0 -35.85 -51.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 53.0 m -54.03 -57.9 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.671 ' HB3' HD13 ' A' ' 152' ' ' ILE . 8.1 m-85 -40.09 -34.37 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.553 ' HA ' HG23 ' A' ' 152' ' ' ILE . 66.9 mt -75.32 -59.84 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.158 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -53.93 -53.43 52.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.598 ' OE1' HG22 ' A' ' 218' ' ' VAL . 1.0 OUTLIER -84.63 18.91 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 19.3 t -60.6 -12.01 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 213' ' ' TYR . 14.9 mm-40 -95.96 -57.2 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -40.59 -38.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -49.63 -61.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -107.86 -53.96 2.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 209' ' ' GLN . 53.2 m-85 -58.06 -28.59 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 64.64 42.83 4.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.68 51.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -63.9 134.9 56.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.25 131.73 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.598 HG22 ' OE1' ' A' ' 207' ' ' GLN . 27.0 m -116.18 163.92 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -169.31 148.54 3.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.866 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -157.83 177.33 11.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.06 -176.57 17.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.512 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.2 p -163.64 129.28 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.373 . . . . 0.0 110.866 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 t -165.71 173.48 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.38 127.45 2.59 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -158.14 146.72 18.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.814 0.34 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -164.73 159.26 18.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -169.98 177.86 4.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.1 116.77 1.64 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.2 68.01 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.663 2.242 . . . . 0.0 112.391 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 173.03 11.6 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.668 2.245 . . . . 0.0 112.344 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -136.51 143.39 43.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.68 129.34 11.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -123.48 108.79 13.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -84.67 36.42 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -58.74 98.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -119.12 140.7 49.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -144.65 174.43 10.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -102.73 -48.77 4.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -37.75 -47.74 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 23' ' ' PHE . 1.7 p90 -39.56 119.89 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.14 -43.55 1.65 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.491 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 16.5 mtp -81.88 139.23 46.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.521 0.676 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 159.78 52.15 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.339 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 tp -55.41 -46.0 76.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -48.67 -35.57 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.63 -48.91 17.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.2 mt -56.03 -44.49 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 36' ' ' PRO . 4.5 m -90.76 171.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.5 p -108.12 144.03 36.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.94 -37.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.51 -42.19 95.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 17.7 mmtp -128.83 96.47 29.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.703 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HA ' HG21 ' A' ' 31' ' ' VAL . 54.0 Cg_endo -69.74 -24.65 29.54 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.8 mt -92.95 130.96 34.54 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 122.5 9.16 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -50.67 -27.43 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -62.3 -61.67 2.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.805 HG13 HD11 ' A' ' 97' ' ' LEU . 42.3 t -50.02 -50.94 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -51.83 -60.05 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 45.1 mmtt -44.3 -39.33 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HB2' HD13 ' A' ' 97' ' ' LEU . 95.2 m -67.5 -45.6 75.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.509 HG13 ' CG ' ' A' ' 154' ' ' HIS . 60.6 t -62.63 -59.54 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.26 -27.7 16.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -70.83 -54.33 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.466 HG22 ' CD1' ' A' ' 53' ' ' LEU . 42.8 mt -56.37 -20.5 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -91.06 -22.05 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.33 -17.62 22.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -82.56 18.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.144 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.38 -42.55 2.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.698 HD11 HG22 ' A' ' 158' ' ' VAL . 12.5 tp 64.7 44.0 3.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.1 p -133.16 30.0 3.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -90.93 127.84 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -60.39 120.76 10.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 48.71 76.04 0.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.812 HD23 ' H ' ' A' ' 58' ' ' LEU . 1.2 pt? -89.38 4.36 49.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.934 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.62 -48.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -59.05 -48.15 82.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.4 t -82.43 146.91 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.2 p -128.26 117.08 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.78 -144.61 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.479 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -64.75 -176.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -107.63 -37.68 6.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 m -53.04 -57.76 9.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.487 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -39.34 -58.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -50.59 -44.57 56.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.73 -51.0 70.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -50.97 -52.1 45.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 93' ' ' VAL . 85.3 mt -43.75 -46.46 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.12 -62.63 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ASP . 48.5 mttt -50.67 -64.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -39.41 -42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -71.66 -38.49 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' LYS . 11.1 t0 -65.33 -41.75 93.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.28 -31.57 71.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -166.89 148.35 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -94.66 -19.55 20.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -78.3 48.47 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 pt -109.98 -176.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.6 125.44 7.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -70.72 -46.69 62.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.01 -48.48 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -59.79 -43.81 94.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.474 ' HB3' HG13 ' A' ' 88' ' ' VAL . 89.9 mtp -59.25 -19.39 45.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 47.6 39.42 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' A' ' 86' ' ' MET . 31.3 m -72.71 164.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 p -74.88 131.89 41.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.3 t -44.36 -48.93 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -46.18 -40.21 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.77 -62.79 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.516 ' HA ' HD13 ' A' ' 71' ' ' ILE . 72.8 t -52.69 -36.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.85 72.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.57 -54.04 4.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.02 -44.39 61.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.805 HD11 HG13 ' A' ' 41' ' ' VAL . 34.0 tp -45.85 -43.67 13.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.11 -47.12 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -39.38 -45.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.25 -54.18 46.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.596 ' HB2' HG21 ' A' ' 179' ' ' THR . 76.3 m-85 -49.61 -47.22 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -54.49 -37.69 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.5 mt -41.45 141.01 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.657 0.741 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.13 32.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -133.25 150.6 75.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.881 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.24 37.47 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.336 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.1 tp -43.03 -53.84 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mt -85.42 124.09 72.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.559 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.79 149.02 66.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -70.43 -8.96 54.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.5 m -83.65 -12.46 55.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.848 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.628 HD13 ' CE1' ' A' ' 140' ' ' PHE . 43.0 mt -120.52 26.25 9.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.5 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.4 m170 -71.02 -60.12 3.04 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.78 -20.62 34.49 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.258 . . . . 0.0 112.328 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.404 ' O ' HD13 ' A' ' 136' ' ' ILE . 12.0 mp0 -70.89 -39.14 72.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.515 ' HB3' HG11 ' A' ' 200' ' ' VAL . 12.8 mt -72.09 -28.72 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.547 HD21 ' CD2' ' A' ' 197' ' ' HIS . 21.9 mt -83.68 -50.21 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.11 -26.36 11.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.61 -21.75 21.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -83.27 -15.4 50.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -95.47 10.23 37.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.3 mt -73.51 132.19 81.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.584 0.707 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -45.39 1.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.375 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 105.56 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HD3' HG21 ' A' ' 217' ' ' ILE . 6.9 ttmt -41.37 -53.04 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.625 HG22 ' CD2' ' A' ' 131' ' ' HIS . 3.0 m -56.02 -59.72 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -49.22 -39.3 29.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -57.46 -42.79 83.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.6 -54.12 8.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.625 ' CD2' HG22 ' A' ' 127' ' ' THR . 15.6 m-70 -46.76 -44.06 18.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.06 -59.66 4.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.533 HD22 ' HE1' ' A' ' 204' ' ' PHE . 16.1 mt -53.82 -33.75 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 137' ' ' VAL . 57.4 tttt -65.68 -34.97 79.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -82.62 -41.38 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 139' ' ' LYS . 87.8 mt -59.62 -21.14 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 134' ' ' LYS . 9.5 p -92.64 -5.91 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -81.02 -35.27 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 136' ' ' ILE . 5.8 pttm -80.57 -7.78 59.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.628 ' CE1' HD13 ' A' ' 113' ' ' LEU . 2.7 m-85 -51.4 149.88 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.599 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -41.83 140.64 1.41 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.4 Cg_endo -69.81 -16.66 37.43 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.653 2.235 . . . . 0.0 112.286 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 91.1 t -96.97 -38.72 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -83.89 -40.23 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 71.4 t80 -46.56 -42.86 16.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -45.18 94.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.1 t -68.33 -61.11 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -44.45 -46.86 9.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.434 ' HB3' ' NH1' ' A' ' 149' ' ' ARG . 7.8 ttp-105 -62.57 -47.97 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.03 -54.19 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 85.0 t -46.4 -65.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.12 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.485 ' HA ' HD12 ' A' ' 155' ' ' LEU . 77.8 mt -44.0 -53.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.9 m -39.77 -36.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.509 ' CG ' HG13 ' A' ' 45' ' ' VAL . 15.1 t60 -80.36 -43.31 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 205' ' ' ILE . 96.5 mt -49.2 -42.99 41.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -52.26 -48.57 65.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -56.91 -29.84 63.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.698 HG22 HD11 ' A' ' 53' ' ' LEU . 42.4 t -80.46 -29.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.093 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 p -75.65 -20.44 58.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.94 -44.37 63.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.715 ' HB3' HD12 ' A' ' 164' ' ' ILE . 1.7 mm100 -97.01 29.48 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.574 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 16.8 p80 -52.48 -39.25 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.574 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 0.8 OUTLIER -59.15 -21.19 58.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 161' ' ' GLN . 49.6 mt -92.73 -64.96 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -76.08 1.41 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 162' ' ' HIS . 43.5 mt 54.6 46.28 25.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.417 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 21.0 mtp -141.12 112.55 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.46 HG22 ' CG ' ' A' ' 162' ' ' HIS . 33.7 p -98.24 160.63 14.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -45.96 -35.39 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -49.05 62.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.86 -44.17 77.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.77 -44.36 96.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -53.07 -40.31 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.454 HG12 ' NE2' ' A' ' 198' ' ' GLN . 9.6 mt -80.71 -41.21 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.142 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.58 -20.77 66.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -108.75 0.04 20.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.577 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.13 -45.92 95.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.533 0.682 . . . . 0.0 110.872 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.5 Cg_exo -47.95 -58.54 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.688 2.259 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.596 HG21 ' HB2' ' A' ' 101' ' ' PHE . 18.2 m -69.69 -62.96 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.1 mt -40.52 -52.23 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 16.1 mmm -128.52 123.25 33.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -102.79 105.96 47.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 0.0 110.842 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 147.41 62.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.64 2.227 . . . . 0.0 112.325 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.58 140.2 29.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 185' ' ' PHE . 1.2 p90 -115.48 -44.8 2.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -116.73 29.16 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -132.23 -179.64 5.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.61 120.8 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -106.56 121.5 44.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -110.87 155.0 23.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -75.7 152.41 37.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.4 t -123.48 58.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.5 m -50.58 -52.54 38.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.168 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 80.7 p -90.57 111.63 23.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -78.08 70.63 4.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 200' ' ' VAL . 87.0 mt -88.76 -36.64 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.547 ' CD2' HD21 ' A' ' 118' ' ' LEU . 9.9 m-70 -48.74 -71.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.454 ' NE2' HG12 ' A' ' 174' ' ' ILE . 7.1 tt0 -40.7 -53.67 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 t -45.88 -41.96 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 196' ' ' ILE . 29.6 t -53.8 -60.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.56 -66.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -38.68 -52.33 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 51.5 m -48.85 -64.6 0.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.533 ' HE1' HD22 ' A' ' 133' ' ' LEU . 7.4 m-85 -34.16 -48.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 155' ' ' LEU . 48.3 mt -66.25 -50.37 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -53.86 -45.61 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -110.02 30.42 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.527 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 0.8 OUTLIER -64.12 -15.32 59.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 213' ' ' TYR . 67.6 mm-40 -88.92 -54.47 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 210' ' ' PHE . 0.9 OUTLIER -42.76 -40.46 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -45.91 -63.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -105.54 -53.32 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 209' ' ' GLN . 56.9 m-85 -56.03 -35.2 66.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.931 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 71.02 28.02 3.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.68 -166.41 1.77 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.508 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.84 151.99 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.593 HG21 ' HD3' ' A' ' 126' ' ' LYS . 54.1 mt -76.42 132.05 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 m -110.22 174.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -114.56 138.23 50.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -167.09 107.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.42 55.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.527 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -115.25 176.23 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.872 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.0 p -45.48 111.18 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.51 68.55 0.48 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.02 155.96 16.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.903 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -87.55 -25.05 23.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.896 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -159.14 163.99 35.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.87 132.52 95.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.617 0.722 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 146.74 61.17 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 156.88 62.19 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.625 2.217 . . . . 0.0 112.347 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -111.52 152.85 27.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -138.85 145.77 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -48.02 -54.24 13.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 66.08 25.44 10.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CZ3' ' HG2' ' A' ' 73' ' ' LYS . 31.5 t-105 69.96 52.17 0.4 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -114.11 144.95 42.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 m -171.37 167.2 6.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -88.63 -38.11 15.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.479 ' O ' ' C ' ' A' ' 23' ' ' PHE . 73.2 m-85 -38.82 -69.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 22' ' ' TYR . 28.1 m-85 -32.25 96.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.92 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' TYR . . . 107.07 24.87 6.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.504 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.862 ' HG3' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -109.43 154.94 42.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 149.43 66.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.694 2.263 . . . . 0.0 112.367 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.665 ' O ' HG22 ' A' ' 31' ' ' VAL . 30.0 tp -70.6 -39.39 73.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.443 ' HB3' HG21 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -52.34 -28.57 19.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.12 -41.24 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.862 HD21 ' HG3' ' A' ' 25' ' ' MET . 14.1 mt -69.37 -39.0 78.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 27' ' ' LEU . 34.6 m -96.26 164.65 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -107.41 168.49 9.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.49 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -53.52 -46.75 70.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 24.4 mmtm -130.74 103.88 15.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.51 ' O ' HG11 ' A' ' 31' ' ' VAL . 54.0 Cg_endo -69.77 -33.6 16.21 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.644 2.23 . . . . 0.0 112.369 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.455 HG22 ' HG3' ' A' ' 42' ' ' GLU . 29.8 mt -74.68 131.36 79.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.611 0.72 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' HD21 ' A' ' 27' ' ' LEU . 54.2 Cg_endo -69.7 147.64 63.68 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.483 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -63.33 -50.03 71.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -42.53 -67.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.753 HG13 HD11 ' A' ' 97' ' ' LEU . 75.0 t -46.93 -54.36 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' HG3' HG22 ' A' ' 37' ' ' ILE . 33.1 mt-10 -47.23 -58.04 4.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 51.8 mmtt -53.05 -37.56 61.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.427 ' O ' HD12 ' A' ' 48' ' ' ILE . 78.4 m -65.22 -43.94 89.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.02 -51.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.27 -45.72 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 93' ' ' VAL . 33.4 t80 -53.53 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 44' ' ' CYS . 41.2 mt -37.48 -56.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -52.06 -48.05 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.05 -44.1 87.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 t -85.87 23.92 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.1 139.65 10.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.434 ' O ' HD11 ' A' ' 58' ' ' LEU . 16.0 tp -110.29 -27.44 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.964 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.9 m -84.48 39.75 0.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.708 ' O ' HD12 ' A' ' 58' ' ' LEU . 11.5 m -82.72 111.67 18.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.4 tt0 -35.97 130.85 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 36.57 77.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 55' ' ' THR . 3.0 mp -60.2 -61.73 2.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.955 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.674 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 59.4 m-85 -93.3 -43.45 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -42.54 -49.02 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.12 88.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 t -68.33 -41.8 80.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.48 -116.57 5.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -79.66 172.18 14.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.371 . . . . 0.0 110.873 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -32.02 6.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -49.94 -35.54 24.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -60.84 -53.83 52.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.35 -27.35 65.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.57 -62.89 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 13.4 p30 -61.71 -44.55 96.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.449 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 47.2 mt -43.5 -42.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.52 -54.81 4.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HG2' ' CZ3' ' A' ' 18' ' ' TRP . 10.3 mtpp -51.22 -61.17 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -51.12 -38.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HA ' HG21 ' A' ' 81' ' ' ILE . 7.7 t80 -62.9 -28.74 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.74 -63.16 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -55.38 -29.31 58.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -131.04 99.05 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -69.92 -17.28 63.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.85 32.62 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.525 HG21 ' HA ' ' A' ' 75' ' ' PHE . 7.1 tt -73.61 157.22 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.461 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 4.8 t30 -132.35 94.74 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -40.49 -46.58 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.48 -50.65 78.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -55.54 -41.41 73.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.427 ' HB3' HG13 ' A' ' 88' ' ' VAL . 22.4 mmm -62.09 -33.86 75.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 61.55 46.51 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 86' ' ' MET . 33.7 m -78.75 165.72 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 74.7 p -67.26 139.44 57.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.9 t -52.82 -55.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -45.92 -44.45 14.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.54 -63.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 47' ' ' PHE . 93.7 t -45.04 -55.55 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.674 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -48.64 -38.7 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.35 -60.82 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.51 -43.92 8.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.753 HD11 HG13 ' A' ' 41' ' ' VAL . 23.8 tp -47.81 -44.55 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -68.01 -48.09 66.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.14 -38.38 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.068 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.25 -46.45 86.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -61.16 -47.51 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.511 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -59.74 -37.79 79.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 104' ' ' LEU . 6.7 t70 -59.42 -36.92 76.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' ASP . 96.2 mt -36.78 144.15 0.29 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -22.12 32.73 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.21 153.97 69.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.629 0.728 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 133.03 24.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.483 HD12 HD22 ' A' ' 144' ' ' ASN . 11.4 tp -38.38 -49.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.0 mt -84.2 123.63 75.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 111.162 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 153.93 68.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.691 2.261 . . . . 0.0 112.318 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.483 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 13.5 m-85 -72.62 -17.5 61.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 m -72.92 -30.45 63.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.39 27.85 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.498 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.0 m170 -71.49 -60.16 2.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.601 0.715 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.75 -33.83 15.85 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.247 . . . . 0.0 112.335 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.526 ' O ' HD13 ' A' ' 136' ' ' ILE . 1.3 mp0 -59.03 -33.3 70.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.44 ' HB3' HG11 ' A' ' 200' ' ' VAL . 12.8 mt -71.85 -40.28 69.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.2 mt -75.09 -58.57 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -42.71 -29.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.95 -28.4 20.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -76.8 -20.91 55.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -92.14 16.21 11.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 30.8 mt -78.22 132.64 66.01 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.59 0.71 . . . . 0.0 111.135 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -45.39 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.671 2.247 . . . . 0.0 112.349 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 126' ' ' LYS . 75.7 m-20 -66.34 92.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 125' ' ' ASP . 38.1 tttt -34.91 -51.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 42.4 m -53.25 -59.92 3.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' ARG . 45.1 mm-40 -54.83 -52.6 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 128' ' ' GLU . 11.4 ttm180 -36.87 -43.5 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 133' ' ' LEU . 22.8 mt -75.84 -61.56 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 130' ' ' LEU . 11.8 m-70 -36.53 -49.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.1 -55.14 30.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.589 HD22 ' HE1' ' A' ' 204' ' ' PHE . 11.0 mt -55.9 -41.37 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -56.3 -29.67 61.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -90.37 -46.33 8.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 116' ' ' GLU . 56.7 mt -56.43 -29.2 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.528 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 7.8 p -76.15 -15.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -73.37 -25.44 60.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -77.38 -19.13 56.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 7.9 m-85 -50.51 146.98 4.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.586 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.4 t-80 -45.48 141.39 3.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.586 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -21.0 34.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 28' ' ' GLN . 84.6 t -89.7 -38.89 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.483 HD22 HD12 ' A' ' 108' ' ' LEU . 2.9 m120 -83.65 -44.06 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 141' ' ' HIS . 14.1 t80 -40.97 -56.77 2.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -46.9 -34.45 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.38 -58.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 24.0 t80 -43.17 -41.65 3.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -70.47 -44.79 67.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -57.71 -42.37 83.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.956 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.466 ' HA ' HD12 ' A' ' 155' ' ' LEU . 86.0 mt -43.4 -53.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.146 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.8 m -41.25 -34.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -83.61 -39.68 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.857 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 152' ' ' ILE . 92.8 mt -56.2 -45.52 79.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.98 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -50.36 -43.66 54.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.407 ' HB3' HD21 ' A' ' 53' ' ' LEU . 22.6 mtp85 -59.86 -30.84 69.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.72 -45.65 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.6 p -57.84 -29.95 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.06 -46.48 88.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -100.86 40.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 166' ' ' LEU . 10.6 p80 -58.54 -41.05 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.414 ' HG2' ' NE2' ' A' ' 162' ' ' HIS . 17.0 mmmt -55.32 -27.57 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 79.9 mt -90.29 -57.07 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' LEU . 0.3 OUTLIER -84.17 18.07 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 162' ' ' HIS . 12.1 mt 34.32 52.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 49.1 mmm -146.34 108.73 4.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.437 HG22 ' ND1' ' A' ' 162' ' ' HIS . 73.9 p -93.94 151.19 19.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.79 -37.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.89 -49.09 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 168' ' ' THR . 41.1 m-20 -54.54 -42.8 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.43 -48.05 79.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 p -58.55 -39.36 80.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.31 -37.48 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.175 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.91 -15.44 63.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -108.16 -8.43 15.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.556 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -56.73 -47.29 99.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.871 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.2 Cg_exo -48.0 -62.12 0.49 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.511 HG23 ' CA ' ' A' ' 102' ' ' ALA . 16.7 m -67.85 -62.97 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.129 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 179' ' ' THR . 48.2 mt -33.2 -44.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.497 ' CE ' ' CD2' ' A' ' 114' ' ' HIS . 31.2 mtp -146.86 140.2 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.426 ' NE ' ' OH ' ' A' ' 111' ' ' TYR . 9.7 ptp180 -52.65 151.94 7.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.827 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 184' ' ' ASP . 53.2 Cg_endo -69.81 117.88 5.35 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.635 2.223 . . . . 0.0 112.333 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' PRO . 8.9 p-10 -35.83 144.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -79.1 -34.29 43.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -41.52 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.44 -27.2 12.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -13.08 51.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -93.79 125.15 38.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.467 ' CD2' ' HG ' ' A' ' 191' ' ' LEU . 36.7 p90 -100.57 -45.79 5.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 190' ' ' PHE . 11.3 mt -85.59 128.14 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.6 t -102.31 89.27 3.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.839 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 22.0 p -78.1 -63.29 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 25.6 m -62.0 119.45 8.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -2.67 14.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 200' ' ' VAL . 65.3 mt -49.07 -36.24 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -43.03 -69.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -67.16 -39.36 86.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 t -43.45 -40.37 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.823 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 196' ' ' ILE . 66.4 t -52.58 -58.25 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.16 -39.96 82.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -58.04 -52.4 65.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.4 m -49.51 -61.77 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.589 ' HE1' HD22 ' A' ' 133' ' ' LEU . 10.0 m-85 -33.83 -52.67 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.435 HG12 HG23 ' A' ' 152' ' ' ILE . 38.8 mt -62.61 -47.7 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -55.92 -47.63 77.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.9 mm-40 -109.84 31.67 5.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 2.4 t -63.55 -21.42 66.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.533 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 10.3 mm-40 -86.53 -51.17 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -45.04 -35.3 2.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -52.76 -62.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -108.07 -55.06 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.533 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 54.7 m-85 -56.63 -14.57 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 52.37 38.75 25.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.41 150.68 33.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 216' ' ' GLU . 2.8 mp0 -49.95 153.3 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.915 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.419 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 93.2 mt -73.69 126.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.092 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.2 m -104.81 177.68 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -152.79 166.67 31.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.903 0.382 . . . . 0.0 110.847 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -165.06 169.05 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.823 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.18 -141.23 4.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -143.72 139.47 29.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.838 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.9 m -110.25 168.45 9.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.3 114.47 1.0 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.504 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -174.56 144.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -61.71 106.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -76.76 -45.37 29.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -82.16 137.56 46.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 167.99 22.87 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.678 2.252 . . . . 0.0 112.347 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -179.16 2.73 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.255 . . . . 0.0 112.343 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -129.18 151.67 49.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -95.87 128.48 42.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -92.61 -42.37 9.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 18' ' ' TRP . 11.2 t-20 49.62 35.14 8.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' ASN . 0.0 OUTLIER 34.11 44.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.58 140.22 58.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -152.14 163.83 38.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -83.31 -30.83 27.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 25' ' ' MET . 13.4 m-85 -49.18 -61.9 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.0 m-30 37.11 48.26 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.26 38.26 93.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.47 ' HB2' HD21 ' A' ' 30' ' ' LEU . 25.4 mmt -93.87 152.03 40.29 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.613 0.721 . . . . 0.0 110.884 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 53.5 Cg_endo -69.73 133.77 26.43 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.642 2.228 . . . . 0.0 112.369 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.434 ' O ' HG22 ' A' ' 31' ' ' VAL . 26.2 tp -53.22 -53.61 48.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HA ' HG11 ' A' ' 143' ' ' VAL . 5.7 pt20 -44.37 -33.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 11.5 t70 -79.24 -48.8 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 25' ' ' MET . 41.4 mt -57.03 -43.95 82.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' LEU . 20.7 m -82.06 -179.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -117.61 147.52 42.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.14 -45.03 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -52.23 -43.09 64.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.75 108.37 13.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.552 0.691 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -39.39 6.55 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HD2' ' A' ' 38' ' ' PRO . 22.3 mt -73.99 132.94 79.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.648 0.737 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.76 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 0.0 112.363 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.621 HD11 ' HE3' ' A' ' 43' ' ' LYS . 2.2 tm? -45.1 -48.02 12.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.511 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 82.0 t80 -43.2 -70.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.932 HG13 HD11 ' A' ' 97' ' ' LEU . 66.2 t -44.17 -50.48 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.069 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -49.13 -53.89 18.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.621 ' HE3' HD11 ' A' ' 39' ' ' LEU . 12.2 mmtp -52.15 -40.76 61.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.0 m -66.53 -47.47 72.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.56 -46.21 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.71 -43.96 71.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 93' ' ' VAL . 63.8 t80 -50.78 -63.1 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.5 mt -39.67 -62.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -49.01 -50.3 36.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.44 -39.0 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.9 p -88.65 25.43 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.29 137.91 1.89 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.508 HD11 HG22 ' A' ' 158' ' ' VAL . 6.1 tp -113.47 47.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.773 0.32 . . . . 0.0 110.874 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.6 p -132.75 37.45 3.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -96.72 119.61 35.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.1 tt0 -37.93 123.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 60' ' ' ARG . . . 34.17 73.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.528 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -69.75 -24.73 63.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -102.59 -57.04 2.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HG3' HG23 ' A' ' 61' ' ' VAL . 15.7 ptm180 -46.65 -33.06 3.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.614 HG23 ' HG3' ' A' ' 60' ' ' ARG . 48.7 t -97.25 102.59 13.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.142 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.9 m -61.97 -58.14 9.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.88 -161.5 23.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.497 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.74 161.89 11.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HD3' ' N ' ' A' ' 65' ' ' LYS . 2.2 mppt? -92.63 -52.49 4.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -40.65 -53.23 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.164 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.1 -45.33 32.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -73.9 -30.94 62.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -62.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -50.63 -34.47 26.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.48 -44.6 89.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -79.06 -46.59 17.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 76' ' ' ASP . 93.2 mttt -59.79 -66.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -40.26 -47.01 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 42.9 t80 -64.29 -37.91 89.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 73' ' ' LYS . 37.6 m-20 -68.74 -58.85 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -53.38 -29.25 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.06 149.88 14.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.23 -17.72 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -83.43 50.75 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.7 pt -112.44 -177.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.403 ' ND2' ' HB ' ' A' ' 84' ' ' VAL . 1.9 t30 -149.26 136.31 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.7 mt -81.28 -46.78 14.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.403 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 93.5 t -44.14 -54.16 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.1 t -55.57 -43.28 75.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.7 mmm -55.95 -28.83 58.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 51.97 45.94 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.99 164.84 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 t -75.22 128.16 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.3 t -40.31 -51.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -38.72 -53.01 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.15 -60.93 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.106 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.506 HG21 ' CD2' ' A' ' 47' ' ' PHE . 94.4 t -47.26 -51.23 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.75 -45.05 58.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.12 -63.35 3.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.78 -42.15 5.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.884 0.373 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.932 HD11 HG13 ' A' ' 41' ' ' VAL . 43.3 tp -48.69 -45.57 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -69.62 -51.17 37.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -40.26 -39.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -58.99 -47.46 85.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.771 ' HB2' HG21 ' A' ' 179' ' ' THR . 51.6 m-85 -62.27 -48.87 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.428 ' N ' HG23 ' A' ' 179' ' ' THR . . . -57.15 -37.13 71.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -34.8 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -41.65 141.29 1.23 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -19.06 36.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.693 2.262 . . . . 0.0 112.357 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -134.14 152.55 78.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.62 26.02 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.708 2.272 . . . . 0.0 112.342 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.2 tp -44.25 -44.26 7.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.8 mt -92.49 123.94 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.617 0.723 . . . . 0.0 111.162 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.699 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.8 Cg_endo -69.77 146.37 59.92 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.345 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.65 ' CD2' ' CE1' ' A' ' 114' ' ' HIS . 73.7 m-85 -66.26 -32.55 74.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m -61.14 -15.11 30.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.699 HD12 ' HG2' ' A' ' 110' ' ' PRO . 27.3 mt -122.0 28.47 7.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.65 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 3.9 m170 -73.0 -60.79 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.569 0.7 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.76 -31.82 19.79 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.694 2.263 . . . . 0.0 112.38 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -59.96 -28.86 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.0 -46.66 33.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 121' ' ' ALA . 12.0 mt -65.12 -55.2 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -45.72 -37.19 5.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.53 -21.08 32.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -86.63 -18.44 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -89.81 -8.85 51.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 128' ' ' GLU . 82.4 mt -56.81 130.17 78.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 111.141 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -46.08 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.12 116.94 10.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.44 ' HG2' HG21 ' A' ' 217' ' ' ILE . 7.4 tppt? -50.99 -49.55 60.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.0 m -53.57 -55.7 23.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.53 ' HB2' HG21 ' A' ' 123' ' ' ILE . 14.2 mt-10 -60.38 -38.95 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -57.75 -49.97 74.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.76 -60.52 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -43.58 -50.15 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.77 78.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 mt -74.57 -27.26 60.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -78.0 -27.16 48.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.0 pt-20 -86.11 -32.99 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.418 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 84.9 mt -74.2 -38.01 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.8 p -62.05 -11.81 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -74.96 -43.09 56.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -61.55 -32.97 73.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -40.52 137.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.59 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -39.33 141.16 0.69 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.849 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.78 -18.99 36.62 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 28' ' ' GLN . 92.1 t -89.86 -37.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.91 -40.26 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.525 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 6.2 t80 -48.69 -51.69 27.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.92 -51.85 21.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.0 -67.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 38.5 t80 -40.21 -40.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.525 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 4.6 mmp_? -66.39 -45.1 81.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.07 -48.15 77.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.99 -64.75 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.751 ' HA ' HD12 ' A' ' 155' ' ' LEU . 91.6 mt -42.82 -53.48 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.3 m -40.26 -36.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.121 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -78.9 -36.89 41.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.751 HD12 ' HA ' ' A' ' 152' ' ' ILE . 53.1 mt -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -47.21 -47.37 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -55.57 -37.65 68.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.549 HG11 HD21 ' A' ' 172' ' ' LEU . 75.7 t -68.94 -50.41 54.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.2 p -55.23 -37.8 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -50.7 -39.87 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -108.46 40.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 167' ' ' MET . 17.9 p80 -58.67 -35.68 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -58.16 -31.99 67.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.55 -57.85 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 166' ' ' LEU . 2.6 m-20 -83.39 17.23 2.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 162' ' ' HIS . 22.0 mt 34.96 50.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.695 ' CE ' HD23 ' A' ' 172' ' ' LEU . 39.4 mmm -146.42 113.83 6.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 169' ' ' ALA . 9.2 p -95.76 153.36 17.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.97 -49.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.07 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -50.17 74.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -53.34 -44.39 68.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.695 HD23 ' CE ' ' A' ' 167' ' ' MET . 16.5 mt -61.69 -41.62 97.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -59.38 -48.9 79.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 42.7 mt -62.74 -34.57 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 40.9 m -69.51 -22.86 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -102.25 -5.77 23.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.583 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -55.1 -46.05 99.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.609 0.718 . . . . 0.0 110.97 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.8 Cg_exo -47.95 -63.12 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 0.0 112.363 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.771 HG21 ' HB2' ' A' ' 101' ' ' PHE . 87.1 m -65.44 -61.4 2.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 179' ' ' THR . 78.6 mt -34.24 -42.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 8.7 ptp -166.6 142.24 4.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.846 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -114.69 147.97 39.33 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 133.33 25.27 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.689 2.259 . . . . 0.0 112.311 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.94 116.54 28.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -92.51 -56.7 2.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -35.99 56.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.88 177.46 6.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.7 tpt85 -101.21 9.62 41.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.833 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -47.77 100.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.847 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -46.22 112.65 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -82.86 114.11 20.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.937 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 86.6 p -126.56 134.79 50.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.9 p -105.61 102.77 12.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.125 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 196' ' ' ILE . 58.5 p -142.13 127.75 19.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.155 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 194' ' ' THR . 14.0 ttmm -35.41 -34.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 194' ' ' THR . 51.1 mt -43.88 -65.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 196' ' ' ILE . 39.1 m-70 -35.4 -61.19 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -56.77 -48.1 78.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 m -49.74 -36.97 27.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.21 -70.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.166 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.17 -53.37 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.454 ' C ' ' OE1' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -38.69 -48.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 204' ' ' PHE . 60.8 m -58.79 -62.12 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.1 m-85 -34.41 -40.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 152' ' ' ILE . 70.6 mt -78.67 -52.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -48.57 -44.92 37.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.6 mm-40 -113.31 35.4 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 6.1 t -64.07 -15.98 60.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.466 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 12.8 mm-40 -89.07 -53.68 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.69 -36.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -53.07 -63.47 1.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -107.53 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.466 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 89.4 m-85 -61.27 -9.98 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 48.5 t30 47.24 43.86 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.63 145.87 28.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.519 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -43.79 143.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.471 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 75.7 mt -63.35 131.15 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.118 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.1 m -112.26 173.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.159 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 219' ' ' GLU . 5.0 tm-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -131.94 125.62 32.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.857 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 t -123.76 159.76 28.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.95 110.14 3.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' SER . 9.1 m -126.35 42.37 3.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' SER . 25.9 t -35.45 104.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.64 150.41 14.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -87.77 119.99 28.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.322 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -100.9 42.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -117.48 112.87 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -108.77 122.81 38.97 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.634 0.73 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 146.93 61.77 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.682 2.255 . . . . 0.0 112.357 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 158.17 57.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.688 2.259 . . . . 0.0 112.33 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 p -63.34 125.49 24.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.126 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 ptt85 -53.64 172.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -72.91 143.68 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -53.3 -45.58 69.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -55.17 99.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.19 159.5 32.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -167.63 163.41 14.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -87.51 -30.17 20.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 24' ' ' GLY . 9.5 m-85 -85.26 -43.87 13.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 22' ' ' TYR . 47.5 p90 35.55 30.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' TYR . . . 112.5 23.55 5.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.509 ' HE3' ' HD2' ' A' ' 26' ' ' PRO . 61.1 mmm -79.57 137.44 55.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.861 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.509 ' HD2' ' HE3' ' A' ' 25' ' ' MET . 53.4 Cg_endo -69.8 128.48 16.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 0.0 112.334 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' HG22 ' A' ' 31' ' ' VAL . 17.1 tp -52.49 -45.1 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.492 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.1 pt20 -49.65 -32.04 12.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.96 -41.47 20.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -63.03 -41.86 99.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.771 HG11 ' O ' ' A' ' 36' ' ' PRO . 23.6 m -85.27 164.8 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 p -110.63 147.91 33.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -42.57 -45.02 4.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -58.58 -41.14 85.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -130.99 97.62 20.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.771 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.9 Cg_endo -69.68 -47.44 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.377 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.425 HG23 ' HD2' ' A' ' 38' ' ' PRO . 43.8 mt -64.09 132.41 95.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.73 . . . . 0.0 111.109 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 147' ' ' VAL . 53.2 Cg_endo -69.78 140.05 41.67 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -57.76 -51.32 70.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.42 ' CD1' ' CD2' ' A' ' 75' ' ' PHE . 28.7 t80 -42.13 -64.42 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 97' ' ' LEU . 71.7 t -46.6 -54.32 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.122 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -50.3 -55.27 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.55 ' HG2' HD13 ' A' ' 39' ' ' LEU . 38.1 mmtt -47.26 -40.97 17.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.464 ' HB2' HD13 ' A' ' 97' ' ' LEU . 81.8 m -63.62 -46.37 86.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 ' CG ' ' A' ' 154' ' ' HIS . 35.1 t -64.89 -56.35 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.28 -45.38 88.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 93' ' ' VAL . 63.6 t80 -42.92 -60.17 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.0 mt -51.34 -48.88 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -56.07 -47.74 77.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -44.55 -47.52 10.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.3 p -84.04 29.84 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.21 163.11 9.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.403 HD21 ' C ' ' A' ' 157' ' ' ARG . 3.6 tp -103.03 37.08 2.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.346 . . . . 0.0 110.939 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.5 p -120.52 40.68 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.448 HG21 HD21 ' A' ' 58' ' ' LEU . 39.6 m -88.88 133.85 34.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.191 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -98.13 110.82 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.37 72.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 55' ' ' THR . 20.3 mt -114.79 119.62 37.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 62.67 28.96 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB2' ' HE1' ' A' ' 167' ' ' MET . 19.4 ttm-85 -129.9 -36.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.0 t -93.37 131.87 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.8 m -78.69 102.93 8.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.06 154.35 47.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.5 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -55.66 131.58 46.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 110.886 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -57.12 -35.59 69.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.5 m -54.03 -41.73 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.162 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.42 -54.04 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.709 ' HA ' HD12 ' A' ' 71' ' ' ILE . 29.5 mt-30 -60.54 -32.63 71.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -67.99 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -52.92 -34.72 56.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 68' ' ' GLN . 49.0 mt -56.68 -40.47 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -85.34 -59.76 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -46.8 -59.66 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.448 ' CB ' HD12 ' A' ' 81' ' ' ILE . 40.1 mm-40 -49.71 -51.58 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CD2' ' CD1' ' A' ' 40' ' ' PHE . 58.2 t80 -58.59 -37.35 75.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.46 -60.1 3.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -58.76 -38.83 79.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.22 111.5 5.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -68.09 -32.41 72.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.4 m-80 -38.88 -36.91 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.448 HD12 ' CB ' ' A' ' 74' ' ' GLN . 13.7 tt -34.51 146.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -134.89 100.68 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 82' ' ' ASN . 56.2 mt -34.35 -54.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.18 -47.31 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' ASN . 3.3 t -63.04 -48.1 80.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.448 ' HB3' HG13 ' A' ' 88' ' ' VAL . 7.7 mmm -57.33 -35.5 69.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 61.33 49.96 5.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 86' ' ' MET . 35.5 m -83.45 171.1 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.114 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.7 p -66.28 123.68 20.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 55' ' ' THR . 91.4 t -44.97 -56.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.109 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -37.78 -41.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.51 -60.47 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 47' ' ' PHE . 99.1 t -45.05 -51.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.9 -44.23 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -50.34 11.68 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.449 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.22 -51.61 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.53 HD11 HG13 ' A' ' 41' ' ' VAL . 32.9 tp -43.77 -44.51 6.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 37.8 mtmt -72.85 -47.7 43.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.15 -45.63 4.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -57.43 -46.92 83.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -57.0 -44.24 82.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.54 90.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -40.48 76.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.4 mt -37.23 145.39 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -18.99 36.38 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.709 2.272 . . . . 0.0 112.306 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.8 152.27 70.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.601 0.715 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.4 Cg_endo -69.77 129.01 16.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 107' ' ' PRO . 11.2 tp -34.45 -45.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.2 mt -96.58 121.7 59.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 111.162 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 151.71 69.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.402 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.97 -22.35 64.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.2 m -68.77 -21.65 64.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 mt -113.89 28.69 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.501 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 3.4 m170 -75.68 -62.94 0.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.7 Cg_endo -69.81 -23.38 30.64 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.613 2.209 . . . . 0.0 112.334 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.4 -32.48 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.3 mt -75.15 -27.09 59.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.14 -51.02 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.95 -25.9 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.407 ' HA ' HD11 ' A' ' 123' ' ' ILE . . . -91.94 -29.45 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -73.08 -21.06 60.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -92.27 20.32 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 124' ' ' PRO . 87.7 mt -84.33 134.16 43.52 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 111.154 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 123' ' ' ILE . 54.1 Cg_endo -69.71 -44.35 2.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.721 2.28 . . . . 0.0 112.381 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 126' ' ' LYS . 24.1 t0 -69.18 95.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.604 ' HE3' HG21 ' A' ' 217' ' ' ILE . 44.1 tttp -38.11 -43.67 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.0 m -58.72 -66.65 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -46.23 -43.55 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 123' ' ' ILE . 20.6 ttp180 -48.07 -42.15 27.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.2 mt -73.12 -52.86 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -49.08 -52.71 24.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.4 -57.61 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.435 HD22 ' HE1' ' A' ' 204' ' ' PHE . 11.9 mt -60.25 -35.22 74.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 137' ' ' VAL . 29.3 tttm -61.61 -30.8 70.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.14 -44.94 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.59 -32.71 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 134' ' ' LYS . 10.1 p -68.6 -16.18 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -72.1 -32.06 66.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -68.55 -30.3 69.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 141' ' ' HIS . 8.4 m-85 -43.59 138.45 2.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -37.25 141.37 0.43 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.556 0.693 . . . . 0.0 110.851 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.3 Cg_endo -69.78 -17.04 37.72 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 28' ' ' GLN . 60.4 t -97.71 -32.34 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -86.76 -39.16 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -49.54 -47.7 48.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.57 -54.53 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 151' ' ' VAL . 61.1 t -60.71 -56.78 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 45.9 t80 -46.76 -48.5 20.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -65.05 -48.51 73.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -54.74 -41.98 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 147' ' ' VAL . 62.6 t -59.52 -59.55 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.936 HG23 HG12 ' A' ' 205' ' ' ILE . 73.0 mt -47.67 -53.89 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' ILE . 24.4 m -36.83 -36.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.495 ' CG ' HG13 ' A' ' 45' ' ' VAL . 69.2 t60 -81.75 -39.41 24.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 152' ' ' ILE . 71.4 mt -56.93 -40.13 75.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.858 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.463 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 43.8 t-20 -56.84 -41.74 78.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.403 ' C ' HD21 ' A' ' 53' ' ' LEU . 23.1 mtp180 -59.11 -40.45 85.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.528 HG13 HD22 ' A' ' 165' ' ' ASN . 67.2 t -65.21 -54.07 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.4 p -46.46 -32.78 3.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' A' ' 156' ' ' ASN . 1.5 mt-30 -67.18 -46.65 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.585 HE21 HD12 ' A' ' 164' ' ' ILE . 31.1 mm100 -88.15 39.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -67.91 -20.37 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -68.83 -30.81 69.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.585 HD12 HE21 ' A' ' 161' ' ' GLN . 50.4 mt -102.47 -53.72 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.528 HD22 HG13 ' A' ' 158' ' ' VAL . 1.5 m-20 -66.38 -23.43 66.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 34.8 mt 65.01 39.95 5.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.426 ' HE1' ' HB2' ' A' ' 60' ' ' ARG . 42.4 mmm -150.11 118.98 6.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.3 p -98.16 172.67 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -56.96 -38.48 73.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -59.69 -47.19 86.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -63.28 -39.48 94.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 169' ' ' ALA . 10.9 mt -66.57 -38.54 87.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.1 t -61.29 -41.4 96.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.5 mt -77.85 -34.4 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 42.3 m -68.95 -14.85 63.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.513 ' CE2' ' HG2' ' A' ' 98' ' ' LYS . 13.3 m-85 -111.48 -5.76 14.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.578 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -54.55 -46.33 99.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -47.96 -53.36 6.74 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.306 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 26.2 m -78.77 -68.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 33.0 mt -34.22 -64.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.554 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 1.0 OUTLIER -112.33 96.9 6.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.446 ' CG ' ' HD2' ' A' ' 183' ' ' PRO . 33.6 ttm-85 -37.31 141.41 0.44 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.633 0.73 . . . . 0.0 110.865 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 182' ' ' ARG . 53.5 Cg_endo -69.72 135.75 31.34 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 0.0 112.347 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.15 120.86 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -56.14 -53.62 54.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -88.91 115.62 26.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -145.96 105.79 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -80.05 136.11 36.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -138.39 112.98 8.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 191' ' ' LEU . 50.4 p90 -72.02 -51.19 22.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 190' ' ' PHE . 56.5 mt -142.89 163.27 33.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 18.3 m -100.43 39.11 1.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 193' ' ' THR . 13.6 t -114.27 38.71 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.091 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 194' ' ' THR . 10.0 t -156.97 123.2 4.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.19 41.23 2.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 200' ' ' VAL . 32.0 mt -67.12 -59.14 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -37.83 -47.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.72 -51.67 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.9 m -40.83 -42.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 121' ' ' ALA . 57.9 t -40.44 -71.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 202' ' ' GLU . 85.5 t -60.08 -61.11 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 201' ' ' VAL . 20.9 tt0 -35.77 -42.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 204' ' ' PHE . 91.3 m -62.72 -59.93 4.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.2 m-85 -33.98 -47.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.936 HG12 HG23 ' A' ' 152' ' ' ILE . 47.4 mt -71.66 -48.71 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -51.84 -45.34 63.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.57 ' NE2' HG22 ' A' ' 218' ' ' VAL . 6.4 mm-40 -113.74 34.1 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.539 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 21.6 t -63.54 -21.85 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.489 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 47.3 mm-40 -84.5 -54.54 4.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -41.13 -34.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.539 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 22.3 m-85 -52.62 -63.4 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -106.11 -56.35 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.489 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 72.1 m-85 -56.92 -17.16 8.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.915 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 51.67 40.1 26.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.925 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.07 135.77 15.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -42.5 137.08 2.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 0.0 110.936 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.604 HG21 ' HE3' ' A' ' 126' ' ' LYS . 68.1 mt -48.43 127.16 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.57 HG22 ' NE2' ' A' ' 207' ' ' GLN . 35.8 m -89.42 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t -148.54 155.25 40.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 110.849 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 p -151.7 175.53 12.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.89 168.47 27.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.477 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.6 p -119.59 159.58 24.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 110.85 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.6 m -89.26 -56.25 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.58 -119.81 5.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp 55.98 42.85 28.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.803 0.335 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -99.37 135.72 40.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -125.44 177.67 6.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.432 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 7.6 t30 -168.51 140.42 2.26 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.607 0.718 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 54.3 Cg_endo -69.72 153.07 69.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.665 2.243 . . . . 0.0 112.411 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 162.49 41.9 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.635 2.223 . . . . 0.0 112.361 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.9 p -98.63 113.56 25.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.184 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -105.81 157.97 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 17' ' ' ASN . 12.2 tpp180 -83.81 155.05 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ARG . 98.0 m-20 -35.08 -44.38 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -163.89 116.99 1.45 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 20' ' ' SER . 0.7 OUTLIER -110.85 140.83 44.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.415 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 75.3 m -135.1 176.2 8.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.848 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -102.86 -35.45 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.671 ' HB3' HD21 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -81.56 -51.48 8.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 22' ' ' TYR . 42.3 p90 45.85 43.64 10.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.22 29.88 4.37 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.9 mtp -113.31 147.38 37.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.572 0.701 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 153.98 68.03 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.7 2.266 . . . . 0.0 112.312 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' VAL . 27.8 tp -62.44 -45.61 92.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.593 ' HA ' HG11 ' A' ' 143' ' ' VAL . 4.9 pt20 -46.79 -31.57 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.97 -44.05 27.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 22' ' ' TYR . 28.0 mt -64.14 -42.09 96.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 27' ' ' LEU . 32.8 m -90.81 158.21 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -100.48 150.53 22.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -45.89 -46.17 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -53.7 -40.32 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 15.2 mmtp -133.75 94.73 18.45 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.7 Cg_endo -69.76 -35.95 11.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.704 2.269 . . . . 0.0 112.365 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 ' HG3' ' A' ' 42' ' ' GLU . 18.9 mt -74.22 131.33 80.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 111.113 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' HG22 ' A' ' 147' ' ' VAL . 53.9 Cg_endo -69.71 121.56 8.26 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.713 2.276 . . . . 0.0 112.345 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.491 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -44.67 -53.88 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -38.72 -68.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.885 HG13 HD11 ' A' ' 97' ' ' LEU . 79.2 t -45.41 -54.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HG3' HG22 ' A' ' 37' ' ' ILE . 88.5 mt-10 -45.94 -60.9 1.99 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 54.5 mmtt -46.94 -39.29 12.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.543 ' HB2' HD13 ' A' ' 97' ' ' LEU . 94.6 m -68.64 -52.49 30.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.93 -32.65 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -82.64 -36.29 26.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -63.15 -55.87 21.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.98 ' O ' HG22 ' A' ' 51' ' ' THR . 23.1 mt -47.75 -52.47 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -70.94 -24.32 62.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.84 -17.71 59.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.98 HG22 ' O ' ' A' ' 48' ' ' ILE . 8.4 t -91.98 26.33 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.54 -34.4 3.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 48' ' ' ILE . 4.7 tp 68.21 53.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.3 p -114.65 -25.33 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -42.74 129.52 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 57' ' ' GLY . 7.3 mp0 -74.21 140.96 45.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 33.93 37.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 59' ' ' TYR . 1.2 pp -38.22 -32.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.765 ' N ' HD12 ' A' ' 58' ' ' LEU . 15.1 m-85 -82.03 -61.83 1.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG3' HG23 ' A' ' 61' ' ' VAL . 11.5 ptm180 -55.33 -14.02 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 60' ' ' ARG . 88.4 t -117.46 108.53 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 77.4 p -79.76 -46.09 17.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.54 -125.03 8.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.509 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -99.75 136.69 39.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.477 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 1.4 mptm? -63.92 -47.48 80.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 m -46.25 -43.68 15.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.13 -58.65 6.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.823 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.809 ' HA ' HD12 ' A' ' 71' ' ' ILE . 1.2 mp0 -58.19 -34.95 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -50.56 -62.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.3 p30 -58.9 -41.26 86.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 68' ' ' GLN . 70.7 mt -46.61 -41.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.56 -57.7 2.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -49.09 -56.24 9.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -54.39 -46.54 73.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -62.38 -35.16 78.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.85 -53.31 52.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -74.42 -24.82 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -130.6 89.62 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.6 -34.63 75.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.68 39.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.724 HD11 ' SD ' ' A' ' 86' ' ' MET . 9.6 tt -79.99 154.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 81' ' ' ILE . 5.0 t30 -124.79 94.56 4.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -41.15 -49.12 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.955 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.432 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 63.3 t -47.41 -44.62 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 t -60.18 -40.49 90.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.724 ' SD ' HD11 ' A' ' 81' ' ' ILE . 77.9 mtp -63.14 -37.97 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 62.95 47.4 4.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.0 m -84.76 171.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.7 p -68.71 118.96 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.9 t -36.56 -54.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -40.04 -47.78 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 -63.08 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.4 t -50.05 -46.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.84 -50.66 33.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.71 -54.16 6.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.64 -40.85 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.885 HD11 HG13 ' A' ' 41' ' ' VAL . 11.1 tp -53.24 -56.31 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.463 ' CG ' ' CE2' ' A' ' 176' ' ' PHE . 6.1 mtmp? -60.34 -46.27 90.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.33 -46.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' A' ' 100' ' ' PHE . 7.3 t80 -57.41 -53.19 60.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -51.46 -41.01 60.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.53 -36.47 81.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -62.23 -38.75 90.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' ASP . 95.9 mt -34.89 144.64 0.21 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 110.934 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.28 36.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -139.26 153.82 71.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.77 128.65 16.32 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 2.263 . . . . 0.0 112.357 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 107' ' ' PRO . 23.8 tp -34.97 -39.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.9 mt -98.46 121.41 56.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.77 144.19 53.21 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 23.6 m-85 -59.38 -30.76 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.9 p -61.36 -16.35 45.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 117' ' ' LEU . 58.1 mt -119.45 29.92 7.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.51 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 3.1 m170 -76.39 -63.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.74 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.2 Cg_endo -69.73 -20.54 34.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.724 2.283 . . . . 0.0 112.364 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -70.6 -34.02 71.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 113' ' ' LEU . 3.1 mt -73.36 -37.09 66.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 121' ' ' ALA . 5.1 mt -77.49 -53.21 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -43.8 -32.37 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.42 -31.74 21.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -71.72 -19.74 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -92.92 26.25 2.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.949 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 128' ' ' GLU . 72.1 mt -92.53 129.87 39.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.606 0.717 . . . . 0.0 111.138 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -44.36 2.11 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.63 2.22 . . . . 0.0 112.35 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.459 ' HB2' ' CG ' ' A' ' 128' ' ' GLU . 0.6 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -37.36 -57.99 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.9 m -46.66 -47.85 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.595 ' HB2' HG21 ' A' ' 123' ' ' ILE . 37.5 mm-40 -64.38 -48.61 74.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -45.97 -57.46 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.583 HD13 ' OE1' ' A' ' 207' ' ' GLN . 16.3 mt -63.33 -67.12 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 130' ' ' LEU . 9.3 m-70 -34.38 -40.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.12 -63.25 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.61 -30.27 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.644 ' O ' HG12 ' A' ' 137' ' ' VAL . 64.8 tttt -65.96 -32.77 74.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -87.93 -47.65 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.3 mt -57.55 -26.07 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.174 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 134' ' ' LYS . 13.5 p -71.7 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -76.39 -34.75 58.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -64.07 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.936 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.2 m-85 -40.7 129.73 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.596 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -33.95 141.11 0.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.7 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.596 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.75 -13.75 35.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.725 2.283 . . . . 0.0 112.352 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 28' ' ' GLN . 95.4 t -97.84 -35.83 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.071 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.53 -39.61 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 1.4 t80 -47.22 -47.87 24.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.81 66.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 151' ' ' VAL . 83.4 t -70.14 -57.99 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 41.3 t80 -48.4 -46.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -62.06 -51.18 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -53.66 -47.73 70.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 147' ' ' VAL . 97.8 t -54.77 -58.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.64 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 86.3 mt -46.78 -52.09 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.6 m -41.36 -37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -80.72 -35.13 33.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.728 HD13 HD11 ' A' ' 205' ' ' ILE . 97.0 mt -57.81 -42.99 85.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -52.6 -44.52 66.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -55.3 -43.4 74.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.656 HG11 HD21 ' A' ' 172' ' ' LEU . 84.5 t -63.35 -42.32 95.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 p -67.53 -27.11 66.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -69.97 -40.42 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -102.14 50.38 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.469 ' CD2' HG22 ' A' ' 168' ' ' THR . 0.6 OUTLIER -80.15 41.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.833 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -122.21 -43.47 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 mt -87.91 -40.97 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.158 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.84 -23.69 18.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 mt 63.99 48.27 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 37.8 mmm -132.2 97.14 4.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.469 HG22 ' CD2' ' A' ' 162' ' ' HIS . 72.3 p -85.36 167.85 15.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -52.32 -41.33 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.054 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.53 -56.42 20.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -50.69 -42.73 57.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 169' ' ' ALA . 7.4 mt -63.09 -43.95 97.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.6 t -57.9 -46.07 85.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.49 -35.16 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.9 t -68.59 -26.17 65.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 98' ' ' LYS . 16.7 m-85 -101.18 -6.58 24.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.589 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -54.61 -45.8 99.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.562 0.696 . . . . 0.0 110.907 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.1 Cg_exo -48.01 -50.18 12.39 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.268 . . . . 0.0 112.304 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 180' ' ' LEU . 20.8 m -81.87 -65.55 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 26.0 mt -33.45 -59.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.565 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 1.4 ttm -114.58 116.62 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -56.4 130.59 75.97 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 117.93 5.37 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.372 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -102.38 169.79 8.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -95.4 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -130.0 123.76 31.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.432 ' H ' ' ND2' ' A' ' 187' ' ' ASN . 0.2 OUTLIER -129.59 137.85 50.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -113.61 163.15 15.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -140.0 123.51 17.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.429 ' O ' ' C ' ' A' ' 191' ' ' LEU . 12.6 t80 -131.4 123.75 28.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -36.08 -47.07 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.91 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.2 t -83.12 149.14 27.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.8 m -63.32 120.12 10.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.429 HG22 HG13 ' A' ' 196' ' ' ILE . 2.9 m -78.96 -67.84 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 15.8 pttm 43.78 33.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 200' ' ' VAL . 82.3 mt -84.65 -59.96 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -40.37 -51.65 2.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.15 -55.05 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.9 m -45.32 -38.62 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 196' ' ' ILE . 94.0 t -45.17 -70.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.102 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.9 t -64.74 -60.37 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 201' ' ' VAL . 22.9 tt0 -34.59 -45.32 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 204' ' ' PHE . 84.2 m -60.16 -59.15 5.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.2 m-85 -34.62 -54.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.728 HD11 HD13 ' A' ' 155' ' ' LEU . 50.5 mt -62.66 -55.52 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -46.28 -54.99 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.935 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.583 ' OE1' HD13 ' A' ' 130' ' ' LEU . 16.5 mm-40 -99.26 27.25 5.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.599 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 3.5 t -61.37 -14.42 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' TYR . 20.9 mm-40 -95.32 -57.53 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.495 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.6 t80 -39.67 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.599 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -52.9 -62.29 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -128.2 -26.78 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 215' ' ' GLY . 27.7 m-85 -83.21 30.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 213' ' ' TYR . 27.5 m-20 33.64 33.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -57.26 146.27 36.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.34 133.28 34.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.48 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 85.5 mt -48.29 122.82 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.1 m -111.49 166.31 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m 51.79 45.27 28.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -127.92 153.97 46.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.871 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.25 156.04 17.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.0 p -153.89 147.75 25.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -114.61 -61.57 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.12 157.86 33.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -136.97 167.38 21.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -139.2 176.37 8.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -133.82 175.03 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -89.12 122.17 68.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.608 0.718 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 150.99 69.02 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.631 2.221 . . . . 0.0 112.357 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -177.7 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.352 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -103.61 151.15 23.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.101 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -84.87 27.82 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -112.93 160.67 17.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -80.77 -42.8 21.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.431 ' CH2' ' HG3' ' A' ' 73' ' ' LYS . 4.7 m95 -132.29 125.79 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -148.37 126.13 11.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.496 ' O ' ' CE2' ' A' ' 23' ' ' PHE . 4.1 t -172.97 175.8 3.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.851 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -97.27 -23.9 15.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -59.72 -50.21 74.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -57.35 123.68 16.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.09 -41.87 2.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 8.4 mtt -84.07 145.14 45.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 110.82 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 147.62 62.99 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.633 2.222 . . . . 0.0 112.337 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.72 -52.4 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.954 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.675 ' CB ' HG21 ' A' ' 143' ' ' VAL . 7.3 pt20 -44.9 -30.13 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.99 -45.03 15.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.05 -44.76 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 36' ' ' PRO . 12.2 m -83.0 164.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -114.2 164.7 13.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.21 63.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -51.66 -54.13 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 23.1 mmtp -119.69 96.41 49.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 0.0 110.883 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.1 Cg_endo -69.79 -35.94 11.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.238 . . . . 0.0 112.328 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.52 HG23 ' HD2' ' A' ' 38' ' ' PRO . 36.5 mt -85.73 134.71 39.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 0.0 111.161 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.0 Cg_endo -69.77 150.48 68.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -68.66 -47.2 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -40.79 -58.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 97' ' ' LEU . 96.8 t -55.28 -62.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -45.8 -62.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -50.74 -37.25 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 68.8 m -69.86 -31.98 70.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG13 ' CG ' ' A' ' 154' ' ' HIS . 84.4 t -78.68 -60.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.46 -40.72 60.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.783 ' CE1' HG21 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -51.04 -41.1 59.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mt -59.9 -64.13 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.44 -33.7 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.58 -24.64 56.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.1 p -107.7 29.23 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.08 134.66 5.21 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.58 -10.65 14.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.931 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.0 m -91.68 40.9 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 56' ' ' GLU . 6.0 m -92.45 113.78 26.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 55' ' ' THR . 2.7 tt0 -33.98 121.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.27 69.3 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.901 HD22 ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -66.49 -9.56 35.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.93 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.685 ' CE2' HD21 ' A' ' 58' ' ' LEU . 8.9 m-85 -122.75 -37.75 2.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -74.1 -40.2 62.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.41 137.1 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.411 ' HA ' ' CB ' ' A' ' 91' ' ' ASN . 63.5 m -131.93 -41.23 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.84 -72.09 0.76 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -117.38 165.52 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.936 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -108.91 -39.02 5.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 69' ' ' ASP . 45.4 m -38.26 -53.74 1.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -35.72 -59.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 71' ' ' ILE . 36.3 mt-30 -52.65 -38.4 60.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.9 t70 -47.84 -56.69 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.8 p30 -68.94 -36.08 77.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 68' ' ' GLN . 57.8 mt -51.09 -42.36 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -82.92 -54.01 5.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' HG3' ' CH2' ' A' ' 18' ' ' TRP . 5.6 mtpm? -54.39 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -45.04 -46.02 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.58 -31.37 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.15 -48.05 38.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -71.35 -30.15 65.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.1 93.18 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.89 37.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.84 HD11 ' SD ' ' A' ' 86' ' ' MET . 10.6 tt -76.58 153.13 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 83' ' ' LEU . 6.0 t30 -124.62 83.87 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 82' ' ' ASN . 26.4 mt -34.35 -47.95 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.22 -54.79 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -52.35 -42.01 63.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.84 ' SD ' HD11 ' A' ' 81' ' ' ILE . 75.2 mtp -60.9 -36.39 79.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 59.4 45.0 14.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.41 160.97 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.183 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 29.0 p -56.12 118.18 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.121 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.1 t -41.52 -54.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -43.23 -35.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 71' ' ' ILE . . . -55.1 -59.3 4.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.783 HG21 ' CE1' ' A' ' 47' ' ' PHE . 89.6 t -50.39 -51.03 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -48.39 -45.34 35.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.32 -55.39 18.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.469 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.8 -40.77 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 41' ' ' VAL . 14.5 tp -48.75 -39.95 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.505 ' CG ' ' CE1' ' A' ' 176' ' ' PHE . 42.6 mtmt -74.41 -45.95 43.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.13 -34.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 6.9 t80 -68.48 -48.09 65.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -56.66 -41.29 76.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' HB2' HG23 ' A' ' 179' ' ' THR . . . -65.75 -37.44 86.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.44 -35.4 73.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.3 mt -39.2 144.56 0.44 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.609 0.718 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -29.12 24.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.91 154.14 81.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 143.8 51.97 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.5 tp -48.16 -58.46 4.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.95 131.17 54.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.656 0.741 . . . . 0.0 111.106 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.404 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.77 162.09 43.41 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 0.0 112.317 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.538 ' CD2' ' CE1' ' A' ' 114' ' ' HIS . 52.8 m-85 -79.87 -25.78 40.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -69.74 -17.03 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 117' ' ' LEU . 43.3 mt -122.42 31.92 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.538 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 3.9 m170 -74.28 -61.76 1.14 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.582 0.706 . . . . 0.0 110.828 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.5 Cg_endo -69.77 -10.73 29.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -68.01 -44.03 77.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 113' ' ' LEU . 4.3 mp -67.23 -34.93 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.545 HD11 ' CE1' ' A' ' 197' ' ' HIS . 9.6 mt -77.45 -58.5 3.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -42.76 -30.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.46 -31.76 18.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -69.08 -21.98 64.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -90.21 19.06 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.4 HG23 ' HD2' ' A' ' 124' ' ' PRO . 66.8 mt -85.53 132.71 43.85 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 0.0 111.099 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.79 -44.57 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.319 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.3 m-20 -64.36 95.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.1 ttpt -35.58 -53.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.4 m -57.34 -61.37 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.121 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -46.38 -46.23 18.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.863 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -48.35 -51.99 23.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.55 -60.1 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -40.96 -53.85 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.73 -49.57 65.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.05 -28.02 69.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 137' ' ' VAL . 44.4 tttt -74.66 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -86.1 -32.43 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.66 -21.71 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 134' ' ' LYS . 10.8 p -87.9 -7.72 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -77.04 -38.6 52.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -12.8 60.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.68 ' HZ ' HD11 ' A' ' 117' ' ' LEU . 2.8 m-85 -53.68 135.92 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.594 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.2 t-80 -34.49 141.51 0.25 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.594 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.77 -14.53 36.18 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.665 2.244 . . . . 0.0 112.383 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.675 HG21 ' CB ' ' A' ' 28' ' ' GLN . 96.7 t -95.36 -25.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.105 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -94.84 -34.59 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -64.87 -54.42 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.475 ' O ' HD11 ' A' ' 37' ' ' ILE . 6.7 p-10 -45.52 -45.39 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.511 HG22 HG12 ' A' ' 37' ' ' ILE . 11.7 t -77.16 -63.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.574 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 27.8 t80 -37.23 -41.4 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -64.77 -54.35 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -53.31 -51.14 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.6 t -48.11 -56.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.684 HG23 HG12 ' A' ' 205' ' ' ILE . 89.0 mt -55.83 -49.25 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.7 m -42.88 -31.03 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.526 ' CG ' HG13 ' A' ' 45' ' ' VAL . 86.5 t60 -85.17 -42.99 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 152' ' ' ILE . 83.0 mt -54.93 -46.58 74.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -51.76 -48.3 63.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -53.55 -38.22 63.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.15 -45.67 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.165 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.2 p -58.35 -21.51 50.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -51.62 -53.75 35.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.483 ' HB3' HD12 ' A' ' 164' ' ' ILE . 10.8 mm100 -102.32 37.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.508 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 24.5 p80 -49.97 -27.67 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.508 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 3.9 mmmp? -70.12 -32.58 70.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 161' ' ' GLN . 92.2 mt -82.66 -65.32 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -2.3 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.5 mt 55.25 46.81 22.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 25.6 mtp -144.69 116.92 8.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.844 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.456 HG22 ' CG ' ' A' ' 162' ' ' HIS . 39.1 p -101.15 159.16 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.107 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.29 -35.03 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.77 -48.97 57.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -55.22 -36.11 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 14.0 mt -72.56 -43.3 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -58.11 -36.91 73.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.492 HG12 ' NE2' ' A' ' 198' ' ' GLN . 17.6 mt -77.8 -35.85 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -69.6 -18.47 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.505 ' CE1' ' CG ' ' A' ' 98' ' ' LYS . 11.6 m-85 -108.71 -8.83 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.571 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -54.34 -46.42 99.0 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.566 0.698 . . . . 0.0 110.917 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -47.95 -60.49 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 180' ' ' LEU . 3.9 m -69.1 -59.45 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 179' ' ' THR . 56.7 mt -33.83 -47.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 34.3 mmm -143.0 136.53 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -39.08 159.52 0.1 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 136.73 33.76 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.655 2.237 . . . . 0.0 112.373 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -47.79 163.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -119.96 -44.01 2.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -153.4 141.02 19.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.887 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -63.47 155.14 30.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.451 ' HG2' HD12 ' A' ' 191' ' ' LEU . 9.2 tpp180 -82.67 140.46 33.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -97.64 -177.0 3.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 28.1 t80 42.49 37.77 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.451 HD12 ' HG2' ' A' ' 188' ' ' ARG . 34.3 mt -154.53 129.78 9.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.4 m -78.04 -56.49 4.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.4 m -111.52 91.64 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 10.0 t -99.94 34.92 2.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -103.32 37.2 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 197' ' ' HIS . 96.8 mt -74.22 -43.61 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.545 ' CE1' HD11 ' A' ' 118' ' ' LEU . 53.1 m-70 -36.74 -62.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.526 ' OE1' ' CD1' ' A' ' 177' ' ' TRP . 18.2 mm100 -43.64 -54.17 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 m -50.61 -36.94 37.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' A' ' 117' ' ' LEU . 23.2 t -54.81 -71.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.09 -54.27 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -45.6 -51.77 11.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 204' ' ' PHE . 93.3 m -50.06 -63.02 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 203' ' ' THR . 13.4 m-85 -34.25 -53.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.684 HG12 HG23 ' A' ' 152' ' ' ILE . 67.1 mt -62.11 -54.87 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -49.06 -57.55 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.465 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 10.3 mm-40 -96.52 28.48 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.503 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 3.1 t -61.86 -20.66 63.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 213' ' ' TYR . 10.9 mm-40 -88.57 -51.44 5.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -44.75 -37.97 4.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.5 m-85 -48.88 -63.07 1.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -104.05 -54.29 2.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 209' ' ' GLN . 60.2 m-85 -56.82 -36.18 69.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.7 t30 73.25 36.23 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.21 174.72 49.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.98 142.71 53.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.465 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 92.9 mt -68.25 137.87 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.62 168.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.3 p -171.9 156.11 4.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.878 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 m -147.22 168.6 21.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.817 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.08 122.65 7.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.498 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.2 m -148.14 172.28 14.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -63.97 168.43 5.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.824 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.84 97.57 0.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.541 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -73.44 159.19 33.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -83.35 54.82 2.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 52.38 45.87 27.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.417 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 8.7 t30 -139.82 140.14 23.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 53.6 Cg_endo -69.73 151.21 69.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.36 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 146.82 61.29 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.724 2.283 . . . . 0.0 112.35 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.7 p -54.19 125.47 19.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -68.46 120.49 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 17' ' ' ASN . 19.1 ptp180 -94.26 -43.9 8.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 16' ' ' ARG . 13.8 p30 48.1 25.69 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.481 ' CG ' ' O ' ' A' ' 18' ' ' TRP . 34.3 t90 -118.89 3.82 11.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -52.4 156.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -129.59 178.67 6.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 22' ' ' TYR . 11.8 m120 -77.98 -43.99 28.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.585 ' CZ ' ' CE1' ' A' ' 23' ' ' PHE . 1.1 p90 -36.92 -37.54 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.585 ' CE1' ' CZ ' ' A' ' 22' ' ' TYR . 12.8 m-85 -49.5 108.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.78 -34.68 4.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -81.92 139.43 46.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.716 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 158.53 56.71 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.67 2.246 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' VAL . 21.1 tp -54.6 -43.82 72.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.785 ' HA ' HG11 ' A' ' 143' ' ' VAL . 3.4 pt20 -51.06 -37.35 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.19 -49.71 26.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.3 -46.43 79.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 27' ' ' LEU . 5.2 m -91.08 168.41 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.5 p -112.33 162.88 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.72 -43.94 73.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.3 -45.46 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -128.93 86.15 58.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -34.34 14.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.39 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.1 mt -78.73 129.2 74.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 111.143 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.658 2.239 . . . . 0.0 112.334 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.495 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -47.69 -48.61 29.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.409 ' CZ ' HG22 ' A' ' 71' ' ' ILE . 90.4 t80 -41.13 -66.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.802 HG13 HD11 ' A' ' 97' ' ' LEU . 41.8 t -45.84 -61.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -40.23 -61.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 43.2 mmtt -46.39 -41.27 13.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 86.7 m -68.69 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.579 HG13 ' CG ' ' A' ' 154' ' ' HIS . 71.7 t -71.79 -61.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -53.62 -35.94 61.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.538 ' CD2' HG11 ' A' ' 93' ' ' VAL . 30.3 t80 -56.72 -49.23 75.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.679 HG22 HD12 ' A' ' 53' ' ' LEU . 17.0 mt -61.67 -20.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -89.75 -14.1 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -95.44 -20.41 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -85.16 23.88 1.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.01 -29.79 3.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.477 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.756 HD11 HG22 ' A' ' 158' ' ' VAL . 6.1 tp 63.25 52.05 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.926 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 16.7 p -133.35 31.61 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 m -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.152 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.09 114.39 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.76 90.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.643 HD12 ' H ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -99.54 -30.13 12.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.98 -47.62 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.71 ' HG3' HG23 ' A' ' 61' ' ' VAL . 14.0 ptt180 -59.59 -15.96 22.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.71 HG23 ' HG3' ' A' ' 60' ' ' ARG . 79.0 t -119.94 101.97 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -66.11 -55.99 13.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.35 -101.55 2.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -116.48 158.24 23.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 66' ' ' THR . 1.6 tmtp? -95.62 -53.11 3.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' ASP . 91.5 m -38.1 -58.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 19.3 m-20 -39.13 -49.34 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HA ' HD12 ' A' ' 71' ' ' ILE . 35.9 mt-30 -72.49 -29.41 63.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 66' ' ' THR . 8.5 t0 -59.39 -54.32 48.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 67' ' ' ASP . 20.2 p30 -54.72 -39.26 68.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.436 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 58.2 mt -49.03 -39.53 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -91.25 -55.1 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 18' ' ' TRP . 50.1 mtmt -46.29 -48.09 18.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -66.31 -56.64 10.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -40.0 -43.42 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.88 -53.09 52.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -56.5 -40.06 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -149.86 134.33 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -91.01 -20.2 22.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -81.13 45.21 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.3 pt -106.12 -178.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -145.18 154.53 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.3 mt -89.24 -34.24 16.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.83 -56.63 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -52.32 -31.14 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.471 ' HB3' HG13 ' A' ' 88' ' ' VAL . 9.5 mmm -69.58 -27.8 65.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 59.13 48.16 10.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 86' ' ' MET . 34.5 m -84.45 162.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' VAL . 58.9 p -69.85 121.18 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' THR . 88.4 t -37.07 -55.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.09 -47.14 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.52 -62.75 1.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.538 HG11 ' CD2' ' A' ' 47' ' ' PHE . 97.2 t -44.41 -43.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' LEU . . . -65.19 -46.9 78.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -55.28 26.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -44.96 35.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 111.121 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.802 HD11 HG13 ' A' ' 41' ' ' VAL . 26.7 tp -44.11 -43.84 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -75.8 -46.57 29.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -42.09 -43.06 3.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -56.79 -46.58 81.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -60.53 -50.22 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.501 ' HB2' HG23 ' A' ' 179' ' ' THR . . . -56.37 -39.88 73.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.57 -39.87 71.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.2 mt -39.02 143.36 0.48 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.711 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.62 31.8 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -133.49 154.83 81.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.731 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.03 68.23 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 148' ' ' PHE . 11.1 tp -62.63 -40.67 97.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.564 HD12 ' HE2' ' A' ' 181' ' ' MET . 65.1 mt -95.51 128.34 38.49 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 111.127 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.9 Cg_endo -69.78 160.48 49.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.344 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 30.6 m-85 -75.45 -36.18 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.5 t -56.19 -14.57 2.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.467 HD21 ' HG3' ' A' ' 139' ' ' LYS . 23.1 mt -127.73 32.0 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.549 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.2 m170 -75.88 -63.15 0.66 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.822 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.71 -11.46 30.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.327 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.92 -32.94 57.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.524 ' CD1' HD13 ' A' ' 109' ' ' ILE . 2.5 mt -70.39 -45.77 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 121' ' ' ALA . 7.7 mt -68.09 -55.04 13.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -47.88 -29.35 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.15 -24.89 26.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -81.06 -32.19 34.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -75.75 -1.29 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 128' ' ' GLU . 53.0 mt -62.43 130.76 93.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.639 0.733 . . . . 0.0 111.151 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.58 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.633 2.222 . . . . 0.0 112.38 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.25 110.81 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -46.07 -54.96 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.2 m -50.98 -56.81 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.516 ' HB2' HG21 ' A' ' 123' ' ' ILE . 63.7 mm-40 -56.25 -38.06 70.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -55.25 -46.54 76.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 207' ' ' GLN . 13.1 mt -70.76 -66.51 0.6 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' LEU . 12.7 m-70 -35.69 -51.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.09 -57.51 9.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 9.3 mt -59.47 -20.52 55.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.533 ' O ' HG12 ' A' ' 137' ' ' VAL . 4.6 ttpm? -81.65 -34.11 30.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 4.5 pt-20 -80.69 -28.61 36.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.545 HG22 ' HE1' ' A' ' 140' ' ' PHE . 39.4 mt -72.58 -34.59 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.097 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.57 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 9.5 p -73.0 -0.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -79.07 -42.92 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.467 ' HG3' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -85.81 18.91 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.57 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 2.7 m-85 -77.67 143.43 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -37.16 141.13 0.43 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.73 -25.6 28.58 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.323 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.785 HG11 ' HA ' ' A' ' 28' ' ' GLN . 40.3 t -92.18 -35.39 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.422 ' OD1' ' CG ' ' A' ' 141' ' ' HIS . 17.6 m120 -81.42 -45.78 15.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.564 ' CE1' ' HD3' ' A' ' 149' ' ' ARG . 4.3 t80 -43.38 -48.53 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -56.25 -59.8 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.7 -63.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.595 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 30.0 t80 -43.97 -44.44 7.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.564 ' HD3' ' CE1' ' A' ' 145' ' ' TYR . 8.2 ttp85 -62.14 -49.04 77.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -59.33 -53.96 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.5 t -45.49 -59.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.595 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 75.0 mt -52.08 -52.67 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.4 m -41.51 -29.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.579 ' CG ' HG13 ' A' ' 45' ' ' VAL . 28.7 t60 -88.44 -42.37 12.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 1.003 HD21 ' CE2' ' A' ' 176' ' ' PHE . 89.8 mt -54.53 -46.84 73.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -51.35 -40.95 60.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -61.3 -41.49 97.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.756 HG22 HD11 ' A' ' 53' ' ' LEU . 76.2 t -60.74 -42.92 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.7 p -61.8 -19.67 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -58.05 -53.2 60.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.474 ' HB3' HD12 ' A' ' 164' ' ' ILE . 8.5 mm100 -99.76 37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.483 ' CG ' HG22 ' A' ' 168' ' ' THR . 19.7 p80 -53.43 -28.25 28.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -67.31 -27.26 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 161' ' ' GLN . 79.3 mt -89.46 -59.03 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' LEU . 3.5 p30 -81.49 15.48 2.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 165' ' ' ASN . 27.3 mt 36.82 50.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 64.3 mmm -145.06 115.24 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.483 HG22 ' CG ' ' A' ' 162' ' ' HIS . 66.1 p -101.19 167.44 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.67 -40.39 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -58.26 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -58.65 -55.67 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.76 -21.73 20.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.452 ' HB2' ' N ' ' A' ' 202' ' ' GLU . 4.7 p -82.92 -39.16 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 49.4 mt -75.75 -25.1 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.3 p -79.39 -36.92 38.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 1.003 ' CE2' HD21 ' A' ' 155' ' ' LEU . 7.2 m-85 -85.24 -38.71 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.864 ' HA ' HD12 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -39.26 -57.14 2.37 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.546 0.689 . . . . 0.0 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.521 ' HD3' ' CG ' ' A' ' 177' ' ' TRP . 65.7 Cg_exo -48.07 -65.89 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.662 2.242 . . . . 0.0 112.317 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 102' ' ' ALA . 94.6 m -54.39 -55.47 28.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 177' ' ' TRP . 32.8 mt -30.24 -39.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.564 ' HE2' HD12 ' A' ' 109' ' ' ILE . 2.5 ptt? -175.65 143.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -98.8 148.46 34.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 122.4 9.08 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 186' ' ' GLU . 11.3 t0 -72.75 153.1 41.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 184' ' ' ASP . 0.8 OUTLIER 33.24 34.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 184' ' ' ASP . 5.9 pt-20 -35.6 111.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -56.77 172.74 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -54.93 178.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -53.86 114.79 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 190' ' ' PHE . 3.8 p90 -114.02 160.17 19.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 9.5 mt -156.19 107.08 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 47.4 m -144.43 153.81 42.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 193' ' ' THR . 14.6 t -83.08 39.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 64.6 p -96.3 93.72 7.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -90.41 40.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 200' ' ' VAL . 88.4 mt -85.56 -58.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.108 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -41.74 -52.54 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.903 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -63.11 -46.11 88.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.6 t -55.0 -40.93 70.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.445 ' CG1' HD22 ' A' ' 117' ' ' LEU . 79.1 t -37.62 -67.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 202' ' ' GLU . 58.5 t -63.9 -51.72 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.452 ' N ' ' HB2' ' A' ' 173' ' ' SER . 15.6 tt0 -37.37 -53.93 1.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.6 m -56.3 -57.26 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 10.7 m-85 -42.62 -36.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 86.0 mt -71.73 -58.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.452 ' HB3' ' CG2' ' A' ' 218' ' ' VAL . 11.3 mt-30 -54.96 -54.76 38.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.497 ' HG3' HD13 ' A' ' 130' ' ' LEU . 61.6 mm-40 -86.44 24.2 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.73 -18.62 62.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 213' ' ' TYR . 18.2 mm-40 -91.6 -51.14 5.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -45.24 -38.49 5.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -50.3 -63.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -106.68 -54.79 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 209' ' ' GLN . 71.4 m-85 -59.62 -16.95 29.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 48.28 47.07 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -90.04 165.6 31.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.89 132.87 42.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 93.4 mt -58.63 106.84 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 206' ' ' GLN . 30.1 m -64.01 168.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 t -158.58 150.46 21.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 t -112.21 -55.57 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 37.98 -122.25 1.1 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.492 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 p -38.84 137.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.8 t -106.91 118.1 35.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.04 63.35 0.32 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -157.81 156.82 32.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.3 . . . . 0.0 110.923 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -94.09 148.49 22.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -170.48 115.58 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.427 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 24.5 t-20 -87.78 140.61 31.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 0.0 110.878 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 53.5 Cg_endo -69.77 154.34 67.81 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.346 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 162.08 43.46 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.694 2.262 . . . . 0.0 112.333 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 t -169.41 157.77 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.13 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.71 151.6 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -109.66 -44.04 3.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 36.94 39.64 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -87.34 42.57 1.04 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -100.55 128.43 46.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.475 ' HB2' ' CD1' ' A' ' 22' ' ' TYR . 1.6 m -117.28 -6.63 11.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.827 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 58.14 40.69 24.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.475 ' CD1' ' HB2' ' A' ' 20' ' ' SER . 4.2 p90 -127.4 -44.76 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' N ' ' CG ' ' A' ' 22' ' ' TYR . 30.5 p90 -51.41 112.15 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.849 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.47 -38.66 3.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.509 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.0 mmt -80.39 152.67 73.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.508 0.671 . . . . 0.0 110.866 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 154.38 67.74 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 31' ' ' VAL . 20.1 tp -61.0 -42.69 98.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.921 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.477 ' HA ' HG11 ' A' ' 143' ' ' VAL . 3.5 pt20 -52.51 -29.23 24.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.81 -48.74 12.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.37 -45.18 84.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 27' ' ' LEU . 5.8 m -87.2 168.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -107.64 146.83 31.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.79 -40.97 6.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.103 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.02 -44.48 82.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 4.5 mmmm -131.02 99.57 17.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.617 0.722 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 54.0 Cg_endo -69.72 -35.51 12.64 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.343 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.71 129.36 74.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 117.37 5.05 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.663 2.242 . . . . 0.0 112.374 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.527 HD11 ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -40.09 -46.3 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -44.69 -64.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.458 HG13 HD11 ' A' ' 97' ' ' LEU . 21.0 t -43.16 -59.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.168 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -45.1 -61.34 1.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HE2' HD11 ' A' ' 39' ' ' LEU . 49.0 mmtt -46.09 -43.17 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.618 ' HB2' HD13 ' A' ' 97' ' ' LEU . 90.1 m -65.29 -30.33 71.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.503 HG13 ' CG ' ' A' ' 154' ' ' HIS . 95.6 t -79.27 -54.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.04 -43.04 86.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.791 ' CE1' HG21 ' A' ' 93' ' ' VAL . 3.2 t80 -49.59 -60.27 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 76.8 mt -45.11 -44.64 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -63.03 -45.65 91.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.02 -42.3 94.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.6 p -85.89 29.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.147 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.71 153.9 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -120.28 38.96 3.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.478 ' HB2' HG21 ' A' ' 164' ' ' ILE . 19.6 p -117.49 42.3 2.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -97.86 133.51 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.04 120.95 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.51 80.07 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.0 -49.69 69.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.851 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 20.1 m-85 -99.49 -48.96 4.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -38.04 -42.03 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.68 137.95 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.0 p -121.01 144.15 48.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.91 -133.55 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.76 166.94 16.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 110.89 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -39.13 18.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -44.36 -54.19 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -45.77 -52.72 10.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.828 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.861 ' HA ' HD12 ' A' ' 71' ' ' ILE . 7.0 mt-30 -67.89 -32.18 72.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.32 -67.9 0.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -49.12 -42.13 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 68' ' ' GLN . 65.0 mt -50.22 -40.81 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -81.27 -57.08 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -50.98 -59.67 3.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HB3' HD12 ' A' ' 81' ' ' ILE . 32.2 mm-40 -49.09 -47.78 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -61.77 -41.39 97.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.31 -48.09 82.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.1 -29.65 61.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -132.53 93.14 3.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.802 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -60.57 -34.34 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.17 36.6 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 74' ' ' GLN . 13.1 tt -77.53 156.16 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.446 ' ND2' ' HB ' ' A' ' 84' ' ' VAL . 2.9 t30 -122.04 87.82 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 82' ' ' ASN . 60.0 mt -37.27 -49.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.446 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 50.1 t -50.05 -42.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ASN . 45.6 t -59.96 -35.14 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.7 mmm -68.99 -34.17 74.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 59.22 50.15 8.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -84.79 172.24 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 90' ' ' VAL . 37.1 p -75.04 117.14 16.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 89' ' ' THR . 75.4 t -36.68 -52.89 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 90' ' ' VAL . 2.6 t-20 -37.16 -46.38 0.7 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.08 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.791 HG21 ' CE1' ' A' ' 47' ' ' PHE . 81.5 t -43.66 -46.5 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.095 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.851 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -51.88 -48.57 64.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.95 -62.71 4.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -43.82 -42.57 5.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 111.066 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.618 HD13 ' HB2' ' A' ' 44' ' ' CYS . 34.8 tp -52.04 -46.91 65.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 99' ' ' ALA . 42.3 mtmt -69.29 -47.92 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -37.5 -41.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.73 -55.22 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 147' ' ' VAL . 17.3 m-85 -54.16 -52.78 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.474 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -54.28 -42.2 69.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.78 -35.57 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -42.47 141.42 1.5 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -19.49 35.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.642 2.228 . . . . 0.0 112.375 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 155.18 73.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.571 0.701 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 151.07 68.73 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.66 2.24 . . . . 0.0 112.376 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 148' ' ' PHE . 10.2 tp -52.46 -51.39 59.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.493 HG21 ' CD1' ' A' ' 117' ' ' LEU . 29.1 mt -83.42 132.31 50.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 0.0 111.129 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.55 ' CG ' HD12 ' A' ' 113' ' ' LEU . 53.9 Cg_endo -69.71 146.76 61.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.369 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.528 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 20.9 m-85 -60.55 -26.0 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE2' ' A' ' 116' ' ' GLU . 33.1 m -65.57 -35.85 82.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.891 HD23 ' CD ' ' A' ' 116' ' ' GLU . 65.4 mt -92.17 35.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.528 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 4.1 m170 -77.56 -60.02 0.77 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.3 Cg_endo -69.79 -58.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.891 ' CD ' HD23 ' A' ' 113' ' ' LEU . 5.2 pt-20 -44.57 -38.13 4.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 113' ' ' LEU . 10.8 mt -66.64 -38.48 86.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.472 ' CD2' ' HA ' ' A' ' 197' ' ' HIS . 6.9 mt -76.65 -56.27 4.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.91 -28.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -81.74 -31.12 32.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.073 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -78.15 -31.9 49.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -82.94 16.77 2.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 129' ' ' ARG . 73.5 mt -79.03 129.86 71.68 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.638 0.733 . . . . 0.0 111.16 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.93 2.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 126' ' ' LYS . 31.7 m-20 -67.21 95.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 125' ' ' ASP . 27.5 ttpt -33.49 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.413 HG22 ' CD2' ' A' ' 131' ' ' HIS . 86.5 m -57.49 -61.76 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.455 ' CB ' HG21 ' A' ' 123' ' ' ILE . 12.4 mt-10 -44.74 -56.47 4.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 123' ' ' ILE . 7.3 ttm180 -37.75 -52.23 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.466 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 22.2 mt -64.87 -66.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 130' ' ' LEU . 20.1 m-70 -34.56 -45.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.404 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . . . -57.61 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.424 ' CD1' HG21 ' A' ' 203' ' ' THR . 18.9 mt -51.65 -27.53 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 137' ' ' VAL . 49.1 tttp -75.18 -37.87 61.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.9 -26.11 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.568 HG22 ' HE1' ' A' ' 140' ' ' PHE . 36.2 mt -75.33 -36.33 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.574 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 8.5 p -69.83 -0.41 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -82.01 -29.61 31.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' CD ' ' O ' ' A' ' 136' ' ' ILE . 0.0 OUTLIER -97.18 14.17 26.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.833 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.3 m-85 -75.11 140.59 43.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.54 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 4.4 t-80 -34.39 141.05 0.26 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.74 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.275 . . . . 0.0 112.355 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 28' ' ' GLN . 39.7 t -88.8 -33.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -83.26 -47.78 11.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.0 t80 -42.68 -44.88 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.2 -55.49 34.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 101' ' ' PHE . 87.2 t -64.33 -60.1 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD1' HD23 ' A' ' 108' ' ' LEU . 20.8 t80 -38.43 -42.02 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -72.32 -49.52 33.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -52.51 -45.13 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.57 -64.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.126 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.538 HG23 HG12 ' A' ' 205' ' ' ILE . 82.1 mt -43.4 -51.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.7 m -43.37 -35.44 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.503 ' CG ' HG13 ' A' ' 45' ' ' VAL . 77.2 t60 -83.36 -37.56 23.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 152' ' ' ILE . 98.8 mt -56.37 -46.32 80.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -51.69 -41.97 61.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.455 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 2.6 mtp-105 -57.12 -35.56 69.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 -42.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.5 p -64.86 -34.53 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 36.2 mt-30 -54.18 -42.25 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.29 37.35 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 166' ' ' LEU . 29.8 p80 -53.96 -34.07 58.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -55.93 -31.22 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 54' ' ' CYS . 74.2 mt -89.75 -58.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.178 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -76.89 7.56 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 162' ' ' HIS . 34.7 mt 40.85 53.38 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 75.4 mmm -152.29 119.85 6.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 169' ' ' ALA . 69.2 p -102.01 153.13 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.173 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.82 -44.29 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.105 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -61.81 -50.87 70.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -53.57 -39.91 65.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 38.9 mt -67.31 -44.35 79.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t -53.59 -50.1 66.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.98 -41.28 89.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.12 -30.66 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.58 -2.27 54.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.582 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -61.86 -45.95 92.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.1 Cg_exo -47.96 -53.94 5.92 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.721 2.281 . . . . 0.0 112.296 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.474 HG23 ' CA ' ' A' ' 102' ' ' ALA . 20.5 m -76.28 -67.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 179' ' ' THR . 24.8 mt -34.29 -48.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 4.4 mmm -136.44 120.98 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.905 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -45.08 142.66 2.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.526 0.679 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 133.35 25.35 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.69 140.23 58.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -60.48 -49.44 77.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.819 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.0 -55.71 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.5 t30 45.01 42.55 6.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -127.8 142.52 51.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.88 119.58 32.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -81.63 -54.14 5.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.2 mt -153.41 168.47 25.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.8 m 39.35 45.36 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -40.02 120.56 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.143 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 11.5 t -90.55 143.91 26.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -130.54 33.65 4.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 197' ' ' HIS . 72.7 mt -78.23 -56.61 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.107 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.472 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 51.2 m80 -36.18 -50.67 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.05 -47.35 71.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.2 m -47.4 -36.84 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.6 t -48.18 -50.46 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.089 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 202' ' ' GLU . 45.2 t -65.69 -59.65 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' VAL . 65.4 tt0 -34.48 -64.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 205' ' ' ILE . 38.2 m -41.49 -66.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 203' ' ' THR . 8.8 m-85 -35.43 -33.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.538 HG12 HG23 ' A' ' 152' ' ' ILE . 82.3 mt -84.64 -46.52 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 203' ' ' THR . 5.6 mm-40 -56.27 -59.28 5.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.476 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 6.5 mm-40 -94.61 31.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.5 t -58.64 -21.55 54.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.576 ' OE1' ' CD2' ' A' ' 213' ' ' TYR . 5.8 mm-40 -86.24 -54.67 4.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -40.03 -35.77 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -54.71 -63.19 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -107.73 -56.51 2.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.576 ' CD2' ' OE1' ' A' ' 209' ' ' GLN . 63.1 m-85 -60.06 -11.55 6.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 46.18 43.65 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.89 168.83 53.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.92 141.89 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.476 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.9 mt -73.91 133.42 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.6 m -109.8 170.97 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.13 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.8 p -173.02 177.91 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.367 . . . . 0.0 110.836 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 t -134.43 175.78 9.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.03 163.07 29.65 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -172.49 -178.88 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.852 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 p -161.94 171.49 17.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.9 -179.43 26.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -165.37 128.03 2.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -142.77 162.67 34.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -169.05 165.8 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -162.08 146.69 9.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.641 0.734 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 169.16 19.53 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.715 2.277 . . . . 0.0 112.344 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 132.14 22.71 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.7 2.267 . . . . 0.0 112.348 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 15' ' ' ARG . 48.9 m -153.9 147.64 25.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.127 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 14' ' ' THR . 17.6 mmt180 -35.56 115.64 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -75.63 133.28 40.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -86.2 48.04 1.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.576 ' CZ3' ' HA ' ' A' ' 73' ' ' LYS . 9.3 t-105 -104.42 84.78 2.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -89.48 174.62 7.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -146.54 137.03 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -125.92 45.78 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.558 ' HB2' HD21 ' A' ' 30' ' ' LEU . 5.4 p90 -126.27 -41.1 1.93 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.2 m-85 35.39 47.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.56 33.42 7.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.463 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.401 ' SD ' ' HD2' ' A' ' 26' ' ' PRO . 19.2 mmt -100.44 138.33 20.15 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.581 0.705 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HD2' ' SD ' ' A' ' 25' ' ' MET . 53.9 Cg_endo -69.71 151.89 69.44 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.375 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.74 HD13 HD21 ' A' ' 104' ' ' LEU . 24.0 tp -46.91 -40.89 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.923 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.718 ' HB3' HG21 ' A' ' 143' ' ' VAL . 4.8 pt20 -50.81 -44.65 59.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.95 -46.24 58.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' A' ' 22' ' ' TYR . 24.8 mt -57.52 -37.28 72.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 36' ' ' PRO . 10.3 m -89.67 164.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 35' ' ' LYS . 20.4 p -106.53 133.18 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -34.68 -44.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -58.13 -47.68 82.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' THR . 33.1 mmtm -124.75 96.65 40.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.549 0.69 . . . . 0.0 110.862 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.4 Cg_endo -69.81 -40.35 5.35 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.553 HG12 HG22 ' A' ' 147' ' ' VAL . 15.7 mt -80.51 130.73 63.75 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.673 0.749 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 54.1 Cg_endo -69.71 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.36 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -38.29 -54.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.415 ' CZ ' ' HG2' ' A' ' 72' ' ' GLN . 25.1 t80 -39.25 -63.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.468 ' CG2' ' HG2' ' A' ' 38' ' ' PRO . 43.1 t -44.31 -52.67 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -53.7 -61.25 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 48.3 mmtt -44.16 -33.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 87.8 m -76.04 -50.44 14.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.613 HG13 ' CG ' ' A' ' 154' ' ' HIS . 96.6 t -58.61 -39.66 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -78.1 -26.36 48.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.552 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 1.1 t80 -79.26 -33.76 43.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG2' HD22 ' A' ' 58' ' ' LEU . 21.5 mt -66.93 -34.24 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -84.36 -33.98 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.83 -24.62 52.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.47 HG21 HG22 ' A' ' 90' ' ' VAL . 47.6 p -84.3 28.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.104 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.64 -32.02 4.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.469 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.517 HD11 HG22 ' A' ' 158' ' ' VAL . 14.2 tp 70.45 27.54 3.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.807 0.337 . . . . 0.0 110.922 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.56 44.65 1.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -101.17 135.59 42.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 57' ' ' GLY . 4.0 mt-10 -65.43 115.62 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.56 68.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.774 HD12 ' N ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -62.48 -15.58 50.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.774 ' N ' HD12 ' A' ' 58' ' ' LEU . 20.0 m-85 -98.22 -56.11 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -59.55 -15.53 18.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG23 ' CD ' ' A' ' 60' ' ' ARG . 39.0 t -96.83 103.23 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.5 p -60.76 125.42 23.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.82 157.87 20.73 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.459 ' ND2' ' HB ' ' A' ' 66' ' ' THR . 53.1 t30 -41.04 146.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -78.78 -42.5 27.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.459 ' HB ' ' ND2' ' A' ' 64' ' ' ASN . 6.4 m -51.04 -45.38 61.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.171 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.481 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 5.1 m-20 -57.81 -58.29 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.436 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 25.3 mt-30 -50.23 -28.34 7.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -60.37 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -57.47 -45.55 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 79.3 mt -47.1 -42.82 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 40' ' ' PHE . 39.1 mt-30 -83.74 -64.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.576 ' HA ' ' CZ3' ' A' ' 18' ' ' TRP . 46.3 mttm -41.72 -54.0 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.497 ' HB3' HD12 ' A' ' 81' ' ' ILE . 31.6 mm-40 -58.85 -40.22 83.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 65.2 t80 -64.73 -61.15 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.32 -57.09 9.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -52.0 -26.63 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.836 ' O ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -162.23 116.22 1.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -71.61 -33.31 68.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -41.07 -46.23 2.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.888 HD11 ' SD ' ' A' ' 86' ' ' MET . 1.8 tt -45.85 145.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.48 ' N ' HG12 ' A' ' 81' ' ' ILE . 56.3 t30 -128.71 119.32 24.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD22 HG23 ' A' ' 71' ' ' ILE . 64.5 mt -47.96 -52.94 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.75 -48.27 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -62.9 -44.69 95.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.888 ' SD ' HD11 ' A' ' 81' ' ' ILE . 25.6 mtp -52.17 -33.9 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 57.72 49.74 11.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 86' ' ' MET . 33.0 m -84.5 171.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.3 p -70.96 116.49 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 51' ' ' THR . 58.4 t -39.55 -45.69 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -48.85 -41.92 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.73 -63.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.42 HG21 ' CE1' ' A' ' 47' ' ' PHE . 87.0 t -50.33 -51.59 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.73 -36.79 5.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.76 -57.21 3.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -43.02 -41.72 3.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.088 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -49.33 -53.76 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -64.46 -43.92 92.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.79 -50.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.068 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -55.04 -57.87 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.509 ' CB ' HG21 ' A' ' 179' ' ' THR . 34.3 m-85 -50.65 -39.3 50.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.13 80.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.28 -33.99 74.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.74 HD21 HD13 ' A' ' 27' ' ' LEU . 95.0 mt -40.29 141.44 0.84 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.39 32.22 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.248 . . . . 0.0 112.388 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.59 155.81 75.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 141.22 44.56 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.485 HD12 HD22 ' A' ' 144' ' ' ASN . 15.4 tp -43.62 -51.6 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 91.2 mt -82.09 128.97 66.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.722 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.6 Cg_endo -69.77 158.84 55.58 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.34 -29.05 47.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -65.48 -5.33 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.862 HD13 ' CD1' ' A' ' 140' ' ' PHE . 13.6 mt -133.46 22.09 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.497 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.4 m170 -70.79 -60.17 3.19 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.892 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.628 ' HA ' HD12 ' A' ' 118' ' ' LEU . 53.2 Cg_endo -69.77 -16.39 37.5 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 0.0 112.309 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -74.29 -36.8 63.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.416 HD11 ' HZ ' ' A' ' 140' ' ' PHE . 14.7 mt -71.79 -26.33 62.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 115' ' ' PRO . 5.4 mt -84.72 -48.47 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -53.59 -31.4 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.17 -25.43 25.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -78.87 -21.33 47.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -89.47 11.2 20.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.659 HG23 ' HD2' ' A' ' 124' ' ' PRO . 85.9 mt -76.62 138.52 66.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.654 0.74 . . . . 0.0 111.151 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.659 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.6 Cg_endo -69.8 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.276 . . . . 0.0 112.299 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.35 101.27 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.718 ' HE3' HD13 ' A' ' 217' ' ' ILE . 33.6 ttpt -44.01 -48.73 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -56.93 -60.8 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -49.94 -48.07 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -45.47 -51.53 11.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.594 HD13 ' HG3' ' A' ' 207' ' ' GLN . 26.0 mt -65.79 -53.7 36.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -45.48 -55.97 5.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.2 -54.87 17.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 130' ' ' LEU . 10.5 mt -55.53 -36.69 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -68.16 -22.45 64.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -89.27 -48.32 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.629 HG22 ' HE1' ' A' ' 140' ' ' PHE . 19.0 mt -56.61 -34.47 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.492 ' O ' ' CE1' ' A' ' 145' ' ' TYR . 7.1 p -71.25 -6.75 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -87.51 -37.91 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 23.2 1.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.862 ' CD1' HD13 ' A' ' 113' ' ' LEU . 2.3 m-30 -81.79 175.2 10.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.886 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.59 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.5 t-80 -65.3 141.14 98.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.584 0.707 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.8 -15.6 37.01 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.266 . . . . 0.0 112.32 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 28' ' ' GLN . 69.6 t -99.21 -25.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.485 HD22 HD12 ' A' ' 108' ' ' LEU . 34.8 m120 -93.98 -33.46 13.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CE1' ' O ' ' A' ' 137' ' ' VAL . 83.1 t80 -65.21 -56.77 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.452 ' OD2' ' CG1' ' A' ' 37' ' ' ILE . 4.6 p-10 -42.86 -49.42 5.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 151' ' ' VAL . 20.0 t -72.46 -55.89 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.747 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 17.4 t80 -42.49 -41.69 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.472 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 19.4 mtp180 -59.8 -59.89 4.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -54.05 -34.63 60.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 147' ' ' VAL . 62.8 t -59.39 -63.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.747 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 21.5 mt -53.01 -53.25 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -39.82 -33.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.613 ' CG ' HG13 ' A' ' 45' ' ' VAL . 74.0 t60 -84.36 -41.86 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 152' ' ' ILE . 76.0 mt -50.83 -48.75 59.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 205' ' ' ILE . 3.9 t-20 -49.33 -45.84 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.457 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 57.5 mtt-85 -53.57 -38.67 64.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 53' ' ' LEU . 39.5 t -74.77 -43.39 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 26.2 p -60.67 -25.22 66.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 41.2 mt-30 -65.55 -37.03 85.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -105.72 36.35 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.549 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 17.5 p80 -55.0 -38.3 67.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.549 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 18.0 mmmt -59.46 -36.72 76.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.53 -61.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -73.31 2.17 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 162' ' ' HIS . 28.3 mt 49.8 42.82 24.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.7 mmm -141.88 112.02 6.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.3 p -94.11 155.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -41.06 -36.37 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.66 -52.57 50.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -57.44 -45.03 85.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.5 mt -62.46 -46.52 88.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -57.53 -24.23 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.82 -39.44 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 8.4 p -63.35 -32.67 74.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.431 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.4 m-85 -90.02 -12.98 36.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -48.76 -46.57 72.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.0 Cg_exo -48.01 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.509 HG21 ' CB ' ' A' ' 101' ' ' PHE . 40.0 m -64.41 -59.89 3.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 179' ' ' THR . 70.2 mt -33.72 -48.15 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.548 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 13.2 ptm -159.06 150.82 20.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -70.8 145.34 91.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.61 0.719 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 134.54 28.23 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.56 41.55 3.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -76.41 48.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -112.77 38.82 2.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -152.67 141.0 20.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -54.38 150.25 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -92.03 -175.07 3.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -138.44 174.36 10.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 191' ' ' LEU . 0.1 OUTLIER -96.29 -58.84 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 73.8 m -43.4 -69.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 33.4 p -118.3 125.01 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 12.0 t -145.15 148.72 33.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm 63.7 46.08 4.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 200' ' ' VAL . 81.1 mt -74.2 -46.8 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.416 ' H ' ' CD2' ' A' ' 197' ' ' HIS . 39.6 m-70 -43.32 -44.82 5.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.18 -54.41 47.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 t -52.81 -40.42 63.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 121' ' ' ALA . 85.3 t -47.1 -69.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.157 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 202' ' ' GLU . 83.1 t -58.14 -60.28 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 201' ' ' VAL . 66.6 tt0 -37.62 -43.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 56.9 m -59.46 -55.38 35.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.547 ' HB3' HD13 ' A' ' 152' ' ' ILE . 9.4 m-85 -38.73 -58.22 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.501 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 63.2 mt -55.56 -50.75 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -53.69 -60.13 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.594 ' HG3' HD13 ' A' ' 130' ' ' LEU . 11.0 mm-40 -92.52 25.57 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.926 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.581 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 1.8 t -60.4 -14.82 21.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' TYR . 14.0 mm-40 -95.86 -57.91 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.473 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 3.8 t80 -39.76 -30.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 23.4 m-85 -52.6 -61.87 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -127.02 -28.33 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 209' ' ' GLN . 26.2 m-85 -83.99 26.82 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' TYR . 75.9 m-20 33.48 34.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -59.08 145.87 43.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.12 129.93 35.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.888 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.718 HD13 ' HE3' ' A' ' 126' ' ' LYS . 53.3 mt -41.32 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.26 163.96 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 m -137.95 160.36 39.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 m -152.19 127.6 9.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.5 127.35 9.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 t -81.84 115.09 20.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 110.843 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.7 m -130.72 121.81 26.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.83 44.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.533 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm 56.9 41.56 27.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -78.06 -25.67 47.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -87.14 -60.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.18 158.25 38.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.86 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 168.27 22.13 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.647 2.232 . . . . 0.0 112.292 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 154.92 67.13 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 p -117.6 170.26 8.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -65.59 166.45 10.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.62 147.58 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -118.83 40.09 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 57.32 41.75 26.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.82 105.32 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -121.25 119.25 31.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -86.81 29.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -122.34 -41.63 2.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.918 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -53.38 123.91 13.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.29 25.26 75.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.479 ' HB2' HD21 ' A' ' 30' ' ' LEU . 63.6 mmm -119.73 150.15 49.78 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.504 0.669 . . . . 0.0 110.91 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 54.2 Cg_endo -69.72 123.46 10.14 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.383 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 31' ' ' VAL . 14.0 tp -49.39 -49.87 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.679 ' HA ' HG11 ' A' ' 143' ' ' VAL . 10.4 pt20 -46.85 -34.66 5.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.446 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 33.2 t70 -77.28 -45.81 25.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 25' ' ' MET . 36.9 mt -59.45 -46.04 89.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 27' ' ' LEU . 33.3 m -88.27 163.22 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.9 p -108.87 149.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.105 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.73 -46.94 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -50.14 -44.45 52.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.923 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 30.0 mmtt -132.66 99.17 15.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.606 0.717 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.7 Cg_endo -69.79 -41.17 4.47 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.692 2.261 . . . . 0.0 112.344 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.513 HG23 ' HD2' ' A' ' 38' ' ' PRO . 34.1 mt -74.84 134.81 74.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.584 0.707 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 148.32 64.65 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.643 2.228 . . . . 0.0 112.356 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.483 ' CD1' ' HG3' ' A' ' 43' ' ' LYS . 1.1 tm? -65.12 -59.36 4.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' LEU . 24.9 t80 -36.09 -64.86 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.915 HG13 HD11 ' A' ' 97' ' ' LEU . 90.2 t -46.67 -63.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -40.53 -56.01 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG3' ' CD1' ' A' ' 39' ' ' LEU . 64.2 mmtt -53.92 -39.43 65.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 80.7 m -65.23 -41.88 93.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.66 -43.86 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -70.45 -38.76 74.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 93' ' ' VAL . 11.0 t80 -56.58 -50.15 72.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 mt -48.83 -68.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 50' ' ' ASP . 2.7 pp20? -55.18 -53.19 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 21.1 t70 -45.46 -42.89 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 p -88.66 29.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 108.65 1.45 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.22 51.41 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 0.0 110.953 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 80.4 m -132.7 30.88 4.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.436 ' O ' HD12 ' A' ' 58' ' ' LEU . 7.5 m -66.54 122.33 17.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.15 130.38 42.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 45.18 87.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 4.6 mp -83.16 143.61 30.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.353 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.647 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 2.6 m-85 47.87 27.88 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HB2' ' HE1' ' A' ' 167' ' ' MET . 15.4 tpp85 -123.41 -46.84 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t -100.37 145.05 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.4 t -171.45 148.05 2.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.5 -52.83 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -71.09 91.28 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 0.7 OUTLIER -66.23 -34.58 78.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -52.87 -36.31 58.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.156 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.96 -58.27 8.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.404 ' NE2' ' HA ' ' A' ' 65' ' ' LYS . 1.3 mp0 -58.91 -33.88 71.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.95 -66.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.3 p30 -57.19 -37.85 72.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.496 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 38.7 mt -52.25 -37.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -90.63 -55.65 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.04 -54.87 20.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -54.04 -43.84 70.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -57.38 -40.68 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.29 -62.0 2.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -58.94 -28.65 66.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -129.67 103.98 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -76.33 -27.24 56.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -96.23 37.21 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.608 HD11 ' SD ' ' A' ' 86' ' ' MET . 9.1 tt -80.69 153.77 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.402 ' N ' HG12 ' A' ' 81' ' ' ILE . 20.9 t30 -123.0 94.78 4.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -37.23 -50.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.4 t -43.66 -46.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.093 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -57.88 -46.41 84.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.608 ' SD ' HD11 ' A' ' 81' ' ' ILE . 82.0 mtp -56.16 -38.11 70.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 62.05 50.12 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.02 178.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 p -75.63 117.76 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -42.08 -51.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -40.39 -49.48 2.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.45 -56.15 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 47' ' ' PHE . 98.3 t -46.65 -55.24 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.647 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -47.07 -45.36 21.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.49 -60.27 5.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.31 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.915 HD11 HG13 ' A' ' 41' ' ' VAL . 20.9 tp -47.98 -42.94 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -64.96 -43.33 93.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.912 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.94 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -60.54 -35.87 77.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -82.15 -41.0 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.861 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.4 -41.71 98.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -57.28 -40.17 77.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.442 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 47.7 mt -36.56 146.98 0.21 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.602 0.715 . . . . 0.0 110.946 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -27.46 26.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 153.98 81.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.64 0.733 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 156.58 63.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.337 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.67 -45.91 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.3 mt -95.93 117.65 66.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 111.146 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.449 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.7 Cg_endo -69.74 137.69 36.12 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.662 2.242 . . . . 0.0 112.323 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.584 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 6.0 m-85 -53.05 -36.47 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -54.91 -23.52 19.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 117' ' ' LEU . 60.8 mt -112.97 30.81 6.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.858 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.584 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.6 m170 -74.3 -61.8 1.13 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 110.847 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.589 ' HA ' HD12 ' A' ' 118' ' ' LEU . 54.1 Cg_endo -69.73 -40.32 5.5 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -47.09 -33.55 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.8 mt -71.62 -43.02 66.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 115' ' ' PRO . 6.3 mt -69.1 -57.95 4.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -43.05 -25.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.06 -27.72 15.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.74 -31.72 52.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -74.1 -15.55 61.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 90.4 mt -50.26 129.35 24.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.736 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -46.94 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.252 . . . . 0.0 112.372 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -59.04 106.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -46.94 -46.49 21.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.6 m -59.78 -67.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 129' ' ' ARG . 58.0 mm-40 -46.6 -51.76 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 128' ' ' GLU . 12.2 ttm180 -36.79 -48.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.47 ' CD2' ' HG2' ' A' ' 207' ' ' GLN . 23.0 mt -73.26 -66.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 130' ' ' LEU . 29.9 m-70 -34.14 -49.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.864 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.92 -59.94 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.84 -40.01 59.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -63.45 -26.47 68.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.44 -39.79 13.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.47 -41.56 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 12.9 p -58.75 -24.9 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -60.04 -32.28 70.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -60.42 -34.88 74.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 141' ' ' HIS . 22.6 m-85 -44.91 132.34 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.588 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.1 t-80 -33.99 141.85 0.23 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.588 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.1 Cg_endo -69.78 -9.55 26.38 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.639 2.226 . . . . 0.0 112.369 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 28' ' ' GLN . 97.6 t -98.83 -38.99 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -84.28 -38.17 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.515 ' CZ ' ' HG3' ' A' ' 149' ' ' ARG . 35.5 t80 -51.71 -43.75 62.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.93 -45.71 82.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.23 -59.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 41.0 t80 -47.92 -42.92 28.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.515 ' HG3' ' CZ ' ' A' ' 145' ' ' TYR . 14.0 mmm180 -65.87 -38.76 89.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -65.28 -45.71 83.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.67 -60.35 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 148' ' ' PHE . 84.7 mt -46.97 -48.58 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.3 m -44.09 -36.21 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -80.79 -36.39 31.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 152' ' ' ILE . 77.9 mt -59.92 -47.0 87.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -49.04 -43.08 40.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.469 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 26.8 mtp85 -61.79 -38.08 86.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.23 -47.51 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.2 p -56.63 -36.4 69.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.2 mt-30 -53.01 -42.04 65.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.928 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.676 ' HB3' HD12 ' A' ' 164' ' ' ILE . 12.7 mm100 -110.66 35.93 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 166' ' ' LEU . 22.5 p80 -47.35 -35.78 8.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 24.3 mmtp -57.71 -33.82 68.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.676 HD12 ' HB3' ' A' ' 161' ' ' GLN . 92.9 mt -80.13 -59.7 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.145 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -81.99 13.04 3.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 162' ' ' HIS . 16.7 mt 39.53 54.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.465 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 18.0 mmm -154.47 116.06 4.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.441 HG22 ' CG ' ' A' ' 162' ' ' HIS . 68.9 p -93.5 154.86 17.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -40.02 -42.73 1.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.101 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.417 ' CG ' ' HG1' ' A' ' 168' ' ' THR . 1.2 p-10 -63.64 -52.48 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -52.63 -48.21 66.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.41 -44.94 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 71.2 p -63.39 -42.42 98.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.04 -33.59 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 m -72.95 -18.85 61.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.4 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 9.6 m-85 -104.25 -9.58 18.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.562 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -50.23 -46.73 83.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.567 0.699 . . . . 0.0 110.909 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.9 Cg_exo -47.97 -59.78 1.12 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.665 2.243 . . . . 0.0 112.334 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 180' ' ' LEU . 25.5 m -69.42 -64.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 179' ' ' THR . 85.2 mt -33.28 -50.18 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 19.4 ptm -157.17 131.26 8.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -86.78 139.88 33.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.845 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 157.32 60.73 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.84 138.29 55.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.65 -52.15 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.77 95.37 5.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 187' ' ' ASN . 0.0 OUTLIER -122.35 30.91 6.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 187' ' ' ASN . 13.4 tpp180 -35.31 144.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 189' ' ' GLU . 5.3 mp0 -74.44 100.48 3.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -115.33 -58.47 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 26.9 mt -127.96 87.65 2.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.3 m -147.1 105.5 3.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 34.8 p -125.05 38.45 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.128 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 1.8 t -173.65 128.62 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -88.68 80.68 7.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 200' ' ' VAL . 40.6 mt -98.01 -49.99 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.473 ' ND1' HD21 ' A' ' 118' ' ' LEU . 94.7 m-70 -34.2 -38.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 196' ' ' ILE . 75.5 mt-30 -80.72 -50.6 9.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.2 p -54.65 -24.89 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 196' ' ' ILE . 92.6 t -58.97 -66.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.53 -37.41 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -55.24 -45.51 76.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.9 m -60.07 -53.87 52.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.401 ' HB3' HD13 ' A' ' 152' ' ' ILE . 6.1 m-85 -39.15 -38.86 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 152' ' ' ILE . 60.5 mt -74.56 -65.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.42 ' HB3' HG23 ' A' ' 218' ' ' VAL . 36.7 mt-30 -45.39 -52.55 9.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.47 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 24.1 mp0 -94.2 29.35 2.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.449 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 35.7 t -67.0 -29.62 69.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 213' ' ' TYR . 9.6 mm-40 -81.85 -45.14 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -48.93 -37.57 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -49.47 -63.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -105.21 -55.76 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 209' ' ' GLN . 80.7 m-85 -57.41 -23.97 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.922 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 59.86 39.76 20.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.851 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -72.92 -177.9 33.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.64 145.44 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.66 116.35 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.42 HG23 ' HB3' ' A' ' 206' ' ' GLN . 30.0 m -91.56 174.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.0 m -119.21 102.84 9.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 0.0 110.843 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -92.13 -56.15 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.63 80.72 0.18 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.514 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.9 p -125.25 90.98 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.935 0.398 . . . . 0.0 110.873 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -79.88 171.54 14.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.23 44.18 0.49 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.472 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -150.2 118.13 6.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -66.34 91.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -90.86 42.61 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -152.36 150.64 25.68 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 147.61 63.13 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.697 2.265 . . . . 0.0 112.298 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 178.34 4.64 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.712 2.274 . . . . 0.0 112.359 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.539 HG23 ' CB ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -71.98 0.3 9.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 53.15 26.39 4.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.539 ' CB ' HG23 ' A' ' 14' ' ' THR . 13.9 tpt180 -127.91 160.5 31.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.97 36.22 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.417 ' HA ' ' CE3' ' A' ' 18' ' ' TRP . 2.7 m95 -74.75 99.89 3.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -129.69 111.95 13.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.472 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 6.1 t -167.43 142.54 3.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -84.31 -7.64 59.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.836 ' CZ ' HD13 ' A' ' 30' ' ' LEU . 2.7 t80 -77.92 -39.07 44.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -73.39 -23.51 60.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.856 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.68 20.15 51.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 14.6 mmt -121.97 157.52 57.46 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.612 0.72 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.49 68.9 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.343 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 147' ' ' VAL . 31.0 tp -60.36 -49.04 79.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.667 ' CB ' HG21 ' A' ' 143' ' ' VAL . 3.6 pt20 -47.46 -28.24 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -45.54 14.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.836 HD13 ' CZ ' ' A' ' 22' ' ' TYR . 49.6 mt -60.76 -44.93 96.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 27' ' ' LEU . 20.0 m -91.2 167.14 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -113.44 167.69 10.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.08 -48.45 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.24 -54.77 43.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -115.3 85.23 12.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.446 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.4 Cg_endo -69.79 -31.71 19.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.0 mt -80.87 130.17 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 111.134 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.09 47.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.442 HD21 ' HE2' ' A' ' 43' ' ' LYS . 5.3 tp -67.19 -31.77 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' A' ' 100' ' ' PHE . 42.0 t80 -56.38 -48.47 76.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 97' ' ' LEU . 19.7 t -65.12 -50.68 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.074 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -58.48 -60.99 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HE2' HD21 ' A' ' 39' ' ' LEU . 17.7 mmtt -46.3 -30.37 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.6 m -76.72 -34.37 58.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.535 HG13 ' CG ' ' A' ' 154' ' ' HIS . 93.2 t -76.78 -60.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -54.54 -39.9 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 51' ' ' THR . 20.3 t80 -53.24 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mt -46.05 -52.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.22 -52.41 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.19 -33.54 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.497 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 82.1 p -91.92 23.66 3.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.09 154.69 24.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.501 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.78 47.73 2.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.0 p -132.39 40.32 3.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -97.84 130.88 44.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -67.14 127.22 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.59 77.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.533 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.27 -66.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.96 -37.11 22.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -50.34 -47.56 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.3 t -108.93 131.34 59.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.0 m -110.15 144.19 39.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.94 -166.17 42.1 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -49.5 139.68 11.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -67.9 -28.04 67.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m -53.97 -39.33 65.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.83 -47.38 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.741 ' HA ' HD12 ' A' ' 71' ' ' ILE . 7.4 mt-30 -65.43 -20.82 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.14 -69.87 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.2 p30 -47.49 -39.25 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 68' ' ' GLN . 50.1 mt -47.15 -42.54 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -82.97 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -45.98 -58.4 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -54.2 -58.18 8.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -55.39 -27.91 50.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.55 -57.33 7.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -73.09 -23.61 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -124.38 120.37 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -95.06 -14.01 24.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -104.55 31.18 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 82' ' ' ASN . 3.2 tt -76.27 158.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.509 ' N ' ' CG1' ' A' ' 81' ' ' ILE . 7.0 t30 -126.24 94.72 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.9 mt -44.87 -45.71 10.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -48.68 -36.81 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.2 t -66.59 -39.24 88.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.525 ' HB3' HG13 ' A' ' 88' ' ' VAL . 6.7 mmm -69.06 -28.9 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 55.83 35.86 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 86' ' ' MET . 16.2 m -66.67 148.72 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.8 p -55.63 129.91 40.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.43 -41.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -52.34 -39.22 60.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.47 -59.76 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.0 -53.31 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -45.59 -33.62 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 -57.7 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.463 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.4 -31.59 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 41' ' ' VAL . 46.1 tp -56.39 -47.96 77.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -64.37 -34.43 78.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.31 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . 7.3 t80 -67.08 -24.96 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.624 ' HB2' HG21 ' A' ' 179' ' ' THR . 51.9 m-85 -90.11 -28.6 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.14 -34.66 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.0 -36.23 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.4 mt -38.56 142.55 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.925 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.24 32.31 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.23 157.37 76.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.85 26.59 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.338 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp -40.59 -42.54 1.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.41 130.02 36.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 111.136 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 159.36 53.67 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.665 2.243 . . . . 0.0 112.343 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.31 -20.64 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.623 ' O ' HD23 ' A' ' 113' ' ' LEU . 21.3 t -76.58 -1.51 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.827 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.633 HD22 ' HE2' ' A' ' 139' ' ' LYS . 18.3 mt -134.78 17.72 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.477 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 3.8 m170 -61.47 -60.49 10.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.606 0.717 . . . . 0.0 110.832 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.76 -36.57 10.55 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.691 2.261 . . . . 0.0 112.375 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -51.86 -32.03 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mt -73.28 -23.87 60.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 121' ' ' ALA . 19.1 mt -94.65 -59.25 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -45.03 -24.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.502 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -96.04 -27.33 15.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -79.65 -18.29 51.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -86.31 -0.63 56.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.554 HG21 ' HB2' ' A' ' 128' ' ' GLU . 79.6 mt -66.37 129.85 94.18 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.631 0.729 . . . . 0.0 111.107 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -44.0 2.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.4 t70 -61.65 94.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.527 ' HD3' HG21 ' A' ' 217' ' ' ILE . 3.4 ttmt -34.88 -39.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.6 m -65.16 -67.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.554 ' HB2' HG21 ' A' ' 123' ' ' ILE . 8.3 mt-10 -49.07 -48.55 44.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -45.0 -55.16 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.63 HD22 ' HG3' ' A' ' 207' ' ' GLN . 18.7 mt -65.92 -58.74 4.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.65 -43.37 2.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.502 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -59.69 -45.51 91.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 130' ' ' LEU . 8.3 mt -69.07 -25.59 64.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -76.25 -30.51 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 0.5 OUTLIER -88.71 -30.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.404 ' O ' ' CD1' ' A' ' 140' ' ' PHE . 54.9 mt -71.83 -25.12 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.35 -7.58 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -81.89 -31.24 31.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.633 ' HE2' HD22 ' A' ' 113' ' ' LEU . 12.1 pttt -88.94 14.05 11.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.632 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.0 m-85 -77.84 166.88 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.9 t-80 -54.96 140.85 60.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.597 0.713 . . . . 0.0 110.88 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.71 -24.31 30.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.703 2.269 . . . . 0.0 112.334 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.667 HG21 ' CB ' ' A' ' 28' ' ' GLN . 17.2 t -91.11 -40.84 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 145' ' ' TYR . 28.8 m120 -77.7 -48.99 15.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.482 ' CZ ' ' HD2' ' A' ' 149' ' ' ARG . 19.7 t80 -37.39 -56.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -49.18 -65.26 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 27' ' ' LEU . 44.1 t -49.75 -59.6 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -43.26 -45.78 5.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.482 ' HD2' ' CZ ' ' A' ' 145' ' ' TYR . 5.3 mtt-85 -63.3 -56.48 16.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -46.04 -45.2 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -56.09 -62.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.559 HG22 ' SG ' ' A' ' 208' ' ' CYS . 5.2 mt -48.02 -50.93 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.2 m -42.18 -38.78 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.535 ' CG ' HG13 ' A' ' 45' ' ' VAL . 56.0 t60 -79.74 -35.73 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 152' ' ' ILE . 95.6 mt -57.29 -44.02 83.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 205' ' ' ILE . 8.5 t-20 -52.1 -46.55 65.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.455 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 44.2 mtt-85 -57.14 -42.39 80.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.785 HG11 HD21 ' A' ' 172' ' ' LEU . 89.9 t -64.32 -47.24 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.6 p -59.3 -40.16 85.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.8 mt-30 -49.7 -44.2 47.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.485 ' OE1' HD12 ' A' ' 164' ' ' ILE . 6.2 mm-40 -100.29 54.17 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.493 ' CG ' HG22 ' A' ' 168' ' ' THR . 2.3 p80 -84.58 29.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -110.17 -36.76 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.485 HD12 ' OE1' ' A' ' 161' ' ' GLN . 24.7 mt -92.27 -47.32 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -88.33 -6.8 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.8 mt 49.44 50.34 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 74.1 mmm -127.6 85.62 2.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.493 HG22 ' CG ' ' A' ' 162' ' ' HIS . 71.0 p -77.77 153.24 33.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.14 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -39.03 -36.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -66.96 -48.72 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -61.76 -40.34 94.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.785 HD21 HG11 ' A' ' 158' ' ' VAL . 13.1 mt -65.49 -47.73 75.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.7 p -55.61 -48.37 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.2 mt -65.67 -38.97 83.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.7 m -63.08 -9.73 11.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.422 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 10.8 m-85 -118.27 -9.48 10.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.581 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -50.64 -46.0 85.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.556 0.694 . . . . 0.0 110.942 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.6 Cg_exo -47.98 -65.5 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.651 2.234 . . . . 0.0 112.37 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 101' ' ' PHE . 52.9 m -63.95 -63.35 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 179' ' ' THR . 45.6 mt -34.3 -60.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 7.4 ptp -139.11 127.63 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 148.53 55.66 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.596 0.712 . . . . 0.0 110.854 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -164.26 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.233 . . . . 0.0 112.31 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 t70 50.2 38.3 16.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 186' ' ' GLU . 18.3 t80 -95.06 43.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 185' ' ' PHE . 46.3 mt-10 -34.36 103.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -111.17 168.07 9.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -45.97 121.48 3.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 191' ' ' LEU . 13.0 mt-10 -106.68 20.8 18.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.864 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.94 ' CZ ' HD12 ' A' ' 191' ' ' LEU . 2.5 p90 -37.5 -32.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.94 HD12 ' CZ ' ' A' ' 190' ' ' PHE . 8.8 mt -105.17 173.71 6.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 193' ' ' THR . 79.5 p -132.82 168.07 19.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.816 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 192' ' ' SER . 28.8 p 34.85 45.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.179 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.7 95.08 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.158 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -72.74 65.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 200' ' ' VAL . 51.5 mt -80.57 -45.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -42.05 -55.46 3.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -40.97 72.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.7 t -50.19 -36.76 31.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.529 HG22 ' CB ' ' A' ' 121' ' ' ALA . 93.4 t -53.47 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.122 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.98 -52.7 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -46.83 -45.88 20.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.4 m -55.77 -57.24 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.542 ' HB3' HD13 ' A' ' 152' ' ' ILE . 12.7 m-85 -38.97 -52.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.421 HD11 HD13 ' A' ' 155' ' ' LEU . 68.6 mt -58.54 -53.86 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -52.76 -55.2 24.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.63 ' HG3' HD22 ' A' ' 130' ' ' LEU . 10.2 mm-40 -93.36 24.68 3.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.569 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 13.2 t -63.37 -7.3 6.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 213' ' ' TYR . 5.8 mm-40 -103.44 -60.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.471 ' HA ' ' N ' ' A' ' 215' ' ' GLY . 4.0 t80 -40.02 -27.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 208' ' ' CYS . 21.9 m-85 -56.09 -61.97 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -125.88 -26.86 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.501 ' O ' ' N ' ' A' ' 215' ' ' GLY . 32.1 m-85 -83.94 25.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' TYR . 0.4 OUTLIER 34.4 32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 213' ' ' TYR . . . -61.7 175.86 5.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -110.06 146.29 35.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.882 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.527 HG21 ' HD3' ' A' ' 126' ' ' LYS . 89.8 mt -65.42 111.51 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.28 168.24 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.425 ' C ' ' CD ' ' A' ' 219' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -166.61 165.71 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.875 0.369 . . . . 0.0 110.85 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 t -174.77 177.32 2.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.86 178.75 44.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.493 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -172.58 177.58 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 0.0 110.855 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 m -144.89 174.38 11.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.31 161.29 30.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' C ' ' CG ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER -115.98 172.72 6.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.924 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -162.24 172.3 15.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 9' ' ' ASN . 70.2 m-85 -159.87 162.99 34.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.848 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -155.86 123.81 2.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.658 0.742 . . . . 0.0 110.903 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 167.26 24.99 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.732 2.288 . . . . 0.0 112.289 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 137.96 36.72 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.552 ' O ' HG22 ' A' ' 14' ' ' THR . 8.8 m -89.29 24.08 2.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -84.96 153.07 23.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -103.4 105.51 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -105.47 33.97 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.817 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -54.47 93.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -136.1 116.93 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 m -123.45 91.31 3.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -59.17 -11.65 4.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 25' ' ' MET . 20.7 m-85 -59.08 -45.79 89.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -44.12 -27.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' N ' ' CD1' ' A' ' 23' ' ' PHE . . . -81.66 -33.39 27.81 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.441 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 22' ' ' TYR . 8.0 mtt -89.03 142.26 30.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.599 0.714 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 153.44 68.83 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.65 2.234 . . . . 0.0 112.313 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 31' ' ' VAL . 21.1 tp -47.3 -56.35 6.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.849 ' HA ' HG11 ' A' ' 143' ' ' VAL . 7.4 pt20 -44.22 -32.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.81 -49.4 18.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.63 -42.09 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 27' ' ' LEU . 28.3 m -89.33 156.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.8 p -103.65 159.85 15.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.65 -44.82 63.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -57.36 -46.5 83.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -126.48 88.28 54.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.616 0.722 . . . . 0.0 110.859 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.5 Cg_endo -69.76 -36.13 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.98 131.29 63.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.721 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 120.98 7.68 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.403 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -43.89 -50.08 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.498 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . 84.7 t80 -42.58 -66.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.425 HG13 HD11 ' A' ' 97' ' ' LEU . 37.5 t -42.72 -57.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -48.56 -57.7 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 47.6 mmtt -46.77 -39.81 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 88.7 m -67.01 -36.8 82.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG13 ' CG ' ' A' ' 154' ' ' HIS . 99.2 t -72.44 -53.98 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -60.63 -35.87 77.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.675 ' CE2' HG21 ' A' ' 93' ' ' VAL . 65.6 t80 -60.77 -65.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -37.2 -39.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.57 -41.68 60.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 47' ' ' PHE . 5.4 m-20 -62.18 -43.73 98.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -79.57 -29.82 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.144 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.04 119.7 1.09 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.495 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -94.62 -32.86 13.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.43 39.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 56' ' ' GLU . 24.3 m -87.16 112.47 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 57' ' ' GLY . 2.3 tt0 -37.01 125.29 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' GLU . . . 34.19 89.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 58' ' ' LEU . 1.6 pt? -106.03 -36.88 6.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.819 0.342 . . . . 0.0 110.907 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 10.8 m-85 -84.13 -61.23 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.555 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -57.65 -12.02 2.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.555 HG23 ' CD ' ' A' ' 60' ' ' ARG . 38.5 t -106.39 113.02 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.9 t -166.61 123.19 1.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.5 -69.84 0.19 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -50.49 146.19 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -113.64 -40.02 3.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -46.69 -49.82 18.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -43.26 -49.69 6.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.574 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 14.2 mt-30 -63.75 -29.45 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.3 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 20.8 p30 -50.52 -43.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.46 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 81.1 mt -51.05 -42.52 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -78.51 -57.29 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.93 -67.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -38.74 -52.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 86.2 t80 -54.16 -55.59 26.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.98 -46.47 71.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -60.83 -33.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.28 141.88 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -93.33 -18.7 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -78.32 46.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.7 pt -109.25 175.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -142.16 117.53 10.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.97 -43.09 83.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.11 -42.24 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 t -60.55 -43.57 97.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 mtp -60.54 -29.82 69.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.811 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.11 43.42 29.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.58 168.36 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 p -65.9 118.16 9.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -38.72 -47.29 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -46.31 -42.97 15.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.39 -59.91 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.675 HG21 ' CE2' ' A' ' 47' ' ' PHE . 58.7 t -51.59 -59.68 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.78 -38.88 0.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.113 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.3 -58.72 2.69 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.44 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -42.36 -39.99 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 111.091 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.425 HD11 HG13 ' A' ' 41' ' ' VAL . 16.4 tp -52.23 -51.21 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -67.26 -41.19 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.88 -39.87 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.61 -52.55 64.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.691 ' HB2' HG21 ' A' ' 179' ' ' THR . 49.4 m-85 -60.34 -43.66 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.32 -41.26 79.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -35.56 65.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.0 mt -39.24 143.9 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.652 0.739 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.61 34.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.706 2.271 . . . . 0.0 112.326 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 156.85 68.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 140.39 42.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.371 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.2 tp -43.91 -49.48 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.7 mt -87.45 125.02 66.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.609 0.719 . . . . 0.0 111.142 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.731 ' HG2' HD12 ' A' ' 113' ' ' LEU . 54.0 Cg_endo -69.76 150.61 68.42 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.645 2.23 . . . . 0.0 112.382 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 7.6 m-85 -67.03 -25.59 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 t -65.14 -15.94 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.94 HD13 ' CE1' ' A' ' 140' ' ' PHE . 21.5 mt -118.55 26.0 9.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.497 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.8 m170 -71.63 -60.22 2.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.598 0.713 . . . . 0.0 110.903 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 53.8 Cg_endo -69.74 -25.56 28.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.27 . . . . 0.0 112.326 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.521 ' O ' HD13 ' A' ' 136' ' ' ILE . 51.3 mm-40 -68.16 -35.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.489 ' HB3' HG11 ' A' ' 200' ' ' VAL . 7.5 mt -72.52 -25.68 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 121' ' ' ALA . 9.8 mt -88.75 -58.65 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -39.47 -30.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.68 -37.68 20.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -65.54 -17.77 64.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.095 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -96.79 26.42 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -89.98 131.48 39.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.649 0.737 . . . . 0.0 111.139 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -45.78 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 126' ' ' LYS . 1.2 m-20 -70.92 95.53 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -35.61 -54.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.9 m -51.64 -51.95 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.85 -45.46 90.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -50.11 -44.46 52.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.25 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -43.15 -50.35 6.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.61 -60.21 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 22.8 mt -52.04 -38.12 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 137' ' ' VAL . 27.5 tttm -62.93 -26.4 68.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 -42.06 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 116' ' ' GLU . 86.4 mt -64.5 -18.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 134' ' ' LYS . 7.6 p -90.51 -6.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -78.95 -39.03 35.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -76.02 -1.93 28.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.94 ' CE1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -64.67 137.05 57.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.534 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 2.6 t-80 -38.69 141.73 0.56 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.599 0.714 . . . . 0.0 110.86 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.7 -15.98 37.58 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.849 HG11 ' HA ' ' A' ' 28' ' ' GLN . 21.4 t -96.04 -39.0 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -76.33 -41.97 46.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 3.1 t80 -56.58 -59.45 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 145' ' ' TYR . 3.4 t0 -35.69 -45.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 151' ' ' VAL . 49.0 t -76.5 -44.21 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.567 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 31.2 t80 -52.86 -46.13 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -66.28 -48.11 71.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -56.28 -44.7 80.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 147' ' ' VAL . 58.2 t -58.74 -64.23 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.181 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.585 HG23 HG12 ' A' ' 205' ' ' ILE . 78.1 mt -45.46 -52.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.122 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.8 m -41.04 -38.31 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.424 ' CG ' HG13 ' A' ' 45' ' ' VAL . 19.3 t60 -78.81 -39.45 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 152' ' ' ILE . 98.7 mt -56.58 -47.1 80.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.79 -44.76 39.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 22.4 mtt-85 -60.38 -28.03 67.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.04 -40.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 84.2 p -64.0 -26.36 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 40.1 mt-30 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.566 ' HB3' HD12 ' A' ' 164' ' ' ILE . 2.1 mm100 -103.38 32.43 3.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.562 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 11.5 p80 -52.73 -43.43 65.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.562 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 14.3 mmtp -59.54 -28.55 67.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 161' ' ' GLN . 82.2 mt -83.09 -55.92 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 166' ' ' LEU . 1.3 m-20 -92.4 22.1 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 162' ' ' HIS . 11.5 mt 35.18 53.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.5 mmm -148.64 110.39 4.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ALA . 61.2 p -96.59 154.01 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -35.08 -41.6 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.95 -50.04 65.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 168' ' ' THR . 38.8 m-20 -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.65 -42.43 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 t -60.27 -27.95 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 47.5 mt -83.43 -35.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.98 -21.33 64.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -104.5 -11.32 17.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.22 -46.45 93.93 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.598 0.713 . . . . 0.0 110.933 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.4 Cg_exo -48.0 -57.4 2.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 0.0 112.346 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 101' ' ' PHE . 59.8 m -73.35 -61.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 80.7 mt -32.54 -48.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.484 ' HG3' ' CZ3' ' A' ' 177' ' ' TRP . 14.1 ptm -158.29 141.97 15.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.829 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -66.95 149.92 98.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.848 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 156.04 64.2 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.684 2.256 . . . . 0.0 112.292 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.07 -178.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -84.9 15.76 3.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -78.57 92.83 4.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -90.76 -63.38 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -60.88 157.41 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.34 118.48 24.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -111.62 163.48 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 192' ' ' SER . 40.6 mt -41.16 155.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 191' ' ' LEU . 98.3 p -35.81 104.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.2 m -84.19 124.97 31.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.188 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 76.3 p -40.24 133.58 1.77 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.153 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.439 ' CD ' ' O ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -85.28 30.62 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 200' ' ' VAL . 96.1 mt -62.23 -45.28 99.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.487 ' ND1' HD21 ' A' ' 118' ' ' LEU . 51.8 m-70 -47.84 -58.76 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.84 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -53.36 -50.32 65.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 m -50.1 -41.48 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 196' ' ' ILE . 66.8 t -44.07 -71.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 202' ' ' GLU . 95.3 t -61.1 -59.68 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 201' ' ' VAL . 10.1 tt0 -34.16 -47.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -60.0 -57.04 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -39.12 -34.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.585 HG12 HG23 ' A' ' 152' ' ' ILE . 95.2 mt -80.81 -62.0 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -47.91 -51.94 21.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.474 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 26.5 mp0 -95.42 30.6 2.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.404 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 8.8 t -65.88 -21.65 66.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.485 ' NE2' ' CD2' ' A' ' 213' ' ' TYR . 6.1 mm-40 -84.65 -53.88 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -40.45 -37.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 19.2 m-85 -53.06 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.21 -55.29 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.485 ' CD2' ' NE2' ' A' ' 209' ' ' GLN . 69.9 m-85 -60.34 -9.96 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.959 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 t30 49.07 37.19 10.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -68.66 172.05 36.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.71 154.86 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.16 132.57 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.85 177.98 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 p -88.7 -57.8 2.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -173.12 173.15 3.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.26 -158.14 7.62 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.2 p -168.2 139.97 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 m -171.46 166.69 6.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.826 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.05 64.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.496 ' HE3' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -80.42 166.16 21.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.888 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -141.25 121.18 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CD1' ' O ' ' A' ' 10' ' ' PHE . 53.1 p90 -136.45 124.8 23.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -102.5 147.98 34.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.654 0.74 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 155.13 66.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.676 2.251 . . . . 0.0 112.328 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 139.66 40.79 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.666 2.244 . . . . 0.0 112.376 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 t -168.69 153.36 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 1.7 mpt_? -91.09 107.22 19.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 17' ' ' ASN . 29.7 ptt180 -62.54 -51.47 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.436 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 17.5 t30 54.75 35.75 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.571 ' CZ2' ' HA ' ' A' ' 73' ' ' LYS . 53.6 t90 -131.75 13.06 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -176.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.495 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 42.2 p -144.0 163.99 31.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.904 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -98.2 -26.83 14.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -58.94 -44.44 91.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 20' ' ' SER . 1.1 p90 -45.69 -34.71 3.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.48 ' N ' ' CD1' ' A' ' 23' ' ' PHE . . . -73.1 -36.9 56.2 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 10.6 mmt -80.98 148.83 65.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 147.25 62.81 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.704 2.269 . . . . 0.0 112.37 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.1 tp -45.03 -55.37 5.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.88 ' HA ' HG11 ' A' ' 143' ' ' VAL . 5.2 pt20 -46.46 -36.16 6.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.63 -39.95 61.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.19 -44.84 82.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -93.37 171.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 p -111.53 147.95 34.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.56 -45.12 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -54.59 -45.44 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 29.8 mmtt -129.34 93.42 35.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 110.948 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 53.3 Cg_endo -69.73 -38.92 7.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.732 2.288 . . . . 0.0 112.346 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.8 mt -78.2 128.46 78.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.664 0.745 . . . . 0.0 111.089 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.87 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.699 2.266 . . . . 0.0 112.345 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.663 HD11 ' HE3' ' A' ' 43' ' ' LYS . 2.4 tm? -99.13 -49.21 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -46.53 -50.32 17.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 97' ' ' LEU . 43.5 t -57.51 -58.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.091 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -46.45 -56.21 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.663 ' HE3' HD11 ' A' ' 39' ' ' LEU . 12.0 mmtp -43.97 -44.53 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 85.3 m -66.76 -62.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -45.36 -47.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.12 -37.17 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.707 ' CD1' HG21 ' A' ' 93' ' ' VAL . 4.9 t80 -55.61 -59.19 5.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 47' ' ' PHE . 10.7 mt -34.82 -68.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.96 -45.71 89.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -40.13 -50.49 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -87.26 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 48' ' ' ILE . . . 149.15 156.21 7.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.506 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.71 HD11 HG22 ' A' ' 158' ' ' VAL . 11.2 tp -126.05 41.45 3.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.307 . . . . 0.0 110.902 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 p -129.92 41.85 3.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 58' ' ' LEU . 50.4 m -95.96 116.25 28.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -39.12 116.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 72.37 0.56 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.506 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.616 HD22 ' O ' ' A' ' 55' ' ' THR . 4.1 mm? -41.73 -45.33 3.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 110.948 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CE2' ' HB1' ' A' ' 94' ' ' ALA . 6.5 m-85 -117.9 -41.69 2.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 59' ' ' TYR . 16.8 tpp85 -34.7 -47.22 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t -93.14 115.3 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -175.09 120.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.42 -53.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.436 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -38.6 -39.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 48.86 25.04 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.6 m -98.12 -27.56 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.01 -50.47 19.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -59.97 -39.08 84.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -46.3 -53.2 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 25.0 p30 -66.03 -38.2 87.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 68' ' ' GLN . 68.6 mt -51.42 -39.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -87.06 -60.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.571 ' HA ' ' CZ2' ' A' ' 18' ' ' TRP . 24.4 mtpt -46.83 -35.63 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 70' ' ' ASN . 52.1 mm-40 -77.7 -43.31 31.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -53.47 -28.81 32.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -75.71 -60.68 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -61.52 -25.84 67.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -130.62 107.07 8.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -79.68 -25.41 41.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -97.35 36.56 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.0 tt -79.83 147.46 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -124.86 102.87 7.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -44.65 -50.22 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.5 t -46.46 -50.1 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -56.5 -46.47 80.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.417 ' HB3' HG13 ' A' ' 88' ' ' VAL . 22.3 mmm -60.03 -26.8 66.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 51.96 51.45 16.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 86' ' ' MET . 34.1 m -85.36 160.2 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 p -56.13 125.18 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.2 t -43.48 -46.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.147 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -51.73 -35.72 44.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.69 -58.44 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.707 HG21 ' CD1' ' A' ' 47' ' ' PHE . 78.4 t -58.49 -37.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB1' ' CE2' ' A' ' 59' ' ' TYR . . . -58.84 -42.22 88.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.076 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.16 -45.89 7.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.39 -46.71 73.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 41' ' ' VAL . 23.2 tp -46.06 -44.19 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.564 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 30.9 mtmt -71.25 -42.06 69.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.33 -48.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 100' ' ' PHE . 4.6 t80 -58.47 -48.61 80.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -53.95 -47.62 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.432 ' CA ' HG23 ' A' ' 179' ' ' THR . . . -59.1 -41.46 88.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -53.18 -34.63 57.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -39.26 147.47 0.3 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.642 0.734 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -25.02 28.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.377 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -135.48 155.82 78.2 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.427 ' HG3' ' CE1' ' A' ' 111' ' ' TYR . 53.6 Cg_endo -69.77 136.57 33.3 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.717 2.278 . . . . 0.0 112.38 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.463 HD21 ' CD1' ' A' ' 148' ' ' PHE . 24.1 tp -43.55 -41.3 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.2 mt -95.05 123.88 55.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.702 . . . . 0.0 111.139 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 140.85 43.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.248 . . . . 0.0 112.323 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.559 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 6.3 m-85 -62.75 -22.4 66.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -66.81 -22.19 66.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 117' ' ' LEU . 41.4 mt -116.58 32.11 6.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.559 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.3 m170 -74.62 -61.48 1.11 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 0.0 110.832 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.72 -27.18 26.96 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.688 2.259 . . . . 0.0 112.325 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -63.77 -33.99 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 113' ' ' LEU . 2.5 mt -73.42 -41.54 63.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.565 HD23 HG21 ' A' ' 200' ' ' VAL . 8.8 mt -69.82 -57.2 5.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -43.82 -35.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.7 -26.79 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.081 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -77.9 -30.4 50.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.095 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -77.56 -10.99 59.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 55.4 mt -51.85 132.61 38.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.16 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -65.63 113.7 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.752 ' HD3' HG21 ' A' ' 217' ' ' ILE . 17.8 ttmt -52.09 -50.89 60.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.8 m -54.59 -65.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.172 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -43.45 -52.81 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -41.01 -52.56 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.5 mt -60.47 -57.22 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.34 -51.64 25.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.01 -24.6 67.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.525 ' O ' HG12 ' A' ' 137' ' ' VAL . 32.4 tttm -77.71 -33.04 53.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 6.1 pt-20 -83.69 -35.46 24.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.496 HG23 ' HZ2' ' A' ' 139' ' ' LYS . 54.3 mt -69.2 -36.57 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 134' ' ' LYS . 8.8 p -65.16 -21.13 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -72.09 -39.48 68.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.496 ' HZ2' HG23 ' A' ' 136' ' ' ILE . 4.6 mttp -59.62 -33.52 71.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -41.98 145.82 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.564 ' CE1' ' NE2' ' A' ' 28' ' ' GLN . 2.4 t-80 -43.25 142.18 1.68 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.816 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.84 -6.4 18.54 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 28' ' ' GLN . 48.8 t -99.19 -45.9 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -79.22 -38.06 36.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 2.3 t80 -42.74 -47.92 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -52.42 65.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -55.93 -64.12 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.587 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 31.3 t80 -43.55 -49.37 7.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 mtp85 -60.5 -47.06 87.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.13 -44.28 92.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 70.9 t -56.93 -60.53 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.67 HG23 HG12 ' A' ' 205' ' ' ILE . 56.3 mt -48.5 -50.14 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.6 m -40.4 -32.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -88.6 -36.83 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 152' ' ' ILE . 75.1 mt -55.96 -46.81 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -49.28 -41.68 38.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.472 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 23.3 mtp85 -60.63 -32.84 71.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 53' ' ' LEU . 47.0 t -73.72 -39.4 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 p -66.22 -28.05 68.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 39.3 mt-30 -63.33 -37.35 86.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.664 ' OE1' HD12 ' A' ' 164' ' ' ILE . 16.2 mm-40 -98.3 32.31 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.561 ' HB2' HG22 ' A' ' 168' ' ' THR . 7.8 p80 -57.13 -21.32 31.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -82.96 -17.56 43.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.664 HD12 ' OE1' ' A' ' 161' ' ' GLN . 60.2 mt -100.12 -63.93 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.73 22.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 165' ' ' ASN . 22.8 mt 33.12 54.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 38.1 mmm -142.68 105.82 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.561 HG22 ' HB2' ' A' ' 162' ' ' HIS . 72.4 p -94.7 150.05 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -33.81 -50.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -55.04 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -55.16 -38.81 68.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.519 HD11 ' HB ' ' A' ' 158' ' ' VAL . 79.5 mt -63.62 -41.8 98.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -71.67 -34.65 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.699 HD11 ' OE1' ' A' ' 198' ' ' GLN . 27.5 mt -80.7 -28.39 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.9 m -75.9 -21.21 57.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.564 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 14.3 m-85 -103.7 -8.74 19.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.568 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.5 OUTLIER -54.37 -46.92 98.88 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.52 0.676 . . . . 0.0 110.902 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 64.7 Cg_exo -48.02 -48.64 15.84 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 180' ' ' LEU . 39.7 m -81.83 -59.13 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 179' ' ' THR . 58.9 mt -33.17 -69.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.566 ' HG2' ' CH2' ' A' ' 177' ' ' TRP . 3.2 ttp -121.01 118.75 30.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.47 ' HD3' ' N ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -40.92 130.65 1.92 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.585 0.707 . . . . 0.0 110.872 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.47 ' N ' ' HD3' ' A' ' 182' ' ' ARG . 54.3 Cg_endo -69.67 122.12 8.83 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.403 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.64 110.81 10.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.882 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.416 ' O ' ' C ' ' A' ' 186' ' ' GLU . 45.4 m-85 -97.43 -50.45 4.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 185' ' ' PHE . 48.5 mp0 -36.42 -56.44 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -48.48 118.8 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -99.37 159.23 15.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -140.84 177.66 7.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.617 ' HD2' HD23 ' A' ' 191' ' ' LEU . 0.7 OUTLIER -50.21 -60.28 3.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.617 HD23 ' HD2' ' A' ' 190' ' ' PHE . 3.8 mm? -89.94 125.18 35.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 96.9 p -44.79 -34.65 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 13.2 t -174.31 150.89 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.105 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.411 HG21 HD12 ' A' ' 196' ' ' ILE . 9.0 t -150.85 155.44 39.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.13 29.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.749 ' O ' HG23 ' A' ' 200' ' ' VAL . 81.8 mt -89.95 -44.34 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.554 ' CD2' HD21 ' A' ' 118' ' ' LEU . 6.0 m80 -50.81 -60.16 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.699 ' OE1' HD11 ' A' ' 174' ' ' ILE . 70.1 mt-30 -57.2 -43.94 83.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 t -55.92 -39.34 71.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 196' ' ' ILE . 92.8 t -46.7 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.124 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.42 -55.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.147 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -40.62 -40.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 204' ' ' PHE . 49.5 m -58.98 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 208' ' ' CYS . 10.7 m-85 -36.08 -56.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.67 HG12 HG23 ' A' ' 152' ' ' ILE . 60.7 mt -59.56 -46.43 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -55.57 -58.03 9.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -99.72 28.98 4.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.564 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -57.91 -27.48 63.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -82.34 -54.55 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.18 -36.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.3 m-85 -50.54 -63.17 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -104.61 -55.74 2.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -55.0 -35.63 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 71.28 39.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -75.53 178.04 48.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.48 137.14 47.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.752 HG21 ' HD3' ' A' ' 126' ' ' LYS . 77.7 mt -59.16 125.92 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.28 170.31 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.166 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.94 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.7 p -145.12 112.77 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -138.07 144.49 40.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.12 165.18 12.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.52 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -131.32 135.73 47.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -102.36 -59.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.39 84.34 0.43 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -44.3 -47.2 9.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.1 t30 49.95 43.06 25.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -95.49 134.44 38.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.404 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 4.9 t30 -129.88 140.23 38.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.623 0.725 . . . . 0.0 110.881 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 11' ' ' ASN . 53.5 Cg_endo -69.75 158.53 56.66 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 150.77 68.48 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.709 2.272 . . . . 0.0 112.372 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.7 p -107.4 141.14 39.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -142.28 144.79 33.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -53.47 121.83 8.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -88.65 43.53 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -130.89 84.93 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -147.39 118.86 7.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -165.58 179.88 5.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.857 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -105.58 -37.33 6.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -38.86 -48.06 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -63.24 121.64 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.63 -43.28 1.7 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.495 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.4 ' SD ' ' HD2' ' A' ' 26' ' ' PRO . 22.8 mmt -79.9 159.83 70.27 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.569 0.7 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD2' ' SD ' ' A' ' 25' ' ' MET . 53.9 Cg_endo -69.71 160.25 50.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.736 2.291 . . . . 0.0 112.369 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 31' ' ' VAL . 17.8 tp -78.74 -45.51 20.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.733 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -48.15 -28.12 2.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -78.02 -45.66 23.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.5 mt -66.16 -42.78 88.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 27' ' ' LEU . 18.3 m -87.77 155.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -103.68 157.78 16.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.05 -44.19 30.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -58.74 -48.84 79.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -121.63 87.6 45.99 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.54 0.686 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.17 9.57 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.656 2.237 . . . . 0.0 112.364 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.434 HG23 ' HD2' ' A' ' 38' ' ' PRO . 72.1 mt -77.35 132.95 68.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.643 0.735 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.82 140.02 41.44 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.26 . . . . 0.0 112.316 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -55.24 -54.07 48.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 39' ' ' LEU . 82.4 t80 -38.17 -69.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.563 HG13 HD11 ' A' ' 97' ' ' LEU . 53.0 t -42.79 -55.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -50.29 -57.84 6.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HG2' HD13 ' A' ' 39' ' ' LEU . 36.2 mmtt -46.74 -39.13 11.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.431 ' HB2' HD13 ' A' ' 97' ' ' LEU . 73.0 m -68.01 -44.73 75.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.67 -53.09 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.8 -45.37 94.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 83' ' ' LEU . 57.8 t80 -43.06 -63.21 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -53.88 -57.3 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -40.85 -53.37 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -59.7 -39.72 85.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -86.37 26.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.148 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.48 172.55 48.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.469 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.66 37.36 3.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.6 p -116.63 29.68 7.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.732 ' O ' HD22 ' A' ' 58' ' ' LEU . 77.9 m -68.81 114.23 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.182 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.03 114.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.43 96.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 55' ' ' THR . 1.8 mm? -90.08 112.29 23.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.348 . . . . 0.0 110.917 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 22.0 m-85 72.29 33.32 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -126.63 -38.02 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.46 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 21.3 t -85.99 124.79 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 t -72.26 115.56 11.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.6 164.66 25.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.526 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -52.13 169.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.366 . . . . 0.0 110.922 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -100.47 -39.36 7.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.2 m -50.22 -30.97 12.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.2 -55.9 7.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HA ' HD12 ' A' ' 71' ' ' ILE . 18.9 mt-30 -59.46 -21.36 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.93 -61.41 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 23.7 p30 -61.46 -41.0 96.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.476 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 80.9 mt -52.34 -43.11 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -81.88 -53.88 5.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ASP . 50.9 mttt -54.62 -65.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -40.94 -44.33 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.5 -35.9 82.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.9 t0 -66.98 -55.48 14.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -54.72 -34.53 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -158.12 151.81 23.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.15 -19.07 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -80.81 49.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.57 -177.78 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.479 ' ND2' ' HB ' ' A' ' 84' ' ' VAL . 4.9 t30 -145.72 139.82 26.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . 14.7 mt -84.25 -41.25 17.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.479 ' HB ' ' ND2' ' A' ' 82' ' ' ASN . 88.4 t -48.55 -50.22 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -57.53 -41.59 81.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 mtp -61.27 -26.43 67.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 54.08 45.81 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.6 151.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.107 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 p -60.83 129.77 43.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.5 t -42.83 -52.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.46 ' ND2' ' HB ' ' A' ' 61' ' ' VAL . 9.9 m120 -40.82 -48.07 3.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.5 -62.86 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.415 HG21 ' CE2' ' A' ' 47' ' ' PHE . 65.6 t -48.7 -54.03 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -46.46 -41.39 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.78 -60.16 4.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -42.67 -41.29 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.563 HD11 HG13 ' A' ' 41' ' ' VAL . 15.7 tp -49.64 -49.92 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 101' ' ' PHE . 32.5 mtmt -68.22 -47.46 67.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -38.13 -33.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -65.38 -47.12 77.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 151' ' ' VAL . 41.5 m-85 -57.04 -44.49 82.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.49 -39.6 88.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.49 -37.99 82.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -37.78 141.6 0.47 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -24.12 29.74 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.232 . . . . 0.0 112.343 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.68 153.83 77.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.655 0.74 . . . . 0.0 110.838 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 134.77 28.76 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.351 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' A' ' 148' ' ' PHE . 19.1 tp -38.95 -52.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.3 mt -87.35 124.35 68.27 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 0.0 111.155 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 154.82 67.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.69 2.26 . . . . 0.0 112.352 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.538 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 21.7 m-85 -68.85 -26.47 65.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 m -65.71 -25.41 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.863 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.6 mt -111.58 36.66 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.967 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.552 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 2.7 m170 -77.94 -65.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.561 0.696 . . . . 0.0 110.829 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.9 Cg_endo -69.71 -21.44 33.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.739 2.293 . . . . 0.0 112.344 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.64 -28.55 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.536 HD22 ' CG1' ' A' ' 200' ' ' VAL . 2.5 mt -79.91 -36.6 36.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.6 -46.47 25.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.95 -31.79 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 132' ' ' ALA . . . -86.84 -29.25 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.7 -21.17 59.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -91.97 22.04 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.2 mt -89.07 130.07 45.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -44.83 1.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 102.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -40.18 -60.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 98.7 m -50.04 -57.09 8.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -50.27 -56.51 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -41.59 -57.15 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.472 ' CD1' ' HG3' ' A' ' 207' ' ' GLN . 52.7 mt -58.26 -54.18 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -47.0 -50.58 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.497 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . . . -52.14 -44.45 64.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.5 mt -71.02 -29.9 65.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -74.07 -30.18 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 7.2 pt-20 -87.32 -36.87 17.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.411 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 88.7 mt -69.89 -37.71 73.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.453 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 5.2 p -63.7 -7.73 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -77.61 -38.65 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.934 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -64.87 -29.88 70.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 141' ' ' HIS . 12.1 m-85 -43.68 128.34 5.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.595 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.3 t-80 -34.09 141.49 0.24 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 54.0 Cg_endo -69.72 -10.11 27.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.733 HG11 ' HA ' ' A' ' 28' ' ' GLN . 41.8 t -99.09 -40.38 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -83.44 -35.12 25.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 145' ' ' TYR . 4.4 t80 -57.0 -43.43 81.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.66 -49.31 70.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 151' ' ' VAL . 69.3 t -66.96 -50.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.532 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 37.4 t80 -54.13 -45.69 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -65.37 -47.15 77.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -59.27 -46.07 89.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 147' ' ' VAL . 85.0 t -53.19 -59.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.646 ' HA ' HD12 ' A' ' 155' ' ' LEU . 73.6 mt -48.88 -52.01 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.074 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.1 m -39.52 -34.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -83.44 -35.67 24.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 152' ' ' ILE . 68.9 mt -61.48 -49.53 76.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -50.01 -49.8 49.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -53.64 -43.36 68.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.8 -50.05 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.8 p -52.5 -21.64 3.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -58.18 -44.13 87.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.442 ' NE2' HD12 ' A' ' 164' ' ' ILE . 24.8 mt-30 -101.25 30.3 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.665 ' ND1' HG22 ' A' ' 168' ' ' THR . 7.4 p80 -45.48 -25.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -74.91 -36.61 62.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.442 HD12 ' NE2' ' A' ' 161' ' ' GLN . 77.0 mt -84.29 -56.41 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.47 ' HB2' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -81.08 16.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 165' ' ' ASN . 11.2 mt 34.49 54.78 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 7.7 mmm -150.12 108.39 3.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.665 HG22 ' ND1' ' A' ' 162' ' ' HIS . 72.4 p -94.09 157.76 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -38.67 -43.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -62.72 -58.73 6.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -45.6 -51.66 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.52 -30.78 70.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -75.69 -32.87 60.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.488 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 62.5 mt -78.24 -31.04 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.3 m -75.26 -34.05 61.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.606 ' CE2' HD21 ' A' ' 155' ' ' LEU . 12.0 m-85 -89.09 -40.75 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.623 ' CE3' ' O ' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.01 -56.81 0.7 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 0.0 110.948 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.513 ' HD3' ' CD1' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.02 -63.7 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.487 ' O ' ' C ' ' A' ' 180' ' ' LEU . 28.6 m -59.37 -56.09 26.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 177' ' ' TRP . 83.3 mt -31.34 -59.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.453 ' O ' ' C ' ' A' ' 182' ' ' ARG . 4.0 ttp -125.94 117.72 23.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 181' ' ' MET . 17.3 ttm180 -34.15 133.91 0.38 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 159.21 54.2 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.245 . . . . 0.0 112.359 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -51.52 149.37 4.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.572 ' CD2' ' HG3' ' A' ' 186' ' ' GLU . 9.6 p90 -84.9 -48.8 8.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.572 ' HG3' ' CD2' ' A' ' 185' ' ' PHE . 10.2 mt-10 -140.21 136.48 33.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -151.74 122.17 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 -24.39 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -82.35 107.21 14.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 190' ' ' PHE . 26.7 p90 -114.07 80.17 1.35 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 14.5 mt -150.25 134.21 16.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 m 47.71 44.45 17.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 95.7 m -76.46 90.8 3.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 78.4 p -60.47 131.08 49.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -86.45 44.76 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.857 ' O ' HG23 ' A' ' 200' ' ' VAL . 74.4 mt -80.38 -34.44 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.104 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -50.58 -50.82 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.21 -44.35 72.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 60.0 m -54.02 -48.31 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 196' ' ' ILE . 74.2 t -38.69 -56.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.54 -50.03 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -46.71 -45.38 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 204' ' ' PHE . 97.7 m -57.93 -61.77 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 203' ' ' THR . 11.8 m-85 -35.04 -47.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 152' ' ' ILE . 68.6 mt -67.64 -58.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 219' ' ' GLU . 18.2 mt-30 -46.37 -41.39 13.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.472 ' HG3' ' CD1' ' A' ' 130' ' ' LEU . 7.1 mm-40 -116.28 34.9 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.578 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 5.8 t -68.38 -22.77 64.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -85.38 -55.35 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -39.95 -34.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.0 m-85 -51.81 -63.18 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.864 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -104.98 -55.86 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -58.01 -22.53 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.929 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 57.35 38.12 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -81.18 143.4 23.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 216' ' ' GLU . 7.5 mp0 -41.98 145.04 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.36 143.56 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.26 170.32 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.417 ' CD ' ' O ' ' A' ' 219' ' ' GLU . 12.7 tm-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -108.97 177.34 4.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.4 t -132.69 86.56 2.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.62 132.21 2.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.463 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.2 m -67.11 122.25 17.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.823 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.0 t -136.77 110.91 8.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.87 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.97 -163.17 10.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -70.58 118.57 13.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -96.73 131.49 43.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 11' ' ' ASN . 10.8 p90 -174.16 179.06 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' PHE . 30.8 m-20 -36.35 143.88 0.28 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.634 0.73 . . . . 0.0 110.874 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 148.54 65.41 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.665 2.244 . . . . 0.0 112.357 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 177.62 5.41 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.712 2.274 . . . . 0.0 112.317 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -109.4 140.14 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -82.72 139.32 33.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 18' ' ' TRP . 6.2 tpt180 -86.28 -53.37 5.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ARG . 5.4 p-10 36.91 32.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.438 ' N ' ' O ' ' A' ' 16' ' ' ARG . 64.3 t-105 -130.19 59.39 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -54.04 111.82 0.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.602 ' O ' ' CE1' ' A' ' 23' ' ' PHE . 58.5 p -134.65 132.85 39.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.36 -5.11 6.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.531 ' CD2' ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -76.24 -60.62 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.602 ' CE1' ' O ' ' A' ' 20' ' ' SER . 21.6 m-85 46.99 30.44 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.36 47.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 15.2 mtm -91.21 144.97 30.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.59 0.71 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 151.9 69.32 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.384 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.53 -53.86 26.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.476 ' CB ' HG21 ' A' ' 143' ' ' VAL . 2.7 pt20 -46.21 -32.01 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -40.68 30.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.01 -43.79 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 36' ' ' PRO . 20.9 m -90.98 172.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.0 p -112.03 161.61 16.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.38 -44.78 72.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.39 -45.2 80.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -127.21 95.37 36.55 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' O ' HG21 ' A' ' 31' ' ' VAL . 54.2 Cg_endo -69.72 -38.03 8.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.577 HG23 ' HD2' ' A' ' 38' ' ' PRO . 10.2 mt -75.04 136.56 72.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.666 0.746 . . . . 0.0 111.114 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.73 169.51 18.72 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.706 2.27 . . . . 0.0 112.333 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.636 HD11 ' HE2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -84.69 -46.07 11.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.923 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -48.19 -64.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 97' ' ' LEU . 55.4 t -43.94 -65.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -39.77 -53.61 2.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HE2' HD11 ' A' ' 39' ' ' LEU . 48.7 mmtt -56.48 -37.19 70.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.692 ' HB2' HD13 ' A' ' 97' ' ' LEU . 69.4 m -69.16 -45.52 69.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.444 HG13 ' CG ' ' A' ' 154' ' ' HIS . 46.4 t -64.01 -49.1 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.96 -43.37 83.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.756 ' CZ ' HG21 ' A' ' 51' ' ' THR . 13.2 t80 -56.52 -61.39 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 44' ' ' CYS . 19.8 mt -41.05 -44.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' OE1' HD13 ' A' ' 53' ' ' LEU . 7.4 mm-40 -64.39 -42.32 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.19 -35.19 79.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.756 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 22.1 p -90.98 29.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.64 150.66 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 158' ' ' VAL . 11.9 tp -120.74 -34.51 3.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.916 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.1 p -56.36 -14.7 3.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.4 m -40.95 105.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -44.51 111.38 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.73 105.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 4.7 mp -105.88 -33.62 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -104.74 -55.63 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.969 ' HD3' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -59.37 -34.82 72.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.969 HG23 ' HD3' ' A' ' 60' ' ' ARG . 3.2 t -103.02 109.48 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 p -137.58 122.86 19.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.818 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.09 -130.33 1.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.529 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -40.91 156.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -103.93 -46.81 4.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.902 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ASP . 87.3 m -39.04 -42.79 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -41.92 -49.96 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.67 ' HG2' ' HB2' ' A' ' 96' ' ' ALA . 8.1 mt-30 -67.58 -28.83 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' THR . 3.0 t70 -53.23 -53.61 48.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 21.6 p30 -60.14 -38.8 84.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 68' ' ' GLN . 54.4 mt -49.92 -50.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.49 -61.01 2.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -46.04 -58.99 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -53.42 -42.04 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -64.66 -37.75 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.06 -49.13 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -76.81 -24.93 52.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -133.31 99.66 4.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -72.32 -29.32 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -91.49 34.91 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.761 HD11 ' SD ' ' A' ' 86' ' ' MET . 10.1 tt -77.98 150.13 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -118.38 93.61 4.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.6 mt -44.51 -42.08 6.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -52.81 -44.02 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 t -65.69 -27.71 68.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.761 ' SD ' HD11 ' A' ' 81' ' ' ILE . 62.6 mtp -70.96 -38.15 72.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 60.18 49.53 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 m -84.49 162.52 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' VAL . 66.8 p -67.23 115.18 6.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 51' ' ' THR . 60.9 t -33.65 -54.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.154 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -37.16 -49.33 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.468 ' HB1' ' HG3' ' A' ' 68' ' ' GLN . . . -55.05 -60.37 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.626 HG21 ' CE1' ' A' ' 47' ' ' PHE . 77.2 t -48.08 -62.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 58' ' ' LEU . . . -41.28 -35.0 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.15 -57.43 2.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.517 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.67 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -45.1 -43.66 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 111.066 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.692 HD13 ' HB2' ' A' ' 44' ' ' CYS . 34.3 tp -43.41 -45.29 6.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.582 ' HG2' ' CE1' ' A' ' 176' ' ' PHE . 28.5 mtmt -65.06 -46.82 79.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -43.67 -34.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -65.93 -38.76 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.84 -36.35 50.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.06 -39.31 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 0.4 OUTLIER -59.95 -37.52 79.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.8 mt -40.42 146.39 0.44 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.596 0.712 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 -21.67 32.99 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.336 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -142.82 155.07 63.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.542 0.687 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.74 48.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.568 HD12 HD22 ' A' ' 144' ' ' ASN . 9.0 tp -43.66 -40.85 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mt -83.37 128.7 63.35 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.676 0.75 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 147.05 62.09 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.722 2.282 . . . . 0.0 112.318 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.562 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 4.7 m-85 -64.66 -37.85 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.3 m -55.91 -15.11 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.8 mt -128.44 35.64 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.562 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 3.2 m170 -76.08 -63.32 0.62 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 0.0 110.859 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 54.0 Cg_endo -69.69 -10.3 28.27 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -74.7 -33.78 62.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.18 -36.15 66.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 115' ' ' PRO . 6.1 mt -73.91 -54.3 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -49.53 -33.06 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.66 -22.46 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.75 -33.81 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -71.45 -10.23 59.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.44 127.92 85.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.622 0.725 . . . . 0.0 111.137 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -44.77 1.88 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.667 2.244 . . . . 0.0 112.351 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.77 108.64 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -46.66 -55.99 6.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.602 HG22 ' CD2' ' A' ' 131' ' ' HIS . 2.6 m -57.34 -65.26 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -42.42 -56.35 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -38.62 -46.14 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.7 mt -69.27 -58.47 3.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.602 ' CD2' HG22 ' A' ' 127' ' ' THR . 50.7 m-70 -44.8 -51.85 9.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.97 -46.23 52.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 20.0 mt -68.53 -28.27 66.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -75.13 -32.54 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 5.2 pt-20 -84.04 -31.29 25.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 74.8 mt -75.26 -32.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.444 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.8 p -76.03 0.35 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.141 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -82.33 -41.13 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.25 22.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 2.3 m-85 -80.1 141.44 35.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.54 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.7 t-80 -39.91 141.94 0.73 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.604 0.716 . . . . 0.0 110.833 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.8 Cg_endo -69.81 -8.06 22.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.476 HG21 ' CB ' ' A' ' 28' ' ' GLN . 74.3 t -99.19 -48.33 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.568 HD22 HD12 ' A' ' 108' ' ' LEU . 30.5 m120 -73.47 -43.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -48.51 -42.19 32.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.95 -56.22 23.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 151' ' ' VAL . 63.8 t -63.63 -62.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.168 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.568 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 26.3 t80 -39.43 -39.94 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -70.43 -46.33 64.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.29 -36.66 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 147' ' ' VAL . 35.0 t -63.1 -64.69 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.078 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.719 HG23 HG12 ' A' ' 205' ' ' ILE . 80.2 mt -47.98 -52.1 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -40.94 -35.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.149 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.444 ' CG ' HG13 ' A' ' 45' ' ' VAL . 23.0 t60 -83.26 -40.91 18.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 176' ' ' PHE . 97.5 mt -54.47 -44.45 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -50.88 -45.34 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.457 ' HA ' ' NE2' ' A' ' 160' ' ' GLN . 72.0 mtt85 -55.77 -39.26 70.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.711 HG11 HD21 ' A' ' 172' ' ' LEU . 76.3 t -69.12 -38.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 p -64.32 -35.34 80.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 157' ' ' ARG . 38.7 mt-30 -54.51 -38.0 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.693 ' OE1' HD12 ' A' ' 164' ' ' ILE . 21.4 mm-40 -99.1 28.77 4.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.57 ' HB2' HG22 ' A' ' 168' ' ' THR . 9.8 p80 -54.6 -31.71 57.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.532 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 20.5 mmtp -73.54 -21.69 60.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.693 HD12 ' OE1' ' A' ' 161' ' ' GLN . 74.3 mt -95.37 -57.59 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -89.86 26.24 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 165' ' ' ASN . 14.2 mt 32.56 41.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 9.7 mmm -128.72 104.5 7.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.57 HG22 ' HB2' ' A' ' 162' ' ' HIS . 60.8 p -96.57 150.67 20.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -36.16 -33.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 168' ' ' THR . 10.0 t70 -63.84 -57.43 9.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -51.4 -57.15 9.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.711 HD21 HG11 ' A' ' 158' ' ' VAL . 10.6 mt -53.67 -29.01 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.0 t -81.13 -37.36 28.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.501 ' O ' ' CD ' ' A' ' 178' ' ' PRO . 70.1 mt -74.51 -24.78 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -75.27 -39.07 60.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.582 ' CE1' ' HG2' ' A' ' 98' ' ' LYS . 9.6 m-85 -88.99 -38.81 14.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.626 ' CE3' ' O ' ' A' ' 177' ' ' TRP . 0.1 OUTLIER -34.78 -56.7 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.563 0.696 . . . . 0.0 110.906 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.501 ' CD ' ' O ' ' A' ' 174' ' ' ILE . 65.7 Cg_exo -48.04 -52.37 8.37 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 180' ' ' LEU . 58.7 m -70.42 -62.0 1.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 179' ' ' THR . 95.9 mt -34.05 -45.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 13.6 mtm -145.5 133.32 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.462 ' CG ' ' HD2' ' A' ' 183' ' ' PRO . 27.7 ttp180 -41.27 139.91 1.29 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 110.884 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.531 ' HA ' ' CZ2' ' A' ' 177' ' ' TRP . 53.9 Cg_endo -69.77 132.62 23.7 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.708 2.272 . . . . 0.0 112.349 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -160.86 137.68 8.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -112.53 50.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -97.64 98.0 9.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -165.34 159.58 17.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.466 ' NE ' ' HG2' ' A' ' 189' ' ' GLU . 3.3 ppt_? -124.57 -22.36 4.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.466 ' HG2' ' NE ' ' A' ' 188' ' ' ARG . 8.8 mm-40 -80.02 107.75 13.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.491 ' CD2' HG22 ' A' ' 194' ' ' THR . 53.4 t80 -120.17 -54.19 2.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 90.6 mt -43.85 -59.92 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 78.5 p -56.29 -56.61 18.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 27.6 m -140.21 143.64 36.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.182 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.491 HG22 ' CD2' ' A' ' 190' ' ' PHE . 82.1 p -112.38 147.43 36.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.166 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 49.68 46.09 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 200' ' ' VAL . 91.0 mt -48.76 -55.32 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 196' ' ' ILE . 60.0 m-70 -35.79 -48.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -68.3 -60.14 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 200' ' ' VAL . 21.1 m -43.28 -41.47 3.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 196' ' ' ILE . 99.5 t -36.75 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' GLU . 90.6 t -68.86 -55.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -34.24 -49.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.5 m -55.68 -62.9 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 11.7 m-85 -35.71 -51.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.719 HG12 HG23 ' A' ' 152' ' ' ILE . 85.8 mt -60.48 -57.35 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.132 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.434 ' HB3' HG23 ' A' ' 218' ' ' VAL . 5.5 mt-30 -49.43 -52.31 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 5.9 mm-40 -101.72 30.69 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.486 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 1.4 t -65.34 -19.45 65.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 213' ' ' TYR . 32.7 mm-40 -87.9 -45.89 9.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -37.17 20.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.486 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -50.71 -63.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -104.77 -55.45 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 209' ' ' GLN . 52.2 m-85 -58.25 -25.1 61.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 57.47 45.21 20.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -83.73 -179.04 52.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.64 147.93 44.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.457 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 45.8 mt -75.13 139.67 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.145 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 206' ' ' GLN . 27.2 m -124.05 177.68 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.3 m -144.43 161.97 37.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.3 p -171.5 173.37 4.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.82 167.61 39.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.454 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.5 p -168.39 177.6 5.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.897 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.6 p -154.04 169.15 24.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.97 147.11 5.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.485 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -166.4 159.85 15.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -161.35 138.77 8.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 10' ' ' PHE . 34.0 p90 -88.96 86.2 6.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -155.0 134.26 7.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 152.1 69.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.684 2.256 . . . . 0.0 112.317 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 150.34 67.91 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.649 2.233 . . . . 0.0 112.324 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.3 p -119.48 163.18 17.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -128.86 -1.53 5.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -157.11 118.92 3.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -109.37 30.28 6.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.524 ' CZ2' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -125.58 43.09 3.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -123.83 173.36 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.5 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 63.7 m -134.25 178.96 6.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -103.93 -33.9 8.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -53.76 -41.41 67.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' CD1' ' O ' ' A' ' 20' ' ' SER . 1.6 p90 -52.26 -26.2 11.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.66 -39.23 8.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.9 mmt -89.39 154.81 48.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.573 0.701 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 158.58 56.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.326 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.473 ' O ' HG22 ' A' ' 31' ' ' VAL . 9.8 tp -72.39 -48.47 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.799 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -48.7 -25.27 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.49 -49.4 12.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.29 -43.81 97.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 27' ' ' LEU . 19.9 m -94.98 156.43 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.4 p -105.25 162.5 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.58 -39.02 61.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -63.45 -45.62 90.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -128.17 81.74 69.87 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -31.33 20.75 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.712 2.275 . . . . 0.0 112.359 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 147' ' ' VAL . 62.1 mt -82.4 127.82 69.49 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.563 0.696 . . . . 0.0 111.139 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 161.67 45.03 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.683 2.256 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.595 HD13 ' HG2' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.63 -56.33 5.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -38.6 -63.83 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.729 HG13 HD11 ' A' ' 97' ' ' LEU . 55.1 t -44.95 -58.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -48.79 -59.93 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HG2' HD13 ' A' ' 39' ' ' LEU . 51.3 mmtt -43.52 -39.8 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.84 -48.87 57.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 150' ' ' TYR . 64.2 t -58.71 -45.59 90.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CD ' ' HA ' ' A' ' 43' ' ' LYS . 11.7 pt-20 -67.22 -41.31 85.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 1.025 ' CE1' HG21 ' A' ' 93' ' ' VAL . 17.7 t80 -53.02 -63.39 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 94' ' ' ALA . 98.1 mt -39.98 -48.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.05 -43.52 98.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.23 -41.03 96.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 90' ' ' VAL . 13.2 t -85.66 28.55 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.141 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.52 165.07 24.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.42 41.52 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 p -129.12 43.36 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -95.09 136.52 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.176 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -81.42 117.88 22.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.4 99.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.837 HD13 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.13 -0.41 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CE1' ' HB1' ' A' ' 94' ' ' ALA . 15.7 m-85 -123.11 -38.31 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -85.0 -29.3 25.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.47 132.99 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.5 p -93.61 -68.72 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.73 -103.91 2.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.474 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -100.28 -44.73 5.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.368 . . . . 0.0 110.895 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt 57.05 25.25 10.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.3 m -91.54 -30.66 16.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.489 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 51.4 m-20 -60.6 -53.36 58.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.68 ' HA ' HD12 ' A' ' 71' ' ' ILE . 44.2 mt-30 -49.12 -40.73 33.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.52 -68.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 24.8 p30 -59.82 -39.5 85.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 68' ' ' GLN . 45.4 mt -43.93 -44.15 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -77.45 -46.28 23.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.524 ' HG3' ' CZ2' ' A' ' 18' ' ' TRP . 6.3 mtpp -56.95 -63.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -43.2 -44.62 5.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.13 -42.12 97.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.08 -46.25 88.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -61.63 -36.22 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -158.34 154.78 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.6 m170 -102.06 -20.69 14.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.47 54.85 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 pt -118.78 -178.8 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -144.69 145.12 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.4 mt -89.15 -42.59 11.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.01 -53.18 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -50.33 -46.58 55.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.6 mtp -52.97 -28.53 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 53.23 41.45 32.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.66 163.95 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.567 HG23 ' H ' ' A' ' 92' ' ' ALA . 13.8 t -70.91 149.38 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.425 HG22 HG21 ' A' ' 51' ' ' THR . 75.6 t -59.98 -54.41 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -40.19 -39.52 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.567 ' H ' HG23 ' A' ' 89' ' ' THR . . . -62.1 -64.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.025 HG21 ' CE1' ' A' ' 47' ' ' PHE . 94.1 t -45.28 -50.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . -43.89 -51.89 7.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.119 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.408 ' C ' ' OE1' ' A' ' 68' ' ' GLN . . . -65.19 -47.31 82.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.678 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -46.32 -48.84 18.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.064 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.729 HD11 HG13 ' A' ' 41' ' ' VAL . 8.2 tp -48.84 -50.01 36.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HD3' ' CD2' ' A' ' 176' ' ' PHE . 43.9 mtmt -65.61 -46.76 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.56 -47.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.66 -53.29 60.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -53.5 -50.25 65.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.85 -42.76 65.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.437 ' OD1' ' CB ' ' A' ' 23' ' ' PHE . 13.1 t0 -52.51 -42.13 64.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 103' ' ' ASP . 80.5 mt -36.62 141.04 0.39 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -18.89 36.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.79 152.68 56.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.674 0.75 . . . . 0.0 110.859 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.8 Cg_endo -69.73 134.82 28.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 107' ' ' PRO . 5.4 tp -33.95 -52.87 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.0 mt -73.86 127.0 89.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.634 0.731 . . . . 0.0 111.161 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.571 ' HG2' HD12 ' A' ' 113' ' ' LEU . 53.6 Cg_endo -69.76 143.93 52.4 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.272 . . . . 0.0 112.331 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.538 ' CD1' ' CE1' ' A' ' 114' ' ' HIS . 4.1 m-85 -59.71 -32.16 70.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 t -59.29 -24.07 62.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.571 HD12 ' HG2' ' A' ' 110' ' ' PRO . 18.1 mt -117.64 30.21 7.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.538 ' CE1' ' CD1' ' A' ' 111' ' ' TYR . 3.6 m170 -75.03 -62.42 0.87 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.642 0.734 . . . . 0.0 110.849 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 114' ' ' HIS . 53.4 Cg_endo -69.78 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -81.04 -30.76 34.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mt -74.22 -38.15 63.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.544 HD23 HG21 ' A' ' 200' ' ' VAL . 10.2 mt -75.39 -59.81 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -40.35 -33.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.509 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -84.27 -33.99 23.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.076 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . -67.16 -26.39 66.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -87.0 26.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 120' ' ' ALA . 95.3 mt -95.64 130.76 30.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 111.182 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -46.63 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 0.0 112.372 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 126' ' ' LYS . 61.9 m-20 -60.39 91.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 125' ' ' ASP . 32.8 tttt -34.7 -56.49 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.0 m -53.1 -58.58 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.65 -57.73 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -39.92 -56.96 1.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.2 mt -55.76 -56.77 16.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -48.64 -38.48 21.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.509 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -63.34 -40.03 96.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 19.5 mt -77.19 -24.35 51.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 138' ' ' LYS . 40.1 tttp -81.67 -23.62 36.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.04 -33.9 16.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.546 HG22 ' HE1' ' A' ' 140' ' ' PHE . 48.5 mt -74.83 -26.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.602 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 6.1 p -77.93 -11.16 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 134' ' ' LYS . 27.9 mttm -74.74 -41.7 59.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -81.39 19.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.1 m-85 -80.73 138.03 36.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 3.6 t-80 -38.06 142.64 0.45 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.75 -7.72 21.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.362 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 28' ' ' GLN . 92.8 t -99.75 -39.11 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.77 -46.48 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.467 ' CE2' ' O ' ' A' ' 137' ' ' VAL . 1.3 t80 -41.83 -54.56 3.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.34 -65.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 151' ' ' VAL . 66.3 t -50.52 -40.58 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.575 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 3.9 t80 -51.07 -48.54 61.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -58.14 -58.35 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.429 ' CE2' HG21 ' A' ' 45' ' ' VAL . 37.8 t80 -52.58 -45.06 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 147' ' ' VAL . 94.8 t -56.51 -66.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.66 HG23 HG12 ' A' ' 205' ' ' ILE . 64.3 mt -54.22 -56.16 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.9 m -41.09 -34.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -76.89 -42.73 38.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.632 HD13 HD11 ' A' ' 205' ' ' ILE . 30.5 mt -60.81 -51.83 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -45.12 -44.27 10.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 56.7 mtt-85 -56.96 -50.47 72.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.23 -50.17 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 p -51.58 -29.67 18.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 157' ' ' ARG . 35.2 mm-40 -46.51 -57.39 4.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -100.58 41.63 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.511 ' ND1' HG22 ' A' ' 168' ' ' THR . 27.3 p80 -57.81 -21.44 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -71.06 -34.15 70.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 90.8 mt -82.83 -58.76 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.088 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -79.58 12.84 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 15.2 mt 38.11 53.86 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.435 ' O ' ' CB ' ' A' ' 162' ' ' HIS . 19.7 mmm -148.53 108.05 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.511 HG22 ' ND1' ' A' ' 162' ' ' HIS . 30.5 p -92.22 166.77 12.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' A' ' 172' ' ' LEU . . . -53.27 -34.25 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.439 ' CG ' ' HG3' ' A' ' 202' ' ' GLU . 1.1 m-20 -70.38 -48.49 56.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -55.82 -35.9 66.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 169' ' ' ALA . 8.6 mt -69.8 -46.9 64.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.2 t -53.9 -38.96 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.403 HG12 ' CD ' ' A' ' 198' ' ' GLN . 15.7 mt -78.95 -33.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.6 m -70.58 -25.6 63.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.51 ' CD2' ' HD3' ' A' ' 98' ' ' LYS . 21.4 m-85 -97.72 -16.8 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.564 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -46.69 -47.16 50.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.567 0.699 . . . . 0.0 110.901 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.1 Cg_exo -48.03 -48.6 15.95 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.692 2.262 . . . . 0.0 112.31 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 180' ' ' LEU . 76.0 m -84.02 -64.48 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 179' ' ' THR . 49.8 mt -34.61 -63.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 46.2 mmm -111.16 117.37 33.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.4 ' HD3' ' N ' ' A' ' 183' ' ' PRO . 1.3 tmt_? -42.55 132.18 2.86 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.4 ' N ' ' HD3' ' A' ' 182' ' ' ARG . 53.7 Cg_endo -69.74 120.49 7.27 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.668 2.245 . . . . 0.0 112.373 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.58 130.89 38.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -78.58 -52.12 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.77 93.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -118.54 150.04 40.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -155.21 145.59 22.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -153.53 168.25 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -164.65 118.49 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 62.7 mt 38.59 42.32 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 67.1 m -150.38 153.21 35.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 8.2 t -90.05 -23.04 21.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.168 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.552 ' O ' HG22 ' A' ' 194' ' ' THR . 21.5 m 43.06 42.73 3.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -92.97 39.64 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 36.5 mt -86.4 -56.79 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.452 ' ND1' HD21 ' A' ' 118' ' ' LEU . 53.3 m-70 -42.58 -60.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.403 ' CD ' HG12 ' A' ' 174' ' ' ILE . 93.2 mt-30 -49.64 -44.52 47.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.0 m -60.64 -42.71 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.544 HG21 HD23 ' A' ' 118' ' ' LEU . 90.9 t -38.08 -69.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 202' ' ' GLU . 60.3 t -62.32 -55.88 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.439 ' HG3' ' CG ' ' A' ' 170' ' ' ASP . 2.1 tm-20 -37.88 -40.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 204' ' ' PHE . 65.8 m -64.9 -60.87 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.12 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' CYS . 12.3 m-85 -34.11 -54.11 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.66 HG12 HG23 ' A' ' 152' ' ' ILE . 68.0 mt -61.85 -56.59 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -46.38 -49.65 17.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 7.7 mm-40 -109.51 34.19 3.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 4.2 t -65.79 -19.72 65.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.889 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.441 ' HA ' ' NE2' ' A' ' 209' ' ' GLN . 3.7 mm-40 -84.94 -54.98 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.87 -38.63 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 24.0 m-85 -47.47 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.13 -53.7 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -58.5 -25.12 62.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 58.68 43.15 19.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 216' ' ' GLU . . . -87.36 144.17 19.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 215' ' ' GLY . 10.1 mm-40 -35.14 149.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.474 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 68.6 mt -74.29 133.81 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.176 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.5 172.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 t -168.25 147.95 4.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.872 0.367 . . . . 0.0 110.85 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.0 p -148.13 179.7 7.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.8 -153.78 6.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 t -169.73 175.9 5.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 110.867 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 t -159.44 178.39 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.49 170.22 29.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.502 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.9 138.28 6.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 10' ' ' PHE . 5.8 p-10 -120.69 141.6 50.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 9' ' ' ASN . 15.5 m-85 -167.7 116.74 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.841 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -116.43 143.59 31.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.649 0.738 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 161.26 46.63 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.637 2.225 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 153.34 69.04 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.701 2.268 . . . . 0.0 112.313 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -127.03 155.12 43.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -75.63 -179.56 4.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -61.7 109.22 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -104.74 31.5 4.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -88.02 49.55 1.82 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.952 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -113.09 107.15 15.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -119.39 175.68 5.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.528 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -132.06 33.25 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.646 ' CD2' HD22 ' A' ' 30' ' ' LEU . 5.6 m-85 -104.74 -39.16 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CG ' ' N ' ' A' ' 24' ' ' GLY . 11.4 p90 -52.77 -41.35 64.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' PHE . . . -67.59 -41.29 90.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.06 145.84 61.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.548 0.69 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 154.12 67.79 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.659 2.24 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 tp -47.54 -46.81 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.86 ' HB3' HG21 ' A' ' 143' ' ' VAL . 6.3 pt20 -53.07 -30.4 35.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -46.02 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.646 HD22 ' CD2' ' A' ' 22' ' ' TYR . 20.8 mt -59.83 -44.11 94.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG11 ' O ' ' A' ' 36' ' ' PRO . 5.2 m -90.43 171.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 p -118.95 156.26 29.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -46.9 -45.97 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -59.66 -46.21 89.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -126.58 86.73 57.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.551 ' O ' HG11 ' A' ' 31' ' ' VAL . 53.3 Cg_endo -69.81 -29.89 22.91 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.684 2.256 . . . . 0.0 112.361 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.492 HG23 ' HD2' ' A' ' 38' ' ' PRO . 7.8 mt -84.16 134.51 43.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 111.154 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.71 146.81 61.62 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.538 HD11 ' CE ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -67.17 -40.81 86.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -51.6 -60.88 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG13 HD11 ' A' ' 97' ' ' LEU . 74.1 t -49.24 -63.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -40.61 -55.43 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.538 ' CE ' HD11 ' A' ' 39' ' ' LEU . 40.9 mmtt -55.87 -41.21 74.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.683 ' HB2' HD13 ' A' ' 97' ' ' LEU . 94.5 m -61.33 -40.71 95.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.656 HG13 ' CG ' ' A' ' 154' ' ' HIS . 25.2 t -71.22 -54.85 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -50.33 -33.69 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' A' ' 93' ' ' VAL . 19.5 t80 -60.74 -62.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.8 mt -47.34 -43.04 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.14 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.95 -26.51 59.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.35 -22.4 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -110.75 11.62 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 164.02 6.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HG ' HG22 ' A' ' 158' ' ' VAL . 1.7 mm? -107.83 75.15 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -25.08 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -51.34 117.22 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.33 117.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.7 94.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.471 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.643 HD23 ' H ' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -101.75 -34.73 9.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.7 -63.96 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.618 ' CD ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.34 -16.22 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.618 HG23 ' CD ' ' A' ' 60' ' ' ARG . 76.2 t -101.57 120.28 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.4 p -98.44 120.76 39.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.19 -161.06 10.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.459 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -80.18 126.92 31.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.918 0.39 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 36.3 tptt -43.96 -29.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -57.46 -43.44 83.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . 6.2 m-20 -54.66 -60.49 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.845 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -59.92 -44.78 94.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -41.62 -49.5 4.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 16.1 p30 -73.17 -34.78 66.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 68' ' ' GLN . 52.1 mt -55.4 -45.97 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -79.57 -48.63 13.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -57.46 -59.27 5.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -50.26 -48.24 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.4 ' O ' ' O ' ' A' ' 78' ' ' ASP . 40.8 t80 -50.01 -56.05 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -54.59 -33.11 59.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -81.72 -18.41 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 75' ' ' PHE . 5.2 t0 -149.53 118.87 6.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -83.75 -24.23 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -98.57 36.38 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.771 HD11 ' SD ' ' A' ' 86' ' ' MET . 6.0 tt -79.73 151.76 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -124.24 94.53 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.7 mt -40.55 -44.39 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.0 t -49.05 -47.88 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 t -58.11 -43.22 87.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.771 ' SD ' HD11 ' A' ' 81' ' ' ILE . 85.4 mtp -59.03 -36.13 74.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 59.28 44.75 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -80.18 173.84 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.9 p -69.11 111.88 5.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.5 t -37.44 -50.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -45.36 -45.44 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 67' ' ' ASP . . . -52.37 -63.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.082 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 47' ' ' PHE . 95.5 t -45.83 -44.85 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.95 -38.59 67.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.58 -56.29 3.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 68' ' ' GLN . . . -45.87 -36.92 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 111.099 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 44' ' ' CYS . 16.8 tp -60.08 -47.39 86.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -65.96 -38.73 89.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.44 -36.87 55.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.093 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -62.9 -40.69 98.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.53 ' HB2' HG21 ' A' ' 179' ' ' THR . 5.1 m-85 -63.02 -41.68 99.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.07 80.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -34.31 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -41.48 147.4 0.48 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -28.71 24.8 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.94 139.47 16.07 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.605 0.717 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 108' ' ' LEU . 53.9 Cg_endo -69.77 136.51 33.16 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.674 2.249 . . . . 0.0 112.321 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.45 HD23 ' CD1' ' A' ' 148' ' ' PHE . 5.5 mp -34.97 -49.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.2 mt -91.51 107.41 21.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 0.0 111.133 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.497 ' HG2' HD12 ' A' ' 113' ' ' LEU . 54.1 Cg_endo -69.72 149.42 67.15 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.407 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 0.7 OUTLIER -62.48 -27.42 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 m -66.02 -8.19 21.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.497 HD12 ' HG2' ' A' ' 110' ' ' PRO . 70.4 mt -128.39 21.7 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.501 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.1 m170 -67.93 -60.13 5.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 0.0 110.81 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.516 ' HA ' HD12 ' A' ' 118' ' ' LEU . 53.7 Cg_endo -69.78 -25.15 28.8 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.93 -27.35 67.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.778 ' HB3' HG11 ' A' ' 200' ' ' VAL . 3.4 mt -78.77 -18.71 53.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.941 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.532 HD23 HG21 ' A' ' 200' ' ' VAL . 10.6 mt -92.56 -47.83 6.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -48.29 -40.37 24.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.599 ' HB1' ' CB ' ' A' ' 132' ' ' ALA . . . -83.73 -20.47 33.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 200' ' ' VAL . . . -77.61 -21.79 51.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -93.8 17.87 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 128' ' ' GLU . 96.5 mt -81.73 129.58 64.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 111.145 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -44.79 1.87 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.317 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 126' ' ' LYS . 2.2 t70 -67.02 94.08 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.838 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 125' ' ' ASP . 18.0 tptp -34.64 -50.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.2 m -52.5 -57.76 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.498 ' HB2' HG21 ' A' ' 123' ' ' ILE . 17.8 mm-40 -56.74 -49.18 75.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -45.74 -53.98 8.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.431 ' CD2' ' HG3' ' A' ' 207' ' ' GLN . 37.3 mt -65.57 -62.24 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -41.82 -28.65 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.599 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -75.52 -50.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 204' ' ' PHE . 13.5 mt -65.77 -22.81 66.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 137' ' ' VAL . 39.7 tttp -81.94 -30.61 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.926 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -85.89 -29.75 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.478 ' HA ' ' CD1' ' A' ' 140' ' ' PHE . 11.1 p -86.66 -6.48 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -77.78 -41.57 36.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -16.06 62.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 3.1 m-85 -46.82 151.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 142' ' ' PRO . 1.9 t-80 -42.46 138.32 2.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 141' ' ' HIS . 53.6 Cg_endo -69.74 -20.72 34.59 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.35 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.86 HG21 ' HB3' ' A' ' 28' ' ' GLN . 43.4 t -92.27 -44.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.406 HD22 HD12 ' A' ' 108' ' ' LEU . 2.7 m120 -73.9 -48.06 33.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -39.24 -53.71 1.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -47.65 -48.93 28.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 151' ' ' VAL . 30.5 t -69.26 -57.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.159 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.488 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 10.7 t80 -42.24 -45.5 4.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -60.85 -53.59 55.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -54.57 -43.83 72.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 147' ' ' VAL . 82.0 t -52.61 -62.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.154 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.49 ' HA ' HD12 ' A' ' 155' ' ' LEU . 3.3 mt -46.49 -51.13 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.4 m -40.93 -37.91 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.656 ' CG ' HG13 ' A' ' 45' ' ' VAL . 84.6 t60 -80.26 -39.2 29.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.575 HD21 ' CE2' ' A' ' 176' ' ' PHE . 96.6 mt -54.52 -45.85 73.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -51.22 -49.82 60.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -51.79 -53.24 42.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.43 HG22 ' HG ' ' A' ' 53' ' ' LEU . 41.0 t -60.24 -35.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.8 p -66.24 -22.34 66.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -73.98 -31.59 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.476 HE21 HD12 ' A' ' 164' ' ' ILE . 3.1 mm100 -95.78 27.7 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.519 ' CE1' ' HG2' ' A' ' 163' ' ' LYS . 11.1 p80 -60.11 -16.47 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.827 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 162' ' ' HIS . 14.0 mmmt -86.5 -5.53 59.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.476 HD12 HE21 ' A' ' 161' ' ' GLN . 26.2 mt -115.33 -60.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -83.37 9.31 11.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.8 mt 47.46 43.95 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 23.2 mtp -129.96 106.26 8.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.473 HG22 ' CG ' ' A' ' 162' ' ' HIS . 78.1 p -97.57 151.24 20.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' THR . . . -34.77 -35.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 168' ' ' THR . 2.1 t70 -66.04 -60.45 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -47.81 -49.07 30.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 7.4 mt -62.13 -49.06 77.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 t -51.71 -43.57 62.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -77.0 -38.01 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 t -64.19 -16.0 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.575 ' CE2' HD21 ' A' ' 155' ' ' LEU . 9.9 m-85 -107.16 -11.72 15.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.565 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -52.23 -46.77 93.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.526 0.679 . . . . 0.0 110.896 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 65.5 Cg_exo -48.0 -63.59 0.3 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.53 HG21 ' HB2' ' A' ' 101' ' ' PHE . 28.9 m -67.04 -57.97 5.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 179' ' ' THR . 39.9 mt -34.22 -51.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.432 ' SD ' ' CZ2' ' A' ' 177' ' ' TRP . 0.6 OUTLIER -152.52 119.2 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.427 ' CG ' ' HD2' ' A' ' 183' ' ' PRO . 42.7 ttm-85 -61.4 138.18 94.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 182' ' ' ARG . 54.1 Cg_endo -69.73 142.57 48.44 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.676 2.25 . . . . 0.0 112.36 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -42.4 147.53 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -38.21 -43.2 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -146.56 147.84 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -115.3 121.7 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 154.45 39.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -94.64 106.09 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -146.15 161.6 39.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 61.1 mt -44.11 112.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 56.9 p -87.28 51.91 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 16.6 p -80.28 -53.44 6.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 194' ' ' THR . 10.8 t -79.56 117.22 20.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -119.25 73.48 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 200' ' ' VAL . 71.4 mt -92.82 -37.99 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.475 ' HA ' HD21 ' A' ' 118' ' ' LEU . 32.8 m80 -41.35 -47.95 3.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -73.43 -56.24 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.0 m -42.09 -39.34 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 196' ' ' ILE . 58.2 t -46.6 -72.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' PHE . 68.9 t -55.04 -57.34 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -39.84 -36.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 60.3 m -69.86 -39.05 76.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.189 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' VAL . 12.2 m-85 -55.53 -41.79 73.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.15 -54.28 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.06 -56.17 25.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.431 ' HG3' ' CD2' ' A' ' 130' ' ' LEU . 38.4 mm-40 -81.9 16.9 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.583 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 18.2 t -58.55 -22.74 56.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.92 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.582 ' N ' ' CD ' ' A' ' 209' ' ' GLN . 0.2 OUTLIER -78.59 -62.51 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -39.5 -39.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 17.4 m-30 -52.2 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -107.57 -52.17 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 209' ' ' GLN . 65.4 m-85 -62.22 -11.71 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 61.3 t30 45.78 41.04 7.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -70.46 -151.35 0.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.435 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.07 165.98 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.0 mt -75.56 121.57 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.9 175.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 p -143.68 135.63 26.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.888 0.375 . . . . 0.0 110.85 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 t -158.79 127.27 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.93 88.37 1.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.1 t -47.27 126.45 9.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.843 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.0 p -130.78 171.99 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.24 119.22 0.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -45.22 139.11 3.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -93.31 159.0 15.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 11' ' ' ASN . 1.9 p90 -120.47 173.32 7.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.411 ' O ' ' CD2' ' A' ' 10' ' ' PHE . 16.4 m120 -86.27 142.08 35.38 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.674 0.75 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 169.5 18.84 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -174.33 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.385 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.2 p -81.15 89.46 6.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -164.49 145.45 8.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.5 ttp-105 -138.12 161.92 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -123.05 27.01 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -115.69 94.02 4.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.73 124.45 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -118.57 -7.75 10.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 60.3 43.76 13.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 23' ' ' PHE . 4.2 p90 -134.95 -44.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' N ' ' CG ' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -67.87 125.86 27.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.896 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.81 -37.08 3.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.8 mmt -84.42 154.23 62.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.581 0.705 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 148.63 65.44 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.681 2.254 . . . . 0.0 112.327 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' VAL . 18.3 tp -64.78 -49.25 71.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HA ' HG11 ' A' ' 143' ' ' VAL . 2.9 pt20 -43.87 -37.2 2.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.91 -50.58 33.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.26 -45.49 83.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 27' ' ' LEU . 33.8 m -91.74 171.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.1 p -120.28 158.06 27.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.21 -46.27 45.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.51 -44.28 72.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -132.1 90.4 35.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -37.97 8.45 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.7 mt -72.8 130.25 85.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 147' ' ' VAL . 54.0 Cg_endo -69.79 108.8 2.16 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.316 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.492 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -36.04 -57.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 39' ' ' LEU . 31.0 t80 -34.21 -64.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 HD11 ' A' ' 97' ' ' LEU . 79.7 t -43.82 -59.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -42.91 -61.94 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' HG2' ' CD1' ' A' ' 39' ' ' LEU . 64.0 mmtt -43.53 -41.09 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 93.9 m -68.35 -41.35 80.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.487 HG13 ' CG ' ' A' ' 154' ' ' HIS . 76.3 t -65.94 -51.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -62.67 -45.28 93.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' A' ' 93' ' ' VAL . 32.5 t80 -45.69 -57.14 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.8 mt -45.27 -44.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.546 ' OE1' HD13 ' A' ' 53' ' ' LEU . 19.0 mm-40 -62.4 -57.41 11.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.65 -39.38 35.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -84.51 29.93 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.44 164.19 21.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.486 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.546 HD13 ' OE1' ' A' ' 49' ' ' GLU . 11.6 tp -126.81 41.04 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.748 0.309 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -124.38 37.99 4.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.6 m -98.75 128.38 44.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.36 145.75 29.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.75 45.24 4.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.535 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 58' ' ' LEU . 2.2 pt? -58.41 -37.96 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.45 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 60.7 m-85 -99.18 -51.95 3.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -44.03 -54.24 5.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.4 t -69.79 135.64 27.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.18 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.8 p -79.84 -44.85 19.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.76 -163.15 53.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -59.52 178.22 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.956 0.408 . . . . 0.0 110.871 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -119.3 -46.84 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.7 m -47.67 -63.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.512 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 2.5 m-20 -41.26 -61.23 1.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.863 ' HA ' HD12 ' A' ' 71' ' ' ILE . 11.9 mt-30 -40.8 -40.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -67.17 -50.41 61.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -50.29 -47.22 55.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.863 HD12 ' HA ' ' A' ' 68' ' ' GLN . 28.4 mt -44.77 -43.9 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.118 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -82.82 -52.26 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -52.85 -62.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.27 -45.65 34.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.57 -44.23 97.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -63.32 -53.3 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -52.25 -39.27 60.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.23 152.58 22.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.78 -22.19 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.84 51.73 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.0 pt -107.19 -174.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 0.3 OUTLIER -151.03 119.32 6.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.26 -50.87 64.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.54 -40.92 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 68.6 m -60.39 -45.49 93.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.3 mtp -52.74 -32.44 43.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 60.86 45.66 9.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.01 168.87 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 90' ' ' VAL . 24.9 p -75.29 116.33 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 89' ' ' THR . 85.2 t -33.75 -54.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.092 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -36.12 -57.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -39.04 -59.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 47' ' ' PHE . 96.9 t -46.01 -55.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 59' ' ' TYR . . . -46.17 -44.48 16.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.24 -60.26 6.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.511 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.05 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HG13 ' A' ' 41' ' ' VAL . 23.5 tp -53.47 -48.94 68.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 101' ' ' PHE . 29.7 mtmt -69.26 -52.5 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 98' ' ' LYS . . . -36.8 -42.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.123 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -59.16 -47.74 84.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' LYS . 16.2 m-85 -56.18 -51.45 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.48 71.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 104' ' ' LEU . 64.4 m-20 -51.3 -42.77 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 103' ' ' ASP . 92.6 mt -34.22 142.26 0.23 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -22.89 31.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -134.7 152.93 78.5 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.582 0.706 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 132.06 22.47 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.34 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -38.47 -47.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 mt -91.87 121.31 67.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 0.0 111.15 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.63 40.86 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.581 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 8.7 m-85 -54.68 -34.31 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.402 ' O ' ' OE1' ' A' ' 116' ' ' GLU . 22.2 m -55.56 -29.15 58.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.2 mt -110.8 36.16 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.581 ' CD2' ' HA ' ' A' ' 111' ' ' TYR . 2.1 m170 -79.13 -65.49 0.3 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.632 0.73 . . . . 0.0 110.879 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.679 ' HA ' HD12 ' A' ' 118' ' ' LEU . 54.3 Cg_endo -69.74 -31.89 19.72 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.382 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 112' ' ' SER . 24.5 mp0 -60.47 -35.38 75.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.544 HD11 ' HZ ' ' A' ' 140' ' ' PHE . 12.1 mt -72.14 -39.46 68.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.679 HD12 ' HA ' ' A' ' 115' ' ' PRO . 4.9 mt -70.45 -55.48 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 13.6 pt-20 -46.82 -36.22 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 123' ' ' ILE . . . -75.99 -25.78 56.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 200' ' ' VAL . . . -78.15 -28.68 48.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 119' ' ' GLU . 2.4 pttt -90.47 27.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.525 HG23 ' HD2' ' A' ' 124' ' ' PRO . 89.0 mt -89.5 135.18 31.26 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.654 0.74 . . . . 0.0 111.109 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.525 ' HD2' HG23 ' A' ' 123' ' ' ILE . 53.3 Cg_endo -69.82 -48.64 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.647 2.231 . . . . 0.0 112.345 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -66.15 95.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 125' ' ' ASP . 14.1 tptm -36.82 -53.44 0.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 50.7 m -52.23 -51.32 59.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -60.31 -49.05 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -47.2 -49.7 22.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.93 -62.65 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -40.43 -50.84 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.29 48.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.0 mt -63.03 -34.12 76.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.55 ' O ' HG12 ' A' ' 137' ' ' VAL . 23.0 tttm -68.32 -35.93 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 136' ' ' ILE . 4.0 pt-20 -81.8 -32.7 31.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.474 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 51.0 mt -73.2 -34.77 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 134' ' ' LYS . 8.4 p -67.35 -18.6 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.88 -34.48 75.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -66.95 -34.97 78.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.544 ' HZ ' HD11 ' A' ' 117' ' ' LEU . 11.8 m-85 -42.66 132.39 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -33.47 142.68 0.19 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 141' ' ' HIS . 53.9 Cg_endo -69.82 -16.94 37.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 28' ' ' GLN . 91.9 t -90.94 -39.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.15 -38.26 24.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.418 ' CZ ' ' HD3' ' A' ' 149' ' ' ARG . 46.3 t80 -52.47 -42.26 64.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.97 -42.44 80.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.84 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 151' ' ' VAL . 98.9 t -74.31 -44.37 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.581 ' CZ ' HD11 ' A' ' 152' ' ' ILE . 26.2 t80 -58.76 -40.92 85.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.854 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.418 ' HD3' ' CZ ' ' A' ' 145' ' ' TYR . 47.2 ttp180 -67.62 -49.95 60.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -60.8 -47.66 85.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 147' ' ' VAL . 93.2 t -50.83 -65.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.139 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.839 HG23 HG12 ' A' ' 205' ' ' ILE . 75.8 mt -41.97 -50.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.7 m -40.51 -40.8 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.487 ' CG ' HG13 ' A' ' 45' ' ' VAL . 85.7 t60 -73.46 -40.14 64.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 152' ' ' ILE . 51.1 mt -59.65 -44.03 93.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.454 ' HB2' HG23 ' A' ' 205' ' ' ILE . 52.4 t-20 -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -58.93 -48.22 82.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.5 t -55.04 -46.86 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.3 p -56.57 -29.43 62.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -47.48 -56.35 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -100.45 33.73 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.598 ' CE1' ' HD3' ' A' ' 163' ' ' LYS . 7.3 p80 -51.62 -19.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.598 ' HD3' ' CE1' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -55.31 -34.68 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.49 -56.46 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -27.16 68.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 75.8 mt 64.12 39.4 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 47.6 mmm -131.52 82.75 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 32.8 p -71.99 163.43 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -43.14 -46.74 5.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.437 ' OD1' HD11 ' A' ' 174' ' ' ILE . 6.7 t70 -60.25 -59.61 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -47.53 -50.01 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.35 -47.75 78.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.6 t -59.1 -44.58 91.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.437 HD11 ' OD1' ' A' ' 170' ' ' ASP . 57.9 mt -70.25 -31.49 47.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 48.9 t -70.79 -34.8 72.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.483 ' CE1' HD21 ' A' ' 155' ' ' LEU . 22.7 m-85 -90.23 -15.55 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.559 ' CZ3' ' HG2' ' A' ' 181' ' ' MET . 0.8 OUTLIER -47.55 -46.67 60.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.926 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' TRP . 66.3 Cg_exo -48.04 -51.66 9.58 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.461 ' O ' ' C ' ' A' ' 180' ' ' LEU . 89.6 m -76.44 -63.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 179' ' ' THR . 87.4 mt -33.49 -70.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.559 ' HG2' ' CZ3' ' A' ' 177' ' ' TRP . 2.3 ttm -100.03 112.04 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.433 ' HA ' ' HD2' ' A' ' 183' ' ' PRO . 38.0 ttm-85 -112.7 103.34 55.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 182' ' ' ARG . 53.3 Cg_endo -69.8 134.63 28.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 0.0 112.343 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 185' ' ' PHE . 4.9 m-20 -107.02 100.62 10.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 184' ' ' ASP . 4.7 t80 37.17 39.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -146.47 136.66 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.855 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -130.3 173.25 10.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -97.25 126.49 42.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -40.91 125.1 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -47.14 127.37 10.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.4 mt -152.08 176.39 11.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 193' ' ' THR . 39.8 t -49.18 153.08 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 192' ' ' SER . 4.0 t -34.06 117.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 23.9 m -117.19 89.21 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -101.98 33.42 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 200' ' ' VAL . 75.9 mt -83.89 -50.79 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.457 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 61.0 m80 -39.08 -63.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -51.91 -58.08 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.3 m -43.37 -44.16 5.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 196' ' ' ILE . 48.1 t -46.25 -68.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.53 -47.32 93.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -46.32 -48.71 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 204' ' ' PHE . 90.1 m -57.42 -57.87 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.457 ' C ' ' O ' ' A' ' 203' ' ' THR . 10.2 m-85 -33.98 -49.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.839 HG12 HG23 ' A' ' 152' ' ' ILE . 49.9 mt -70.39 -50.67 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -48.5 -45.45 37.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 217' ' ' ILE . 9.4 mm-40 -117.44 36.92 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.572 ' HA ' ' CD2' ' A' ' 211' ' ' PHE . 22.9 t -64.1 -30.74 71.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -75.13 -51.67 12.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -43.82 -37.04 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 208' ' ' CYS . 23.2 m-85 -51.19 -63.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -101.25 -56.7 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -56.26 -38.04 70.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 73.18 42.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.3 169.29 53.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -58.82 136.05 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.429 ' HA ' ' NE2' ' A' ' 207' ' ' GLN . 66.3 mt -61.39 121.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -94.15 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.954 . . . . . . . . 0 0 . 1 stop_ save_